data_5wyo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5wyo _Structure_validation_residue.Date_analyzed 2017-11-17 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.529 0.27 0 N-CA-C 115.807 1.426 . . . . 0.0 115.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -64.33 2.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -126.04 21.32 7.49 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.932 1.693 . . . . 0.0 113.124 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -142.55 -13.22 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -131.26 169.75 15.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.624 1.556 . . . . 0.0 113.835 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.1 p -85.86 166.11 16.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.2 1.4 . . . . 0.0 114.221 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -21.37 2.75 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.87 -35.86 62.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.981 1.264 . . . . 0.0 111.596 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.66 -16.28 64.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.762 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.61 -24.18 45.49 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.799 -1.188 . . . . 0.0 112.129 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.35 -8.67 57.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.872 1.269 . . . . 0.0 113.046 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.39 60.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.084 1.354 . . . . 0.0 112.551 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.73 141.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.939 2.495 . . . . 0.0 110.508 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.35 156.88 36.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.921 0.888 . . . . 0.0 112.743 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.38 -30.67 60.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.109 1.364 . . . . 0.0 111.64 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 m -61.0 -28.32 68.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.156 1.783 . . . . 0.0 113.872 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -127.4 -7.1 5.82 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -56.47 -38.74 71.78 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 119.584 -1.948 . . . . 0.0 114.024 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.84 -27.09 79.96 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.624 2.216 . . . . 0.0 113.272 169.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 55.3 m -79.59 -34.35 40.87 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.712 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.14 92.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.452 . . . . 0.0 113.75 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.09 -36.51 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 119.367 0.985 . . . . 0.0 110.913 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.11 13.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.984 1.278 . . . . 0.0 113.798 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.15 -39.58 93.18 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.249 2.025 . . . . 0.0 112.323 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.0 67.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -102.11 -34.05 9.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.93 0.892 . . . . 0.0 112.714 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -52.44 65.67 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.746 1.619 . . . . 0.0 110.401 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -14.97 63.11 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.837 0.855 . . . . 0.0 111.144 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -14.79 50.13 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.142 -0.974 . . . . 0.0 113.436 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.283 4.6 p30 -123.41 10.67 9.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.83 152.63 0.97 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 130.59 3.556 . . . . 0.0 105.568 168.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.69 -32.33 18.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.222 2.209 . . . . 0.0 113.059 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.5 156.83 79.6 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 127.227 2.211 . . . . 0.0 110.151 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -84.65 8.65 4.51 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.989 1.793 . . . . 0.0 114.84 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.22 -21.33 22.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.393 1.477 . . . . 0.0 114.232 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.52 14.68 20.24 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.285 1.434 . . . . 0.0 113.332 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.97 113.59 24.66 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.262 -1.523 . . . . 0.0 112.106 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.78 11.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 125.647 1.579 . . . . 0.0 111.423 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.49 155.0 0.07 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 129.495 3.118 . . . . 0.0 112.801 -168.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -119.11 62.22 0.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.522 1.529 . . . . 0.0 110.811 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.0 -56.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.641 1.177 . . . . 0.0 113.475 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -63.14 -36.87 85.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.343 0.974 . . . . 0.0 111.5 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.55 -52.51 52.68 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mt -62.72 -42.77 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.45 0.7 . . . . 0.0 111.449 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.06 -34.72 71.47 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.102 -0.999 . . . . 0.0 113.067 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -70.25 -37.11 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.029 1.332 . . . . 0.0 111.848 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.76 -23.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.117 1.367 . . . . 0.0 113.327 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.3 m -45.28 -59.83 3.93 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 125.877 1.671 . . . . 0.0 112.935 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.48 0.85 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.56 -66.43 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.6 1.16 . . . . 0.0 110.603 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -32.2 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.017 -1.052 . . . . 0.0 112.911 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.74 -49.31 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.367 1.067 . . . . 0.0 110.353 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.51 -46.86 36.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.274 0.559 . . . . 0.0 110.892 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.54 68.94 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.1 m -76.34 -17.17 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.29 -30.85 21.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.087 1.312 . . . . 0.0 111.429 169.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -60.63 -38.24 84.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.408 1.083 . . . . 0.0 112.012 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -146.15 86.56 1.71 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.656 0.783 . . . . 0.0 112.425 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -54.07 -33.82 58.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.647 1.179 . . . . 0.0 111.714 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -86.85 -0.07 55.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.339 1.455 . . . . 0.0 113.526 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.36 147.83 43.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.938 0.895 . . . . 0.0 111.384 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.93 155.14 40.81 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.396 1.078 . . . . 0.0 112.312 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -53.32 151.37 5.44 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 112.049 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 tptp 60.44 -32.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 129.039 2.935 . . . . 0.0 116.299 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.87 -28.26 68.73 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.36 1.864 . . . . 0.0 112.259 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -70.77 -44.11 67.39 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.54 -0.725 . . . . 0.0 112.567 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.11 -37.12 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.027 1.285 . . . . 0.0 111.268 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -64.84 -48.44 74.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.65 0.78 . . . . 0.0 111.614 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.9 -39.48 96.55 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.975 1.274 . . . . 0.0 113.242 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -35.33 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.818 1.309 . . . . 0.0 113.013 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -63.35 -38.09 89.8 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.958 -1.089 . . . . 0.0 111.956 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.41 -43.84 98.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.523 1.129 . . . . 0.0 111.782 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -25.02 67.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.83 -1.169 . . . . 0.0 112.86 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mt . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 125.038 1.335 . . . . 0.0 112.523 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 N-CA-C 112.518 0.161 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 23.0 m -49.82 -23.56 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 125.988 1.715 . . . . 0.0 115.292 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -82.49 4.36 24.67 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.618 1.567 . . . . 0.0 113.987 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -142.05 -40.52 0.36 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.453 2.301 . . . . 0.0 112.358 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -50.67 143.36 9.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.724 2.809 . . . . 0.0 112.79 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -109.3 155.45 21.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.16 -24.83 66.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.35 -38.24 79.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.592 -1.317 . . . . 0.0 111.122 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.23 -13.18 53.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.433 1.093 . . . . 0.0 112.95 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -67.47 -28.53 67.94 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.721 -1.237 . . . . 0.0 110.664 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 mt -74.13 -16.78 61.0 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.33 -0.856 . . . . 0.0 113.175 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.79 28.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.296 1.039 . . . . 0.0 113.346 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 p -71.58 140.12 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 109.872 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.81 157.34 30.64 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.847 1.259 . . . . 0.0 113.342 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -58.57 -34.52 71.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.575 1.15 . . . . 0.0 111.748 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.9 m -57.84 -25.66 60.97 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.427 1.891 . . . . 0.0 113.901 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -124.97 0.13 7.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 113.122 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.49 -44.47 97.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 119.809 -1.807 . . . . 0.0 112.416 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -63.49 -20.2 69.29 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.804 2.336 . . . . 0.0 114.393 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 57.2 m -67.8 -37.29 81.8 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.087 -1.008 . . . . 0.0 110.13 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.8 86.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.453 1.501 . . . . 0.0 114.076 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.86 -34.29 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.432 -1.418 . . . . 0.0 110.731 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.9 4.07 8.48 Favored Glycine 0 CA--C 1.545 1.969 0 C-N-CA 125.985 1.755 . . . . 0.0 116.148 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.77 -10.36 9.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.435 1.894 . . . . 0.0 113.547 170.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.72 -70.98 0.7 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.407 1.083 . . . . 0.0 111.571 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -71.24 -20.78 62.2 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.98 -1.075 . . . . 0.0 112.424 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.18 97.63 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.963 1.705 . . . . 0.0 113.833 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -43.91 18.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.653 0.781 . . . . 0.0 109.679 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.36 -24.52 67.4 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -85.77 -10.48 55.45 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -130.08 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 110.933 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -157.07 -54.12 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 127.407 2.283 . . . . 0.0 112.499 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -125.07 164.25 32.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 126.768 2.027 . . . . 0.0 111.639 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.75 9.78 3.04 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.156 2.57 . . . . 0.0 114.055 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.69 -28.4 69.91 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.625 -1.297 . . . . 0.0 113.14 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -106.14 -7.24 18.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.855 1.262 . . . . 0.0 114.035 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.57 145.21 47.56 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 120.848 -1.158 . . . . 0.0 113.403 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.18 25.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.547 1.539 . . . . 0.0 111.277 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 60.47 144.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.671 2.788 . . . . 0.0 112.738 -166.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -87.93 44.44 1.19 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.621 -1.299 . . . . 0.0 110.469 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -47.16 -53.55 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.836 1.655 . . . . 0.0 114.109 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -70.24 -34.04 72.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.689 1.131 . . . . 0.0 111.444 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.68 -48.23 74.87 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.533 0.587 . . . . 0.0 111.856 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.22 -43.57 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.642 1.577 . . . . 0.0 110.73 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.09 -32.64 73.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.108 0.963 . . . . 0.0 112.916 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 43.2 m -68.69 -42.9 77.15 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.558 1.143 . . . . 0.0 111.926 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.1 t -84.16 -26.09 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.91 1.684 . . . . 0.0 113.313 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.5 m -50.65 -64.21 1.44 Allowed Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 125.733 1.613 . . . . 0.0 113.094 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.91 -25.35 77.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.19 1.927 . . . . 0.0 112.685 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.39 -59.12 5.1 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.229 1.012 . . . . 0.0 110.805 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.01 -31.49 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.11 -0.994 . . . . 0.0 112.224 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.83 -51.27 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.937 1.295 . . . . 0.0 110.657 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -68.35 -44.29 75.56 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.397 0.279 . . . . 0.0 110.885 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.8 73.12 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.056 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.49 -14.51 62.14 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -35.91 13.81 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.902 1.228 . . . . 0.0 111.542 167.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -58.03 -42.66 85.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.062 0.945 . . . . 0.0 111.796 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -141.44 69.98 1.34 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 111.32 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -52.37 -34.88 49.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.693 1.997 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -84.59 -1.5 56.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.061 0.944 . . . . 0.0 113.263 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.53 147.82 48.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.637 1.175 . . . . 0.0 112.852 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.47 130.4 41.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.673 1.189 . . . . 0.0 108.406 168.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.4 -42.03 95.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.615 0.766 . . . . 0.0 113.063 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -60.08 -38.39 82.75 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.466 -0.771 . . . . 0.0 112.757 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -69.48 -34.42 74.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.282 0.633 . . . . 0.0 112.093 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -73.14 -38.12 66.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.98 -37.81 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.03 1.287 . . . . 0.0 111.64 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -62.38 -43.64 98.35 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.616 0.766 . . . . 0.0 112.182 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.76 -47.16 91.82 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.545 1.069 . . . . 0.0 113.194 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.32 -33.52 65.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.544 1.172 . . . . 0.0 113.009 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.81 -39.92 90.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.203 1.365 . . . . 0.0 111.998 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.59 -47.38 84.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.514 1.126 . . . . 0.0 112.048 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -27.24 68.73 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.101 -0.999 . . . . 0.0 111.944 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 36.9 mt -76.83 -51.67 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.059 1.744 . . . . 0.0 111.812 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt . . . . . 0 N--CA 1.479 1.001 0 C-N-CA 125.509 1.524 . . . . 0.0 113.294 -170.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 113.53 0.55 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.08 -24.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -76.22 -35.07 59.22 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.348 0.659 . . . . 0.0 112.629 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -103.56 -27.98 12.02 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -91.09 174.71 7.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.041 0.924 . . . . 0.0 113.425 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 p -103.86 165.96 10.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.667 1.587 . . . . 0.0 114.213 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -17.53 48.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 115.211 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.97 -34.71 73.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.774 1.17 . . . . 0.0 111.424 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.08 -28.98 70.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.656 -0.653 . . . . 0.0 112.319 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.61 -21.48 66.72 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.882 -1.136 . . . . 0.0 111.646 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -91.65 -13.42 31.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.418 1.487 . . . . 0.0 113.202 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.02 -31.65 34.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.378 1.071 . . . . 0.0 110.983 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -68.84 132.68 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.68 1.592 . . . . 0.0 109.782 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -68.9 160.67 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.252 1.421 . . . . 0.0 113.111 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.26 -35.92 72.48 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.906 -1.121 . . . . 0.0 112.09 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 m -62.22 -23.86 66.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.004 1.722 . . . . 0.0 113.827 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -125.45 -3.83 7.3 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.801 1.24 . . . . 0.0 113.51 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.17 -41.86 93.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 120.019 -1.676 . . . . 0.0 112.815 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -59.34 -27.35 84.75 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.927 2.418 . . . . 0.0 113.691 168.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.5 m -78.92 -27.9 43.79 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 111.902 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.96 -48.43 74.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 112.811 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.03 -36.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 118.73 0.695 . . . . 0.0 110.466 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.94 -48.17 52.27 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.674 1.13 . . . . 0.0 113.849 170.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.05 -19.0 64.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.864 2.832 . . . . 0.0 113.192 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.93 -53.46 5.29 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.47 -0.769 . . . . 0.0 110.7 165.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.7 -19.73 60.14 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.99 27.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 111.951 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.95 -31.42 18.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.282 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -67.33 -20.57 65.62 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.04 -8.38 21.51 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.26 0.4 OUTLIER -141.41 -129.52 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.187 1.395 . . . . 0.0 113.287 -175.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.87 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.989 1.716 . . . . 0.0 113.759 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -136.41 164.44 42.79 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.763 2.425 . . . . 0.0 110.056 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.34 -5.27 14.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.498 1.466 . . . . 0.0 114.55 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.61 -25.21 68.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.937 1.244 . . . . 0.0 113.747 -168.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.31 -16.55 29.03 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.157 2.183 . . . . 0.0 113.648 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 154.26 33.46 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -169.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.77 1.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 125.133 1.373 . . . . 0.0 113.795 -174.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 62.78 112.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.842 2.857 . . . . 0.0 112.584 -168.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.9 54.07 2.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.899 1.68 . . . . 0.0 112.495 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 0.6 OUTLIER -55.22 -40.82 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 -165.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.73 -35.45 78.1 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 122.746 2.521 . . . . 0.0 112.707 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.02 -22.16 60.03 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 124.755 1.169 . . . . 0.0 113.804 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.74 -50.78 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.433 1.493 . . . . 0.0 111.132 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.18 77.54 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.016 1.326 . . . . 0.0 113.78 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -63.73 -39.24 93.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.391 1.076 . . . . 0.0 111.735 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.45 -19.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.681 1.192 . . . . 0.0 113.314 -172.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.6 m -41.85 -60.0 2.22 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 125.962 1.705 . . . . 0.0 112.368 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.4 1.24 4.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.715 2.943 . . . . 0.0 114.822 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.46 -59.66 1.78 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 0.0 110.485 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -34.99 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.345 0.975 . . . . 0.0 112.118 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.82 -40.9 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.444 0.565 . . . . 0.0 112.326 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -78.26 -47.91 16.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.25 -29.39 70.17 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.096 0.958 . . . . 0.0 113.561 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.37 -11.6 59.86 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.54 -33.95 16.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.304 1.411 . . . . 0.0 110.58 166.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -58.02 -40.11 80.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 111.652 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.51 88.0 1.75 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.757 0.789 . . . . 0.0 111.984 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -55.01 -31.42 61.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.747 1.619 . . . . 0.0 112.489 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -89.53 -2.74 58.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.188 1.395 . . . . 0.0 112.854 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 154.95 40.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.716 0.806 . . . . 0.0 110.548 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -64.58 137.34 57.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.992 0.517 . . . . 0.0 110.349 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.52 -53.1 62.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.907 1.283 . . . . 0.0 111.766 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -65.54 -38.23 89.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.08 0.952 . . . . 0.0 112.245 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.56 -37.36 83.55 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.485 0.714 . . . . 0.0 111.463 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -73.61 -33.68 64.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.85 -47.3 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 118.448 0.567 . . . . 0.0 110.698 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.66 -44.57 95.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.876 0.87 . . . . 0.0 111.825 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.65 -46.13 93.74 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.722 1.153 . . . . 0.0 113.092 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -73.29 -31.99 64.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.695 1.248 . . . . 0.0 113.447 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -61.49 -42.21 98.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.982 1.265 . . . . 0.0 111.714 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.68 -47.99 78.99 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.66 0.784 . . . . 0.0 111.476 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.413 -1.429 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.1 mt . . . . . 0 CA--C 1.538 0.519 0 C-N-CA 123.84 0.856 . . . . 0.0 112.038 178.201 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.542 0.908 0 N-CA-C 109.832 -0.872 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -48.3 -30.01 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -87.69 -7.75 56.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m -132.13 28.83 4.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.041 2.536 . . . . 0.0 111.084 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -101.15 141.52 33.92 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.679 1.992 . . . . 0.0 111.299 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 36.7 p -110.33 149.82 29.65 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -19.92 66.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.52 -39.29 61.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 110.986 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.67 -34.86 78.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 112.179 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.47 -30.16 71.33 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.083 -1.011 . . . . 0.0 111.445 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.4 -4.23 58.11 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.558 1.143 . . . . 0.0 113.466 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.99 15.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.113 1.365 . . . . 0.0 111.152 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.57 138.49 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.356 1.862 . . . . 0.0 109.646 169.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.92 158.62 32.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.244 1.018 . . . . 0.0 112.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.88 -35.85 71.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.596 1.158 . . . . 0.0 111.349 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.5 m -61.92 -23.0 66.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.782 1.633 . . . . 0.0 114.029 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.89 -1.46 7.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.294 1.438 . . . . 0.0 112.746 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.57 -43.91 90.13 Favored Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 119.728 -1.858 . . . . 0.0 112.444 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.52 -25.22 75.63 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.035 1.823 . . . . 0.0 113.214 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -72.69 -39.99 66.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.146 0.978 . . . . 0.0 110.159 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -20.07 63.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.975 1.71 . . . . 0.0 115.537 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.8 -39.99 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-N 121.145 1.793 . . . . 0.0 109.612 163.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.79 23.13 0.18 Allowed Glycine 0 CA--C 1.54 1.624 0 C-N-CA 127.907 2.67 . . . . 0.0 117.424 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -126.39 -57.57 1.38 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.362 1.581 . . . . 0.0 111.041 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.59 78.16 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.221 -0.924 . . . . 0.0 111.773 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.38 -38.41 35.01 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.811 -0.556 . . . . 0.0 111.956 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.76 -46.04 69.84 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 113.296 -171.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -33.32 69.02 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.924 -0.485 . . . . 0.0 110.871 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.27 -28.19 66.98 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.12 -3.93 50.16 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -146.11 -122.97 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.361 1.864 . . . . 0.0 111.208 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -160.3 -79.31 0.05 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.625 1.57 . . . . 0.0 112.092 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -123.88 164.2 30.61 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 127.065 2.146 . . . . 0.0 109.262 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.74 1.98 7.48 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 121.283 1.494 . . . . 0.0 114.826 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -55.74 -27.84 52.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.206 1.402 . . . . 0.0 111.481 168.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.75 3.97 23.2 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.816 2.046 . . . . 0.0 113.279 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.94 126.88 35.59 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 119.725 -1.86 . . . . 0.0 113.744 -169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.96 132.52 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.151 2.181 . . . . 0.0 106.471 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.81 116.24 9.96 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.631 1.105 . . . . 0.0 109.787 -174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -86.28 61.44 6.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.06 1.344 . . . . 0.0 110.588 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.315 1.2 p -68.65 -34.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.385 -167.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.13 -39.04 89.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.852 1.66 . . . . 0.0 111.991 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.39 -48.39 79.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.538 0.589 . . . . 0.0 111.677 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.75 -43.21 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.46 1.104 . . . . 0.0 111.702 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.9 -37.8 76.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.288 1.035 . . . . 0.0 112.315 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -62.12 -39.89 94.06 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.453 1.101 . . . . 0.0 112.007 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.0 -26.19 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.41 1.484 . . . . 0.0 113.594 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -44.77 -60.49 2.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 126.603 1.961 . . . . 0.0 113.571 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.52 -19.49 67.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.262 1.975 . . . . 0.0 113.149 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.04 -58.07 4.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.097 0.959 . . . . 0.0 111.274 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -20.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.26 -0.9 . . . . 0.0 113.255 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.8 -52.82 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.614 1.097 . . . . 0.0 110.28 173.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.18 -47.69 34.01 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 122.458 0.303 . . . . 0.0 111.476 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.03 -28.57 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.692 -1.255 . . . . 0.0 113.24 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.01 -16.24 60.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.69 21.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.278 1.399 . . . . 0.0 111.34 168.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.95 -38.87 76.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.772 0.829 . . . . 0.0 112.544 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -146.65 83.5 1.6 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -56.86 -37.83 71.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.933 1.293 . . . . 0.0 111.937 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.9 -6.13 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 113.018 -172.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.88 137.42 58.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.836 0.744 . . . . 0.0 109.219 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -122.59 44.25 2.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.386 -167.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -138.36 143.04 39.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -165.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -67.41 -26.92 66.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.369 1.068 . . . . 0.0 110.381 166.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -64.19 -24.8 67.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.895 1.278 . . . . 0.0 113.216 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.05 -31.62 72.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.046 -1.034 . . . . 0.0 111.98 170.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.43 -47.15 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.719 1.608 . . . . 0.0 110.453 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -65.32 -34.22 77.81 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.292 1.037 . . . . 0.0 113.286 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.42 -34.87 76.89 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.659 1.124 . . . . 0.0 113.69 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -75.69 -32.85 60.29 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.601 1.2 . . . . 0.0 113.187 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.92 -39.47 94.25 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.893 -1.129 . . . . 0.0 111.065 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -61.48 -48.55 80.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 111.756 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -24.15 67.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.984 -1.072 . . . . 0.0 112.289 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 27.9 mt -83.94 -48.09 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.417 1.487 . . . . 0.0 112.373 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.076 1.351 . . . . 0.0 114.014 -169.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.472 0.256 0 CA-C-O 121.405 0.502 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.5 7.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.29 21.84 7.24 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.297 2.239 . . . . 0.0 113.153 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.0 p -116.05 -32.01 5.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -129.26 163.13 26.32 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -73.16 168.02 19.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.204 1.402 . . . . 0.0 113.733 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -27.44 46.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.68 -38.32 74.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.156 0.982 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.02 -12.67 59.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.498 1.519 . . . . 0.0 113.065 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -76.26 -16.73 59.74 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.516 -1.365 . . . . 0.0 111.344 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.37 1.76 47.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.017 1.327 . . . . 0.0 114.145 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.48 56.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 112.27 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.55 136.65 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.752 2.021 . . . . 0.0 110.954 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.42 157.8 25.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.51 1.124 . . . . 0.0 112.457 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -53.47 -31.37 45.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.482 1.513 . . . . 0.0 111.758 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 m -61.74 -29.49 70.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.193 1.797 . . . . 0.0 113.89 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -126.45 -1.51 6.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.792 1.637 . . . . 0.0 112.702 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -53.57 -46.81 98.04 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.91 -1.744 . . . . 0.0 112.365 170.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -67.56 -17.83 48.54 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.415 2.076 . . . . 0.0 112.924 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.6 m -79.76 -36.91 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.218 1.407 . . . . 0.0 110.702 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.59 98.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.526 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.9 -48.41 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.723 0.809 . . . . 0.0 109.288 168.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.04 -52.37 35.8 Favored Glycine 0 C--O 1.213 -1.21 0 C-N-CA 125.214 1.388 . . . . 0.0 113.149 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -68.81 -12.69 61.79 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.649 2.725 . . . . 0.0 114.664 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.38 -50.07 5.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.002 0.819 . . . . 0.0 111.12 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -75.51 -24.1 56.79 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.126 -0.984 . . . . 0.0 113.221 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.35 76.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.404 -1.435 . . . . 0.0 112.003 -176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.8 -33.17 62.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.32 1.048 . . . . 0.0 110.32 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -56.84 -23.19 42.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.978 1.711 . . . . 0.0 113.59 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -91.09 -18.53 24.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -120.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.115 1.325 . . . . 0.0 113.52 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -161.18 -58.88 0.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.532 1.533 . . . . 0.0 113.954 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.03 166.25 27.45 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 128.125 2.57 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.87 14.03 2.32 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.033 1.762 . . . . 0.0 114.804 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.22 -23.71 66.81 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.282 1.433 . . . . 0.0 111.783 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -127.94 26.8 5.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.901 1.68 . . . . 0.0 114.111 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.64 35.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.995 -1.69 . . . . 0.0 112.445 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.04 -16.33 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 66.64 110.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.856 2.462 . . . . 0.0 112.195 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.39 59.83 1.88 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.777 1.231 . . . . 0.0 111.659 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 2.4 p -62.3 -19.61 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.606 -1.309 . . . . 0.0 114.42 -168.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.51 -44.68 56.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 112.169 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.97 -47.71 6.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -58.17 -51.09 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.746 1.218 . . . . 0.0 112.265 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.71 66.69 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -66.61 -49.0 67.74 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.018 1.327 . . . . 0.0 112.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.22 -18.45 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -46.4 -60.7 3.34 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.634 1.174 . . . . 0.0 112.807 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.93 -4.18 12.94 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.295 2.663 . . . . 0.0 114.113 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -62.72 1.43 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.363 1.465 . . . . 0.0 111.158 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -30.85 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.951 -1.093 . . . . 0.0 113.175 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.46 -41.09 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.099 0.863 . . . . 0.0 112.66 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.72 -44.34 28.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.084 0.953 . . . . 0.0 110.789 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.18 93.35 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.429 -0.794 . . . . 0.0 112.402 -171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.69 -7.15 56.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -34.52 16.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.115 1.325 . . . . 0.0 111.565 169.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -78.83 -32.98 46.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -117.09 49.18 1.21 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.665 1.586 . . . . 0.0 112.06 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -48.93 -36.79 18.18 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.743 -1.223 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -87.92 -2.86 58.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.664 1.186 . . . . 0.0 113.624 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.05 157.51 35.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.004 0.922 . . . . 0.0 111.352 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -76.68 161.39 28.57 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.505 1.145 . . . . 0.0 113.759 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -48.28 153.09 0.76 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.788 2.435 . . . . 0.0 114.132 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp 60.29 -34.63 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 130.031 3.332 . . . . 0.0 117.253 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -30.57 70.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.971 1.709 . . . . 0.0 111.995 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -74.1 -35.49 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.8 -46.15 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.086 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -63.76 -43.38 96.6 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.354 1.062 . . . . 0.0 112.113 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.24 98.5 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.931 1.729 . . . . 0.0 113.771 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -73.5 -33.57 64.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.565 1.682 . . . . 0.0 113.13 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -62.85 -39.28 93.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.364 -1.46 . . . . 0.0 111.157 171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.04 -46.64 83.5 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.547 1.139 . . . . 0.0 112.106 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -31.8 72.32 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.057 -1.027 . . . . 0.0 112.08 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.2 mt . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 111.304 -177.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.537 0.63 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 m -47.56 -29.71 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.276 2.23 . . . . 0.0 114.996 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -93.99 -9.33 37.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 58.0 p -116.15 -32.57 5.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.74 1.154 . . . . 0.0 113.757 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -93.7 163.56 13.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.207 1.003 . . . . 0.0 113.549 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.0 p -99.73 155.78 17.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.298 1.439 . . . . 0.0 114.275 -169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -20.4 18.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.238 1.815 . . . . 0.0 115.275 -174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.96 -40.65 89.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.03 1.286 . . . . 0.0 111.679 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -78.1 -12.36 59.98 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.938 0.895 . . . . 0.0 112.146 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -94.13 -17.29 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.774 -1.204 . . . . 0.0 112.986 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.07 -17.42 57.02 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.939 -1.101 . . . . 0.0 113.254 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.3 50.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.687 1.195 . . . . 0.0 113.905 -171.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.71 139.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.024 1.73 . . . . 0.0 111.113 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.61 158.68 29.29 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.638 1.575 . . . . 0.0 113.744 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.16 -33.27 70.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.852 1.261 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.5 m -59.43 -26.75 65.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.087 1.755 . . . . 0.0 113.656 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.51 -0.93 8.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.607 1.563 . . . . 0.0 112.523 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.44 -46.38 99.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 120.009 -1.682 . . . . 0.0 112.805 172.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -64.96 -25.4 59.53 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.353 2.035 . . . . 0.0 112.848 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 58.0 m -70.12 -38.43 75.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.039 0.936 . . . . 0.0 110.345 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.05 92.54 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.35 -35.62 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.739 1.154 . . . . 0.0 110.76 170.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.31 -42.03 88.13 Favored Glycine 0 C--O 1.217 -0.915 0 C-N-CA 124.764 1.173 . . . . 0.0 113.687 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -44.4 71.16 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.147 1.973 . . . . 0.0 111.51 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.84 82.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.76 -39.14 73.41 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.012 -1.055 . . . . 0.0 113.557 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.62 87.68 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.021 -1.049 . . . . 0.0 111.386 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.53 -38.81 33.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.578 0.751 . . . . 0.0 111.056 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.0 -31.39 72.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.076 0.95 . . . . 0.0 113.198 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.77 -16.84 49.73 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.16 -124.14 0.03 OUTLIER 'General case' 0 C--N 1.35 0.629 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -163.66 -45.68 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.494 1.518 . . . . 0.0 114.205 -167.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.04 161.99 56.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 127.298 2.239 . . . . 0.0 110.158 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.9 5.55 6.2 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.764 1.643 . . . . 0.0 113.909 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -56.51 -29.74 62.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.377 1.471 . . . . 0.0 111.86 169.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -111.94 15.12 20.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.198 1.799 . . . . 0.0 112.964 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.72 120.96 24.12 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 119.408 -2.057 . . . . 0.0 111.999 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.34 128.81 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.791 1.636 . . . . 0.0 106.917 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.1 116.75 16.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.626 0.648 . . . . 0.0 110.488 -169.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.07 48.98 1.73 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.27 1.828 . . . . 0.0 111.43 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.351 1.7 p -62.8 -32.73 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -166.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -59.82 -50.56 73.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.626 1.557 . . . . 0.0 110.027 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.79 -39.51 55.0 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.797 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -58.37 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.488 1.115 . . . . 0.0 110.979 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.06 75.66 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.83 1.195 . . . . 0.0 112.526 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 53.3 m -62.39 -43.38 98.95 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.383 1.073 . . . . 0.0 111.872 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 35.0 t -83.69 -30.43 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.494 1.518 . . . . 0.0 113.082 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.5 m -37.04 -61.93 0.62 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 127.132 2.173 . . . . 0.0 114.245 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.21 -22.7 60.72 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.059 1.839 . . . . 0.0 113.026 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.95 -60.53 2.56 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.286 1.035 . . . . 0.0 110.689 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.428 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -70.5 -25.6 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 178.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -52.15 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.12 0.873 . . . . 0.0 110.654 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.35 -43.44 60.71 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.655 0.382 . . . . 0.0 111.287 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.73 -29.13 69.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.749 -1.219 . . . . 0.0 112.852 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 34.4 m -69.75 -13.93 62.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 169.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.23 -38.43 13.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.652 1.569 . . . . 0.0 110.872 166.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -59.81 -38.77 82.9 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.959 0.904 . . . . 0.0 112.396 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.54 75.41 1.46 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 122.359 1.076 . . . . 0.0 111.246 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -52.26 -27.21 14.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.042 1.737 . . . . 0.0 112.357 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.94 -2.63 55.63 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.383 1.473 . . . . 0.0 113.516 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.59 152.13 36.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.51 1.124 . . . . 0.0 111.702 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -70.19 136.27 49.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.313 1.445 . . . . 0.0 111.099 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.19 -43.65 81.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -60.47 -41.34 93.96 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.217 1.371 . . . . 0.0 110.705 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.03 -36.81 84.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.343 0.657 . . . . 0.0 112.311 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -70.9 -39.31 72.84 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.92 -46.17 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 119.65 1.114 . . . . 0.0 109.968 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -65.33 -46.52 79.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.864 0.866 . . . . 0.0 112.359 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.15 99.24 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.832 1.206 . . . . 0.0 113.394 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -71.83 -34.32 69.22 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.702 1.251 . . . . 0.0 112.307 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -61.35 -39.92 92.36 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.66 -1.275 . . . . 0.0 111.725 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.81 -47.74 79.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.425 0.69 . . . . 0.0 111.394 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.52 68.95 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.393 -1.442 . . . . 0.0 111.849 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.8 mt -73.9 -47.6 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.908 1.683 . . . . 0.0 112.785 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 124.85 1.26 . . . . 0.0 113.321 -172.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.528 0.222 0 N-CA-C 114.667 0.987 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.82 -14.98 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.37 1.468 . . . . 0.0 113.802 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -85.97 -10.73 54.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.866 2.066 . . . . 0.0 113.502 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -133.38 -25.8 1.7 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.67 151.83 46.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.175 0.898 . . . . 0.0 111.76 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -97.35 165.17 12.15 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.883 1.325 . . . . 0.0 113.05 -172.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 m -62.1 -21.97 65.42 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.48 -44.75 95.63 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.711 170.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -63.87 -25.84 68.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.397 -0.815 . . . . 0.0 112.167 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.24 -16.39 63.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.945 -1.097 . . . . 0.0 112.664 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.5 mt -87.19 -9.51 55.0 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.021 -1.049 . . . . 0.0 112.378 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -26.75 13.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.099 1.76 . . . . 0.0 113.404 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.02 -4.31 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t70 64.8 155.12 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 129.076 2.951 . . . . 0.0 116.319 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.06 -34.5 63.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.128 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 m -67.73 -25.04 65.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -127.32 3.3 6.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.583 1.153 . . . . 0.0 112.014 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -57.3 -52.3 75.28 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.311 -1.493 . . . . 0.0 110.449 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -67.66 -12.15 34.57 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.417 2.078 . . . . 0.0 114.39 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.6 m -73.27 -32.71 64.84 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.795 -1.191 . . . . 0.0 110.678 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.26 85.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.387 1.075 . . . . 0.0 112.145 169.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.91 -45.18 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.353 1.061 . . . . 0.0 109.001 170.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.45 6.03 0.38 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.54 2.019 . . . . 0.0 116.78 169.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -121.68 -61.36 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.999 1.72 . . . . 0.0 110.078 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.41 -30.4 70.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.26 -32.56 13.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.683 0.674 . . . . 0.0 112.392 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.05 -46.29 88.22 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -12.43 60.13 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.05 0.94 . . . . 0.0 111.939 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -85.81 -21.92 27.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.66 1.184 . . . . 0.0 113.028 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -95.89 -16.28 21.89 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.863 0.865 . . . . 0.0 113.225 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -170.59 153.33 4.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.971 2.908 . . . . 0.0 106.835 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -84.26 -41.74 16.59 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 111.556 -2.565 . . . . 0.0 112.718 -173.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -131.56 159.59 71.14 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 127.071 2.148 . . . . 0.0 110.057 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -90.23 12.04 2.59 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.3 2.0 . . . . 0.0 114.432 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.07 -23.71 65.68 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.241 1.016 . . . . 0.0 112.651 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.77 -15.84 24.77 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.333 1.853 . . . . 0.0 113.787 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.21 127.09 32.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.51 18.38 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 125.586 1.555 . . . . 0.0 111.336 169.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 57.21 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.833 2.853 . . . . 0.0 110.739 -168.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.38 62.37 6.03 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.876 -1.765 . . . . 0.0 110.973 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p -72.42 -24.14 21.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -167.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -58.1 -45.12 87.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.589 1.541 . . . . 0.0 111.455 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.05 -45.2 88.98 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.947 -0.47 . . . . 0.0 112.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.68 -44.86 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.775 1.23 . . . . 0.0 111.657 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.94 63.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 112.742 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.8 m -67.44 -45.55 75.71 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.667 1.187 . . . . 0.0 111.244 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -27.03 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -172.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.8 m -49.48 -62.44 2.47 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.201 1.4 . . . . 0.0 112.831 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -8.29 22.56 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.071 2.514 . . . . 0.0 113.578 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.67 -57.18 3.8 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.312 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.79 -29.8 30.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 C-N-CA 124.084 0.954 . . . . 0.0 112.135 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.55 -53.12 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.574 1.079 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.51 -40.83 80.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.952 0.405 . . . . 0.0 110.609 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.43 97.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.8 m -74.39 -14.67 60.89 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.39 -36.17 24.51 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.11 1.323 . . . . 0.0 111.494 171.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -81.33 -27.15 35.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -125.98 50.14 1.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.436 1.894 . . . . 0.0 112.532 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -51.36 -38.16 51.78 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.703 1.601 . . . . 0.0 113.158 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -81.91 -6.42 59.09 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.29 163.78 20.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.51 1.124 . . . . 0.0 113.019 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -67.0 140.12 57.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.505 1.522 . . . . 0.0 110.755 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.32 -41.02 92.65 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -65.41 -33.56 76.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.01 -1.056 . . . . 0.0 112.38 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.54 -42.24 91.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.465 1.106 . . . . 0.0 111.668 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -41.25 95.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.33 -48.72 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.104 0.411 . . . . 0.0 110.474 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -63.46 -45.79 89.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.69 92.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.701 1.144 . . . . 0.0 113.176 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.05 -34.82 61.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.513 1.156 . . . . 0.0 112.527 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -59.8 -40.26 87.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.545 1.52 . . . . 0.0 111.78 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.43 -46.49 88.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.179 0.992 . . . . 0.0 111.844 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -28.07 69.33 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.904 -1.123 . . . . 0.0 111.92 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.2 mt . . . . . 0 CA--C 1.541 0.633 0 C-N-CA 124.831 1.253 . . . . 0.0 111.956 -179.153 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 CA--C 1.542 0.878 0 N-CA-C 118.773 2.567 . . . . 0.0 118.773 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.01 -19.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.062 1.745 . . . . 0.0 114.82 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -98.92 -2.13 38.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.806 1.242 . . . . 0.0 114.018 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 78.0 p -134.81 -6.14 2.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -177.24 4.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.804 1.242 . . . . 0.0 113.734 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 82.2 p -97.76 166.39 11.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -16.39 6.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.76 -34.41 71.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.086 1.312 . . . . 0.0 111.41 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.56 -27.05 67.37 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.246 -0.909 . . . . 0.0 112.805 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -71.77 -15.71 62.18 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.407 -0.808 . . . . 0.0 112.346 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 mt -95.76 -19.42 19.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.525 1.13 . . . . 0.0 113.22 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.51 65.17 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.206 1.002 . . . . 0.0 112.576 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.22 140.38 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.179 2.192 . . . . 0.0 111.758 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.87 158.99 34.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.807 1.243 . . . . 0.0 113.228 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.9 -32.02 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.679 1.591 . . . . 0.0 111.876 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.2 m -59.13 -28.24 66.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.851 1.661 . . . . 0.0 113.815 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -128.06 -2.89 5.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.29 1.436 . . . . 0.0 113.443 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -58.16 -40.82 86.0 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 119.619 -1.926 . . . . 0.0 113.475 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -60.54 -26.53 83.04 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.66 2.24 . . . . 0.0 113.241 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 42.6 m -77.41 -33.88 54.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.714 1.206 . . . . 0.0 111.483 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.62 80.95 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.733 1.213 . . . . 0.0 113.079 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.02 -34.33 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 111.171 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.64 -58.42 10.22 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.537 1.065 . . . . 0.0 112.655 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.32 -37.08 76.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.233 2.017 . . . . 0.0 112.677 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.74 -29.2 67.56 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -111.83 -33.3 6.35 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.465 1.906 . . . . 0.0 112.705 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -42.2 28.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 110.21 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.03 -32.35 73.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -168.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.35 -7.06 58.77 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.14 -45.41 0.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.33 1.3 p30 56.04 140.22 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.855 2.462 . . . . 0.0 115.94 -166.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 42.9 mttp 63.79 140.9 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.758 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.75 0.09 5.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.629 1.553 . . . . 0.0 114.524 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.27 -16.48 63.6 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.038 1.29 . . . . 0.0 113.657 -170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -123.56 5.01 8.94 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.734 1.614 . . . . 0.0 113.863 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.51 141.32 44.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.469 -1.394 . . . . 0.0 113.741 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.94 132.71 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.58 1.952 . . . . 0.0 107.708 170.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.61 127.35 32.7 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.91 43.72 1.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.939 -1.1 . . . . 0.0 113.623 -166.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.261 14.3 p -64.69 -21.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.528 -1.358 . . . . 0.0 112.775 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -54.91 -30.46 58.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.654 1.581 . . . . 0.0 113.125 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.28 -56.27 1.49 Allowed Glycine 0 N--CA 1.465 0.583 0 C-N-CA 123.507 0.575 . . . . 0.0 112.368 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -54.36 -45.56 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 121.606 -0.938 . . . . 0.0 113.074 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.87 66.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.682 1.128 . . . . 0.0 113.071 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -71.28 -44.56 65.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.946 1.298 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -89.04 -18.32 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.3 m -41.36 -59.95 2.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.455 1.502 . . . . 0.0 113.431 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.47 -16.9 54.98 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.136 2.558 . . . . 0.0 114.121 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.26 -58.25 3.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.354 1.062 . . . . 0.0 111.612 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -37.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.189 -0.944 . . . . 0.0 112.558 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.28 -42.73 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.923 0.489 . . . . 0.0 112.069 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.54 -45.25 46.82 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.74 0.816 . . . . 0.0 110.903 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.31 71.92 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.461 -1.4 . . . . 0.0 113.43 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 10.9 m -74.82 -11.52 60.17 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.74 -34.54 16.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.49 1.496 . . . . 0.0 111.057 167.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -58.26 -38.76 77.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.699 1.2 . . . . 0.0 111.95 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -143.8 83.07 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.41 0.684 . . . . 0.0 111.871 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -55.81 -25.9 43.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.972 1.309 . . . . 0.0 112.946 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -95.13 3.98 54.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.096 1.758 . . . . 0.0 113.269 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.09 149.72 31.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.091 1.356 . . . . 0.0 113.397 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.65 86.92 6.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.58 1.152 . . . . 0.0 113.011 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . 0.258 1.4 p90 44.43 -117.95 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -21.31 64.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.23 1.412 . . . . 0.0 113.462 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.66 -31.65 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.943 0.897 . . . . 0.0 112.267 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -74.73 -42.55 58.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.3 -35.12 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.874 1.216 . . . . 0.0 111.586 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.59 -48.14 76.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.915 0.886 . . . . 0.0 111.843 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.53 -41.42 98.71 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.121 0.867 . . . . 0.0 113.178 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.25 -29.11 63.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.381 1.091 . . . . 0.0 113.161 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -66.13 -43.16 87.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.38 0.991 . . . . 0.0 111.532 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.84 -43.9 97.92 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.684 0.793 . . . . 0.0 111.183 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.3 -40.61 5.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.931 1.693 . . . . 0.0 113.307 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 mt -85.98 -38.82 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.905 0.882 . . . . 0.0 112.421 -171.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -177.512 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 CA--C 1.529 0.272 0 N-CA-C 111.15 -0.366 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.15 -18.51 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -82.49 -19.52 38.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.177 1.391 . . . . 0.0 113.951 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.3 m -141.39 44.8 1.75 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.156 2.182 . . . . 0.0 110.73 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -129.86 139.72 51.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.275 1.83 . . . . 0.0 109.912 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.5 p -102.65 161.43 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.972 1.367 . . . . 0.0 114.159 -168.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 m -77.03 -21.43 54.58 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.83 -42.27 79.34 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.305 0.957 . . . . 0.0 110.648 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.76 -28.75 60.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.092 0.957 . . . . 0.0 112.209 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -66.15 -33.97 76.98 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.658 -1.276 . . . . 0.0 111.262 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.33 -10.52 59.66 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.93 -29.4 27.14 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.248 1.019 . . . . 0.0 112.551 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.85 137.47 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.047 1.739 . . . . 0.0 110.069 170.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.43 157.4 34.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.764 0.826 . . . . 0.0 113.02 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -55.96 -28.93 59.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 111.724 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.7 m -62.78 -27.17 69.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.043 1.737 . . . . 0.0 114.243 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.7 -10.58 5.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.63 1.172 . . . . 0.0 113.511 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.83 -40.45 85.12 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 119.641 -1.912 . . . . 0.0 112.522 169.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -65.53 -24.15 56.61 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.771 2.314 . . . . 0.0 113.435 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.6 m -73.35 -36.53 66.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 110.243 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.54 85.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.647 1.179 . . . . 0.0 113.898 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.84 -35.28 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 119.203 0.911 . . . . 0.0 110.684 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.17 -43.51 74.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.878 1.228 . . . . 0.0 114.448 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -68.29 -49.06 63.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.986 2.393 . . . . 0.0 112.536 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.82 -29.96 71.12 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.147 0.579 . . . . 0.0 112.186 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.55 -45.46 10.44 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.21 90.94 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.679 -1.263 . . . . 0.0 111.308 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.47 62.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.426 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -74.18 -18.96 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.053 0.842 . . . . 0.0 113.221 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.3 -28.59 42.21 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.39 -0.818 . . . . 0.0 112.868 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -154.69 -128.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.48 1.512 . . . . 0.0 112.55 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.9 -39.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.578 2.351 . . . . 0.0 114.261 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -134.2 162.09 59.81 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 127.175 2.19 . . . . 0.0 110.363 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -94.84 9.72 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.939 1.759 . . . . 0.0 114.647 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.91 -18.26 63.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.153 -0.967 . . . . 0.0 112.936 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -112.39 -2.35 14.79 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.133 1.773 . . . . 0.0 113.971 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.55 55.44 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.43 145.07 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.467 1.907 . . . . 0.0 107.339 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.2 137.24 36.64 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 119.233 0.924 . . . . 0.0 113.11 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -94.27 47.66 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.498 -1.376 . . . . 0.0 113.749 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 1.7 p -63.29 -50.28 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -165.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -60.22 -35.19 74.87 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.647 2.021 . . . . 0.0 111.854 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.77 -41.83 88.03 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 121.276 0.376 . . . . 0.0 112.54 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.4 mt -65.7 -45.84 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.422 1.489 . . . . 0.0 111.444 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.05 -25.69 65.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.064 1.346 . . . . 0.0 112.973 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 m -63.92 -46.45 84.71 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.927 1.291 . . . . 0.0 110.98 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.15 -19.12 7.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -47.02 -60.94 3.24 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 125.284 1.433 . . . . 0.0 112.156 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.83 1.32 5.26 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.726 2.951 . . . . 0.0 114.334 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 -55.68 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.065 1.746 . . . . 0.0 110.938 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.07 -32.15 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.017 1.327 . . . . 0.0 111.463 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.11 -45.49 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.774 0.83 . . . . 0.0 112.097 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -67.88 -46.19 72.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.836 0.455 . . . . 0.0 110.181 175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.13 -31.61 69.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.79 0.836 . . . . 0.0 112.632 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.05 -20.28 61.01 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -30.17 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.434 1.015 . . . . 0.0 111.951 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.26 -39.09 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.366 1.067 . . . . 0.0 112.119 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -145.96 82.57 1.62 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 112.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -51.77 -35.53 44.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.878 1.271 . . . . 0.0 112.036 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.75 8.36 34.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.573 1.949 . . . . 0.0 114.595 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.38 45.12 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t30 60.42 20.18 9.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -155.13 150.55 27.26 Favored 'General case' 0 N--CA 1.486 1.363 1 N-CA-C 122.662 4.319 . . . . 0.0 122.662 -170.658 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -60.21 -25.15 65.38 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 113.749 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.79 -24.15 55.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.518 0.599 . . . . 0.0 111.568 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -64.35 -34.12 77.43 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.398 1.079 . . . . 0.0 113.805 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.78 -37.73 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.886 1.221 . . . . 0.0 112.149 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -79.88 -31.9 40.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.37 -33.59 81.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.665 1.126 . . . . 0.0 113.475 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.38 -32.92 55.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.722 1.261 . . . . 0.0 113.325 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -59.91 -41.44 91.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.591 1.087 . . . . 0.0 110.683 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.23 -51.04 70.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.923 0.889 . . . . 0.0 110.967 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -28.81 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 112.451 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 112.535 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 120.536 0.14 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.0 -15.66 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -85.01 -10.74 56.69 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.182 1.393 . . . . 0.0 114.129 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 48.1 m -144.72 49.37 1.3 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.388 2.275 . . . . 0.0 110.477 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -141.29 139.91 33.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.498 1.519 . . . . 0.0 110.435 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 39.6 p -98.76 150.0 22.28 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.65 -26.67 65.72 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.09 -39.28 85.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.978 -1.076 . . . . 0.0 111.418 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.16 -17.41 46.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.75 -29.03 66.28 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.794 -1.192 . . . . 0.0 110.353 168.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mp -73.79 -13.77 61.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.954 -1.091 . . . . 0.0 113.478 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.36 -33.45 25.83 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.486 1.039 . . . . 0.0 113.523 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.31 140.23 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.943 1.297 . . . . 0.0 110.597 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -67.13 158.78 30.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.868 1.267 . . . . 0.0 113.347 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.47 -32.69 71.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.44 1.096 . . . . 0.0 112.03 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.4 m -62.4 -23.44 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.909 1.684 . . . . 0.0 113.924 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -124.78 -5.96 7.45 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.765 1.226 . . . . 0.0 113.206 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -57.0 -46.78 99.84 Favored Pre-proline 0 CA--C 1.549 0.909 0 O-C-N 120.272 -1.517 . . . . 0.0 111.699 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -65.65 -18.31 58.57 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.097 2.531 . . . . 0.0 114.366 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 25.6 m -77.13 -38.02 52.92 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.818 1.247 . . . . 0.0 110.464 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.26 99.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.262 1.025 . . . . 0.0 112.476 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.56 -45.71 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.78 . . . . 0.0 109.094 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.5 -57.57 10.32 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 125.645 1.593 . . . . 0.0 113.464 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.62 -12.32 60.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.485 2.642 . . . . 0.0 113.905 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.54 -31.35 13.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.841 1.2 . . . . 0.0 113.627 169.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -88.59 -45.69 9.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.215 1.006 . . . . 0.0 112.343 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.61 84.09 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.791 2.436 . . . . 0.0 113.474 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -18.27 39.25 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.49 1.116 . . . . 0.0 111.865 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -84.69 -35.78 22.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 112.563 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.27 -6.82 54.73 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -146.67 -140.23 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.139 2.576 . . . . 0.0 107.621 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -153.68 -65.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -127.71 160.92 58.33 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 126.966 2.106 . . . . 0.0 110.031 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -82.09 0.24 9.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.16 1.45 . . . . 0.0 114.475 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -60.62 -19.46 57.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 113.456 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -131.79 7.89 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.011 1.324 . . . . 0.0 113.774 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.78 138.81 40.12 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.378 -1.451 . . . . 0.0 114.502 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.86 143.28 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.01 2.124 . . . . 0.0 107.087 168.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.15 133.39 44.07 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.415 1.007 . . . . 0.0 108.983 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -94.35 38.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.834 -1.166 . . . . 0.0 112.684 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 13.1 p -66.66 -21.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.809 -1.807 . . . . 0.0 112.845 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -55.2 -29.84 58.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.684 1.593 . . . . 0.0 112.915 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -94.47 -53.51 1.69 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.612 0.625 . . . . 0.0 112.567 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.24 -42.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.181 0.992 . . . . 0.0 113.357 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.99 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.143 1.338 . . . . 0.0 112.945 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 16.6 m -73.19 -37.73 66.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.556 1.142 . . . . 0.0 111.844 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.42 -27.74 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.074 1.75 . . . . 0.0 113.408 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 26.4 m -53.17 -59.69 8.57 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.323 1.449 . . . . 0.0 112.917 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.32 -15.12 46.29 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.298 2.665 . . . . 0.0 113.52 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.89 -62.51 1.47 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.115 0.966 . . . . 0.0 111.052 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 33.1 mt -69.74 -30.99 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.38 -0.825 . . . . 0.0 112.822 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.38 -44.02 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.01 -1.056 . . . . 0.0 112.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -71.73 -46.08 59.71 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 110.807 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -27.05 67.72 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.577 -1.327 . . . . 0.0 113.309 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 m -75.1 -14.72 60.6 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.06 -36.02 21.47 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.595 1.543 . . . . 0.0 110.562 167.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -59.8 -38.62 82.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.038 0.935 . . . . 0.0 112.464 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -135.71 61.69 1.65 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.931 1.292 . . . . 0.0 112.022 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -49.16 -38.02 24.21 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.994 1.317 . . . . 0.0 112.877 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.51 -2.53 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.407 1.083 . . . . 0.0 113.825 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.68 158.42 24.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 112.638 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -80.44 137.38 36.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.388 1.475 . . . . 0.0 111.274 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.64 -44.14 91.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.367 1.067 . . . . 0.0 113.364 -170.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.79 -41.94 78.6 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.315 0.961 . . . . 0.0 112.111 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.25 -36.71 83.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.876 0.471 . . . . 0.0 112.059 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -74.62 -37.65 62.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.34 -38.73 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.099 1.318 . . . . 0.0 111.466 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.07 -45.53 93.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.291 0.636 . . . . 0.0 111.609 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.98 -49.07 69.03 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.763 1.173 . . . . 0.0 113.613 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.75 -34.34 66.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.634 1.217 . . . . 0.0 112.939 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -61.74 -37.14 83.12 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.193 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.26 -43.36 95.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.651 0.781 . . . . 0.0 111.825 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -23.13 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.728 -1.232 . . . . 0.0 112.331 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.84 -45.8 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.565 1.946 . . . . 0.0 112.528 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt . . . . . 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 0.0 113.8 -175.436 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 CA--C 1.534 0.488 0 N-CA-C 113.812 0.659 . . . . 0.0 113.812 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.37 1.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.22 2.208 . . . . 0.0 116.869 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.7 9.73 7.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.226 1.41 . . . . 0.0 113.576 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -132.86 -40.84 0.94 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.742 1.217 . . . . 0.0 113.904 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -83.89 158.7 21.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.596 0.713 . . . . 0.0 112.601 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -85.0 151.15 24.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -23.93 25.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.391 1.876 . . . . 0.0 114.127 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.34 -36.13 68.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.545 1.066 . . . . 0.0 111.378 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.73 -21.66 60.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.884 0.874 . . . . 0.0 113.071 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -66.64 -24.2 66.27 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -80.32 -14.79 58.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.266 1.426 . . . . 0.0 113.146 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.71 -29.87 40.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.941 . . . . 0.0 112.248 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.37 138.16 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.591 1.956 . . . . 0.0 110.118 172.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.2 157.74 30.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.728 0.811 . . . . 0.0 112.713 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -56.06 -30.92 62.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.228 1.411 . . . . 0.0 111.577 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.6 m -62.48 -27.67 69.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.229 1.812 . . . . 0.0 113.984 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -127.45 -9.35 5.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.745 1.218 . . . . 0.0 113.896 -170.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -55.2 -40.98 88.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 119.543 -1.973 . . . . 0.0 112.034 168.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -62.74 -24.18 74.63 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.305 2.67 . . . . 0.0 113.848 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.9 m -78.73 -33.53 46.6 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.418 1.087 . . . . 0.0 110.455 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.87 91.53 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.0 -36.08 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.048 0.84 . . . . 0.0 110.974 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.58 56.92 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.437 1.017 . . . . 0.0 114.489 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -11.44 60.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.568 2.184 . . . . 0.0 113.788 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.99 -48.25 7.91 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.092 166.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.32 -33.36 55.56 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 113.691 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.03 94.22 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.937 1.295 . . . . 0.0 112.159 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.95 -40.51 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.65 1.18 . . . . 0.0 110.595 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.28 -20.84 65.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.984 0.914 . . . . 0.0 113.433 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -84.21 -19.88 33.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -153.53 -124.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.251 . . . . 0.0 112.761 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -162.91 -64.13 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.071 2.148 . . . . 0.0 111.913 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -113.62 160.57 31.28 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.539 2.336 . . . . 0.0 111.196 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.41 2.59 8.29 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 114.578 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -59.17 -26.48 64.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.663 1.185 . . . . 0.0 112.768 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -118.7 25.69 10.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.01 1.724 . . . . 0.0 112.211 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.7 118.35 29.24 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.499 -1.376 . . . . 0.0 112.165 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.89 127.99 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.58 122.6 16.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.648 1.113 . . . . 0.0 110.153 -169.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -89.69 46.71 1.39 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.161 -0.962 . . . . 0.0 113.015 -168.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.369 2.5 p -63.7 -15.06 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 O-C-N 120.645 -1.285 . . . . 0.0 112.43 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.78 -44.67 70.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.695 1.598 . . . . 0.0 112.185 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.66 4.98 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -50.17 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.825 . . . . 0.0 112.702 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.39 67.14 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.501 1.046 . . . . 0.0 112.453 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 m -66.19 -48.8 69.48 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.129 1.372 . . . . 0.0 112.218 171.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.2 m -87.04 -18.47 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -46.92 -63.1 1.51 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.107 1.363 . . . . 0.0 112.037 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -69.44 0.39 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.614 2.876 . . . . 0.0 114.57 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.52 -57.2 2.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.178 1.791 . . . . 0.0 110.029 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mt -68.83 -32.2 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.828 1.251 . . . . 0.0 112.369 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.79 -42.16 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.958 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -72.99 -46.9 49.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.456 0.646 . . . . 0.0 110.017 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.43 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.305 -0.872 . . . . 0.0 113.06 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.7 m -74.17 -14.26 60.93 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -34.99 16.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.36 1.436 . . . . 0.0 111.53 168.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -60.84 -38.0 83.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.16 . . . . 0.0 111.904 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -138.72 56.64 1.7 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.541 1.536 . . . . 0.0 112.318 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -49.97 -33.98 19.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.852 2.061 . . . . 0.0 113.121 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.6 -1.9 58.16 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.55 144.36 44.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.042 0.837 . . . . 0.0 111.827 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.76 29.37 0.2 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.287 1.835 . . . . 0.0 114.411 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 t80 52.01 -171.25 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.704 2.002 . . . . 0.0 112.814 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 tttt 62.26 -44.32 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 129.657 3.183 . . . . 0.0 115.288 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.77 -35.73 64.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.494 1.918 . . . . 0.0 111.671 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -43.59 79.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.673 0.789 . . . . 0.0 112.9 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.38 -37.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.003 0.819 . . . . 0.0 111.405 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -69.37 -48.79 60.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.242 1.017 . . . . 0.0 111.968 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.96 94.64 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.147 1.356 . . . . 0.0 113.845 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.21 -34.17 63.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.202 1.501 . . . . 0.0 112.637 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.5 -41.62 94.66 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.565 1.075 . . . . 0.0 111.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.97 -48.17 83.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.25 1.02 . . . . 0.0 111.393 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -28.88 70.14 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.427 -1.421 . . . . 0.0 112.346 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.2 mt . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.956 1.303 . . . . 0.0 112.707 -178.039 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 CA--C 1.537 0.641 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 m -55.71 -25.38 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.22 -27.68 60.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.552 1.141 . . . . 0.0 113.097 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m -119.04 -19.28 8.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -169.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.24 160.76 29.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.142 0.883 . . . . 0.0 111.878 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 53.4 p -95.73 168.42 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.708 1.242 . . . . 0.0 113.871 -169.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.46 -26.7 67.32 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.293 -0.88 . . . . 0.0 112.119 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -62.74 -42.12 99.51 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.421 168.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.4 -30.4 71.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.375 0.67 . . . . 0.0 112.087 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.417 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 66.0 t80 -69.17 -23.74 63.98 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.035 -1.041 . . . . 0.0 111.636 173.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.04 -8.96 56.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.417 1.087 . . . . 0.0 113.359 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.08 -34.99 43.13 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.187 0.995 . . . . 0.0 112.699 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.05 139.12 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.614 1.566 . . . . 0.0 110.187 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.4 158.87 32.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.368 1.067 . . . . 0.0 113.318 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.83 -32.34 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.492 1.517 . . . . 0.0 112.125 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.6 m -59.62 -29.44 68.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.727 1.611 . . . . 0.0 113.53 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.45 -4.38 6.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.871 1.268 . . . . 0.0 114.09 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -56.02 -41.18 89.71 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 120.168 -1.582 . . . . 0.0 113.001 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -62.76 -26.45 75.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.676 2.251 . . . . 0.0 113.239 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 27.6 m -76.2 -35.6 59.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.526 1.13 . . . . 0.0 111.26 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.39 98.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.693 1.197 . . . . 0.0 113.645 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.63 -35.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.146 1.339 . . . . 0.0 109.793 168.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.88 -46.47 60.48 Favored Glycine 0 C--O 1.218 -0.89 0 C-N-CA 125.02 1.295 . . . . 0.0 114.589 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.29 -35.14 77.38 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 121.489 2.644 . . . . 0.0 112.738 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.83 70.81 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.186 -0.946 . . . . 0.0 112.45 173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -76.71 -46.48 25.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.348 1.059 . . . . 0.0 111.985 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.64 67.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.478 1.511 . . . . 0.0 111.99 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -31.08 69.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.431 0.692 . . . . 0.0 111.086 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.41 -21.44 65.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.795 0.838 . . . . 0.0 113.196 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -84.43 -21.81 30.61 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.4 -124.79 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -162.98 -66.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 128.006 2.523 . . . . 0.0 110.281 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.6 164.97 13.76 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 126.714 2.005 . . . . 0.0 110.417 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -90.94 7.06 3.66 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.958 2.439 . . . . 0.0 114.001 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -63.95 -25.91 68.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.759 -1.213 . . . . 0.0 113.011 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.14 0.9 25.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.558 1.543 . . . . 0.0 114.382 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.62 131.27 44.37 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.833 -1.167 . . . . 0.0 113.563 -172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.24 129.58 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 127.051 2.14 . . . . 0.0 106.814 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.8 130.98 45.54 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.661 1.118 . . . . 0.0 112.269 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -88.98 50.29 1.93 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.958 1.303 . . . . 0.0 111.442 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.25 -38.87 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -166.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.84 -36.64 84.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.734 1.607 . . . . 0.0 111.476 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.5 41.19 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 123.95 0.786 . . . . 0.0 111.529 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.3 -42.95 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.998 0.919 . . . . 0.0 111.547 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.58 -34.94 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 112.761 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 24.7 m -64.56 -43.6 93.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.561 1.145 . . . . 0.0 111.73 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 25.2 t -80.14 -33.19 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.995 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.9 m -40.5 -61.9 1.08 Allowed Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.425 1.89 . . . . 0.0 113.891 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.85 -15.23 48.17 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.493 2.129 . . . . 0.0 113.632 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.44 -61.38 1.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.219 1.008 . . . . 0.0 111.231 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -25.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.957 -1.089 . . . . 0.0 113.066 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.84 -52.77 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.026 0.83 . . . . 0.0 110.641 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -68.88 -47.1 66.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.705 0.402 . . . . 0.0 110.894 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -29.75 70.43 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.61 -1.306 . . . . 0.0 113.008 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.94 -15.25 60.21 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -32.29 22.61 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.058 1.299 . . . . 0.0 111.238 167.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -61.39 -38.22 86.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.945 0.898 . . . . 0.0 112.121 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -145.15 70.69 1.27 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 0.0 112.224 -170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -54.91 -42.26 71.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -76.53 -15.72 59.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.87 158.4 35.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 111.926 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -69.21 143.66 53.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 169.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 35.7 t80 -58.1 -41.31 83.27 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -62.65 -33.02 74.2 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.4 -39.18 86.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.319 1.047 . . . . 0.0 111.838 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -37.86 62.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.937 0.895 . . . . 0.0 112.736 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.95 -48.33 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 119.302 0.955 . . . . 0.0 109.906 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.54 -46.83 74.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.01 0.924 . . . . 0.0 112.395 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.26 -42.23 99.72 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.26 0.934 . . . . 0.0 113.479 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.62 -33.61 62.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.454 1.127 . . . . 0.0 112.679 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.73 -37.88 88.28 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.465 -1.397 . . . . 0.0 111.878 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.41 -47.59 83.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.331 1.052 . . . . 0.0 111.933 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -26.15 68.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.051 -1.03 . . . . 0.0 112.285 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 31.6 mt -79.23 -49.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.913 1.685 . . . . 0.0 112.194 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt . . . . . 0 N--CA 1.482 1.15 0 C-N-CA 125.138 1.375 . . . . 0.0 113.523 -171.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 N--CA 1.471 0.205 0 N-CA-C 113.043 0.363 . . . . 0.0 113.043 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.77 -22.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.656 1.182 . . . . 0.0 113.605 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -68.57 -25.62 64.99 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.736 2.014 . . . . 0.0 113.827 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -133.25 -11.53 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -76.72 123.13 25.71 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 109.161 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -90.07 148.08 23.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 112.935 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -54.96 -30.0 58.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -63.26 -42.06 99.11 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.786 1.175 . . . . 0.0 111.693 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.23 0.27 57.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.865 1.266 . . . . 0.0 112.36 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 -28.07 20.77 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.036 -1.04 . . . . 0.0 111.838 171.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.82 -5.54 6.18 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.154 -0.966 . . . . 0.0 112.588 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.49 -27.17 60.45 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.427 1.491 . . . . 0.0 112.021 170.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.44 135.02 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.355 1.862 . . . . 0.0 109.749 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.09 157.46 33.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.636 0.774 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.85 -27.77 63.52 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.181 1.392 . . . . 0.0 112.238 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 m -66.53 -23.16 66.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 172.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -124.94 -11.09 7.16 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -61.38 -38.72 55.58 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.619 -1.925 . . . . 0.0 112.303 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.81 -26.06 74.77 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.129 2.552 . . . . 0.0 112.714 169.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -73.71 -36.34 65.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.651 1.18 . . . . 0.0 110.772 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.08 -49.73 74.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.218 1.007 . . . . 0.0 113.577 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.256 4.2 p -64.18 -33.77 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 118.99 0.814 . . . . 0.0 110.343 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.39 -52.06 34.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.405 168.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.36 -39.92 89.45 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.623 2.211 . . . . 0.0 112.599 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.97 68.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.244 -0.91 . . . . 0.0 112.69 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.69 -40.52 11.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.699 1.2 . . . . 0.0 112.385 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.34 80.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 111.859 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -26.44 60.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 0.0 111.058 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -68.27 -22.79 64.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -86.65 -24.69 25.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -154.13 -141.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.503 1.521 . . . . 0.0 111.108 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -165.11 136.23 4.01 Favored 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.105 4.162 . . . . 0.0 108.291 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.98 163.6 0.1 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.772 2.029 . . . . 0.0 113.061 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -92.59 9.27 2.6 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.034 1.823 . . . . 0.0 113.807 172.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -57.26 -24.63 56.05 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 112.971 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -130.6 31.93 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.563 1.545 . . . . 0.0 111.996 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.02 138.78 31.22 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.002 -1.686 . . . . 0.0 113.638 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.42 134.76 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.787 2.435 . . . . 0.0 106.174 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 111.74 4.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.012 1.278 . . . . 0.0 108.941 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -85.61 53.87 2.92 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.935 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.363 2.7 p -64.0 -14.24 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 -169.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.4 -42.57 53.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.853 1.661 . . . . 0.0 111.993 166.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.85 -52.94 4.15 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.24 -48.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.364 1.065 . . . . 0.0 112.923 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.02 71.37 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.585 1.084 . . . . 0.0 112.457 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.3 m -71.57 -43.62 65.98 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.658 1.583 . . . . 0.0 112.829 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.93 -22.97 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.135 0.974 . . . . 0.0 113.623 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 m -49.26 -60.82 4.16 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 125.155 1.382 . . . . 0.0 112.945 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -66.33 -5.34 12.4 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.374 2.716 . . . . 0.0 114.465 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.4 -61.73 1.67 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -67.41 -35.23 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.361 1.064 . . . . 0.0 112.245 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.29 -51.66 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.416 1.086 . . . . 0.0 110.384 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -73.02 -42.34 63.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.388 0.613 . . . . 0.0 110.902 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -29.69 70.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.351 0.66 . . . . 0.0 112.358 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.42 -17.16 64.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -35.45 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.216 1.371 . . . . 0.0 111.726 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.93 -38.14 84.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.893 0.877 . . . . 0.0 112.601 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -140.29 72.98 1.41 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -51.01 -31.76 19.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.659 1.983 . . . . 0.0 113.294 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -93.49 0.09 56.59 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.91 154.22 36.14 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 111.418 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.63 149.35 34.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 110.262 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.1 -37.44 82.74 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.215 -0.928 . . . . 0.0 113.261 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -60.4 -37.66 81.52 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.577 -1.327 . . . . 0.0 112.765 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.82 -39.75 94.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.438 0.695 . . . . 0.0 111.315 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -62.84 -44.02 97.24 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.32 -41.36 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.056 0.843 . . . . 0.0 110.712 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.53 -54.1 22.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.517 0.727 . . . . 0.0 112.116 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.85 99.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.944 0.783 . . . . 0.0 113.108 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -28.07 57.31 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.425 -1.044 . . . . 0.0 113.275 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -65.07 -40.74 95.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.618 1.099 . . . . 0.0 111.146 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.01 -43.33 99.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.353 0.661 . . . . 0.0 111.731 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -38.21 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.192 1.797 . . . . 0.0 114.226 169.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 124.425 1.09 . . . . 0.0 112.095 -168.445 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 CA-C-O 121.339 0.475 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -67.64 9.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.573 1.549 . . . . 0.0 114.266 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.35 5.29 8.41 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.567 1.947 . . . . 0.0 113.549 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 8.1 p -144.57 -21.67 0.53 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -87.82 -176.29 5.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.2 p -113.35 167.43 10.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.303 1.441 . . . . 0.0 113.912 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -20.82 28.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.01 -34.56 72.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.759 1.163 . . . . 0.0 112.44 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.5 -20.95 63.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.661 0.784 . . . . 0.0 113.099 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.66 -23.65 66.17 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.801 -1.187 . . . . 0.0 111.921 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.8 -17.62 43.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.904 1.281 . . . . 0.0 113.598 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.44 -28.82 56.75 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.93 0.892 . . . . 0.0 111.598 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.32 135.78 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.12 1.768 . . . . 0.0 110.14 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.04 158.85 30.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.008 0.923 . . . . 0.0 112.844 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.51 -35.4 60.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.833 1.253 . . . . 0.0 112.032 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 m -65.31 -22.49 66.84 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.784 1.234 . . . . 0.0 114.241 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -126.36 -5.11 6.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -58.33 -39.22 73.75 Favored Pre-proline 0 N--CA 1.478 0.936 0 O-C-N 119.689 -1.882 . . . . 0.0 113.43 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.81 -26.43 79.47 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.348 2.032 . . . . 0.0 112.984 169.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -76.96 -32.69 57.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.424 1.089 . . . . 0.0 111.715 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.57 92.36 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.879 -1.138 . . . . 0.0 113.239 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.88 -34.48 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.674 0.67 . . . . 0.0 110.764 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.81 -56.84 14.23 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.364 0.983 . . . . 0.0 112.954 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.74 -16.92 62.38 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.748 2.274 . . . . 0.0 113.807 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.72 -28.64 18.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -109.48 -30.62 7.86 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.507 1.503 . . . . 0.0 113.419 -173.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.66 77.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.313 2.245 . . . . 0.0 112.194 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.11 -24.6 30.23 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.898 1.279 . . . . 0.0 111.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -18.15 64.7 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.04 0.836 . . . . 0.0 113.053 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -110.66 -5.12 15.1 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -128.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.189 1.396 . . . . 0.0 112.163 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -159.65 -62.08 0.07 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.516 1.926 . . . . 0.0 112.491 -169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -119.89 162.25 34.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 126.975 2.11 . . . . 0.0 110.796 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.79 5.22 6.55 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.273 1.982 . . . . 0.0 114.619 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.19 -24.89 60.64 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.43 13.63 18.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.827 2.051 . . . . 0.0 112.975 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.74 22.81 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 119.78 -1.825 . . . . 0.0 112.928 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.9 107.23 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.341 1.857 . . . . 0.0 106.162 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.52 124.94 22.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.143 0.577 . . . . 0.0 109.496 -170.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -99.21 66.79 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.477 1.035 . . . . 0.0 111.98 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 p -64.63 -33.9 66.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.7 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.62 -39.67 84.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.827 1.649 . . . . 0.0 111.937 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.24 -48.22 66.03 Favored Glycine 0 N--CA 1.47 0.961 0 O-C-N 122.037 -0.414 . . . . 0.0 112.219 171.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.18 -41.42 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.626 -0.926 . . . . 0.0 112.264 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.04 71.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.432 1.469 . . . . 0.0 112.325 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 44.1 m -63.22 -43.25 98.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.677 0.791 . . . . 0.0 111.464 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -84.7 -27.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.987 1.315 . . . . 0.0 113.583 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.4 m -42.2 -61.36 1.6 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.681 1.993 . . . . 0.0 113.536 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.64 -12.35 34.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.313 2.009 . . . . 0.0 113.916 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.9 -64.53 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.013 . . . . 0.0 110.98 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.48 HD12 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -71.16 -24.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 120.887 -1.133 . . . . 0.0 113.432 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 t -58.94 -51.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 110.204 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -73.41 -47.91 38.1 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.184 0.594 . . . . 0.0 111.042 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.63 68.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.515 -1.365 . . . . 0.0 113.531 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.5 m -74.76 -21.64 59.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 169.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -30.99 33.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.202 1.365 . . . . 0.0 111.553 169.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -63.29 -38.24 90.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.846 0.858 . . . . 0.0 111.531 168.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -143.09 66.63 1.31 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.06 0.944 . . . . 0.0 112.243 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.16 -37.21 53.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.004 1.322 . . . . 0.0 112.328 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -82.38 -1.16 49.03 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.788 1.235 . . . . 0.0 113.545 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.47 146.44 44.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 112.094 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -65.71 149.36 50.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.749 1.22 . . . . 0.0 111.205 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -48.89 151.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.079 1.352 . . . . 0.0 112.182 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm 60.26 -29.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.489 2.716 . . . . 0.0 116.792 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.66 -34.28 76.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.809 1.644 . . . . 0.0 111.714 172.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.08 -37.55 78.54 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.601 -0.687 . . . . 0.0 112.367 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.96 -47.74 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 124.11 0.964 . . . . 0.0 110.034 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -64.68 -42.91 95.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 112.342 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.64 -41.03 99.19 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.625 1.107 . . . . 0.0 113.165 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.47 -35.45 65.7 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.111 -1.229 . . . . 0.0 112.934 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.24 -37.72 86.51 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.988 -1.07 . . . . 0.0 112.037 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.5 -46.29 90.68 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 0.0 111.812 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -20.0 65.99 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.946 -1.096 . . . . 0.0 112.789 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.3 mt -86.46 -47.02 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.552 1.941 . . . . 0.0 112.396 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.48 1.067 0 C-N-CA 125.215 1.406 . . . . 0.0 113.348 -173.704 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.533 0.443 0 CA-C-O 122.054 0.772 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.25 -19.19 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.663 1.585 . . . . 0.0 114.874 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -95.29 -15.95 22.78 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.9 p -109.56 -32.73 7.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.984 1.265 . . . . 0.0 114.146 -172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -88.6 -179.96 6.15 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.771 0.829 . . . . 0.0 113.152 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.9 p -105.62 160.42 15.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.436 1.494 . . . . 0.0 114.352 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -25.29 60.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.527 1.931 . . . . 0.0 115.239 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.84 -35.31 66.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.582 1.083 . . . . 0.0 111.463 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.07 -18.12 60.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.266 1.026 . . . . 0.0 113.54 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -65.93 -29.3 69.69 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.808 -1.182 . . . . 0.0 110.573 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.91 -18.45 58.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.638 1.575 . . . . 0.0 113.082 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.36 -27.73 38.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.482 1.113 . . . . 0.0 112.006 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.8 137.62 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.843 1.657 . . . . 0.0 108.906 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -65.69 154.89 37.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.882 0.873 . . . . 0.0 112.536 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.11 -35.32 73.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.429 1.092 . . . . 0.0 111.777 -174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.4 m -61.65 -25.13 67.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.902 1.681 . . . . 0.0 113.713 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.98 -2.8 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.055 -173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -57.56 -43.73 99.08 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 119.906 -1.746 . . . . 0.0 112.148 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -62.69 -25.21 75.01 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.871 2.381 . . . . 0.0 113.92 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.5 m -75.8 -34.2 60.16 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.029 0.931 . . . . 0.0 110.702 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.768 1.227 . . . . 0.0 113.587 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.18 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.079 0.854 . . . . 0.0 110.931 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.49 -51.1 50.13 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 124.973 1.273 . . . . 0.0 113.755 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.13 -23.51 63.99 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.283 2.542 . . . . 0.0 113.339 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 -61.48 1.79 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.325 -0.86 . . . . 0.0 109.296 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -73.66 -29.78 62.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.392 -1.443 . . . . 0.0 114.739 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.39 97.28 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.03 -1.044 . . . . 0.0 110.933 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -38.52 21.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.456 1.102 . . . . 0.0 110.329 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -64.3 -33.52 76.02 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.571 1.148 . . . . 0.0 113.483 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -80.66 -13.77 58.73 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -155.25 -136.1 0.05 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.995 1.718 . . . . 0.0 110.769 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -172.18 127.08 0.56 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 130.532 3.533 . . . . 0.0 108.879 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 mttt 60.58 166.35 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.033 0 C-N-CA 125.787 1.635 . . . . 0.0 113.845 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -88.16 15.18 2.16 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.033 1.822 . . . . 0.0 114.846 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.77 -30.41 70.01 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.863 -1.148 . . . . 0.0 112.203 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -116.54 27.52 9.15 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.57 1.948 . . . . 0.0 112.167 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 107.75 14.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.915 -1.74 . . . . 0.0 111.763 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.54 118.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.4 117.15 8.98 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.173 0.897 . . . . 0.0 112.406 -167.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -89.72 53.16 2.49 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.404 -1.435 . . . . 0.0 111.608 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.323 1.2 p -60.75 -41.33 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -167.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -63.23 -38.51 91.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.583 1.538 . . . . 0.0 112.305 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -54.09 39.85 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -43.45 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.492 -1.005 . . . . 0.0 112.164 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.29 67.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.203 . . . . 0.0 112.804 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -71.25 -45.13 63.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.251 1.421 . . . . 0.0 111.885 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.53 -19.66 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.1 m -45.64 -61.91 2.11 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 125.123 1.369 . . . . 0.0 112.415 173.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.47 -3.66 12.92 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.599 2.866 . . . . 0.0 114.178 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.8 -64.45 1.17 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.899 1.28 . . . . 0.0 108.984 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.78 -34.67 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.959 0.904 . . . . 0.0 111.977 -172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.57 -49.69 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.88 0.872 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.13 -45.92 58.62 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.77 -28.72 69.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.291 -0.88 . . . . 0.0 113.183 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.0 m -75.26 -13.31 60.43 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.47 -34.99 16.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.469 1.486 . . . . 0.0 111.178 167.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -60.63 -38.27 84.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.82 170.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -138.18 52.94 1.82 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.15 1.38 . . . . 0.0 112.68 -168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -48.51 -35.8 13.92 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.731 2.013 . . . . 0.0 113.259 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -88.49 -6.99 57.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.592 1.157 . . . . 0.0 113.755 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.78 161.58 27.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.044 0.938 . . . . 0.0 112.023 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.16 139.11 57.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 112.234 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.5 -53.1 59.78 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.841 . . . . 0.0 112.844 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -71.96 -32.67 67.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.693 -1.254 . . . . 0.0 112.853 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -64.98 -27.38 68.8 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.106 -0.996 . . . . 0.0 112.383 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -70.31 -37.37 74.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.504 1.047 . . . . 0.0 113.041 171.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.97 -38.24 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.771 1.169 . . . . 0.0 111.327 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -61.02 -48.33 82.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.055 0.942 . . . . 0.0 111.509 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.02 98.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.981 1.277 . . . . 0.0 113.649 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.8 -36.47 67.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.757 1.278 . . . . 0.0 112.651 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -60.62 -39.97 90.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.562 1.073 . . . . 0.0 111.631 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.04 -44.51 96.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.463 1.105 . . . . 0.0 111.931 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -26.45 68.59 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.962 -1.086 . . . . 0.0 112.352 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.251 10.1 mt . . . . . 0 CA--C 1.54 0.591 0 C-N-CA 124.892 1.277 . . . . 0.0 112.564 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 CA--C 1.539 0.727 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 m -55.39 -24.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.887 1.675 . . . . 0.0 114.242 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.98 -10.39 53.29 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.3 p -121.85 -29.74 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -86.94 172.36 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.4 p -92.67 160.91 14.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -24.0 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.38 -37.54 70.23 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.853 -1.155 . . . . 0.0 111.505 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.14 -28.43 69.64 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.981 0.912 . . . . 0.0 112.973 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.27 -27.16 69.15 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.113 -0.992 . . . . 0.0 111.152 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.2 mt -84.49 -10.71 57.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.802 1.241 . . . . 0.0 113.104 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.96 -29.38 22.09 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.959 1.303 . . . . 0.0 112.371 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.4 140.05 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.998 1.719 . . . . 0.0 110.242 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.6 159.39 32.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.271 1.029 . . . . 0.0 113.067 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.93 -33.89 71.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.086 1.354 . . . . 0.0 111.951 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m -66.18 -21.18 66.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.666 1.587 . . . . 0.0 114.007 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -126.73 -8.85 6.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.39 1.076 . . . . 0.0 113.308 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.81 -43.31 99.32 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 120.06 -1.65 . . . . 0.0 112.536 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.65 -25.0 61.99 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.688 2.259 . . . . 0.0 113.151 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 18.4 m -72.96 -32.37 65.17 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 111.218 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.77 89.42 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 170.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.98 -33.73 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.683 1.583 . . . . 0.0 110.043 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.76 7.6 2.12 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 126.57 2.033 . . . . 0.0 116.008 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -121.48 -12.32 8.58 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.58 1.69 . . . . 0.0 112.852 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.17 -69.24 0.76 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.452 1.023 . . . . 0.0 110.77 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.74 -32.33 72.86 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.895 -1.128 . . . . 0.0 111.492 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.58 -35.88 68.72 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.472 1.109 . . . . 0.0 113.169 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.96 -42.56 16.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.186 0.994 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.04 -39.3 74.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 0.0 113.834 -173.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -92.44 -8.28 45.17 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -9.6 0.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -171.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.326 3.8 p30 55.28 -34.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 121.437 3.866 . . . . 0.0 121.437 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -137.6 153.76 74.49 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 126.941 2.096 . . . . 0.0 110.648 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.84 -1.12 8.78 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 121.685 1.637 . . . . 0.0 114.67 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.29 -13.49 60.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.779 1.232 . . . . 0.0 112.87 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -127.78 8.25 6.29 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.133 1.373 . . . . 0.0 113.93 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.0 130.52 36.6 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.304 -1.497 . . . . 0.0 114.51 -170.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 20.6 t -117.28 135.35 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.759 2.024 . . . . 0.0 106.852 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.7 127.26 32.66 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.503 1.047 . . . . 0.0 111.446 -169.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -89.75 52.56 2.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.532 1.533 . . . . 0.0 111.939 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.378 1.7 p -67.29 -44.69 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -64.32 -36.94 85.75 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 123.075 2.671 . . . . 0.0 111.164 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.49 -47.34 88.11 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mt -56.46 -48.62 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.295 1.438 . . . . 0.0 111.618 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.6 81.45 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.531 1.059 . . . . 0.0 112.22 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 52.1 m -67.05 -42.29 85.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.937 1.295 . . . . 0.0 111.811 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.99 -24.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.498 1.519 . . . . 0.0 113.04 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -43.71 -61.02 2.14 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 126.748 2.019 . . . . 0.0 113.588 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.24 -14.16 43.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.537 2.158 . . . . 0.0 113.638 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.86 -56.37 4.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.105 0.962 . . . . 0.0 111.416 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -25.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.925 -1.109 . . . . 0.0 113.436 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.1 t -57.62 -51.36 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.824 0.85 . . . . 0.0 110.265 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 -46.86 34.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.429 0.692 . . . . 0.0 111.151 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.62 69.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.608 -1.308 . . . . 0.0 113.152 -171.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.3 m -77.09 -11.31 59.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.48 -31.63 18.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.074 1.306 . . . . 0.0 111.192 167.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -59.34 -38.73 81.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.199 1.0 . . . . 0.0 112.47 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -145.17 85.54 1.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.718 0.77 . . . . 0.0 112.095 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -62.53 -39.32 93.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.463 1.505 . . . . 0.0 112.406 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.89 -10.2 59.74 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.23 141.93 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.784 0.834 . . . . 0.0 112.828 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.1 40.39 0.98 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.392 2.277 . . . . 0.0 111.298 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -106.81 117.75 34.87 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -163.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -76.84 -26.42 54.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.015 1.326 . . . . 0.0 109.428 162.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.91 -23.16 63.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.376 1.471 . . . . 0.0 112.707 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -63.08 -40.32 97.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.779 0.832 . . . . 0.0 111.809 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -39.93 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.812 0.845 . . . . 0.0 110.69 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -65.41 -38.78 90.96 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.672 0.789 . . . . 0.0 112.112 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.95 99.75 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.986 1.279 . . . . 0.0 112.783 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.35 -36.1 71.38 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.688 1.244 . . . . 0.0 113.075 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.93 -42.08 93.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.736 1.153 . . . . 0.0 111.594 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -49.63 76.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.088 1.355 . . . . 0.0 110.937 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -27.53 68.92 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.731 -1.231 . . . . 0.0 112.072 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -80.23 -47.41 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.957 1.703 . . . . 0.0 113.027 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 N--CA 1.481 1.098 0 C-N-CA 124.749 1.22 . . . . 0.0 112.932 -171.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.534 0.479 0 CA-C-O 121.273 0.447 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -65.97 -15.68 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.814 1.245 . . . . 0.0 113.241 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -93.86 10.75 31.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.182 1.793 . . . . 0.0 113.176 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -151.04 -42.07 0.12 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -83.97 148.8 26.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.34 1.066 . . . . 0.0 113.561 -169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.6 p -77.75 172.79 12.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.967 1.707 . . . . 0.0 113.653 -168.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -18.46 8.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.824 1.786 . . . . 0.0 115.824 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.4 -39.1 78.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.273 1.397 . . . . 0.0 110.751 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.55 -22.88 66.15 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.01 -1.057 . . . . 0.0 112.968 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.38 -1.87 32.21 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.699 -0.626 . . . . 0.0 112.507 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.4 mt -110.93 -24.7 10.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.546 1.539 . . . . 0.0 112.615 168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.66 67.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.128 0.971 . . . . 0.0 112.15 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.76 141.6 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.522 1.929 . . . . 0.0 110.655 169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.55 157.51 32.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.489 0.715 . . . . 0.0 112.555 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -54.61 -34.28 61.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.101 1.361 . . . . 0.0 111.981 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 m -64.48 -23.14 67.18 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -125.79 -4.1 7.07 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.738 1.215 . . . . 0.0 112.895 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -60.88 -43.85 92.87 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 119.568 -1.957 . . . . 0.0 112.591 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.05 -18.08 60.9 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.495 2.13 . . . . 0.0 113.241 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -78.82 -34.4 45.3 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.678 1.191 . . . . 0.0 111.653 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.81 99.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.193 . . . . 0.0 111.852 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.14 -47.37 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.975 0.91 . . . . 0.0 108.898 169.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.56 -49.49 60.78 Favored Glycine 0 C--O 1.209 -1.428 0 C-N-CA 124.996 1.284 . . . . 0.0 113.582 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -69.42 -11.82 61.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 122.109 2.955 . . . . 0.0 114.205 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.28 -49.88 5.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.582 0.753 . . . . 0.0 110.505 166.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -73.34 -30.67 63.49 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.23 -0.919 . . . . 0.0 113.049 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.54 89.15 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 119.497 -2.002 . . . . 0.0 111.479 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -13.69 52.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.026 1.33 . . . . 0.0 111.652 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 -22.28 60.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.003 1.321 . . . . 0.0 113.012 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 -2.68 13.2 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.84 158.57 0.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.978 3.311 . . . . 0.0 106.399 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.89 -27.91 16.81 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 128.091 2.556 . . . . 0.0 114.249 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.42 156.41 79.74 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 126.701 2.001 . . . . 0.0 110.964 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.94 6.83 5.51 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.054 1.836 . . . . 0.0 114.529 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.08 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.688 -1.258 . . . . 0.0 111.936 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.24 2.36 28.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.227 1.811 . . . . 0.0 113.168 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.74 123.46 27.71 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 119.765 -1.835 . . . . 0.0 112.45 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.48 -2.85 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 125.455 1.502 . . . . 0.0 111.972 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 61.78 119.08 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.403 3.081 . . . . 0.0 112.752 -172.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -93.1 55.43 2.33 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.224 -1.547 . . . . 0.0 112.095 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.322 2.5 p -69.54 -22.02 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.711 -1.243 . . . . 0.0 113.827 -169.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -58.02 -45.74 86.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.928 1.24 . . . . 0.0 111.21 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.46 -49.87 8.8 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.16 -44.43 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.893 0.877 . . . . 0.0 111.81 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.0 66.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.511 1.505 . . . . 0.0 112.773 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -70.99 -37.48 72.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.873 1.269 . . . . 0.0 111.586 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.4 -21.7 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.405 1.482 . . . . 0.0 113.417 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.4 m -46.86 -59.72 4.85 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 125.998 1.719 . . . . 0.0 112.819 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.97 0.52 4.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.157 2.572 . . . . 0.0 114.206 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.74 -64.31 1.17 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.389 1.476 . . . . 0.0 110.441 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -29.31 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.907 -1.121 . . . . 0.0 113.2 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.32 -47.33 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.693 0.797 . . . . 0.0 110.459 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.13 -47.34 20.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.435 0.636 . . . . 0.0 110.866 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.99 71.45 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.2 m -76.01 -13.62 60.23 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.205 -0.935 . . . . 0.0 113.48 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.3 -29.05 21.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.849 1.204 . . . . 0.0 111.282 168.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.4 -38.29 80.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.453 0.701 . . . . 0.0 111.993 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.35 90.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 112.429 170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -55.81 -36.02 66.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.145 1.378 . . . . 0.0 111.367 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -86.99 3.58 45.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.085 1.354 . . . . 0.0 113.375 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.92 151.5 21.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.983 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -59.37 139.25 57.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.788 1.235 . . . . 0.0 111.472 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -56.07 145.14 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.054 1.342 . . . . 0.0 113.401 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 59.06 -24.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.974 2.91 . . . . 0.0 116.916 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.78 -31.13 70.51 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.875 1.67 . . . . 0.0 111.627 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -68.7 -37.03 79.21 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.76 -47.15 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.41 1.084 . . . . 0.0 109.833 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.45 -42.6 98.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.868 0.867 . . . . 0.0 112.358 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.81 -45.62 95.34 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.216 1.389 . . . . 0.0 113.257 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -72.11 -35.52 69.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.461 1.131 . . . . 0.0 113.16 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -59.84 -40.55 88.89 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.018 -1.051 . . . . 0.0 111.429 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.78 -45.1 95.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.72 1.208 . . . . 0.0 111.743 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -24.59 67.93 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.135 -0.978 . . . . 0.0 112.623 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.258 5.5 mt . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.111 1.364 . . . . 0.0 112.729 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.542 0.896 0 CA-C-O 120.919 0.3 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.26 -25.95 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 125.621 1.568 . . . . 0.0 114.75 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -79.11 -16.76 56.24 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 18.1 m -128.28 -22.29 3.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -86.95 166.26 15.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.447 1.099 . . . . 0.0 112.598 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 51.5 p -96.46 158.6 15.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.2 -24.56 67.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.32 1.448 . . . . 0.0 114.437 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.66 -37.78 73.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.812 1.187 . . . . 0.0 111.213 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.12 -30.56 71.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.268 1.027 . . . . 0.0 112.786 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -67.02 -23.73 65.94 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.175 -0.953 . . . . 0.0 111.67 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 49.6 mt -80.71 -15.77 55.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.504 1.122 . . . . 0.0 113.178 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.06 -28.85 43.2 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.121 0.968 . . . . 0.0 112.172 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.68 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.916 1.686 . . . . 0.0 110.191 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.39 158.62 33.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.0 112.856 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -53.88 -34.17 58.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.098 1.359 . . . . 0.0 112.368 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 33.5 m -65.95 -22.36 66.48 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.699 1.199 . . . . 0.0 114.107 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.08 -8.16 5.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.556 1.142 . . . . 0.0 113.509 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -57.77 -44.57 99.53 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 119.785 -1.822 . . . . 0.0 112.2 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.29 -27.43 77.99 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.693 2.262 . . . . 0.0 113.254 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 65.5 m -72.87 -38.92 66.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 0.0 110.962 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.4 94.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.334 1.453 . . . . 0.0 114.147 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.83 -32.69 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 119.432 1.014 . . . . 0.0 110.75 169.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.48 -55.11 21.31 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 125.301 1.429 . . . . 0.0 113.667 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.86 -35.73 79.14 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.561 2.181 . . . . 0.0 112.178 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.92 65.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -104.95 -31.44 9.23 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.1 99.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.34 1.456 . . . . 0.0 111.319 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.86 -32.02 57.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.942 0.897 . . . . 0.0 110.93 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -65.12 -27.51 68.8 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -98.01 -8.61 27.55 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 -132.62 0.07 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.961 1.705 . . . . 0.0 110.478 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -156.79 -55.75 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.268 2.227 . . . . 0.0 112.276 -173.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -120.21 168.09 11.2 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 127.179 2.192 . . . . 0.0 110.194 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.78 10.37 3.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.108 1.872 . . . . 0.0 114.308 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 -25.92 67.22 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.782 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -118.5 25.18 10.45 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.734 2.014 . . . . 0.0 113.366 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.96 34.88 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.586 -1.322 . . . . 0.0 112.702 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.96 -13.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.284 1.034 . . . . 0.0 113.52 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.6 107.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.48 2.312 . . . . 0.0 110.648 -168.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.68 62.96 7.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.734 -1.229 . . . . 0.0 110.804 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.35 1.6 p -66.69 -25.14 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.148 -0.929 . . . . 0.0 113.334 -168.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.28 -50.75 72.49 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.807 1.64 . . . . 0.0 111.6 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.54 80.09 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mt -62.86 -45.26 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.049 0.94 . . . . 0.0 112.036 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.48 -32.34 72.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 120.628 1.558 . . . . 0.0 112.475 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 42.8 m -64.55 -44.21 91.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.832 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -82.67 -29.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.953 1.301 . . . . 0.0 113.161 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.7 m -41.04 -62.51 1.0 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 126.532 1.933 . . . . 0.0 114.018 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.99 -22.47 73.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.18 1.92 . . . . 0.0 112.931 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.57 -58.03 4.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.4 1.08 . . . . 0.0 111.33 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -24.58 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.086 -1.009 . . . . 0.0 112.895 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.11 -52.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.466 1.03 . . . . 0.0 110.629 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -72.16 -47.16 52.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.586 0.232 . . . . 0.0 111.131 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.19 72.2 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.666 -1.271 . . . . 0.0 113.316 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.6 -13.44 61.38 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 170.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.66 16.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.247 1.385 . . . . 0.0 111.212 167.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.56 -43.15 97.58 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.26 0.624 . . . . 0.0 111.657 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -134.96 63.93 1.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.529 1.531 . . . . 0.0 111.093 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -51.34 -32.88 27.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.611 -1.305 . . . . 0.0 112.452 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -87.74 -3.12 58.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.099 1.36 . . . . 0.0 113.562 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 155.06 39.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.074 0.95 . . . . 0.0 111.599 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -66.84 135.55 54.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.565 1.146 . . . . 0.0 109.64 169.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.79 -51.7 60.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -67.81 -29.28 68.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.47 1.486 . . . . 0.0 112.521 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.58 -37.37 83.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.643 -0.661 . . . . 0.0 111.739 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -71.87 -35.34 69.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.477 -0.764 . . . . 0.0 112.914 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.15 -46.46 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.455 1.025 . . . . 0.0 109.926 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -65.44 -43.55 90.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.282 1.033 . . . . 0.0 112.475 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.17 -41.07 99.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.299 0.952 . . . . 0.0 113.246 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.71 -34.18 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.234 -1.156 . . . . 0.0 112.654 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -58.12 -41.98 84.8 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.753 1.615 . . . . 0.0 111.919 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.08 -50.79 72.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.862 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -29.15 70.6 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.896 -1.128 . . . . 0.0 112.256 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 30.7 mt -76.37 -49.5 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.229 1.811 . . . . 0.0 112.448 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 125.132 1.373 . . . . 0.0 112.769 -170.294 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.531 0.33 0 CA-C-O 120.602 0.167 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.17 -17.72 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -71.74 -29.92 65.04 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 112.396 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 -32.47 9.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 114.008 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.44 148.68 50.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.159 0.98 . . . . 0.0 111.526 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.6 p -97.31 167.44 11.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.028 1.394 . . . . 0.0 114.167 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.4 m -66.06 -24.21 66.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.948 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.88 -44.82 91.89 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.65 1.114 . . . . 0.0 110.249 169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.79 -29.43 69.43 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.919 -0.488 . . . . 0.0 111.601 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -72.32 -11.88 60.9 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.983 -1.073 . . . . 0.0 113.336 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.54 -2.19 45.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.253 1.021 . . . . 0.0 112.48 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.81 -34.08 17.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.725 1.21 . . . . 0.0 112.352 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.35 138.84 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.31 1.844 . . . . 0.0 111.136 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.4 156.27 39.09 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 113.062 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.52 -35.03 38.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.834 1.254 . . . . 0.0 112.817 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 t -65.6 -26.37 67.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.369 1.068 . . . . 0.0 113.432 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -123.14 -0.66 8.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.228 1.411 . . . . 0.0 113.312 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -59.18 -46.42 99.26 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 119.574 -1.954 . . . . 0.0 111.424 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.35 -17.77 55.11 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.427 2.085 . . . . 0.0 114.412 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 m -67.71 -40.31 84.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 110.527 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.55 75.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.448 1.099 . . . . 0.0 113.866 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.55 -34.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.753 0.706 . . . . 0.0 109.989 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -57.89 15.11 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.644 -1.087 . . . . 0.0 112.919 168.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.73 -43.47 98.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.367 2.084 . . . . 0.0 112.411 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.7 -26.71 66.31 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -98.49 -35.75 10.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 113.159 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.02 71.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.041 1.336 . . . . 0.0 111.745 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.35 -24.88 61.35 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.884 -0.51 . . . . 0.0 110.954 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -24.42 57.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.73 0.812 . . . . 0.0 112.898 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.96 -7.17 25.49 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.77 -130.62 0.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.13 1.772 . . . . 0.0 110.342 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.61 -44.06 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.232 2.213 . . . . 0.0 112.245 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -123.62 164.95 25.46 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 127.966 2.507 . . . . 0.0 110.148 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.33 13.02 2.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.324 2.016 . . . . 0.0 114.185 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.98 -27.43 66.84 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.806 -1.184 . . . . 0.0 112.926 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.73 18.56 14.86 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.268 1.427 . . . . 0.0 114.196 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 129.7 40.62 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.851 -1.156 . . . . 0.0 112.607 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.52 -11.67 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.775 1.23 . . . . 0.0 113.271 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.77 114.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.787 2.435 . . . . 0.0 110.555 -167.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -82.85 51.87 2.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.403 -1.435 . . . . 0.0 110.74 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.422 2.7 p -69.04 -28.37 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -166.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.12 -39.37 82.08 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.332 1.878 . . . . 0.0 111.389 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.2 -51.24 10.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.369 0.985 . . . . 0.0 112.102 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -40.36 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.179 0.992 . . . . 0.0 111.987 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.43 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.19 1.359 . . . . 0.0 112.652 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -68.27 -40.98 81.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.751 1.22 . . . . 0.0 111.492 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.7 t -81.66 -31.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.202 1.401 . . . . 0.0 113.617 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -41.78 -59.92 2.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 125.798 1.639 . . . . 0.0 114.47 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.42 -24.23 75.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.96 1.773 . . . . 0.0 113.204 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.29 -61.56 2.46 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.426 1.49 . . . . 0.0 110.571 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -31.95 53.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 t -59.47 -51.85 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.805 1.242 . . . . 0.0 110.466 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.08 -49.96 45.77 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.066 0.46 . . . . 0.0 110.872 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.86 70.24 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.829 0.852 . . . . 0.0 112.727 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.9 m -72.9 -17.05 61.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -30.34 20.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.677 1.191 . . . . 0.0 111.233 168.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -64.0 -38.26 90.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.126 0.97 . . . . 0.0 112.405 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -145.3 85.09 1.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.818 1.247 . . . . 0.0 111.574 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.76 -39.78 71.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.223 1.409 . . . . 0.0 112.209 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.11 -11.99 59.99 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.22 152.5 44.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.005 0.922 . . . . 0.0 112.162 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -73.35 144.81 46.35 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.8 -44.32 90.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -67.11 -32.02 72.88 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.783 -1.198 . . . . 0.0 113.011 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.48 -40.42 86.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.969 0.908 . . . . 0.0 111.152 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.747 -1.12 . . . . 0.0 112.888 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -41.4 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.607 1.549 . . . . 0.0 111.334 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -64.21 -48.48 75.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.719 0.808 . . . . 0.0 111.676 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.41 99.72 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.36 0.981 . . . . 0.0 113.099 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -74.26 -35.63 63.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.605 1.202 . . . . 0.0 113.196 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -59.56 -40.21 86.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.005 1.275 . . . . 0.0 111.486 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.47 -45.51 93.94 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.21 1.004 . . . . 0.0 111.742 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -23.5 67.34 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.969 -1.082 . . . . 0.0 112.655 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.841 1.256 . . . . 0.0 113.065 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 CA-C-O 121.094 0.372 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 m -66.01 -4.82 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.668 1.587 . . . . 0.0 114.558 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -112.93 21.37 15.51 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.234 1.813 . . . . 0.0 112.934 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -143.82 -49.48 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -93.71 147.08 23.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.922 0.783 . . . . 0.0 112.207 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p -70.92 173.36 7.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.368 1.867 . . . . 0.0 113.965 -171.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -49.91 -20.56 0.93 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.66 -40.27 39.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.62 -30.63 69.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.144 0.978 . . . . 0.0 112.619 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -70.96 -17.65 62.66 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.511 -0.743 . . . . 0.0 111.967 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.92 -18.49 23.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.188 0.995 . . . . 0.0 112.911 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.85 62.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.278 1.031 . . . . 0.0 112.436 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.72 138.9 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.814 2.046 . . . . 0.0 111.119 171.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.67 159.13 32.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.477 1.111 . . . . 0.0 113.223 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.09 -33.64 58.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.353 1.461 . . . . 0.0 111.809 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.0 m -59.17 -27.46 65.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.114 1.765 . . . . 0.0 113.817 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.58 -3.95 5.99 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.392 1.477 . . . . 0.0 113.307 -171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -56.96 -44.85 99.94 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.241 -1.537 . . . . 0.0 112.528 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.41 -18.34 59.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.595 2.197 . . . . 0.0 114.007 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 40.6 m -81.43 -31.86 32.91 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.789 1.236 . . . . 0.0 111.449 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.1 97.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.521 1.055 . . . . 0.0 110.902 167.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.55 -47.0 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.084 0.954 . . . . 0.0 109.191 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.88 12.64 1.03 Allowed Glycine 0 CA--C 1.544 1.891 0 C-N-CA 126.798 2.142 . . . . 0.0 117.353 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.39 -14.18 7.46 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.609 1.563 . . . . 0.0 112.98 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.67 -72.6 0.62 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.84 0.856 . . . . 0.0 110.086 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -72.69 -20.44 61.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.042 -1.036 . . . . 0.0 112.61 -170.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.29 -42.42 70.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.427 1.091 . . . . 0.0 112.843 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -47.02 13.88 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.701 0.801 . . . . 0.0 109.541 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -6.9 57.79 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.93 -15.2 52.28 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.237 0.926 . . . . 0.0 113.205 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -150.92 -129.97 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.757 1.623 . . . . 0.0 110.861 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -156.41 -61.38 0.1 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.872 1.669 . . . . 0.0 113.104 -169.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.42 161.13 65.02 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.956 2.102 . . . . 0.0 110.705 -172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -86.49 10.41 3.64 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.705 2.27 . . . . 0.0 113.789 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.02 -27.74 63.9 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.876 -1.14 . . . . 0.0 112.052 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.79 -9.28 11.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.241 1.416 . . . . 0.0 114.158 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.35 136.19 47.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.958 -1.088 . . . . 0.0 111.949 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.68 8.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.987 1.715 . . . . 0.0 112.888 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 58.67 113.79 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 129.564 3.146 . . . . 0.0 111.344 -169.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.37 51.62 2.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.717 1.607 . . . . 0.0 111.506 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 0.4 OUTLIER -68.52 -31.7 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -164.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -64.61 -42.04 95.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.401 1.001 . . . . 0.0 111.575 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.29 -44.22 60.27 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mt -58.86 -48.22 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.278 1.031 . . . . 0.0 111.471 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.25 73.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.237 0.926 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 47.0 m -67.71 -43.86 79.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.455 1.102 . . . . 0.0 112.2 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 t -80.52 -30.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.886 1.674 . . . . 0.0 113.353 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -39.97 -62.08 0.96 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.026 1.73 . . . . 0.0 113.783 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.19 -13.56 38.64 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.729 2.286 . . . . 0.0 114.176 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.97 -64.87 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.048 0.939 . . . . 0.0 111.081 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.454 HD12 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.92 -25.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.766 -1.209 . . . . 0.0 113.379 -178.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.8 -49.71 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.263 1.025 . . . . 0.0 110.586 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.78 -44.99 22.0 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 111.464 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.59 -30.41 70.01 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.592 -1.318 . . . . 0.0 112.833 -169.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.4 m -72.44 -13.09 61.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 169.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -35.1 16.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.493 1.497 . . . . 0.0 111.15 167.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -59.29 -39.05 81.76 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 112.071 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -142.47 79.88 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.816 0.847 . . . . 0.0 111.676 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -55.5 -29.18 58.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.94 1.79 55.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.549 1.54 . . . . 0.0 113.116 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 155.55 37.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.647 1.179 . . . . 0.0 113.306 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.07 57.1 2.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.307 1.843 . . . . 0.0 113.374 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 p90 44.62 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.866 2.066 . . . . 0.0 116.005 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -67.43 -26.53 66.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 0.0 112.239 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.9 -36.56 77.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.153 0.981 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -72.33 -40.48 67.4 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 118.477 -0.773 . . . . 0.0 112.774 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.81 -42.46 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.326 0.966 . . . . 0.0 110.565 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -69.42 -46.99 65.5 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.924 1.29 . . . . 0.0 112.526 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.15 98.49 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.861 0.743 . . . . 0.0 113.129 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.52 -27.16 63.96 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.344 -1.092 . . . . 0.0 113.215 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -67.95 -41.0 83.14 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.081 -1.012 . . . . 0.0 111.1 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.56 -41.29 98.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.446 0.698 . . . . 0.0 111.411 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.63 -38.43 6.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 113.151 168.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.94 -39.58 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 112.286 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 57.2 mttt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 CA-C-O 121.341 0.475 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -19.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -78.99 -13.95 59.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.682 1.193 . . . . 0.0 114.084 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 m -131.5 -26.91 2.0 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -169.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.24 156.27 39.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.193 0.906 . . . . 0.0 112.681 -177.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.0 p -92.63 157.9 16.25 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.369 1.081 . . . . 0.0 113.62 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.33 -22.85 65.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.28 -39.69 87.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.949 -1.094 . . . . 0.0 111.203 173.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.02 -25.5 62.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 118.722 -0.656 . . . . 0.0 112.593 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.61 -30.6 70.23 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.6 1.545 . . . . 0.0 111.304 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.34 -13.21 60.15 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 171.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.45 -28.39 52.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.32 136.11 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.933 1.693 . . . . 0.0 110.534 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.03 159.99 31.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 113.189 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -33.73 72.22 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.769 -1.207 . . . . 0.0 111.849 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.8 m -61.93 -23.58 66.44 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 114.164 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.97 -7.38 6.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.84 1.256 . . . . 0.0 113.317 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -57.99 -41.96 92.65 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 119.498 -2.001 . . . . 0.0 112.544 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -64.93 -17.96 60.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.665 2.243 . . . . 0.0 114.109 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.5 m -76.71 -38.26 54.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.924 1.29 . . . . 0.0 111.148 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.31 97.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.433 1.093 . . . . 0.0 112.73 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.75 -46.56 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.24 -56.34 13.01 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 125.559 1.552 . . . . 0.0 113.889 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -11.51 59.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 122.072 2.936 . . . . 0.0 113.938 -173.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.55 -47.77 5.81 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.618 1.099 . . . . 0.0 111.995 168.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -76.52 -27.58 56.06 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.959 -1.088 . . . . 0.0 113.566 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.36 -62.94 1.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.854 1.261 . . . . 0.0 110.412 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.77 -18.81 65.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.766 1.226 . . . . 0.0 111.55 -174.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.09 -18.88 58.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.299 1.04 . . . . 0.0 113.671 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.47 9.19 5.52 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.52 148.06 7.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.999 2.92 . . . . 0.0 105.909 171.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.16 -44.11 8.52 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.5 2.32 . . . . 0.0 115.195 -166.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.33 160.13 58.43 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 127.375 2.27 . . . . 0.0 109.622 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.26 16.58 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 121.25 1.482 . . . . 0.0 114.126 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.58 -22.45 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.341 1.456 . . . . 0.0 112.841 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -128.37 -0.9 5.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.515 1.526 . . . . 0.0 114.195 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.84 146.18 53.08 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.34 151.21 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.873 1.669 . . . . 0.0 110.491 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.38 124.49 27.21 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.461 1.105 . . . . 0.0 109.687 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -89.28 46.66 1.4 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.772 1.229 . . . . 0.0 112.493 -168.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.37 2.7 p -64.49 -27.86 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -60.45 -41.56 94.34 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.084 1.765 . . . . 0.0 111.708 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.36 -49.29 9.48 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.4 mt -57.11 -46.21 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.527 1.131 . . . . 0.0 111.525 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.76 68.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.841 1.201 . . . . 0.0 112.681 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -68.99 -39.89 79.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.868 1.267 . . . . 0.0 111.551 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.43 -27.03 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.132 1.373 . . . . 0.0 113.334 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 m -41.77 -61.39 1.49 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.318 1.847 . . . . 0.0 113.928 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.91 -21.87 73.45 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.349 2.032 . . . . 0.0 113.093 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.14 -61.54 1.87 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.78 1.632 . . . . 0.0 110.424 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -28.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.696 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -57.57 -46.84 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -74.73 -50.42 17.49 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.438 0.637 . . . . 0.0 111.168 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.01 71.16 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.53 -15.12 61.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.05 -33.48 17.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.224 1.374 . . . . 0.0 111.526 168.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -61.43 -37.96 85.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.262 1.025 . . . . 0.0 111.897 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -143.42 61.18 1.39 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.951 1.3 . . . . 0.0 113.0 -170.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -54.52 -37.16 65.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.386 1.874 . . . . 0.0 113.022 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.79 -10.04 59.06 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.43 162.65 19.88 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.258 1.023 . . . . 0.0 112.803 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -63.78 136.87 57.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.135 1.374 . . . . 0.0 110.808 173.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.18 -39.67 79.51 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.009 0.924 . . . . 0.0 112.785 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -65.25 -37.67 87.96 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.208 -0.933 . . . . 0.0 112.345 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.24 -39.99 88.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.468 1.107 . . . . 0.0 111.27 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -38.56 80.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.9 -43.67 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.267 0.627 . . . . 0.0 110.618 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -61.94 -45.01 95.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.472 0.709 . . . . 0.0 112.088 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.55 -47.88 87.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.706 1.146 . . . . 0.0 113.159 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -73.11 -31.43 64.33 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.659 1.23 . . . . 0.0 113.348 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.31 -44.2 95.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.067 1.303 . . . . 0.0 111.081 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.62 -48.79 79.28 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.794 0.837 . . . . 0.0 110.935 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -30.3 70.87 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.885 -1.134 . . . . 0.0 111.728 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 124.263 1.025 . . . . 0.0 112.234 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 C--O 1.231 0.171 0 N-CA-C 115.96 1.485 . . . . 0.0 115.96 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.91 15.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.344 2.258 . . . . 0.0 114.555 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.408 ' HA ' ' CE2' ' B' ' 163' ' ' PHE . 0.7 OUTLIER -134.1 10.05 3.84 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.812 1.645 . . . . 0.0 113.586 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 13.9 m -141.6 -2.23 1.23 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -170.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -132.91 156.72 46.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.554 1.142 . . . . 0.0 113.243 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 40.3 p -87.2 163.21 17.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.301 1.041 . . . . 0.0 112.046 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.321 0.1 OUTLIER -67.62 -4.25 11.37 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -172.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -35.42 68.67 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.715 -1.241 . . . . 0.0 111.243 168.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.07 -23.74 67.25 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.4 -0.813 . . . . 0.0 112.984 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -67.5 -18.51 65.08 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.074 -1.016 . . . . 0.0 112.219 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.27 -18.62 31.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.094 0.958 . . . . 0.0 112.819 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.32 50.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 112.886 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.75 139.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.939 1.695 . . . . 0.0 110.749 170.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.87 159.35 33.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.459 1.104 . . . . 0.0 113.466 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -52.73 -35.61 56.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.25 1.42 . . . . 0.0 112.303 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -62.73 -22.93 66.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.31 -2.98 6.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.216 1.406 . . . . 0.0 112.909 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -60.18 -47.22 97.31 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 119.625 -1.922 . . . . 0.0 111.706 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.52 -20.19 60.61 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.945 2.43 . . . . 0.0 113.812 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 94.1 m -75.19 -37.78 61.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.889 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.432 1.093 . . . . 0.0 112.013 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.67 -46.47 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.088 0.955 . . . . 0.0 109.511 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.96 13.42 0.48 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 127.106 2.289 . . . . 0.0 117.081 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.36 -54.1 2.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.843 1.822 . . . . 0.0 110.538 167.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.75 92.5 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.838 -1.164 . . . . 0.0 111.3 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.31 -37.47 52.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.35 94.45 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.728 -1.232 . . . . 0.0 111.58 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -32.29 58.25 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.849 -0.532 . . . . 0.0 111.184 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.24 -29.26 68.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.935 0.789 . . . . 0.0 112.55 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -89.48 -8.12 53.58 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . 0.401 ' HB3' ' H ' ' B' ' 132' ' ' ASP . 30.4 mmtt -136.18 -148.01 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.372 1.869 . . . . 0.0 111.493 -168.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' B' ' 131' ' ' LYS . 23.7 t70 -170.36 -48.83 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 130.839 3.655 . . . . 0.0 110.908 -173.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.42 165.83 33.84 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 128.436 2.694 . . . . 0.0 109.518 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.15 7.55 4.93 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 121.917 1.72 . . . . 0.0 115.15 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -64.24 -25.62 68.14 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.836 -1.165 . . . . 0.0 112.592 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.73 8.6 26.91 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.274 1.83 . . . . 0.0 112.476 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.47 125.83 33.34 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 119.888 -1.758 . . . . 0.0 111.927 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.89 134.52 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.103 1.761 . . . . 0.0 106.93 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -77.31 107.49 9.76 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.312 0.96 . . . . 0.0 110.349 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -89.57 51.23 2.05 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.36 1.864 . . . . 0.0 111.704 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.269 3.6 p -62.0 -35.98 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -166.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.2 -36.99 78.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.706 2.048 . . . . 0.0 111.856 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.68 -46.96 51.75 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.267 0.46 . . . . 0.0 112.336 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.06 -45.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.579 1.152 . . . . 0.0 111.492 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.87 75.27 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.824 1.25 . . . . 0.0 112.222 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 49.6 m -64.82 -42.53 94.91 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.869 0.868 . . . . 0.0 111.95 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.69 -27.01 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.133 1.373 . . . . 0.0 112.974 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.6 m -42.33 -61.13 1.72 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 126.247 1.819 . . . . 0.0 113.886 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.76 -23.02 75.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.177 1.918 . . . . 0.0 112.93 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.26 -58.11 4.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.211 1.004 . . . . 0.0 111.466 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -24.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.638 1.108 . . . . 0.0 113.016 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 11.8 t -62.76 -50.74 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.712 1.142 . . . . 0.0 110.674 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.11 -43.63 42.32 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.152 -0.343 . . . . 0.0 111.667 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.53 81.42 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 120.956 -1.09 . . . . 0.0 112.177 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 92.0 m -76.88 -3.69 39.91 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.932 -1.105 . . . . 0.0 113.97 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -37.22 11.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.377 1.071 . . . . 0.0 111.592 168.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.11 -32.27 50.44 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -121.55 45.96 2.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.686 1.995 . . . . 0.0 110.744 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -50.48 -30.11 12.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.811 1.244 . . . . 0.0 113.272 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -90.17 -0.92 57.85 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.386 1.474 . . . . 0.0 112.958 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.25 159.42 33.47 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.856 1.262 . . . . 0.0 112.713 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.89 142.11 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.583 1.553 . . . . 0.0 112.463 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' B' ' 103' ' ' ASN . 14.5 p90 -43.71 -47.12 7.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.787 2.435 . . . . 0.0 115.966 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -95.18 -38.06 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.765 1.226 . . . . 0.0 110.904 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.23 -33.61 75.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.816 0.847 . . . . 0.0 112.324 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -73.93 -36.43 64.68 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.211 1.004 . . . . 0.0 113.049 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.4 -50.89 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.374 -0.829 . . . . 0.0 110.55 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.61 -37.47 82.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.411 1.084 . . . . 0.0 112.416 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.03 88.69 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.97 1.272 . . . . 0.0 113.063 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -71.83 -35.3 69.85 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.975 1.388 . . . . 0.0 112.638 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -59.74 -42.14 92.49 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.191 -0.943 . . . . 0.0 111.96 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.14 -47.52 85.57 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.796 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -23.31 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.932 -1.105 . . . . 0.0 112.678 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.33 -44.94 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.638 1.975 . . . . 0.0 113.149 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 124.767 1.227 . . . . 0.0 113.05 -173.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.531 0.362 0 CA-C-O 121.176 0.407 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.99 -23.35 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.2 -4.86 59.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.944 1.697 . . . . 0.0 115.108 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.8 m -127.85 -25.68 3.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.183 1.393 . . . . 0.0 114.341 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.47 160.03 32.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.308 1.052 . . . . 0.0 111.892 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -93.36 168.3 11.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.088 1.423 . . . . 0.0 113.645 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -26.02 67.91 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.787 168.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.78 -43.09 99.72 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.772 -1.205 . . . . 0.0 110.751 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.18 -28.06 69.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.176 -0.953 . . . . 0.0 112.344 169.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD2' ' CE1' ' A' ' 74' ' ' PHE . 41.1 t80 -69.37 -12.83 61.99 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.687 -1.258 . . . . 0.0 112.62 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 mt -94.47 -7.84 40.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.325 1.05 . . . . 0.0 112.49 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.88 -31.17 28.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 0.0 111.633 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.79 138.12 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.276 1.43 . . . . 0.0 110.608 169.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.2 159.61 33.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.185 1.394 . . . . 0.0 113.619 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.39 -36.28 75.52 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.038 -1.039 . . . . 0.0 112.076 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.9 m -61.26 -24.47 66.41 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.933 1.693 . . . . 0.0 113.806 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.33 -3.43 7.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.217 1.407 . . . . 0.0 113.033 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -58.13 -47.59 98.58 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.224 -1.548 . . . . 0.0 110.852 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 -16.48 50.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.738 2.292 . . . . 0.0 114.007 172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.5 m -77.84 -38.75 45.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.295 1.438 . . . . 0.0 110.738 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.61 97.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.612 1.165 . . . . 0.0 112.23 168.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.77 -46.48 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.86 -48.21 57.73 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 125.736 1.636 . . . . 0.0 114.684 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -68.78 -36.22 78.02 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.995 2.397 . . . . 0.0 112.551 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.1 75.23 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.853 0.751 . . . . 0.0 112.325 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -80.43 -46.52 15.82 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.477 -0.764 . . . . 0.0 111.645 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.96 78.08 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.016 -1.052 . . . . 0.0 111.735 -171.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -24.67 61.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.163 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 -14.6 63.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -89.18 -28.64 19.87 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.87 -121.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -168.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -158.89 -72.88 0.08 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.43 2.292 . . . . 0.0 111.078 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -103.13 163.95 16.48 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 126.75 2.02 . . . . 0.0 110.7 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.2 10.18 3.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.602 2.202 . . . . 0.0 114.402 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -12.73 61.65 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.906 -1.121 . . . . 0.0 112.949 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.79 30.47 4.04 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.605 1.962 . . . . 0.0 111.722 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.21 136.19 33.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 119.724 -1.86 . . . . 0.0 113.489 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.72 141.77 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.966 1.707 . . . . 0.0 109.192 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.54 131.94 46.62 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.456 1.503 . . . . 0.0 111.73 -168.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -83.26 50.48 1.76 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 119.982 -1.699 . . . . 0.0 111.958 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.431 2.1 p -66.85 -45.26 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -163.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.63 -34.24 72.53 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 121.621 2.009 . . . . 0.0 111.526 174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.16 -53.44 18.25 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.737 0.684 . . . . 0.0 112.448 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 mt -52.27 -46.45 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.784 1.634 . . . . 0.0 110.872 171.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.05 75.58 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.441 1.096 . . . . 0.0 113.103 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.6 m -71.48 -36.98 71.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 111.793 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -87.02 -23.11 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 112.923 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -47.32 -59.46 5.44 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 125.922 1.689 . . . . 0.0 112.412 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.84 -2.12 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.258 2.639 . . . . 0.0 114.219 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.82 -64.95 1.07 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 171.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.91 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.652 -1.28 . . . . 0.0 113.004 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 t -58.57 -48.45 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.163 0.985 . . . . 0.0 110.838 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.01 -48.53 20.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.335 0.588 . . . . 0.0 110.904 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.86 69.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 25.3 m -77.19 -13.59 59.92 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.85 -32.85 17.59 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.886 1.221 . . . . 0.0 111.068 167.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.59 -38.62 88.24 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.835 0.854 . . . . 0.0 111.854 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -139.06 57.5 1.66 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.017 1.327 . . . . 0.0 112.765 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -52.84 -36.07 58.28 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.754 1.621 . . . . 0.0 113.108 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.21 -8.34 59.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.265 1.026 . . . . 0.0 113.519 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.75 161.21 27.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.213 1.005 . . . . 0.0 112.711 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.23 132.86 47.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.747 1.219 . . . . 0.0 110.235 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CD2' ' A' ' 21' ' ' PHE . 50.5 t80 -58.26 -44.22 88.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -66.17 -33.78 76.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.516 1.053 . . . . 0.0 112.221 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.11 -31.47 71.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.304 0.641 . . . . 0.0 112.372 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -70.16 -37.11 75.12 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.219 -0.926 . . . . 0.0 113.243 169.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -42.6 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 118.962 0.801 . . . . 0.0 110.597 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -62.1 -45.72 92.24 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.828 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.18 -43.42 98.64 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.26 0.933 . . . . 0.0 113.322 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -75.59 -25.29 56.88 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.118 -1.225 . . . . 0.0 113.573 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -67.42 -42.21 83.57 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.958 -1.089 . . . . 0.0 110.592 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.451 1.101 . . . . 0.0 112.165 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -49.0 16.59 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.32 1.848 . . . . 0.0 113.003 169.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.25 3.1 mt . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.888 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 116.135 1.552 . . . . 0.0 116.135 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.5 2.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.21 1.404 . . . . 0.0 114.573 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.459 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 17.1 m-80 -119.72 20.92 12.2 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.257 1.823 . . . . 0.0 112.898 169.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 57.0 m -142.49 -24.63 0.65 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.78 166.8 22.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -170.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.7 p -112.44 154.05 26.42 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.14 1.776 . . . . 0.0 110.434 168.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -25.21 62.24 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.8 -43.01 68.99 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.052 1.341 . . . . 0.0 111.184 170.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.72 -22.02 61.69 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.37 -0.831 . . . . 0.0 112.805 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -68.44 -15.06 63.41 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 111.861 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -91.27 -12.48 35.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.01 1.324 . . . . 0.0 113.061 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.32 -34.0 55.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.417 1.087 . . . . 0.0 112.743 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.04 137.28 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.608 1.563 . . . . 0.0 110.546 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.81 160.12 31.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.073 1.349 . . . . 0.0 113.724 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -59.48 -34.63 72.8 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 0.0 111.932 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.1 m -62.64 -25.01 67.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.036 1.734 . . . . 0.0 113.855 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.62 -6.03 8.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.797 1.239 . . . . 0.0 113.38 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -58.04 -42.68 96.39 Favored Pre-proline 0 N--CA 1.481 1.077 0 O-C-N 119.927 -1.733 . . . . 0.0 113.396 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.88 -28.37 86.28 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.962 2.441 . . . . 0.0 112.93 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -75.93 -33.52 59.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.373 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.55 83.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.528 1.531 . . . . 0.0 113.665 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.27 -33.23 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.221 0.919 . . . . 0.0 110.18 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.13 -52.78 44.75 Favored Glycine 0 C--O 1.216 -1.007 0 C-N-CA 124.535 1.064 . . . . 0.0 113.225 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.08 -12.76 29.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.973 2.387 . . . . 0.0 113.892 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.48 -62.41 1.46 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.762 0.825 . . . . 0.0 110.659 164.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -68.19 -34.33 76.08 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.897 -1.127 . . . . 0.0 113.257 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.74 81.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.197 1.799 . . . . 0.0 112.114 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -39.29 50.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.584 1.154 . . . . 0.0 110.471 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -9.72 50.5 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -173.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -87.71 -23.92 24.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.233 1.013 . . . . 0.0 113.311 173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -153.95 -122.03 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.857 1.263 . . . . 0.0 114.044 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -162.24 -65.44 0.05 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.403 1.881 . . . . 0.0 112.055 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -116.02 161.91 28.51 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 126.229 1.812 . . . . 0.0 110.568 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.5 11.61 2.84 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.364 2.043 . . . . 0.0 114.407 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.13 -34.11 65.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.06 1.344 . . . . 0.0 111.785 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.48 19.34 16.98 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.494 1.918 . . . . 0.0 112.733 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.7 118.2 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 119.78 -1.825 . . . . 0.0 111.229 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.69 -4.91 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.003 1.321 . . . . 0.0 112.389 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 59.61 112.75 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.414 3.085 . . . . 0.0 112.869 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -91.99 62.48 4.26 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.634 -1.291 . . . . 0.0 111.744 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 1.2 p -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 117.338 -1.315 . . . . 0.0 114.041 -168.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -63.96 -35.31 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.789 2.086 . . . . 0.0 111.672 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.89 -48.36 61.27 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.679 0.657 . . . . 0.0 111.857 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.88 -40.52 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.122 0.969 . . . . 0.0 112.257 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.62 71.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.785 1.234 . . . . 0.0 112.382 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 0.0 111.632 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.95 -33.1 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.356 1.463 . . . . 0.0 113.319 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.9 m -43.89 -58.37 4.78 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 126.235 1.814 . . . . 0.0 113.855 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.92 -11.36 30.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.807 2.338 . . . . 0.0 113.822 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -65.61 0.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.667 1.187 . . . . 0.0 111.601 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.441 HD11 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.0 -27.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.664 -1.272 . . . . 0.0 113.671 -173.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.5 -44.68 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.526 1.057 . . . . 0.0 112.304 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -73.68 -46.75 44.43 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.024 0.929 . . . . 0.0 110.885 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.27 67.54 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 113.2 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 9.4 m -74.87 -13.07 60.51 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -33.92 18.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.317 1.417 . . . . 0.0 110.755 167.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -60.76 -40.35 92.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.807 0.843 . . . . 0.0 112.16 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -132.81 64.99 1.6 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.727 1.211 . . . . 0.0 111.902 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -52.15 -32.61 36.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.512 -1.367 . . . . 0.0 113.63 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -92.83 1.31 57.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.825 1.25 . . . . 0.0 113.068 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.96 154.53 41.4 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.246 1.022 . . . . 0.0 112.301 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.97 152.25 33.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.834 1.654 . . . . 0.0 112.61 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.459 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 35.0 p90 -47.6 153.9 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.982 1.713 . . . . 0.0 113.526 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 43.7 tttt 60.82 -40.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 129.642 3.177 . . . . 0.0 115.93 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.41 -34.67 77.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.485 1.914 . . . . 0.0 112.199 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -69.09 -37.81 78.62 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.605 -0.684 . . . . 0.0 112.334 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.15 -41.3 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 119.101 0.864 . . . . 0.0 111.11 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.13 -45.44 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.664 0.786 . . . . 0.0 111.633 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.83 95.41 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.994 1.283 . . . . 0.0 113.485 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.95 -35.66 77.03 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 112.593 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -63.66 -36.94 85.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.69 -1.256 . . . . 0.0 112.007 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.87 -47.48 77.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.501 0.72 . . . . 0.0 111.683 171.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -24.66 67.57 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.573 -1.329 . . . . 0.0 111.93 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.7 mt -75.6 -45.96 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.934 1.693 . . . . 0.0 112.687 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.075 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 N--CA 1.476 0.481 0 N-CA-C 112.487 0.149 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.37 -16.44 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -76.76 -35.15 57.91 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.33 1.052 . . . . 0.0 112.615 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.8 m -100.48 -22.49 14.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.325 2.25 . . . . 0.0 113.904 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -64.78 140.78 58.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.018 2.527 . . . . 0.0 109.648 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.4 p -100.95 166.47 10.81 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.827 1.298 . . . . 0.0 113.54 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.16 -25.28 66.88 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.587 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -65.5 -42.83 91.69 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.853 -1.155 . . . . 0.0 110.421 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.59 -27.05 68.92 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.848 -0.532 . . . . 0.0 112.09 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -69.08 -12.19 61.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.785 -1.197 . . . . 0.0 113.119 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.09 -6.45 38.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.754 1.221 . . . . 0.0 112.64 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.13 -30.51 21.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.674 1.189 . . . . 0.0 112.375 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 p -72.56 141.95 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.751 1.62 . . . . 0.0 110.753 169.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.17 160.31 32.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.46 1.104 . . . . 0.0 113.084 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.21 -35.41 73.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.726 1.21 . . . . 0.0 111.848 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -62.95 -21.96 66.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.547 1.539 . . . . 0.0 113.79 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.09 -5.25 6.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 113.47 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -55.42 -47.22 99.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 O-C-N 120.131 -1.606 . . . . 0.0 111.478 170.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -60.47 -25.74 81.22 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.565 2.177 . . . . 0.0 113.857 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -70.5 -34.44 72.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.391 0.676 . . . . 0.0 111.915 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.05 -46.52 74.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.848 1.203 . . . . 0.0 113.005 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.11 -34.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 118.75 0.705 . . . . 0.0 110.249 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.13 88.13 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 118.819 -0.989 . . . . 0.0 113.524 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.13 -24.16 66.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.249 2.524 . . . . 0.0 113.609 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.88 -55.25 4.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.495 -0.753 . . . . 0.0 110.939 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -68.01 -31.64 71.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.454 -0.779 . . . . 0.0 112.5 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.98 84.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.396 1.078 . . . . 0.0 111.576 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -36.75 49.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.329 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -23.15 63.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -81.6 -17.91 46.59 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.85 -122.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.186 1.394 . . . . 0.0 112.341 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -160.8 -66.99 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.399 1.48 . . . . 0.0 113.03 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -129.73 164.29 41.16 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 127.906 2.482 . . . . 0.0 109.669 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 3.82 6.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.352 1.519 . . . . 0.0 114.716 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -55.27 -23.79 24.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.479 1.512 . . . . 0.0 112.564 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.16 9.27 15.8 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.788 2.035 . . . . 0.0 113.014 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.76 125.16 32.31 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 119.614 -1.929 . . . . 0.0 113.644 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.38 129.53 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.933 2.093 . . . . 0.0 105.866 173.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 116.62 10.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.14 1.336 . . . . 0.0 109.678 -173.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.47 58.2 4.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.806 1.642 . . . . 0.0 110.991 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -69.55 -31.67 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.74 -35.13 79.86 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 121.239 1.836 . . . . 0.0 111.875 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.84 68.24 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.724 0.678 . . . . 0.0 112.237 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.41 -47.31 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.6 1.16 . . . . 0.0 111.123 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.76 -28.3 67.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.359 1.464 . . . . 0.0 112.993 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.5 m -66.02 -48.52 70.87 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.771 1.229 . . . . 0.0 111.001 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.67 -19.98 8.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -46.9 -63.07 1.52 Allowed Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 125.129 1.372 . . . . 0.0 112.258 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.65 -5.61 16.56 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.553 2.835 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.57 -61.15 1.83 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.437 1.495 . . . . 0.0 110.05 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.64 -30.72 48.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 124.752 1.221 . . . . 0.0 111.721 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.08 -44.18 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.431 1.014 . . . . 0.0 112.849 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -74.42 -46.01 42.85 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.029 0.531 . . . . 0.0 109.706 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.31 75.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.927 0.891 . . . . 0.0 112.861 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.8 m -74.24 -17.43 60.88 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -30.58 32.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.257 1.39 . . . . 0.0 110.79 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -65.29 -38.68 91.01 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.329 0.652 . . . . 0.0 112.626 170.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -130.26 55.81 1.79 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.606 1.563 . . . . 0.0 112.674 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -49.27 -40.19 33.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.602 1.161 . . . . 0.0 112.845 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.29 -2.5 57.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.105 0.962 . . . . 0.0 113.494 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.53 158.74 28.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.16 0.984 . . . . 0.0 112.007 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.9 141.32 47.88 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.825 0.85 . . . . 0.0 110.588 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -66.9 -47.39 71.94 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -64.14 -33.24 75.34 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.064 -1.023 . . . . 0.0 113.009 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.64 -34.03 74.98 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.241 0.616 . . . . 0.0 111.979 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -75.07 -36.38 61.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.28 -39.88 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.295 1.407 . . . . 0.0 111.203 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -61.55 -45.68 93.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.477 0.711 . . . . 0.0 111.584 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.16 -45.48 95.25 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.74 1.162 . . . . 0.0 113.789 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.24 -35.57 63.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.752 1.276 . . . . 0.0 112.867 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -59.58 -40.42 87.33 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.69 1.132 . . . . 0.0 111.562 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.66 -46.17 89.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.515 1.126 . . . . 0.0 112.052 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -26.39 68.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.205 -0.934 . . . . 0.0 112.331 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 124.722 1.209 . . . . 0.0 112.291 -178.042 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.542 0.877 0 N-CA-C 114.007 0.733 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -63.62 6.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 127.041 2.137 . . . . 0.0 115.796 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 2.1 p30 -135.36 32.53 3.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.635 2.374 . . . . 0.0 111.215 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -148.28 -47.53 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.175 1.39 . . . . 0.0 113.673 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -99.01 139.3 34.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.872 0.869 . . . . 0.0 111.346 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 p -75.29 172.19 12.88 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.202 1.801 . . . . 0.0 114.578 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -21.63 1.54 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -55.34 -36.09 65.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.952 1.251 . . . . 0.0 111.444 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.6 -26.38 68.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.245 -0.91 . . . . 0.0 112.829 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -70.18 -18.45 63.19 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.206 -0.933 . . . . 0.0 111.884 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -91.84 -21.23 20.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 112.222 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.31 -34.25 61.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.663 1.185 . . . . 0.0 112.49 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.85 137.48 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.083 1.353 . . . . 0.0 110.64 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.35 158.31 31.94 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.065 1.346 . . . . 0.0 113.303 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -57.91 -35.82 71.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.684 1.194 . . . . 0.0 112.213 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -22.98 65.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.699 1.6 . . . . 0.0 114.002 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.82 0.09 6.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.56 1.544 . . . . 0.0 112.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.17 -42.75 94.97 Favored Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 119.765 -1.834 . . . . 0.0 112.788 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -61.66 -26.84 80.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.582 2.188 . . . . 0.0 113.386 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -74.57 -32.86 62.53 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 124.105 0.962 . . . . 0.0 111.246 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.27 90.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.85 1.26 . . . . 0.0 114.11 170.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.05 -36.15 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.436 1.016 . . . . 0.0 110.69 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.01 -49.48 58.85 Favored Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.889 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.25 -13.57 60.59 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.797 2.299 . . . . 0.0 114.331 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.64 -56.7 2.92 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.753 -0.592 . . . . 0.0 109.862 165.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.09 -37.28 81.03 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.154 -0.966 . . . . 0.0 113.032 -169.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.88 72.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.655 1.982 . . . . 0.0 112.397 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -37.2 16.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.167 1.387 . . . . 0.0 110.676 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.02 -30.46 35.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.375 1.87 . . . . 0.0 113.798 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -98.33 -10.86 23.18 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -170.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.25 1.1 ptpm? -150.0 -126.7 0.05 OUTLIER 'General case' 0 C--N 1.351 0.636 0 CA-C-N 120.114 1.325 . . . . 0.0 113.328 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -161.82 -48.63 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -167.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -143.54 161.4 47.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 126.92 2.088 . . . . 0.0 110.664 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.51 -1.08 11.29 Favored 'Trans proline' 0 C--N 1.358 1.034 0 CA-C-N 121.453 1.555 . . . . 0.0 115.654 -174.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.83 -24.85 54.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.629 1.172 . . . . 0.0 113.037 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -114.86 7.06 15.62 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.0 1.72 . . . . 0.0 113.176 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.9 123.68 32.28 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 119.727 -1.858 . . . . 0.0 112.035 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.5 136.8 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 110.2 4.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.323 1.419 . . . . 0.0 108.186 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -91.02 59.64 4.1 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.072 0.949 . . . . 0.0 110.356 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.326 2.9 p -67.39 -15.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.063 -1.023 . . . . 0.0 112.183 -170.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.23 -33.03 57.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.416 1.486 . . . . 0.0 112.245 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.34 -61.23 1.92 Allowed Glycine 0 N--CA 1.467 0.728 0 C-N-CA 124.443 1.02 . . . . 0.0 112.171 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.48 -44.4 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.842 -1.387 . . . . 0.0 113.189 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.95 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.989 1.268 . . . . 0.0 112.547 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 8.9 m -67.31 -46.68 72.82 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.548 1.139 . . . . 0.0 112.066 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.99 -16.33 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.4 m -41.5 -60.47 1.83 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 125.906 1.682 . . . . 0.0 113.359 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.47 -14.39 44.66 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.73 2.287 . . . . 0.0 113.361 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.05 -57.61 3.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.723 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -37.98 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 119.392 0.996 . . . . 0.0 112.221 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.96 -43.22 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.99 -0.443 . . . . 0.0 112.052 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -71.31 -47.45 56.61 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.931 0.893 . . . . 0.0 110.866 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.95 71.64 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.496 -1.378 . . . . 0.0 113.205 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.4 m -76.16 -11.03 59.86 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.02 -34.15 16.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.397 1.453 . . . . 0.0 110.614 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -57.94 -38.67 76.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.308 1.043 . . . . 0.0 111.996 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -145.53 86.4 1.74 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.906 0.86 . . . . 0.0 112.001 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -55.0 -28.48 52.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.574 1.55 . . . . 0.0 112.89 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.23 3.5 55.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 113.048 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.46 161.08 15.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.115 1.366 . . . . 0.0 113.828 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.52 54.73 0.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.505 1.922 . . . . 0.0 113.495 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 1.1 p90 45.2 -104.31 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 115.391 166.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -48.45 -32.67 8.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.155 2.182 . . . . 0.0 113.892 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.03 -29.67 68.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 112.703 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -72.52 -39.71 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.319 -0.863 . . . . 0.0 112.557 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.72 -39.93 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.732 1.151 . . . . 0.0 110.964 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.22 -42.32 96.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.006 0.922 . . . . 0.0 112.142 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.37 99.34 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.789 1.185 . . . . 0.0 113.354 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.72 -34.15 66.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 1.153 . . . . 0.0 112.574 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -58.14 -42.77 86.6 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.781 1.173 . . . . 0.0 111.475 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.03 -45.17 94.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 0.0 111.624 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -23.89 67.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.982 -1.074 . . . . 0.0 112.655 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 19.0 mt -85.97 -49.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.334 1.853 . . . . 0.0 112.661 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 125.653 1.581 . . . . 0.0 112.92 -171.071 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -73.69 0.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.08 1.352 . . . . 0.0 113.886 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HA ' ' CE1' ' A' ' 74' ' ' PHE . 61.1 m-80 -123.98 19.79 9.2 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.76 1.624 . . . . 0.0 112.864 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -140.06 -39.87 0.44 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -94.81 153.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 111.818 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -79.97 175.39 10.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.698 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -19.4 0.66 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -55.8 -31.74 62.9 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 120.041 1.292 . . . . 0.0 112.029 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.04 -33.25 64.77 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.002 -1.061 . . . . 0.0 111.901 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.03 -10.62 60.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 mt -103.77 -22.17 13.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.53 70.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.202 1.001 . . . . 0.0 111.745 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.24 137.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 111.201 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.47 158.88 30.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.375 1.07 . . . . 0.0 112.683 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.16 -34.29 56.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.11 1.364 . . . . 0.0 112.153 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 m -60.04 -28.18 67.54 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.066 1.746 . . . . 0.0 113.697 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -127.49 0.4 6.25 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.655 1.582 . . . . 0.0 113.179 -171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.88 -45.88 99.91 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.533 -1.354 . . . . 0.0 111.883 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -60.15 -25.43 79.9 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.935 2.423 . . . . 0.0 113.938 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.6 m -77.84 -30.79 51.22 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.331 1.053 . . . . 0.0 111.56 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.43 85.57 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.883 -1.136 . . . . 0.0 113.36 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.27 -36.87 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 119.108 0.867 . . . . 0.0 110.084 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.53 -52.76 31.77 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 124.628 1.109 . . . . 0.0 113.234 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -69.34 -15.21 63.28 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 121.374 2.587 . . . . 0.0 114.128 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.17 -31.79 15.34 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.498 1.044 . . . . 0.0 113.183 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -93.65 -29.36 15.48 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.17 90.12 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.164 1.785 . . . . 0.0 111.963 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -36.05 27.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.979 0.912 . . . . 0.0 111.106 -174.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -65.06 -27.09 68.55 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -91.59 -9.08 45.46 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.85 -130.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.159 1.784 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.23 -43.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.282 1.833 . . . . 0.0 114.556 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.6 mmpp? -128.13 164.51 36.88 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 127.193 2.197 . . . . 0.0 110.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.13 -2.72 8.75 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.016 1.811 . . . . 0.0 114.281 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.62 -22.87 65.32 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.85 -1.157 . . . . 0.0 113.061 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.92 -5.11 23.84 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.563 1.545 . . . . 0.0 114.03 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 127.52 32.91 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.947 -1.096 . . . . 0.0 113.739 -169.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.26 128.29 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.212 1.805 . . . . 0.0 107.303 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.04 120.78 14.83 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 119.153 0.888 . . . . 0.0 110.439 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -90.15 52.42 2.26 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.58 -1.325 . . . . 0.0 111.369 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.295 0.9 OUTLIER -64.32 -28.21 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -167.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -59.42 -39.9 85.01 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.756 2.071 . . . . 0.0 111.458 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.08 -54.6 13.15 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.48 -45.37 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.754 -0.851 . . . . 0.0 111.626 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.19 67.91 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.883 1.22 . . . . 0.0 112.747 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -69.02 -47.3 65.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.646 1.178 . . . . 0.0 111.885 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 t -89.96 -18.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -43.22 -60.8 2.17 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 125.862 1.665 . . . . 0.0 112.395 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.1 -0.47 5.63 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.585 2.856 . . . . 0.0 114.503 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.32 -57.77 2.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.082 1.753 . . . . 0.0 111.219 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -35.75 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 119.874 1.216 . . . . 0.0 111.986 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.06 -41.49 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 112.604 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -76.63 -47.7 21.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.474 0.709 . . . . 0.0 110.198 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.19 75.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.075 -1.016 . . . . 0.0 112.937 -170.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.1 m -76.2 -10.52 59.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -33.32 19.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.565 1.53 . . . . 0.0 110.381 167.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -61.52 -39.13 89.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.312 0.645 . . . . 0.0 111.695 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.45 61.29 1.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 112.744 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -54.0 -33.37 56.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.479 -1.388 . . . . 0.0 113.143 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.3 -1.82 58.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.149 1.379 . . . . 0.0 113.329 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.33 171.09 12.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.331 1.062 . . . . 0.0 113.271 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -64.71 141.02 58.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.44 1.496 . . . . 0.0 113.349 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.428 ' CE1' ' HA ' ' A' ' 14' ' ' ASN . 7.0 p90 -58.35 -41.65 85.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.762 2.425 . . . . 0.0 115.173 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -93.25 -35.5 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.598 1.159 . . . . 0.0 111.621 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.2 -30.83 69.63 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.157 0.983 . . . . 0.0 111.621 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -74.72 -40.06 61.54 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -68.21 -40.8 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.879 1.218 . . . . 0.0 111.088 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.47 -45.71 78.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.236 1.014 . . . . 0.0 111.451 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.31 -44.07 97.48 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.324 1.44 . . . . 0.0 113.401 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.74 -32.74 65.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.165 1.483 . . . . 0.0 113.171 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -62.0 -42.95 99.71 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.642 -1.287 . . . . 0.0 111.21 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.71 -46.53 89.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.806 1.242 . . . . 0.0 111.878 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -28.23 69.88 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.118 -0.989 . . . . 0.0 111.812 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 mt . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 124.055 0.942 . . . . 0.0 111.889 179.774 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 CA-C-O 120.581 0.159 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.59 -20.85 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.8 -40.17 29.18 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.51 -0.744 . . . . 0.0 112.824 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 17.9 m -94.44 -27.44 16.02 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -169.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.31 161.79 27.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.983 0.897 . . . . 0.0 111.989 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 48.9 p -100.07 171.38 7.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 122.472 1.129 . . . . 0.0 113.899 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.33 -26.21 66.39 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.62 -0.675 . . . . 0.0 112.616 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.52 -43.81 97.91 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.39 0.995 . . . . 0.0 110.146 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -63.81 -31.51 72.71 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.485 0.714 . . . . 0.0 111.895 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 89.7 t80 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.765 1.166 . . . . 0.0 111.328 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.48 -8.2 55.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.01 45.2 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.319 0.963 . . . . 0.0 112.164 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.03 140.6 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.333 1.853 . . . . 0.0 109.124 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.35 155.3 35.77 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -52.67 -35.13 54.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.809 1.244 . . . . 0.0 112.093 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.9 m -64.49 -23.49 67.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -124.53 -1.77 8.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.998 1.319 . . . . 0.0 112.787 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.32 -46.43 90.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.061 -1.65 . . . . 0.0 111.546 171.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -61.19 -25.98 81.62 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.587 2.191 . . . . 0.0 113.497 169.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 89.6 m -72.76 -36.96 67.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.208 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.49 92.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.872 1.269 . . . . 0.0 114.071 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.33 -33.05 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 119.975 1.261 . . . . 0.0 110.497 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.75 -52.0 36.3 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 124.998 1.285 . . . . 0.0 113.816 170.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -65.8 -25.85 67.43 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.663 2.231 . . . . 0.0 113.206 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.39 -58.7 3.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.091 0.86 . . . . 0.0 110.935 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -58.44 -44.07 89.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.267 1.827 . . . . 0.0 112.165 -174.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.39 -46.73 82.05 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.421 1.488 . . . . 0.0 112.075 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.88 -31.49 45.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.843 0.857 . . . . 0.0 111.809 -176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -71.2 -23.14 61.98 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -96.58 -11.5 25.27 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 -132.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.929 1.691 . . . . 0.0 110.88 -176.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -155.11 -56.2 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.998 2.119 . . . . 0.0 112.581 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -122.03 168.71 10.87 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.781 2.432 . . . . 0.0 109.965 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.22 6.28 4.58 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.66 1.573 . . . . 0.0 114.466 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.61 -26.66 68.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 112.625 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.22 21.7 15.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.686 1.995 . . . . 0.0 113.897 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.03 133.11 35.1 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.248 -1.532 . . . . 0.0 112.261 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.92 -1.36 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.67 1.188 . . . . 0.0 112.86 -173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 56.31 106.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.233 2.613 . . . . 0.0 110.561 -168.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.54 60.03 4.96 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.283 -1.511 . . . . 0.0 111.075 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.349 2.1 p -68.92 -24.77 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 120.721 -1.237 . . . . 0.0 112.282 -169.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -65.46 -42.96 91.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.723 -1.236 . . . . 0.0 112.209 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.96 -49.0 57.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.05 -43.79 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.953 1.301 . . . . 0.0 111.924 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -28.71 65.3 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.001 1.273 . . . . 0.0 112.736 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 50.5 m -69.8 -42.06 74.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 111.607 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 29.0 t -85.41 -27.79 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.971 1.708 . . . . 0.0 113.474 -171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 22.2 m -50.74 -63.44 1.88 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 112.495 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.3 -17.68 58.75 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.459 2.106 . . . . 0.0 113.096 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.76 -58.29 4.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.434 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 33.0 mt -71.88 -32.32 44.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 112.34 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.49 -51.07 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.517 1.127 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.41 -48.16 73.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.632 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.6 74.17 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.0 113.454 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.0 m -73.5 -17.55 61.21 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.12 -31.11 19.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.624 1.102 . . . . 0.0 111.886 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.97 -41.89 97.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 111.253 169.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.34 80.02 1.55 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.895 0.855 . . . . 0.0 111.448 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.78 -38.98 67.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.176 1.79 . . . . 0.0 112.408 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.24 -8.86 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -169.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.8 148.08 52.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 112.266 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -65.22 135.29 55.24 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.209 1.004 . . . . 0.0 109.214 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.464 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 61.9 t80 -62.27 -52.32 64.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -58.9 -32.45 69.53 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.734 1.152 . . . . 0.0 112.386 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -70.94 -34.51 71.55 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 112.905 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -71.61 -34.95 70.27 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.682 -1.261 . . . . 0.0 112.606 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.89 -48.96 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.066 0.946 . . . . 0.0 110.077 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -59.0 -43.17 91.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.684 1.193 . . . . 0.0 111.744 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.04 -43.94 88.2 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.392 0.996 . . . . 0.0 113.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -80.39 -30.29 37.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.389 1.095 . . . . 0.0 113.517 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . 0.44 ' CD1' ' HE3' ' B' ' 175' ' ' LYS . 45.0 m0 -57.05 -40.02 75.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.195 1.362 . . . . 0.0 111.081 169.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -70.13 -14.78 62.8 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.653 -1.279 . . . . 0.0 114.083 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -21.55 25.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.339 1.456 . . . . 0.0 113.749 170.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.59 -45.66 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 126.523 1.929 . . . . 0.0 113.997 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' B' ' 171' ' ' TRP . 55.5 mttt . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 127.094 2.158 . . . . 0.0 111.829 -175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 CA-C-O 121.276 0.448 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.87 -26.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -74.4 -27.91 60.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.176 0.991 . . . . 0.0 112.932 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.6 m -114.79 -26.87 7.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.905 1.282 . . . . 0.0 114.304 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -92.97 171.88 8.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.632 1.173 . . . . 0.0 112.951 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.5 p -97.58 165.07 12.16 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -167.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.07 -16.92 8.4 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.763 1.625 . . . . 0.0 114.491 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.4 -35.44 62.88 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.729 1.149 . . . . 0.0 111.049 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.01 -32.31 67.82 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.765 -1.21 . . . . 0.0 112.502 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.95 -7.59 51.75 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 112.318 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.77 -16.46 14.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.248 1.419 . . . . 0.0 112.207 169.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.19 65.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.545 1.138 . . . . 0.0 111.513 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.64 139.32 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.334 1.854 . . . . 0.0 109.897 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.85 158.18 28.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.69 0.796 . . . . 0.0 112.092 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.77 -34.63 62.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.782 1.233 . . . . 0.0 111.69 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.8 m -59.14 -27.69 65.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.181 1.792 . . . . 0.0 113.516 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.44 3.16 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.482 1.513 . . . . 0.0 113.117 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -55.57 -45.63 99.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 120.002 -1.686 . . . . 0.0 111.276 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -60.31 -24.64 78.1 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.324 . . . . 0.0 114.249 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.3 m -75.95 -37.62 58.44 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.791 1.236 . . . . 0.0 110.759 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.23 97.42 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.42 -37.06 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 118.808 0.731 . . . . 0.0 111.574 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.23 12.04 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.798 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.73 -44.83 93.6 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.714 2.257 . . . . 0.0 112.409 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.0 -26.65 67.64 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -94.44 -35.93 12.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.48 84.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.428 1.891 . . . . 0.0 112.18 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.27 -26.22 39.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.151 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -18.33 48.54 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.458 -0.776 . . . . 0.0 113.091 -169.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -97.2 -14.18 21.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.4 -136.06 0.1 Allowed 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.972 1.709 . . . . 0.0 110.731 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -149.97 -60.78 0.2 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.594 1.958 . . . . 0.0 113.187 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -127.5 162.96 45.69 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.973 2.109 . . . . 0.0 110.326 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.05 5.85 5.96 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.722 1.615 . . . . 0.0 114.219 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -58.57 -24.77 61.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.523 1.129 . . . . 0.0 111.446 168.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -111.22 11.94 21.78 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.781 2.032 . . . . 0.0 113.383 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.09 34.83 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.023 -1.673 . . . . 0.0 113.005 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.34 -3.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 125.065 1.346 . . . . 0.0 112.387 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.41 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.691 2.796 . . . . 0.0 110.749 -168.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -89.04 63.83 6.85 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.502 -1.374 . . . . 0.0 110.93 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.27 -28.63 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -168.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -54.13 -43.69 70.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.074 1.35 . . . . 0.0 112.199 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.9 -51.67 7.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.44 -48.19 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.188 0.995 . . . . 0.0 111.923 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.42 -28.34 67.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -70.2 -51.6 29.75 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.647 1.179 . . . . 0.0 112.539 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.01 -15.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -170.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.6 m -45.26 -63.31 1.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 120.261 1.391 . . . . 0.0 112.095 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -2.0 6.48 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.131 2.554 . . . . 0.0 114.805 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -64.13 1.14 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.964 1.706 . . . . 0.0 110.92 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -27.4 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.871 -1.143 . . . . 0.0 113.008 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -54.17 -48.2 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.926 1.29 . . . . 0.0 110.815 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -81.47 -48.47 11.82 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.239 0.543 . . . . 0.0 110.689 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.76 68.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.0 m -77.42 -13.92 59.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.08 -33.19 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.417 1.462 . . . . 0.0 110.917 168.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -61.82 -38.75 89.3 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.412 1.085 . . . . 0.0 111.847 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.82 55.61 1.72 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 0.0 112.834 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -53.75 -33.66 56.49 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.386 1.474 . . . . 0.0 113.232 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.18 -6.38 56.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.847 1.259 . . . . 0.0 113.705 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.04 159.61 26.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.785 0.834 . . . . 0.0 111.649 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -58.9 134.35 56.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 111.08 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.26 -47.24 71.31 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.391 -0.818 . . . . 0.0 112.96 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -64.27 -36.48 84.24 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.287 0.949 . . . . 0.0 111.963 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -59.61 -32.0 70.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.019 0.528 . . . . 0.0 112.068 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -74.83 -38.34 62.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.781 -1.104 . . . . 0.0 113.829 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.73 -41.15 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.923 1.692 . . . . 0.0 111.031 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.57 -44.05 91.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.317 1.047 . . . . 0.0 111.438 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.31 94.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.21 1.385 . . . . 0.0 113.5 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -71.93 -33.9 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.276 1.538 . . . . 0.0 113.4 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -60.33 -42.82 96.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.681 1.128 . . . . 0.0 111.383 171.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.04 -45.76 90.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.558 1.143 . . . . 0.0 111.969 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.59 71.62 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.002 -1.061 . . . . 0.0 111.826 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 124.142 0.977 . . . . 0.0 111.785 179.515 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 CA--C 1.541 0.854 0 CA-C-O 120.844 0.268 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.21 -26.82 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -80.08 -17.64 52.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.365 1.066 . . . . 0.0 113.563 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -106.4 -44.98 4.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.874 1.27 . . . . 0.0 113.939 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -101.8 176.05 5.35 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 77.7 p -91.2 164.55 13.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -167.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -20.7 21.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.553 1.941 . . . . 0.0 114.272 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.64 -31.78 57.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.625 1.102 . . . . 0.0 111.468 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.51 -36.32 64.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.839 1.256 . . . . 0.0 113.025 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.88 -20.05 64.25 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 111.633 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 43.4 mt -89.47 -12.52 39.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.008 1.323 . . . . 0.0 113.228 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -40.28 46.35 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.925 0.89 . . . . 0.0 111.176 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.34 137.74 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 128.013 2.525 . . . . 0.0 110.243 168.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.3 157.31 31.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.283 1.033 . . . . 0.0 112.947 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -50.34 -36.7 33.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.94 1.296 . . . . 0.0 112.68 171.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -66.58 -25.65 66.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.601 1.161 . . . . 0.0 113.483 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.4 -3.35 10.48 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.956 1.302 . . . . 0.0 113.843 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -56.88 -40.94 88.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.851 -1.781 . . . . 0.0 113.218 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -61.3 -26.82 82.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.606 2.204 . . . . 0.0 113.386 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 46.8 m -76.18 -35.0 59.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.377 1.071 . . . . 0.0 111.211 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.26 85.47 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.204 1.002 . . . . 0.0 113.228 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.78 -36.59 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 118.34 0.518 . . . . 0.0 110.926 170.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.51 -55.29 17.42 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 125.267 1.413 . . . . 0.0 113.711 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -59.89 -33.95 72.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.23 2.015 . . . . 0.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.6 -47.74 30.59 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.472 -0.768 . . . . 0.0 112.943 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.08 -32.44 50.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.71 1.141 . . . . 0.0 112.847 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.77 55.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.067 1.347 . . . . 0.0 112.066 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -30.61 68.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.76 0.824 . . . . 0.0 110.95 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -68.11 -25.79 65.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.149 0.979 . . . . 0.0 113.218 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -80.18 -22.48 41.9 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -151.95 -130.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.245 1.418 . . . . 0.0 111.25 -169.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -163.82 -38.28 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.396 1.878 . . . . 0.0 114.023 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.49 164.86 40.96 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 127.377 2.271 . . . . 0.0 109.593 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -87.65 15.09 2.22 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.395 2.063 . . . . 0.0 114.26 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.12 -30.23 67.98 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.135 1.334 . . . . 0.0 113.239 -170.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.29 8.37 18.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.538 1.535 . . . . 0.0 114.259 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.17 127.64 33.5 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.938 -1.101 . . . . 0.0 112.045 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.53 14.05 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 126.201 1.8 . . . . 0.0 111.574 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 57.72 109.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.427 3.091 . . . . 0.0 110.439 -168.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -85.68 51.89 2.32 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.071 -1.643 . . . . 0.0 112.838 -167.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.31 0.4 OUTLIER -70.44 -11.82 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.744 -1.223 . . . . 0.0 113.564 -169.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -52.66 -34.09 50.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.362 . . . . 0.0 111.077 167.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.53 -58.39 1.85 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 113.002 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -43.53 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 118.301 1.051 . . . . 0.0 113.312 -174.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.96 64.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.996 1.271 . . . . 0.0 112.642 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 73.8 m -70.03 -38.77 75.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 112.097 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.93 -24.98 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.728 1.611 . . . . 0.0 114.011 -169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.4 m -43.56 -56.25 7.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 120.283 1.401 . . . . 0.0 113.525 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.62 -9.43 18.29 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.038 2.492 . . . . 0.0 114.587 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.94 -64.52 1.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.098 1.359 . . . . 0.0 112.225 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -21.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.68 -40.76 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.845 1.202 . . . . 0.0 112.17 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.67 -47.93 13.33 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.218 1.007 . . . . 0.0 111.307 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.39 86.38 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.543 -1.348 . . . . 0.0 113.069 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -76.26 -8.66 57.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.94 -37.27 14.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.111 1.323 . . . . 0.0 111.685 169.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -75.64 -31.51 59.86 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -129.02 54.3 1.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.702 1.201 . . . . 0.0 111.752 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -52.35 -32.21 37.15 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.861 1.664 . . . . 0.0 113.075 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -90.02 -6.63 55.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.301 1.44 . . . . 0.0 114.05 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.2 156.71 31.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.95 0.796 . . . . 0.0 110.867 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -69.19 137.59 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.738 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -65.36 -38.63 90.66 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.062 -1.024 . . . . 0.0 112.721 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -59.35 -37.88 78.98 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.426 -0.796 . . . . 0.0 112.833 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.8 -35.27 76.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.27 0.628 . . . . 0.0 111.96 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -72.95 -37.9 66.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.237 -0.887 . . . . 0.0 113.235 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 14.2 m -64.45 -38.19 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.127 1.33 . . . . 0.0 111.285 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -63.79 -44.86 92.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.38 0.672 . . . . 0.0 111.948 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.1 98.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.303 0.954 . . . . 0.0 113.256 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.54 -36.06 65.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.464 1.132 . . . . 0.0 113.066 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -57.89 -41.57 82.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.406 1.003 . . . . 0.0 111.408 171.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.26 -47.56 81.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.603 1.161 . . . . 0.0 111.231 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -26.59 68.59 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.487 -1.383 . . . . 0.0 112.452 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.72 -46.62 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.982 1.713 . . . . 0.0 112.914 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 48.6 mttt . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.259 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.534 0.51 0 CA-C-O 121.466 0.528 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -62.67 -15.26 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -96.88 2.1 51.31 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.476 1.51 . . . . 0.0 113.607 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 m -137.97 -17.95 1.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.18 173.19 11.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.8 p -105.63 159.43 15.97 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.051 0.941 . . . . 0.0 111.706 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -21.32 43.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.63 -37.52 70.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.617 1.099 . . . . 0.0 111.46 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -67.68 -23.29 65.29 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.128 -0.983 . . . . 0.0 112.628 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.53 -11.05 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.877 -1.139 . . . . 0.0 111.908 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -98.34 -11.02 22.95 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.269 1.428 . . . . 0.0 112.663 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.96 -30.96 44.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.151 0.98 . . . . 0.0 111.73 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.85 137.23 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.767 2.027 . . . . 0.0 111.07 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.26 158.24 26.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 113.198 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -53.81 -33.47 56.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.956 1.302 . . . . 0.0 111.974 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 m -60.83 -27.71 68.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 113.623 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -127.18 -2.26 6.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 113.408 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.45 -43.44 98.08 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 119.91 -1.744 . . . . 0.0 112.348 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.84 -25.95 82.18 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.851 2.368 . . . . 0.0 113.367 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 52.3 m -76.23 -34.76 59.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.061 0.944 . . . . 0.0 111.531 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.63 1.172 . . . . 0.0 113.348 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.88 -34.54 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.92 0.782 . . . . 0.0 110.436 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.1 -46.05 79.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.614 1.578 . . . . 0.0 114.902 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.6 -41.62 83.75 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 121.361 2.58 . . . . 0.0 111.953 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.14 98.78 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.474 0.71 . . . . 0.0 112.173 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -85.24 -38.65 18.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.308 0.643 . . . . 0.0 112.524 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.24 63.8 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.28 -1.512 . . . . 0.0 111.146 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -18.24 61.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.123 0.569 . . . . 0.0 111.726 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -72.5 -21.71 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 113.029 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -98.04 -20.32 17.45 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.33 153.89 1.61 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 129.156 2.983 . . . . 0.0 106.56 -170.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.41 -17.92 19.39 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 128.836 2.854 . . . . 0.0 115.035 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -133.28 152.58 79.67 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.414 1.885 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -86.41 4.46 6.37 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.793 1.662 . . . . 0.0 114.503 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.15 -24.6 63.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.486 1.114 . . . . 0.0 112.439 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -111.36 15.38 21.37 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.536 1.934 . . . . 0.0 112.579 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.57 117.13 22.93 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 119.769 -1.832 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.28 107.92 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -57.32 126.77 28.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -165.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -98.01 52.25 1.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.422 1.489 . . . . 0.0 112.298 -170.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.24 -30.75 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.128 -0.983 . . . . 0.0 112.16 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -60.27 -34.78 74.21 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.256 1.389 . . . . 0.0 112.064 175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.31 -55.06 5.3 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.204 0.906 . . . . 0.0 112.835 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.19 -42.24 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.026 -1.279 . . . . 0.0 112.394 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.28 64.99 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.687 -1.258 . . . . 0.0 112.872 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -69.8 -44.07 70.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 0.0 111.616 172.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.5 -20.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -43.23 -62.51 1.33 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.751 1.62 . . . . 0.0 112.371 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.17 -0.6 6.66 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.743 2.962 . . . . 0.0 114.485 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.68 -61.37 1.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.743 1.617 . . . . 0.0 109.766 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.14 -35.01 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.72 0.808 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.94 -43.6 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.872 0.869 . . . . 0.0 112.217 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.53 -46.83 45.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.356 0.598 . . . . 0.0 110.164 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.02 72.06 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.885 0.874 . . . . 0.0 113.039 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -75.86 -13.26 60.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.61 -33.68 16.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.111 1.323 . . . . 0.0 111.072 167.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -59.67 -40.44 87.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.403 1.081 . . . . 0.0 111.714 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -138.95 71.72 1.39 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -51.99 -31.17 28.2 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.649 1.18 . . . . 0.0 113.149 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -92.32 1.29 57.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 113.067 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.59 150.98 42.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.083 0.953 . . . . 0.0 112.053 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -93.38 103.03 15.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.938 1.295 . . . . 0.0 112.451 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.258 14.7 p90 43.12 -144.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -53.88 -17.13 2.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.644 2.778 . . . . 0.0 115.176 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.13 -27.84 62.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.168 0.987 . . . . 0.0 112.41 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -65.99 -43.34 88.06 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.733 1.151 . . . . 0.0 112.42 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.99 -38.08 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.138 0.881 . . . . 0.0 111.126 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.07 -45.18 93.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.703 0.801 . . . . 0.0 111.874 171.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.82 -43.5 98.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.93 1.252 . . . . 0.0 113.261 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.96 -35.33 69.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.039 1.42 . . . . 0.0 112.754 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -61.48 -41.26 96.99 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.909 -1.119 . . . . 0.0 111.479 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.91 -46.43 89.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.649 1.18 . . . . 0.0 111.853 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -26.66 68.48 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.004 -1.06 . . . . 0.0 111.735 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 124.28 1.032 . . . . 0.0 112.351 -179.314 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 CA--C 1.538 0.712 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -58.32 -22.98 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -79.12 -18.1 53.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.226 . . . . 0.0 114.147 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -127.4 -23.16 3.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.49 161.64 30.53 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.962 0.887 . . . . 0.0 112.845 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 50.1 p -93.99 167.2 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.646 1.212 . . . . 0.0 114.086 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.83 -26.55 66.98 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.08 -40.93 97.32 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.977 -1.077 . . . . 0.0 110.495 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.1 -31.4 72.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.106 0.563 . . . . 0.0 112.069 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -69.75 -26.75 64.46 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.47 -11.85 59.62 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.031 -1.043 . . . . 0.0 113.666 170.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.27 38.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.315 0.961 . . . . 0.0 112.866 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.51 141.91 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.045 1.738 . . . . 0.0 110.823 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.17 157.79 32.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.374 1.069 . . . . 0.0 113.346 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.34 -31.48 54.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.551 1.54 . . . . 0.0 112.04 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -61.54 -27.92 68.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.8 1.64 . . . . 0.0 114.079 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.62 -4.37 5.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.365 1.466 . . . . 0.0 112.697 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -57.02 -45.89 99.92 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 120.078 -1.639 . . . . 0.0 111.696 169.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -64.95 -22.52 62.69 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.356 2.038 . . . . 0.0 113.67 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 65.0 m -73.26 -35.81 66.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.988 0.915 . . . . 0.0 110.531 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.4 -41.91 84.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.04 -33.53 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.243 1.383 . . . . 0.0 110.875 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.94 -55.14 29.41 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 124.485 1.041 . . . . 0.0 111.912 168.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.76 -10.7 29.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 120.857 2.329 . . . . 0.0 114.408 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.15 -62.76 1.37 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.54 0.736 . . . . 0.0 110.051 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -73.43 -28.97 62.26 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.72 -1.237 . . . . 0.0 114.115 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.82 78.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.102 1.761 . . . . 0.0 112.274 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -37.79 19.26 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.737 1.215 . . . . 0.0 110.082 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -59.58 -38.67 81.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.59 1.156 . . . . 0.0 113.381 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -91.4 -9.59 44.17 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 -128.49 0.09 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.663 1.585 . . . . 0.0 110.974 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -162.6 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.279 1.431 . . . . 0.0 113.24 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -135.76 165.6 34.8 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 127.283 2.233 . . . . 0.0 109.834 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.08 2.09 8.72 Favored 'Trans proline' 0 C--N 1.354 0.868 0 CA-C-N 121.429 1.546 . . . . 0.0 114.136 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.22 -28.36 67.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.446 1.098 . . . . 0.0 112.6 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.93 -20.23 30.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.281 1.432 . . . . 0.0 113.306 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.62 123.9 24.91 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.021 -1.049 . . . . 0.0 112.983 -169.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.31 17.18 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 126.202 1.801 . . . . 0.0 110.897 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 52.63 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.983 3.713 . . . . 0.0 110.127 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.14 48.77 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.488 . . . . 0.0 112.425 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.289 3.9 p -70.77 -11.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -169.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.26 -29.73 24.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.611 1.564 . . . . 0.0 112.921 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.68 -55.62 1.88 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.71 0.671 . . . . 0.0 113.128 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 10.1 mt -51.16 -45.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.8 1.24 . . . . 0.0 113.282 -172.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.29 -28.79 63.32 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.611 1.096 . . . . 0.0 112.848 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 18.8 m -73.38 -41.59 63.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.897 1.279 . . . . 0.0 111.908 170.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 34.4 t -78.81 -28.9 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.076 1.75 . . . . 0.0 112.89 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.0 m -51.75 -63.76 1.88 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 125.697 1.599 . . . . 0.0 113.144 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.23 -18.59 61.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.745 2.297 . . . . 0.0 113.219 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.7 -58.84 3.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.893 0.877 . . . . 0.0 110.802 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 31.8 mt -72.59 -28.92 28.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 O-C-N 121.372 -0.83 . . . . 0.0 112.402 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -51.1 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 110.618 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.22 -47.42 70.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.719 0.408 . . . . 0.0 110.903 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.09 71.18 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.739 -1.225 . . . . 0.0 113.239 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.3 m -75.35 -12.7 60.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.09 -35.55 16.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.483 1.492 . . . . 0.0 110.945 167.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -58.1 -38.13 75.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.009 0.924 . . . . 0.0 111.95 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.6 57.33 1.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.567 1.147 . . . . 0.0 112.85 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -52.12 -40.33 61.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.047 1.739 . . . . 0.0 112.968 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -80.53 -7.58 59.26 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.07 165.6 17.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.239 1.016 . . . . 0.0 112.657 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -62.57 138.79 58.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.851 1.261 . . . . 0.0 110.739 170.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.41 -43.7 88.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.253 1.021 . . . . 0.0 113.294 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -65.19 -30.53 71.44 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.224 -0.923 . . . . 0.0 112.446 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.69 -38.46 81.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.472 1.109 . . . . 0.0 112.128 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -39.57 72.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.87 0.868 . . . . 0.0 112.577 172.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.91 -47.03 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 118.594 0.634 . . . . 0.0 110.302 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.16 -50.06 65.24 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.466 1.106 . . . . 0.0 111.921 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.63 98.94 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.599 1.095 . . . . 0.0 113.779 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -73.96 -33.14 63.77 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.751 1.275 . . . . 0.0 112.584 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.81 -37.26 86.04 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.965 -1.084 . . . . 0.0 111.852 170.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.83 -46.77 86.36 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.352 -0.843 . . . . 0.0 111.048 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -23.18 66.41 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 119.91 -1.744 . . . . 0.0 112.609 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -78.05 -46.58 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.358 1.863 . . . . 0.0 112.74 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 N--CA 1.482 1.169 0 C-N-CA 124.904 1.281 . . . . 0.0 113.203 -172.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.535 0.55 0 CA-C-O 121.034 0.347 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.81 -29.28 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.306 1.443 . . . . 0.0 114.507 -169.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.19 -15.96 57.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 114.13 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 t -110.95 -38.23 5.15 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 113.345 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -85.25 169.85 13.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.309 1.052 . . . . 0.0 113.597 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.5 p -99.93 161.15 13.79 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -19.51 49.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.572 1.949 . . . . 0.0 115.171 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.81 -34.98 70.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.792 1.178 . . . . 0.0 111.049 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.89 -26.53 68.65 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.081 -1.012 . . . . 0.0 112.802 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.66 -13.31 62.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.246 -0.909 . . . . 0.0 112.146 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.13 -19.36 18.72 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.644 1.178 . . . . 0.0 112.117 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.25 -37.45 32.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.759 1.224 . . . . 0.0 112.163 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.89 134.38 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 0.0 109.604 168.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.76 160.48 22.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 112.513 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.36 -36.63 73.76 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.134 -0.979 . . . . 0.0 111.788 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.6 m -59.65 -26.92 65.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.222 1.809 . . . . 0.0 113.728 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.45 -2.9 9.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.465 1.506 . . . . 0.0 112.76 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -59.07 -50.48 87.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 120.049 -1.657 . . . . 0.0 111.025 172.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -67.69 -16.85 47.34 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.294 1.996 . . . . 0.0 113.622 172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 m -75.75 -36.14 59.97 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.134 0.974 . . . . 0.0 110.912 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.18 83.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.464 1.106 . . . . 0.0 111.418 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.82 -47.41 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.257 1.023 . . . . 0.0 109.567 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 10.64 0.58 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.824 2.155 . . . . 0.0 117.209 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.64 -53.72 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.408 1.604 . . . . 0.0 109.945 167.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.7 85.11 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.221 -0.925 . . . . 0.0 112.655 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.3 -37.06 26.36 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.303 -0.873 . . . . 0.0 112.26 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.55 -49.21 72.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.993 -1.067 . . . . 0.0 111.778 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -18.32 61.03 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.956 0.902 . . . . 0.0 112.061 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -78.25 -21.97 49.06 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.062 -1.024 . . . . 0.0 112.916 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.69 -20.48 20.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.98 151.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.883 2.873 . . . . 0.0 106.969 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.95 -32.85 17.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.936 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -134.61 159.51 71.94 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 127.386 2.274 . . . . 0.0 109.736 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.2 15.92 2.05 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.698 1.599 . . . . 0.0 114.426 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -61.75 -21.96 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.935 1.294 . . . . 0.0 112.307 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.31 20.14 13.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.646 1.979 . . . . 0.0 112.438 173.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.85 109.38 16.93 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 119.493 -2.004 . . . . 0.0 110.875 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.94 8.03 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.038 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 49.17 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.518 3.927 . . . . 0.0 114.67 -172.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -89.46 64.51 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.028 1.331 . . . . 0.0 111.475 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -39.1 84.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.073 -171.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.91 -36.55 84.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.366 1.439 . . . . 0.0 112.415 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.48 -48.91 59.9 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.676 0.655 . . . . 0.0 112.029 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.15 -42.79 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.528 1.131 . . . . 0.0 111.745 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.68 62.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.891 1.676 . . . . 0.0 113.159 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.1 m -72.62 -37.88 67.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.826 1.25 . . . . 0.0 111.463 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.81 -24.33 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.373 1.469 . . . . 0.0 113.626 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.8 m -49.65 -62.93 2.01 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 125.665 1.586 . . . . 0.0 112.619 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.93 -4.21 11.99 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.402 2.735 . . . . 0.0 113.926 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.35 -64.56 1.16 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.364 1.466 . . . . 0.0 108.807 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.94 -27.59 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.269 -0.894 . . . . 0.0 112.028 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -55.51 -48.43 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.674 1.189 . . . . 0.0 110.727 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.34 -48.06 18.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.546 0.688 . . . . 0.0 110.544 174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.71 69.89 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -169.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.1 m -76.94 -13.39 59.98 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -32.82 21.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.426 1.466 . . . . 0.0 110.757 168.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -61.24 -38.61 87.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.739 0.815 . . . . 0.0 112.089 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -135.81 58.72 1.74 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.379 1.471 . . . . 0.0 112.814 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -50.75 -36.1 34.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.562 -1.337 . . . . 0.0 113.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.61 -3.77 58.12 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.995 1.318 . . . . 0.0 113.624 -172.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.34 161.56 23.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.264 1.026 . . . . 0.0 111.496 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -65.52 134.64 53.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.844 1.258 . . . . 0.0 111.412 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -66.06 -52.27 50.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.397 -0.815 . . . . 0.0 112.826 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -62.33 -34.16 76.09 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.576 1.08 . . . . 0.0 112.297 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.6 -36.24 82.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.476 0.71 . . . . 0.0 112.152 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.0 -34.29 68.76 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.54 -46.2 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.089 0.556 . . . . 0.0 110.018 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -62.59 -43.4 98.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.763 0.825 . . . . 0.0 112.185 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.92 -44.38 98.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.018 1.294 . . . . 0.0 113.545 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.19 -35.1 68.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.784 1.292 . . . . 0.0 112.864 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -61.99 -38.06 87.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.909 1.232 . . . . 0.0 112.127 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.68 -49.85 75.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.537 1.135 . . . . 0.0 111.214 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -28.54 69.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.371 -1.456 . . . . 0.0 112.458 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.816 1.246 . . . . 0.0 112.541 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 CA--C 1.538 0.72 0 N-CA-C 110.962 -0.438 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.41 -24.46 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -70.85 -25.91 63.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.259 1.024 . . . . 0.0 113.445 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -126.82 -18.5 4.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.27 1.428 . . . . 0.0 114.73 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -86.68 170.59 11.66 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.013 1.725 . . . . 0.0 111.835 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.3 p -104.45 156.24 18.11 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.342 1.057 . . . . 0.0 113.142 -170.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.353 0.3 OUTLIER -73.63 -3.21 26.65 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.98 -31.6 65.22 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.851 -1.155 . . . . 0.0 111.353 168.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.38 -35.75 60.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.226 1.01 . . . . 0.0 112.754 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.25 -15.47 63.58 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.214 -0.929 . . . . 0.0 112.64 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.5 mt -92.2 -19.22 22.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.164 0.986 . . . . 0.0 112.764 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.48 -25.69 20.18 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.555 1.542 . . . . 0.0 112.954 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.93 -2.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 t70 66.12 157.85 0.11 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 128.232 2.613 . . . . 0.0 116.611 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -55.47 -35.21 65.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.155 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 30.4 m -69.04 -24.09 64.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -127.71 4.67 6.09 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.546 1.138 . . . . 0.0 112.547 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.84 -52.07 77.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 125.71 1.604 . . . . 0.0 111.998 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -61.52 -23.7 77.0 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.323 2.016 . . . . 0.0 113.573 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 23.2 m -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.007 1.323 . . . . 0.0 111.171 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.43 82.4 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.665 1.186 . . . . 0.0 113.793 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.5 -33.85 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 119.627 1.103 . . . . 0.0 110.458 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.8 -51.56 44.18 Favored Glycine 0 C--O 1.216 -0.973 0 C-N-CA 124.347 0.975 . . . . 0.0 112.795 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.65 -16.81 64.09 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.87 2.335 . . . . 0.0 113.862 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.78 -43.7 12.32 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.55 1.068 . . . . 0.0 112.211 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.55 -34.01 23.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.002 -1.061 . . . . 0.0 113.548 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.24 99.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.864 2.066 . . . . 0.0 112.69 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -34.19 34.47 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.242 1.017 . . . . 0.0 110.583 -175.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.09 -28.4 68.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -94.02 -1.73 54.05 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.53 -127.31 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.598 1.559 . . . . 0.0 111.248 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.26 -55.67 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.604 1.562 . . . . 0.0 113.513 -170.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -136.41 162.32 57.02 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 126.763 2.025 . . . . 0.0 110.446 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.31 6.01 5.05 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.729 1.619 . . . . 0.0 114.979 -174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.0 -29.37 43.03 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.944 0.898 . . . . 0.0 111.496 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -112.32 17.67 19.21 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.215 2.206 . . . . 0.0 113.117 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.94 134.78 38.54 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.174 -1.579 . . . . 0.0 113.955 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.41 -4.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.013 1.325 . . . . 0.0 113.828 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.26 119.16 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.878 2.471 . . . . 0.0 111.52 -167.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -81.95 53.25 2.15 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 119.608 -1.932 . . . . 0.0 112.016 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.404 0.6 OUTLIER -65.38 -46.9 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -163.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -60.54 -34.38 74.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.909 2.14 . . . . 0.0 111.783 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.35 -48.93 48.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.188 0.899 . . . . 0.0 112.424 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.21 -42.18 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 111.443 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.54 71.2 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.682 1.128 . . . . 0.0 112.817 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -66.35 -38.89 88.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.709 1.204 . . . . 0.0 111.682 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.6 -30.36 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.508 1.523 . . . . 0.0 113.212 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 37.0 m -45.19 -56.11 9.95 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 -7.59 16.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.445 2.763 . . . . 0.0 114.593 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -61.97 1.69 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.099 1.36 . . . . 0.0 111.658 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -20.18 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 120.884 -1.135 . . . . 0.0 113.972 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.39 -41.88 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.581 1.537 . . . . 0.0 112.018 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.01 -51.25 10.63 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 110.436 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.14 69.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.361 -1.462 . . . . 0.0 113.38 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 78.9 m -80.17 -7.37 58.91 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.73 -34.56 14.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.341 1.056 . . . . 0.0 110.44 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -60.91 -39.7 90.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.517 1.127 . . . . 0.0 112.229 171.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -142.49 54.85 1.42 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.948 0.899 . . . . 0.0 112.906 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -53.73 -37.24 63.13 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.427 1.891 . . . . 0.0 113.302 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.71 -8.85 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.842 1.257 . . . . 0.0 113.84 -169.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -83.88 166.81 17.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 112.078 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.57 139.0 56.49 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.172 1.389 . . . . 0.0 112.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -63.79 -46.97 82.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.564 1.146 . . . . 0.0 111.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -64.03 -38.52 91.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.854 0.862 . . . . 0.0 112.188 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.926 0.89 . . . . 0.0 111.952 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' B' ' 166' ' ' LYS . 0.1 OUTLIER -71.94 -43.39 65.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.189 -0.91 . . . . 0.0 113.234 174.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.37 -40.41 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.182 1.355 . . . . 0.0 111.669 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.11 -42.99 93.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.875 0.87 . . . . 0.0 112.258 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.2 -45.3 96.81 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.312 0.958 . . . . 0.0 112.983 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.77 -33.74 64.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.485 1.142 . . . . 0.0 112.973 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -59.43 -41.83 90.45 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.862 1.21 . . . . 0.0 111.943 170.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.51 -47.26 84.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.562 1.145 . . . . 0.0 111.943 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.36 68.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.161 -0.962 . . . . 0.0 112.061 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.49 -50.89 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.886 1.674 . . . . 0.0 112.175 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 125.33 1.452 . . . . 0.0 113.322 -170.237 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 CA--C 1.532 0.388 0 CA-C-O 121.312 0.463 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.97 -20.08 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.107 1.363 . . . . 0.0 114.417 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -72.7 -35.31 67.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.105 0.962 . . . . 0.0 113.523 173.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 m -110.5 -21.89 11.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.769 1.227 . . . . 0.0 114.112 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -94.37 171.27 8.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.2 1.4 . . . . 0.0 112.219 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.5 p -107.5 166.21 10.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.838 1.304 . . . . 0.0 114.498 -168.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -19.18 35.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.983 1.713 . . . . 0.0 115.436 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.49 -32.81 63.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.92 1.236 . . . . 0.0 111.365 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.83 -32.21 67.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.939 0.896 . . . . 0.0 112.728 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -74.05 -14.68 61.04 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.81 -0.556 . . . . 0.0 112.142 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.0 mt -96.45 -18.89 19.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.47 1.108 . . . . 0.0 112.281 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.76 54.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.425 1.09 . . . . 0.0 111.951 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.41 138.29 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.563 1.545 . . . . 0.0 110.652 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.23 160.51 31.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.287 1.035 . . . . 0.0 112.987 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.23 -37.43 74.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.696 1.198 . . . . 0.0 111.786 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.67 -20.84 63.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.526 1.53 . . . . 0.0 113.873 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -126.73 -2.91 6.62 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.237 1.415 . . . . 0.0 113.001 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -55.51 -47.71 98.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.143 -1.598 . . . . 0.0 111.91 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -62.45 -23.06 74.81 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.764 2.31 . . . . 0.0 113.804 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -77.02 -36.79 56.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.749 1.22 . . . . 0.0 110.977 175.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.45 98.44 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 113.519 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.91 -35.77 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 119.417 1.008 . . . . 0.0 110.329 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.54 -48.19 49.79 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.327 1.441 . . . . 0.0 114.571 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.44 -39.69 89.05 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 121.253 2.526 . . . . 0.0 112.306 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.54 76.16 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.467 -0.771 . . . . 0.0 112.528 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -85.22 -38.81 18.51 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.06 -52.52 62.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.37 1.068 . . . . 0.0 110.878 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -18.24 64.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.503 1.121 . . . . 0.0 111.732 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -80.17 -17.46 52.36 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.209 1.004 . . . . 0.0 113.386 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.27 3.3 p30 -123.39 11.12 9.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 150.21 1.49 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 129.73 3.212 . . . . 0.0 106.504 168.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -86.41 -31.8 21.24 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 128.563 2.745 . . . . 0.0 113.204 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.59 158.09 73.9 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 127.518 2.327 . . . . 0.0 109.375 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.35 5.58 6.17 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.023 1.401 . . . . 0.0 114.046 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.7 -16.36 63.32 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.603 -1.311 . . . . 0.0 112.724 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -103.58 3.98 35.19 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.339 1.855 . . . . 0.0 113.22 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.69 122.67 26.28 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 119.981 -1.699 . . . . 0.0 112.654 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.53 -7.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 125.161 1.384 . . . . 0.0 112.271 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 62.53 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.826 3.25 . . . . 0.0 113.224 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.07 58.17 4.04 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.775 1.23 . . . . 0.0 111.453 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.6 p -65.94 -22.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.995 -1.066 . . . . 0.0 113.459 -169.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -62.85 -49.82 73.36 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 121.157 1.799 . . . . 0.0 112.076 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.23 76.8 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.3 -44.26 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.281 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.4 68.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.95 1.705 . . . . 0.0 112.858 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 m -68.77 -36.58 78.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.5 t -90.8 -23.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.109 1.363 . . . . 0.0 113.523 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -44.27 -60.46 2.82 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 126.211 1.804 . . . . 0.0 112.477 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.5 -0.61 5.35 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.328 2.685 . . . . 0.0 114.462 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 -64.6 1.12 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.215 1.406 . . . . 0.0 110.584 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -29.29 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.234 -0.916 . . . . 0.0 112.313 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 t -52.74 -48.33 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.988 1.315 . . . . 0.0 110.488 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.74 -47.88 11.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.435 0.636 . . . . 0.0 110.609 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.85 69.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.1 m -77.8 -12.05 59.94 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -33.64 16.66 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.133 1.333 . . . . 0.0 110.764 167.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -58.78 -38.63 78.93 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.507 1.123 . . . . 0.0 112.116 172.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -145.55 85.5 1.71 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.715 0.806 . . . . 0.0 112.293 170.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -57.73 -27.94 63.44 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.973 1.309 . . . . 0.0 112.505 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -92.26 -4.75 53.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.551 1.541 . . . . 0.0 112.943 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.54 154.37 41.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.542 1.137 . . . . 0.0 111.346 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -65.72 137.24 57.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.089 0.956 . . . . 0.0 111.544 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.04 -47.43 80.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.676 0.791 . . . . 0.0 112.64 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -61.69 -41.2 97.26 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.96 0.904 . . . . 0.0 111.479 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.28 -34.35 77.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.665 0.786 . . . . 0.0 112.34 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.58 -42.17 68.1 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.748 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.22 -38.53 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.159 1.345 . . . . 0.0 111.203 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -63.28 -45.1 93.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.179 0.592 . . . . 0.0 111.837 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.32 -44.71 97.28 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.958 1.266 . . . . 0.0 113.422 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.44 -35.41 70.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.972 1.386 . . . . 0.0 112.967 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -62.49 -41.26 98.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.644 1.111 . . . . 0.0 111.651 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.17 -48.82 80.12 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.788 1.235 . . . . 0.0 111.479 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.22 72.22 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.815 -1.178 . . . . 0.0 111.678 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 124.307 1.043 . . . . 0.0 112.375 -178.314 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.543 0.945 0 CA-C-O 121.484 0.535 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.35 0.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -108.24 15.57 24.0 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.279 1.832 . . . . 0.0 112.652 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 28.4 m -144.08 -43.83 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.52 120.17 32.1 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.301 0.955 . . . . 0.0 111.726 -174.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -71.04 169.23 15.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.045 1.738 . . . . 0.0 114.41 -169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -24.88 17.74 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.0 -35.75 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.907 1.231 . . . . 0.0 111.578 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.33 -20.68 58.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.198 0.999 . . . . 0.0 113.208 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -67.66 -25.22 65.6 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.086 -1.009 . . . . 0.0 111.292 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.35 -13.85 56.24 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.335 1.054 . . . . 0.0 113.17 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.04 -36.36 30.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.388 1.075 . . . . 0.0 113.07 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.07 139.47 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.052 1.341 . . . . 0.0 110.212 169.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.81 160.48 30.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.466 1.106 . . . . 0.0 113.289 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -58.98 -34.87 72.32 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 0.0 111.885 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -62.37 -22.1 65.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.547 1.539 . . . . 0.0 113.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -127.3 -3.13 6.25 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -60.95 -45.85 96.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 O-C-N 119.957 -1.714 . . . . 0.0 111.937 170.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.28 -28.92 85.35 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.004 2.469 . . . . 0.0 113.13 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 61.1 m -70.15 -38.49 75.48 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.487 1.115 . . . . 0.0 110.743 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.08 95.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.172 1.389 . . . . 0.0 114.457 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.74 -33.41 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 119.984 1.266 . . . . 0.0 110.824 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.99 -55.28 26.72 Favored Glycine 0 C--O 1.217 -0.937 0 C-N-CA 124.292 0.949 . . . . 0.0 112.65 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -64.81 -11.36 36.26 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.504 2.152 . . . . 0.0 114.386 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.61 -62.64 1.44 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.84 0.745 . . . . 0.0 110.169 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.46 -27.16 58.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.57 89.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.634 1.573 . . . . 0.0 112.069 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -38.63 22.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.828 1.251 . . . . 0.0 110.241 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -59.42 -33.18 70.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.792 1.237 . . . . 0.0 113.603 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.34 -11.49 37.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -143.51 -123.31 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.66 1.118 . . . . 0.0 113.744 -171.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.95 -68.89 0.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.894 1.278 . . . . 0.0 112.94 -168.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -139.38 167.01 20.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 127.588 2.355 . . . . 0.0 109.4 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.18 6.26 4.82 Favored 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.331 1.868 . . . . 0.0 114.439 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.76 -19.98 64.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.391 1.477 . . . . 0.0 111.434 168.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -113.12 11.63 18.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.854 2.062 . . . . 0.0 113.378 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.05 129.74 35.62 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 119.991 -1.693 . . . . 0.0 113.301 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.11 -6.05 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 125.03 1.332 . . . . 0.0 113.143 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 61.21 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.855 3.262 . . . . 0.0 112.96 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.13 60.35 1.19 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.361 -1.462 . . . . 0.0 111.849 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.297 2.4 p -66.11 -21.57 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.75 -1.219 . . . . 0.0 113.225 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.673 1.579 . . . . 0.0 112.522 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.44 -50.36 26.84 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mt -61.7 -43.21 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.642 0.777 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.67 -28.46 64.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.548 1.522 . . . . 0.0 112.491 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 39.0 m -68.7 -42.67 77.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.112 0.965 . . . . 0.0 111.698 169.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.24 -26.91 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.796 1.638 . . . . 0.0 113.503 -172.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.2 m -50.51 -63.38 1.88 Allowed Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 126.184 1.793 . . . . 0.0 113.087 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.52 -25.89 70.06 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.924 1.75 . . . . 0.0 112.334 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -57.83 9.85 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.447 1.099 . . . . 0.0 110.341 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.96 -31.92 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.442 -0.786 . . . . 0.0 111.957 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.71 -51.15 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.351 1.061 . . . . 0.0 110.393 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.35 -45.99 68.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.767 0.317 . . . . 0.0 111.159 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.19 -30.75 71.84 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.658 -1.276 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 29.2 m -73.85 -12.71 60.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -37.48 14.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.507 1.503 . . . . 0.0 110.78 166.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -57.3 -40.4 77.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.958 0.903 . . . . 0.0 111.806 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -142.15 72.71 1.38 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.481 1.112 . . . . 0.0 111.027 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -53.42 -31.06 43.4 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.116 1.766 . . . . 0.0 112.923 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.98 1.91 51.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.071 1.348 . . . . 0.0 113.114 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.41 152.98 36.66 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 114.305 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.18 59.27 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.351 1.86 . . . . 0.0 113.334 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 46.0 -103.73 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 165.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -47.07 -33.34 4.81 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.682 2.393 . . . . 0.0 113.716 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.0 -36.52 79.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.084 . . . . 0.0 112.807 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.4 -33.34 63.0 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.238 -0.914 . . . . 0.0 112.353 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.5 -48.79 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.709 0.803 . . . . 0.0 110.121 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.08 -42.81 99.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.979 0.911 . . . . 0.0 112.172 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.4 94.55 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.85 1.214 . . . . 0.0 113.48 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.61 -35.36 67.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.561 1.18 . . . . 0.0 112.608 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -60.66 -37.66 82.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.609 1.095 . . . . 0.0 112.216 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.77 -45.56 92.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.324 1.05 . . . . 0.0 111.933 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -24.45 67.24 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.584 -1.322 . . . . 0.0 112.438 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.41 -46.04 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.517 1.927 . . . . 0.0 112.821 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 125.193 1.397 . . . . 0.0 113.45 -174.357 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo . . . . . 0 C--O 1.234 0.321 0 CA-C-O 121.645 0.602 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.9 5.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.833 1.653 . . . . 0.0 115.031 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -122.27 11.24 10.06 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.027 2.131 . . . . 0.0 113.914 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 m -141.02 -27.79 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -175.27 4.03 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -171.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.6 p -119.93 164.69 15.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.19 1.396 . . . . 0.0 114.391 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.12 -19.86 55.57 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.44 -37.14 79.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.228 1.376 . . . . 0.0 111.465 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.72 -20.3 63.53 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.377 -0.827 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -67.02 -18.45 65.37 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.874 -1.141 . . . . 0.0 111.631 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.12 -6.75 41.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.193 1.397 . . . . 0.0 112.704 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.94 -34.1 17.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.648 1.179 . . . . 0.0 112.04 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.0 137.75 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.016 1.326 . . . . 0.0 109.954 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.27 160.25 29.69 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.184 0.993 . . . . 0.0 112.804 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -58.44 -36.58 73.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 m -62.08 -21.87 65.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.653 1.581 . . . . 0.0 113.743 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -126.27 -3.57 6.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.575 1.55 . . . . 0.0 112.684 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -59.46 -46.58 98.85 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 120.103 -1.623 . . . . 0.0 110.996 171.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -28.33 87.2 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.195 2.597 . . . . 0.0 113.564 169.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 m -72.27 -35.6 68.8 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.034 0.934 . . . . 0.0 111.423 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.26 81.35 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.819 1.248 . . . . 0.0 113.927 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -36.69 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 119.377 0.989 . . . . 0.0 110.845 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.52 63.58 Favored Glycine 0 C--O 1.214 -1.11 0 C-N-CA 124.326 0.965 . . . . 0.0 112.826 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.11 -18.09 65.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 121.276 2.538 . . . . 0.0 113.988 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.37 -57.72 3.04 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.471 0.578 . . . . 0.0 110.444 165.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -76.46 -21.24 56.14 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.18 94.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.344 1.458 . . . . 0.0 111.107 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -40.15 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.509 1.123 . . . . 0.0 110.642 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -62.18 -30.09 70.82 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -93.41 -5.31 49.68 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -124.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.005 1.322 . . . . 0.0 112.274 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -161.79 -58.3 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.24 1.416 . . . . 0.0 113.932 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.14 162.43 48.0 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 127.615 2.366 . . . . 0.0 110.678 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.22 -1.77 11.96 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.811 1.674 . . . . 0.0 114.693 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -54.91 -27.87 46.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.893 1.277 . . . . 0.0 113.423 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -95.54 -11.27 27.67 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.098 1.359 . . . . 0.0 113.846 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 121.78 26.24 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.674 -1.266 . . . . 0.0 113.754 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.44 9.96 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 125.41 1.484 . . . . 0.0 111.701 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? 59.99 121.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.591 3.156 . . . . 0.0 111.992 -168.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -87.11 45.62 1.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.619 -1.301 . . . . 0.0 111.963 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 3.0 p -66.19 -22.22 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.234 -1.541 . . . . 0.0 112.182 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.86 -33.5 66.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.845 1.258 . . . . 0.0 112.552 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.15 -59.56 1.94 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.619 1.104 . . . . 0.0 112.097 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.56 -44.77 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.709 -1.465 . . . . 0.0 112.949 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.97 -27.21 64.54 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.275 1.398 . . . . 0.0 112.435 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -66.96 -46.38 74.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.27 1.428 . . . . 0.0 111.955 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.12 -18.08 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 m -42.52 -59.32 2.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 C-N-CA 125.676 1.591 . . . . 0.0 112.588 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.65 -2.69 9.77 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.352 2.701 . . . . 0.0 114.539 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.81 -58.1 2.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.959 1.304 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -36.5 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 120.489 1.495 . . . . 0.0 112.123 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.5 -49.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.821 1.248 . . . . 0.0 110.62 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.98 -45.52 34.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.655 0.741 . . . . 0.0 110.986 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.78 70.02 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.781 0.832 . . . . 0.0 112.954 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.3 m -75.48 -13.2 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 170.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.13 -36.09 18.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.797 1.635 . . . . 0.0 110.516 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -57.02 -38.65 73.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.253 1.021 . . . . 0.0 111.813 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -144.92 84.55 1.72 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.534 0.683 . . . . 0.0 111.768 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -54.98 -31.34 60.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.105 1.362 . . . . 0.0 112.188 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.68 -0.93 57.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.272 1.429 . . . . 0.0 112.909 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.65 144.58 56.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.252 1.021 . . . . 0.0 111.72 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -77.75 160.89 28.1 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.377 1.084 . . . . 0.0 113.669 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -40.58 151.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.563 2.745 . . . . 0.0 115.13 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt 62.03 -38.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 129.487 3.115 . . . . 0.0 116.309 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.73 -31.86 70.01 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.846 1.659 . . . . 0.0 112.174 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -69.67 -43.91 71.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.71 -0.619 . . . . 0.0 112.509 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.03 -36.69 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.763 1.165 . . . . 0.0 111.459 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.15 -46.05 78.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.274 1.029 . . . . 0.0 111.949 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.87 96.97 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.824 1.202 . . . . 0.0 113.1 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -25.93 59.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.846 -1.385 . . . . 0.0 113.485 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -70.93 -42.32 70.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.479 -0.763 . . . . 0.0 111.248 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -58.23 -42.89 87.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.205 1.402 . . . . 0.0 111.68 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.18 -38.8 27.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.483 1.913 . . . . 0.0 114.212 170.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.241 -168.609 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 0 CA--C 1.543 0.948 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.57 -21.26 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -74.33 -19.99 60.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.688 1.195 . . . . 0.0 113.565 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 70.0 m -122.46 -20.86 5.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.849 2.46 . . . . 0.0 113.953 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -53.09 140.97 24.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.367 2.667 . . . . 0.0 111.556 172.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -98.6 168.12 10.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.869 1.319 . . . . 0.0 112.866 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.36 -28.35 67.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.035 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -61.22 -43.58 98.64 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.078 -1.014 . . . . 0.0 110.327 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -66.64 -30.11 70.29 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.449 0.7 . . . . 0.0 112.139 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.409 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 73.7 t80 -67.69 -31.87 72.13 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.317 -1.489 . . . . 0.0 111.751 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.78 -9.3 58.48 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.03 44.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.769 1.168 . . . . 0.0 112.353 172.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.42 135.18 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.663 1.585 . . . . 0.0 110.145 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.22 157.77 34.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.375 1.07 . . . . 0.0 112.888 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.28 -34.26 72.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.271 1.028 . . . . 0.0 111.851 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.3 m -61.24 -25.55 67.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.421 1.888 . . . . 0.0 113.973 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.0 -6.11 7.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.246 1.018 . . . . 0.0 113.73 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.86 -43.49 98.66 Favored Pre-proline 0 N--CA 1.476 0.858 0 O-C-N 120.204 -1.56 . . . . 0.0 113.389 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -61.71 -27.73 81.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.932 2.421 . . . . 0.0 113.046 170.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 26.2 m -74.24 -36.84 63.92 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.903 1.281 . . . . 0.0 111.294 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.19 93.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.015 1.326 . . . . 0.0 113.996 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.06 -33.07 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 119.422 1.01 . . . . 0.0 110.767 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.54 -51.08 50.49 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 125.492 1.52 . . . . 0.0 114.099 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.43 -32.78 74.59 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.283 2.542 . . . . 0.0 112.419 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.46 -54.02 19.7 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.046 0.839 . . . . 0.0 111.21 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.44 -22.59 40.98 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.63 -46.19 32.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.594 1.158 . . . . 0.0 111.056 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -33.99 59.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.009 -176.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -73.13 -10.3 59.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -101.61 -11.27 19.35 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.61 -129.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.084 1.354 . . . . 0.0 112.303 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -161.64 -51.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.141 1.776 . . . . 0.0 113.189 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -132.66 166.93 25.42 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.339 2.256 . . . . 0.0 109.757 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.87 12.43 2.87 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 114.183 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.78 -14.62 62.86 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.679 -1.263 . . . . 0.0 113.934 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -119.89 4.68 10.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 113.518 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.29 134.2 41.13 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.911 -1.118 . . . . 0.0 113.605 -169.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.37 136.6 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.902 2.081 . . . . 0.0 107.317 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.28 119.95 11.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.461 1.028 . . . . 0.0 109.163 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.4 54.65 3.23 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.698 -1.251 . . . . 0.0 110.996 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 1.5 p -67.03 -25.03 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -165.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -63.04 -41.63 99.56 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 121.161 1.801 . . . . 0.0 111.133 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.08 -49.31 34.73 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 123.984 0.802 . . . . 0.0 111.416 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.22 -43.18 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.869 0.868 . . . . 0.0 111.533 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.15 -31.75 68.08 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 120.253 1.388 . . . . 0.0 112.726 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m -65.36 -42.84 92.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.097 0.959 . . . . 0.0 111.568 170.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -82.73 -29.41 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.978 1.311 . . . . 0.0 113.047 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.6 m -43.48 -61.05 2.06 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 126.113 1.765 . . . . 0.0 113.77 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.16 -14.44 44.35 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.577 2.185 . . . . 0.0 113.367 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.66 -63.47 1.16 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.131 0.972 . . . . 0.0 110.838 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -25.53 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.05 -1.031 . . . . 0.0 113.141 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.69 -51.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.605 1.093 . . . . 0.0 110.753 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.39 -47.21 51.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.935 0.397 . . . . 0.0 111.057 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.54 -28.32 69.08 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.662 -1.274 . . . . 0.0 113.175 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.96 -15.89 60.09 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 169.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -30.32 21.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 111.202 168.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -61.23 -38.38 86.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.875 0.87 . . . . 0.0 112.535 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.68 88.16 1.68 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.636 0.774 . . . . 0.0 111.922 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.93 -41.91 68.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.356 1.462 . . . . 0.0 111.579 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -79.51 -3.24 45.85 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.8 153.07 44.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.012 0.925 . . . . 0.0 112.071 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.69 134.0 46.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 0.0 109.333 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.409 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 46.2 t80 -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.289 -0.882 . . . . 0.0 112.663 -175.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -62.67 -40.14 96.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.209 0.913 . . . . 0.0 111.588 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.31 -38.97 93.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.557 0.743 . . . . 0.0 111.913 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.72 -37.14 73.48 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.953 0.797 . . . . 0.0 113.027 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.45 -48.33 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.173 0.989 . . . . 0.0 110.116 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -64.07 -47.36 80.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.989 0.916 . . . . 0.0 112.011 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.91 99.39 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.627 1.108 . . . . 0.0 113.269 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -73.12 -35.83 66.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.225 -1.162 . . . . 0.0 112.792 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -60.53 -38.16 83.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.633 1.106 . . . . 0.0 111.881 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.87 -44.68 96.32 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.395 -0.815 . . . . 0.0 111.611 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -19.33 65.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.838 -1.164 . . . . 0.0 112.558 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.3 -41.48 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.466 1.906 . . . . 0.0 112.973 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 124.796 1.239 . . . . 0.0 113.441 -177.806 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.364 0 CA-C-O 122.202 0.834 . . . . 0.0 114.035 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.53 -12.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -104.76 -4.26 22.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.318 1.447 . . . . 0.0 114.807 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -124.36 -28.31 3.67 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -92.5 151.84 19.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.151 0.977 . . . . 0.0 111.484 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -85.47 170.07 13.01 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.49 -18.78 3.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.845 1.658 . . . . 0.0 114.732 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -51.7 -28.99 16.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 111.961 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -46.35 -42.06 14.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.206 1.402 . . . . 0.0 113.178 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.32 -15.25 61.89 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.98 -18.11 17.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.02 1.328 . . . . 0.0 111.799 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.92 -37.46 22.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.501 1.52 . . . . 0.0 112.374 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.49 137.72 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.593 1.557 . . . . 0.0 110.744 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.59 159.56 31.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 112.923 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.85 -36.19 74.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.889 -1.132 . . . . 0.0 111.97 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -60.43 -25.53 66.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.732 1.613 . . . . 0.0 113.857 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -124.33 -2.41 8.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.591 1.556 . . . . 0.0 112.96 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -53.92 -46.72 98.45 Favored Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 120.28 -1.513 . . . . 0.0 111.794 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -70.71 -16.42 33.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.226 1.951 . . . . 0.0 113.459 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.2 m -75.74 -33.84 60.28 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.047 -1.033 . . . . 0.0 111.136 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.51 82.0 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.406 -0.809 . . . . 0.0 111.569 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 t -59.1 -49.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.388 1.075 . . . . 0.0 109.031 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.8 19.1 0.32 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 126.321 1.915 . . . . 0.0 116.874 172.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.56 -63.14 1.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.404 1.881 . . . . 0.0 109.101 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.96 93.16 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.158 -0.964 . . . . 0.0 112.337 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -86.52 -28.82 23.14 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.708 -0.62 . . . . 0.0 112.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.05 -48.12 81.65 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.36 -1.462 . . . . 0.0 112.013 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -26.78 60.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.268 0.627 . . . . 0.0 111.302 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.82 -26.44 68.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.617 1.167 . . . . 0.0 113.672 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.85 -1.22 43.56 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -171.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -125.61 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.757 1.623 . . . . 0.0 111.255 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -167.14 -46.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.363 2.265 . . . . 0.0 112.399 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -129.36 165.69 30.85 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 127.991 2.517 . . . . 0.0 109.938 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.74 15.73 2.14 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.231 1.954 . . . . 0.0 114.527 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -61.36 -33.44 73.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.376 1.07 . . . . 0.0 112.071 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.22 23.91 11.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.478 1.911 . . . . 0.0 113.575 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 118.2 19.42 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.613 -1.305 . . . . 0.0 110.827 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 t -106.91 -11.31 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.218 1.007 . . . . 0.0 113.101 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 64.91 113.24 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.946 2.498 . . . . 0.0 111.164 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -95.1 64.05 2.72 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.337 5.2 p -70.45 -21.66 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 111.74 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -54.11 -48.8 70.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.981 0.81 . . . . 0.0 110.991 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.98 -52.16 5.48 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.9 mt -56.83 -46.25 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.35 69.55 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.277 1.399 . . . . 0.0 112.781 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.3 m -78.24 -34.81 48.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.104 1.362 . . . . 0.0 112.098 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.29 -19.9 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.713 1.605 . . . . 0.0 112.77 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.8 m -43.77 -61.07 2.14 Favored Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 126.235 1.814 . . . . 0.0 112.866 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.31 -0.19 6.19 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.329 2.686 . . . . 0.0 114.348 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.56 -64.23 1.18 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.885 1.274 . . . . 0.0 110.614 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.65 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.068 -1.02 . . . . 0.0 113.216 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.35 -46.54 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.252 0.933 . . . . 0.0 110.713 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -73.82 -47.52 37.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.069 0.548 . . . . 0.0 111.329 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.19 73.77 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.428 -0.795 . . . . 0.0 112.989 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.5 m -75.42 -16.62 60.33 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.979 -1.076 . . . . 0.0 113.315 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -30.22 47.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.716 1.598 . . . . 0.0 110.917 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -61.1 -36.41 79.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.774 0.83 . . . . 0.0 112.789 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -142.47 76.45 1.53 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -54.45 -37.16 64.86 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.965 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -86.72 -0.21 55.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.058 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.89 29.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.957 0.903 . . . . 0.0 112.492 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -85.64 53.67 2.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.16 1.384 . . . . 0.0 110.475 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -102.33 90.5 3.92 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -166.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -68.41 -22.49 64.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.111 -0.993 . . . . 0.0 109.327 162.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.26 -24.81 66.65 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.237 1.815 . . . . 0.0 112.802 168.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -63.4 -40.43 97.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 0.0 110.49 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.58 -50.77 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.852 1.261 . . . . 0.0 110.294 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -63.5 -42.0 98.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.196 0.598 . . . . 0.0 112.022 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.78 93.11 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.135 1.35 . . . . 0.0 112.76 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.55 -31.33 63.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.802 1.301 . . . . 0.0 113.481 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.12 -43.97 97.66 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 169.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.79 -41.45 97.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.455 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -25.25 66.94 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 125.01 1.324 . . . . 0.0 112.403 -174.901 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 CA--C 1.54 0.777 0 CA-C-O 120.54 0.142 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.13 -21.99 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.892 1.677 . . . . 0.0 114.649 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -81.37 -16.65 51.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 60.3 m -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.225 1.81 . . . . 0.0 113.492 170.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -54.69 148.72 12.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 123.039 1.399 . . . . 0.0 113.226 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.9 p -95.11 167.95 11.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.81 166.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.0 -26.05 66.61 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.53 -0.731 . . . . 0.0 112.266 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.94 -40.32 95.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.764 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.02 -31.34 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.396 -0.815 . . . . 0.0 112.152 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.43 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 53.1 t80 -70.2 -24.25 63.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.121 0.873 . . . . 0.0 112.322 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 68.5 mt -80.9 -16.98 52.12 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.135 -0.978 . . . . 0.0 113.318 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -33.06 53.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.839 0.855 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.5 p -76.24 141.27 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.932 1.693 . . . . 0.0 110.53 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.69 161.68 30.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.435 1.094 . . . . 0.0 113.471 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.71 -36.1 73.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.129 1.372 . . . . 0.0 112.083 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -64.48 -20.55 66.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.104 1.361 . . . . 0.0 113.835 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.3 -5.28 6.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.866 1.267 . . . . 0.0 113.397 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -57.7 -45.55 99.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 O-C-N 120.184 -1.573 . . . . 0.0 112.162 169.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.45 -28.19 86.89 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.32 2.68 . . . . 0.0 113.414 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 29.4 m -76.87 -36.06 57.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.349 1.459 . . . . 0.0 111.45 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.67 91.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.669 1.188 . . . . 0.0 113.649 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.98 -35.75 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 119.78 1.173 . . . . 0.0 110.973 169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.37 -53.21 32.72 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.274 0.94 . . . . 0.0 112.195 168.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.97 -11.93 58.22 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 121.08 2.44 . . . . 0.0 114.513 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.35 -55.99 3.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.073 0.851 . . . . 0.0 109.841 166.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.14 -36.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.321 1.049 . . . . 0.0 113.455 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.0 76.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.203 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.14 -36.87 22.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.747 1.219 . . . . 0.0 110.617 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -54.41 -34.93 62.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.604 1.561 . . . . 0.0 113.688 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.53 -7.03 45.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.02 -133.4 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.394 1.477 . . . . 0.0 110.898 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.57 -58.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.599 2.36 . . . . 0.0 112.454 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 164.5 43.57 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 127.359 2.264 . . . . 0.0 109.831 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.01 36.81 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.711 2.274 . . . . 0.0 113.409 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.73 -28.86 50.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 111.947 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.22 0.7 11.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.341 1.456 . . . . 0.0 113.847 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.09 133.92 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.221 1.009 . . . . 0.0 113.295 -170.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.6 -12.66 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.93 1.292 . . . . 0.0 113.727 -174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.87 102.05 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.699 1.999 . . . . 0.0 107.747 -165.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -85.12 71.01 10.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.985 -1.072 . . . . 0.0 108.841 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.323 1.6 p -66.27 -18.81 24.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 O-C-N 121.38 -0.825 . . . . 0.0 110.327 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -42.79 97.06 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.598 -1.314 . . . . 0.0 111.381 167.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.19 14.98 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.636 -0.665 . . . . 0.0 111.908 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.8 -44.34 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 121.383 -1.069 . . . . 0.0 112.55 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.97 66.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.667 1.576 . . . . 0.0 112.255 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 99.9 m -66.37 -46.24 77.35 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 111.853 169.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -84.34 -31.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.829 1.252 . . . . 0.0 112.845 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -40.05 -62.98 0.77 Allowed Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 126.937 2.095 . . . . 0.0 113.569 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.97 -22.66 73.93 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.245 1.963 . . . . 0.0 113.208 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.01 -59.46 3.02 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.162 0.985 . . . . 0.0 111.312 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -24.5 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.401 -0.812 . . . . 0.0 112.688 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.0 -51.85 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.811 1.187 . . . . 0.0 110.69 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.88 -47.49 45.53 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.157 -0.339 . . . . 0.0 111.084 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.755 -1.216 . . . . 0.0 113.257 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.8 m -76.13 -12.4 60.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.56 -33.58 16.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.184 1.356 . . . . 0.0 111.005 167.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -60.35 -39.04 85.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.871 0.868 . . . . 0.0 112.167 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.73 59.85 1.49 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.105 0.962 . . . . 0.0 112.618 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -53.7 -36.34 62.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.931 1.692 . . . . 0.0 113.109 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -86.27 -6.08 59.04 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.15 164.02 26.05 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.084 0.954 . . . . 0.0 111.966 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.88 138.05 52.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.467 1.107 . . . . 0.0 111.152 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 16.5 t80 -64.15 -51.28 64.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.418 -0.801 . . . . 0.0 112.81 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -66.29 -30.82 71.32 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.616 1.098 . . . . 0.0 112.071 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.38 -39.57 94.88 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.808 -0.558 . . . . 0.0 111.813 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -70.41 -34.79 72.92 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.248 -0.907 . . . . 0.0 112.832 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.12 -49.0 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.163 0.892 . . . . 0.0 109.67 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.29 -42.68 99.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.027 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.15 -44.89 97.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.513 1.054 . . . . 0.0 113.299 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -72.93 -35.4 67.02 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.052 -1.264 . . . . 0.0 112.618 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -60.06 -39.92 87.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.68 -1.262 . . . . 0.0 111.78 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.2 -46.57 88.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 111.874 173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -26.66 68.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 112.104 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 mt -79.29 -49.19 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.307 1.843 . . . . 0.0 112.087 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.482 1.155 0 C-N-CA 125.308 1.443 . . . . 0.0 113.254 -171.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.74 -22.3 14.44 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.03 53.04 2.63 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.038 0.923 . . . . 0.0 111.857 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -158.89 150.26 20.53 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.008 2.123 . . . . 0.0 111.621 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 56.46 -69.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.021 2.528 . . . . 0.0 115.166 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.04 -56.84 0.13 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.423 2.289 . . . . 0.0 110.684 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -165.57 166.34 18.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.475 1.91 . . . . 0.0 111.346 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.56 124.17 22.47 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . 0.309 13.8 p30 62.76 13.91 6.86 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.961 2.904 . . . . 0.0 118.617 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -95.51 -33.36 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.1 51.86 4.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 125.656 1.582 . . . . 0.0 112.56 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.89 165.74 20.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.589 2.859 . . . . 0.0 115.807 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -64.33 2.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -126.04 21.32 7.49 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.932 1.693 . . . . 0.0 113.124 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -142.55 -13.22 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -131.26 169.75 15.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.624 1.556 . . . . 0.0 113.835 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.1 p -85.86 166.11 16.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.2 1.4 . . . . 0.0 114.221 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -21.37 2.75 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.87 -35.86 62.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.981 1.264 . . . . 0.0 111.596 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.66 -16.28 64.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.762 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.61 -24.18 45.49 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.799 -1.188 . . . . 0.0 112.129 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.35 -8.67 57.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.872 1.269 . . . . 0.0 113.046 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.39 60.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.084 1.354 . . . . 0.0 112.551 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.73 141.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.939 2.495 . . . . 0.0 110.508 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.35 156.88 36.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.921 0.888 . . . . 0.0 112.743 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.38 -30.67 60.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.109 1.364 . . . . 0.0 111.64 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 m -61.0 -28.32 68.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.156 1.783 . . . . 0.0 113.872 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -127.4 -7.1 5.82 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -56.47 -38.74 71.78 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 119.584 -1.948 . . . . 0.0 114.024 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.84 -27.09 79.96 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.624 2.216 . . . . 0.0 113.272 169.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 55.3 m -79.59 -34.35 40.87 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.712 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.14 92.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.452 . . . . 0.0 113.75 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.09 -36.51 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 119.367 0.985 . . . . 0.0 110.913 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.11 13.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.984 1.278 . . . . 0.0 113.798 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.15 -39.58 93.18 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.249 2.025 . . . . 0.0 112.323 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.0 67.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -102.11 -34.05 9.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.93 0.892 . . . . 0.0 112.714 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -52.44 65.67 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.746 1.619 . . . . 0.0 110.401 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -14.97 63.11 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.837 0.855 . . . . 0.0 111.144 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -14.79 50.13 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.142 -0.974 . . . . 0.0 113.436 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.283 4.6 p30 -123.41 10.67 9.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.83 152.63 0.97 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 130.59 3.556 . . . . 0.0 105.568 168.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.69 -32.33 18.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.222 2.209 . . . . 0.0 113.059 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.5 156.83 79.6 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 127.227 2.211 . . . . 0.0 110.151 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -84.65 8.65 4.51 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.989 1.793 . . . . 0.0 114.84 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.22 -21.33 22.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.393 1.477 . . . . 0.0 114.232 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.52 14.68 20.24 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.285 1.434 . . . . 0.0 113.332 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.97 113.59 24.66 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.262 -1.523 . . . . 0.0 112.106 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.78 11.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 125.647 1.579 . . . . 0.0 111.423 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.49 155.0 0.07 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 129.495 3.118 . . . . 0.0 112.801 -168.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -119.11 62.22 0.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.522 1.529 . . . . 0.0 110.811 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.0 -56.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.641 1.177 . . . . 0.0 113.475 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -63.14 -36.87 85.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.343 0.974 . . . . 0.0 111.5 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.55 -52.51 52.68 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mt -62.72 -42.77 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.45 0.7 . . . . 0.0 111.449 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.06 -34.72 71.47 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.102 -0.999 . . . . 0.0 113.067 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -70.25 -37.11 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.029 1.332 . . . . 0.0 111.848 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.76 -23.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.117 1.367 . . . . 0.0 113.327 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.3 m -45.28 -59.83 3.93 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 125.877 1.671 . . . . 0.0 112.935 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.48 0.85 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.56 -66.43 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.6 1.16 . . . . 0.0 110.603 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -32.2 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.017 -1.052 . . . . 0.0 112.911 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.74 -49.31 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.367 1.067 . . . . 0.0 110.353 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.51 -46.86 36.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.274 0.559 . . . . 0.0 110.892 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.54 68.94 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.1 m -76.34 -17.17 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.29 -30.85 21.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.087 1.312 . . . . 0.0 111.429 169.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -60.63 -38.24 84.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.408 1.083 . . . . 0.0 112.012 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -146.15 86.56 1.71 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.656 0.783 . . . . 0.0 112.425 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -54.07 -33.82 58.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.647 1.179 . . . . 0.0 111.714 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -86.85 -0.07 55.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.339 1.455 . . . . 0.0 113.526 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.36 147.83 43.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.938 0.895 . . . . 0.0 111.384 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.93 155.14 40.81 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.396 1.078 . . . . 0.0 112.312 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -53.32 151.37 5.44 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 112.049 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 tptp 60.44 -32.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 129.039 2.935 . . . . 0.0 116.299 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.87 -28.26 68.73 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.36 1.864 . . . . 0.0 112.259 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -70.77 -44.11 67.39 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.54 -0.725 . . . . 0.0 112.567 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.11 -37.12 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.027 1.285 . . . . 0.0 111.268 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -64.84 -48.44 74.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.65 0.78 . . . . 0.0 111.614 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.9 -39.48 96.55 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.975 1.274 . . . . 0.0 113.242 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -35.33 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.818 1.309 . . . . 0.0 113.013 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -63.35 -38.09 89.8 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.958 -1.089 . . . . 0.0 111.956 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.41 -43.84 98.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.523 1.129 . . . . 0.0 111.782 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -25.02 67.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.83 -1.169 . . . . 0.0 112.86 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mt -87.98 -40.6 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.038 1.335 . . . . 0.0 112.523 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.64 -59.75 1.83 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.287 1.435 . . . . 0.0 113.692 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.6 -25.12 67.25 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.845 1.658 . . . . 0.0 113.501 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -26.02 67.43 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.732 1.213 . . . . 0.0 113.712 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 44.6 ttp . . . . . 0 C--O 1.254 1.318 0 C-N-CA 128.298 2.639 . . . . 0.0 115.371 172.005 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.89 -29.18 25.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.42 15.8 7.34 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -144.66 140.47 28.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.633 1.173 . . . . 0.0 113.09 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp 37.51 48.94 0.94 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.567 2.347 . . . . 0.0 115.723 166.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.29 128.31 35.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.188 0.595 . . . . 0.0 110.343 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.85 150.83 42.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -135.68 123.36 22.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.122 1.769 . . . . 0.0 107.748 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 51.98 15.53 0.42 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.024 2.13 . . . . 0.0 116.103 -174.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 56.4 105.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.244 2.617 . . . . 0.0 112.04 -167.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -122.6 61.86 16.41 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 126.387 1.875 . . . . 0.0 112.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.48 -175.37 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.314 4.009 . . . . 0.0 112.518 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 23.0 m -49.82 -23.56 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 125.988 1.715 . . . . 0.0 115.292 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -82.49 4.36 24.67 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.618 1.567 . . . . 0.0 113.987 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -142.05 -40.52 0.36 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.453 2.301 . . . . 0.0 112.358 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -50.67 143.36 9.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.724 2.809 . . . . 0.0 112.79 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -109.3 155.45 21.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.16 -24.83 66.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.35 -38.24 79.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.592 -1.317 . . . . 0.0 111.122 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.23 -13.18 53.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.433 1.093 . . . . 0.0 112.95 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -67.47 -28.53 67.94 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.721 -1.237 . . . . 0.0 110.664 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 mt -74.13 -16.78 61.0 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.33 -0.856 . . . . 0.0 113.175 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.79 28.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.296 1.039 . . . . 0.0 113.346 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 p -71.58 140.12 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 109.872 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.81 157.34 30.64 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.847 1.259 . . . . 0.0 113.342 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -58.57 -34.52 71.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.575 1.15 . . . . 0.0 111.748 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.9 m -57.84 -25.66 60.97 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.427 1.891 . . . . 0.0 113.901 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -124.97 0.13 7.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 113.122 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.49 -44.47 97.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 119.809 -1.807 . . . . 0.0 112.416 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -63.49 -20.2 69.29 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.804 2.336 . . . . 0.0 114.393 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 57.2 m -67.8 -37.29 81.8 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.087 -1.008 . . . . 0.0 110.13 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.8 86.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.453 1.501 . . . . 0.0 114.076 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.86 -34.29 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.432 -1.418 . . . . 0.0 110.731 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.9 4.07 8.48 Favored Glycine 0 CA--C 1.545 1.969 0 C-N-CA 125.985 1.755 . . . . 0.0 116.148 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.77 -10.36 9.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.435 1.894 . . . . 0.0 113.547 170.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.72 -70.98 0.7 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.407 1.083 . . . . 0.0 111.571 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -71.24 -20.78 62.2 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.98 -1.075 . . . . 0.0 112.424 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.18 97.63 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.963 1.705 . . . . 0.0 113.833 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -43.91 18.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.653 0.781 . . . . 0.0 109.679 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.36 -24.52 67.4 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -85.77 -10.48 55.45 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -130.08 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 110.933 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -157.07 -54.12 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 127.407 2.283 . . . . 0.0 112.499 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -125.07 164.25 32.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 126.768 2.027 . . . . 0.0 111.639 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.75 9.78 3.04 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.156 2.57 . . . . 0.0 114.055 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.69 -28.4 69.91 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.625 -1.297 . . . . 0.0 113.14 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -106.14 -7.24 18.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.855 1.262 . . . . 0.0 114.035 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.57 145.21 47.56 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 120.848 -1.158 . . . . 0.0 113.403 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.18 25.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.547 1.539 . . . . 0.0 111.277 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 60.47 144.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.671 2.788 . . . . 0.0 112.738 -166.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -87.93 44.44 1.19 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.621 -1.299 . . . . 0.0 110.469 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -47.16 -53.55 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.836 1.655 . . . . 0.0 114.109 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -70.24 -34.04 72.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.689 1.131 . . . . 0.0 111.444 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.68 -48.23 74.87 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.533 0.587 . . . . 0.0 111.856 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.22 -43.57 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.642 1.577 . . . . 0.0 110.73 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.09 -32.64 73.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.108 0.963 . . . . 0.0 112.916 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 43.2 m -68.69 -42.9 77.15 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.558 1.143 . . . . 0.0 111.926 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.1 t -84.16 -26.09 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.91 1.684 . . . . 0.0 113.313 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.5 m -50.65 -64.21 1.44 Allowed Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 125.733 1.613 . . . . 0.0 113.094 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.91 -25.35 77.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.19 1.927 . . . . 0.0 112.685 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.39 -59.12 5.1 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.229 1.012 . . . . 0.0 110.805 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.01 -31.49 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.11 -0.994 . . . . 0.0 112.224 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.83 -51.27 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.937 1.295 . . . . 0.0 110.657 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -68.35 -44.29 75.56 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.397 0.279 . . . . 0.0 110.885 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.8 73.12 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.056 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.49 -14.51 62.14 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -35.91 13.81 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.902 1.228 . . . . 0.0 111.542 167.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -58.03 -42.66 85.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.062 0.945 . . . . 0.0 111.796 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -141.44 69.98 1.34 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 111.32 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -52.37 -34.88 49.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.693 1.997 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -84.59 -1.5 56.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.061 0.944 . . . . 0.0 113.263 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.53 147.82 48.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.637 1.175 . . . . 0.0 112.852 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.47 130.4 41.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.673 1.189 . . . . 0.0 108.406 168.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.4 -42.03 95.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.615 0.766 . . . . 0.0 113.063 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -60.08 -38.39 82.75 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.466 -0.771 . . . . 0.0 112.757 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -69.48 -34.42 74.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.282 0.633 . . . . 0.0 112.093 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -73.14 -38.12 66.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.98 -37.81 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.03 1.287 . . . . 0.0 111.64 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -62.38 -43.64 98.35 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.616 0.766 . . . . 0.0 112.182 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.76 -47.16 91.82 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.545 1.069 . . . . 0.0 113.194 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.32 -33.52 65.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.544 1.172 . . . . 0.0 113.009 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.81 -39.92 90.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.203 1.365 . . . . 0.0 111.998 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.59 -47.38 84.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.514 1.126 . . . . 0.0 112.048 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -27.24 68.73 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.101 -0.999 . . . . 0.0 111.944 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 36.9 mt -76.83 -51.67 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.059 1.744 . . . . 0.0 111.812 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -101.47 -61.82 1.33 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.509 1.524 . . . . 0.0 113.294 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.39 -24.86 67.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.232 1.813 . . . . 0.0 113.647 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.82 -22.66 67.03 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.198 1.399 . . . . 0.0 114.135 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 124.762 1.225 . . . . 0.0 113.315 -179.651 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -145.74 96.44 2.81 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.02 33.58 7.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -63.11 -22.41 66.84 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -12.92 61.31 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 45.35 -115.4 0.5 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.67 1.588 . . . . 0.0 113.054 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.98 5.83 17.97 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.3 t0 60.16 24.6 13.92 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.205 1.802 . . . . 0.0 113.511 -170.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -147.57 -5.56 0.48 Allowed 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -95.52 -29.06 14.57 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -119.76 33.99 0.21 Allowed Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.23 152.1 72.08 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.891 . . . . 0.0 113.53 -169.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.08 -24.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -76.22 -35.07 59.22 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.348 0.659 . . . . 0.0 112.629 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -103.56 -27.98 12.02 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -91.09 174.71 7.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.041 0.924 . . . . 0.0 113.425 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 p -103.86 165.96 10.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.667 1.587 . . . . 0.0 114.213 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -17.53 48.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 115.211 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.97 -34.71 73.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.774 1.17 . . . . 0.0 111.424 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.08 -28.98 70.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.656 -0.653 . . . . 0.0 112.319 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.61 -21.48 66.72 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.882 -1.136 . . . . 0.0 111.646 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -91.65 -13.42 31.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.418 1.487 . . . . 0.0 113.202 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.02 -31.65 34.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.378 1.071 . . . . 0.0 110.983 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -68.84 132.68 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.68 1.592 . . . . 0.0 109.782 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -68.9 160.67 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.252 1.421 . . . . 0.0 113.111 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.26 -35.92 72.48 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.906 -1.121 . . . . 0.0 112.09 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 m -62.22 -23.86 66.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.004 1.722 . . . . 0.0 113.827 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -125.45 -3.83 7.3 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.801 1.24 . . . . 0.0 113.51 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.17 -41.86 93.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 120.019 -1.676 . . . . 0.0 112.815 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -59.34 -27.35 84.75 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.927 2.418 . . . . 0.0 113.691 168.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.5 m -78.92 -27.9 43.79 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 111.902 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.96 -48.43 74.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 112.811 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.03 -36.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 118.73 0.695 . . . . 0.0 110.466 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.94 -48.17 52.27 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.674 1.13 . . . . 0.0 113.849 170.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.05 -19.0 64.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.864 2.832 . . . . 0.0 113.192 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.93 -53.46 5.29 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.47 -0.769 . . . . 0.0 110.7 165.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.7 -19.73 60.14 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.99 27.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 111.951 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.95 -31.42 18.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.282 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -67.33 -20.57 65.62 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.04 -8.38 21.51 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.26 0.4 OUTLIER -141.41 -129.52 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.187 1.395 . . . . 0.0 113.287 -175.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.87 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.989 1.716 . . . . 0.0 113.759 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -136.41 164.44 42.79 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.763 2.425 . . . . 0.0 110.056 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.34 -5.27 14.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.498 1.466 . . . . 0.0 114.55 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.61 -25.21 68.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.937 1.244 . . . . 0.0 113.747 -168.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.31 -16.55 29.03 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.157 2.183 . . . . 0.0 113.648 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 154.26 33.46 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -169.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.77 1.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 125.133 1.373 . . . . 0.0 113.795 -174.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 62.78 112.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.842 2.857 . . . . 0.0 112.584 -168.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.9 54.07 2.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.899 1.68 . . . . 0.0 112.495 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 0.6 OUTLIER -55.22 -40.82 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 -165.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.73 -35.45 78.1 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 122.746 2.521 . . . . 0.0 112.707 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.02 -22.16 60.03 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 124.755 1.169 . . . . 0.0 113.804 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.74 -50.78 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.433 1.493 . . . . 0.0 111.132 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.18 77.54 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.016 1.326 . . . . 0.0 113.78 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -63.73 -39.24 93.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.391 1.076 . . . . 0.0 111.735 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.45 -19.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.681 1.192 . . . . 0.0 113.314 -172.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.6 m -41.85 -60.0 2.22 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 125.962 1.705 . . . . 0.0 112.368 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.4 1.24 4.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.715 2.943 . . . . 0.0 114.822 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.46 -59.66 1.78 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 0.0 110.485 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -34.99 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.345 0.975 . . . . 0.0 112.118 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.82 -40.9 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.444 0.565 . . . . 0.0 112.326 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -78.26 -47.91 16.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.25 -29.39 70.17 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.096 0.958 . . . . 0.0 113.561 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.37 -11.6 59.86 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.54 -33.95 16.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.304 1.411 . . . . 0.0 110.58 166.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -58.02 -40.11 80.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 111.652 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.51 88.0 1.75 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.757 0.789 . . . . 0.0 111.984 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -55.01 -31.42 61.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.747 1.619 . . . . 0.0 112.489 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -89.53 -2.74 58.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.188 1.395 . . . . 0.0 112.854 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 154.95 40.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.716 0.806 . . . . 0.0 110.548 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -64.58 137.34 57.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.992 0.517 . . . . 0.0 110.349 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.52 -53.1 62.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.907 1.283 . . . . 0.0 111.766 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -65.54 -38.23 89.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.08 0.952 . . . . 0.0 112.245 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.56 -37.36 83.55 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.485 0.714 . . . . 0.0 111.463 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -73.61 -33.68 64.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.85 -47.3 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 118.448 0.567 . . . . 0.0 110.698 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.66 -44.57 95.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.876 0.87 . . . . 0.0 111.825 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.65 -46.13 93.74 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.722 1.153 . . . . 0.0 113.092 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -73.29 -31.99 64.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.695 1.248 . . . . 0.0 113.447 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -61.49 -42.21 98.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.982 1.265 . . . . 0.0 111.714 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.68 -47.99 78.99 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.66 0.784 . . . . 0.0 111.476 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.413 -1.429 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.1 mt -72.96 -44.97 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.84 0.856 . . . . 0.0 112.038 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -99.63 -59.34 1.74 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.903 1.281 . . . . 0.0 113.541 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -67.32 -40.63 85.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.303 1.441 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.7 t70 54.57 15.3 1.01 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.484 2.313 . . . . 0.0 115.129 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.403 2.281 . . . . 0.0 111.218 179.615 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -140.23 143.07 35.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.103 0.961 . . . . 0.0 112.1 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.12 66.99 0.42 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.946 1.298 . . . . 0.0 111.544 171.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -58.84 -16.95 19.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -11.17 60.55 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 169.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.12 67.99 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -170.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.7 -2.49 54.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . 0.257 1.6 p30 59.86 -29.78 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 130.198 3.399 . . . . 0.0 119.128 171.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.84 7.3 6.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.654 1.582 . . . . 0.0 113.865 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -99.77 124.29 44.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.195 1.398 . . . . 0.0 110.774 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 48.67 40.56 0.78 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 127.211 2.204 . . . . 0.0 116.781 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -65.5 159.17 49.11 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 122.149 1.803 . . . . 0.0 109.832 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -48.3 -30.01 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -87.69 -7.75 56.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m -132.13 28.83 4.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.041 2.536 . . . . 0.0 111.084 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -101.15 141.52 33.92 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.679 1.992 . . . . 0.0 111.299 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 36.7 p -110.33 149.82 29.65 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -19.92 66.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.52 -39.29 61.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 110.986 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.67 -34.86 78.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 112.179 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.47 -30.16 71.33 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.083 -1.011 . . . . 0.0 111.445 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.4 -4.23 58.11 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.558 1.143 . . . . 0.0 113.466 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.99 15.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.113 1.365 . . . . 0.0 111.152 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.57 138.49 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.356 1.862 . . . . 0.0 109.646 169.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.92 158.62 32.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.244 1.018 . . . . 0.0 112.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.88 -35.85 71.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.596 1.158 . . . . 0.0 111.349 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.5 m -61.92 -23.0 66.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.782 1.633 . . . . 0.0 114.029 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.89 -1.46 7.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.294 1.438 . . . . 0.0 112.746 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.57 -43.91 90.13 Favored Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 119.728 -1.858 . . . . 0.0 112.444 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.52 -25.22 75.63 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.035 1.823 . . . . 0.0 113.214 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -72.69 -39.99 66.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.146 0.978 . . . . 0.0 110.159 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -20.07 63.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.975 1.71 . . . . 0.0 115.537 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.8 -39.99 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-N 121.145 1.793 . . . . 0.0 109.612 163.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.79 23.13 0.18 Allowed Glycine 0 CA--C 1.54 1.624 0 C-N-CA 127.907 2.67 . . . . 0.0 117.424 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -126.39 -57.57 1.38 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.362 1.581 . . . . 0.0 111.041 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.59 78.16 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.221 -0.924 . . . . 0.0 111.773 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.38 -38.41 35.01 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.811 -0.556 . . . . 0.0 111.956 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.76 -46.04 69.84 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 113.296 -171.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -33.32 69.02 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.924 -0.485 . . . . 0.0 110.871 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.27 -28.19 66.98 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.12 -3.93 50.16 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -146.11 -122.97 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.361 1.864 . . . . 0.0 111.208 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -160.3 -79.31 0.05 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.625 1.57 . . . . 0.0 112.092 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -123.88 164.2 30.61 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 127.065 2.146 . . . . 0.0 109.262 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.74 1.98 7.48 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 121.283 1.494 . . . . 0.0 114.826 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -55.74 -27.84 52.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.206 1.402 . . . . 0.0 111.481 168.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.75 3.97 23.2 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.816 2.046 . . . . 0.0 113.279 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.94 126.88 35.59 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 119.725 -1.86 . . . . 0.0 113.744 -169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.96 132.52 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.151 2.181 . . . . 0.0 106.471 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.81 116.24 9.96 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.631 1.105 . . . . 0.0 109.787 -174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -86.28 61.44 6.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.06 1.344 . . . . 0.0 110.588 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.315 1.2 p -68.65 -34.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.385 -167.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.13 -39.04 89.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.852 1.66 . . . . 0.0 111.991 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.39 -48.39 79.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.538 0.589 . . . . 0.0 111.677 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.75 -43.21 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.46 1.104 . . . . 0.0 111.702 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.9 -37.8 76.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.288 1.035 . . . . 0.0 112.315 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -62.12 -39.89 94.06 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.453 1.101 . . . . 0.0 112.007 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.0 -26.19 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.41 1.484 . . . . 0.0 113.594 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -44.77 -60.49 2.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 126.603 1.961 . . . . 0.0 113.571 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.52 -19.49 67.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.262 1.975 . . . . 0.0 113.149 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.04 -58.07 4.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.097 0.959 . . . . 0.0 111.274 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -20.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.26 -0.9 . . . . 0.0 113.255 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.8 -52.82 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.614 1.097 . . . . 0.0 110.28 173.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.18 -47.69 34.01 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 122.458 0.303 . . . . 0.0 111.476 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.03 -28.57 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.692 -1.255 . . . . 0.0 113.24 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.01 -16.24 60.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.69 21.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.278 1.399 . . . . 0.0 111.34 168.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.95 -38.87 76.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.772 0.829 . . . . 0.0 112.544 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -146.65 83.5 1.6 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -56.86 -37.83 71.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.933 1.293 . . . . 0.0 111.937 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.9 -6.13 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 113.018 -172.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.88 137.42 58.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.836 0.744 . . . . 0.0 109.219 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -122.59 44.25 2.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.386 -167.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -138.36 143.04 39.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -165.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -67.41 -26.92 66.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.369 1.068 . . . . 0.0 110.381 166.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -64.19 -24.8 67.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.895 1.278 . . . . 0.0 113.216 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.05 -31.62 72.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.046 -1.034 . . . . 0.0 111.98 170.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.43 -47.15 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.719 1.608 . . . . 0.0 110.453 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -65.32 -34.22 77.81 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.292 1.037 . . . . 0.0 113.286 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.42 -34.87 76.89 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.659 1.124 . . . . 0.0 113.69 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -75.69 -32.85 60.29 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.601 1.2 . . . . 0.0 113.187 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.92 -39.47 94.25 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.893 -1.129 . . . . 0.0 111.065 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -61.48 -48.55 80.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 111.756 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -24.15 67.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.984 -1.072 . . . . 0.0 112.289 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 27.9 mt -83.94 -48.09 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.417 1.487 . . . . 0.0 112.373 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -103.57 -51.2 3.25 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.076 1.351 . . . . 0.0 114.014 -169.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -74.46 -29.14 61.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.108 1.363 . . . . 0.0 113.11 -172.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.28 -27.47 35.08 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.035 1.334 . . . . 0.0 114.13 -170.112 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.359 0.124 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -115.44 26.42 10.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.677 1.991 . . . . 0.0 111.692 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.65 156.92 16.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.707 1.203 . . . . 0.0 111.302 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.432 ' HB3' ' H ' ' B' ' 142' ' ' GLN . 12.5 pt20 -157.75 -176.94 6.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.506 1.123 . . . . 0.0 112.344 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -77.48 37.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 46.9 57.74 5.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.712 2.005 . . . . 0.0 115.86 169.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.71 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.689 -1.257 . . . . 0.0 113.184 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.74 -22.62 65.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.627 1.571 . . . . 0.0 114.315 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -122.36 12.12 10.11 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.257 1.823 . . . . 0.0 112.833 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 40.24 92.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 129.074 2.95 . . . . 0.0 115.524 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -115.9 60.71 1.81 Allowed Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 126.028 1.731 . . . . 0.0 111.372 168.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.29 167.46 23.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.358 3.372 . . . . 0.0 113.393 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.5 7.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.29 21.84 7.24 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.297 2.239 . . . . 0.0 113.153 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.0 p -116.05 -32.01 5.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -129.26 163.13 26.32 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -73.16 168.02 19.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.204 1.402 . . . . 0.0 113.733 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -27.44 46.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.68 -38.32 74.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.156 0.982 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.02 -12.67 59.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.498 1.519 . . . . 0.0 113.065 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -76.26 -16.73 59.74 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.516 -1.365 . . . . 0.0 111.344 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.37 1.76 47.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.017 1.327 . . . . 0.0 114.145 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.48 56.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 112.27 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.55 136.65 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.752 2.021 . . . . 0.0 110.954 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.42 157.8 25.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.51 1.124 . . . . 0.0 112.457 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -53.47 -31.37 45.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.482 1.513 . . . . 0.0 111.758 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 m -61.74 -29.49 70.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.193 1.797 . . . . 0.0 113.89 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -126.45 -1.51 6.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.792 1.637 . . . . 0.0 112.702 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -53.57 -46.81 98.04 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.91 -1.744 . . . . 0.0 112.365 170.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -67.56 -17.83 48.54 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.415 2.076 . . . . 0.0 112.924 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.6 m -79.76 -36.91 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.218 1.407 . . . . 0.0 110.702 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.59 98.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.526 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.9 -48.41 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.723 0.809 . . . . 0.0 109.288 168.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.04 -52.37 35.8 Favored Glycine 0 C--O 1.213 -1.21 0 C-N-CA 125.214 1.388 . . . . 0.0 113.149 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -68.81 -12.69 61.79 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.649 2.725 . . . . 0.0 114.664 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.38 -50.07 5.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.002 0.819 . . . . 0.0 111.12 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -75.51 -24.1 56.79 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.126 -0.984 . . . . 0.0 113.221 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.35 76.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.404 -1.435 . . . . 0.0 112.003 -176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.8 -33.17 62.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.32 1.048 . . . . 0.0 110.32 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -56.84 -23.19 42.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.978 1.711 . . . . 0.0 113.59 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -91.09 -18.53 24.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HZ1' ' CG ' ' B' ' 97' ' ' ASP . 1.0 OUTLIER -156.13 -120.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.115 1.325 . . . . 0.0 113.52 -171.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -161.18 -58.88 0.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.532 1.533 . . . . 0.0 113.954 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.03 166.25 27.45 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 128.125 2.57 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.87 14.03 2.32 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.033 1.762 . . . . 0.0 114.804 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.22 -23.71 66.81 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.282 1.433 . . . . 0.0 111.783 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -127.94 26.8 5.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.901 1.68 . . . . 0.0 114.111 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.64 35.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.995 -1.69 . . . . 0.0 112.445 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.04 -16.33 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 66.64 110.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.856 2.462 . . . . 0.0 112.195 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.39 59.83 1.88 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.777 1.231 . . . . 0.0 111.659 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 2.4 p -62.3 -19.61 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.606 -1.309 . . . . 0.0 114.42 -168.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.51 -44.68 56.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 112.169 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.97 -47.71 6.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -58.17 -51.09 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.746 1.218 . . . . 0.0 112.265 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.71 66.69 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -66.61 -49.0 67.74 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.018 1.327 . . . . 0.0 112.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.22 -18.45 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -46.4 -60.7 3.34 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.634 1.174 . . . . 0.0 112.807 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.93 -4.18 12.94 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.295 2.663 . . . . 0.0 114.113 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -62.72 1.43 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.363 1.465 . . . . 0.0 111.158 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -30.85 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.951 -1.093 . . . . 0.0 113.175 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.46 -41.09 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.099 0.863 . . . . 0.0 112.66 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.72 -44.34 28.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.084 0.953 . . . . 0.0 110.789 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.18 93.35 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.429 -0.794 . . . . 0.0 112.402 -171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.69 -7.15 56.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -34.52 16.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.115 1.325 . . . . 0.0 111.565 169.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -78.83 -32.98 46.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -117.09 49.18 1.21 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.665 1.586 . . . . 0.0 112.06 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -48.93 -36.79 18.18 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.743 -1.223 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -87.92 -2.86 58.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.664 1.186 . . . . 0.0 113.624 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.05 157.51 35.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.004 0.922 . . . . 0.0 111.352 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -76.68 161.39 28.57 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.505 1.145 . . . . 0.0 113.759 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -48.28 153.09 0.76 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.788 2.435 . . . . 0.0 114.132 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp 60.29 -34.63 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 130.031 3.332 . . . . 0.0 117.253 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -30.57 70.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.971 1.709 . . . . 0.0 111.995 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -74.1 -35.49 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.8 -46.15 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.086 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -63.76 -43.38 96.6 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.354 1.062 . . . . 0.0 112.113 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.24 98.5 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.931 1.729 . . . . 0.0 113.771 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -73.5 -33.57 64.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.565 1.682 . . . . 0.0 113.13 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -62.85 -39.28 93.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.364 -1.46 . . . . 0.0 111.157 171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.04 -46.64 83.5 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.547 1.139 . . . . 0.0 112.106 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -31.8 72.32 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.057 -1.027 . . . . 0.0 112.08 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.2 mt -79.08 -48.37 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 111.304 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -101.86 -59.7 1.66 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.218 1.407 . . . . 0.0 113.221 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -66.66 -26.36 67.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.7 1.6 . . . . 0.0 113.476 -170.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.62 -19.68 64.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.59 1.156 . . . . 0.0 114.086 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.0 tpp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.185 1.394 . . . . 0.0 112.939 -178.088 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -142.5 127.74 18.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.238 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.75 159.95 0.09 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.661 1.984 . . . . 0.0 114.657 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -154.21 0.48 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.005 0.922 . . . . 0.0 113.32 -167.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -73.99 42.69 0.15 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.329 2.651 . . . . 0.0 114.058 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 58.35 90.6 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.121 2.568 . . . . 0.0 115.271 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 52.84 -154.65 0.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.985 2.114 . . . . 0.0 114.312 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . 0.489 ' CG ' ' HZ1' ' A' ' 42' ' ' LYS . 36.5 t70 -96.55 -11.91 24.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.641 1.576 . . . . 0.0 113.703 -173.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -149.76 13.53 0.81 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -88.73 -40.75 13.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 121.976 2.171 . . . . 0.0 115.693 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -118.19 49.9 1.08 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 125.12 1.368 . . . . 0.0 113.074 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.7 151.2 85.18 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.392 1.394 . . . . 0.0 114.407 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 m -47.56 -29.71 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.276 2.23 . . . . 0.0 114.996 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -93.99 -9.33 37.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 58.0 p -116.15 -32.57 5.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.74 1.154 . . . . 0.0 113.757 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -93.7 163.56 13.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.207 1.003 . . . . 0.0 113.549 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.0 p -99.73 155.78 17.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.298 1.439 . . . . 0.0 114.275 -169.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -20.4 18.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.238 1.815 . . . . 0.0 115.275 -174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.96 -40.65 89.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.03 1.286 . . . . 0.0 111.679 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -78.1 -12.36 59.98 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.938 0.895 . . . . 0.0 112.146 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -94.13 -17.29 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.774 -1.204 . . . . 0.0 112.986 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.07 -17.42 57.02 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.939 -1.101 . . . . 0.0 113.254 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.3 50.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.687 1.195 . . . . 0.0 113.905 -171.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.71 139.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.024 1.73 . . . . 0.0 111.113 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.61 158.68 29.29 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.638 1.575 . . . . 0.0 113.744 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.16 -33.27 70.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.852 1.261 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.5 m -59.43 -26.75 65.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.087 1.755 . . . . 0.0 113.656 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.51 -0.93 8.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.607 1.563 . . . . 0.0 112.523 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.44 -46.38 99.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 120.009 -1.682 . . . . 0.0 112.805 172.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -64.96 -25.4 59.53 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.353 2.035 . . . . 0.0 112.848 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 58.0 m -70.12 -38.43 75.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.039 0.936 . . . . 0.0 110.345 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.05 92.54 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.35 -35.62 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.739 1.154 . . . . 0.0 110.76 170.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.31 -42.03 88.13 Favored Glycine 0 C--O 1.217 -0.915 0 C-N-CA 124.764 1.173 . . . . 0.0 113.687 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -44.4 71.16 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.147 1.973 . . . . 0.0 111.51 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.84 82.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.76 -39.14 73.41 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.012 -1.055 . . . . 0.0 113.557 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.62 87.68 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.021 -1.049 . . . . 0.0 111.386 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.53 -38.81 33.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.578 0.751 . . . . 0.0 111.056 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.0 -31.39 72.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.076 0.95 . . . . 0.0 113.198 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.77 -16.84 49.73 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.16 -124.14 0.03 OUTLIER 'General case' 0 C--N 1.35 0.629 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -163.66 -45.68 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.494 1.518 . . . . 0.0 114.205 -167.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.04 161.99 56.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 127.298 2.239 . . . . 0.0 110.158 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.9 5.55 6.2 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.764 1.643 . . . . 0.0 113.909 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -56.51 -29.74 62.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.377 1.471 . . . . 0.0 111.86 169.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -111.94 15.12 20.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.198 1.799 . . . . 0.0 112.964 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.72 120.96 24.12 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 119.408 -2.057 . . . . 0.0 111.999 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.34 128.81 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.791 1.636 . . . . 0.0 106.917 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.1 116.75 16.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.626 0.648 . . . . 0.0 110.488 -169.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.07 48.98 1.73 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.27 1.828 . . . . 0.0 111.43 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.351 1.7 p -62.8 -32.73 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -166.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.432 ' H ' ' HB3' ' A' ' 4' ' ' GLN . 3.0 tm0? -59.82 -50.56 73.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.626 1.557 . . . . 0.0 110.027 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.79 -39.51 55.0 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.797 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -58.37 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.488 1.115 . . . . 0.0 110.979 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.06 75.66 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.83 1.195 . . . . 0.0 112.526 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 53.3 m -62.39 -43.38 98.95 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.383 1.073 . . . . 0.0 111.872 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 35.0 t -83.69 -30.43 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.494 1.518 . . . . 0.0 113.082 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.5 m -37.04 -61.93 0.62 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 127.132 2.173 . . . . 0.0 114.245 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.21 -22.7 60.72 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.059 1.839 . . . . 0.0 113.026 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.95 -60.53 2.56 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.286 1.035 . . . . 0.0 110.689 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.428 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -70.5 -25.6 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 178.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -52.15 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.12 0.873 . . . . 0.0 110.654 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.35 -43.44 60.71 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.655 0.382 . . . . 0.0 111.287 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.73 -29.13 69.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.749 -1.219 . . . . 0.0 112.852 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 34.4 m -69.75 -13.93 62.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 169.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.23 -38.43 13.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.652 1.569 . . . . 0.0 110.872 166.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -59.81 -38.77 82.9 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.959 0.904 . . . . 0.0 112.396 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.54 75.41 1.46 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 122.359 1.076 . . . . 0.0 111.246 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -52.26 -27.21 14.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.042 1.737 . . . . 0.0 112.357 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.94 -2.63 55.63 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.383 1.473 . . . . 0.0 113.516 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.59 152.13 36.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.51 1.124 . . . . 0.0 111.702 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -70.19 136.27 49.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.313 1.445 . . . . 0.0 111.099 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.19 -43.65 81.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -60.47 -41.34 93.96 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.217 1.371 . . . . 0.0 110.705 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.03 -36.81 84.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.343 0.657 . . . . 0.0 112.311 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -70.9 -39.31 72.84 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.92 -46.17 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 119.65 1.114 . . . . 0.0 109.968 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -65.33 -46.52 79.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.864 0.866 . . . . 0.0 112.359 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.15 99.24 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.832 1.206 . . . . 0.0 113.394 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -71.83 -34.32 69.22 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.702 1.251 . . . . 0.0 112.307 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -61.35 -39.92 92.36 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.66 -1.275 . . . . 0.0 111.725 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.81 -47.74 79.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.425 0.69 . . . . 0.0 111.394 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.52 68.95 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.393 -1.442 . . . . 0.0 111.849 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.8 mt -73.9 -47.6 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.908 1.683 . . . . 0.0 112.785 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -99.5 -58.82 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.85 1.26 . . . . 0.0 113.321 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.65 -36.19 81.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.029 1.332 . . . . 0.0 111.731 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.0 t0 50.22 50.76 18.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.658 1.983 . . . . 0.0 112.629 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.965 1.706 . . . . 0.0 113.279 -177.273 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.76 -20.95 57.89 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.21 46.36 23.95 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.26 -20.69 63.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.29 131.5 47.51 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.591 -0.693 . . . . 0.0 110.457 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.7 124.33 30.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.97 -81.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.948 1.699 . . . . 0.0 112.86 -167.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -167.73 -47.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.878 1.671 . . . . 0.0 111.127 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -115.88 15.76 16.27 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -168.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.345 0.0 OUTLIER -128.77 18.61 6.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 -168.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -123.99 57.29 12.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 125.011 1.324 . . . . 0.0 111.007 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.23 161.92 44.23 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.781 2.987 . . . . 0.0 114.667 -168.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.82 -14.98 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.37 1.468 . . . . 0.0 113.802 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -85.97 -10.73 54.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.866 2.066 . . . . 0.0 113.502 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -133.38 -25.8 1.7 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.67 151.83 46.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.175 0.898 . . . . 0.0 111.76 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -97.35 165.17 12.15 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.883 1.325 . . . . 0.0 113.05 -172.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 m -62.1 -21.97 65.42 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.48 -44.75 95.63 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.711 170.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -63.87 -25.84 68.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.397 -0.815 . . . . 0.0 112.167 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.24 -16.39 63.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.945 -1.097 . . . . 0.0 112.664 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.5 mt -87.19 -9.51 55.0 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.021 -1.049 . . . . 0.0 112.378 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -26.75 13.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.099 1.76 . . . . 0.0 113.404 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.02 -4.31 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t70 64.8 155.12 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 129.076 2.951 . . . . 0.0 116.319 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.06 -34.5 63.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.128 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 m -67.73 -25.04 65.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -127.32 3.3 6.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.583 1.153 . . . . 0.0 112.014 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -57.3 -52.3 75.28 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.311 -1.493 . . . . 0.0 110.449 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -67.66 -12.15 34.57 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.417 2.078 . . . . 0.0 114.39 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 79.6 m -73.27 -32.71 64.84 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.795 -1.191 . . . . 0.0 110.678 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.26 85.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.387 1.075 . . . . 0.0 112.145 169.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.91 -45.18 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.353 1.061 . . . . 0.0 109.001 170.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.45 6.03 0.38 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.54 2.019 . . . . 0.0 116.78 169.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -121.68 -61.36 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.999 1.72 . . . . 0.0 110.078 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.41 -30.4 70.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.26 -32.56 13.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.683 0.674 . . . . 0.0 112.392 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.05 -46.29 88.22 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -12.43 60.13 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.05 0.94 . . . . 0.0 111.939 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -85.81 -21.92 27.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.66 1.184 . . . . 0.0 113.028 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -95.89 -16.28 21.89 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.863 0.865 . . . . 0.0 113.225 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -170.59 153.33 4.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.971 2.908 . . . . 0.0 106.835 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -84.26 -41.74 16.59 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 111.556 -2.565 . . . . 0.0 112.718 -173.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -131.56 159.59 71.14 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 127.071 2.148 . . . . 0.0 110.057 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -90.23 12.04 2.59 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.3 2.0 . . . . 0.0 114.432 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.07 -23.71 65.68 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.241 1.016 . . . . 0.0 112.651 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.77 -15.84 24.77 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.333 1.853 . . . . 0.0 113.787 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.21 127.09 32.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.51 18.38 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 125.586 1.555 . . . . 0.0 111.336 169.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 57.21 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.833 2.853 . . . . 0.0 110.739 -168.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.38 62.37 6.03 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.876 -1.765 . . . . 0.0 110.973 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p -72.42 -24.14 21.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -167.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -58.1 -45.12 87.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.589 1.541 . . . . 0.0 111.455 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.05 -45.2 88.98 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.947 -0.47 . . . . 0.0 112.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.68 -44.86 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.775 1.23 . . . . 0.0 111.657 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.94 63.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 112.742 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.8 m -67.44 -45.55 75.71 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.667 1.187 . . . . 0.0 111.244 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -27.03 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -172.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.8 m -49.48 -62.44 2.47 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.201 1.4 . . . . 0.0 112.831 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -8.29 22.56 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.071 2.514 . . . . 0.0 113.578 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.67 -57.18 3.8 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.312 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.79 -29.8 30.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 C-N-CA 124.084 0.954 . . . . 0.0 112.135 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.55 -53.12 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.574 1.079 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.51 -40.83 80.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.952 0.405 . . . . 0.0 110.609 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.43 97.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.8 m -74.39 -14.67 60.89 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.39 -36.17 24.51 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.11 1.323 . . . . 0.0 111.494 171.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -81.33 -27.15 35.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -125.98 50.14 1.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.436 1.894 . . . . 0.0 112.532 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -51.36 -38.16 51.78 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.703 1.601 . . . . 0.0 113.158 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -81.91 -6.42 59.09 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.29 163.78 20.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.51 1.124 . . . . 0.0 113.019 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -67.0 140.12 57.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.505 1.522 . . . . 0.0 110.755 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.32 -41.02 92.65 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -65.41 -33.56 76.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.01 -1.056 . . . . 0.0 112.38 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.54 -42.24 91.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.465 1.106 . . . . 0.0 111.668 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -41.25 95.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.33 -48.72 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.104 0.411 . . . . 0.0 110.474 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -63.46 -45.79 89.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.69 92.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.701 1.144 . . . . 0.0 113.176 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.05 -34.82 61.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.513 1.156 . . . . 0.0 112.527 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -59.8 -40.26 87.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.545 1.52 . . . . 0.0 111.78 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.43 -46.49 88.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.179 0.992 . . . . 0.0 111.844 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -28.07 69.33 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.904 -1.123 . . . . 0.0 111.92 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.74 -46.17 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.831 1.253 . . . . 0.0 111.956 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -104.33 -62.83 1.27 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.923 1.689 . . . . 0.0 113.367 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -64.82 -24.02 67.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.339 1.855 . . . . 0.0 114.189 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.12 -23.46 65.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.98 1.312 . . . . 0.0 113.869 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.565 1.546 . . . . 0.0 111.888 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -150.2 120.64 7.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.144 0.978 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.21 30.82 8.27 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 167.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -45.79 -40.52 9.74 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.281 1.432 . . . . 0.0 114.035 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 0.38 51.39 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.11 9.59 7.42 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.007 1.323 . . . . 0.0 114.092 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.77 62.34 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 58.75 -22.4 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.57 3.148 . . . . 0.0 117.824 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -65.97 -17.88 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.891 1.677 . . . . 0.0 111.796 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 157.97 41.1 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 128.153 2.581 . . . . 0.0 109.765 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.31 165.41 14.32 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.19 0.996 . . . . 0.0 112.63 -169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -45.99 165.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 1 C-N-CA 126.682 4.921 . . . . 0.0 118.773 176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.01 -19.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.062 1.745 . . . . 0.0 114.82 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -98.92 -2.13 38.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.806 1.242 . . . . 0.0 114.018 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 78.0 p -134.81 -6.14 2.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -177.24 4.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.804 1.242 . . . . 0.0 113.734 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 82.2 p -97.76 166.39 11.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -16.39 6.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.76 -34.41 71.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.086 1.312 . . . . 0.0 111.41 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.56 -27.05 67.37 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.246 -0.909 . . . . 0.0 112.805 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -71.77 -15.71 62.18 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.407 -0.808 . . . . 0.0 112.346 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 mt -95.76 -19.42 19.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.525 1.13 . . . . 0.0 113.22 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.51 65.17 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.206 1.002 . . . . 0.0 112.576 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.22 140.38 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.179 2.192 . . . . 0.0 111.758 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.87 158.99 34.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.807 1.243 . . . . 0.0 113.228 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.9 -32.02 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.679 1.591 . . . . 0.0 111.876 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.2 m -59.13 -28.24 66.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.851 1.661 . . . . 0.0 113.815 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -128.06 -2.89 5.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.29 1.436 . . . . 0.0 113.443 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -58.16 -40.82 86.0 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 119.619 -1.926 . . . . 0.0 113.475 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -60.54 -26.53 83.04 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.66 2.24 . . . . 0.0 113.241 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 42.6 m -77.41 -33.88 54.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.714 1.206 . . . . 0.0 111.483 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.62 80.95 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.733 1.213 . . . . 0.0 113.079 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.02 -34.33 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 111.171 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.64 -58.42 10.22 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.537 1.065 . . . . 0.0 112.655 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.32 -37.08 76.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.233 2.017 . . . . 0.0 112.677 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.74 -29.2 67.56 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -111.83 -33.3 6.35 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.465 1.906 . . . . 0.0 112.705 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -42.2 28.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 110.21 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.03 -32.35 73.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -168.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.35 -7.06 58.77 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.14 -45.41 0.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.33 1.3 p30 56.04 140.22 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.855 2.462 . . . . 0.0 115.94 -166.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 42.9 mttp 63.79 140.9 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.758 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.75 0.09 5.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.629 1.553 . . . . 0.0 114.524 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.27 -16.48 63.6 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.038 1.29 . . . . 0.0 113.657 -170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -123.56 5.01 8.94 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.734 1.614 . . . . 0.0 113.863 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.51 141.32 44.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.469 -1.394 . . . . 0.0 113.741 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.94 132.71 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.58 1.952 . . . . 0.0 107.708 170.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.61 127.35 32.7 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.91 43.72 1.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.939 -1.1 . . . . 0.0 113.623 -166.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.261 14.3 p -64.69 -21.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.528 -1.358 . . . . 0.0 112.775 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -54.91 -30.46 58.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.654 1.581 . . . . 0.0 113.125 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.28 -56.27 1.49 Allowed Glycine 0 N--CA 1.465 0.583 0 C-N-CA 123.507 0.575 . . . . 0.0 112.368 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -54.36 -45.56 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 121.606 -0.938 . . . . 0.0 113.074 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.87 66.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.682 1.128 . . . . 0.0 113.071 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -71.28 -44.56 65.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.946 1.298 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -89.04 -18.32 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.3 m -41.36 -59.95 2.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.455 1.502 . . . . 0.0 113.431 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.47 -16.9 54.98 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.136 2.558 . . . . 0.0 114.121 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.26 -58.25 3.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.354 1.062 . . . . 0.0 111.612 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -37.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.189 -0.944 . . . . 0.0 112.558 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.28 -42.73 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.923 0.489 . . . . 0.0 112.069 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.54 -45.25 46.82 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.74 0.816 . . . . 0.0 110.903 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.31 71.92 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.461 -1.4 . . . . 0.0 113.43 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 10.9 m -74.82 -11.52 60.17 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.74 -34.54 16.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.49 1.496 . . . . 0.0 111.057 167.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -58.26 -38.76 77.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.699 1.2 . . . . 0.0 111.95 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -143.8 83.07 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.41 0.684 . . . . 0.0 111.871 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -55.81 -25.9 43.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.972 1.309 . . . . 0.0 112.946 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -95.13 3.98 54.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.096 1.758 . . . . 0.0 113.269 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.09 149.72 31.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.091 1.356 . . . . 0.0 113.397 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.65 86.92 6.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.58 1.152 . . . . 0.0 113.011 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . 0.258 1.4 p90 44.43 -117.95 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -21.31 64.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.23 1.412 . . . . 0.0 113.462 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.66 -31.65 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.943 0.897 . . . . 0.0 112.267 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -74.73 -42.55 58.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.3 -35.12 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.874 1.216 . . . . 0.0 111.586 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.59 -48.14 76.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.915 0.886 . . . . 0.0 111.843 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.53 -41.42 98.71 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.121 0.867 . . . . 0.0 113.178 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.25 -29.11 63.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.381 1.091 . . . . 0.0 113.161 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -66.13 -43.16 87.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.38 0.991 . . . . 0.0 111.532 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.84 -43.9 97.92 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.684 0.793 . . . . 0.0 111.183 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.3 -40.61 5.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.931 1.693 . . . . 0.0 113.307 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 mt -85.98 -38.82 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.905 0.882 . . . . 0.0 112.421 -171.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -96.42 -54.1 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -78.77 -34.77 45.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.701 1.6 . . . . 0.0 112.776 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 24.9 t0 48.78 48.67 19.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.776 2.03 . . . . 0.0 113.365 -168.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.929 2.092 . . . . 0.0 112.16 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.31 -4.06 58.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.29 36.95 28.33 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -28.12 42.62 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -94.7 13.26 24.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.04 0.936 . . . . 0.0 113.219 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.35 -20.09 65.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.757 1.623 . . . . 0.0 114.315 -172.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.6 62.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.189 0.995 . . . . 0.0 113.076 169.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 t70 61.77 -10.7 0.07 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 129.045 2.938 . . . . 0.0 116.844 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -117.18 -6.76 11.32 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.84 1.656 . . . . 0.0 113.439 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.32 -171.67 3.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 58.3 34.94 0.23 Allowed Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 129.066 2.946 . . . . 0.0 114.585 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.19 147.3 47.79 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.853 1.702 . . . . 0.0 111.15 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.15 -18.51 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -82.49 -19.52 38.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.177 1.391 . . . . 0.0 113.951 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.3 m -141.39 44.8 1.75 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.156 2.182 . . . . 0.0 110.73 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -129.86 139.72 51.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.275 1.83 . . . . 0.0 109.912 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.5 p -102.65 161.43 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.972 1.367 . . . . 0.0 114.159 -168.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 m -77.03 -21.43 54.58 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.83 -42.27 79.34 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.305 0.957 . . . . 0.0 110.648 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.76 -28.75 60.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.092 0.957 . . . . 0.0 112.209 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -66.15 -33.97 76.98 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.658 -1.276 . . . . 0.0 111.262 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.33 -10.52 59.66 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.93 -29.4 27.14 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.248 1.019 . . . . 0.0 112.551 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.85 137.47 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.047 1.739 . . . . 0.0 110.069 170.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.43 157.4 34.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.764 0.826 . . . . 0.0 113.02 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -55.96 -28.93 59.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 111.724 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.7 m -62.78 -27.17 69.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.043 1.737 . . . . 0.0 114.243 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.7 -10.58 5.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.63 1.172 . . . . 0.0 113.511 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.83 -40.45 85.12 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 119.641 -1.912 . . . . 0.0 112.522 169.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -65.53 -24.15 56.61 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.771 2.314 . . . . 0.0 113.435 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.6 m -73.35 -36.53 66.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 110.243 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.54 85.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.647 1.179 . . . . 0.0 113.898 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.84 -35.28 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 119.203 0.911 . . . . 0.0 110.684 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.17 -43.51 74.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.878 1.228 . . . . 0.0 114.448 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -68.29 -49.06 63.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.986 2.393 . . . . 0.0 112.536 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.82 -29.96 71.12 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.147 0.579 . . . . 0.0 112.186 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.55 -45.46 10.44 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.21 90.94 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.679 -1.263 . . . . 0.0 111.308 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.47 62.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.426 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -74.18 -18.96 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.053 0.842 . . . . 0.0 113.221 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.3 -28.59 42.21 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.39 -0.818 . . . . 0.0 112.868 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -154.69 -128.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.48 1.512 . . . . 0.0 112.55 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.9 -39.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.578 2.351 . . . . 0.0 114.261 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -134.2 162.09 59.81 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 127.175 2.19 . . . . 0.0 110.363 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -94.84 9.72 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.939 1.759 . . . . 0.0 114.647 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.91 -18.26 63.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.153 -0.967 . . . . 0.0 112.936 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -112.39 -2.35 14.79 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.133 1.773 . . . . 0.0 113.971 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.55 55.44 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.43 145.07 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.467 1.907 . . . . 0.0 107.339 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.2 137.24 36.64 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 119.233 0.924 . . . . 0.0 113.11 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -94.27 47.66 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.498 -1.376 . . . . 0.0 113.749 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 1.7 p -63.29 -50.28 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -165.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -60.22 -35.19 74.87 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.647 2.021 . . . . 0.0 111.854 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.77 -41.83 88.03 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 121.276 0.376 . . . . 0.0 112.54 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.4 mt -65.7 -45.84 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.422 1.489 . . . . 0.0 111.444 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.05 -25.69 65.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.064 1.346 . . . . 0.0 112.973 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 m -63.92 -46.45 84.71 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.927 1.291 . . . . 0.0 110.98 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.15 -19.12 7.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -47.02 -60.94 3.24 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 125.284 1.433 . . . . 0.0 112.156 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.83 1.32 5.26 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.726 2.951 . . . . 0.0 114.334 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 -55.68 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.065 1.746 . . . . 0.0 110.938 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.07 -32.15 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.017 1.327 . . . . 0.0 111.463 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.11 -45.49 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.774 0.83 . . . . 0.0 112.097 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -67.88 -46.19 72.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.836 0.455 . . . . 0.0 110.181 175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.13 -31.61 69.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.79 0.836 . . . . 0.0 112.632 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.05 -20.28 61.01 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -30.17 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.434 1.015 . . . . 0.0 111.951 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.26 -39.09 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.366 1.067 . . . . 0.0 112.119 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -145.96 82.57 1.62 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 112.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -51.77 -35.53 44.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.878 1.271 . . . . 0.0 112.036 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.75 8.36 34.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.573 1.949 . . . . 0.0 114.595 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.38 45.12 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t30 60.42 20.18 9.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -155.13 150.55 27.26 Favored 'General case' 0 N--CA 1.486 1.363 1 N-CA-C 122.662 4.319 . . . . 0.0 122.662 -170.658 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -60.21 -25.15 65.38 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 113.749 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.79 -24.15 55.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.518 0.599 . . . . 0.0 111.568 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -64.35 -34.12 77.43 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.398 1.079 . . . . 0.0 113.805 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.78 -37.73 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.886 1.221 . . . . 0.0 112.149 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -79.88 -31.9 40.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.37 -33.59 81.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.665 1.126 . . . . 0.0 113.475 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.38 -32.92 55.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.722 1.261 . . . . 0.0 113.325 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -59.91 -41.44 91.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.591 1.087 . . . . 0.0 110.683 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.23 -51.04 70.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.923 0.889 . . . . 0.0 110.967 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -28.81 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 112.451 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mt -79.82 -47.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 112.535 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -99.23 -58.09 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.522 1.129 . . . . 0.0 112.987 -171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 89' ' ' MET . 4.4 mmmm -64.88 -42.24 94.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.645 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.5 t70 58.05 -7.83 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 130.631 3.572 . . . . 0.0 115.868 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 87' ' ' LYS . 28.0 ttt . . . . . 0 C--O 1.254 1.297 0 C-N-CA 128.696 2.798 . . . . 0.0 111.071 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.79 0.329 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -138.74 30.72 2.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 112.205 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.65 153.4 22.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.494 1.518 . . . . 0.0 109.39 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.46 178.3 4.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.225 1.01 . . . . 0.0 112.054 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -55.21 44.44 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 130.213 3.405 . . . . 0.0 118.464 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.9 37.1 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.3 -5.92 28.89 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 56.75 5.72 0.24 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.121 2.168 . . . . 0.0 116.232 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -140.88 -4.95 1.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -88.06 147.28 25.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.41 1.459 . . . . 0.0 111.217 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.4 pttt 31.67 55.0 0.93 Allowed Pre-proline 0 N--CA 1.484 1.273 0 C-N-CA 128.405 2.682 . . . . 0.0 115.768 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.49 155.99 67.55 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.88 2.387 . . . . 0.0 112.238 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.0 -15.66 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -85.01 -10.74 56.69 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.182 1.393 . . . . 0.0 114.129 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 48.1 m -144.72 49.37 1.3 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.388 2.275 . . . . 0.0 110.477 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -141.29 139.91 33.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.498 1.519 . . . . 0.0 110.435 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 39.6 p -98.76 150.0 22.28 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.65 -26.67 65.72 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.09 -39.28 85.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.978 -1.076 . . . . 0.0 111.418 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.16 -17.41 46.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.75 -29.03 66.28 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.794 -1.192 . . . . 0.0 110.353 168.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mp -73.79 -13.77 61.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.954 -1.091 . . . . 0.0 113.478 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.36 -33.45 25.83 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.486 1.039 . . . . 0.0 113.523 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.31 140.23 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.943 1.297 . . . . 0.0 110.597 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -67.13 158.78 30.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.868 1.267 . . . . 0.0 113.347 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.47 -32.69 71.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.44 1.096 . . . . 0.0 112.03 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.4 m -62.4 -23.44 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.909 1.684 . . . . 0.0 113.924 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -124.78 -5.96 7.45 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.765 1.226 . . . . 0.0 113.206 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -57.0 -46.78 99.84 Favored Pre-proline 0 CA--C 1.549 0.909 0 O-C-N 120.272 -1.517 . . . . 0.0 111.699 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -65.65 -18.31 58.57 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.097 2.531 . . . . 0.0 114.366 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 25.6 m -77.13 -38.02 52.92 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.818 1.247 . . . . 0.0 110.464 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.26 99.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.262 1.025 . . . . 0.0 112.476 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.56 -45.71 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.78 . . . . 0.0 109.094 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.5 -57.57 10.32 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 125.645 1.593 . . . . 0.0 113.464 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.62 -12.32 60.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.485 2.642 . . . . 0.0 113.905 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.54 -31.35 13.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.841 1.2 . . . . 0.0 113.627 169.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -88.59 -45.69 9.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.215 1.006 . . . . 0.0 112.343 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.61 84.09 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.791 2.436 . . . . 0.0 113.474 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -18.27 39.25 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.49 1.116 . . . . 0.0 111.865 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -84.69 -35.78 22.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 112.563 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.27 -6.82 54.73 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -146.67 -140.23 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.139 2.576 . . . . 0.0 107.621 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -153.68 -65.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -127.71 160.92 58.33 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 126.966 2.106 . . . . 0.0 110.031 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -82.09 0.24 9.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.16 1.45 . . . . 0.0 114.475 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -60.62 -19.46 57.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 113.456 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -131.79 7.89 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.011 1.324 . . . . 0.0 113.774 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.78 138.81 40.12 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.378 -1.451 . . . . 0.0 114.502 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.86 143.28 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.01 2.124 . . . . 0.0 107.087 168.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.15 133.39 44.07 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.415 1.007 . . . . 0.0 108.983 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -94.35 38.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.834 -1.166 . . . . 0.0 112.684 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 13.1 p -66.66 -21.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.809 -1.807 . . . . 0.0 112.845 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -55.2 -29.84 58.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.684 1.593 . . . . 0.0 112.915 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -94.47 -53.51 1.69 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.612 0.625 . . . . 0.0 112.567 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.24 -42.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.181 0.992 . . . . 0.0 113.357 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.99 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.143 1.338 . . . . 0.0 112.945 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 16.6 m -73.19 -37.73 66.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.556 1.142 . . . . 0.0 111.844 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.42 -27.74 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.074 1.75 . . . . 0.0 113.408 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 26.4 m -53.17 -59.69 8.57 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.323 1.449 . . . . 0.0 112.917 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.32 -15.12 46.29 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.298 2.665 . . . . 0.0 113.52 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.89 -62.51 1.47 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.115 0.966 . . . . 0.0 111.052 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 33.1 mt -69.74 -30.99 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.38 -0.825 . . . . 0.0 112.822 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.38 -44.02 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.01 -1.056 . . . . 0.0 112.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -71.73 -46.08 59.71 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 110.807 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -27.05 67.72 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.577 -1.327 . . . . 0.0 113.309 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 m -75.1 -14.72 60.6 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.06 -36.02 21.47 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.595 1.543 . . . . 0.0 110.562 167.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -59.8 -38.62 82.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.038 0.935 . . . . 0.0 112.464 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -135.71 61.69 1.65 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.931 1.292 . . . . 0.0 112.022 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -49.16 -38.02 24.21 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.994 1.317 . . . . 0.0 112.877 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.51 -2.53 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.407 1.083 . . . . 0.0 113.825 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.68 158.42 24.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 112.638 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -80.44 137.38 36.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.388 1.475 . . . . 0.0 111.274 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.64 -44.14 91.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.367 1.067 . . . . 0.0 113.364 -170.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.79 -41.94 78.6 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.315 0.961 . . . . 0.0 112.111 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.25 -36.71 83.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.876 0.471 . . . . 0.0 112.059 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -74.62 -37.65 62.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.34 -38.73 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.099 1.318 . . . . 0.0 111.466 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.07 -45.53 93.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.291 0.636 . . . . 0.0 111.609 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.98 -49.07 69.03 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.763 1.173 . . . . 0.0 113.613 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.75 -34.34 66.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.634 1.217 . . . . 0.0 112.939 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -61.74 -37.14 83.12 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.193 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.26 -43.36 95.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.651 0.781 . . . . 0.0 111.825 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -23.13 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.728 -1.232 . . . . 0.0 112.331 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.84 -45.8 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.565 1.946 . . . . 0.0 112.528 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.22 -60.22 1.68 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 0.0 113.8 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -62.93 -28.41 70.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.388 1.475 . . . . 0.0 113.607 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.29 -23.62 67.36 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.742 2.417 . . . . 0.0 114.333 177.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.96 -43.39 15.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.713 0.805 . . . . 0.0 113.163 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.24 162.57 25.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.955 0.902 . . . . 0.0 111.137 173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 59.62 -41.2 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -77.44 -30.09 53.19 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.544 1.52 . . . . 0.0 112.499 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.2 -88.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.453 2.301 . . . . 0.0 114.997 174.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.77 11.38 11.22 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.282 1.433 . . . . 0.0 113.373 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.3 t70 65.42 -30.9 0.13 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 129.583 3.153 . . . . 0.0 116.185 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -133.03 -4.85 3.1 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -169.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -84.36 -22.2 30.63 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 -166.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.271 50.2 pttt -121.51 52.62 3.34 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.55 159.09 53.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.164 2.576 . . . . 0.0 113.812 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.37 1.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.22 2.208 . . . . 0.0 116.869 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.7 9.73 7.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.226 1.41 . . . . 0.0 113.576 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -132.86 -40.84 0.94 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.742 1.217 . . . . 0.0 113.904 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -83.89 158.7 21.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.596 0.713 . . . . 0.0 112.601 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -85.0 151.15 24.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -23.93 25.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.391 1.876 . . . . 0.0 114.127 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.34 -36.13 68.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.545 1.066 . . . . 0.0 111.378 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.73 -21.66 60.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.884 0.874 . . . . 0.0 113.071 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -66.64 -24.2 66.27 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -80.32 -14.79 58.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.266 1.426 . . . . 0.0 113.146 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.71 -29.87 40.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.941 . . . . 0.0 112.248 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.37 138.16 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.591 1.956 . . . . 0.0 110.118 172.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.2 157.74 30.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.728 0.811 . . . . 0.0 112.713 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -56.06 -30.92 62.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.228 1.411 . . . . 0.0 111.577 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.6 m -62.48 -27.67 69.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.229 1.812 . . . . 0.0 113.984 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -127.45 -9.35 5.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.745 1.218 . . . . 0.0 113.896 -170.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -55.2 -40.98 88.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 119.543 -1.973 . . . . 0.0 112.034 168.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -62.74 -24.18 74.63 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.305 2.67 . . . . 0.0 113.848 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.9 m -78.73 -33.53 46.6 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.418 1.087 . . . . 0.0 110.455 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.87 91.53 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.0 -36.08 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.048 0.84 . . . . 0.0 110.974 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.58 56.92 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.437 1.017 . . . . 0.0 114.489 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -11.44 60.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.568 2.184 . . . . 0.0 113.788 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.99 -48.25 7.91 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.092 166.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.32 -33.36 55.56 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 113.691 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.03 94.22 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.937 1.295 . . . . 0.0 112.159 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.95 -40.51 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.65 1.18 . . . . 0.0 110.595 -175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.28 -20.84 65.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.984 0.914 . . . . 0.0 113.433 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -84.21 -19.88 33.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -153.53 -124.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.251 . . . . 0.0 112.761 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -162.91 -64.13 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.071 2.148 . . . . 0.0 111.913 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -113.62 160.57 31.28 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.539 2.336 . . . . 0.0 111.196 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.41 2.59 8.29 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 114.578 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -59.17 -26.48 64.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.663 1.185 . . . . 0.0 112.768 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -118.7 25.69 10.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.01 1.724 . . . . 0.0 112.211 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.7 118.35 29.24 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.499 -1.376 . . . . 0.0 112.165 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.89 127.99 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.58 122.6 16.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.648 1.113 . . . . 0.0 110.153 -169.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -89.69 46.71 1.39 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.161 -0.962 . . . . 0.0 113.015 -168.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.369 2.5 p -63.7 -15.06 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 O-C-N 120.645 -1.285 . . . . 0.0 112.43 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.78 -44.67 70.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.695 1.598 . . . . 0.0 112.185 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.66 4.98 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -50.17 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.825 . . . . 0.0 112.702 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.39 67.14 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.501 1.046 . . . . 0.0 112.453 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 m -66.19 -48.8 69.48 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.129 1.372 . . . . 0.0 112.218 171.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.2 m -87.04 -18.47 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -46.92 -63.1 1.51 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.107 1.363 . . . . 0.0 112.037 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -69.44 0.39 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.614 2.876 . . . . 0.0 114.57 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.52 -57.2 2.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.178 1.791 . . . . 0.0 110.029 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mt -68.83 -32.2 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.828 1.251 . . . . 0.0 112.369 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.79 -42.16 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.958 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -72.99 -46.9 49.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.456 0.646 . . . . 0.0 110.017 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.43 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.305 -0.872 . . . . 0.0 113.06 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.7 m -74.17 -14.26 60.93 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -34.99 16.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.36 1.436 . . . . 0.0 111.53 168.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -60.84 -38.0 83.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.16 . . . . 0.0 111.904 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -138.72 56.64 1.7 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.541 1.536 . . . . 0.0 112.318 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -49.97 -33.98 19.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.852 2.061 . . . . 0.0 113.121 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.6 -1.9 58.16 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.55 144.36 44.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.042 0.837 . . . . 0.0 111.827 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.76 29.37 0.2 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.287 1.835 . . . . 0.0 114.411 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 t80 52.01 -171.25 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.704 2.002 . . . . 0.0 112.814 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 tttt 62.26 -44.32 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 129.657 3.183 . . . . 0.0 115.288 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.77 -35.73 64.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.494 1.918 . . . . 0.0 111.671 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -43.59 79.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.673 0.789 . . . . 0.0 112.9 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.38 -37.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.003 0.819 . . . . 0.0 111.405 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -69.37 -48.79 60.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.242 1.017 . . . . 0.0 111.968 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.96 94.64 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.147 1.356 . . . . 0.0 113.845 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.21 -34.17 63.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.202 1.501 . . . . 0.0 112.637 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.5 -41.62 94.66 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.565 1.075 . . . . 0.0 111.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.97 -48.17 83.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.25 1.02 . . . . 0.0 111.393 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -28.88 70.14 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.427 -1.421 . . . . 0.0 112.346 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.2 mt -81.2 -45.2 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.956 1.303 . . . . 0.0 112.707 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -102.61 -57.78 1.99 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.953 1.301 . . . . 0.0 113.101 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -66.25 -34.61 78.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.609 1.164 . . . . 0.0 111.835 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.53 61.38 3.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.074 2.15 . . . . 0.0 112.752 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 C--O 1.255 1.367 0 C-N-CA 127.792 2.437 . . . . 0.0 113.834 -174.32 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -142.73 118.57 10.55 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 47.2 42.54 13.49 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 166.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -11.75 61.08 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.751 -1.218 . . . . 0.0 113.621 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -75.83 53.04 0.72 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.926 2.091 . . . . 0.0 111.504 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.46 54.83 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.8 64.78 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.6 104.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.694 2.398 . . . . 0.0 114.115 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . 0.297 0.0 OUTLIER 66.51 4.49 3.33 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.385 2.274 . . . . 0.0 116.676 176.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -136.12 -162.52 1.28 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.626 1.97 . . . . 0.0 111.714 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 63.95 44.79 0.53 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 127.627 2.371 . . . . 0.0 113.266 -168.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.63 166.42 29.93 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.298 2.666 . . . . 0.0 113.249 -173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 m -55.71 -25.38 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.22 -27.68 60.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.552 1.141 . . . . 0.0 113.097 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m -119.04 -19.28 8.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -169.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.24 160.76 29.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.142 0.883 . . . . 0.0 111.878 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 53.4 p -95.73 168.42 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.708 1.242 . . . . 0.0 113.871 -169.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.46 -26.7 67.32 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.293 -0.88 . . . . 0.0 112.119 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -62.74 -42.12 99.51 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.421 168.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.4 -30.4 71.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.375 0.67 . . . . 0.0 112.087 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.417 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 66.0 t80 -69.17 -23.74 63.98 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.035 -1.041 . . . . 0.0 111.636 173.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.04 -8.96 56.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.417 1.087 . . . . 0.0 113.359 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.08 -34.99 43.13 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.187 0.995 . . . . 0.0 112.699 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.05 139.12 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.614 1.566 . . . . 0.0 110.187 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.4 158.87 32.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.368 1.067 . . . . 0.0 113.318 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.83 -32.34 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.492 1.517 . . . . 0.0 112.125 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.6 m -59.62 -29.44 68.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.727 1.611 . . . . 0.0 113.53 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.45 -4.38 6.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.871 1.268 . . . . 0.0 114.09 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -56.02 -41.18 89.71 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 120.168 -1.582 . . . . 0.0 113.001 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -62.76 -26.45 75.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.676 2.251 . . . . 0.0 113.239 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 27.6 m -76.2 -35.6 59.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.526 1.13 . . . . 0.0 111.26 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.39 98.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.693 1.197 . . . . 0.0 113.645 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.63 -35.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.146 1.339 . . . . 0.0 109.793 168.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.88 -46.47 60.48 Favored Glycine 0 C--O 1.218 -0.89 0 C-N-CA 125.02 1.295 . . . . 0.0 114.589 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.29 -35.14 77.38 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 121.489 2.644 . . . . 0.0 112.738 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.83 70.81 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.186 -0.946 . . . . 0.0 112.45 173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -76.71 -46.48 25.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.348 1.059 . . . . 0.0 111.985 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.64 67.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.478 1.511 . . . . 0.0 111.99 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -31.08 69.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.431 0.692 . . . . 0.0 111.086 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.41 -21.44 65.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.795 0.838 . . . . 0.0 113.196 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -84.43 -21.81 30.61 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.4 -124.79 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -162.98 -66.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 128.006 2.523 . . . . 0.0 110.281 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.6 164.97 13.76 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 126.714 2.005 . . . . 0.0 110.417 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -90.94 7.06 3.66 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.958 2.439 . . . . 0.0 114.001 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -63.95 -25.91 68.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.759 -1.213 . . . . 0.0 113.011 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.14 0.9 25.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.558 1.543 . . . . 0.0 114.382 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.62 131.27 44.37 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.833 -1.167 . . . . 0.0 113.563 -172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.24 129.58 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 127.051 2.14 . . . . 0.0 106.814 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.8 130.98 45.54 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.661 1.118 . . . . 0.0 112.269 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -88.98 50.29 1.93 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.958 1.303 . . . . 0.0 111.442 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.25 -38.87 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -166.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.84 -36.64 84.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.734 1.607 . . . . 0.0 111.476 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.5 41.19 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 123.95 0.786 . . . . 0.0 111.529 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.3 -42.95 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.998 0.919 . . . . 0.0 111.547 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.58 -34.94 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 112.761 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 24.7 m -64.56 -43.6 93.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.561 1.145 . . . . 0.0 111.73 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 25.2 t -80.14 -33.19 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.995 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.9 m -40.5 -61.9 1.08 Allowed Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.425 1.89 . . . . 0.0 113.891 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.85 -15.23 48.17 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.493 2.129 . . . . 0.0 113.632 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.44 -61.38 1.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.219 1.008 . . . . 0.0 111.231 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -25.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.957 -1.089 . . . . 0.0 113.066 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.84 -52.77 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.026 0.83 . . . . 0.0 110.641 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -68.88 -47.1 66.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.705 0.402 . . . . 0.0 110.894 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -29.75 70.43 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.61 -1.306 . . . . 0.0 113.008 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.94 -15.25 60.21 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -32.29 22.61 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.058 1.299 . . . . 0.0 111.238 167.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -61.39 -38.22 86.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.945 0.898 . . . . 0.0 112.121 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -145.15 70.69 1.27 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 0.0 112.224 -170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -54.91 -42.26 71.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -76.53 -15.72 59.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.87 158.4 35.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 111.926 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -69.21 143.66 53.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 169.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 35.7 t80 -58.1 -41.31 83.27 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -62.65 -33.02 74.2 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.4 -39.18 86.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.319 1.047 . . . . 0.0 111.838 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -37.86 62.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.937 0.895 . . . . 0.0 112.736 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.95 -48.33 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 119.302 0.955 . . . . 0.0 109.906 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.54 -46.83 74.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.01 0.924 . . . . 0.0 112.395 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.26 -42.23 99.72 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.26 0.934 . . . . 0.0 113.479 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.62 -33.61 62.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.454 1.127 . . . . 0.0 112.679 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.73 -37.88 88.28 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.465 -1.397 . . . . 0.0 111.878 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.41 -47.59 83.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.331 1.052 . . . . 0.0 111.933 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -26.15 68.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.051 -1.03 . . . . 0.0 112.285 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 31.6 mt -79.23 -49.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.913 1.685 . . . . 0.0 112.194 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.91 -60.19 1.59 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.138 1.375 . . . . 0.0 113.523 -171.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -65.2 -26.89 68.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.751 1.62 . . . . 0.0 113.603 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.78 -20.39 63.48 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.863 1.265 . . . . 0.0 114.391 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.241 1.417 . . . . 0.0 113.287 -175.642 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.32 -12.64 27.61 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -124.93 -175.18 3.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.754 1.622 . . . . 0.0 111.638 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.383 0.4 OUTLIER 46.59 -93.31 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.93 2.092 . . . . 0.0 115.484 175.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.8 0.94 16.25 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.04 33.53 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.2 -20.41 64.84 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.04 -6.89 0.07 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.85 2.86 . . . . 0.0 117.237 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.58 -5.12 9.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.705 1.602 . . . . 0.0 114.04 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -177.87 5.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.23 1.412 . . . . 0.0 113.454 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 16' ' ' TRP . 27.1 tttp 65.39 32.46 0.1 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 128.434 2.694 . . . . 0.0 116.973 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.23 164.19 35.9 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.192 1.928 . . . . 0.0 113.043 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.77 -22.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.656 1.182 . . . . 0.0 113.605 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -68.57 -25.62 64.99 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.736 2.014 . . . . 0.0 113.827 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -133.25 -11.53 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.435 ' CE2' ' HE3' ' A' ' 11' ' ' LYS . 4.6 t90 -76.72 123.13 25.71 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 109.161 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -90.07 148.08 23.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 112.935 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -54.96 -30.0 58.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -63.26 -42.06 99.11 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.786 1.175 . . . . 0.0 111.693 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.23 0.27 57.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.865 1.266 . . . . 0.0 112.36 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 -28.07 20.77 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.036 -1.04 . . . . 0.0 111.838 171.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.82 -5.54 6.18 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.154 -0.966 . . . . 0.0 112.588 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.49 -27.17 60.45 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.427 1.491 . . . . 0.0 112.021 170.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.44 135.02 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.355 1.862 . . . . 0.0 109.749 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.09 157.46 33.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.636 0.774 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.85 -27.77 63.52 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.181 1.392 . . . . 0.0 112.238 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 m -66.53 -23.16 66.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 172.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -124.94 -11.09 7.16 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -61.38 -38.72 55.58 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.619 -1.925 . . . . 0.0 112.303 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.81 -26.06 74.77 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.129 2.552 . . . . 0.0 112.714 169.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -73.71 -36.34 65.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.651 1.18 . . . . 0.0 110.772 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.08 -49.73 74.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.218 1.007 . . . . 0.0 113.577 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.256 4.2 p -64.18 -33.77 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 118.99 0.814 . . . . 0.0 110.343 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.39 -52.06 34.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.405 168.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.36 -39.92 89.45 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.623 2.211 . . . . 0.0 112.599 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.97 68.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.244 -0.91 . . . . 0.0 112.69 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.69 -40.52 11.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.699 1.2 . . . . 0.0 112.385 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.34 80.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 111.859 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -26.44 60.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 0.0 111.058 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -68.27 -22.79 64.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -86.65 -24.69 25.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -154.13 -141.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.503 1.521 . . . . 0.0 111.108 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -165.11 136.23 4.01 Favored 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.105 4.162 . . . . 0.0 108.291 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.98 163.6 0.1 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.772 2.029 . . . . 0.0 113.061 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -92.59 9.27 2.6 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.034 1.823 . . . . 0.0 113.807 172.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -57.26 -24.63 56.05 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 112.971 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -130.6 31.93 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.563 1.545 . . . . 0.0 111.996 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.02 138.78 31.22 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.002 -1.686 . . . . 0.0 113.638 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.42 134.76 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.787 2.435 . . . . 0.0 106.174 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 111.74 4.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.012 1.278 . . . . 0.0 108.941 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -85.61 53.87 2.92 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.935 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.363 2.7 p -64.0 -14.24 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 -169.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.4 -42.57 53.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.853 1.661 . . . . 0.0 111.993 166.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.85 -52.94 4.15 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.24 -48.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.364 1.065 . . . . 0.0 112.923 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.02 71.37 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.585 1.084 . . . . 0.0 112.457 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.3 m -71.57 -43.62 65.98 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.658 1.583 . . . . 0.0 112.829 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.93 -22.97 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.135 0.974 . . . . 0.0 113.623 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 m -49.26 -60.82 4.16 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 125.155 1.382 . . . . 0.0 112.945 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -66.33 -5.34 12.4 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.374 2.716 . . . . 0.0 114.465 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.4 -61.73 1.67 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -67.41 -35.23 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.361 1.064 . . . . 0.0 112.245 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.29 -51.66 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.416 1.086 . . . . 0.0 110.384 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -73.02 -42.34 63.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.388 0.613 . . . . 0.0 110.902 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -29.69 70.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.351 0.66 . . . . 0.0 112.358 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.42 -17.16 64.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -35.45 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.216 1.371 . . . . 0.0 111.726 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.93 -38.14 84.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.893 0.877 . . . . 0.0 112.601 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -140.29 72.98 1.41 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -51.01 -31.76 19.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.659 1.983 . . . . 0.0 113.294 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -93.49 0.09 56.59 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.91 154.22 36.14 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 111.418 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.63 149.35 34.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 110.262 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.1 -37.44 82.74 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.215 -0.928 . . . . 0.0 113.261 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -60.4 -37.66 81.52 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.577 -1.327 . . . . 0.0 112.765 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.82 -39.75 94.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.438 0.695 . . . . 0.0 111.315 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -62.84 -44.02 97.24 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.32 -41.36 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.056 0.843 . . . . 0.0 110.712 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.53 -54.1 22.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.517 0.727 . . . . 0.0 112.116 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.85 99.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.944 0.783 . . . . 0.0 113.108 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -28.07 57.31 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.425 -1.044 . . . . 0.0 113.275 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -65.07 -40.74 95.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.618 1.099 . . . . 0.0 111.146 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.01 -43.33 99.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.353 0.661 . . . . 0.0 111.731 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -38.21 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.192 1.797 . . . . 0.0 114.226 169.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt -92.17 -37.01 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.425 1.09 . . . . 0.0 112.095 -168.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.98 -59.47 1.84 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.409 1.484 . . . . 0.0 113.565 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -66.83 -27.99 67.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.167 1.387 . . . . 0.0 113.596 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.58 -18.27 62.91 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.1 tpp . . . . . 0 C--O 1.255 1.385 0 C-N-CA 125.521 1.528 . . . . 0.0 112.579 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -150.39 125.1 9.73 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.585 0.754 . . . . 0.0 112.841 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 47.14 43.64 14.57 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 167.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -70.76 -47.63 58.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.192 -0.943 . . . . 0.0 112.426 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -150.87 47.21 0.86 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.078 1.751 . . . . 0.0 111.654 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.96 -17.47 63.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.412 1.085 . . . . 0.0 113.615 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.11 99.89 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.856 0.836 . . . . 0.0 110.975 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.77 -13.12 3.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.055 2.542 . . . . 0.0 114.924 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -90.68 -11.32 40.11 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.441 1.096 . . . . 0.0 113.598 171.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -101.44 149.11 24.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.756 2.022 . . . . 0.0 112.225 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 32.83 49.68 0.56 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 129.036 2.934 . . . . 0.0 115.277 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.35 152.11 38.75 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.77 1.647 . . . . 0.0 111.57 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -67.64 9.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.573 1.549 . . . . 0.0 114.266 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.35 5.29 8.41 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.567 1.947 . . . . 0.0 113.549 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 8.1 p -144.57 -21.67 0.53 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -87.82 -176.29 5.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.2 p -113.35 167.43 10.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.303 1.441 . . . . 0.0 113.912 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -20.82 28.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.01 -34.56 72.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.759 1.163 . . . . 0.0 112.44 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.5 -20.95 63.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.661 0.784 . . . . 0.0 113.099 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.66 -23.65 66.17 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.801 -1.187 . . . . 0.0 111.921 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.8 -17.62 43.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.904 1.281 . . . . 0.0 113.598 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.44 -28.82 56.75 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.93 0.892 . . . . 0.0 111.598 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.32 135.78 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.12 1.768 . . . . 0.0 110.14 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.04 158.85 30.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.008 0.923 . . . . 0.0 112.844 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.51 -35.4 60.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.833 1.253 . . . . 0.0 112.032 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 m -65.31 -22.49 66.84 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.784 1.234 . . . . 0.0 114.241 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -126.36 -5.11 6.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -58.33 -39.22 73.75 Favored Pre-proline 0 N--CA 1.478 0.936 0 O-C-N 119.689 -1.882 . . . . 0.0 113.43 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.81 -26.43 79.47 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.348 2.032 . . . . 0.0 112.984 169.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -76.96 -32.69 57.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.424 1.089 . . . . 0.0 111.715 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.57 92.36 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.879 -1.138 . . . . 0.0 113.239 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.88 -34.48 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.674 0.67 . . . . 0.0 110.764 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.81 -56.84 14.23 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.364 0.983 . . . . 0.0 112.954 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.74 -16.92 62.38 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.748 2.274 . . . . 0.0 113.807 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.72 -28.64 18.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -109.48 -30.62 7.86 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.507 1.503 . . . . 0.0 113.419 -173.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.66 77.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.313 2.245 . . . . 0.0 112.194 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.11 -24.6 30.23 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.898 1.279 . . . . 0.0 111.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -18.15 64.7 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.04 0.836 . . . . 0.0 113.053 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -110.66 -5.12 15.1 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -128.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.189 1.396 . . . . 0.0 112.163 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -159.65 -62.08 0.07 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.516 1.926 . . . . 0.0 112.491 -169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -119.89 162.25 34.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 126.975 2.11 . . . . 0.0 110.796 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.79 5.22 6.55 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.273 1.982 . . . . 0.0 114.619 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.19 -24.89 60.64 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.43 13.63 18.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.827 2.051 . . . . 0.0 112.975 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.74 22.81 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 119.78 -1.825 . . . . 0.0 112.928 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.9 107.23 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.341 1.857 . . . . 0.0 106.162 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.52 124.94 22.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.143 0.577 . . . . 0.0 109.496 -170.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -99.21 66.79 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.477 1.035 . . . . 0.0 111.98 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 p -64.63 -33.9 66.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.7 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.62 -39.67 84.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.827 1.649 . . . . 0.0 111.937 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.24 -48.22 66.03 Favored Glycine 0 N--CA 1.47 0.961 0 O-C-N 122.037 -0.414 . . . . 0.0 112.219 171.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.18 -41.42 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.626 -0.926 . . . . 0.0 112.264 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.04 71.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.432 1.469 . . . . 0.0 112.325 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 44.1 m -63.22 -43.25 98.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.677 0.791 . . . . 0.0 111.464 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -84.7 -27.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.987 1.315 . . . . 0.0 113.583 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.4 m -42.2 -61.36 1.6 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.681 1.993 . . . . 0.0 113.536 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.64 -12.35 34.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.313 2.009 . . . . 0.0 113.916 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.9 -64.53 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.013 . . . . 0.0 110.98 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.48 HD12 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -71.16 -24.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 120.887 -1.133 . . . . 0.0 113.432 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 t -58.94 -51.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 110.204 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -73.41 -47.91 38.1 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.184 0.594 . . . . 0.0 111.042 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.63 68.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.515 -1.365 . . . . 0.0 113.531 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.5 m -74.76 -21.64 59.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 169.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -30.99 33.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.202 1.365 . . . . 0.0 111.553 169.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -63.29 -38.24 90.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.846 0.858 . . . . 0.0 111.531 168.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -143.09 66.63 1.31 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.06 0.944 . . . . 0.0 112.243 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.16 -37.21 53.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.004 1.322 . . . . 0.0 112.328 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -82.38 -1.16 49.03 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.788 1.235 . . . . 0.0 113.545 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.47 146.44 44.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 112.094 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -65.71 149.36 50.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.749 1.22 . . . . 0.0 111.205 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -48.89 151.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.079 1.352 . . . . 0.0 112.182 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm 60.26 -29.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.489 2.716 . . . . 0.0 116.792 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.66 -34.28 76.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.809 1.644 . . . . 0.0 111.714 172.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.08 -37.55 78.54 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.601 -0.687 . . . . 0.0 112.367 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.96 -47.74 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 124.11 0.964 . . . . 0.0 110.034 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -64.68 -42.91 95.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 112.342 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.64 -41.03 99.19 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.625 1.107 . . . . 0.0 113.165 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.47 -35.45 65.7 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.111 -1.229 . . . . 0.0 112.934 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.24 -37.72 86.51 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.988 -1.07 . . . . 0.0 112.037 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.5 -46.29 90.68 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 0.0 111.812 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -20.0 65.99 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.946 -1.096 . . . . 0.0 112.789 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.3 mt -86.46 -47.02 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.552 1.941 . . . . 0.0 112.396 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -104.73 -59.77 1.7 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.215 1.406 . . . . 0.0 113.348 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -64.74 -28.31 69.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.542 1.537 . . . . 0.0 113.323 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.35 -11.68 59.93 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.213 1.405 . . . . 0.0 114.257 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 C--O 1.255 1.366 0 C-N-CA 125.201 1.4 . . . . 0.0 113.122 -175.195 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -143.94 131.42 21.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.235 1.014 . . . . 0.0 111.617 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.58 20.23 10.09 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 115.466 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 61.02 -175.3 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.007 2.123 . . . . 0.0 114.831 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -75.82 158.8 31.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.271 0.628 . . . . 0.0 110.358 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.85 99.9 0.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -167.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.9 169.2 9.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 110.082 167.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 62.93 -57.58 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.73 2.412 . . . . 0.0 112.155 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -84.65 61.07 6.49 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -46.54 121.51 3.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.8 2.44 . . . . 0.0 116.138 -166.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -130.83 55.43 18.97 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 127.083 2.153 . . . . 0.0 110.697 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -61.64 163.33 18.68 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.252 3.301 . . . . 0.0 113.727 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.25 -19.19 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.663 1.585 . . . . 0.0 114.874 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -95.29 -15.95 22.78 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.9 p -109.56 -32.73 7.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.984 1.265 . . . . 0.0 114.146 -172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -88.6 -179.96 6.15 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.771 0.829 . . . . 0.0 113.152 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.9 p -105.62 160.42 15.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.436 1.494 . . . . 0.0 114.352 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -25.29 60.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.527 1.931 . . . . 0.0 115.239 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.84 -35.31 66.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.582 1.083 . . . . 0.0 111.463 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.07 -18.12 60.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.266 1.026 . . . . 0.0 113.54 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -65.93 -29.3 69.69 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.808 -1.182 . . . . 0.0 110.573 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.91 -18.45 58.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.638 1.575 . . . . 0.0 113.082 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.36 -27.73 38.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.482 1.113 . . . . 0.0 112.006 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.8 137.62 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.843 1.657 . . . . 0.0 108.906 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -65.69 154.89 37.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.882 0.873 . . . . 0.0 112.536 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.11 -35.32 73.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.429 1.092 . . . . 0.0 111.777 -174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.4 m -61.65 -25.13 67.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.902 1.681 . . . . 0.0 113.713 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.98 -2.8 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.055 -173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -57.56 -43.73 99.08 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 119.906 -1.746 . . . . 0.0 112.148 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -62.69 -25.21 75.01 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.871 2.381 . . . . 0.0 113.92 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.5 m -75.8 -34.2 60.16 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.029 0.931 . . . . 0.0 110.702 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.768 1.227 . . . . 0.0 113.587 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.18 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.079 0.854 . . . . 0.0 110.931 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.49 -51.1 50.13 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 124.973 1.273 . . . . 0.0 113.755 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.13 -23.51 63.99 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.283 2.542 . . . . 0.0 113.339 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 -61.48 1.79 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.325 -0.86 . . . . 0.0 109.296 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -73.66 -29.78 62.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.392 -1.443 . . . . 0.0 114.739 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.39 97.28 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.03 -1.044 . . . . 0.0 110.933 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -38.52 21.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.456 1.102 . . . . 0.0 110.329 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -64.3 -33.52 76.02 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.571 1.148 . . . . 0.0 113.483 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -80.66 -13.77 58.73 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -155.25 -136.1 0.05 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.995 1.718 . . . . 0.0 110.769 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -172.18 127.08 0.56 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 130.532 3.533 . . . . 0.0 108.879 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 mttt 60.58 166.35 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.033 0 C-N-CA 125.787 1.635 . . . . 0.0 113.845 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -88.16 15.18 2.16 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.033 1.822 . . . . 0.0 114.846 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.77 -30.41 70.01 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.863 -1.148 . . . . 0.0 112.203 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -116.54 27.52 9.15 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.57 1.948 . . . . 0.0 112.167 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 107.75 14.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.915 -1.74 . . . . 0.0 111.763 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.54 118.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.4 117.15 8.98 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.173 0.897 . . . . 0.0 112.406 -167.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -89.72 53.16 2.49 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.404 -1.435 . . . . 0.0 111.608 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.323 1.2 p -60.75 -41.33 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -167.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -63.23 -38.51 91.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.583 1.538 . . . . 0.0 112.305 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -54.09 39.85 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -43.45 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.492 -1.005 . . . . 0.0 112.164 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.29 67.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.203 . . . . 0.0 112.804 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -71.25 -45.13 63.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.251 1.421 . . . . 0.0 111.885 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.53 -19.66 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.1 m -45.64 -61.91 2.11 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 125.123 1.369 . . . . 0.0 112.415 173.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.47 -3.66 12.92 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.599 2.866 . . . . 0.0 114.178 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.8 -64.45 1.17 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.899 1.28 . . . . 0.0 108.984 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.8 mt -67.78 -34.67 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.959 0.904 . . . . 0.0 111.977 -172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.57 -49.69 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.88 0.872 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.13 -45.92 58.62 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.77 -28.72 69.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.291 -0.88 . . . . 0.0 113.183 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.0 m -75.26 -13.31 60.43 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.47 -34.99 16.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.469 1.486 . . . . 0.0 111.178 167.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -60.63 -38.27 84.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.82 170.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -138.18 52.94 1.82 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.15 1.38 . . . . 0.0 112.68 -168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -48.51 -35.8 13.92 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.731 2.013 . . . . 0.0 113.259 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -88.49 -6.99 57.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.592 1.157 . . . . 0.0 113.755 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.78 161.58 27.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.044 0.938 . . . . 0.0 112.023 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.16 139.11 57.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 112.234 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.5 -53.1 59.78 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.841 . . . . 0.0 112.844 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -71.96 -32.67 67.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.693 -1.254 . . . . 0.0 112.853 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -64.98 -27.38 68.8 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.106 -0.996 . . . . 0.0 112.383 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -70.31 -37.37 74.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.504 1.047 . . . . 0.0 113.041 171.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.97 -38.24 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.771 1.169 . . . . 0.0 111.327 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -61.02 -48.33 82.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.055 0.942 . . . . 0.0 111.509 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.02 98.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.981 1.277 . . . . 0.0 113.649 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.8 -36.47 67.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.757 1.278 . . . . 0.0 112.651 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -60.62 -39.97 90.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.562 1.073 . . . . 0.0 111.631 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.04 -44.51 96.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.463 1.105 . . . . 0.0 111.931 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -26.45 68.59 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.962 -1.086 . . . . 0.0 112.352 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.251 10.1 mt -84.44 -43.08 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.892 1.277 . . . . 0.0 112.564 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -106.31 -61.46 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.286 1.434 . . . . 0.0 113.514 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -64.4 -25.71 68.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.907 1.683 . . . . 0.0 113.78 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.77 -24.66 67.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.508 1.123 . . . . 0.0 113.907 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 C--O 1.253 1.273 0 C-N-CA 127.734 2.413 . . . . 0.0 114.147 177.572 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.405 0.145 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.83 -29.85 26.97 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -111.77 24.92 12.16 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -151.48 0.38 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.7 1.2 . . . . 0.0 112.251 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -52.17 -20.01 2.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.686 2.394 . . . . 0.0 116.301 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 61.75 -23.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 61.49 -19.83 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.957 2.503 . . . . 0.0 117.554 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.41 -26.13 68.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.681 1.192 . . . . 0.0 112.331 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.38 -12.48 59.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.005 1.722 . . . . 0.0 113.921 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt 42.01 68.2 0.49 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 128.001 2.52 . . . . 0.0 113.289 -170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.28 58.69 0.69 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 126.237 1.815 . . . . 0.0 112.727 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.48 166.99 15.92 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.652 2.901 . . . . 0.0 114.175 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 m -55.39 -24.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.887 1.675 . . . . 0.0 114.242 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.98 -10.39 53.29 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.3 p -121.85 -29.74 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -86.94 172.36 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.4 p -92.67 160.91 14.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -24.0 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.38 -37.54 70.23 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.853 -1.155 . . . . 0.0 111.505 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.14 -28.43 69.64 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.981 0.912 . . . . 0.0 112.973 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.27 -27.16 69.15 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.113 -0.992 . . . . 0.0 111.152 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.2 mt -84.49 -10.71 57.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.802 1.241 . . . . 0.0 113.104 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.96 -29.38 22.09 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.959 1.303 . . . . 0.0 112.371 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.4 140.05 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.998 1.719 . . . . 0.0 110.242 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.6 159.39 32.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.271 1.029 . . . . 0.0 113.067 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.93 -33.89 71.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.086 1.354 . . . . 0.0 111.951 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m -66.18 -21.18 66.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.666 1.587 . . . . 0.0 114.007 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -126.73 -8.85 6.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.39 1.076 . . . . 0.0 113.308 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.81 -43.31 99.32 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 120.06 -1.65 . . . . 0.0 112.536 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.65 -25.0 61.99 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.688 2.259 . . . . 0.0 113.151 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 18.4 m -72.96 -32.37 65.17 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 111.218 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.77 89.42 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 170.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.98 -33.73 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.683 1.583 . . . . 0.0 110.043 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.76 7.6 2.12 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 126.57 2.033 . . . . 0.0 116.008 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -121.48 -12.32 8.58 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.58 1.69 . . . . 0.0 112.852 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.17 -69.24 0.76 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.452 1.023 . . . . 0.0 110.77 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.74 -32.33 72.86 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.895 -1.128 . . . . 0.0 111.492 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.58 -35.88 68.72 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.472 1.109 . . . . 0.0 113.169 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.96 -42.56 16.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.186 0.994 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.04 -39.3 74.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 0.0 113.834 -173.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -92.44 -8.28 45.17 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -9.6 0.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -171.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.326 3.8 p30 55.28 -34.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 121.437 3.866 . . . . 0.0 121.437 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -137.6 153.76 74.49 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 126.941 2.096 . . . . 0.0 110.648 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.84 -1.12 8.78 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 121.685 1.637 . . . . 0.0 114.67 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.29 -13.49 60.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.779 1.232 . . . . 0.0 112.87 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -127.78 8.25 6.29 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.133 1.373 . . . . 0.0 113.93 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.0 130.52 36.6 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.304 -1.497 . . . . 0.0 114.51 -170.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 20.6 t -117.28 135.35 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.759 2.024 . . . . 0.0 106.852 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.7 127.26 32.66 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.503 1.047 . . . . 0.0 111.446 -169.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -89.75 52.56 2.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.532 1.533 . . . . 0.0 111.939 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.378 1.7 p -67.29 -44.69 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -64.32 -36.94 85.75 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 123.075 2.671 . . . . 0.0 111.164 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.49 -47.34 88.11 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mt -56.46 -48.62 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.295 1.438 . . . . 0.0 111.618 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.6 81.45 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.531 1.059 . . . . 0.0 112.22 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 52.1 m -67.05 -42.29 85.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.937 1.295 . . . . 0.0 111.811 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.99 -24.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.498 1.519 . . . . 0.0 113.04 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -43.71 -61.02 2.14 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 126.748 2.019 . . . . 0.0 113.588 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.24 -14.16 43.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.537 2.158 . . . . 0.0 113.638 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.86 -56.37 4.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.105 0.962 . . . . 0.0 111.416 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -25.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.925 -1.109 . . . . 0.0 113.436 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.1 t -57.62 -51.36 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.824 0.85 . . . . 0.0 110.265 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 -46.86 34.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.429 0.692 . . . . 0.0 111.151 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.62 69.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.608 -1.308 . . . . 0.0 113.152 -171.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.3 m -77.09 -11.31 59.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.48 -31.63 18.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.074 1.306 . . . . 0.0 111.192 167.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -59.34 -38.73 81.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.199 1.0 . . . . 0.0 112.47 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -145.17 85.54 1.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.718 0.77 . . . . 0.0 112.095 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -62.53 -39.32 93.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.463 1.505 . . . . 0.0 112.406 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.89 -10.2 59.74 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.23 141.93 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.784 0.834 . . . . 0.0 112.828 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.1 40.39 0.98 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.392 2.277 . . . . 0.0 111.298 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -106.81 117.75 34.87 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -163.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -76.84 -26.42 54.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.015 1.326 . . . . 0.0 109.428 162.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.91 -23.16 63.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.376 1.471 . . . . 0.0 112.707 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -63.08 -40.32 97.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.779 0.832 . . . . 0.0 111.809 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -39.93 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.812 0.845 . . . . 0.0 110.69 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -65.41 -38.78 90.96 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.672 0.789 . . . . 0.0 112.112 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.95 99.75 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.986 1.279 . . . . 0.0 112.783 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.35 -36.1 71.38 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.688 1.244 . . . . 0.0 113.075 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.93 -42.08 93.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.736 1.153 . . . . 0.0 111.594 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -49.63 76.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.088 1.355 . . . . 0.0 110.937 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -27.53 68.92 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.731 -1.231 . . . . 0.0 112.072 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -80.23 -47.41 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.957 1.703 . . . . 0.0 113.027 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -100.46 -55.53 2.58 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.749 1.22 . . . . 0.0 112.932 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -70.24 -34.38 72.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.108 1.363 . . . . 0.0 111.547 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.62 46.69 25.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.348 2.259 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 C--O 1.255 1.379 0 C-N-CA 125.513 1.525 . . . . 0.0 113.137 179.085 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -109.77 -26.16 9.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.27 -64.19 1.19 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -170.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -102.14 -55.35 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.697 0.68 . . . . 0.0 111.539 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -91.34 63.22 4.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.85 1.66 . . . . 0.0 108.707 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.58 -18.31 60.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.773 2.029 . . . . 0.0 115.3 -168.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.55 -3.46 55.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 56.22 18.91 3.54 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.636 1.575 . . . . 0.0 113.936 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -163.62 -146.8 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.781 2.432 . . . . 0.0 107.523 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt 66.3 -43.83 0.4 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 129.099 2.96 . . . . 0.0 118.425 168.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -121.12 53.99 3.84 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.055 1.342 . . . . 0.0 112.632 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.09 157.99 30.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.697 2.931 . . . . 0.0 112.795 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -65.97 -15.68 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.814 1.245 . . . . 0.0 113.241 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -93.86 10.75 31.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.182 1.793 . . . . 0.0 113.176 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -151.04 -42.07 0.12 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -83.97 148.8 26.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.34 1.066 . . . . 0.0 113.561 -169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.6 p -77.75 172.79 12.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.967 1.707 . . . . 0.0 113.653 -168.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -18.46 8.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.824 1.786 . . . . 0.0 115.824 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.4 -39.1 78.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.273 1.397 . . . . 0.0 110.751 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.55 -22.88 66.15 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.01 -1.057 . . . . 0.0 112.968 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.38 -1.87 32.21 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.699 -0.626 . . . . 0.0 112.507 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.4 mt -110.93 -24.7 10.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.546 1.539 . . . . 0.0 112.615 168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.66 67.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.128 0.971 . . . . 0.0 112.15 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.76 141.6 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.522 1.929 . . . . 0.0 110.655 169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.55 157.51 32.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.489 0.715 . . . . 0.0 112.555 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -54.61 -34.28 61.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.101 1.361 . . . . 0.0 111.981 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 m -64.48 -23.14 67.18 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -125.79 -4.1 7.07 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.738 1.215 . . . . 0.0 112.895 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -60.88 -43.85 92.87 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 119.568 -1.957 . . . . 0.0 112.591 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.05 -18.08 60.9 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.495 2.13 . . . . 0.0 113.241 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -78.82 -34.4 45.3 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.678 1.191 . . . . 0.0 111.653 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.81 99.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.193 . . . . 0.0 111.852 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.14 -47.37 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.975 0.91 . . . . 0.0 108.898 169.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.56 -49.49 60.78 Favored Glycine 0 C--O 1.209 -1.428 0 C-N-CA 124.996 1.284 . . . . 0.0 113.582 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -69.42 -11.82 61.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 122.109 2.955 . . . . 0.0 114.205 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.28 -49.88 5.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.582 0.753 . . . . 0.0 110.505 166.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -73.34 -30.67 63.49 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.23 -0.919 . . . . 0.0 113.049 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.54 89.15 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 119.497 -2.002 . . . . 0.0 111.479 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -13.69 52.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.026 1.33 . . . . 0.0 111.652 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 -22.28 60.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.003 1.321 . . . . 0.0 113.012 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 -2.68 13.2 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.84 158.57 0.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.978 3.311 . . . . 0.0 106.399 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.89 -27.91 16.81 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 128.091 2.556 . . . . 0.0 114.249 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.42 156.41 79.74 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 126.701 2.001 . . . . 0.0 110.964 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.94 6.83 5.51 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.054 1.836 . . . . 0.0 114.529 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.08 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.688 -1.258 . . . . 0.0 111.936 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.24 2.36 28.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.227 1.811 . . . . 0.0 113.168 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.74 123.46 27.71 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 119.765 -1.835 . . . . 0.0 112.45 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.48 -2.85 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 125.455 1.502 . . . . 0.0 111.972 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 61.78 119.08 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.403 3.081 . . . . 0.0 112.752 -172.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -93.1 55.43 2.33 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.224 -1.547 . . . . 0.0 112.095 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.322 2.5 p -69.54 -22.02 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.711 -1.243 . . . . 0.0 113.827 -169.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -58.02 -45.74 86.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.928 1.24 . . . . 0.0 111.21 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.46 -49.87 8.8 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.16 -44.43 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.893 0.877 . . . . 0.0 111.81 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.0 66.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.511 1.505 . . . . 0.0 112.773 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -70.99 -37.48 72.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.873 1.269 . . . . 0.0 111.586 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.4 -21.7 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.405 1.482 . . . . 0.0 113.417 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.4 m -46.86 -59.72 4.85 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 125.998 1.719 . . . . 0.0 112.819 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.97 0.52 4.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.157 2.572 . . . . 0.0 114.206 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.74 -64.31 1.17 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.389 1.476 . . . . 0.0 110.441 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -29.31 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.907 -1.121 . . . . 0.0 113.2 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.32 -47.33 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.693 0.797 . . . . 0.0 110.459 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.13 -47.34 20.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.435 0.636 . . . . 0.0 110.866 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.99 71.45 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.2 m -76.01 -13.62 60.23 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.205 -0.935 . . . . 0.0 113.48 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.3 -29.05 21.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.849 1.204 . . . . 0.0 111.282 168.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.4 -38.29 80.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.453 0.701 . . . . 0.0 111.993 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.35 90.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 112.429 170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -55.81 -36.02 66.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.145 1.378 . . . . 0.0 111.367 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -86.99 3.58 45.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.085 1.354 . . . . 0.0 113.375 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.92 151.5 21.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.983 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -59.37 139.25 57.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.788 1.235 . . . . 0.0 111.472 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -56.07 145.14 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.054 1.342 . . . . 0.0 113.401 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 59.06 -24.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.974 2.91 . . . . 0.0 116.916 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.78 -31.13 70.51 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.875 1.67 . . . . 0.0 111.627 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -68.7 -37.03 79.21 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.76 -47.15 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.41 1.084 . . . . 0.0 109.833 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.45 -42.6 98.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.868 0.867 . . . . 0.0 112.358 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.81 -45.62 95.34 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.216 1.389 . . . . 0.0 113.257 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -72.11 -35.52 69.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.461 1.131 . . . . 0.0 113.16 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -59.84 -40.55 88.89 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.018 -1.051 . . . . 0.0 111.429 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.78 -45.1 95.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.72 1.208 . . . . 0.0 111.743 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -24.59 67.93 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.135 -0.978 . . . . 0.0 112.623 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.258 5.5 mt -89.33 -42.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.111 1.364 . . . . 0.0 112.729 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -106.37 -59.87 1.73 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.463 1.505 . . . . 0.0 113.084 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -66.22 -24.12 66.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.842 1.657 . . . . 0.0 113.762 -170.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.23 -23.22 66.54 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.312 1.445 . . . . 0.0 113.457 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 174.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 119.944 -0.074 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.0 60.84 1.61 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.756 0.822 . . . . 0.0 112.973 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.28 53.28 12.65 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.15 -24.31 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -95.68 21.5 8.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.085 1.754 . . . . 0.0 114.814 -177.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.24 64.0 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.53 63.13 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 60.01 -13.61 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 129.474 3.109 . . . . 0.0 117.051 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -122.36 -11.8 8.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.735 1.614 . . . . 0.0 113.622 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -146.55 -167.02 2.64 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 57.93 34.48 0.23 Allowed Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 128.455 2.702 . . . . 0.0 114.321 -167.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.56 159.25 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.061 1.841 . . . . 0.0 112.534 -169.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.26 -25.95 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 125.621 1.568 . . . . 0.0 114.75 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -79.11 -16.76 56.24 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 18.1 m -128.28 -22.29 3.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -86.95 166.26 15.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.447 1.099 . . . . 0.0 112.598 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 51.5 p -96.46 158.6 15.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.2 -24.56 67.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.32 1.448 . . . . 0.0 114.437 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.66 -37.78 73.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.812 1.187 . . . . 0.0 111.213 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.12 -30.56 71.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.268 1.027 . . . . 0.0 112.786 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -67.02 -23.73 65.94 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.175 -0.953 . . . . 0.0 111.67 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 49.6 mt -80.71 -15.77 55.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.504 1.122 . . . . 0.0 113.178 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.06 -28.85 43.2 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.121 0.968 . . . . 0.0 112.172 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.68 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.916 1.686 . . . . 0.0 110.191 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.39 158.62 33.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.0 112.856 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -53.88 -34.17 58.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.098 1.359 . . . . 0.0 112.368 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 33.5 m -65.95 -22.36 66.48 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.699 1.199 . . . . 0.0 114.107 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.08 -8.16 5.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.556 1.142 . . . . 0.0 113.509 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -57.77 -44.57 99.53 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 119.785 -1.822 . . . . 0.0 112.2 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.29 -27.43 77.99 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.693 2.262 . . . . 0.0 113.254 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 65.5 m -72.87 -38.92 66.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 0.0 110.962 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.4 94.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.334 1.453 . . . . 0.0 114.147 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.83 -32.69 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 119.432 1.014 . . . . 0.0 110.75 169.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.48 -55.11 21.31 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 125.301 1.429 . . . . 0.0 113.667 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.86 -35.73 79.14 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.561 2.181 . . . . 0.0 112.178 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.92 65.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -104.95 -31.44 9.23 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.1 99.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.34 1.456 . . . . 0.0 111.319 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.86 -32.02 57.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.942 0.897 . . . . 0.0 110.93 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -65.12 -27.51 68.8 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -98.01 -8.61 27.55 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 -132.62 0.07 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.961 1.705 . . . . 0.0 110.478 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -156.79 -55.75 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.268 2.227 . . . . 0.0 112.276 -173.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -120.21 168.09 11.2 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 127.179 2.192 . . . . 0.0 110.194 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.78 10.37 3.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.108 1.872 . . . . 0.0 114.308 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 -25.92 67.22 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.782 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -118.5 25.18 10.45 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.734 2.014 . . . . 0.0 113.366 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.96 34.88 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.586 -1.322 . . . . 0.0 112.702 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.96 -13.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.284 1.034 . . . . 0.0 113.52 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 65.6 107.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.48 2.312 . . . . 0.0 110.648 -168.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.68 62.96 7.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.734 -1.229 . . . . 0.0 110.804 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.35 1.6 p -66.69 -25.14 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.148 -0.929 . . . . 0.0 113.334 -168.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.28 -50.75 72.49 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.807 1.64 . . . . 0.0 111.6 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.54 80.09 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mt -62.86 -45.26 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.049 0.94 . . . . 0.0 112.036 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.48 -32.34 72.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 120.628 1.558 . . . . 0.0 112.475 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 42.8 m -64.55 -44.21 91.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.832 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -82.67 -29.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.953 1.301 . . . . 0.0 113.161 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.7 m -41.04 -62.51 1.0 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 126.532 1.933 . . . . 0.0 114.018 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.99 -22.47 73.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.18 1.92 . . . . 0.0 112.931 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.57 -58.03 4.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.4 1.08 . . . . 0.0 111.33 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -24.58 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.086 -1.009 . . . . 0.0 112.895 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.11 -52.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.466 1.03 . . . . 0.0 110.629 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -72.16 -47.16 52.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.586 0.232 . . . . 0.0 111.131 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.19 72.2 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.666 -1.271 . . . . 0.0 113.316 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.6 -13.44 61.38 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 170.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.66 16.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.247 1.385 . . . . 0.0 111.212 167.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.56 -43.15 97.58 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.26 0.624 . . . . 0.0 111.657 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -134.96 63.93 1.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.529 1.531 . . . . 0.0 111.093 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -51.34 -32.88 27.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.611 -1.305 . . . . 0.0 112.452 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -87.74 -3.12 58.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.099 1.36 . . . . 0.0 113.562 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 155.06 39.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.074 0.95 . . . . 0.0 111.599 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -66.84 135.55 54.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.565 1.146 . . . . 0.0 109.64 169.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.79 -51.7 60.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -67.81 -29.28 68.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.47 1.486 . . . . 0.0 112.521 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.58 -37.37 83.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.643 -0.661 . . . . 0.0 111.739 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -71.87 -35.34 69.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.477 -0.764 . . . . 0.0 112.914 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.15 -46.46 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.455 1.025 . . . . 0.0 109.926 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -65.44 -43.55 90.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.282 1.033 . . . . 0.0 112.475 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.17 -41.07 99.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.299 0.952 . . . . 0.0 113.246 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.71 -34.18 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.234 -1.156 . . . . 0.0 112.654 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -58.12 -41.98 84.8 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.753 1.615 . . . . 0.0 111.919 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.08 -50.79 72.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.862 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -29.15 70.6 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.896 -1.128 . . . . 0.0 112.256 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 30.7 mt -76.37 -49.5 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.229 1.811 . . . . 0.0 112.448 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.99 -55.76 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.132 1.373 . . . . 0.0 112.769 -170.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -69.92 -35.16 74.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.772 1.229 . . . . 0.0 111.431 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.62 47.73 23.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.863 2.065 . . . . 0.0 113.147 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 35.6 mmt . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.636 1.574 . . . . 0.0 112.88 176.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 111.306 0.113 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -140.85 55.57 1.57 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.49 38.46 29.75 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -58.42 -24.31 59.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -78.51 -9.3 59.28 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.6 -21.59 66.44 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.31 65.72 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.2 t70 57.55 -10.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 129.056 2.942 . . . . 0.0 117.571 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.54 -10.47 6.24 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.048 1.339 . . . . 0.0 114.596 -169.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 170.07 18.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -173.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 29.7 ttpt 51.15 46.18 3.45 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 129.614 3.166 . . . . 0.0 115.482 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.44 168.87 15.25 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 112.435 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.17 -17.72 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -71.74 -29.92 65.04 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 112.396 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 -32.47 9.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 114.008 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.44 148.68 50.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.159 0.98 . . . . 0.0 111.526 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.6 p -97.31 167.44 11.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.028 1.394 . . . . 0.0 114.167 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.4 m -66.06 -24.21 66.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.948 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.88 -44.82 91.89 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.65 1.114 . . . . 0.0 110.249 169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.79 -29.43 69.43 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.919 -0.488 . . . . 0.0 111.601 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -72.32 -11.88 60.9 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.983 -1.073 . . . . 0.0 113.336 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.54 -2.19 45.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.253 1.021 . . . . 0.0 112.48 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.81 -34.08 17.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.725 1.21 . . . . 0.0 112.352 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.35 138.84 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.31 1.844 . . . . 0.0 111.136 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.4 156.27 39.09 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 113.062 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.52 -35.03 38.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.834 1.254 . . . . 0.0 112.817 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 t -65.6 -26.37 67.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.369 1.068 . . . . 0.0 113.432 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -123.14 -0.66 8.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.228 1.411 . . . . 0.0 113.312 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -59.18 -46.42 99.26 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 119.574 -1.954 . . . . 0.0 111.424 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.35 -17.77 55.11 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.427 2.085 . . . . 0.0 114.412 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 m -67.71 -40.31 84.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 110.527 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.55 75.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.448 1.099 . . . . 0.0 113.866 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.55 -34.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.753 0.706 . . . . 0.0 109.989 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -57.89 15.11 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.644 -1.087 . . . . 0.0 112.919 168.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.73 -43.47 98.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.367 2.084 . . . . 0.0 112.411 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.7 -26.71 66.31 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -98.49 -35.75 10.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 113.159 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.02 71.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.041 1.336 . . . . 0.0 111.745 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.35 -24.88 61.35 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.884 -0.51 . . . . 0.0 110.954 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -24.42 57.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.73 0.812 . . . . 0.0 112.898 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.96 -7.17 25.49 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.77 -130.62 0.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.13 1.772 . . . . 0.0 110.342 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.61 -44.06 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.232 2.213 . . . . 0.0 112.245 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -123.62 164.95 25.46 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 127.966 2.507 . . . . 0.0 110.148 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.33 13.02 2.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.324 2.016 . . . . 0.0 114.185 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.98 -27.43 66.84 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.806 -1.184 . . . . 0.0 112.926 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.73 18.56 14.86 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.268 1.427 . . . . 0.0 114.196 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 129.7 40.62 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.851 -1.156 . . . . 0.0 112.607 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.52 -11.67 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.775 1.23 . . . . 0.0 113.271 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.77 114.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.787 2.435 . . . . 0.0 110.555 -167.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -82.85 51.87 2.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.403 -1.435 . . . . 0.0 110.74 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.422 2.7 p -69.04 -28.37 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -166.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.12 -39.37 82.08 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.332 1.878 . . . . 0.0 111.389 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.2 -51.24 10.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.369 0.985 . . . . 0.0 112.102 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -40.36 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.179 0.992 . . . . 0.0 111.987 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.43 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.19 1.359 . . . . 0.0 112.652 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -68.27 -40.98 81.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.751 1.22 . . . . 0.0 111.492 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.7 t -81.66 -31.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.202 1.401 . . . . 0.0 113.617 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -41.78 -59.92 2.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 125.798 1.639 . . . . 0.0 114.47 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.42 -24.23 75.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.96 1.773 . . . . 0.0 113.204 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.29 -61.56 2.46 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.426 1.49 . . . . 0.0 110.571 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -31.95 53.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 t -59.47 -51.85 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.805 1.242 . . . . 0.0 110.466 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.08 -49.96 45.77 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.066 0.46 . . . . 0.0 110.872 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.86 70.24 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.829 0.852 . . . . 0.0 112.727 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.9 m -72.9 -17.05 61.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -30.34 20.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.677 1.191 . . . . 0.0 111.233 168.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -64.0 -38.26 90.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.126 0.97 . . . . 0.0 112.405 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -145.3 85.09 1.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.818 1.247 . . . . 0.0 111.574 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.76 -39.78 71.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.223 1.409 . . . . 0.0 112.209 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.11 -11.99 59.99 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.22 152.5 44.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.005 0.922 . . . . 0.0 112.162 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -73.35 144.81 46.35 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.8 -44.32 90.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -67.11 -32.02 72.88 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.783 -1.198 . . . . 0.0 113.011 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.48 -40.42 86.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.969 0.908 . . . . 0.0 111.152 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.747 -1.12 . . . . 0.0 112.888 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -41.4 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.607 1.549 . . . . 0.0 111.334 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -64.21 -48.48 75.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.719 0.808 . . . . 0.0 111.676 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.41 99.72 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.36 0.981 . . . . 0.0 113.099 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -74.26 -35.63 63.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.605 1.202 . . . . 0.0 113.196 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -59.56 -40.21 86.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.005 1.275 . . . . 0.0 111.486 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.47 -45.51 93.94 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.21 1.004 . . . . 0.0 111.742 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -23.5 67.34 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.969 -1.082 . . . . 0.0 112.655 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -88.42 -40.15 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.841 1.256 . . . . 0.0 113.065 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.41 -57.9 2.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.486 1.514 . . . . 0.0 113.728 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -68.47 -29.24 67.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.693 1.597 . . . . 0.0 113.467 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.73 -52.01 14.63 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.091 1.756 . . . . 0.0 111.491 178.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -106.37 -40.86 5.47 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 162.01 29.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.755 0.822 . . . . 0.0 111.418 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.33 0.0 OUTLIER 46.05 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 131.017 3.727 . . . . 0.0 119.66 -170.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -85.03 -13.6 49.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.306 1.842 . . . . 0.0 112.37 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 53.7 -51.27 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 1 C-N-CA 132.365 4.266 . . . . 0.0 117.908 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.02 24.94 7.42 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.661 1.584 . . . . 0.0 112.153 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 31.3 t70 70.86 -18.38 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.182 2.593 . . . . 0.0 114.673 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.8 5.32 8.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.634 1.573 . . . . 0.0 115.173 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.38 144.83 25.18 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.091 1.314 . . . . 0.0 112.799 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 50.85 53.68 14.26 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 126.972 2.109 . . . . 0.0 114.223 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.89 165.4 26.15 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.984 2.456 . . . . 0.0 111.921 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 m -66.01 -4.82 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.668 1.587 . . . . 0.0 114.558 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -112.93 21.37 15.51 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.234 1.813 . . . . 0.0 112.934 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -143.82 -49.48 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -93.71 147.08 23.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.922 0.783 . . . . 0.0 112.207 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p -70.92 173.36 7.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.368 1.867 . . . . 0.0 113.965 -171.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -49.91 -20.56 0.93 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.66 -40.27 39.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.62 -30.63 69.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.144 0.978 . . . . 0.0 112.619 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -70.96 -17.65 62.66 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.511 -0.743 . . . . 0.0 111.967 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.92 -18.49 23.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.188 0.995 . . . . 0.0 112.911 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.85 62.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.278 1.031 . . . . 0.0 112.436 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.72 138.9 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.814 2.046 . . . . 0.0 111.119 171.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.67 159.13 32.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.477 1.111 . . . . 0.0 113.223 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.09 -33.64 58.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.353 1.461 . . . . 0.0 111.809 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.0 m -59.17 -27.46 65.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.114 1.765 . . . . 0.0 113.817 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.58 -3.95 5.99 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.392 1.477 . . . . 0.0 113.307 -171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -56.96 -44.85 99.94 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.241 -1.537 . . . . 0.0 112.528 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.41 -18.34 59.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.595 2.197 . . . . 0.0 114.007 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 40.6 m -81.43 -31.86 32.91 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.789 1.236 . . . . 0.0 111.449 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.1 97.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.521 1.055 . . . . 0.0 110.902 167.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.55 -47.0 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.084 0.954 . . . . 0.0 109.191 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.88 12.64 1.03 Allowed Glycine 0 CA--C 1.544 1.891 0 C-N-CA 126.798 2.142 . . . . 0.0 117.353 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.39 -14.18 7.46 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.609 1.563 . . . . 0.0 112.98 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.67 -72.6 0.62 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.84 0.856 . . . . 0.0 110.086 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -72.69 -20.44 61.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.042 -1.036 . . . . 0.0 112.61 -170.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.29 -42.42 70.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.427 1.091 . . . . 0.0 112.843 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -47.02 13.88 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.701 0.801 . . . . 0.0 109.541 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -6.9 57.79 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.93 -15.2 52.28 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.237 0.926 . . . . 0.0 113.205 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -150.92 -129.97 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.757 1.623 . . . . 0.0 110.861 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -156.41 -61.38 0.1 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.872 1.669 . . . . 0.0 113.104 -169.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.42 161.13 65.02 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.956 2.102 . . . . 0.0 110.705 -172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -86.49 10.41 3.64 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.705 2.27 . . . . 0.0 113.789 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.02 -27.74 63.9 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.876 -1.14 . . . . 0.0 112.052 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.79 -9.28 11.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.241 1.416 . . . . 0.0 114.158 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.35 136.19 47.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.958 -1.088 . . . . 0.0 111.949 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.68 8.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.987 1.715 . . . . 0.0 112.888 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 58.67 113.79 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 129.564 3.146 . . . . 0.0 111.344 -169.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.37 51.62 2.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.717 1.607 . . . . 0.0 111.506 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 0.4 OUTLIER -68.52 -31.7 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -164.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -64.61 -42.04 95.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.401 1.001 . . . . 0.0 111.575 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.29 -44.22 60.27 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mt -58.86 -48.22 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.278 1.031 . . . . 0.0 111.471 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.25 73.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.237 0.926 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 47.0 m -67.71 -43.86 79.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.455 1.102 . . . . 0.0 112.2 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 t -80.52 -30.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.886 1.674 . . . . 0.0 113.353 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -39.97 -62.08 0.96 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.026 1.73 . . . . 0.0 113.783 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.19 -13.56 38.64 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.729 2.286 . . . . 0.0 114.176 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.97 -64.87 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.048 0.939 . . . . 0.0 111.081 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.454 HD12 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.92 -25.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.766 -1.209 . . . . 0.0 113.379 -178.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.8 -49.71 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.263 1.025 . . . . 0.0 110.586 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.78 -44.99 22.0 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 111.464 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.59 -30.41 70.01 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.592 -1.318 . . . . 0.0 112.833 -169.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.4 m -72.44 -13.09 61.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 169.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -35.1 16.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.493 1.497 . . . . 0.0 111.15 167.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -59.29 -39.05 81.76 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 112.071 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -142.47 79.88 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.816 0.847 . . . . 0.0 111.676 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -55.5 -29.18 58.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.94 1.79 55.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.549 1.54 . . . . 0.0 113.116 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 155.55 37.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.647 1.179 . . . . 0.0 113.306 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.07 57.1 2.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.307 1.843 . . . . 0.0 113.374 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 p90 44.62 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.866 2.066 . . . . 0.0 116.005 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -67.43 -26.53 66.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 0.0 112.239 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.9 -36.56 77.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.153 0.981 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -72.33 -40.48 67.4 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 118.477 -0.773 . . . . 0.0 112.774 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.81 -42.46 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.326 0.966 . . . . 0.0 110.565 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -69.42 -46.99 65.5 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.924 1.29 . . . . 0.0 112.526 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.15 98.49 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.861 0.743 . . . . 0.0 113.129 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.52 -27.16 63.96 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.344 -1.092 . . . . 0.0 113.215 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -67.95 -41.0 83.14 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.081 -1.012 . . . . 0.0 111.1 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.56 -41.29 98.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.446 0.698 . . . . 0.0 111.411 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.63 -38.43 6.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 113.151 168.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.94 -39.58 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 112.286 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -95.36 -54.49 3.38 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -77.86 -32.69 52.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.737 1.615 . . . . 0.0 112.892 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.0 t0 46.76 48.34 14.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.16 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--O 1.256 1.398 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 179.724 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.92 102.26 2.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.197 0.999 . . . . 0.0 111.853 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.24 44.77 19.92 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.36 -20.15 65.93 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.84 36.98 4.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.137 2.175 . . . . 0.0 112.558 -170.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -23.59 60.97 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.03 -14.1 61.35 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 63.27 -32.52 0.11 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 129.896 3.279 . . . . 0.0 117.636 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -94.99 3.4 54.98 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.03 1.332 . . . . 0.0 113.98 174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -100.67 170.09 8.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.815 2.046 . . . . 0.0 112.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 52.88 41.31 0.94 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 127.86 2.464 . . . . 0.0 116.976 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -66.39 149.89 84.61 Favored 'Trans proline' 0 C--N 1.351 0.694 0 CA-C-N 121.394 1.534 . . . . 0.0 112.057 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -19.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -78.99 -13.95 59.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.682 1.193 . . . . 0.0 114.084 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 m -131.5 -26.91 2.0 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -169.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.24 156.27 39.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.193 0.906 . . . . 0.0 112.681 -177.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.0 p -92.63 157.9 16.25 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.369 1.081 . . . . 0.0 113.62 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.33 -22.85 65.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.28 -39.69 87.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.949 -1.094 . . . . 0.0 111.203 173.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.02 -25.5 62.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 118.722 -0.656 . . . . 0.0 112.593 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.61 -30.6 70.23 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.6 1.545 . . . . 0.0 111.304 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.34 -13.21 60.15 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 171.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.45 -28.39 52.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.32 136.11 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.933 1.693 . . . . 0.0 110.534 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.03 159.99 31.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 113.189 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -33.73 72.22 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.769 -1.207 . . . . 0.0 111.849 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.8 m -61.93 -23.58 66.44 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 114.164 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.97 -7.38 6.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.84 1.256 . . . . 0.0 113.317 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -57.99 -41.96 92.65 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 119.498 -2.001 . . . . 0.0 112.544 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -64.93 -17.96 60.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.665 2.243 . . . . 0.0 114.109 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.5 m -76.71 -38.26 54.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.924 1.29 . . . . 0.0 111.148 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.31 97.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.433 1.093 . . . . 0.0 112.73 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.75 -46.56 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.24 -56.34 13.01 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 125.559 1.552 . . . . 0.0 113.889 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -11.51 59.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 122.072 2.936 . . . . 0.0 113.938 -173.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.55 -47.77 5.81 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.618 1.099 . . . . 0.0 111.995 168.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -76.52 -27.58 56.06 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.959 -1.088 . . . . 0.0 113.566 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.36 -62.94 1.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.854 1.261 . . . . 0.0 110.412 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.77 -18.81 65.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.766 1.226 . . . . 0.0 111.55 -174.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.09 -18.88 58.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.299 1.04 . . . . 0.0 113.671 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.47 9.19 5.52 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.52 148.06 7.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.999 2.92 . . . . 0.0 105.909 171.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.16 -44.11 8.52 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.5 2.32 . . . . 0.0 115.195 -166.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.33 160.13 58.43 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 127.375 2.27 . . . . 0.0 109.622 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.26 16.58 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 121.25 1.482 . . . . 0.0 114.126 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.58 -22.45 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.341 1.456 . . . . 0.0 112.841 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -128.37 -0.9 5.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.515 1.526 . . . . 0.0 114.195 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.84 146.18 53.08 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.34 151.21 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.873 1.669 . . . . 0.0 110.491 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.38 124.49 27.21 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.461 1.105 . . . . 0.0 109.687 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -89.28 46.66 1.4 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.772 1.229 . . . . 0.0 112.493 -168.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.37 2.7 p -64.49 -27.86 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -60.45 -41.56 94.34 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.084 1.765 . . . . 0.0 111.708 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.36 -49.29 9.48 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.4 mt -57.11 -46.21 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.527 1.131 . . . . 0.0 111.525 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.76 68.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.841 1.201 . . . . 0.0 112.681 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -68.99 -39.89 79.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.868 1.267 . . . . 0.0 111.551 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.43 -27.03 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.132 1.373 . . . . 0.0 113.334 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 m -41.77 -61.39 1.49 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.318 1.847 . . . . 0.0 113.928 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.91 -21.87 73.45 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.349 2.032 . . . . 0.0 113.093 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.14 -61.54 1.87 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.78 1.632 . . . . 0.0 110.424 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -28.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.696 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -57.57 -46.84 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -74.73 -50.42 17.49 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.438 0.637 . . . . 0.0 111.168 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.01 71.16 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.53 -15.12 61.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.05 -33.48 17.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.224 1.374 . . . . 0.0 111.526 168.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -61.43 -37.96 85.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.262 1.025 . . . . 0.0 111.897 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -143.42 61.18 1.39 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.951 1.3 . . . . 0.0 113.0 -170.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -54.52 -37.16 65.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.386 1.874 . . . . 0.0 113.022 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.79 -10.04 59.06 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.43 162.65 19.88 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.258 1.023 . . . . 0.0 112.803 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -63.78 136.87 57.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.135 1.374 . . . . 0.0 110.808 173.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.18 -39.67 79.51 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.009 0.924 . . . . 0.0 112.785 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -65.25 -37.67 87.96 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.208 -0.933 . . . . 0.0 112.345 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.24 -39.99 88.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.468 1.107 . . . . 0.0 111.27 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -38.56 80.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.9 -43.67 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.267 0.627 . . . . 0.0 110.618 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -61.94 -45.01 95.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.472 0.709 . . . . 0.0 112.088 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.55 -47.88 87.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.706 1.146 . . . . 0.0 113.159 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -73.11 -31.43 64.33 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.659 1.23 . . . . 0.0 113.348 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.31 -44.2 95.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.067 1.303 . . . . 0.0 111.081 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.62 -48.79 79.28 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.794 0.837 . . . . 0.0 110.935 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -30.3 70.87 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.885 -1.134 . . . . 0.0 111.728 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.86 -47.86 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.263 1.025 . . . . 0.0 112.234 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -99.92 -59.74 1.66 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.558 1.143 . . . . 0.0 113.107 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 89' ' ' MET . 1.8 mmmp? -63.43 -44.68 93.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 110.916 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.03 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 130.025 3.33 . . . . 0.0 115.519 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 87' ' ' LYS . 28.0 ttt . . . . . 0 C--O 1.255 1.352 0 C-N-CA 129.053 2.941 . . . . 0.0 110.379 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -147.91 128.02 13.73 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.808 0.843 . . . . 0.0 112.741 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.91 25.54 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 167.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.4 -28.4 63.21 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.984 -1.072 . . . . 0.0 113.719 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.56 11.48 18.32 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -169.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.3 80.47 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.007 0.923 . . . . 0.0 111.57 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.0 139.75 22.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.7 2.0 . . . . 0.0 108.294 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -11.04 60.05 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 121.157 -0.964 . . . . 0.0 113.473 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -83.97 5.1 26.86 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -82.44 -66.02 0.94 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -115.48 39.17 0.24 Allowed Pre-proline 0 N--CA 1.491 1.577 0 C-N-CA 125.533 1.533 . . . . 0.0 114.845 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.16 151.53 83.42 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.442 2.095 . . . . 0.0 115.96 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.91 15.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.344 2.258 . . . . 0.0 114.555 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.408 ' HA ' ' CE2' ' B' ' 163' ' ' PHE . 0.7 OUTLIER -134.1 10.05 3.84 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.812 1.645 . . . . 0.0 113.586 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 13.9 m -141.6 -2.23 1.23 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -170.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -132.91 156.72 46.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.554 1.142 . . . . 0.0 113.243 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 40.3 p -87.2 163.21 17.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.301 1.041 . . . . 0.0 112.046 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.321 0.1 OUTLIER -67.62 -4.25 11.37 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -172.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -35.42 68.67 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.715 -1.241 . . . . 0.0 111.243 168.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.07 -23.74 67.25 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.4 -0.813 . . . . 0.0 112.984 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -67.5 -18.51 65.08 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.074 -1.016 . . . . 0.0 112.219 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.27 -18.62 31.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.094 0.958 . . . . 0.0 112.819 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.32 50.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 112.886 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.75 139.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.939 1.695 . . . . 0.0 110.749 170.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.87 159.35 33.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.459 1.104 . . . . 0.0 113.466 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -52.73 -35.61 56.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.25 1.42 . . . . 0.0 112.303 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -62.73 -22.93 66.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.31 -2.98 6.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.216 1.406 . . . . 0.0 112.909 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -60.18 -47.22 97.31 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 119.625 -1.922 . . . . 0.0 111.706 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.52 -20.19 60.61 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.945 2.43 . . . . 0.0 113.812 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 94.1 m -75.19 -37.78 61.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.889 174.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.432 1.093 . . . . 0.0 112.013 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.67 -46.47 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.088 0.955 . . . . 0.0 109.511 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.96 13.42 0.48 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 127.106 2.289 . . . . 0.0 117.081 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.36 -54.1 2.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.843 1.822 . . . . 0.0 110.538 167.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.75 92.5 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.838 -1.164 . . . . 0.0 111.3 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.31 -37.47 52.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.35 94.45 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.728 -1.232 . . . . 0.0 111.58 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -32.29 58.25 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.849 -0.532 . . . . 0.0 111.184 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.24 -29.26 68.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.935 0.789 . . . . 0.0 112.55 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -89.48 -8.12 53.58 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . 0.401 ' HB3' ' H ' ' B' ' 132' ' ' ASP . 30.4 mmtt -136.18 -148.01 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.372 1.869 . . . . 0.0 111.493 -168.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' B' ' 131' ' ' LYS . 23.7 t70 -170.36 -48.83 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 130.839 3.655 . . . . 0.0 110.908 -173.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.42 165.83 33.84 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 128.436 2.694 . . . . 0.0 109.518 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.15 7.55 4.93 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 121.917 1.72 . . . . 0.0 115.15 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -64.24 -25.62 68.14 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.836 -1.165 . . . . 0.0 112.592 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.73 8.6 26.91 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.274 1.83 . . . . 0.0 112.476 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.47 125.83 33.34 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 119.888 -1.758 . . . . 0.0 111.927 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.89 134.52 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.103 1.761 . . . . 0.0 106.93 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -77.31 107.49 9.76 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.312 0.96 . . . . 0.0 110.349 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -89.57 51.23 2.05 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.36 1.864 . . . . 0.0 111.704 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.269 3.6 p -62.0 -35.98 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -166.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.2 -36.99 78.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.706 2.048 . . . . 0.0 111.856 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.68 -46.96 51.75 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.267 0.46 . . . . 0.0 112.336 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.06 -45.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.579 1.152 . . . . 0.0 111.492 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.87 75.27 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.824 1.25 . . . . 0.0 112.222 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 49.6 m -64.82 -42.53 94.91 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.869 0.868 . . . . 0.0 111.95 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.69 -27.01 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.133 1.373 . . . . 0.0 112.974 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.6 m -42.33 -61.13 1.72 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 126.247 1.819 . . . . 0.0 113.886 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.76 -23.02 75.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.177 1.918 . . . . 0.0 112.93 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.26 -58.11 4.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.211 1.004 . . . . 0.0 111.466 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -24.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.638 1.108 . . . . 0.0 113.016 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 11.8 t -62.76 -50.74 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.712 1.142 . . . . 0.0 110.674 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.11 -43.63 42.32 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.152 -0.343 . . . . 0.0 111.667 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.53 81.42 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 120.956 -1.09 . . . . 0.0 112.177 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 92.0 m -76.88 -3.69 39.91 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.932 -1.105 . . . . 0.0 113.97 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -37.22 11.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.377 1.071 . . . . 0.0 111.592 168.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.11 -32.27 50.44 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -121.55 45.96 2.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.686 1.995 . . . . 0.0 110.744 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -50.48 -30.11 12.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.811 1.244 . . . . 0.0 113.272 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -90.17 -0.92 57.85 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.386 1.474 . . . . 0.0 112.958 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.25 159.42 33.47 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.856 1.262 . . . . 0.0 112.713 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.89 142.11 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.583 1.553 . . . . 0.0 112.463 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' B' ' 103' ' ' ASN . 14.5 p90 -43.71 -47.12 7.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.787 2.435 . . . . 0.0 115.966 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -95.18 -38.06 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.765 1.226 . . . . 0.0 110.904 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.23 -33.61 75.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.816 0.847 . . . . 0.0 112.324 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -73.93 -36.43 64.68 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.211 1.004 . . . . 0.0 113.049 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.4 -50.89 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.374 -0.829 . . . . 0.0 110.55 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.61 -37.47 82.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.411 1.084 . . . . 0.0 112.416 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.03 88.69 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.97 1.272 . . . . 0.0 113.063 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -71.83 -35.3 69.85 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.975 1.388 . . . . 0.0 112.638 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -59.74 -42.14 92.49 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.191 -0.943 . . . . 0.0 111.96 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.14 -47.52 85.57 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.796 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -23.31 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.932 -1.105 . . . . 0.0 112.678 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.33 -44.94 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.638 1.975 . . . . 0.0 113.149 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -102.17 -56.2 2.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.767 1.227 . . . . 0.0 113.05 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -68.76 -36.31 78.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.813 1.245 . . . . 0.0 111.687 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.1 t0 47.8 44.03 17.61 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.382 2.273 . . . . 0.0 113.235 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.254 1.334 0 C-N-CA 125.535 1.534 . . . . 0.0 112.96 -178.138 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.122 0.011 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -142.49 8.12 1.75 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.33 -48.95 68.04 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -168.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -99.54 -20.87 16.17 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 45.4 2.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.026 1.731 . . . . 0.0 112.692 -167.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 -22.21 66.84 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.863 1.265 . . . . 0.0 114.274 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.58 4.15 19.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.25 1.42 . . . . 0.0 113.604 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.0 t70 60.0 -51.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 131.601 3.961 . . . . 0.0 118.348 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -123.78 -9.47 7.82 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -168.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -97.29 -1.58 44.39 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -167.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -113.95 49.94 0.49 Allowed Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 124.755 1.222 . . . . 0.0 113.726 172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -65.85 155.9 66.97 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.972 1.782 . . . . 0.0 111.68 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.99 -23.35 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.2 -4.86 59.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.944 1.697 . . . . 0.0 115.108 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.8 m -127.85 -25.68 3.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.183 1.393 . . . . 0.0 114.341 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.47 160.03 32.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.308 1.052 . . . . 0.0 111.892 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -93.36 168.3 11.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.088 1.423 . . . . 0.0 113.645 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -26.02 67.91 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.787 168.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.78 -43.09 99.72 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.772 -1.205 . . . . 0.0 110.751 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.18 -28.06 69.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.176 -0.953 . . . . 0.0 112.344 169.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD2' ' CE1' ' A' ' 74' ' ' PHE . 41.1 t80 -69.37 -12.83 61.99 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.687 -1.258 . . . . 0.0 112.62 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 mt -94.47 -7.84 40.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.325 1.05 . . . . 0.0 112.49 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.88 -31.17 28.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 0.0 111.633 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.79 138.12 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.276 1.43 . . . . 0.0 110.608 169.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.2 159.61 33.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.185 1.394 . . . . 0.0 113.619 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.39 -36.28 75.52 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.038 -1.039 . . . . 0.0 112.076 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.9 m -61.26 -24.47 66.41 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.933 1.693 . . . . 0.0 113.806 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.33 -3.43 7.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.217 1.407 . . . . 0.0 113.033 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -58.13 -47.59 98.58 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.224 -1.548 . . . . 0.0 110.852 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 -16.48 50.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.738 2.292 . . . . 0.0 114.007 172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.5 m -77.84 -38.75 45.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.295 1.438 . . . . 0.0 110.738 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.61 97.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.612 1.165 . . . . 0.0 112.23 168.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.77 -46.48 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.86 -48.21 57.73 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 125.736 1.636 . . . . 0.0 114.684 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -68.78 -36.22 78.02 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.995 2.397 . . . . 0.0 112.551 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.1 75.23 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.853 0.751 . . . . 0.0 112.325 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -80.43 -46.52 15.82 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.477 -0.764 . . . . 0.0 111.645 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.96 78.08 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.016 -1.052 . . . . 0.0 111.735 -171.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -24.67 61.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.163 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 -14.6 63.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -89.18 -28.64 19.87 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.87 -121.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -168.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -158.89 -72.88 0.08 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.43 2.292 . . . . 0.0 111.078 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -103.13 163.95 16.48 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 126.75 2.02 . . . . 0.0 110.7 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.2 10.18 3.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.602 2.202 . . . . 0.0 114.402 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -12.73 61.65 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.906 -1.121 . . . . 0.0 112.949 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.79 30.47 4.04 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.605 1.962 . . . . 0.0 111.722 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.21 136.19 33.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 119.724 -1.86 . . . . 0.0 113.489 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.72 141.77 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.966 1.707 . . . . 0.0 109.192 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.54 131.94 46.62 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.456 1.503 . . . . 0.0 111.73 -168.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -83.26 50.48 1.76 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 119.982 -1.699 . . . . 0.0 111.958 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.431 2.1 p -66.85 -45.26 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -163.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.63 -34.24 72.53 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 121.621 2.009 . . . . 0.0 111.526 174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.16 -53.44 18.25 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.737 0.684 . . . . 0.0 112.448 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 mt -52.27 -46.45 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.784 1.634 . . . . 0.0 110.872 171.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.05 75.58 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.441 1.096 . . . . 0.0 113.103 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.6 m -71.48 -36.98 71.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 111.793 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.6 t -87.02 -23.11 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 112.923 -177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -47.32 -59.46 5.44 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 125.922 1.689 . . . . 0.0 112.412 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.84 -2.12 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.258 2.639 . . . . 0.0 114.219 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.82 -64.95 1.07 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 171.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.91 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.652 -1.28 . . . . 0.0 113.004 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 t -58.57 -48.45 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.163 0.985 . . . . 0.0 110.838 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.01 -48.53 20.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.335 0.588 . . . . 0.0 110.904 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.86 69.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 25.3 m -77.19 -13.59 59.92 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.85 -32.85 17.59 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.886 1.221 . . . . 0.0 111.068 167.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.59 -38.62 88.24 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.835 0.854 . . . . 0.0 111.854 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -139.06 57.5 1.66 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.017 1.327 . . . . 0.0 112.765 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -52.84 -36.07 58.28 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.754 1.621 . . . . 0.0 113.108 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.21 -8.34 59.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.265 1.026 . . . . 0.0 113.519 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.75 161.21 27.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.213 1.005 . . . . 0.0 112.711 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.23 132.86 47.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.747 1.219 . . . . 0.0 110.235 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CD2' ' A' ' 21' ' ' PHE . 50.5 t80 -58.26 -44.22 88.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -66.17 -33.78 76.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.516 1.053 . . . . 0.0 112.221 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.11 -31.47 71.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.304 0.641 . . . . 0.0 112.372 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -70.16 -37.11 75.12 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.219 -0.926 . . . . 0.0 113.243 169.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -42.6 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 118.962 0.801 . . . . 0.0 110.597 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -62.1 -45.72 92.24 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.828 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.18 -43.42 98.64 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.26 0.933 . . . . 0.0 113.322 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -75.59 -25.29 56.88 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.118 -1.225 . . . . 0.0 113.573 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -67.42 -42.21 83.57 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.958 -1.089 . . . . 0.0 110.592 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.451 1.101 . . . . 0.0 112.165 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -49.0 16.59 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.32 1.848 . . . . 0.0 113.003 169.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.25 3.1 mt -88.5 -38.3 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.888 -166.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.01 -59.59 1.68 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.361 1.464 . . . . 0.0 112.799 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -67.11 -24.51 65.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.685 1.594 . . . . 0.0 114.026 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.81 -22.53 66.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.056 1.342 . . . . 0.0 113.842 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.295 1.438 . . . . 0.0 111.976 173.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -147.96 28.87 0.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.428 1.491 . . . . 0.0 112.897 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.16 149.97 19.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 0.0 110.109 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.79 175.97 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.183 0.993 . . . . 0.0 113.279 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 52.69 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.054 2.542 . . . . 0.0 117.252 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -28.21 68.88 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.074 0.852 . . . . 0.0 111.714 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.93 143.55 50.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.919 2.087 . . . . 0.0 108.425 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -89.66 2.32 54.9 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -113.06 11.2 18.88 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.972 1.709 . . . . 0.0 115.094 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -67.21 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.048 1.339 . . . . 0.0 114.149 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.37 50.28 5.81 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 127.091 2.156 . . . . 0.0 112.153 171.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.7 169.45 2.49 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.878 3.052 . . . . 0.0 116.135 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.5 2.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.21 1.404 . . . . 0.0 114.573 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.459 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 17.1 m-80 -119.72 20.92 12.2 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.257 1.823 . . . . 0.0 112.898 169.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 57.0 m -142.49 -24.63 0.65 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.78 166.8 22.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -170.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.7 p -112.44 154.05 26.42 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.14 1.776 . . . . 0.0 110.434 168.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -25.21 62.24 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.8 -43.01 68.99 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.052 1.341 . . . . 0.0 111.184 170.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.72 -22.02 61.69 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.37 -0.831 . . . . 0.0 112.805 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -68.44 -15.06 63.41 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 111.861 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -91.27 -12.48 35.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.01 1.324 . . . . 0.0 113.061 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.32 -34.0 55.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.417 1.087 . . . . 0.0 112.743 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.04 137.28 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.608 1.563 . . . . 0.0 110.546 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.81 160.12 31.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.073 1.349 . . . . 0.0 113.724 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -59.48 -34.63 72.8 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 0.0 111.932 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.1 m -62.64 -25.01 67.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.036 1.734 . . . . 0.0 113.855 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.62 -6.03 8.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.797 1.239 . . . . 0.0 113.38 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -58.04 -42.68 96.39 Favored Pre-proline 0 N--CA 1.481 1.077 0 O-C-N 119.927 -1.733 . . . . 0.0 113.396 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.88 -28.37 86.28 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.962 2.441 . . . . 0.0 112.93 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -75.93 -33.52 59.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.373 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.55 83.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.528 1.531 . . . . 0.0 113.665 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.27 -33.23 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.221 0.919 . . . . 0.0 110.18 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.13 -52.78 44.75 Favored Glycine 0 C--O 1.216 -1.007 0 C-N-CA 124.535 1.064 . . . . 0.0 113.225 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.08 -12.76 29.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.973 2.387 . . . . 0.0 113.892 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.48 -62.41 1.46 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.762 0.825 . . . . 0.0 110.659 164.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -68.19 -34.33 76.08 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.897 -1.127 . . . . 0.0 113.257 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.74 81.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.197 1.799 . . . . 0.0 112.114 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -39.29 50.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.584 1.154 . . . . 0.0 110.471 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -9.72 50.5 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -173.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -87.71 -23.92 24.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.233 1.013 . . . . 0.0 113.311 173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -153.95 -122.03 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.857 1.263 . . . . 0.0 114.044 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -162.24 -65.44 0.05 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.403 1.881 . . . . 0.0 112.055 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -116.02 161.91 28.51 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 126.229 1.812 . . . . 0.0 110.568 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.5 11.61 2.84 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.364 2.043 . . . . 0.0 114.407 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.13 -34.11 65.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.06 1.344 . . . . 0.0 111.785 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.48 19.34 16.98 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.494 1.918 . . . . 0.0 112.733 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.7 118.2 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 119.78 -1.825 . . . . 0.0 111.229 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.69 -4.91 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.003 1.321 . . . . 0.0 112.389 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 59.61 112.75 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.414 3.085 . . . . 0.0 112.869 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -91.99 62.48 4.26 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.634 -1.291 . . . . 0.0 111.744 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 1.2 p -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 117.338 -1.315 . . . . 0.0 114.041 -168.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -63.96 -35.31 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.789 2.086 . . . . 0.0 111.672 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.89 -48.36 61.27 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.679 0.657 . . . . 0.0 111.857 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.88 -40.52 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.122 0.969 . . . . 0.0 112.257 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.62 71.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.785 1.234 . . . . 0.0 112.382 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 0.0 111.632 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.95 -33.1 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.356 1.463 . . . . 0.0 113.319 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.9 m -43.89 -58.37 4.78 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 126.235 1.814 . . . . 0.0 113.855 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.92 -11.36 30.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.807 2.338 . . . . 0.0 113.822 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -65.61 0.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.667 1.187 . . . . 0.0 111.601 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.441 HD11 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.0 -27.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.664 -1.272 . . . . 0.0 113.671 -173.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.5 -44.68 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.526 1.057 . . . . 0.0 112.304 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -73.68 -46.75 44.43 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.024 0.929 . . . . 0.0 110.885 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.27 67.54 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 113.2 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 9.4 m -74.87 -13.07 60.51 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -33.92 18.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.317 1.417 . . . . 0.0 110.755 167.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -60.76 -40.35 92.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.807 0.843 . . . . 0.0 112.16 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -132.81 64.99 1.6 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.727 1.211 . . . . 0.0 111.902 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -52.15 -32.61 36.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.512 -1.367 . . . . 0.0 113.63 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -92.83 1.31 57.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.825 1.25 . . . . 0.0 113.068 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.96 154.53 41.4 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.246 1.022 . . . . 0.0 112.301 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.97 152.25 33.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.834 1.654 . . . . 0.0 112.61 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.459 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 35.0 p90 -47.6 153.9 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.982 1.713 . . . . 0.0 113.526 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 43.7 tttt 60.82 -40.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 129.642 3.177 . . . . 0.0 115.93 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.41 -34.67 77.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.485 1.914 . . . . 0.0 112.199 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -69.09 -37.81 78.62 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.605 -0.684 . . . . 0.0 112.334 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.15 -41.3 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 119.101 0.864 . . . . 0.0 111.11 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.13 -45.44 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.664 0.786 . . . . 0.0 111.633 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.83 95.41 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.994 1.283 . . . . 0.0 113.485 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.95 -35.66 77.03 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 112.593 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -63.66 -36.94 85.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.69 -1.256 . . . . 0.0 112.007 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.87 -47.48 77.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.501 0.72 . . . . 0.0 111.683 171.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -24.66 67.57 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.573 -1.329 . . . . 0.0 111.93 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.7 mt -75.6 -45.96 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.934 1.693 . . . . 0.0 112.687 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.51 -59.79 1.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -62.68 -26.4 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.319 1.848 . . . . 0.0 113.981 -170.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.76 -21.43 66.77 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 C--O 1.255 1.374 0 C-N-CA 125.87 1.668 . . . . 0.0 114.57 -177.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.258 69.4 m-20 54.58 35.93 24.7 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.934 1.294 . . . . 0.0 113.921 -170.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.32 176.31 7.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.319 1.447 . . . . 0.0 111.533 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.37 138.92 57.9 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 142.05 8.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.357 1.863 . . . . 0.0 109.759 166.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.7 29.55 5.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.415 1.486 . . . . 0.0 112.987 -170.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 -24.68 61.65 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.107 -0.996 . . . . 0.0 112.71 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.87 -24.92 67.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.01 0.924 . . . . 0.0 112.871 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -126.52 23.71 6.8 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.537 1.535 . . . . 0.0 112.117 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 27.03 86.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 128.882 2.873 . . . . 0.0 115.47 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -112.53 65.44 0.82 Allowed Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 125.212 1.405 . . . . 0.0 110.994 167.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.78 169.74 16.93 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.74 3.626 . . . . 0.0 112.487 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.37 -16.44 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -76.76 -35.15 57.91 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.33 1.052 . . . . 0.0 112.615 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.8 m -100.48 -22.49 14.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.325 2.25 . . . . 0.0 113.904 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -64.78 140.78 58.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.018 2.527 . . . . 0.0 109.648 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.4 p -100.95 166.47 10.81 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.827 1.298 . . . . 0.0 113.54 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.16 -25.28 66.88 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.587 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -65.5 -42.83 91.69 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.853 -1.155 . . . . 0.0 110.421 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.59 -27.05 68.92 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.848 -0.532 . . . . 0.0 112.09 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -69.08 -12.19 61.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.785 -1.197 . . . . 0.0 113.119 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.09 -6.45 38.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.754 1.221 . . . . 0.0 112.64 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.13 -30.51 21.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.674 1.189 . . . . 0.0 112.375 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 p -72.56 141.95 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.751 1.62 . . . . 0.0 110.753 169.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.17 160.31 32.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.46 1.104 . . . . 0.0 113.084 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.21 -35.41 73.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.726 1.21 . . . . 0.0 111.848 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -62.95 -21.96 66.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.547 1.539 . . . . 0.0 113.79 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.09 -5.25 6.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 113.47 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -55.42 -47.22 99.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 O-C-N 120.131 -1.606 . . . . 0.0 111.478 170.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -60.47 -25.74 81.22 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.565 2.177 . . . . 0.0 113.857 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -70.5 -34.44 72.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.391 0.676 . . . . 0.0 111.915 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.05 -46.52 74.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.848 1.203 . . . . 0.0 113.005 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.11 -34.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 118.75 0.705 . . . . 0.0 110.249 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.13 88.13 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 118.819 -0.989 . . . . 0.0 113.524 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.13 -24.16 66.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.249 2.524 . . . . 0.0 113.609 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.88 -55.25 4.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.495 -0.753 . . . . 0.0 110.939 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -68.01 -31.64 71.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.454 -0.779 . . . . 0.0 112.5 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.98 84.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.396 1.078 . . . . 0.0 111.576 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -36.75 49.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.329 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -23.15 63.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -81.6 -17.91 46.59 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.85 -122.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.186 1.394 . . . . 0.0 112.341 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -160.8 -66.99 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.399 1.48 . . . . 0.0 113.03 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -129.73 164.29 41.16 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 127.906 2.482 . . . . 0.0 109.669 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 3.82 6.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.352 1.519 . . . . 0.0 114.716 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -55.27 -23.79 24.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.479 1.512 . . . . 0.0 112.564 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.16 9.27 15.8 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.788 2.035 . . . . 0.0 113.014 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.76 125.16 32.31 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 119.614 -1.929 . . . . 0.0 113.644 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.38 129.53 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.933 2.093 . . . . 0.0 105.866 173.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 116.62 10.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.14 1.336 . . . . 0.0 109.678 -173.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.47 58.2 4.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.806 1.642 . . . . 0.0 110.991 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -69.55 -31.67 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.74 -35.13 79.86 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 121.239 1.836 . . . . 0.0 111.875 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.84 68.24 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.724 0.678 . . . . 0.0 112.237 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.41 -47.31 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.6 1.16 . . . . 0.0 111.123 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.76 -28.3 67.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.359 1.464 . . . . 0.0 112.993 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.5 m -66.02 -48.52 70.87 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.771 1.229 . . . . 0.0 111.001 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.67 -19.98 8.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -46.9 -63.07 1.52 Allowed Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 125.129 1.372 . . . . 0.0 112.258 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.65 -5.61 16.56 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.553 2.835 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.57 -61.15 1.83 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.437 1.495 . . . . 0.0 110.05 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.64 -30.72 48.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 124.752 1.221 . . . . 0.0 111.721 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.08 -44.18 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.431 1.014 . . . . 0.0 112.849 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -74.42 -46.01 42.85 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.029 0.531 . . . . 0.0 109.706 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.31 75.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.927 0.891 . . . . 0.0 112.861 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.8 m -74.24 -17.43 60.88 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -30.58 32.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.257 1.39 . . . . 0.0 110.79 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -65.29 -38.68 91.01 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.329 0.652 . . . . 0.0 112.626 170.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -130.26 55.81 1.79 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.606 1.563 . . . . 0.0 112.674 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -49.27 -40.19 33.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.602 1.161 . . . . 0.0 112.845 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.29 -2.5 57.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.105 0.962 . . . . 0.0 113.494 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.53 158.74 28.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.16 0.984 . . . . 0.0 112.007 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.9 141.32 47.88 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.825 0.85 . . . . 0.0 110.588 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -66.9 -47.39 71.94 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -64.14 -33.24 75.34 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.064 -1.023 . . . . 0.0 113.009 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.64 -34.03 74.98 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.241 0.616 . . . . 0.0 111.979 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -75.07 -36.38 61.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.28 -39.88 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.295 1.407 . . . . 0.0 111.203 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -61.55 -45.68 93.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.477 0.711 . . . . 0.0 111.584 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.16 -45.48 95.25 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.74 1.162 . . . . 0.0 113.789 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.24 -35.57 63.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.752 1.276 . . . . 0.0 112.867 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -59.58 -40.42 87.33 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.69 1.132 . . . . 0.0 111.562 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.66 -46.17 89.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.515 1.126 . . . . 0.0 112.052 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -26.39 68.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.205 -0.934 . . . . 0.0 112.331 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.2 -44.92 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.722 1.209 . . . . 0.0 112.291 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -104.35 -60.27 1.61 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.681 1.592 . . . . 0.0 112.993 -173.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.15 -24.36 66.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.673 1.589 . . . . 0.0 113.933 -171.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.55 -22.74 67.06 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.884 1.274 . . . . 0.0 113.755 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.198 1.399 . . . . 0.0 112.417 177.699 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.92 121.25 10.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.206 1.002 . . . . 0.0 111.649 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.44 25.87 3.81 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -50.47 -33.99 23.24 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.263 0.0 OUTLIER -82.88 -8.16 59.6 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 44.86 -109.16 0.16 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.803 1.641 . . . . 0.0 113.737 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.68 5.59 9.0 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.38 1.472 . . . . 0.0 114.664 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.21 7.51 5.53 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.438 2.295 . . . . 0.0 113.828 -168.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -134.58 -25.01 1.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.428 1.891 . . . . 0.0 114.133 -170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -89.94 158.0 17.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.829 1.252 . . . . 0.0 111.825 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . 0.263 20.6 ptmt 43.77 43.73 1.21 Allowed Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 128.772 2.829 . . . . 0.0 116.684 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -66.79 172.46 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.33 2.687 . . . . 0.0 114.007 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -63.62 6.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 127.041 2.137 . . . . 0.0 115.796 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 2.1 p30 -135.36 32.53 3.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.635 2.374 . . . . 0.0 111.215 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -148.28 -47.53 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.175 1.39 . . . . 0.0 113.673 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -99.01 139.3 34.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.872 0.869 . . . . 0.0 111.346 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 p -75.29 172.19 12.88 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.202 1.801 . . . . 0.0 114.578 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -21.63 1.54 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -55.34 -36.09 65.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.952 1.251 . . . . 0.0 111.444 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.6 -26.38 68.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.245 -0.91 . . . . 0.0 112.829 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -70.18 -18.45 63.19 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.206 -0.933 . . . . 0.0 111.884 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -91.84 -21.23 20.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 112.222 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.31 -34.25 61.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.663 1.185 . . . . 0.0 112.49 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.85 137.48 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.083 1.353 . . . . 0.0 110.64 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.35 158.31 31.94 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.065 1.346 . . . . 0.0 113.303 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -57.91 -35.82 71.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.684 1.194 . . . . 0.0 112.213 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -22.98 65.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.699 1.6 . . . . 0.0 114.002 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.82 0.09 6.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.56 1.544 . . . . 0.0 112.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.17 -42.75 94.97 Favored Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 119.765 -1.834 . . . . 0.0 112.788 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -61.66 -26.84 80.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.582 2.188 . . . . 0.0 113.386 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -74.57 -32.86 62.53 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 124.105 0.962 . . . . 0.0 111.246 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.62 -46.27 90.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.85 1.26 . . . . 0.0 114.11 170.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.05 -36.15 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.436 1.016 . . . . 0.0 110.69 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.01 -49.48 58.85 Favored Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.889 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.25 -13.57 60.59 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.797 2.299 . . . . 0.0 114.331 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.64 -56.7 2.92 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.753 -0.592 . . . . 0.0 109.862 165.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.09 -37.28 81.03 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.154 -0.966 . . . . 0.0 113.032 -169.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.88 72.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.655 1.982 . . . . 0.0 112.397 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.84 -37.2 16.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.167 1.387 . . . . 0.0 110.676 -177.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.02 -30.46 35.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.375 1.87 . . . . 0.0 113.798 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -98.33 -10.86 23.18 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -170.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.25 1.1 ptpm? -150.0 -126.7 0.05 OUTLIER 'General case' 0 C--N 1.351 0.636 0 CA-C-N 120.114 1.325 . . . . 0.0 113.328 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -161.82 -48.63 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -167.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -143.54 161.4 47.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 126.92 2.088 . . . . 0.0 110.664 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.51 -1.08 11.29 Favored 'Trans proline' 0 C--N 1.358 1.034 0 CA-C-N 121.453 1.555 . . . . 0.0 115.654 -174.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.83 -24.85 54.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.629 1.172 . . . . 0.0 113.037 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -114.86 7.06 15.62 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.0 1.72 . . . . 0.0 113.176 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.9 123.68 32.28 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 119.727 -1.858 . . . . 0.0 112.035 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.5 136.8 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 110.2 4.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.323 1.419 . . . . 0.0 108.186 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -91.02 59.64 4.1 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.072 0.949 . . . . 0.0 110.356 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.326 2.9 p -67.39 -15.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.063 -1.023 . . . . 0.0 112.183 -170.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.23 -33.03 57.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.416 1.486 . . . . 0.0 112.245 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.34 -61.23 1.92 Allowed Glycine 0 N--CA 1.467 0.728 0 C-N-CA 124.443 1.02 . . . . 0.0 112.171 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.48 -44.4 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.842 -1.387 . . . . 0.0 113.189 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.95 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.989 1.268 . . . . 0.0 112.547 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 8.9 m -67.31 -46.68 72.82 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.548 1.139 . . . . 0.0 112.066 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.99 -16.33 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.4 m -41.5 -60.47 1.83 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 125.906 1.682 . . . . 0.0 113.359 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.47 -14.39 44.66 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.73 2.287 . . . . 0.0 113.361 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.05 -57.61 3.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.723 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -37.98 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 119.392 0.996 . . . . 0.0 112.221 -176.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.96 -43.22 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.99 -0.443 . . . . 0.0 112.052 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -71.31 -47.45 56.61 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.931 0.893 . . . . 0.0 110.866 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.95 71.64 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.496 -1.378 . . . . 0.0 113.205 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.4 m -76.16 -11.03 59.86 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.02 -34.15 16.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.397 1.453 . . . . 0.0 110.614 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -57.94 -38.67 76.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.308 1.043 . . . . 0.0 111.996 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -145.53 86.4 1.74 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.906 0.86 . . . . 0.0 112.001 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -55.0 -28.48 52.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.574 1.55 . . . . 0.0 112.89 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.23 3.5 55.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 113.048 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.46 161.08 15.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.115 1.366 . . . . 0.0 113.828 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.52 54.73 0.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.505 1.922 . . . . 0.0 113.495 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 1.1 p90 45.2 -104.31 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 115.391 166.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -48.45 -32.67 8.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.155 2.182 . . . . 0.0 113.892 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.03 -29.67 68.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 112.703 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -72.52 -39.71 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.319 -0.863 . . . . 0.0 112.557 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.72 -39.93 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.732 1.151 . . . . 0.0 110.964 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.22 -42.32 96.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.006 0.922 . . . . 0.0 112.142 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.37 99.34 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.789 1.185 . . . . 0.0 113.354 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.72 -34.15 66.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 1.153 . . . . 0.0 112.574 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -58.14 -42.77 86.6 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.781 1.173 . . . . 0.0 111.475 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.03 -45.17 94.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 0.0 111.624 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -23.89 67.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.982 -1.074 . . . . 0.0 112.655 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 19.0 mt -85.97 -49.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.334 1.853 . . . . 0.0 112.661 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -100.48 -59.3 1.73 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.653 1.581 . . . . 0.0 112.92 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -65.08 -26.86 68.41 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.468 1.507 . . . . 0.0 113.123 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.04 -18.77 63.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.249 1.42 . . . . 0.0 114.21 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.957 1.303 . . . . 0.0 113.394 -177.413 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 119.855 -0.117 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -138.28 54.91 1.77 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -169.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.55 40.29 29.61 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 169.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -63.15 -15.65 57.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -171.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.76 4.66 13.23 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.79 -36.28 16.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.605 1.562 . . . . 0.0 114.068 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.25 151.98 32.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.389 1.076 . . . . 0.0 111.573 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -71.91 56.88 0.31 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.36 2.264 . . . . 0.0 112.248 173.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -151.57 -47.75 0.11 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.545 1.538 . . . . 0.0 113.374 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -72.76 -47.38 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -172.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -137.55 32.07 0.19 Allowed Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -59.08 139.21 89.58 Favored 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 123.188 2.174 . . . . 0.0 113.848 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -73.69 0.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.08 1.352 . . . . 0.0 113.886 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HA ' ' CE1' ' A' ' 74' ' ' PHE . 61.1 m-80 -123.98 19.79 9.2 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.76 1.624 . . . . 0.0 112.864 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -140.06 -39.87 0.44 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -94.81 153.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 111.818 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -79.97 175.39 10.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.698 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -19.4 0.66 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -55.8 -31.74 62.9 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 120.041 1.292 . . . . 0.0 112.029 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.04 -33.25 64.77 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.002 -1.061 . . . . 0.0 111.901 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.03 -10.62 60.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 mt -103.77 -22.17 13.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.53 70.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.202 1.001 . . . . 0.0 111.745 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.24 137.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 111.201 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.47 158.88 30.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.375 1.07 . . . . 0.0 112.683 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.16 -34.29 56.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.11 1.364 . . . . 0.0 112.153 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 m -60.04 -28.18 67.54 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.066 1.746 . . . . 0.0 113.697 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -127.49 0.4 6.25 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.655 1.582 . . . . 0.0 113.179 -171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.88 -45.88 99.91 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.533 -1.354 . . . . 0.0 111.883 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -60.15 -25.43 79.9 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.935 2.423 . . . . 0.0 113.938 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.6 m -77.84 -30.79 51.22 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.331 1.053 . . . . 0.0 111.56 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.43 85.57 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.883 -1.136 . . . . 0.0 113.36 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.27 -36.87 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 119.108 0.867 . . . . 0.0 110.084 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.53 -52.76 31.77 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 124.628 1.109 . . . . 0.0 113.234 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -69.34 -15.21 63.28 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 121.374 2.587 . . . . 0.0 114.128 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.17 -31.79 15.34 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.498 1.044 . . . . 0.0 113.183 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -93.65 -29.36 15.48 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.17 90.12 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.164 1.785 . . . . 0.0 111.963 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -36.05 27.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.979 0.912 . . . . 0.0 111.106 -174.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -65.06 -27.09 68.55 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -91.59 -9.08 45.46 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.85 -130.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.159 1.784 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.23 -43.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.282 1.833 . . . . 0.0 114.556 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.6 mmpp? -128.13 164.51 36.88 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 127.193 2.197 . . . . 0.0 110.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.13 -2.72 8.75 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.016 1.811 . . . . 0.0 114.281 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.62 -22.87 65.32 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.85 -1.157 . . . . 0.0 113.061 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.92 -5.11 23.84 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.563 1.545 . . . . 0.0 114.03 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 127.52 32.91 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.947 -1.096 . . . . 0.0 113.739 -169.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.26 128.29 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.212 1.805 . . . . 0.0 107.303 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.04 120.78 14.83 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 119.153 0.888 . . . . 0.0 110.439 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -90.15 52.42 2.26 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.58 -1.325 . . . . 0.0 111.369 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.295 0.9 OUTLIER -64.32 -28.21 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -167.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -59.42 -39.9 85.01 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.756 2.071 . . . . 0.0 111.458 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.08 -54.6 13.15 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.48 -45.37 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.754 -0.851 . . . . 0.0 111.626 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.19 67.91 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.883 1.22 . . . . 0.0 112.747 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -69.02 -47.3 65.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.646 1.178 . . . . 0.0 111.885 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 t -89.96 -18.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -43.22 -60.8 2.17 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 125.862 1.665 . . . . 0.0 112.395 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.1 -0.47 5.63 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.585 2.856 . . . . 0.0 114.503 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.32 -57.77 2.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.082 1.753 . . . . 0.0 111.219 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -35.75 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 119.874 1.216 . . . . 0.0 111.986 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.06 -41.49 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 112.604 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -76.63 -47.7 21.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.474 0.709 . . . . 0.0 110.198 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.19 75.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.075 -1.016 . . . . 0.0 112.937 -170.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.1 m -76.2 -10.52 59.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -33.32 19.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.565 1.53 . . . . 0.0 110.381 167.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -61.52 -39.13 89.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.312 0.645 . . . . 0.0 111.695 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.45 61.29 1.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 112.744 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -54.0 -33.37 56.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.479 -1.388 . . . . 0.0 113.143 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.3 -1.82 58.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.149 1.379 . . . . 0.0 113.329 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.33 171.09 12.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.331 1.062 . . . . 0.0 113.271 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -64.71 141.02 58.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.44 1.496 . . . . 0.0 113.349 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.428 ' CE1' ' HA ' ' A' ' 14' ' ' ASN . 7.0 p90 -58.35 -41.65 85.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.762 2.425 . . . . 0.0 115.173 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -93.25 -35.5 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.598 1.159 . . . . 0.0 111.621 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.2 -30.83 69.63 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.157 0.983 . . . . 0.0 111.621 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -74.72 -40.06 61.54 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -68.21 -40.8 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.879 1.218 . . . . 0.0 111.088 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.47 -45.71 78.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.236 1.014 . . . . 0.0 111.451 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.31 -44.07 97.48 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.324 1.44 . . . . 0.0 113.401 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.74 -32.74 65.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.165 1.483 . . . . 0.0 113.171 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -62.0 -42.95 99.71 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.642 -1.287 . . . . 0.0 111.21 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.71 -46.53 89.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.806 1.242 . . . . 0.0 111.878 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -28.23 69.88 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.118 -0.989 . . . . 0.0 111.812 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 mt -79.44 -48.48 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.055 0.942 . . . . 0.0 111.889 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.2 -57.18 2.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.355 1.462 . . . . 0.0 113.629 -169.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.16 -28.2 65.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.888 1.675 . . . . 0.0 113.242 -171.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.38 -49.61 47.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 113.352 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 C--O 1.254 1.299 0 C-N-CA 126.629 1.972 . . . . 0.0 112.762 175.186 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.57 -50.39 2.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.76 147.38 53.47 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.225 -0.922 . . . . 0.0 112.791 -169.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.26 -15.56 0.41 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.761 2.424 . . . . 0.0 115.047 -172.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 45.35 0.85 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.13 1.372 . . . . 0.0 113.207 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.59 -27.99 68.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 -10.29 59.27 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 59.32 -16.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.097 2.959 . . . . 0.0 116.901 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -114.08 -10.56 12.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.458 1.903 . . . . 0.0 113.145 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -96.1 155.65 16.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.381 1.872 . . . . 0.0 111.372 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 51.49 43.64 1.74 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 127.862 2.465 . . . . 0.0 115.89 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -64.41 163.19 27.6 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.964 1.776 . . . . 0.0 112.031 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.59 -20.85 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.8 -40.17 29.18 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.51 -0.744 . . . . 0.0 112.824 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 17.9 m -94.44 -27.44 16.02 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -169.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.31 161.79 27.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.983 0.897 . . . . 0.0 111.989 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 48.9 p -100.07 171.38 7.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 122.472 1.129 . . . . 0.0 113.899 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.33 -26.21 66.39 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.62 -0.675 . . . . 0.0 112.616 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.52 -43.81 97.91 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.39 0.995 . . . . 0.0 110.146 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -63.81 -31.51 72.71 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.485 0.714 . . . . 0.0 111.895 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 89.7 t80 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.765 1.166 . . . . 0.0 111.328 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.48 -8.2 55.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.01 45.2 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.319 0.963 . . . . 0.0 112.164 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.03 140.6 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.333 1.853 . . . . 0.0 109.124 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.35 155.3 35.77 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -52.67 -35.13 54.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.809 1.244 . . . . 0.0 112.093 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.9 m -64.49 -23.49 67.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -124.53 -1.77 8.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.998 1.319 . . . . 0.0 112.787 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.32 -46.43 90.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.061 -1.65 . . . . 0.0 111.546 171.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -61.19 -25.98 81.62 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.587 2.191 . . . . 0.0 113.497 169.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 89.6 m -72.76 -36.96 67.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.208 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.49 92.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.872 1.269 . . . . 0.0 114.071 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.33 -33.05 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 119.975 1.261 . . . . 0.0 110.497 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.75 -52.0 36.3 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 124.998 1.285 . . . . 0.0 113.816 170.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -65.8 -25.85 67.43 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.663 2.231 . . . . 0.0 113.206 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.39 -58.7 3.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.091 0.86 . . . . 0.0 110.935 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -58.44 -44.07 89.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.267 1.827 . . . . 0.0 112.165 -174.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.39 -46.73 82.05 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.421 1.488 . . . . 0.0 112.075 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.88 -31.49 45.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.843 0.857 . . . . 0.0 111.809 -176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -71.2 -23.14 61.98 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -96.58 -11.5 25.27 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 -132.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.929 1.691 . . . . 0.0 110.88 -176.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -155.11 -56.2 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.998 2.119 . . . . 0.0 112.581 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -122.03 168.71 10.87 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.781 2.432 . . . . 0.0 109.965 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.22 6.28 4.58 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.66 1.573 . . . . 0.0 114.466 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.61 -26.66 68.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 112.625 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.22 21.7 15.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.686 1.995 . . . . 0.0 113.897 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.03 133.11 35.1 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.248 -1.532 . . . . 0.0 112.261 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.92 -1.36 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.67 1.188 . . . . 0.0 112.86 -173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 56.31 106.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.233 2.613 . . . . 0.0 110.561 -168.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.54 60.03 4.96 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.283 -1.511 . . . . 0.0 111.075 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.349 2.1 p -68.92 -24.77 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 120.721 -1.237 . . . . 0.0 112.282 -169.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -65.46 -42.96 91.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.723 -1.236 . . . . 0.0 112.209 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.96 -49.0 57.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.05 -43.79 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.953 1.301 . . . . 0.0 111.924 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -28.71 65.3 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.001 1.273 . . . . 0.0 112.736 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 50.5 m -69.8 -42.06 74.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 111.607 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 29.0 t -85.41 -27.79 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.971 1.708 . . . . 0.0 113.474 -171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 22.2 m -50.74 -63.44 1.88 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 112.495 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.3 -17.68 58.75 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.459 2.106 . . . . 0.0 113.096 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.76 -58.29 4.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.434 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 33.0 mt -71.88 -32.32 44.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 112.34 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.49 -51.07 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.517 1.127 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.41 -48.16 73.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.632 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.6 74.17 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.0 113.454 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.0 m -73.5 -17.55 61.21 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.12 -31.11 19.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.624 1.102 . . . . 0.0 111.886 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.97 -41.89 97.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 111.253 169.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.34 80.02 1.55 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.895 0.855 . . . . 0.0 111.448 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.78 -38.98 67.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.176 1.79 . . . . 0.0 112.408 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.24 -8.86 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -169.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.8 148.08 52.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 112.266 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -65.22 135.29 55.24 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.209 1.004 . . . . 0.0 109.214 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.464 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 61.9 t80 -62.27 -52.32 64.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -58.9 -32.45 69.53 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.734 1.152 . . . . 0.0 112.386 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -70.94 -34.51 71.55 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 112.905 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -71.61 -34.95 70.27 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.682 -1.261 . . . . 0.0 112.606 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.89 -48.96 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.066 0.946 . . . . 0.0 110.077 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -59.0 -43.17 91.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.684 1.193 . . . . 0.0 111.744 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.04 -43.94 88.2 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.392 0.996 . . . . 0.0 113.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -80.39 -30.29 37.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.389 1.095 . . . . 0.0 113.517 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . 0.44 ' CD1' ' HE3' ' B' ' 175' ' ' LYS . 45.0 m0 -57.05 -40.02 75.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.195 1.362 . . . . 0.0 111.081 169.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -70.13 -14.78 62.8 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.653 -1.279 . . . . 0.0 114.083 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -21.55 25.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.339 1.456 . . . . 0.0 113.749 170.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.59 -45.66 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 126.523 1.929 . . . . 0.0 113.997 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' B' ' 171' ' ' TRP . 55.5 mttt -87.83 -52.55 5.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.094 2.158 . . . . 0.0 111.829 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -69.85 -26.79 64.38 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.128 1.371 . . . . 0.0 113.279 -172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -71.57 -16.56 62.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.047 1.339 . . . . 0.0 114.156 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.255 1.36 0 C-N-CA 125.593 1.557 . . . . 0.0 113.378 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 t70 51.0 41.99 27.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.815 1.646 . . . . 0.0 114.779 -176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.7 -45.58 7.63 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -168.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -96.92 -159.12 0.71 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.386 1.475 . . . . 0.0 112.664 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt 57.02 40.36 28.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.325 1.85 . . . . 0.0 112.939 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.39 144.1 37.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.641 1.177 . . . . 0.0 110.937 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.5 1.97 0.3 Allowed 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.5 t70 60.61 -50.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 129.669 3.188 . . . . 0.0 117.262 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -105.33 -1.29 25.34 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -144.86 -156.84 0.73 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.83 1.252 . . . . 0.0 113.944 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 58.81 35.87 0.26 Allowed Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 128.384 2.674 . . . . 0.0 115.45 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.97 160.51 45.74 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.503 2.135 . . . . 0.0 112.726 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.87 -26.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -74.4 -27.91 60.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.176 0.991 . . . . 0.0 112.932 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.6 m -114.79 -26.87 7.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.905 1.282 . . . . 0.0 114.304 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -92.97 171.88 8.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.632 1.173 . . . . 0.0 112.951 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.5 p -97.58 165.07 12.16 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -167.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.07 -16.92 8.4 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.763 1.625 . . . . 0.0 114.491 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.4 -35.44 62.88 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.729 1.149 . . . . 0.0 111.049 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.01 -32.31 67.82 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.765 -1.21 . . . . 0.0 112.502 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.95 -7.59 51.75 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 112.318 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.77 -16.46 14.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.248 1.419 . . . . 0.0 112.207 169.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.19 65.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.545 1.138 . . . . 0.0 111.513 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.64 139.32 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.334 1.854 . . . . 0.0 109.897 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.85 158.18 28.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.69 0.796 . . . . 0.0 112.092 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.77 -34.63 62.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.782 1.233 . . . . 0.0 111.69 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.8 m -59.14 -27.69 65.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.181 1.792 . . . . 0.0 113.516 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.44 3.16 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.482 1.513 . . . . 0.0 113.117 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -55.57 -45.63 99.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 120.002 -1.686 . . . . 0.0 111.276 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -60.31 -24.64 78.1 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.324 . . . . 0.0 114.249 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.3 m -75.95 -37.62 58.44 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.791 1.236 . . . . 0.0 110.759 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.23 97.42 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.42 -37.06 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 118.808 0.731 . . . . 0.0 111.574 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.23 12.04 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.798 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.73 -44.83 93.6 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.714 2.257 . . . . 0.0 112.409 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.0 -26.65 67.64 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -94.44 -35.93 12.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.48 84.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.428 1.891 . . . . 0.0 112.18 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.27 -26.22 39.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.151 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -18.33 48.54 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.458 -0.776 . . . . 0.0 113.091 -169.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -97.2 -14.18 21.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.4 -136.06 0.1 Allowed 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.972 1.709 . . . . 0.0 110.731 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -149.97 -60.78 0.2 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.594 1.958 . . . . 0.0 113.187 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -127.5 162.96 45.69 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.973 2.109 . . . . 0.0 110.326 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.05 5.85 5.96 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.722 1.615 . . . . 0.0 114.219 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -58.57 -24.77 61.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.523 1.129 . . . . 0.0 111.446 168.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -111.22 11.94 21.78 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.781 2.032 . . . . 0.0 113.383 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.09 34.83 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.023 -1.673 . . . . 0.0 113.005 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.34 -3.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 125.065 1.346 . . . . 0.0 112.387 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.41 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.691 2.796 . . . . 0.0 110.749 -168.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -89.04 63.83 6.85 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.502 -1.374 . . . . 0.0 110.93 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.27 -28.63 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -168.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -54.13 -43.69 70.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.074 1.35 . . . . 0.0 112.199 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.9 -51.67 7.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.44 -48.19 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.188 0.995 . . . . 0.0 111.923 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.42 -28.34 67.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -70.2 -51.6 29.75 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.647 1.179 . . . . 0.0 112.539 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.01 -15.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -170.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.6 m -45.26 -63.31 1.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 120.261 1.391 . . . . 0.0 112.095 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -2.0 6.48 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.131 2.554 . . . . 0.0 114.805 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -64.13 1.14 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.964 1.706 . . . . 0.0 110.92 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -27.4 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.871 -1.143 . . . . 0.0 113.008 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -54.17 -48.2 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.926 1.29 . . . . 0.0 110.815 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -81.47 -48.47 11.82 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.239 0.543 . . . . 0.0 110.689 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.76 68.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.0 m -77.42 -13.92 59.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.08 -33.19 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.417 1.462 . . . . 0.0 110.917 168.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -61.82 -38.75 89.3 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.412 1.085 . . . . 0.0 111.847 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.82 55.61 1.72 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 0.0 112.834 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -53.75 -33.66 56.49 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.386 1.474 . . . . 0.0 113.232 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.18 -6.38 56.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.847 1.259 . . . . 0.0 113.705 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.04 159.61 26.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.785 0.834 . . . . 0.0 111.649 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -58.9 134.35 56.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 111.08 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.26 -47.24 71.31 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.391 -0.818 . . . . 0.0 112.96 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -64.27 -36.48 84.24 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.287 0.949 . . . . 0.0 111.963 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -59.61 -32.0 70.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.019 0.528 . . . . 0.0 112.068 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -74.83 -38.34 62.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.781 -1.104 . . . . 0.0 113.829 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.73 -41.15 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.923 1.692 . . . . 0.0 111.031 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.57 -44.05 91.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.317 1.047 . . . . 0.0 111.438 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.31 94.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.21 1.385 . . . . 0.0 113.5 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -71.93 -33.9 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.276 1.538 . . . . 0.0 113.4 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -60.33 -42.82 96.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.681 1.128 . . . . 0.0 111.383 171.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.04 -45.76 90.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.558 1.143 . . . . 0.0 111.969 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.59 71.62 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.002 -1.061 . . . . 0.0 111.826 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.72 -49.01 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.142 0.977 . . . . 0.0 111.785 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -101.66 -59.83 1.63 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.296 1.439 . . . . 0.0 113.319 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -66.67 -25.97 66.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.956 1.702 . . . . 0.0 113.587 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.97 -20.54 65.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.894 1.278 . . . . 0.0 114.2 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.389 1.476 . . . . 0.0 112.883 -178.585 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.18 15.0 4.19 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.857 -1.152 . . . . 0.0 113.248 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -162.48 156.9 21.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.379 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -144.52 -97.5 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 174.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' B' ' 109' ' ' ASP . 10.5 mmmm -97.32 -7.16 32.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.05 1.74 . . . . 0.0 113.934 -167.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 61.15 152.26 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.18 2.592 . . . . 0.0 114.723 -170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 57.47 -18.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 128.029 2.531 . . . . 0.0 117.185 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 60.43 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 130.065 3.346 . . . . 0.0 116.84 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -110.5 -1.17 17.11 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.959 2.104 . . . . 0.0 112.562 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.65 158.55 19.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.086 2.154 . . . . 0.0 112.314 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 51.78 43.81 1.8 Allowed Pre-proline 0 N--CA 1.483 1.202 0 C-N-CA 128.017 2.527 . . . . 0.0 115.713 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -65.26 164.19 26.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.562 2.174 . . . . 0.0 112.64 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.21 -26.82 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -80.08 -17.64 52.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.365 1.066 . . . . 0.0 113.563 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -106.4 -44.98 4.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.874 1.27 . . . . 0.0 113.939 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -101.8 176.05 5.35 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 77.7 p -91.2 164.55 13.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -167.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -20.7 21.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.553 1.941 . . . . 0.0 114.272 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.64 -31.78 57.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.625 1.102 . . . . 0.0 111.468 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' B' ' 94' ' ' LYS . 24.3 t70 -54.51 -36.32 64.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.839 1.256 . . . . 0.0 113.025 171.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.88 -20.05 64.25 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 111.633 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 43.4 mt -89.47 -12.52 39.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.008 1.323 . . . . 0.0 113.228 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -40.28 46.35 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.925 0.89 . . . . 0.0 111.176 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.34 137.74 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 128.013 2.525 . . . . 0.0 110.243 168.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.3 157.31 31.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.283 1.033 . . . . 0.0 112.947 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -50.34 -36.7 33.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.94 1.296 . . . . 0.0 112.68 171.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -66.58 -25.65 66.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.601 1.161 . . . . 0.0 113.483 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.4 -3.35 10.48 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.956 1.302 . . . . 0.0 113.843 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -56.88 -40.94 88.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.851 -1.781 . . . . 0.0 113.218 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -61.3 -26.82 82.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.606 2.204 . . . . 0.0 113.386 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 46.8 m -76.18 -35.0 59.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.377 1.071 . . . . 0.0 111.211 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.26 85.47 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.204 1.002 . . . . 0.0 113.228 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.78 -36.59 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 118.34 0.518 . . . . 0.0 110.926 170.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.51 -55.29 17.42 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 125.267 1.413 . . . . 0.0 113.711 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -59.89 -33.95 72.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.23 2.015 . . . . 0.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.6 -47.74 30.59 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.472 -0.768 . . . . 0.0 112.943 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.08 -32.44 50.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.71 1.141 . . . . 0.0 112.847 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.77 55.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.067 1.347 . . . . 0.0 112.066 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -30.61 68.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.76 0.824 . . . . 0.0 110.95 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -68.11 -25.79 65.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.149 0.979 . . . . 0.0 113.218 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -80.18 -22.48 41.9 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -151.95 -130.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.245 1.418 . . . . 0.0 111.25 -169.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -163.82 -38.28 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.396 1.878 . . . . 0.0 114.023 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.49 164.86 40.96 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 127.377 2.271 . . . . 0.0 109.593 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -87.65 15.09 2.22 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.395 2.063 . . . . 0.0 114.26 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.12 -30.23 67.98 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.135 1.334 . . . . 0.0 113.239 -170.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.29 8.37 18.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.538 1.535 . . . . 0.0 114.259 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.17 127.64 33.5 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.938 -1.101 . . . . 0.0 112.045 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.53 14.05 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 126.201 1.8 . . . . 0.0 111.574 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 57.72 109.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.427 3.091 . . . . 0.0 110.439 -168.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -85.68 51.89 2.32 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.071 -1.643 . . . . 0.0 112.838 -167.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.31 0.4 OUTLIER -70.44 -11.82 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.744 -1.223 . . . . 0.0 113.564 -169.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -52.66 -34.09 50.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.362 . . . . 0.0 111.077 167.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.53 -58.39 1.85 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 113.002 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -43.53 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 118.301 1.051 . . . . 0.0 113.312 -174.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.96 64.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.996 1.271 . . . . 0.0 112.642 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 73.8 m -70.03 -38.77 75.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 112.097 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.93 -24.98 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.728 1.611 . . . . 0.0 114.011 -169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.4 m -43.56 -56.25 7.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 120.283 1.401 . . . . 0.0 113.525 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.62 -9.43 18.29 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.038 2.492 . . . . 0.0 114.587 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.94 -64.52 1.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.098 1.359 . . . . 0.0 112.225 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -21.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.68 -40.76 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.845 1.202 . . . . 0.0 112.17 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.67 -47.93 13.33 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.218 1.007 . . . . 0.0 111.307 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.39 86.38 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.543 -1.348 . . . . 0.0 113.069 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -76.26 -8.66 57.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.94 -37.27 14.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.111 1.323 . . . . 0.0 111.685 169.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -75.64 -31.51 59.86 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -129.02 54.3 1.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.702 1.201 . . . . 0.0 111.752 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -52.35 -32.21 37.15 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.861 1.664 . . . . 0.0 113.075 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -90.02 -6.63 55.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.301 1.44 . . . . 0.0 114.05 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.2 156.71 31.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.95 0.796 . . . . 0.0 110.867 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -69.19 137.59 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.738 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -65.36 -38.63 90.66 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.062 -1.024 . . . . 0.0 112.721 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -59.35 -37.88 78.98 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.426 -0.796 . . . . 0.0 112.833 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.8 -35.27 76.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.27 0.628 . . . . 0.0 111.96 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -72.95 -37.9 66.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.237 -0.887 . . . . 0.0 113.235 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 14.2 m -64.45 -38.19 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.127 1.33 . . . . 0.0 111.285 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -63.79 -44.86 92.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.38 0.672 . . . . 0.0 111.948 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.1 98.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.303 0.954 . . . . 0.0 113.256 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.54 -36.06 65.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.464 1.132 . . . . 0.0 113.066 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -57.89 -41.57 82.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.406 1.003 . . . . 0.0 111.408 171.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.26 -47.56 81.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.603 1.161 . . . . 0.0 111.231 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -26.59 68.59 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.487 -1.383 . . . . 0.0 112.452 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.72 -46.62 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.982 1.713 . . . . 0.0 112.914 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -100.44 -58.49 1.89 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -63.57 -36.75 84.81 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.724 1.21 . . . . 0.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.58 48.37 21.51 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.245 2.218 . . . . 0.0 113.485 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 C--O 1.254 1.299 0 C-N-CA 126.541 1.936 . . . . 0.0 114.352 -176.361 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.86 -26.49 66.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.24 47.8 23.16 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.93 -74.22 0.14 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.382 0.673 . . . . 0.0 111.741 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 41.44 46.19 2.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.165 2.186 . . . . 0.0 114.266 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.43 36.26 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.447 1.899 . . . . 0.0 115.349 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.84 -22.32 62.34 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.349 -1.469 . . . . 0.0 112.206 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.03 -21.14 66.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.706 1.202 . . . . 0.0 113.699 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -126.77 21.81 6.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.535 1.534 . . . . 0.0 111.989 169.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 35.3 73.4 0.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.31 2.644 . . . . 0.0 114.504 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -113.1 58.17 0.63 Allowed Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 124.841 1.256 . . . . 0.0 114.209 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.27 169.44 18.27 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.22 2.613 . . . . 0.0 112.137 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -62.67 -15.26 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -96.88 2.1 51.31 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.476 1.51 . . . . 0.0 113.607 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 m -137.97 -17.95 1.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.18 173.19 11.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.8 p -105.63 159.43 15.97 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.051 0.941 . . . . 0.0 111.706 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -21.32 43.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.63 -37.52 70.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.617 1.099 . . . . 0.0 111.46 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -67.68 -23.29 65.29 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.128 -0.983 . . . . 0.0 112.628 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.53 -11.05 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.877 -1.139 . . . . 0.0 111.908 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -98.34 -11.02 22.95 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.269 1.428 . . . . 0.0 112.663 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.96 -30.96 44.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.151 0.98 . . . . 0.0 111.73 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.85 137.23 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.767 2.027 . . . . 0.0 111.07 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.26 158.24 26.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 113.198 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -53.81 -33.47 56.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.956 1.302 . . . . 0.0 111.974 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 m -60.83 -27.71 68.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 113.623 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -127.18 -2.26 6.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 113.408 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.45 -43.44 98.08 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 119.91 -1.744 . . . . 0.0 112.348 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.84 -25.95 82.18 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.851 2.368 . . . . 0.0 113.367 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 52.3 m -76.23 -34.76 59.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.061 0.944 . . . . 0.0 111.531 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.63 1.172 . . . . 0.0 113.348 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.88 -34.54 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.92 0.782 . . . . 0.0 110.436 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.1 -46.05 79.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.614 1.578 . . . . 0.0 114.902 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.6 -41.62 83.75 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 121.361 2.58 . . . . 0.0 111.953 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.14 98.78 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.474 0.71 . . . . 0.0 112.173 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -85.24 -38.65 18.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.308 0.643 . . . . 0.0 112.524 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.24 63.8 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.28 -1.512 . . . . 0.0 111.146 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.58 -18.24 61.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.123 0.569 . . . . 0.0 111.726 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -72.5 -21.71 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 113.029 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -98.04 -20.32 17.45 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.33 153.89 1.61 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 129.156 2.983 . . . . 0.0 106.56 -170.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.41 -17.92 19.39 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 128.836 2.854 . . . . 0.0 115.035 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -133.28 152.58 79.67 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.414 1.885 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -86.41 4.46 6.37 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.793 1.662 . . . . 0.0 114.503 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.15 -24.6 63.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.486 1.114 . . . . 0.0 112.439 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -111.36 15.38 21.37 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.536 1.934 . . . . 0.0 112.579 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.57 117.13 22.93 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 119.769 -1.832 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.28 107.92 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -57.32 126.77 28.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -165.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -98.01 52.25 1.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.422 1.489 . . . . 0.0 112.298 -170.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.24 -30.75 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.128 -0.983 . . . . 0.0 112.16 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -60.27 -34.78 74.21 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.256 1.389 . . . . 0.0 112.064 175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.31 -55.06 5.3 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.204 0.906 . . . . 0.0 112.835 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.19 -42.24 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.026 -1.279 . . . . 0.0 112.394 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.28 64.99 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.687 -1.258 . . . . 0.0 112.872 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -69.8 -44.07 70.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 0.0 111.616 172.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.5 -20.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -43.23 -62.51 1.33 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.751 1.62 . . . . 0.0 112.371 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.17 -0.6 6.66 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.743 2.962 . . . . 0.0 114.485 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.68 -61.37 1.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.743 1.617 . . . . 0.0 109.766 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.14 -35.01 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.72 0.808 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.94 -43.6 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.872 0.869 . . . . 0.0 112.217 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.53 -46.83 45.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.356 0.598 . . . . 0.0 110.164 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.02 72.06 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.885 0.874 . . . . 0.0 113.039 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -75.86 -13.26 60.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.61 -33.68 16.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.111 1.323 . . . . 0.0 111.072 167.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -59.67 -40.44 87.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.403 1.081 . . . . 0.0 111.714 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -138.95 71.72 1.39 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -51.99 -31.17 28.2 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.649 1.18 . . . . 0.0 113.149 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -92.32 1.29 57.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 113.067 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.59 150.98 42.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.083 0.953 . . . . 0.0 112.053 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -93.38 103.03 15.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.938 1.295 . . . . 0.0 112.451 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.258 14.7 p90 43.12 -144.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -53.88 -17.13 2.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.644 2.778 . . . . 0.0 115.176 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.13 -27.84 62.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.168 0.987 . . . . 0.0 112.41 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -65.99 -43.34 88.06 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.733 1.151 . . . . 0.0 112.42 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.99 -38.08 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.138 0.881 . . . . 0.0 111.126 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.07 -45.18 93.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.703 0.801 . . . . 0.0 111.874 171.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.82 -43.5 98.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.93 1.252 . . . . 0.0 113.261 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.96 -35.33 69.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.039 1.42 . . . . 0.0 112.754 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -61.48 -41.26 96.99 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.909 -1.119 . . . . 0.0 111.479 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.91 -46.43 89.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.649 1.18 . . . . 0.0 111.853 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -26.66 68.48 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.004 -1.06 . . . . 0.0 111.735 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 mt -81.69 -45.49 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.28 1.032 . . . . 0.0 112.351 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -104.42 -59.04 1.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.342 1.457 . . . . 0.0 113.217 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.08 -28.68 67.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.809 1.643 . . . . 0.0 113.631 -171.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.91 -56.6 4.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.774 0.829 . . . . 0.0 113.022 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.992 2.117 . . . . 0.0 110.966 178.264 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -82.86 -9.39 59.34 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.46 174.97 10.05 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.02 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 57.09 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.004 1.722 . . . . 0.0 114.051 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -96.26 28.51 3.22 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -169.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.11 -27.13 42.91 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.259 1.023 . . . . 0.0 112.42 171.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.79 152.53 43.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.491 1.917 . . . . 0.0 110.01 167.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -107.59 -19.04 13.68 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.308 1.443 . . . . 0.0 114.1 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -77.09 -9.77 58.95 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.733 -1.23 . . . . 0.0 113.521 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -74.63 -82.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.52 1.928 . . . . 0.0 115.777 -170.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -129.43 57.19 28.68 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.103 1.761 . . . . 0.0 114.585 -171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.48 157.85 6.51 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.178 2.585 . . . . 0.0 114.175 168.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -58.32 -22.98 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -79.12 -18.1 53.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.226 . . . . 0.0 114.147 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -127.4 -23.16 3.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.49 161.64 30.53 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.962 0.887 . . . . 0.0 112.845 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 50.1 p -93.99 167.2 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.646 1.212 . . . . 0.0 114.086 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.83 -26.55 66.98 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.08 -40.93 97.32 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.977 -1.077 . . . . 0.0 110.495 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.1 -31.4 72.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.106 0.563 . . . . 0.0 112.069 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -69.75 -26.75 64.46 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.47 -11.85 59.62 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.031 -1.043 . . . . 0.0 113.666 170.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.27 38.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.315 0.961 . . . . 0.0 112.866 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.51 141.91 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.045 1.738 . . . . 0.0 110.823 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.17 157.79 32.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.374 1.069 . . . . 0.0 113.346 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.34 -31.48 54.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.551 1.54 . . . . 0.0 112.04 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -61.54 -27.92 68.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.8 1.64 . . . . 0.0 114.079 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.62 -4.37 5.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.365 1.466 . . . . 0.0 112.697 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -57.02 -45.89 99.92 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 120.078 -1.639 . . . . 0.0 111.696 169.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -64.95 -22.52 62.69 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.356 2.038 . . . . 0.0 113.67 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 65.0 m -73.26 -35.81 66.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.988 0.915 . . . . 0.0 110.531 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.4 -41.91 84.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.04 -33.53 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.243 1.383 . . . . 0.0 110.875 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.94 -55.14 29.41 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 124.485 1.041 . . . . 0.0 111.912 168.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.76 -10.7 29.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 120.857 2.329 . . . . 0.0 114.408 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.15 -62.76 1.37 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.54 0.736 . . . . 0.0 110.051 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -73.43 -28.97 62.26 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.72 -1.237 . . . . 0.0 114.115 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.82 78.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.102 1.761 . . . . 0.0 112.274 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -37.79 19.26 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.737 1.215 . . . . 0.0 110.082 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -59.58 -38.67 81.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.59 1.156 . . . . 0.0 113.381 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -91.4 -9.59 44.17 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 -128.49 0.09 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.663 1.585 . . . . 0.0 110.974 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -162.6 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.279 1.431 . . . . 0.0 113.24 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -135.76 165.6 34.8 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 127.283 2.233 . . . . 0.0 109.834 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.08 2.09 8.72 Favored 'Trans proline' 0 C--N 1.354 0.868 0 CA-C-N 121.429 1.546 . . . . 0.0 114.136 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.22 -28.36 67.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.446 1.098 . . . . 0.0 112.6 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.93 -20.23 30.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.281 1.432 . . . . 0.0 113.306 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.62 123.9 24.91 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.021 -1.049 . . . . 0.0 112.983 -169.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.31 17.18 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 126.202 1.801 . . . . 0.0 110.897 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 52.63 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.983 3.713 . . . . 0.0 110.127 -166.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.14 48.77 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.488 . . . . 0.0 112.425 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.289 3.9 p -70.77 -11.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -169.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.26 -29.73 24.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.611 1.564 . . . . 0.0 112.921 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.68 -55.62 1.88 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.71 0.671 . . . . 0.0 113.128 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 10.1 mt -51.16 -45.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.8 1.24 . . . . 0.0 113.282 -172.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.29 -28.79 63.32 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.611 1.096 . . . . 0.0 112.848 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 18.8 m -73.38 -41.59 63.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.897 1.279 . . . . 0.0 111.908 170.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 34.4 t -78.81 -28.9 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.076 1.75 . . . . 0.0 112.89 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.0 m -51.75 -63.76 1.88 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 125.697 1.599 . . . . 0.0 113.144 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.23 -18.59 61.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.745 2.297 . . . . 0.0 113.219 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.7 -58.84 3.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.893 0.877 . . . . 0.0 110.802 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 31.8 mt -72.59 -28.92 28.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 O-C-N 121.372 -0.83 . . . . 0.0 112.402 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -51.1 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 110.618 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.22 -47.42 70.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.719 0.408 . . . . 0.0 110.903 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.09 71.18 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.739 -1.225 . . . . 0.0 113.239 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.3 m -75.35 -12.7 60.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.09 -35.55 16.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.483 1.492 . . . . 0.0 110.945 167.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -58.1 -38.13 75.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.009 0.924 . . . . 0.0 111.95 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.6 57.33 1.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.567 1.147 . . . . 0.0 112.85 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -52.12 -40.33 61.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.047 1.739 . . . . 0.0 112.968 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -80.53 -7.58 59.26 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.07 165.6 17.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.239 1.016 . . . . 0.0 112.657 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -62.57 138.79 58.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.851 1.261 . . . . 0.0 110.739 170.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.41 -43.7 88.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.253 1.021 . . . . 0.0 113.294 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -65.19 -30.53 71.44 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.224 -0.923 . . . . 0.0 112.446 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.69 -38.46 81.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.472 1.109 . . . . 0.0 112.128 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -39.57 72.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.87 0.868 . . . . 0.0 112.577 172.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.91 -47.03 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 118.594 0.634 . . . . 0.0 110.302 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.16 -50.06 65.24 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.466 1.106 . . . . 0.0 111.921 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.63 98.94 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.599 1.095 . . . . 0.0 113.779 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -73.96 -33.14 63.77 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.751 1.275 . . . . 0.0 112.584 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.81 -37.26 86.04 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.965 -1.084 . . . . 0.0 111.852 170.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.83 -46.77 86.36 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.352 -0.843 . . . . 0.0 111.048 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -23.18 66.41 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 119.91 -1.744 . . . . 0.0 112.609 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -78.05 -46.58 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.358 1.863 . . . . 0.0 112.74 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.43 -52.88 3.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.904 1.281 . . . . 0.0 113.203 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -68.8 -37.78 79.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.39 1.476 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.6 t0 51.52 49.76 20.24 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.471 1.908 . . . . 0.0 112.956 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.93 1.692 . . . . 0.0 113.267 -179.276 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -140.95 41.66 1.82 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.497 1.519 . . . . 0.0 110.461 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.67 147.9 20.64 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.006 1.323 . . . . 0.0 109.154 -169.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -169.63 -161.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.042 0.937 . . . . 0.0 111.417 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -68.82 -34.66 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.43 -96.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.704 1.602 . . . . 0.0 113.798 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.6 1.2 56.75 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.386 1.474 . . . . 0.0 114.544 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.9 -4.73 0.59 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.124 2.57 . . . . 0.0 116.169 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -130.68 5.15 4.65 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -169.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -90.7 -46.77 8.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -125.2 41.44 0.63 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.635 1.174 . . . . 0.0 113.549 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -65.83 153.97 75.9 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 112.426 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.81 -29.28 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.306 1.443 . . . . 0.0 114.507 -169.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.19 -15.96 57.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 114.13 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 t -110.95 -38.23 5.15 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 113.345 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -85.25 169.85 13.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.309 1.052 . . . . 0.0 113.597 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.5 p -99.93 161.15 13.79 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -19.51 49.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.572 1.949 . . . . 0.0 115.171 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.81 -34.98 70.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.792 1.178 . . . . 0.0 111.049 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.89 -26.53 68.65 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.081 -1.012 . . . . 0.0 112.802 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.66 -13.31 62.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.246 -0.909 . . . . 0.0 112.146 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.13 -19.36 18.72 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.644 1.178 . . . . 0.0 112.117 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.25 -37.45 32.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.759 1.224 . . . . 0.0 112.163 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.89 134.38 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 0.0 109.604 168.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.76 160.48 22.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 112.513 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.36 -36.63 73.76 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.134 -0.979 . . . . 0.0 111.788 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.6 m -59.65 -26.92 65.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.222 1.809 . . . . 0.0 113.728 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.45 -2.9 9.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.465 1.506 . . . . 0.0 112.76 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -59.07 -50.48 87.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 120.049 -1.657 . . . . 0.0 111.025 172.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -67.69 -16.85 47.34 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.294 1.996 . . . . 0.0 113.622 172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 m -75.75 -36.14 59.97 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.134 0.974 . . . . 0.0 110.912 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.18 83.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.464 1.106 . . . . 0.0 111.418 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.82 -47.41 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.257 1.023 . . . . 0.0 109.567 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 10.64 0.58 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.824 2.155 . . . . 0.0 117.209 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.64 -53.72 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.408 1.604 . . . . 0.0 109.945 167.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.7 85.11 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.221 -0.925 . . . . 0.0 112.655 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.3 -37.06 26.36 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.303 -0.873 . . . . 0.0 112.26 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.55 -49.21 72.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.993 -1.067 . . . . 0.0 111.778 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -18.32 61.03 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.956 0.902 . . . . 0.0 112.061 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -78.25 -21.97 49.06 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.062 -1.024 . . . . 0.0 112.916 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.69 -20.48 20.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.98 151.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.883 2.873 . . . . 0.0 106.969 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.95 -32.85 17.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.936 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -134.61 159.51 71.94 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 127.386 2.274 . . . . 0.0 109.736 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.2 15.92 2.05 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.698 1.599 . . . . 0.0 114.426 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -61.75 -21.96 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.935 1.294 . . . . 0.0 112.307 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.31 20.14 13.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.646 1.979 . . . . 0.0 112.438 173.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.85 109.38 16.93 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 119.493 -2.004 . . . . 0.0 110.875 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.94 8.03 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.038 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 49.17 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.518 3.927 . . . . 0.0 114.67 -172.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -89.46 64.51 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.028 1.331 . . . . 0.0 111.475 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -39.1 84.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.073 -171.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.91 -36.55 84.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.366 1.439 . . . . 0.0 112.415 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.48 -48.91 59.9 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.676 0.655 . . . . 0.0 112.029 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.15 -42.79 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.528 1.131 . . . . 0.0 111.745 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.68 62.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.891 1.676 . . . . 0.0 113.159 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.1 m -72.62 -37.88 67.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.826 1.25 . . . . 0.0 111.463 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.81 -24.33 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.373 1.469 . . . . 0.0 113.626 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.8 m -49.65 -62.93 2.01 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 125.665 1.586 . . . . 0.0 112.619 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.93 -4.21 11.99 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.402 2.735 . . . . 0.0 113.926 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.35 -64.56 1.16 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.364 1.466 . . . . 0.0 108.807 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.94 -27.59 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.269 -0.894 . . . . 0.0 112.028 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -55.51 -48.43 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.674 1.189 . . . . 0.0 110.727 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.34 -48.06 18.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.546 0.688 . . . . 0.0 110.544 174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.71 69.89 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -169.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.1 m -76.94 -13.39 59.98 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -32.82 21.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.426 1.466 . . . . 0.0 110.757 168.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -61.24 -38.61 87.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.739 0.815 . . . . 0.0 112.089 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -135.81 58.72 1.74 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.379 1.471 . . . . 0.0 112.814 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -50.75 -36.1 34.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.562 -1.337 . . . . 0.0 113.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.61 -3.77 58.12 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.995 1.318 . . . . 0.0 113.624 -172.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.34 161.56 23.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.264 1.026 . . . . 0.0 111.496 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -65.52 134.64 53.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.844 1.258 . . . . 0.0 111.412 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -66.06 -52.27 50.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.397 -0.815 . . . . 0.0 112.826 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -62.33 -34.16 76.09 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.576 1.08 . . . . 0.0 112.297 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.6 -36.24 82.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.476 0.71 . . . . 0.0 112.152 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.0 -34.29 68.76 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.54 -46.2 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.089 0.556 . . . . 0.0 110.018 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -62.59 -43.4 98.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.763 0.825 . . . . 0.0 112.185 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.92 -44.38 98.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.018 1.294 . . . . 0.0 113.545 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.19 -35.1 68.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.784 1.292 . . . . 0.0 112.864 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -61.99 -38.06 87.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.909 1.232 . . . . 0.0 112.127 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.68 -49.85 75.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.537 1.135 . . . . 0.0 111.214 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -28.54 69.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.371 -1.456 . . . . 0.0 112.458 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.0 mt -77.98 -43.9 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.816 1.246 . . . . 0.0 112.541 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -102.48 -58.92 1.79 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.96 1.304 . . . . 0.0 113.223 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -66.42 -36.56 83.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.221 1.408 . . . . 0.0 111.316 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.67 42.9 24.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.939 2.096 . . . . 0.0 113.402 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.3 ttm . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.45 1.5 . . . . 0.0 112.592 -179.787 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.31 -25.81 1.93 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.89 51.9 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.282 -0.886 . . . . 0.0 112.641 -170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 58.99 -48.02 0.06 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.374 2.67 . . . . 0.0 116.232 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -73.95 9.96 1.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -171.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.48 128.25 36.12 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.609 -0.682 . . . . 0.0 110.529 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.02 23.48 0.46 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.084 0.954 . . . . 0.0 113.088 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -59.04 -29.41 67.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.775 1.23 . . . . 0.0 113.708 -168.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -140.29 30.98 1.94 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.182 2.593 . . . . 0.0 108.64 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 60.6 -50.5 0.1 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 129.499 3.12 . . . . 0.0 115.278 -167.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 52.44 28.73 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 127.922 2.489 . . . . 0.0 117.432 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.26 158.32 54.89 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 122.838 2.049 . . . . 0.0 110.962 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.41 -24.46 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -70.85 -25.91 63.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.259 1.024 . . . . 0.0 113.445 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -126.82 -18.5 4.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.27 1.428 . . . . 0.0 114.73 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -86.68 170.59 11.66 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.013 1.725 . . . . 0.0 111.835 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.3 p -104.45 156.24 18.11 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.342 1.057 . . . . 0.0 113.142 -170.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.353 0.3 OUTLIER -73.63 -3.21 26.65 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.98 -31.6 65.22 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.851 -1.155 . . . . 0.0 111.353 168.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.38 -35.75 60.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.226 1.01 . . . . 0.0 112.754 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.25 -15.47 63.58 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.214 -0.929 . . . . 0.0 112.64 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.5 mt -92.2 -19.22 22.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.164 0.986 . . . . 0.0 112.764 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.48 -25.69 20.18 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.555 1.542 . . . . 0.0 112.954 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.93 -2.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 t70 66.12 157.85 0.11 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 128.232 2.613 . . . . 0.0 116.611 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -55.47 -35.21 65.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.155 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 30.4 m -69.04 -24.09 64.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -127.71 4.67 6.09 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.546 1.138 . . . . 0.0 112.547 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.84 -52.07 77.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 125.71 1.604 . . . . 0.0 111.998 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -61.52 -23.7 77.0 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.323 2.016 . . . . 0.0 113.573 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 23.2 m -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.007 1.323 . . . . 0.0 111.171 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.43 82.4 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.665 1.186 . . . . 0.0 113.793 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.5 -33.85 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 119.627 1.103 . . . . 0.0 110.458 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.8 -51.56 44.18 Favored Glycine 0 C--O 1.216 -0.973 0 C-N-CA 124.347 0.975 . . . . 0.0 112.795 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.65 -16.81 64.09 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.87 2.335 . . . . 0.0 113.862 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.78 -43.7 12.32 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.55 1.068 . . . . 0.0 112.211 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.55 -34.01 23.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.002 -1.061 . . . . 0.0 113.548 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.24 99.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.864 2.066 . . . . 0.0 112.69 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -34.19 34.47 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.242 1.017 . . . . 0.0 110.583 -175.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.09 -28.4 68.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -94.02 -1.73 54.05 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.53 -127.31 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.598 1.559 . . . . 0.0 111.248 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.26 -55.67 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.604 1.562 . . . . 0.0 113.513 -170.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -136.41 162.32 57.02 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 126.763 2.025 . . . . 0.0 110.446 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.31 6.01 5.05 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.729 1.619 . . . . 0.0 114.979 -174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.0 -29.37 43.03 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.944 0.898 . . . . 0.0 111.496 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -112.32 17.67 19.21 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.215 2.206 . . . . 0.0 113.117 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.94 134.78 38.54 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.174 -1.579 . . . . 0.0 113.955 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.41 -4.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.013 1.325 . . . . 0.0 113.828 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.26 119.16 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.878 2.471 . . . . 0.0 111.52 -167.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -81.95 53.25 2.15 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 119.608 -1.932 . . . . 0.0 112.016 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.404 0.6 OUTLIER -65.38 -46.9 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -163.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -60.54 -34.38 74.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.909 2.14 . . . . 0.0 111.783 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.35 -48.93 48.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.188 0.899 . . . . 0.0 112.424 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.21 -42.18 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 111.443 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.54 71.2 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.682 1.128 . . . . 0.0 112.817 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -66.35 -38.89 88.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.709 1.204 . . . . 0.0 111.682 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.6 -30.36 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.508 1.523 . . . . 0.0 113.212 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 37.0 m -45.19 -56.11 9.95 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 -7.59 16.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.445 2.763 . . . . 0.0 114.593 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -61.97 1.69 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.099 1.36 . . . . 0.0 111.658 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -20.18 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 120.884 -1.135 . . . . 0.0 113.972 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.39 -41.88 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.581 1.537 . . . . 0.0 112.018 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.01 -51.25 10.63 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 110.436 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.14 69.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.361 -1.462 . . . . 0.0 113.38 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 78.9 m -80.17 -7.37 58.91 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.73 -34.56 14.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.341 1.056 . . . . 0.0 110.44 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -60.91 -39.7 90.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.517 1.127 . . . . 0.0 112.229 171.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -142.49 54.85 1.42 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.948 0.899 . . . . 0.0 112.906 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -53.73 -37.24 63.13 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.427 1.891 . . . . 0.0 113.302 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.71 -8.85 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.842 1.257 . . . . 0.0 113.84 -169.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -83.88 166.81 17.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 112.078 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.57 139.0 56.49 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.172 1.389 . . . . 0.0 112.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -63.79 -46.97 82.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.564 1.146 . . . . 0.0 111.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -64.03 -38.52 91.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.854 0.862 . . . . 0.0 112.188 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.926 0.89 . . . . 0.0 111.952 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' B' ' 166' ' ' LYS . 0.1 OUTLIER -71.94 -43.39 65.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.189 -0.91 . . . . 0.0 113.234 174.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.37 -40.41 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.182 1.355 . . . . 0.0 111.669 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.11 -42.99 93.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.875 0.87 . . . . 0.0 112.258 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.2 -45.3 96.81 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.312 0.958 . . . . 0.0 112.983 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.77 -33.74 64.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.485 1.142 . . . . 0.0 112.973 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -59.43 -41.83 90.45 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.862 1.21 . . . . 0.0 111.943 170.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.51 -47.26 84.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.562 1.145 . . . . 0.0 111.943 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.36 68.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.161 -0.962 . . . . 0.0 112.061 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.49 -50.89 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.886 1.674 . . . . 0.0 112.175 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -100.79 -59.71 1.65 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.33 1.452 . . . . 0.0 113.322 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -67.66 -25.2 65.59 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.245 1.818 . . . . 0.0 113.749 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.1 -19.55 65.66 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.393 1.477 . . . . 0.0 114.307 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.121 1.768 . . . . 0.0 114.574 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.82 -14.63 31.5 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.16 177.58 8.87 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.147 1.379 . . . . 0.0 111.222 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 62.69 -54.6 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.171 2.588 . . . . 0.0 115.238 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -78.5 -11.36 59.95 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.202 1.001 . . . . 0.0 113.266 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.91 -76.12 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.294 3.037 . . . . 0.0 116.505 168.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.38 90.86 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.952 0.796 . . . . 0.0 111.951 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.03 -34.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 129.452 3.101 . . . . 0.0 118.072 171.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -80.62 -1.05 40.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.279 1.432 . . . . 0.0 114.148 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.52 -175.5 4.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.563 1.945 . . . . 0.0 112.791 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 59.35 49.45 2.52 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 127.324 2.25 . . . . 0.0 114.927 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.53 163.95 37.33 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.669 2.912 . . . . 0.0 112.434 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.97 -20.08 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.107 1.363 . . . . 0.0 114.417 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -72.7 -35.31 67.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.105 0.962 . . . . 0.0 113.523 173.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 m -110.5 -21.89 11.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.769 1.227 . . . . 0.0 114.112 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -94.37 171.27 8.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.2 1.4 . . . . 0.0 112.219 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.5 p -107.5 166.21 10.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.838 1.304 . . . . 0.0 114.498 -168.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -19.18 35.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.983 1.713 . . . . 0.0 115.436 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.49 -32.81 63.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.92 1.236 . . . . 0.0 111.365 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.83 -32.21 67.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.939 0.896 . . . . 0.0 112.728 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -74.05 -14.68 61.04 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.81 -0.556 . . . . 0.0 112.142 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.0 mt -96.45 -18.89 19.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.47 1.108 . . . . 0.0 112.281 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.76 54.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.425 1.09 . . . . 0.0 111.951 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.41 138.29 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.563 1.545 . . . . 0.0 110.652 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.23 160.51 31.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.287 1.035 . . . . 0.0 112.987 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.23 -37.43 74.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.696 1.198 . . . . 0.0 111.786 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.67 -20.84 63.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.526 1.53 . . . . 0.0 113.873 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -126.73 -2.91 6.62 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.237 1.415 . . . . 0.0 113.001 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -55.51 -47.71 98.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.143 -1.598 . . . . 0.0 111.91 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -62.45 -23.06 74.81 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.764 2.31 . . . . 0.0 113.804 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -77.02 -36.79 56.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.749 1.22 . . . . 0.0 110.977 175.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.45 98.44 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 113.519 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.91 -35.77 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 119.417 1.008 . . . . 0.0 110.329 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.54 -48.19 49.79 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.327 1.441 . . . . 0.0 114.571 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.44 -39.69 89.05 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 121.253 2.526 . . . . 0.0 112.306 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.54 76.16 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.467 -0.771 . . . . 0.0 112.528 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -85.22 -38.81 18.51 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.06 -52.52 62.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.37 1.068 . . . . 0.0 110.878 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -18.24 64.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.503 1.121 . . . . 0.0 111.732 -177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -80.17 -17.46 52.36 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.209 1.004 . . . . 0.0 113.386 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.27 3.3 p30 -123.39 11.12 9.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 150.21 1.49 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 129.73 3.212 . . . . 0.0 106.504 168.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -86.41 -31.8 21.24 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 128.563 2.745 . . . . 0.0 113.204 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.59 158.09 73.9 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 127.518 2.327 . . . . 0.0 109.375 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.35 5.58 6.17 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.023 1.401 . . . . 0.0 114.046 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.7 -16.36 63.32 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.603 -1.311 . . . . 0.0 112.724 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -103.58 3.98 35.19 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.339 1.855 . . . . 0.0 113.22 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.69 122.67 26.28 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 119.981 -1.699 . . . . 0.0 112.654 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.53 -7.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 125.161 1.384 . . . . 0.0 112.271 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 62.53 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.826 3.25 . . . . 0.0 113.224 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.07 58.17 4.04 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.775 1.23 . . . . 0.0 111.453 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.6 p -65.94 -22.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.995 -1.066 . . . . 0.0 113.459 -169.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -62.85 -49.82 73.36 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 121.157 1.799 . . . . 0.0 112.076 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.23 76.8 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.3 -44.26 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.281 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.4 68.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.95 1.705 . . . . 0.0 112.858 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 m -68.77 -36.58 78.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.5 t -90.8 -23.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.109 1.363 . . . . 0.0 113.523 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -44.27 -60.46 2.82 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 126.211 1.804 . . . . 0.0 112.477 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.5 -0.61 5.35 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.328 2.685 . . . . 0.0 114.462 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 -64.6 1.12 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.215 1.406 . . . . 0.0 110.584 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -29.29 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.234 -0.916 . . . . 0.0 112.313 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 t -52.74 -48.33 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.988 1.315 . . . . 0.0 110.488 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.74 -47.88 11.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.435 0.636 . . . . 0.0 110.609 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.85 69.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.1 m -77.8 -12.05 59.94 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -33.64 16.66 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.133 1.333 . . . . 0.0 110.764 167.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -58.78 -38.63 78.93 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.507 1.123 . . . . 0.0 112.116 172.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -145.55 85.5 1.71 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.715 0.806 . . . . 0.0 112.293 170.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -57.73 -27.94 63.44 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.973 1.309 . . . . 0.0 112.505 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -92.26 -4.75 53.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.551 1.541 . . . . 0.0 112.943 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.54 154.37 41.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.542 1.137 . . . . 0.0 111.346 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -65.72 137.24 57.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.089 0.956 . . . . 0.0 111.544 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.04 -47.43 80.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.676 0.791 . . . . 0.0 112.64 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -61.69 -41.2 97.26 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.96 0.904 . . . . 0.0 111.479 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.28 -34.35 77.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.665 0.786 . . . . 0.0 112.34 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.58 -42.17 68.1 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.748 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.22 -38.53 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.159 1.345 . . . . 0.0 111.203 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -63.28 -45.1 93.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.179 0.592 . . . . 0.0 111.837 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.32 -44.71 97.28 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.958 1.266 . . . . 0.0 113.422 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.44 -35.41 70.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.972 1.386 . . . . 0.0 112.967 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -62.49 -41.26 98.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.644 1.111 . . . . 0.0 111.651 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.17 -48.82 80.12 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.788 1.235 . . . . 0.0 111.479 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.22 72.22 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.815 -1.178 . . . . 0.0 111.678 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt -76.93 -46.07 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.307 1.043 . . . . 0.0 112.375 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -101.89 -57.54 2.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.045 1.338 . . . . 0.0 113.136 -172.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.47 -34.94 79.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.88 1.272 . . . . 0.0 111.686 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t0 48.57 51.19 15.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.984 2.114 . . . . 0.0 112.828 171.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.459 1.904 . . . . 0.0 113.68 -175.178 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -106.08 -37.13 6.71 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -168.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.06 47.94 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.78 140.4 48.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 49.87 41.43 22.61 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.522 1.529 . . . . 0.0 114.62 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.35 45.69 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.253 0.621 . . . . 0.0 111.686 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.37 12.32 2.48 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -76.34 -22.14 55.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.88 1.272 . . . . 0.0 112.67 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.68 52.42 1.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.768 2.427 . . . . 0.0 107.585 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -47.99 122.72 5.36 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.83 72.42 52.86 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 127.865 2.466 . . . . 0.0 108.014 168.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.57 -176.96 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.66 2.907 . . . . 0.0 113.05 -171.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.35 0.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -108.24 15.57 24.0 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.279 1.832 . . . . 0.0 112.652 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 28.4 m -144.08 -43.83 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.52 120.17 32.1 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.301 0.955 . . . . 0.0 111.726 -174.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -71.04 169.23 15.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.045 1.738 . . . . 0.0 114.41 -169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -24.88 17.74 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.0 -35.75 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.907 1.231 . . . . 0.0 111.578 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.33 -20.68 58.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.198 0.999 . . . . 0.0 113.208 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -67.66 -25.22 65.6 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.086 -1.009 . . . . 0.0 111.292 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.35 -13.85 56.24 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.335 1.054 . . . . 0.0 113.17 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.04 -36.36 30.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.388 1.075 . . . . 0.0 113.07 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.07 139.47 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.052 1.341 . . . . 0.0 110.212 169.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.81 160.48 30.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.466 1.106 . . . . 0.0 113.289 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -58.98 -34.87 72.32 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 0.0 111.885 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -62.37 -22.1 65.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.547 1.539 . . . . 0.0 113.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -127.3 -3.13 6.25 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -60.95 -45.85 96.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 O-C-N 119.957 -1.714 . . . . 0.0 111.937 170.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.28 -28.92 85.35 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.004 2.469 . . . . 0.0 113.13 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 61.1 m -70.15 -38.49 75.48 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.487 1.115 . . . . 0.0 110.743 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.08 95.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.172 1.389 . . . . 0.0 114.457 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.74 -33.41 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 119.984 1.266 . . . . 0.0 110.824 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.99 -55.28 26.72 Favored Glycine 0 C--O 1.217 -0.937 0 C-N-CA 124.292 0.949 . . . . 0.0 112.65 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -64.81 -11.36 36.26 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.504 2.152 . . . . 0.0 114.386 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.61 -62.64 1.44 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.84 0.745 . . . . 0.0 110.169 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.46 -27.16 58.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.57 89.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.634 1.573 . . . . 0.0 112.069 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -38.63 22.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.828 1.251 . . . . 0.0 110.241 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -59.42 -33.18 70.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.792 1.237 . . . . 0.0 113.603 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.34 -11.49 37.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -143.51 -123.31 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.66 1.118 . . . . 0.0 113.744 -171.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.95 -68.89 0.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.894 1.278 . . . . 0.0 112.94 -168.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -139.38 167.01 20.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 127.588 2.355 . . . . 0.0 109.4 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.18 6.26 4.82 Favored 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.331 1.868 . . . . 0.0 114.439 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.76 -19.98 64.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.391 1.477 . . . . 0.0 111.434 168.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -113.12 11.63 18.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.854 2.062 . . . . 0.0 113.378 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.05 129.74 35.62 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 119.991 -1.693 . . . . 0.0 113.301 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.11 -6.05 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 125.03 1.332 . . . . 0.0 113.143 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 61.21 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.855 3.262 . . . . 0.0 112.96 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.13 60.35 1.19 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.361 -1.462 . . . . 0.0 111.849 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.297 2.4 p -66.11 -21.57 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.75 -1.219 . . . . 0.0 113.225 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.673 1.579 . . . . 0.0 112.522 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.44 -50.36 26.84 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mt -61.7 -43.21 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.642 0.777 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.67 -28.46 64.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.548 1.522 . . . . 0.0 112.491 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 39.0 m -68.7 -42.67 77.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.112 0.965 . . . . 0.0 111.698 169.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.24 -26.91 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.796 1.638 . . . . 0.0 113.503 -172.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.2 m -50.51 -63.38 1.88 Allowed Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 126.184 1.793 . . . . 0.0 113.087 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.52 -25.89 70.06 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.924 1.75 . . . . 0.0 112.334 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -57.83 9.85 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.447 1.099 . . . . 0.0 110.341 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.96 -31.92 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.442 -0.786 . . . . 0.0 111.957 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.71 -51.15 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.351 1.061 . . . . 0.0 110.393 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.35 -45.99 68.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.767 0.317 . . . . 0.0 111.159 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.19 -30.75 71.84 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.658 -1.276 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 29.2 m -73.85 -12.71 60.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -37.48 14.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.507 1.503 . . . . 0.0 110.78 166.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -57.3 -40.4 77.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.958 0.903 . . . . 0.0 111.806 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -142.15 72.71 1.38 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.481 1.112 . . . . 0.0 111.027 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -53.42 -31.06 43.4 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.116 1.766 . . . . 0.0 112.923 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.98 1.91 51.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.071 1.348 . . . . 0.0 113.114 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.41 152.98 36.66 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 114.305 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.18 59.27 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.351 1.86 . . . . 0.0 113.334 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 46.0 -103.73 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 165.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -47.07 -33.34 4.81 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.682 2.393 . . . . 0.0 113.716 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.0 -36.52 79.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.084 . . . . 0.0 112.807 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.4 -33.34 63.0 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.238 -0.914 . . . . 0.0 112.353 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.5 -48.79 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.709 0.803 . . . . 0.0 110.121 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.08 -42.81 99.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.979 0.911 . . . . 0.0 112.172 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.4 94.55 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.85 1.214 . . . . 0.0 113.48 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.61 -35.36 67.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.561 1.18 . . . . 0.0 112.608 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -60.66 -37.66 82.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.609 1.095 . . . . 0.0 112.216 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.77 -45.56 92.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.324 1.05 . . . . 0.0 111.933 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -24.45 67.24 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.584 -1.322 . . . . 0.0 112.438 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.41 -46.04 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.517 1.927 . . . . 0.0 112.821 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.07 -59.97 1.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.193 1.397 . . . . 0.0 113.45 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -64.83 -25.77 68.05 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.182 1.793 . . . . 0.0 113.553 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.45 -24.17 67.11 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--O 1.255 1.369 0 C-N-CA 127.64 2.376 . . . . 0.0 114.428 177.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.08 -33.78 2.17 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.79 148.51 50.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.686 -1.259 . . . . 0.0 112.003 -172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 68.73 -31.39 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 127.666 2.386 . . . . 0.0 114.247 -170.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.23 -38.49 51.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.246 1.418 . . . . 0.0 111.315 171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.52 -19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 130.8 3.64 . . . . 0.0 118.39 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.46 -7.7 1.72 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.655 1.582 . . . . 0.0 114.819 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 60.25 -36.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.129 2.972 . . . . 0.0 117.622 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.55 -12.15 59.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.504 1.121 . . . . 0.0 112.866 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.79 168.98 10.32 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.584 1.954 . . . . 0.0 112.087 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 mttt 60.06 28.64 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.78 150.75 56.49 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.408 1.896 . . . . 0.0 111.81 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.9 5.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.833 1.653 . . . . 0.0 115.031 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -122.27 11.24 10.06 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.027 2.131 . . . . 0.0 113.914 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 m -141.02 -27.79 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -175.27 4.03 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -171.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.6 p -119.93 164.69 15.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.19 1.396 . . . . 0.0 114.391 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.12 -19.86 55.57 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.44 -37.14 79.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.228 1.376 . . . . 0.0 111.465 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.72 -20.3 63.53 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.377 -0.827 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -67.02 -18.45 65.37 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.874 -1.141 . . . . 0.0 111.631 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.12 -6.75 41.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.193 1.397 . . . . 0.0 112.704 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.94 -34.1 17.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.648 1.179 . . . . 0.0 112.04 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.0 137.75 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.016 1.326 . . . . 0.0 109.954 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.27 160.25 29.69 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.184 0.993 . . . . 0.0 112.804 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -58.44 -36.58 73.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 m -62.08 -21.87 65.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.653 1.581 . . . . 0.0 113.743 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -126.27 -3.57 6.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.575 1.55 . . . . 0.0 112.684 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -59.46 -46.58 98.85 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 120.103 -1.623 . . . . 0.0 110.996 171.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -28.33 87.2 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.195 2.597 . . . . 0.0 113.564 169.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 m -72.27 -35.6 68.8 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.034 0.934 . . . . 0.0 111.423 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.26 81.35 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.819 1.248 . . . . 0.0 113.927 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -36.69 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 119.377 0.989 . . . . 0.0 110.845 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.52 63.58 Favored Glycine 0 C--O 1.214 -1.11 0 C-N-CA 124.326 0.965 . . . . 0.0 112.826 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.11 -18.09 65.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 121.276 2.538 . . . . 0.0 113.988 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.37 -57.72 3.04 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.471 0.578 . . . . 0.0 110.444 165.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -76.46 -21.24 56.14 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.18 94.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.344 1.458 . . . . 0.0 111.107 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -40.15 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.509 1.123 . . . . 0.0 110.642 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -62.18 -30.09 70.82 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -93.41 -5.31 49.68 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -124.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.005 1.322 . . . . 0.0 112.274 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -161.79 -58.3 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.24 1.416 . . . . 0.0 113.932 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.14 162.43 48.0 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 127.615 2.366 . . . . 0.0 110.678 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.22 -1.77 11.96 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.811 1.674 . . . . 0.0 114.693 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -54.91 -27.87 46.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.893 1.277 . . . . 0.0 113.423 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -95.54 -11.27 27.67 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.098 1.359 . . . . 0.0 113.846 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 121.78 26.24 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.674 -1.266 . . . . 0.0 113.754 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.44 9.96 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 125.41 1.484 . . . . 0.0 111.701 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? 59.99 121.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.591 3.156 . . . . 0.0 111.992 -168.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -87.11 45.62 1.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.619 -1.301 . . . . 0.0 111.963 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 3.0 p -66.19 -22.22 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.234 -1.541 . . . . 0.0 112.182 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.86 -33.5 66.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.845 1.258 . . . . 0.0 112.552 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.15 -59.56 1.94 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.619 1.104 . . . . 0.0 112.097 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.56 -44.77 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.709 -1.465 . . . . 0.0 112.949 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.97 -27.21 64.54 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.275 1.398 . . . . 0.0 112.435 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -66.96 -46.38 74.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.27 1.428 . . . . 0.0 111.955 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.12 -18.08 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 m -42.52 -59.32 2.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 C-N-CA 125.676 1.591 . . . . 0.0 112.588 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.65 -2.69 9.77 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.352 2.701 . . . . 0.0 114.539 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.81 -58.1 2.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.959 1.304 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -36.5 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 120.489 1.495 . . . . 0.0 112.123 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.5 -49.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.821 1.248 . . . . 0.0 110.62 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.98 -45.52 34.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.655 0.741 . . . . 0.0 110.986 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.78 70.02 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.781 0.832 . . . . 0.0 112.954 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.3 m -75.48 -13.2 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 170.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.13 -36.09 18.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.797 1.635 . . . . 0.0 110.516 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -57.02 -38.65 73.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.253 1.021 . . . . 0.0 111.813 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -144.92 84.55 1.72 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.534 0.683 . . . . 0.0 111.768 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -54.98 -31.34 60.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.105 1.362 . . . . 0.0 112.188 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.68 -0.93 57.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.272 1.429 . . . . 0.0 112.909 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.65 144.58 56.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.252 1.021 . . . . 0.0 111.72 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -77.75 160.89 28.1 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.377 1.084 . . . . 0.0 113.669 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -40.58 151.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.563 2.745 . . . . 0.0 115.13 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt 62.03 -38.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 129.487 3.115 . . . . 0.0 116.309 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.73 -31.86 70.01 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.846 1.659 . . . . 0.0 112.174 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -69.67 -43.91 71.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.71 -0.619 . . . . 0.0 112.509 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.03 -36.69 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.763 1.165 . . . . 0.0 111.459 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.15 -46.05 78.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.274 1.029 . . . . 0.0 111.949 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.87 96.97 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.824 1.202 . . . . 0.0 113.1 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -25.93 59.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.846 -1.385 . . . . 0.0 113.485 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -70.93 -42.32 70.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.479 -0.763 . . . . 0.0 111.248 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -58.23 -42.89 87.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.205 1.402 . . . . 0.0 111.68 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.18 -38.8 27.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.483 1.913 . . . . 0.0 114.212 170.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt -90.74 -42.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.241 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -102.96 -60.0 1.62 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 113.349 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -68.4 -25.65 65.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.347 1.459 . . . . 0.0 113.662 -171.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.99 -21.97 66.44 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.769 1.228 . . . . 0.0 114.07 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 125.198 1.399 . . . . 0.0 112.226 178.155 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -145.93 34.11 1.01 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.641 1.576 . . . . 0.0 111.005 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.38 146.0 24.17 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.256 18.4 pt20 40.54 -47.14 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 1 C-N-CA 132.962 4.505 . . . . 0.0 121.418 171.805 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -10.25 59.58 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.102 1.774 . . . . 0.0 115.04 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.31 -26.49 68.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.07 -26.37 56.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.63 -36.16 0.19 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.843 2.457 . . . . 0.0 116.184 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -77.29 42.63 0.35 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.567 1.947 . . . . 0.0 112.05 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -93.4 174.17 7.34 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 128.233 2.613 . . . . 0.0 115.277 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.68 89.2 7.31 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 127.342 2.257 . . . . 0.0 110.276 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.84 168.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 1 C-N-CA 126.24 4.627 . . . . 0.0 114.798 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.57 -21.26 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -74.33 -19.99 60.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.688 1.195 . . . . 0.0 113.565 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 70.0 m -122.46 -20.86 5.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.849 2.46 . . . . 0.0 113.953 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -53.09 140.97 24.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.367 2.667 . . . . 0.0 111.556 172.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -98.6 168.12 10.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.869 1.319 . . . . 0.0 112.866 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.36 -28.35 67.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.035 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -61.22 -43.58 98.64 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.078 -1.014 . . . . 0.0 110.327 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -66.64 -30.11 70.29 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.449 0.7 . . . . 0.0 112.139 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.409 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 73.7 t80 -67.69 -31.87 72.13 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.317 -1.489 . . . . 0.0 111.751 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.78 -9.3 58.48 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.03 44.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.769 1.168 . . . . 0.0 112.353 172.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.42 135.18 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.663 1.585 . . . . 0.0 110.145 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.22 157.77 34.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.375 1.07 . . . . 0.0 112.888 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.28 -34.26 72.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.271 1.028 . . . . 0.0 111.851 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.3 m -61.24 -25.55 67.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.421 1.888 . . . . 0.0 113.973 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.0 -6.11 7.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.246 1.018 . . . . 0.0 113.73 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.86 -43.49 98.66 Favored Pre-proline 0 N--CA 1.476 0.858 0 O-C-N 120.204 -1.56 . . . . 0.0 113.389 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -61.71 -27.73 81.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.932 2.421 . . . . 0.0 113.046 170.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 26.2 m -74.24 -36.84 63.92 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.903 1.281 . . . . 0.0 111.294 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.19 93.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.015 1.326 . . . . 0.0 113.996 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.06 -33.07 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 119.422 1.01 . . . . 0.0 110.767 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.54 -51.08 50.49 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 125.492 1.52 . . . . 0.0 114.099 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.43 -32.78 74.59 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.283 2.542 . . . . 0.0 112.419 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.46 -54.02 19.7 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.046 0.839 . . . . 0.0 111.21 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.44 -22.59 40.98 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.63 -46.19 32.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.594 1.158 . . . . 0.0 111.056 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -33.99 59.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.009 -176.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -73.13 -10.3 59.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -101.61 -11.27 19.35 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.61 -129.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.084 1.354 . . . . 0.0 112.303 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -161.64 -51.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.141 1.776 . . . . 0.0 113.189 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -132.66 166.93 25.42 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.339 2.256 . . . . 0.0 109.757 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.87 12.43 2.87 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 114.183 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.78 -14.62 62.86 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.679 -1.263 . . . . 0.0 113.934 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -119.89 4.68 10.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 113.518 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.29 134.2 41.13 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.911 -1.118 . . . . 0.0 113.605 -169.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.37 136.6 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.902 2.081 . . . . 0.0 107.317 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.28 119.95 11.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.461 1.028 . . . . 0.0 109.163 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.4 54.65 3.23 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.698 -1.251 . . . . 0.0 110.996 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 1.5 p -67.03 -25.03 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -165.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -63.04 -41.63 99.56 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 121.161 1.801 . . . . 0.0 111.133 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.08 -49.31 34.73 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 123.984 0.802 . . . . 0.0 111.416 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.22 -43.18 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.869 0.868 . . . . 0.0 111.533 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.15 -31.75 68.08 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 120.253 1.388 . . . . 0.0 112.726 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m -65.36 -42.84 92.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.097 0.959 . . . . 0.0 111.568 170.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -82.73 -29.41 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.978 1.311 . . . . 0.0 113.047 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.6 m -43.48 -61.05 2.06 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 126.113 1.765 . . . . 0.0 113.77 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.16 -14.44 44.35 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.577 2.185 . . . . 0.0 113.367 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.66 -63.47 1.16 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.131 0.972 . . . . 0.0 110.838 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -25.53 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.05 -1.031 . . . . 0.0 113.141 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.69 -51.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.605 1.093 . . . . 0.0 110.753 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.39 -47.21 51.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.935 0.397 . . . . 0.0 111.057 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.54 -28.32 69.08 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.662 -1.274 . . . . 0.0 113.175 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.96 -15.89 60.09 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 169.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -30.32 21.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 111.202 168.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -61.23 -38.38 86.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.875 0.87 . . . . 0.0 112.535 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.68 88.16 1.68 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.636 0.774 . . . . 0.0 111.922 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.93 -41.91 68.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.356 1.462 . . . . 0.0 111.579 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -79.51 -3.24 45.85 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.8 153.07 44.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.012 0.925 . . . . 0.0 112.071 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.69 134.0 46.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 0.0 109.333 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.409 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 46.2 t80 -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.289 -0.882 . . . . 0.0 112.663 -175.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -62.67 -40.14 96.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.209 0.913 . . . . 0.0 111.588 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.31 -38.97 93.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.557 0.743 . . . . 0.0 111.913 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.72 -37.14 73.48 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.953 0.797 . . . . 0.0 113.027 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.45 -48.33 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.173 0.989 . . . . 0.0 110.116 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -64.07 -47.36 80.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.989 0.916 . . . . 0.0 112.011 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.91 99.39 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.627 1.108 . . . . 0.0 113.269 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -73.12 -35.83 66.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.225 -1.162 . . . . 0.0 112.792 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -60.53 -38.16 83.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.633 1.106 . . . . 0.0 111.881 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.87 -44.68 96.32 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.395 -0.815 . . . . 0.0 111.611 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -19.33 65.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.838 -1.164 . . . . 0.0 112.558 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.3 -41.48 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.466 1.906 . . . . 0.0 112.973 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.92 -60.51 1.74 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.796 1.239 . . . . 0.0 113.441 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -62.68 -29.66 70.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.022 1.329 . . . . 0.0 113.468 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.2 -15.43 61.01 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 C--O 1.255 1.384 0 C-N-CA 124.96 1.304 . . . . 0.0 113.629 -172.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 55.6 -11.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 120.802 3.63 . . . . 0.0 120.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.58 27.16 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 121.575 1.989 . . . . 0.0 114.718 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.55 12.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.082 1.353 . . . . 0.0 112.854 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -123.68 28.86 6.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.363 1.865 . . . . 0.0 112.829 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.44 69.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.564 1.145 . . . . 0.0 113.548 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.87 88.19 6.35 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -73.52 49.77 0.3 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.184 2.194 . . . . 0.0 113.503 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -151.88 -25.29 0.19 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.739 1.616 . . . . 0.0 115.176 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER -94.43 -21.63 18.81 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 119.965 3.321 . . . . 0.0 119.965 -166.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -131.99 53.47 11.44 Favored Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 171.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.91 156.32 66.35 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.071 2.514 . . . . 0.0 114.035 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.53 -12.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -104.76 -4.26 22.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.318 1.447 . . . . 0.0 114.807 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -124.36 -28.31 3.67 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -92.5 151.84 19.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.151 0.977 . . . . 0.0 111.484 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -85.47 170.07 13.01 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.49 -18.78 3.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.845 1.658 . . . . 0.0 114.732 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -51.7 -28.99 16.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 111.961 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -46.35 -42.06 14.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.206 1.402 . . . . 0.0 113.178 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.32 -15.25 61.89 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.98 -18.11 17.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.02 1.328 . . . . 0.0 111.799 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.92 -37.46 22.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.501 1.52 . . . . 0.0 112.374 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.49 137.72 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.593 1.557 . . . . 0.0 110.744 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.59 159.56 31.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 112.923 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.85 -36.19 74.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.889 -1.132 . . . . 0.0 111.97 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -60.43 -25.53 66.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.732 1.613 . . . . 0.0 113.857 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -124.33 -2.41 8.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.591 1.556 . . . . 0.0 112.96 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -53.92 -46.72 98.45 Favored Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 120.28 -1.513 . . . . 0.0 111.794 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -70.71 -16.42 33.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.226 1.951 . . . . 0.0 113.459 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.2 m -75.74 -33.84 60.28 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.047 -1.033 . . . . 0.0 111.136 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.51 82.0 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.406 -0.809 . . . . 0.0 111.569 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 t -59.1 -49.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.388 1.075 . . . . 0.0 109.031 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.8 19.1 0.32 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 126.321 1.915 . . . . 0.0 116.874 172.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.56 -63.14 1.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.404 1.881 . . . . 0.0 109.101 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.96 93.16 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.158 -0.964 . . . . 0.0 112.337 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -86.52 -28.82 23.14 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.708 -0.62 . . . . 0.0 112.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.05 -48.12 81.65 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.36 -1.462 . . . . 0.0 112.013 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -26.78 60.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.268 0.627 . . . . 0.0 111.302 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.82 -26.44 68.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.617 1.167 . . . . 0.0 113.672 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.85 -1.22 43.56 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -171.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -125.61 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.757 1.623 . . . . 0.0 111.255 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -167.14 -46.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.363 2.265 . . . . 0.0 112.399 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -129.36 165.69 30.85 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 127.991 2.517 . . . . 0.0 109.938 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.74 15.73 2.14 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.231 1.954 . . . . 0.0 114.527 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -61.36 -33.44 73.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.376 1.07 . . . . 0.0 112.071 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.22 23.91 11.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.478 1.911 . . . . 0.0 113.575 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 118.2 19.42 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.613 -1.305 . . . . 0.0 110.827 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 t -106.91 -11.31 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.218 1.007 . . . . 0.0 113.101 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 64.91 113.24 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.946 2.498 . . . . 0.0 111.164 -168.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -95.1 64.05 2.72 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.337 5.2 p -70.45 -21.66 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 111.74 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -54.11 -48.8 70.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.981 0.81 . . . . 0.0 110.991 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.98 -52.16 5.48 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.9 mt -56.83 -46.25 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.35 69.55 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.277 1.399 . . . . 0.0 112.781 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.3 m -78.24 -34.81 48.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.104 1.362 . . . . 0.0 112.098 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.29 -19.9 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.713 1.605 . . . . 0.0 112.77 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.8 m -43.77 -61.07 2.14 Favored Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 126.235 1.814 . . . . 0.0 112.866 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.31 -0.19 6.19 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.329 2.686 . . . . 0.0 114.348 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.56 -64.23 1.18 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.885 1.274 . . . . 0.0 110.614 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.65 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.068 -1.02 . . . . 0.0 113.216 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.35 -46.54 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.252 0.933 . . . . 0.0 110.713 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -73.82 -47.52 37.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.069 0.548 . . . . 0.0 111.329 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.19 73.77 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.428 -0.795 . . . . 0.0 112.989 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.5 m -75.42 -16.62 60.33 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.979 -1.076 . . . . 0.0 113.315 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -30.22 47.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.716 1.598 . . . . 0.0 110.917 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -61.1 -36.41 79.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.774 0.83 . . . . 0.0 112.789 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -142.47 76.45 1.53 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -54.45 -37.16 64.86 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.965 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -86.72 -0.21 55.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.058 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.89 29.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.957 0.903 . . . . 0.0 112.492 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -85.64 53.67 2.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.16 1.384 . . . . 0.0 110.475 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -102.33 90.5 3.92 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -166.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -68.41 -22.49 64.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.111 -0.993 . . . . 0.0 109.327 162.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.26 -24.81 66.65 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.237 1.815 . . . . 0.0 112.802 168.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -63.4 -40.43 97.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 0.0 110.49 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.58 -50.77 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.852 1.261 . . . . 0.0 110.294 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -63.5 -42.0 98.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.196 0.598 . . . . 0.0 112.022 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.78 93.11 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.135 1.35 . . . . 0.0 112.76 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.55 -31.33 63.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.802 1.301 . . . . 0.0 113.481 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.402 ' CZ2' ' HE2' ' A' ' 86' ' ' LYS . 57.7 t-105 -62.12 -43.97 97.66 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 169.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.79 -41.45 97.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.455 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -25.25 66.94 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 mt -102.62 -45.66 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.01 1.324 . . . . 0.0 112.403 -174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HE2' ' CZ2' ' A' ' 82' ' ' TRP . 17.8 mmmt -93.09 -57.32 2.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.428 1.491 . . . . 0.0 111.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -68.21 -26.53 65.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.254 1.422 . . . . 0.0 113.365 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.86 -20.22 65.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.964 1.305 . . . . 0.0 114.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.35 1.46 . . . . 0.0 112.773 179.43 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -149.98 127.02 11.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.085 0.954 . . . . 0.0 112.993 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.68 20.66 1.61 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 118.867 2.914 . . . . 0.0 118.867 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -9.22 54.04 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -123.45 24.65 8.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.508 1.523 . . . . 0.0 114.457 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.01 -27.97 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 -8.89 58.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.7 t70 62.75 -40.65 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.697 3.199 . . . . 0.0 117.019 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -93.12 -18.46 22.57 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.419 1.488 . . . . 0.0 113.754 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -80.83 162.07 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.021 1.329 . . . . 0.0 113.331 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt 39.1 54.39 4.96 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 129.282 3.033 . . . . 0.0 115.411 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.24 157.15 61.46 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.494 1.463 . . . . 0.0 111.747 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.13 -21.99 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.892 1.677 . . . . 0.0 114.649 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -81.37 -16.65 51.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 60.3 m -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.225 1.81 . . . . 0.0 113.492 170.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -54.69 148.72 12.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 123.039 1.399 . . . . 0.0 113.226 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.9 p -95.11 167.95 11.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.81 166.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.0 -26.05 66.61 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.53 -0.731 . . . . 0.0 112.266 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.94 -40.32 95.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.764 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.02 -31.34 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.396 -0.815 . . . . 0.0 112.152 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.43 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 53.1 t80 -70.2 -24.25 63.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.121 0.873 . . . . 0.0 112.322 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 68.5 mt -80.9 -16.98 52.12 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.135 -0.978 . . . . 0.0 113.318 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -33.06 53.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.839 0.855 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.5 p -76.24 141.27 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.932 1.693 . . . . 0.0 110.53 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.69 161.68 30.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.435 1.094 . . . . 0.0 113.471 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.71 -36.1 73.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.129 1.372 . . . . 0.0 112.083 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -64.48 -20.55 66.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.104 1.361 . . . . 0.0 113.835 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.3 -5.28 6.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.866 1.267 . . . . 0.0 113.397 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -57.7 -45.55 99.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 O-C-N 120.184 -1.573 . . . . 0.0 112.162 169.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.45 -28.19 86.89 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.32 2.68 . . . . 0.0 113.414 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 29.4 m -76.87 -36.06 57.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.349 1.459 . . . . 0.0 111.45 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.67 91.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.669 1.188 . . . . 0.0 113.649 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.98 -35.75 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 119.78 1.173 . . . . 0.0 110.973 169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.37 -53.21 32.72 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.274 0.94 . . . . 0.0 112.195 168.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.97 -11.93 58.22 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 121.08 2.44 . . . . 0.0 114.513 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.35 -55.99 3.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.073 0.851 . . . . 0.0 109.841 166.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.14 -36.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.321 1.049 . . . . 0.0 113.455 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.0 76.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.203 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.14 -36.87 22.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.747 1.219 . . . . 0.0 110.617 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -54.41 -34.93 62.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.604 1.561 . . . . 0.0 113.688 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.53 -7.03 45.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.02 -133.4 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.394 1.477 . . . . 0.0 110.898 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.57 -58.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.599 2.36 . . . . 0.0 112.454 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 164.5 43.57 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 127.359 2.264 . . . . 0.0 109.831 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.01 36.81 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.711 2.274 . . . . 0.0 113.409 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.73 -28.86 50.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 111.947 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.22 0.7 11.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.341 1.456 . . . . 0.0 113.847 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.09 133.92 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.221 1.009 . . . . 0.0 113.295 -170.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.6 -12.66 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.93 1.292 . . . . 0.0 113.727 -174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.87 102.05 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.699 1.999 . . . . 0.0 107.747 -165.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -85.12 71.01 10.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.985 -1.072 . . . . 0.0 108.841 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.323 1.6 p -66.27 -18.81 24.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 O-C-N 121.38 -0.825 . . . . 0.0 110.327 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -42.79 97.06 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.598 -1.314 . . . . 0.0 111.381 167.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.19 14.98 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.636 -0.665 . . . . 0.0 111.908 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.8 -44.34 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 121.383 -1.069 . . . . 0.0 112.55 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.97 66.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.667 1.576 . . . . 0.0 112.255 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 99.9 m -66.37 -46.24 77.35 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 111.853 169.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -84.34 -31.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.829 1.252 . . . . 0.0 112.845 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -40.05 -62.98 0.77 Allowed Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 126.937 2.095 . . . . 0.0 113.569 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.97 -22.66 73.93 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.245 1.963 . . . . 0.0 113.208 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.01 -59.46 3.02 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.162 0.985 . . . . 0.0 111.312 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -24.5 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.401 -0.812 . . . . 0.0 112.688 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.0 -51.85 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.811 1.187 . . . . 0.0 110.69 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.88 -47.49 45.53 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.157 -0.339 . . . . 0.0 111.084 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.755 -1.216 . . . . 0.0 113.257 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.8 m -76.13 -12.4 60.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.56 -33.58 16.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.184 1.356 . . . . 0.0 111.005 167.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -60.35 -39.04 85.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.871 0.868 . . . . 0.0 112.167 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.73 59.85 1.49 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.105 0.962 . . . . 0.0 112.618 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -53.7 -36.34 62.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.931 1.692 . . . . 0.0 113.109 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -86.27 -6.08 59.04 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.15 164.02 26.05 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.084 0.954 . . . . 0.0 111.966 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.88 138.05 52.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.467 1.107 . . . . 0.0 111.152 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 16.5 t80 -64.15 -51.28 64.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.418 -0.801 . . . . 0.0 112.81 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -66.29 -30.82 71.32 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.616 1.098 . . . . 0.0 112.071 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.38 -39.57 94.88 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.808 -0.558 . . . . 0.0 111.813 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -70.41 -34.79 72.92 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.248 -0.907 . . . . 0.0 112.832 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.12 -49.0 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.163 0.892 . . . . 0.0 109.67 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.29 -42.68 99.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.027 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.15 -44.89 97.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.513 1.054 . . . . 0.0 113.299 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -72.93 -35.4 67.02 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.052 -1.264 . . . . 0.0 112.618 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -60.06 -39.92 87.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.68 -1.262 . . . . 0.0 111.78 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.2 -46.57 88.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 111.874 173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -26.66 68.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 112.104 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 mt -79.29 -49.19 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.307 1.843 . . . . 0.0 112.087 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.21 -61.5 1.4 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.308 1.443 . . . . 0.0 113.254 -171.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.79 -25.94 68.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.995 1.718 . . . . 0.0 113.568 -171.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.26 -24.03 67.69 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.796 2.439 . . . . 0.0 114.423 178.448 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.529 0.27 0 N-CA-C 115.807 1.426 . . . . 0.0 115.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -64.33 2.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -126.04 21.32 7.49 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.932 1.693 . . . . 0.0 113.124 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -142.55 -13.22 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -131.26 169.75 15.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.624 1.556 . . . . 0.0 113.835 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.1 p -85.86 166.11 16.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.2 1.4 . . . . 0.0 114.221 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -21.37 2.75 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.87 -35.86 62.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.981 1.264 . . . . 0.0 111.596 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.66 -16.28 64.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.762 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.61 -24.18 45.49 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.799 -1.188 . . . . 0.0 112.129 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.35 -8.67 57.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.872 1.269 . . . . 0.0 113.046 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.39 60.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.084 1.354 . . . . 0.0 112.551 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.73 141.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.939 2.495 . . . . 0.0 110.508 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.35 156.88 36.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.921 0.888 . . . . 0.0 112.743 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.38 -30.67 60.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.109 1.364 . . . . 0.0 111.64 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 m -61.0 -28.32 68.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.156 1.783 . . . . 0.0 113.872 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -127.4 -7.1 5.82 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -56.47 -38.74 71.78 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 119.584 -1.948 . . . . 0.0 114.024 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.84 -27.09 79.96 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.624 2.216 . . . . 0.0 113.272 169.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 55.3 m -79.59 -34.35 40.87 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.712 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.14 92.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.452 . . . . 0.0 113.75 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.09 -36.51 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 119.367 0.985 . . . . 0.0 110.913 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.11 13.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.984 1.278 . . . . 0.0 113.798 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.15 -39.58 93.18 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.249 2.025 . . . . 0.0 112.323 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.0 67.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -102.11 -34.05 9.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.93 0.892 . . . . 0.0 112.714 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -52.44 65.67 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.746 1.619 . . . . 0.0 110.401 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -14.97 63.11 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.837 0.855 . . . . 0.0 111.144 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -14.79 50.13 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.142 -0.974 . . . . 0.0 113.436 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.283 4.6 p30 -123.41 10.67 9.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.83 152.63 0.97 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 130.59 3.556 . . . . 0.0 105.568 168.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.69 -32.33 18.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.222 2.209 . . . . 0.0 113.059 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.5 156.83 79.6 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 127.227 2.211 . . . . 0.0 110.151 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -84.65 8.65 4.51 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.989 1.793 . . . . 0.0 114.84 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.22 -21.33 22.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.393 1.477 . . . . 0.0 114.232 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.52 14.68 20.24 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.285 1.434 . . . . 0.0 113.332 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.97 113.59 24.66 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.262 -1.523 . . . . 0.0 112.106 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.78 11.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 125.647 1.579 . . . . 0.0 111.423 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER 64.49 155.0 0.07 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 129.495 3.118 . . . . 0.0 112.801 -168.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.619 ' H ' HD13 ' A' ' 50' ' ' LEU . 44.5 t0 -119.11 62.22 0.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.522 1.529 . . . . 0.0 110.811 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.0 -56.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.641 1.177 . . . . 0.0 113.475 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -63.14 -36.87 85.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.343 0.974 . . . . 0.0 111.5 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.55 -52.51 52.68 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mt -62.72 -42.77 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.45 0.7 . . . . 0.0 111.449 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.06 -34.72 71.47 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.102 -0.999 . . . . 0.0 113.067 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -70.25 -37.11 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.029 1.332 . . . . 0.0 111.848 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.1 t -87.76 -23.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.117 1.367 . . . . 0.0 113.327 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.3 m -45.28 -59.83 3.93 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 125.877 1.671 . . . . 0.0 112.935 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.48 0.85 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.56 -66.43 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.6 1.16 . . . . 0.0 110.603 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.43 -32.2 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.017 -1.052 . . . . 0.0 112.911 -178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.74 -49.31 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.367 1.067 . . . . 0.0 110.353 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.51 -46.86 36.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.274 0.559 . . . . 0.0 110.892 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.54 68.94 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.1 m -76.34 -17.17 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.29 -30.85 21.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.087 1.312 . . . . 0.0 111.429 169.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -60.63 -38.24 84.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.408 1.083 . . . . 0.0 112.012 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -146.15 86.56 1.71 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.656 0.783 . . . . 0.0 112.425 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -54.07 -33.82 58.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.647 1.179 . . . . 0.0 111.714 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -86.85 -0.07 55.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.339 1.455 . . . . 0.0 113.526 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.36 147.83 43.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.938 0.895 . . . . 0.0 111.384 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.93 155.14 40.81 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.396 1.078 . . . . 0.0 112.312 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -53.32 151.37 5.44 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 112.049 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 tptp 60.44 -32.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 129.039 2.935 . . . . 0.0 116.299 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.87 -28.26 68.73 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.36 1.864 . . . . 0.0 112.259 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -70.77 -44.11 67.39 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.54 -0.725 . . . . 0.0 112.567 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.11 -37.12 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.027 1.285 . . . . 0.0 111.268 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -64.84 -48.44 74.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.65 0.78 . . . . 0.0 111.614 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.9 -39.48 96.55 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.975 1.274 . . . . 0.0 113.242 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -35.33 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.818 1.309 . . . . 0.0 113.013 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -63.35 -38.09 89.8 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.958 -1.089 . . . . 0.0 111.956 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.41 -43.84 98.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.523 1.129 . . . . 0.0 111.782 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -25.02 67.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.83 -1.169 . . . . 0.0 112.86 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mt . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 125.038 1.335 . . . . 0.0 112.523 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 N-CA-C 112.518 0.161 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 23.0 m -49.82 -23.56 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 125.988 1.715 . . . . 0.0 115.292 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -82.49 4.36 24.67 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.618 1.567 . . . . 0.0 113.987 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -142.05 -40.52 0.36 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.453 2.301 . . . . 0.0 112.358 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -50.67 143.36 9.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.724 2.809 . . . . 0.0 112.79 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -109.3 155.45 21.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.16 -24.83 66.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.35 -38.24 79.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.592 -1.317 . . . . 0.0 111.122 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.23 -13.18 53.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.433 1.093 . . . . 0.0 112.95 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -67.47 -28.53 67.94 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.721 -1.237 . . . . 0.0 110.664 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 mt -74.13 -16.78 61.0 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.33 -0.856 . . . . 0.0 113.175 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.79 28.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.296 1.039 . . . . 0.0 113.346 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 p -71.58 140.12 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 109.872 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.81 157.34 30.64 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.847 1.259 . . . . 0.0 113.342 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -58.57 -34.52 71.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.575 1.15 . . . . 0.0 111.748 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.9 m -57.84 -25.66 60.97 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.427 1.891 . . . . 0.0 113.901 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -124.97 0.13 7.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 113.122 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.49 -44.47 97.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 119.809 -1.807 . . . . 0.0 112.416 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -63.49 -20.2 69.29 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.804 2.336 . . . . 0.0 114.393 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 57.2 m -67.8 -37.29 81.8 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.087 -1.008 . . . . 0.0 110.13 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.8 86.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.453 1.501 . . . . 0.0 114.076 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.86 -34.29 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.432 -1.418 . . . . 0.0 110.731 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.9 4.07 8.48 Favored Glycine 0 CA--C 1.545 1.969 0 C-N-CA 125.985 1.755 . . . . 0.0 116.148 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.77 -10.36 9.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.435 1.894 . . . . 0.0 113.547 170.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.72 -70.98 0.7 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.407 1.083 . . . . 0.0 111.571 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -71.24 -20.78 62.2 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.98 -1.075 . . . . 0.0 112.424 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.18 97.63 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.963 1.705 . . . . 0.0 113.833 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -43.91 18.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.653 0.781 . . . . 0.0 109.679 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.36 -24.52 67.4 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -85.77 -10.48 55.45 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -130.08 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 110.933 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -157.07 -54.12 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 127.407 2.283 . . . . 0.0 112.499 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -125.07 164.25 32.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 126.768 2.027 . . . . 0.0 111.639 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.75 9.78 3.04 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.156 2.57 . . . . 0.0 114.055 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.69 -28.4 69.91 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.625 -1.297 . . . . 0.0 113.14 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -106.14 -7.24 18.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.855 1.262 . . . . 0.0 114.035 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.57 145.21 47.56 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 120.848 -1.158 . . . . 0.0 113.403 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.18 25.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.547 1.539 . . . . 0.0 111.277 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 60.47 144.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.671 2.788 . . . . 0.0 112.738 -166.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -87.93 44.44 1.19 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.621 -1.299 . . . . 0.0 110.469 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -47.16 -53.55 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.836 1.655 . . . . 0.0 114.109 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -70.24 -34.04 72.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.689 1.131 . . . . 0.0 111.444 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.68 -48.23 74.87 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.533 0.587 . . . . 0.0 111.856 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.22 -43.57 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.642 1.577 . . . . 0.0 110.73 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.09 -32.64 73.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.108 0.963 . . . . 0.0 112.916 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 43.2 m -68.69 -42.9 77.15 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.558 1.143 . . . . 0.0 111.926 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.497 HG12 HD12 ' B' ' 151' ' ' ILE . 38.1 t -84.16 -26.09 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.91 1.684 . . . . 0.0 113.313 -171.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.5 m -50.65 -64.21 1.44 Allowed Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 125.733 1.613 . . . . 0.0 113.094 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.91 -25.35 77.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.19 1.927 . . . . 0.0 112.685 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.39 -59.12 5.1 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.229 1.012 . . . . 0.0 110.805 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.497 HD12 HG12 ' B' ' 147' ' ' VAL . 24.1 mt -70.01 -31.49 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.11 -0.994 . . . . 0.0 112.224 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.83 -51.27 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.937 1.295 . . . . 0.0 110.657 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -68.35 -44.29 75.56 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.397 0.279 . . . . 0.0 110.885 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.8 73.12 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.056 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.49 -14.51 62.14 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -35.91 13.81 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.902 1.228 . . . . 0.0 111.542 167.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -58.03 -42.66 85.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.062 0.945 . . . . 0.0 111.796 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -141.44 69.98 1.34 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 111.32 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -52.37 -34.88 49.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.693 1.997 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -84.59 -1.5 56.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.061 0.944 . . . . 0.0 113.263 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.53 147.82 48.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.637 1.175 . . . . 0.0 112.852 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.47 130.4 41.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.673 1.189 . . . . 0.0 108.406 168.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.4 -42.03 95.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.615 0.766 . . . . 0.0 113.063 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -60.08 -38.39 82.75 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.466 -0.771 . . . . 0.0 112.757 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -69.48 -34.42 74.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.282 0.633 . . . . 0.0 112.093 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -73.14 -38.12 66.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.98 -37.81 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.03 1.287 . . . . 0.0 111.64 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -62.38 -43.64 98.35 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.616 0.766 . . . . 0.0 112.182 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.76 -47.16 91.82 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.545 1.069 . . . . 0.0 113.194 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.32 -33.52 65.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.544 1.172 . . . . 0.0 113.009 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.81 -39.92 90.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.203 1.365 . . . . 0.0 111.998 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.59 -47.38 84.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.514 1.126 . . . . 0.0 112.048 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -27.24 68.73 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.101 -0.999 . . . . 0.0 111.944 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 36.9 mt -76.83 -51.67 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.059 1.744 . . . . 0.0 111.812 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt . . . . . 0 N--CA 1.479 1.001 0 C-N-CA 125.509 1.524 . . . . 0.0 113.294 -170.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 113.53 0.55 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.08 -24.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -76.22 -35.07 59.22 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.348 0.659 . . . . 0.0 112.629 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -103.56 -27.98 12.02 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -91.09 174.71 7.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.041 0.924 . . . . 0.0 113.425 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 p -103.86 165.96 10.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.667 1.587 . . . . 0.0 114.213 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -17.53 48.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 115.211 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.97 -34.71 73.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.774 1.17 . . . . 0.0 111.424 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.08 -28.98 70.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.656 -0.653 . . . . 0.0 112.319 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.61 -21.48 66.72 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.882 -1.136 . . . . 0.0 111.646 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -91.65 -13.42 31.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.418 1.487 . . . . 0.0 113.202 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.02 -31.65 34.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.378 1.071 . . . . 0.0 110.983 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -68.84 132.68 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.68 1.592 . . . . 0.0 109.782 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -68.9 160.67 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.252 1.421 . . . . 0.0 113.111 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.26 -35.92 72.48 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.906 -1.121 . . . . 0.0 112.09 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 m -62.22 -23.86 66.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.004 1.722 . . . . 0.0 113.827 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -125.45 -3.83 7.3 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.801 1.24 . . . . 0.0 113.51 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.17 -41.86 93.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 120.019 -1.676 . . . . 0.0 112.815 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -59.34 -27.35 84.75 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.927 2.418 . . . . 0.0 113.691 168.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.5 m -78.92 -27.9 43.79 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 111.902 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -64.96 -48.43 74.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 112.811 170.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.03 -36.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 118.73 0.695 . . . . 0.0 110.466 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.94 -48.17 52.27 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.674 1.13 . . . . 0.0 113.849 170.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.05 -19.0 64.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.864 2.832 . . . . 0.0 113.192 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.93 -53.46 5.29 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.47 -0.769 . . . . 0.0 110.7 165.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.7 -19.73 60.14 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.99 27.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 111.951 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.95 -31.42 18.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.282 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -67.33 -20.57 65.62 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.04 -8.38 21.51 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.26 0.4 OUTLIER -141.41 -129.52 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.187 1.395 . . . . 0.0 113.287 -175.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.87 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.989 1.716 . . . . 0.0 113.759 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -136.41 164.44 42.79 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.763 2.425 . . . . 0.0 110.056 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.34 -5.27 14.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.498 1.466 . . . . 0.0 114.55 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.61 -25.21 68.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.937 1.244 . . . . 0.0 113.747 -168.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.31 -16.55 29.03 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.157 2.183 . . . . 0.0 113.648 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 154.26 33.46 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -169.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.77 1.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 125.133 1.373 . . . . 0.0 113.795 -174.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? 62.78 112.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.842 2.857 . . . . 0.0 112.584 -168.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.9 54.07 2.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.899 1.68 . . . . 0.0 112.495 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 0.6 OUTLIER -55.22 -40.82 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 -165.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.73 -35.45 78.1 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 122.746 2.521 . . . . 0.0 112.707 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.02 -22.16 60.03 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 124.755 1.169 . . . . 0.0 113.804 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.74 -50.78 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.433 1.493 . . . . 0.0 111.132 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.18 77.54 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.016 1.326 . . . . 0.0 113.78 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -63.73 -39.24 93.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.391 1.076 . . . . 0.0 111.735 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HD13 ' A' ' 62' ' ' ILE . 1.3 t -95.45 -19.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.681 1.192 . . . . 0.0 113.314 -172.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.6 m -41.85 -60.0 2.22 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 125.962 1.705 . . . . 0.0 112.368 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.4 1.24 4.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.715 2.943 . . . . 0.0 114.822 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.46 -59.66 1.78 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 0.0 110.485 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.471 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.23 -34.99 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.345 0.975 . . . . 0.0 112.118 -178.049 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.82 -40.9 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.444 0.565 . . . . 0.0 112.326 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -78.26 -47.91 16.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.25 -29.39 70.17 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.096 0.958 . . . . 0.0 113.561 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.37 -11.6 59.86 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.54 -33.95 16.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.304 1.411 . . . . 0.0 110.58 166.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -58.02 -40.11 80.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 111.652 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.51 88.0 1.75 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.757 0.789 . . . . 0.0 111.984 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -55.01 -31.42 61.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.747 1.619 . . . . 0.0 112.489 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -89.53 -2.74 58.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.188 1.395 . . . . 0.0 112.854 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 154.95 40.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.716 0.806 . . . . 0.0 110.548 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -64.58 137.34 57.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.992 0.517 . . . . 0.0 110.349 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.52 -53.1 62.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.907 1.283 . . . . 0.0 111.766 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -65.54 -38.23 89.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.08 0.952 . . . . 0.0 112.245 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.56 -37.36 83.55 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.485 0.714 . . . . 0.0 111.463 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -73.61 -33.68 64.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.85 -47.3 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 118.448 0.567 . . . . 0.0 110.698 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.66 -44.57 95.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.876 0.87 . . . . 0.0 111.825 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.65 -46.13 93.74 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.722 1.153 . . . . 0.0 113.092 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -73.29 -31.99 64.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.695 1.248 . . . . 0.0 113.447 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -61.49 -42.21 98.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.982 1.265 . . . . 0.0 111.714 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.68 -47.99 78.99 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.66 0.784 . . . . 0.0 111.476 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.413 -1.429 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.1 mt . . . . . 0 CA--C 1.538 0.519 0 C-N-CA 123.84 0.856 . . . . 0.0 112.038 178.201 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.542 0.908 0 N-CA-C 109.832 -0.872 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -48.3 -30.01 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -87.69 -7.75 56.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m -132.13 28.83 4.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.041 2.536 . . . . 0.0 111.084 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -101.15 141.52 33.92 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.679 1.992 . . . . 0.0 111.299 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 36.7 p -110.33 149.82 29.65 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -19.92 66.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.52 -39.29 61.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 110.986 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.67 -34.86 78.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 112.179 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.47 -30.16 71.33 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.083 -1.011 . . . . 0.0 111.445 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.4 -4.23 58.11 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.558 1.143 . . . . 0.0 113.466 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.99 15.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.113 1.365 . . . . 0.0 111.152 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.57 138.49 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.356 1.862 . . . . 0.0 109.646 169.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.92 158.62 32.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.244 1.018 . . . . 0.0 112.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.88 -35.85 71.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.596 1.158 . . . . 0.0 111.349 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.5 m -61.92 -23.0 66.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.782 1.633 . . . . 0.0 114.029 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.89 -1.46 7.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.294 1.438 . . . . 0.0 112.746 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.57 -43.91 90.13 Favored Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 119.728 -1.858 . . . . 0.0 112.444 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.52 -25.22 75.63 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.035 1.823 . . . . 0.0 113.214 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.747 HG22 HD21 ' A' ' 50' ' ' LEU . 24.2 m -72.69 -39.99 66.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.146 0.978 . . . . 0.0 110.159 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -20.07 63.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.975 1.71 . . . . 0.0 115.537 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.8 -39.99 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-N 121.145 1.793 . . . . 0.0 109.612 163.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.79 23.13 0.18 Allowed Glycine 0 CA--C 1.54 1.624 0 C-N-CA 127.907 2.67 . . . . 0.0 117.424 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -126.39 -57.57 1.38 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.362 1.581 . . . . 0.0 111.041 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.59 78.16 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.221 -0.924 . . . . 0.0 111.773 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.38 -38.41 35.01 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.811 -0.556 . . . . 0.0 111.956 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.76 -46.04 69.84 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 113.296 -171.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -33.32 69.02 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.924 -0.485 . . . . 0.0 110.871 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.27 -28.19 66.98 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.12 -3.93 50.16 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -146.11 -122.97 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.361 1.864 . . . . 0.0 111.208 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -160.3 -79.31 0.05 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.625 1.57 . . . . 0.0 112.092 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -123.88 164.2 30.61 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 127.065 2.146 . . . . 0.0 109.262 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.74 1.98 7.48 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 121.283 1.494 . . . . 0.0 114.826 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -55.74 -27.84 52.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.206 1.402 . . . . 0.0 111.481 168.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.75 3.97 23.2 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.816 2.046 . . . . 0.0 113.279 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.94 126.88 35.59 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 119.725 -1.86 . . . . 0.0 113.744 -169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.96 132.52 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.151 2.181 . . . . 0.0 106.471 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -69.81 116.24 9.96 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.631 1.105 . . . . 0.0 109.787 -174.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -86.28 61.44 6.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.06 1.344 . . . . 0.0 110.588 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.315 1.2 p -68.65 -34.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.385 -167.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.13 -39.04 89.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.852 1.66 . . . . 0.0 111.991 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.39 -48.39 79.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.538 0.589 . . . . 0.0 111.677 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.75 -43.21 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.46 1.104 . . . . 0.0 111.702 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.9 -37.8 76.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.288 1.035 . . . . 0.0 112.315 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -62.12 -39.89 94.06 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.453 1.101 . . . . 0.0 112.007 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.0 -26.19 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.41 1.484 . . . . 0.0 113.594 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -44.77 -60.49 2.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 126.603 1.961 . . . . 0.0 113.571 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.52 -19.49 67.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.262 1.975 . . . . 0.0 113.149 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -69.04 -58.07 4.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.097 0.959 . . . . 0.0 111.274 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -20.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.26 -0.9 . . . . 0.0 113.255 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.8 -52.82 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.614 1.097 . . . . 0.0 110.28 173.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.18 -47.69 34.01 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 122.458 0.303 . . . . 0.0 111.476 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.03 -28.57 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.692 -1.255 . . . . 0.0 113.24 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.01 -16.24 60.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.69 21.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.278 1.399 . . . . 0.0 111.34 168.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.95 -38.87 76.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.772 0.829 . . . . 0.0 112.544 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -146.65 83.5 1.6 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -56.86 -37.83 71.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.933 1.293 . . . . 0.0 111.937 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.9 -6.13 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 113.018 -172.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.88 137.42 58.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.836 0.744 . . . . 0.0 109.219 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -122.59 44.25 2.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.386 -167.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -138.36 143.04 39.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -165.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -67.41 -26.92 66.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.369 1.068 . . . . 0.0 110.381 166.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -64.19 -24.8 67.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.895 1.278 . . . . 0.0 113.216 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.05 -31.62 72.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.046 -1.034 . . . . 0.0 111.98 170.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.43 -47.15 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.719 1.608 . . . . 0.0 110.453 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -65.32 -34.22 77.81 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.292 1.037 . . . . 0.0 113.286 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.42 -34.87 76.89 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.659 1.124 . . . . 0.0 113.69 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 24.3 mm-40 -75.69 -32.85 60.29 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.601 1.2 . . . . 0.0 113.187 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.92 -39.47 94.25 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.893 -1.129 . . . . 0.0 111.065 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -61.48 -48.55 80.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 111.756 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -24.15 67.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.984 -1.072 . . . . 0.0 112.289 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 27.9 mt -83.94 -48.09 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.417 1.487 . . . . 0.0 112.373 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.076 1.351 . . . . 0.0 114.014 -169.885 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.472 0.256 0 CA-C-O 121.405 0.502 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.5 7.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.29 21.84 7.24 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.297 2.239 . . . . 0.0 113.153 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.0 p -116.05 -32.01 5.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -129.26 163.13 26.32 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -73.16 168.02 19.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.204 1.402 . . . . 0.0 113.733 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -27.44 46.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.68 -38.32 74.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.156 0.982 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.02 -12.67 59.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.498 1.519 . . . . 0.0 113.065 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -76.26 -16.73 59.74 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.516 -1.365 . . . . 0.0 111.344 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.37 1.76 47.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.017 1.327 . . . . 0.0 114.145 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.48 56.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 112.27 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.55 136.65 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.752 2.021 . . . . 0.0 110.954 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.42 157.8 25.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.51 1.124 . . . . 0.0 112.457 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -53.47 -31.37 45.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.482 1.513 . . . . 0.0 111.758 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 m -61.74 -29.49 70.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.193 1.797 . . . . 0.0 113.89 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -126.45 -1.51 6.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.792 1.637 . . . . 0.0 112.702 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 33.3 mm-40 -53.57 -46.81 98.04 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.91 -1.744 . . . . 0.0 112.365 170.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 36.5 Cg_exo -67.56 -17.83 48.54 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.415 2.076 . . . . 0.0 112.924 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.851 HG22 HD21 ' B' ' 139' ' ' LEU . 20.6 m -79.76 -36.91 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.218 1.407 . . . . 0.0 110.702 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.59 98.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.526 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.9 -48.41 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.723 0.809 . . . . 0.0 109.288 168.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.04 -52.37 35.8 Favored Glycine 0 C--O 1.213 -1.21 0 C-N-CA 125.214 1.388 . . . . 0.0 113.149 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -68.81 -12.69 61.79 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.649 2.725 . . . . 0.0 114.664 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.38 -50.07 5.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.002 0.819 . . . . 0.0 111.12 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -75.51 -24.1 56.79 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.126 -0.984 . . . . 0.0 113.221 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.35 76.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.404 -1.435 . . . . 0.0 112.003 -176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -74.8 -33.17 62.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.32 1.048 . . . . 0.0 110.32 -176.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -56.84 -23.19 42.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.978 1.711 . . . . 0.0 113.59 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -91.09 -18.53 24.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -120.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.115 1.325 . . . . 0.0 113.52 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -161.18 -58.88 0.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.532 1.533 . . . . 0.0 113.954 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.03 166.25 27.45 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 128.125 2.57 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.87 14.03 2.32 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.033 1.762 . . . . 0.0 114.804 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.22 -23.71 66.81 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.282 1.433 . . . . 0.0 111.783 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -127.94 26.8 5.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.901 1.68 . . . . 0.0 114.111 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.64 35.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.995 -1.69 . . . . 0.0 112.445 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.04 -16.33 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.845 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 66.64 110.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.856 2.462 . . . . 0.0 112.195 -169.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.39 59.83 1.88 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.777 1.231 . . . . 0.0 111.659 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 2.4 p -62.3 -19.61 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.606 -1.309 . . . . 0.0 114.42 -168.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.51 -44.68 56.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 112.169 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.97 -47.71 6.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -58.17 -51.09 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.746 1.218 . . . . 0.0 112.265 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.71 66.69 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -66.61 -49.0 67.74 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.018 1.327 . . . . 0.0 112.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.22 -18.45 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -46.4 -60.7 3.34 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.634 1.174 . . . . 0.0 112.807 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.93 -4.18 12.94 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.295 2.663 . . . . 0.0 114.113 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -62.72 1.43 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.363 1.465 . . . . 0.0 111.158 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -30.85 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.951 -1.093 . . . . 0.0 113.175 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.46 -41.09 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.099 0.863 . . . . 0.0 112.66 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.72 -44.34 28.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.084 0.953 . . . . 0.0 110.789 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.18 93.35 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.429 -0.794 . . . . 0.0 112.402 -171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.69 -7.15 56.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -34.52 16.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.115 1.325 . . . . 0.0 111.565 169.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -78.83 -32.98 46.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -117.09 49.18 1.21 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.665 1.586 . . . . 0.0 112.06 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -48.93 -36.79 18.18 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.743 -1.223 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -87.92 -2.86 58.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.664 1.186 . . . . 0.0 113.624 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.05 157.51 35.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.004 0.922 . . . . 0.0 111.352 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -76.68 161.39 28.57 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.505 1.145 . . . . 0.0 113.759 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -48.28 153.09 0.76 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.788 2.435 . . . . 0.0 114.132 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp 60.29 -34.63 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 130.031 3.332 . . . . 0.0 117.253 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -30.57 70.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.971 1.709 . . . . 0.0 111.995 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -74.1 -35.49 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.8 -46.15 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.086 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -63.76 -43.38 96.6 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.354 1.062 . . . . 0.0 112.113 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.24 98.5 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.931 1.729 . . . . 0.0 113.771 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -73.5 -33.57 64.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.565 1.682 . . . . 0.0 113.13 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -62.85 -39.28 93.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.364 -1.46 . . . . 0.0 111.157 171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.04 -46.64 83.5 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.547 1.139 . . . . 0.0 112.106 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -31.8 72.32 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.057 -1.027 . . . . 0.0 112.08 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.2 mt . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 111.304 -177.936 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.537 0.63 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 m -47.56 -29.71 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.276 2.23 . . . . 0.0 114.996 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -93.99 -9.33 37.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 58.0 p -116.15 -32.57 5.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.74 1.154 . . . . 0.0 113.757 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -93.7 163.56 13.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.207 1.003 . . . . 0.0 113.549 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.0 p -99.73 155.78 17.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.298 1.439 . . . . 0.0 114.275 -169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -20.4 18.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.238 1.815 . . . . 0.0 115.275 -174.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.96 -40.65 89.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.03 1.286 . . . . 0.0 111.679 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -78.1 -12.36 59.98 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.938 0.895 . . . . 0.0 112.146 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -94.13 -17.29 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.774 -1.204 . . . . 0.0 112.986 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.07 -17.42 57.02 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.939 -1.101 . . . . 0.0 113.254 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.3 50.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.687 1.195 . . . . 0.0 113.905 -171.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.71 139.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.024 1.73 . . . . 0.0 111.113 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.61 158.68 29.29 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.638 1.575 . . . . 0.0 113.744 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.16 -33.27 70.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.852 1.261 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.5 m -59.43 -26.75 65.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.087 1.755 . . . . 0.0 113.656 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.51 -0.93 8.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.607 1.563 . . . . 0.0 112.523 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.44 -46.38 99.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 120.009 -1.682 . . . . 0.0 112.805 172.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -64.96 -25.4 59.53 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.353 2.035 . . . . 0.0 112.848 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 50' ' ' LEU . 58.0 m -70.12 -38.43 75.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.039 0.936 . . . . 0.0 110.345 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.05 92.54 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.35 -35.62 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.739 1.154 . . . . 0.0 110.76 170.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.31 -42.03 88.13 Favored Glycine 0 C--O 1.217 -0.915 0 C-N-CA 124.764 1.173 . . . . 0.0 113.687 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -44.4 71.16 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.147 1.973 . . . . 0.0 111.51 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.84 82.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.76 -39.14 73.41 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.012 -1.055 . . . . 0.0 113.557 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.62 87.68 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.021 -1.049 . . . . 0.0 111.386 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -79.53 -38.81 33.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.578 0.751 . . . . 0.0 111.056 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.0 -31.39 72.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.076 0.95 . . . . 0.0 113.198 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.77 -16.84 49.73 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.16 -124.14 0.03 OUTLIER 'General case' 0 C--N 1.35 0.629 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -163.66 -45.68 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.494 1.518 . . . . 0.0 114.205 -167.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.04 161.99 56.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 127.298 2.239 . . . . 0.0 110.158 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.9 5.55 6.2 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.764 1.643 . . . . 0.0 113.909 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -56.51 -29.74 62.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.377 1.471 . . . . 0.0 111.86 169.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -111.94 15.12 20.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.198 1.799 . . . . 0.0 112.964 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.72 120.96 24.12 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 119.408 -2.057 . . . . 0.0 111.999 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.34 128.81 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.791 1.636 . . . . 0.0 106.917 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 31' ' ' THR . 2.1 tm? -75.1 116.75 16.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.626 0.648 . . . . 0.0 110.488 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.07 48.98 1.73 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.27 1.828 . . . . 0.0 111.43 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.351 1.7 p -62.8 -32.73 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -166.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -59.82 -50.56 73.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.626 1.557 . . . . 0.0 110.027 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.79 -39.51 55.0 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.797 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -58.37 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.488 1.115 . . . . 0.0 110.979 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.06 75.66 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.83 1.195 . . . . 0.0 112.526 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 53.3 m -62.39 -43.38 98.95 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.383 1.073 . . . . 0.0 111.872 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' B' ' 151' ' ' ILE . 35.0 t -83.69 -30.43 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.494 1.518 . . . . 0.0 113.082 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.5 m -37.04 -61.93 0.62 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 127.132 2.173 . . . . 0.0 114.245 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.21 -22.7 60.72 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.059 1.839 . . . . 0.0 113.026 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.95 -60.53 2.56 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.286 1.035 . . . . 0.0 110.689 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.528 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -70.5 -25.6 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 178.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -52.15 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.12 0.873 . . . . 0.0 110.654 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.35 -43.44 60.71 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.655 0.382 . . . . 0.0 111.287 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.73 -29.13 69.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.749 -1.219 . . . . 0.0 112.852 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 34.4 m -69.75 -13.93 62.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 169.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.23 -38.43 13.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.652 1.569 . . . . 0.0 110.872 166.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -59.81 -38.77 82.9 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.959 0.904 . . . . 0.0 112.396 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.54 75.41 1.46 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 122.359 1.076 . . . . 0.0 111.246 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -52.26 -27.21 14.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.042 1.737 . . . . 0.0 112.357 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.94 -2.63 55.63 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.383 1.473 . . . . 0.0 113.516 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.59 152.13 36.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.51 1.124 . . . . 0.0 111.702 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -70.19 136.27 49.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.313 1.445 . . . . 0.0 111.099 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.19 -43.65 81.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -60.47 -41.34 93.96 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.217 1.371 . . . . 0.0 110.705 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.03 -36.81 84.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.343 0.657 . . . . 0.0 112.311 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -70.9 -39.31 72.84 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.92 -46.17 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 119.65 1.114 . . . . 0.0 109.968 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -65.33 -46.52 79.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.864 0.866 . . . . 0.0 112.359 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.15 99.24 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.832 1.206 . . . . 0.0 113.394 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -71.83 -34.32 69.22 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.702 1.251 . . . . 0.0 112.307 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -61.35 -39.92 92.36 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.66 -1.275 . . . . 0.0 111.725 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.81 -47.74 79.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.425 0.69 . . . . 0.0 111.394 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.52 68.95 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.393 -1.442 . . . . 0.0 111.849 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.8 mt -73.9 -47.6 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.908 1.683 . . . . 0.0 112.785 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 124.85 1.26 . . . . 0.0 113.321 -172.878 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.528 0.222 0 N-CA-C 114.667 0.987 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.82 -14.98 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.37 1.468 . . . . 0.0 113.802 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -85.97 -10.73 54.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.866 2.066 . . . . 0.0 113.502 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -133.38 -25.8 1.7 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.67 151.83 46.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.175 0.898 . . . . 0.0 111.76 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -97.35 165.17 12.15 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.883 1.325 . . . . 0.0 113.05 -172.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 m -62.1 -21.97 65.42 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.48 -44.75 95.63 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.711 170.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -63.87 -25.84 68.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.397 -0.815 . . . . 0.0 112.167 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.24 -16.39 63.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.945 -1.097 . . . . 0.0 112.664 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.5 mt -87.19 -9.51 55.0 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.021 -1.049 . . . . 0.0 112.378 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -26.75 13.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.099 1.76 . . . . 0.0 113.404 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.02 -4.31 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t70 64.8 155.12 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 129.076 2.951 . . . . 0.0 116.319 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.06 -34.5 63.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.128 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 m -67.73 -25.04 65.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -127.32 3.3 6.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.583 1.153 . . . . 0.0 112.014 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -57.3 -52.3 75.28 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.311 -1.493 . . . . 0.0 110.449 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -67.66 -12.15 34.57 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.417 2.078 . . . . 0.0 114.39 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.553 HG22 HD21 ' B' ' 139' ' ' LEU . 79.6 m -73.27 -32.71 64.84 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.795 -1.191 . . . . 0.0 110.678 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.26 85.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.387 1.075 . . . . 0.0 112.145 169.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.91 -45.18 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.353 1.061 . . . . 0.0 109.001 170.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.45 6.03 0.38 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.54 2.019 . . . . 0.0 116.78 169.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -121.68 -61.36 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.999 1.72 . . . . 0.0 110.078 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.41 -30.4 70.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.26 -32.56 13.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.683 0.674 . . . . 0.0 112.392 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.05 -46.29 88.22 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.404 HD22 HD22 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -76.01 -12.43 60.13 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.05 0.94 . . . . 0.0 111.939 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -85.81 -21.92 27.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.66 1.184 . . . . 0.0 113.028 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -95.89 -16.28 21.89 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.863 0.865 . . . . 0.0 113.225 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -170.59 153.33 4.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.971 2.908 . . . . 0.0 106.835 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -84.26 -41.74 16.59 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 111.556 -2.565 . . . . 0.0 112.718 -173.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -131.56 159.59 71.14 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 127.071 2.148 . . . . 0.0 110.057 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -90.23 12.04 2.59 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.3 2.0 . . . . 0.0 114.432 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.07 -23.71 65.68 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.241 1.016 . . . . 0.0 112.651 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.77 -15.84 24.77 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.333 1.853 . . . . 0.0 113.787 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.21 127.09 32.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.51 18.38 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 125.586 1.555 . . . . 0.0 111.336 169.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER 57.21 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.833 2.853 . . . . 0.0 110.739 -168.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.38 62.37 6.03 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.876 -1.765 . . . . 0.0 110.973 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p -72.42 -24.14 21.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -167.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -58.1 -45.12 87.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.589 1.541 . . . . 0.0 111.455 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.05 -45.2 88.98 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.947 -0.47 . . . . 0.0 112.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.68 -44.86 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.775 1.23 . . . . 0.0 111.657 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.94 63.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 112.742 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.8 m -67.44 -45.55 75.71 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.667 1.187 . . . . 0.0 111.244 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -27.03 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -172.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.8 m -49.48 -62.44 2.47 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.201 1.4 . . . . 0.0 112.831 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -8.29 22.56 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.071 2.514 . . . . 0.0 113.578 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.67 -57.18 3.8 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.312 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.79 -29.8 30.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 C-N-CA 124.084 0.954 . . . . 0.0 112.135 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.55 -53.12 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.574 1.079 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.51 -40.83 80.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.952 0.405 . . . . 0.0 110.609 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.43 97.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.8 m -74.39 -14.67 60.89 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.39 -36.17 24.51 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.11 1.323 . . . . 0.0 111.494 171.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -81.33 -27.15 35.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -125.98 50.14 1.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.436 1.894 . . . . 0.0 112.532 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -51.36 -38.16 51.78 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.703 1.601 . . . . 0.0 113.158 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -81.91 -6.42 59.09 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.29 163.78 20.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.51 1.124 . . . . 0.0 113.019 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -67.0 140.12 57.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.505 1.522 . . . . 0.0 110.755 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.32 -41.02 92.65 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -65.41 -33.56 76.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.01 -1.056 . . . . 0.0 112.38 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.54 -42.24 91.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.465 1.106 . . . . 0.0 111.668 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -41.25 95.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.33 -48.72 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.104 0.411 . . . . 0.0 110.474 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -63.46 -45.79 89.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.69 92.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.701 1.144 . . . . 0.0 113.176 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.05 -34.82 61.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.513 1.156 . . . . 0.0 112.527 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -59.8 -40.26 87.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.545 1.52 . . . . 0.0 111.78 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.43 -46.49 88.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.179 0.992 . . . . 0.0 111.844 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -28.07 69.33 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.904 -1.123 . . . . 0.0 111.92 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.2 mt . . . . . 0 CA--C 1.541 0.633 0 C-N-CA 124.831 1.253 . . . . 0.0 111.956 -179.153 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 CA--C 1.542 0.878 0 N-CA-C 118.773 2.567 . . . . 0.0 118.773 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.01 -19.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.062 1.745 . . . . 0.0 114.82 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -98.92 -2.13 38.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.806 1.242 . . . . 0.0 114.018 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 78.0 p -134.81 -6.14 2.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -177.24 4.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.804 1.242 . . . . 0.0 113.734 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 82.2 p -97.76 166.39 11.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -16.39 6.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.76 -34.41 71.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.086 1.312 . . . . 0.0 111.41 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.56 -27.05 67.37 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.246 -0.909 . . . . 0.0 112.805 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -71.77 -15.71 62.18 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.407 -0.808 . . . . 0.0 112.346 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 mt -95.76 -19.42 19.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.525 1.13 . . . . 0.0 113.22 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.51 65.17 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.206 1.002 . . . . 0.0 112.576 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.22 140.38 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.179 2.192 . . . . 0.0 111.758 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.87 158.99 34.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.807 1.243 . . . . 0.0 113.228 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.9 -32.02 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.679 1.591 . . . . 0.0 111.876 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.2 m -59.13 -28.24 66.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.851 1.661 . . . . 0.0 113.815 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -128.06 -2.89 5.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.29 1.436 . . . . 0.0 113.443 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -58.16 -40.82 86.0 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 119.619 -1.926 . . . . 0.0 113.475 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -60.54 -26.53 83.04 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.66 2.24 . . . . 0.0 113.241 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 42.6 m -77.41 -33.88 54.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.714 1.206 . . . . 0.0 111.483 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -60.26 -48.62 80.95 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.733 1.213 . . . . 0.0 113.079 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.02 -34.33 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 111.171 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.64 -58.42 10.22 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.537 1.065 . . . . 0.0 112.655 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.32 -37.08 76.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.233 2.017 . . . . 0.0 112.677 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.74 -29.2 67.56 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -111.83 -33.3 6.35 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.465 1.906 . . . . 0.0 112.705 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.404 HD22 HD22 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -78.78 -42.2 28.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 110.21 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.03 -32.35 73.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -168.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.35 -7.06 58.77 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.14 -45.41 0.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.33 1.3 p30 56.04 140.22 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.855 2.462 . . . . 0.0 115.94 -166.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 42.9 mttp 63.79 140.9 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.758 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.75 0.09 5.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.629 1.553 . . . . 0.0 114.524 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.27 -16.48 63.6 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.038 1.29 . . . . 0.0 113.657 -170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -123.56 5.01 8.94 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.734 1.614 . . . . 0.0 113.863 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.51 141.32 44.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.469 -1.394 . . . . 0.0 113.741 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.94 132.71 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.58 1.952 . . . . 0.0 107.708 170.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.553 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -68.61 127.35 32.7 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.91 43.72 1.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.939 -1.1 . . . . 0.0 113.623 -166.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.261 14.3 p -64.69 -21.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.528 -1.358 . . . . 0.0 112.775 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -54.91 -30.46 58.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.654 1.581 . . . . 0.0 113.125 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.28 -56.27 1.49 Allowed Glycine 0 N--CA 1.465 0.583 0 C-N-CA 123.507 0.575 . . . . 0.0 112.368 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -54.36 -45.56 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 121.606 -0.938 . . . . 0.0 113.074 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.87 66.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.682 1.128 . . . . 0.0 113.071 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -71.28 -44.56 65.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.946 1.298 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -89.04 -18.32 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.3 m -41.36 -59.95 2.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.455 1.502 . . . . 0.0 113.431 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.47 -16.9 54.98 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.136 2.558 . . . . 0.0 114.121 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.26 -58.25 3.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.354 1.062 . . . . 0.0 111.612 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -37.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.189 -0.944 . . . . 0.0 112.558 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.28 -42.73 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.923 0.489 . . . . 0.0 112.069 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.54 -45.25 46.82 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.74 0.816 . . . . 0.0 110.903 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.31 71.92 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.461 -1.4 . . . . 0.0 113.43 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 10.9 m -74.82 -11.52 60.17 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.74 -34.54 16.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.49 1.496 . . . . 0.0 111.057 167.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -58.26 -38.76 77.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.699 1.2 . . . . 0.0 111.95 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -143.8 83.07 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.41 0.684 . . . . 0.0 111.871 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -55.81 -25.9 43.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.972 1.309 . . . . 0.0 112.946 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -95.13 3.98 54.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.096 1.758 . . . . 0.0 113.269 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.09 149.72 31.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.091 1.356 . . . . 0.0 113.397 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.65 86.92 6.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.58 1.152 . . . . 0.0 113.011 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . 0.258 1.4 p90 44.43 -117.95 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -21.31 64.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.23 1.412 . . . . 0.0 113.462 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.66 -31.65 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.943 0.897 . . . . 0.0 112.267 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -74.73 -42.55 58.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.3 -35.12 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.874 1.216 . . . . 0.0 111.586 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.59 -48.14 76.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.915 0.886 . . . . 0.0 111.843 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.53 -41.42 98.71 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.121 0.867 . . . . 0.0 113.178 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.25 -29.11 63.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.381 1.091 . . . . 0.0 113.161 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -66.13 -43.16 87.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.38 0.991 . . . . 0.0 111.532 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.84 -43.9 97.92 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.684 0.793 . . . . 0.0 111.183 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.3 -40.61 5.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.931 1.693 . . . . 0.0 113.307 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 mt -85.98 -38.82 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.905 0.882 . . . . 0.0 112.421 -171.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -177.512 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 CA--C 1.529 0.272 0 N-CA-C 111.15 -0.366 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.15 -18.51 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -82.49 -19.52 38.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.177 1.391 . . . . 0.0 113.951 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.3 m -141.39 44.8 1.75 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.156 2.182 . . . . 0.0 110.73 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -129.86 139.72 51.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.275 1.83 . . . . 0.0 109.912 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.5 p -102.65 161.43 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.972 1.367 . . . . 0.0 114.159 -168.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 m -77.03 -21.43 54.58 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.83 -42.27 79.34 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.305 0.957 . . . . 0.0 110.648 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.76 -28.75 60.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.092 0.957 . . . . 0.0 112.209 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -66.15 -33.97 76.98 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.658 -1.276 . . . . 0.0 111.262 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.33 -10.52 59.66 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.93 -29.4 27.14 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.248 1.019 . . . . 0.0 112.551 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.85 137.47 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.047 1.739 . . . . 0.0 110.069 170.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.43 157.4 34.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.764 0.826 . . . . 0.0 113.02 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -55.96 -28.93 59.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 111.724 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.7 m -62.78 -27.17 69.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.043 1.737 . . . . 0.0 114.243 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.7 -10.58 5.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.63 1.172 . . . . 0.0 113.511 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.83 -40.45 85.12 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 119.641 -1.912 . . . . 0.0 112.522 169.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -65.53 -24.15 56.61 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.771 2.314 . . . . 0.0 113.435 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 HD21 ' B' ' 139' ' ' LEU . 95.6 m -73.35 -36.53 66.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 110.243 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.54 85.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.647 1.179 . . . . 0.0 113.898 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.84 -35.28 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 119.203 0.911 . . . . 0.0 110.684 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.17 -43.51 74.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.878 1.228 . . . . 0.0 114.448 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -68.29 -49.06 63.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.986 2.393 . . . . 0.0 112.536 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.82 -29.96 71.12 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.147 0.579 . . . . 0.0 112.186 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.55 -45.46 10.44 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.21 90.94 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.679 -1.263 . . . . 0.0 111.308 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.47 62.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.426 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -74.18 -18.96 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.053 0.842 . . . . 0.0 113.221 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.3 -28.59 42.21 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.39 -0.818 . . . . 0.0 112.868 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -154.69 -128.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.48 1.512 . . . . 0.0 112.55 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.9 -39.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.578 2.351 . . . . 0.0 114.261 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -134.2 162.09 59.81 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 127.175 2.19 . . . . 0.0 110.363 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -94.84 9.72 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.939 1.759 . . . . 0.0 114.647 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.91 -18.26 63.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.153 -0.967 . . . . 0.0 112.936 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -112.39 -2.35 14.79 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.133 1.773 . . . . 0.0 113.971 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.55 55.44 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.43 145.07 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.467 1.907 . . . . 0.0 107.339 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD21 HG22 ' B' ' 120' ' ' THR . 1.4 tm? -80.2 137.24 36.64 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 119.233 0.924 . . . . 0.0 113.11 -168.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -94.27 47.66 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.498 -1.376 . . . . 0.0 113.749 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 ' CG ' ' B' ' 117' ' ' PHE 0.387 1.7 p -63.29 -50.28 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -60.22 -35.19 74.87 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.647 2.021 . . . . 0.0 111.854 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.77 -41.83 88.03 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 121.276 0.376 . . . . 0.0 112.54 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 HD13 HG21 ' B' ' 120' ' ' THR . 21.4 mt -65.7 -45.84 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.422 1.489 . . . . 0.0 111.444 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.05 -25.69 65.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.064 1.346 . . . . 0.0 112.973 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 m -63.92 -46.45 84.71 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.927 1.291 . . . . 0.0 110.98 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.15 -19.12 7.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -47.02 -60.94 3.24 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 125.284 1.433 . . . . 0.0 112.156 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.83 1.32 5.26 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.726 2.951 . . . . 0.0 114.334 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 -55.68 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.065 1.746 . . . . 0.0 110.938 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.07 -32.15 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.017 1.327 . . . . 0.0 111.463 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.11 -45.49 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.774 0.83 . . . . 0.0 112.097 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -67.88 -46.19 72.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.836 0.455 . . . . 0.0 110.181 175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.13 -31.61 69.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.79 0.836 . . . . 0.0 112.632 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.05 -20.28 61.01 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -30.17 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.434 1.015 . . . . 0.0 111.951 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.26 -39.09 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.366 1.067 . . . . 0.0 112.119 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -145.96 82.57 1.62 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 112.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -51.77 -35.53 44.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.878 1.271 . . . . 0.0 112.036 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.75 8.36 34.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.573 1.949 . . . . 0.0 114.595 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.38 45.12 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t30 60.42 20.18 9.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -155.13 150.55 27.26 Favored 'General case' 0 N--CA 1.486 1.363 1 N-CA-C 122.662 4.319 . . . . 0.0 122.662 -170.658 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -60.21 -25.15 65.38 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 113.749 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.79 -24.15 55.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.518 0.599 . . . . 0.0 111.568 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -64.35 -34.12 77.43 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.398 1.079 . . . . 0.0 113.805 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.78 -37.73 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.886 1.221 . . . . 0.0 112.149 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -79.88 -31.9 40.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.37 -33.59 81.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.665 1.126 . . . . 0.0 113.475 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.38 -32.92 55.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.722 1.261 . . . . 0.0 113.325 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -59.91 -41.44 91.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.591 1.087 . . . . 0.0 110.683 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.23 -51.04 70.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.923 0.889 . . . . 0.0 110.967 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -28.81 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 112.451 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 112.535 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 120.536 0.14 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.0 -15.66 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -85.01 -10.74 56.69 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.182 1.393 . . . . 0.0 114.129 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 48.1 m -144.72 49.37 1.3 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.388 2.275 . . . . 0.0 110.477 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -141.29 139.91 33.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.498 1.519 . . . . 0.0 110.435 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 39.6 p -98.76 150.0 22.28 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.65 -26.67 65.72 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.09 -39.28 85.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.978 -1.076 . . . . 0.0 111.418 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.16 -17.41 46.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.75 -29.03 66.28 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.794 -1.192 . . . . 0.0 110.353 168.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mp -73.79 -13.77 61.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.954 -1.091 . . . . 0.0 113.478 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.36 -33.45 25.83 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.486 1.039 . . . . 0.0 113.523 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.31 140.23 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.943 1.297 . . . . 0.0 110.597 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -67.13 158.78 30.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.868 1.267 . . . . 0.0 113.347 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.47 -32.69 71.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.44 1.096 . . . . 0.0 112.03 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.4 m -62.4 -23.44 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.909 1.684 . . . . 0.0 113.924 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.4 ' CG ' HG23 ' A' ' 52' ' ' VAL . 11.2 m-85 -124.78 -5.96 7.45 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.765 1.226 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -57.0 -46.78 99.84 Favored Pre-proline 0 CA--C 1.549 0.909 0 O-C-N 120.272 -1.517 . . . . 0.0 111.699 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -65.65 -18.31 58.57 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.097 2.531 . . . . 0.0 114.366 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.545 HG22 HD21 ' A' ' 50' ' ' LEU . 25.6 m -77.13 -38.02 52.92 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.818 1.247 . . . . 0.0 110.464 173.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.26 99.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.262 1.025 . . . . 0.0 112.476 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.56 -45.71 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.78 . . . . 0.0 109.094 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.5 -57.57 10.32 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 125.645 1.593 . . . . 0.0 113.464 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.62 -12.32 60.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.485 2.642 . . . . 0.0 113.905 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.54 -31.35 13.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.841 1.2 . . . . 0.0 113.627 169.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -88.59 -45.69 9.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.215 1.006 . . . . 0.0 112.343 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.61 84.09 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.791 2.436 . . . . 0.0 113.474 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -18.27 39.25 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.49 1.116 . . . . 0.0 111.865 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -84.69 -35.78 22.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 112.563 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.27 -6.82 54.73 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -146.67 -140.23 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.139 2.576 . . . . 0.0 107.621 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -153.68 -65.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -127.71 160.92 58.33 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 126.966 2.106 . . . . 0.0 110.031 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -82.09 0.24 9.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.16 1.45 . . . . 0.0 114.475 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -60.62 -19.46 57.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 113.456 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -131.79 7.89 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.011 1.324 . . . . 0.0 113.774 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.78 138.81 40.12 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.378 -1.451 . . . . 0.0 114.502 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.86 143.28 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.01 2.124 . . . . 0.0 107.087 168.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.582 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -73.15 133.39 44.07 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.415 1.007 . . . . 0.0 108.983 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -94.35 38.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.834 -1.166 . . . . 0.0 112.684 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 13.1 p -66.66 -21.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.809 -1.807 . . . . 0.0 112.845 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -55.2 -29.84 58.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.684 1.593 . . . . 0.0 112.915 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -94.47 -53.51 1.69 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.612 0.625 . . . . 0.0 112.567 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.24 -42.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.181 0.992 . . . . 0.0 113.357 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.99 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.143 1.338 . . . . 0.0 112.945 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 16.6 m -73.19 -37.73 66.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.556 1.142 . . . . 0.0 111.844 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.419 HG12 HD12 ' B' ' 151' ' ' ILE . 23.5 t -83.42 -27.74 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.074 1.75 . . . . 0.0 113.408 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 26.4 m -53.17 -59.69 8.57 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.323 1.449 . . . . 0.0 112.917 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.32 -15.12 46.29 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.298 2.665 . . . . 0.0 113.52 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.89 -62.51 1.47 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.115 0.966 . . . . 0.0 111.052 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 147' ' ' VAL . 33.1 mt -69.74 -30.99 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.38 -0.825 . . . . 0.0 112.822 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.38 -44.02 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.01 -1.056 . . . . 0.0 112.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -71.73 -46.08 59.71 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 110.807 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -27.05 67.72 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.577 -1.327 . . . . 0.0 113.309 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 m -75.1 -14.72 60.6 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.06 -36.02 21.47 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.595 1.543 . . . . 0.0 110.562 167.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -59.8 -38.62 82.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.038 0.935 . . . . 0.0 112.464 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -135.71 61.69 1.65 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.931 1.292 . . . . 0.0 112.022 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -49.16 -38.02 24.21 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.994 1.317 . . . . 0.0 112.877 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.51 -2.53 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.407 1.083 . . . . 0.0 113.825 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.68 158.42 24.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 112.638 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -80.44 137.38 36.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.388 1.475 . . . . 0.0 111.274 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.64 -44.14 91.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.367 1.067 . . . . 0.0 113.364 -170.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.79 -41.94 78.6 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.315 0.961 . . . . 0.0 112.111 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.25 -36.71 83.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.876 0.471 . . . . 0.0 112.059 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -74.62 -37.65 62.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.34 -38.73 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.099 1.318 . . . . 0.0 111.466 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.07 -45.53 93.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.291 0.636 . . . . 0.0 111.609 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.98 -49.07 69.03 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.763 1.173 . . . . 0.0 113.613 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.75 -34.34 66.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.634 1.217 . . . . 0.0 112.939 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -61.74 -37.14 83.12 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.193 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.26 -43.36 95.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.651 0.781 . . . . 0.0 111.825 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -23.13 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.728 -1.232 . . . . 0.0 112.331 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.84 -45.8 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.565 1.946 . . . . 0.0 112.528 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt . . . . . 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 0.0 113.8 -175.436 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 CA--C 1.534 0.488 0 N-CA-C 113.812 0.659 . . . . 0.0 113.812 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.37 1.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.22 2.208 . . . . 0.0 116.869 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.7 9.73 7.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.226 1.41 . . . . 0.0 113.576 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -132.86 -40.84 0.94 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.742 1.217 . . . . 0.0 113.904 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -83.89 158.7 21.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.596 0.713 . . . . 0.0 112.601 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -85.0 151.15 24.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -23.93 25.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.391 1.876 . . . . 0.0 114.127 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.34 -36.13 68.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.545 1.066 . . . . 0.0 111.378 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.73 -21.66 60.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.884 0.874 . . . . 0.0 113.071 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -66.64 -24.2 66.27 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -80.32 -14.79 58.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.266 1.426 . . . . 0.0 113.146 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.71 -29.87 40.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.941 . . . . 0.0 112.248 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.37 138.16 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.591 1.956 . . . . 0.0 110.118 172.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.2 157.74 30.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.728 0.811 . . . . 0.0 112.713 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -56.06 -30.92 62.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.228 1.411 . . . . 0.0 111.577 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.6 m -62.48 -27.67 69.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.229 1.812 . . . . 0.0 113.984 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -127.45 -9.35 5.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.745 1.218 . . . . 0.0 113.896 -170.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -55.2 -40.98 88.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 119.543 -1.973 . . . . 0.0 112.034 168.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -62.74 -24.18 74.63 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.305 2.67 . . . . 0.0 113.848 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.9 m -78.73 -33.53 46.6 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.418 1.087 . . . . 0.0 110.455 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.87 91.53 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.0 -36.08 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.048 0.84 . . . . 0.0 110.974 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.58 56.92 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.437 1.017 . . . . 0.0 114.489 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -11.44 60.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.568 2.184 . . . . 0.0 113.788 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.99 -48.25 7.91 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.092 166.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.32 -33.36 55.56 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 113.691 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.03 94.22 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.937 1.295 . . . . 0.0 112.159 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' B' ' 127' ' ' ALA . 0.6 OUTLIER -77.95 -40.51 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.65 1.18 . . . . 0.0 110.595 -175.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.28 -20.84 65.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.984 0.914 . . . . 0.0 113.433 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -84.21 -19.88 33.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -153.53 -124.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.251 . . . . 0.0 112.761 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -162.91 -64.13 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.071 2.148 . . . . 0.0 111.913 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -113.62 160.57 31.28 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.539 2.336 . . . . 0.0 111.196 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.41 2.59 8.29 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 114.578 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -59.17 -26.48 64.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.663 1.185 . . . . 0.0 112.768 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -118.7 25.69 10.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.01 1.724 . . . . 0.0 112.211 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.7 118.35 29.24 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.499 -1.376 . . . . 0.0 112.165 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.89 127.99 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.627 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -63.58 122.6 16.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.648 1.113 . . . . 0.0 110.153 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -89.69 46.71 1.39 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.161 -0.962 . . . . 0.0 113.015 -168.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.369 2.5 p -63.7 -15.06 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 O-C-N 120.645 -1.285 . . . . 0.0 112.43 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.78 -44.67 70.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.695 1.598 . . . . 0.0 112.185 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.66 4.98 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -50.17 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.825 . . . . 0.0 112.702 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.39 67.14 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.501 1.046 . . . . 0.0 112.453 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 m -66.19 -48.8 69.48 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.129 1.372 . . . . 0.0 112.218 171.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.2 m -87.04 -18.47 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -46.92 -63.1 1.51 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.107 1.363 . . . . 0.0 112.037 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -69.44 0.39 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.614 2.876 . . . . 0.0 114.57 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.52 -57.2 2.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.178 1.791 . . . . 0.0 110.029 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mt -68.83 -32.2 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.828 1.251 . . . . 0.0 112.369 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.79 -42.16 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.958 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -72.99 -46.9 49.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.456 0.646 . . . . 0.0 110.017 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.43 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.305 -0.872 . . . . 0.0 113.06 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.7 m -74.17 -14.26 60.93 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -34.99 16.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.36 1.436 . . . . 0.0 111.53 168.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -60.84 -38.0 83.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.16 . . . . 0.0 111.904 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -138.72 56.64 1.7 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.541 1.536 . . . . 0.0 112.318 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -49.97 -33.98 19.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.852 2.061 . . . . 0.0 113.121 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.6 -1.9 58.16 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.55 144.36 44.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.042 0.837 . . . . 0.0 111.827 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.76 29.37 0.2 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.287 1.835 . . . . 0.0 114.411 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 t80 52.01 -171.25 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.704 2.002 . . . . 0.0 112.814 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 tttt 62.26 -44.32 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 129.657 3.183 . . . . 0.0 115.288 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.77 -35.73 64.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.494 1.918 . . . . 0.0 111.671 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -43.59 79.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.673 0.789 . . . . 0.0 112.9 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.38 -37.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.003 0.819 . . . . 0.0 111.405 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -69.37 -48.79 60.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.242 1.017 . . . . 0.0 111.968 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.96 94.64 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.147 1.356 . . . . 0.0 113.845 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.21 -34.17 63.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.202 1.501 . . . . 0.0 112.637 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.5 -41.62 94.66 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.565 1.075 . . . . 0.0 111.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.97 -48.17 83.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.25 1.02 . . . . 0.0 111.393 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -28.88 70.14 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.427 -1.421 . . . . 0.0 112.346 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.2 mt . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.956 1.303 . . . . 0.0 112.707 -178.039 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 CA--C 1.537 0.641 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 m -55.71 -25.38 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.22 -27.68 60.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.552 1.141 . . . . 0.0 113.097 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m -119.04 -19.28 8.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -169.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.24 160.76 29.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.142 0.883 . . . . 0.0 111.878 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 53.4 p -95.73 168.42 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.708 1.242 . . . . 0.0 113.871 -169.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.46 -26.7 67.32 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.293 -0.88 . . . . 0.0 112.119 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -62.74 -42.12 99.51 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.421 168.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.4 -30.4 71.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.375 0.67 . . . . 0.0 112.087 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.417 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 66.0 t80 -69.17 -23.74 63.98 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.035 -1.041 . . . . 0.0 111.636 173.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.04 -8.96 56.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.417 1.087 . . . . 0.0 113.359 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.08 -34.99 43.13 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.187 0.995 . . . . 0.0 112.699 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.05 139.12 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.614 1.566 . . . . 0.0 110.187 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.4 158.87 32.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.368 1.067 . . . . 0.0 113.318 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.83 -32.34 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.492 1.517 . . . . 0.0 112.125 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.6 m -59.62 -29.44 68.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.727 1.611 . . . . 0.0 113.53 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.45 -4.38 6.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.871 1.268 . . . . 0.0 114.09 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -56.02 -41.18 89.71 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 120.168 -1.582 . . . . 0.0 113.001 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -62.76 -26.45 75.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.676 2.251 . . . . 0.0 113.239 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 50' ' ' LEU . 27.6 m -76.2 -35.6 59.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.526 1.13 . . . . 0.0 111.26 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.39 98.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.693 1.197 . . . . 0.0 113.645 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.63 -35.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.146 1.339 . . . . 0.0 109.793 168.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.88 -46.47 60.48 Favored Glycine 0 C--O 1.218 -0.89 0 C-N-CA 125.02 1.295 . . . . 0.0 114.589 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.29 -35.14 77.38 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 121.489 2.644 . . . . 0.0 112.738 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.83 70.81 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.186 -0.946 . . . . 0.0 112.45 173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -76.71 -46.48 25.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.348 1.059 . . . . 0.0 111.985 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -61.75 -51.64 67.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.478 1.511 . . . . 0.0 111.99 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -31.08 69.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.431 0.692 . . . . 0.0 111.086 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.41 -21.44 65.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.795 0.838 . . . . 0.0 113.196 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -84.43 -21.81 30.61 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.4 -124.79 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -162.98 -66.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 128.006 2.523 . . . . 0.0 110.281 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.6 164.97 13.76 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 126.714 2.005 . . . . 0.0 110.417 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -90.94 7.06 3.66 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.958 2.439 . . . . 0.0 114.001 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -63.95 -25.91 68.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.759 -1.213 . . . . 0.0 113.011 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.14 0.9 25.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.558 1.543 . . . . 0.0 114.382 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.62 131.27 44.37 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.833 -1.167 . . . . 0.0 113.563 -172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.24 129.58 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 127.051 2.14 . . . . 0.0 106.814 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.8 130.98 45.54 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.661 1.118 . . . . 0.0 112.269 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -88.98 50.29 1.93 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.958 1.303 . . . . 0.0 111.442 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.25 -38.87 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -166.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.84 -36.64 84.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.734 1.607 . . . . 0.0 111.476 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.5 41.19 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 123.95 0.786 . . . . 0.0 111.529 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.3 -42.95 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.998 0.919 . . . . 0.0 111.547 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.58 -34.94 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 112.761 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 24.7 m -64.56 -43.6 93.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.561 1.145 . . . . 0.0 111.73 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 25.2 t -80.14 -33.19 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.995 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.9 m -40.5 -61.9 1.08 Allowed Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.425 1.89 . . . . 0.0 113.891 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.85 -15.23 48.17 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.493 2.129 . . . . 0.0 113.632 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.44 -61.38 1.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.219 1.008 . . . . 0.0 111.231 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.34 -25.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.957 -1.089 . . . . 0.0 113.066 177.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.84 -52.77 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.026 0.83 . . . . 0.0 110.641 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -68.88 -47.1 66.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.705 0.402 . . . . 0.0 110.894 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -29.75 70.43 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.61 -1.306 . . . . 0.0 113.008 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.94 -15.25 60.21 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -32.29 22.61 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.058 1.299 . . . . 0.0 111.238 167.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -61.39 -38.22 86.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.945 0.898 . . . . 0.0 112.121 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -145.15 70.69 1.27 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 0.0 112.224 -170.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -54.91 -42.26 71.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -76.53 -15.72 59.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.87 158.4 35.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 111.926 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -69.21 143.66 53.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 169.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 35.7 t80 -58.1 -41.31 83.27 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -62.65 -33.02 74.2 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.4 -39.18 86.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.319 1.047 . . . . 0.0 111.838 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -37.86 62.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.937 0.895 . . . . 0.0 112.736 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.95 -48.33 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 119.302 0.955 . . . . 0.0 109.906 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.54 -46.83 74.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.01 0.924 . . . . 0.0 112.395 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.26 -42.23 99.72 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.26 0.934 . . . . 0.0 113.479 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.62 -33.61 62.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.454 1.127 . . . . 0.0 112.679 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.73 -37.88 88.28 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.465 -1.397 . . . . 0.0 111.878 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.41 -47.59 83.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.331 1.052 . . . . 0.0 111.933 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -26.15 68.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.051 -1.03 . . . . 0.0 112.285 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 31.6 mt -79.23 -49.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.913 1.685 . . . . 0.0 112.194 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt . . . . . 0 N--CA 1.482 1.15 0 C-N-CA 125.138 1.375 . . . . 0.0 113.523 -171.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 N--CA 1.471 0.205 0 N-CA-C 113.043 0.363 . . . . 0.0 113.043 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.77 -22.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.656 1.182 . . . . 0.0 113.605 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -68.57 -25.62 64.99 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.736 2.014 . . . . 0.0 113.827 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -133.25 -11.53 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -76.72 123.13 25.71 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 109.161 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -90.07 148.08 23.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 112.935 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -54.96 -30.0 58.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -63.26 -42.06 99.11 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.786 1.175 . . . . 0.0 111.693 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.23 0.27 57.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.865 1.266 . . . . 0.0 112.36 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 -28.07 20.77 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.036 -1.04 . . . . 0.0 111.838 171.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.82 -5.54 6.18 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.154 -0.966 . . . . 0.0 112.588 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.49 -27.17 60.45 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.427 1.491 . . . . 0.0 112.021 170.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.44 135.02 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.355 1.862 . . . . 0.0 109.749 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.09 157.46 33.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.636 0.774 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.85 -27.77 63.52 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.181 1.392 . . . . 0.0 112.238 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 m -66.53 -23.16 66.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 172.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CG ' HG23 ' B' ' 141' ' ' VAL . 17.9 m-85 -124.94 -11.09 7.16 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -61.38 -38.72 55.58 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.619 -1.925 . . . . 0.0 112.303 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.81 -26.06 74.77 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.129 2.552 . . . . 0.0 112.714 169.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 HD21 ' B' ' 139' ' ' LEU . 51.7 m -73.71 -36.34 65.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.651 1.18 . . . . 0.0 110.772 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.08 -49.73 74.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.218 1.007 . . . . 0.0 113.577 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 58' ' ' VAL 0.256 4.2 p -64.18 -33.77 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 118.99 0.814 . . . . 0.0 110.343 170.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.39 -52.06 34.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.405 168.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.36 -39.92 89.45 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.623 2.211 . . . . 0.0 112.599 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.97 68.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.244 -0.91 . . . . 0.0 112.69 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.69 -40.52 11.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.699 1.2 . . . . 0.0 112.385 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.34 80.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 111.859 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -26.44 60.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 0.0 111.058 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -68.27 -22.79 64.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -86.65 -24.69 25.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -154.13 -141.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.503 1.521 . . . . 0.0 111.108 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -165.11 136.23 4.01 Favored 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.105 4.162 . . . . 0.0 108.291 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.98 163.6 0.1 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.772 2.029 . . . . 0.0 113.061 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -92.59 9.27 2.6 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.034 1.823 . . . . 0.0 113.807 172.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -57.26 -24.63 56.05 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 112.971 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -130.6 31.93 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.563 1.545 . . . . 0.0 111.996 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.02 138.78 31.22 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.002 -1.686 . . . . 0.0 113.638 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.42 134.76 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.787 2.435 . . . . 0.0 106.174 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 111.74 4.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.012 1.278 . . . . 0.0 108.941 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -85.61 53.87 2.92 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.935 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.363 2.7 p -64.0 -14.24 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 -169.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.4 -42.57 53.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.853 1.661 . . . . 0.0 111.993 166.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.85 -52.94 4.15 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.24 -48.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.364 1.065 . . . . 0.0 112.923 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.02 71.37 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.585 1.084 . . . . 0.0 112.457 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.3 m -71.57 -43.62 65.98 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.658 1.583 . . . . 0.0 112.829 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 33' ' ' VAL . 1.6 p -79.93 -22.97 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.135 0.974 . . . . 0.0 113.623 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 m -49.26 -60.82 4.16 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 125.155 1.382 . . . . 0.0 112.945 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -66.33 -5.34 12.4 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.374 2.716 . . . . 0.0 114.465 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.4 -61.73 1.67 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -67.41 -35.23 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.361 1.064 . . . . 0.0 112.245 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.29 -51.66 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.416 1.086 . . . . 0.0 110.384 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -73.02 -42.34 63.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.388 0.613 . . . . 0.0 110.902 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -29.69 70.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.351 0.66 . . . . 0.0 112.358 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.42 -17.16 64.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -35.45 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.216 1.371 . . . . 0.0 111.726 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.93 -38.14 84.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.893 0.877 . . . . 0.0 112.601 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -140.29 72.98 1.41 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -51.01 -31.76 19.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.659 1.983 . . . . 0.0 113.294 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -93.49 0.09 56.59 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.91 154.22 36.14 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 111.418 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.63 149.35 34.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 110.262 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.1 -37.44 82.74 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.215 -0.928 . . . . 0.0 113.261 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -60.4 -37.66 81.52 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.577 -1.327 . . . . 0.0 112.765 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.82 -39.75 94.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.438 0.695 . . . . 0.0 111.315 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -62.84 -44.02 97.24 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.32 -41.36 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.056 0.843 . . . . 0.0 110.712 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.53 -54.1 22.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.517 0.727 . . . . 0.0 112.116 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.85 99.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.944 0.783 . . . . 0.0 113.108 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -28.07 57.31 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.425 -1.044 . . . . 0.0 113.275 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -65.07 -40.74 95.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.618 1.099 . . . . 0.0 111.146 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.01 -43.33 99.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.353 0.661 . . . . 0.0 111.731 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -38.21 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.192 1.797 . . . . 0.0 114.226 169.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 124.425 1.09 . . . . 0.0 112.095 -168.445 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 CA-C-O 121.339 0.475 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -67.64 9.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.573 1.549 . . . . 0.0 114.266 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.35 5.29 8.41 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.567 1.947 . . . . 0.0 113.549 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 8.1 p -144.57 -21.67 0.53 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -87.82 -176.29 5.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.2 p -113.35 167.43 10.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.303 1.441 . . . . 0.0 113.912 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -20.82 28.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.01 -34.56 72.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.759 1.163 . . . . 0.0 112.44 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.5 -20.95 63.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.661 0.784 . . . . 0.0 113.099 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.66 -23.65 66.17 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.801 -1.187 . . . . 0.0 111.921 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.8 -17.62 43.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.904 1.281 . . . . 0.0 113.598 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.44 -28.82 56.75 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.93 0.892 . . . . 0.0 111.598 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.32 135.78 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.12 1.768 . . . . 0.0 110.14 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.04 158.85 30.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.008 0.923 . . . . 0.0 112.844 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.51 -35.4 60.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.833 1.253 . . . . 0.0 112.032 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 m -65.31 -22.49 66.84 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.784 1.234 . . . . 0.0 114.241 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -126.36 -5.11 6.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -58.33 -39.22 73.75 Favored Pre-proline 0 N--CA 1.478 0.936 0 O-C-N 119.689 -1.882 . . . . 0.0 113.43 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.81 -26.43 79.47 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.348 2.032 . . . . 0.0 112.984 169.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -76.96 -32.69 57.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.424 1.089 . . . . 0.0 111.715 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.57 92.36 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.879 -1.138 . . . . 0.0 113.239 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.88 -34.48 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.674 0.67 . . . . 0.0 110.764 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.81 -56.84 14.23 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.364 0.983 . . . . 0.0 112.954 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.74 -16.92 62.38 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.748 2.274 . . . . 0.0 113.807 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.72 -28.64 18.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -109.48 -30.62 7.86 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.507 1.503 . . . . 0.0 113.419 -173.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.66 77.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.313 2.245 . . . . 0.0 112.194 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.11 -24.6 30.23 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.898 1.279 . . . . 0.0 111.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -18.15 64.7 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.04 0.836 . . . . 0.0 113.053 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -110.66 -5.12 15.1 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -128.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.189 1.396 . . . . 0.0 112.163 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -159.65 -62.08 0.07 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.516 1.926 . . . . 0.0 112.491 -169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -119.89 162.25 34.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 126.975 2.11 . . . . 0.0 110.796 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.79 5.22 6.55 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.273 1.982 . . . . 0.0 114.619 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.19 -24.89 60.64 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.43 13.63 18.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.827 2.051 . . . . 0.0 112.975 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.74 22.81 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 119.78 -1.825 . . . . 0.0 112.928 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.9 107.23 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.341 1.857 . . . . 0.0 106.162 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 31' ' ' THR . 2.9 tm? -61.52 124.94 22.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.143 0.577 . . . . 0.0 109.496 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -99.21 66.79 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.477 1.035 . . . . 0.0 111.98 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' VAL . . . . . 0.404 HG23 ' CG ' ' A' ' 28' ' ' PHE . 1.8 p -64.63 -33.9 66.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.7 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.62 -39.67 84.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.827 1.649 . . . . 0.0 111.937 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.24 -48.22 66.03 Favored Glycine 0 N--CA 1.47 0.961 0 O-C-N 122.037 -0.414 . . . . 0.0 112.219 171.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.18 -41.42 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.626 -0.926 . . . . 0.0 112.264 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.04 71.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.432 1.469 . . . . 0.0 112.325 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 44.1 m -63.22 -43.25 98.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.677 0.791 . . . . 0.0 111.464 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -84.7 -27.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.987 1.315 . . . . 0.0 113.583 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.4 m -42.2 -61.36 1.6 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.681 1.993 . . . . 0.0 113.536 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.64 -12.35 34.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.313 2.009 . . . . 0.0 113.916 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.9 -64.53 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.013 . . . . 0.0 110.98 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.551 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -71.16 -24.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 120.887 -1.133 . . . . 0.0 113.432 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 t -58.94 -51.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 110.204 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -73.41 -47.91 38.1 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.184 0.594 . . . . 0.0 111.042 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.63 68.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.515 -1.365 . . . . 0.0 113.531 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.5 m -74.76 -21.64 59.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 169.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -30.99 33.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.202 1.365 . . . . 0.0 111.553 169.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -63.29 -38.24 90.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.846 0.858 . . . . 0.0 111.531 168.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -143.09 66.63 1.31 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.06 0.944 . . . . 0.0 112.243 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.16 -37.21 53.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.004 1.322 . . . . 0.0 112.328 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -82.38 -1.16 49.03 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.788 1.235 . . . . 0.0 113.545 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.47 146.44 44.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 112.094 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -65.71 149.36 50.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.749 1.22 . . . . 0.0 111.205 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -48.89 151.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.079 1.352 . . . . 0.0 112.182 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm 60.26 -29.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.489 2.716 . . . . 0.0 116.792 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.66 -34.28 76.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.809 1.644 . . . . 0.0 111.714 172.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.08 -37.55 78.54 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.601 -0.687 . . . . 0.0 112.367 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.96 -47.74 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 124.11 0.964 . . . . 0.0 110.034 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -64.68 -42.91 95.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 112.342 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.64 -41.03 99.19 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.625 1.107 . . . . 0.0 113.165 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.47 -35.45 65.7 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.111 -1.229 . . . . 0.0 112.934 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.24 -37.72 86.51 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.988 -1.07 . . . . 0.0 112.037 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.5 -46.29 90.68 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 0.0 111.812 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -20.0 65.99 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.946 -1.096 . . . . 0.0 112.789 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.3 mt -86.46 -47.02 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.552 1.941 . . . . 0.0 112.396 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.48 1.067 0 C-N-CA 125.215 1.406 . . . . 0.0 113.348 -173.704 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.533 0.443 0 CA-C-O 122.054 0.772 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.25 -19.19 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.663 1.585 . . . . 0.0 114.874 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -95.29 -15.95 22.78 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.9 p -109.56 -32.73 7.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.984 1.265 . . . . 0.0 114.146 -172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -88.6 -179.96 6.15 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.771 0.829 . . . . 0.0 113.152 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.9 p -105.62 160.42 15.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.436 1.494 . . . . 0.0 114.352 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -25.29 60.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.527 1.931 . . . . 0.0 115.239 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.84 -35.31 66.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.582 1.083 . . . . 0.0 111.463 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.07 -18.12 60.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.266 1.026 . . . . 0.0 113.54 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -65.93 -29.3 69.69 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.808 -1.182 . . . . 0.0 110.573 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.91 -18.45 58.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.638 1.575 . . . . 0.0 113.082 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.36 -27.73 38.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.482 1.113 . . . . 0.0 112.006 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.8 137.62 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.843 1.657 . . . . 0.0 108.906 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -65.69 154.89 37.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.882 0.873 . . . . 0.0 112.536 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.11 -35.32 73.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.429 1.092 . . . . 0.0 111.777 -174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.4 m -61.65 -25.13 67.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.902 1.681 . . . . 0.0 113.713 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.98 -2.8 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.055 -173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -57.56 -43.73 99.08 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 119.906 -1.746 . . . . 0.0 112.148 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -62.69 -25.21 75.01 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.871 2.381 . . . . 0.0 113.92 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 HD13 ' B' ' 144' ' ' ILE . 89.5 m -75.8 -34.2 60.16 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.029 0.931 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.768 1.227 . . . . 0.0 113.587 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.18 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.079 0.854 . . . . 0.0 110.931 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.49 -51.1 50.13 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 124.973 1.273 . . . . 0.0 113.755 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 144' ' ' ILE . 3.2 m-85 -69.13 -23.51 63.99 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.283 2.542 . . . . 0.0 113.339 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 -61.48 1.79 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.325 -0.86 . . . . 0.0 109.296 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -73.66 -29.78 62.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.392 -1.443 . . . . 0.0 114.739 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' B' ' 124' ' ' PHE . . . -64.11 -41.39 97.28 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.03 -1.044 . . . . 0.0 110.933 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.434 HD13 HD13 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -83.39 -38.52 21.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.456 1.102 . . . . 0.0 110.329 -178.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -64.3 -33.52 76.02 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.571 1.148 . . . . 0.0 113.483 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -80.66 -13.77 58.73 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -155.25 -136.1 0.05 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.995 1.718 . . . . 0.0 110.769 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -172.18 127.08 0.56 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 130.532 3.533 . . . . 0.0 108.879 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 mttt 60.58 166.35 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.033 0 C-N-CA 125.787 1.635 . . . . 0.0 113.845 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -88.16 15.18 2.16 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.033 1.822 . . . . 0.0 114.846 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.77 -30.41 70.01 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.863 -1.148 . . . . 0.0 112.203 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -116.54 27.52 9.15 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.57 1.948 . . . . 0.0 112.167 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 107.75 14.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.915 -1.74 . . . . 0.0 111.763 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.54 118.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.685 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? -67.4 117.15 8.98 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.173 0.897 . . . . 0.0 112.406 -167.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -89.72 53.16 2.49 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.404 -1.435 . . . . 0.0 111.608 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.323 1.2 p -60.75 -41.33 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -167.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -63.23 -38.51 91.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.583 1.538 . . . . 0.0 112.305 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -54.09 39.85 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -43.45 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.492 -1.005 . . . . 0.0 112.164 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.29 67.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.203 . . . . 0.0 112.804 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -71.25 -45.13 63.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.251 1.421 . . . . 0.0 111.885 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 62' ' ' ILE . 2.2 t -86.53 -19.66 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.1 m -45.64 -61.91 2.11 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 125.123 1.369 . . . . 0.0 112.415 173.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.47 -3.66 12.92 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.599 2.866 . . . . 0.0 114.178 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.8 -64.45 1.17 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.899 1.28 . . . . 0.0 108.984 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 58' ' ' VAL . 21.8 mt -67.78 -34.67 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.959 0.904 . . . . 0.0 111.977 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.57 -49.69 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.88 0.872 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.13 -45.92 58.62 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.77 -28.72 69.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.291 -0.88 . . . . 0.0 113.183 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.0 m -75.26 -13.31 60.43 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.47 -34.99 16.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.469 1.486 . . . . 0.0 111.178 167.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -60.63 -38.27 84.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.82 170.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -138.18 52.94 1.82 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.15 1.38 . . . . 0.0 112.68 -168.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -48.51 -35.8 13.92 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.731 2.013 . . . . 0.0 113.259 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -88.49 -6.99 57.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.592 1.157 . . . . 0.0 113.755 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.78 161.58 27.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.044 0.938 . . . . 0.0 112.023 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.16 139.11 57.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 112.234 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.5 -53.1 59.78 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.841 . . . . 0.0 112.844 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -71.96 -32.67 67.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.693 -1.254 . . . . 0.0 112.853 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -64.98 -27.38 68.8 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.106 -0.996 . . . . 0.0 112.383 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -70.31 -37.37 74.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.504 1.047 . . . . 0.0 113.041 171.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.97 -38.24 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.771 1.169 . . . . 0.0 111.327 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -61.02 -48.33 82.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.055 0.942 . . . . 0.0 111.509 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.02 98.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.981 1.277 . . . . 0.0 113.649 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.8 -36.47 67.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.757 1.278 . . . . 0.0 112.651 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -60.62 -39.97 90.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.562 1.073 . . . . 0.0 111.631 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.04 -44.51 96.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.463 1.105 . . . . 0.0 111.931 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -26.45 68.59 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.962 -1.086 . . . . 0.0 112.352 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.251 10.1 mt . . . . . 0 CA--C 1.54 0.591 0 C-N-CA 124.892 1.277 . . . . 0.0 112.564 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 CA--C 1.539 0.727 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 m -55.39 -24.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.887 1.675 . . . . 0.0 114.242 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.98 -10.39 53.29 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.3 p -121.85 -29.74 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -86.94 172.36 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.4 p -92.67 160.91 14.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -24.0 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.38 -37.54 70.23 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.853 -1.155 . . . . 0.0 111.505 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.14 -28.43 69.64 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.981 0.912 . . . . 0.0 112.973 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.27 -27.16 69.15 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.113 -0.992 . . . . 0.0 111.152 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.2 mt -84.49 -10.71 57.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.802 1.241 . . . . 0.0 113.104 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.96 -29.38 22.09 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.959 1.303 . . . . 0.0 112.371 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.4 140.05 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.998 1.719 . . . . 0.0 110.242 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.6 159.39 32.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.271 1.029 . . . . 0.0 113.067 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.93 -33.89 71.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.086 1.354 . . . . 0.0 111.951 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m -66.18 -21.18 66.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.666 1.587 . . . . 0.0 114.007 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -126.73 -8.85 6.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.39 1.076 . . . . 0.0 113.308 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.81 -43.31 99.32 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 120.06 -1.65 . . . . 0.0 112.536 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.65 -25.0 61.99 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.688 2.259 . . . . 0.0 113.151 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.685 HG22 HD21 ' A' ' 50' ' ' LEU . 18.4 m -72.96 -32.37 65.17 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 111.218 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.77 89.42 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 170.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.98 -33.73 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.683 1.583 . . . . 0.0 110.043 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.76 7.6 2.12 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 126.57 2.033 . . . . 0.0 116.008 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 2.4 m-85 -121.48 -12.32 8.58 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.58 1.69 . . . . 0.0 112.852 169.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.17 -69.24 0.76 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.452 1.023 . . . . 0.0 110.77 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.74 -32.33 72.86 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.895 -1.128 . . . . 0.0 111.492 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.58 -35.88 68.72 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.472 1.109 . . . . 0.0 113.169 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -83.96 -42.56 16.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.186 0.994 . . . . 0.0 109.319 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.04 -39.3 74.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 0.0 113.834 -173.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -92.44 -8.28 45.17 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -9.6 0.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -171.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.326 3.8 p30 55.28 -34.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 121.437 3.866 . . . . 0.0 121.437 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -137.6 153.76 74.49 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 126.941 2.096 . . . . 0.0 110.648 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.84 -1.12 8.78 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 121.685 1.637 . . . . 0.0 114.67 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.29 -13.49 60.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.779 1.232 . . . . 0.0 112.87 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -127.78 8.25 6.29 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.133 1.373 . . . . 0.0 113.93 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.0 130.52 36.6 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.304 -1.497 . . . . 0.0 114.51 -170.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 20.6 t -117.28 135.35 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.759 2.024 . . . . 0.0 106.852 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 31' ' ' THR . 2.3 tm? -75.7 127.26 32.66 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.503 1.047 . . . . 0.0 111.446 -169.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -89.75 52.56 2.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.532 1.533 . . . . 0.0 111.939 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.378 1.7 p -67.29 -44.69 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -64.32 -36.94 85.75 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 123.075 2.671 . . . . 0.0 111.164 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.49 -47.34 88.11 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.642 HD13 HG21 ' A' ' 31' ' ' THR . 22.9 mt -56.46 -48.62 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.295 1.438 . . . . 0.0 111.618 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.6 81.45 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.531 1.059 . . . . 0.0 112.22 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 52.1 m -67.05 -42.29 85.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.937 1.295 . . . . 0.0 111.811 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.99 -24.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.498 1.519 . . . . 0.0 113.04 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -43.71 -61.02 2.14 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 126.748 2.019 . . . . 0.0 113.588 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.24 -14.16 43.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.537 2.158 . . . . 0.0 113.638 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -74.86 -56.37 4.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.105 0.962 . . . . 0.0 111.416 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -25.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.925 -1.109 . . . . 0.0 113.436 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.1 t -57.62 -51.36 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.824 0.85 . . . . 0.0 110.265 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 -46.86 34.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.429 0.692 . . . . 0.0 111.151 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.62 69.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.608 -1.308 . . . . 0.0 113.152 -171.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.3 m -77.09 -11.31 59.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.48 -31.63 18.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.074 1.306 . . . . 0.0 111.192 167.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -59.34 -38.73 81.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.199 1.0 . . . . 0.0 112.47 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -145.17 85.54 1.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.718 0.77 . . . . 0.0 112.095 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -62.53 -39.32 93.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.463 1.505 . . . . 0.0 112.406 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.89 -10.2 59.74 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.23 141.93 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.784 0.834 . . . . 0.0 112.828 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.1 40.39 0.98 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.392 2.277 . . . . 0.0 111.298 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -106.81 117.75 34.87 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -163.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -76.84 -26.42 54.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.015 1.326 . . . . 0.0 109.428 162.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.91 -23.16 63.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.376 1.471 . . . . 0.0 112.707 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -63.08 -40.32 97.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.779 0.832 . . . . 0.0 111.809 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -39.93 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.812 0.845 . . . . 0.0 110.69 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -65.41 -38.78 90.96 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.672 0.789 . . . . 0.0 112.112 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.95 99.75 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.986 1.279 . . . . 0.0 112.783 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' GLU . . . . . 0.453 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 25.7 mm-40 -71.35 -36.1 71.38 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.688 1.244 . . . . 0.0 113.075 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.93 -42.08 93.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.736 1.153 . . . . 0.0 111.594 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -49.63 76.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.088 1.355 . . . . 0.0 110.937 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -27.53 68.92 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.731 -1.231 . . . . 0.0 112.072 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -80.23 -47.41 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.957 1.703 . . . . 0.0 113.027 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 N--CA 1.481 1.098 0 C-N-CA 124.749 1.22 . . . . 0.0 112.932 -171.891 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.534 0.479 0 CA-C-O 121.273 0.447 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -65.97 -15.68 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.814 1.245 . . . . 0.0 113.241 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -93.86 10.75 31.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.182 1.793 . . . . 0.0 113.176 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -151.04 -42.07 0.12 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -83.97 148.8 26.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.34 1.066 . . . . 0.0 113.561 -169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.6 p -77.75 172.79 12.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.967 1.707 . . . . 0.0 113.653 -168.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -18.46 8.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.824 1.786 . . . . 0.0 115.824 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.4 -39.1 78.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.273 1.397 . . . . 0.0 110.751 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.55 -22.88 66.15 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.01 -1.057 . . . . 0.0 112.968 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.38 -1.87 32.21 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.699 -0.626 . . . . 0.0 112.507 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.4 mt -110.93 -24.7 10.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.546 1.539 . . . . 0.0 112.615 168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.66 67.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.128 0.971 . . . . 0.0 112.15 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.76 141.6 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.522 1.929 . . . . 0.0 110.655 169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.55 157.51 32.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.489 0.715 . . . . 0.0 112.555 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -54.61 -34.28 61.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.101 1.361 . . . . 0.0 111.981 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 m -64.48 -23.14 67.18 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -125.79 -4.1 7.07 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.738 1.215 . . . . 0.0 112.895 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -60.88 -43.85 92.87 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 119.568 -1.957 . . . . 0.0 112.591 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.05 -18.08 60.9 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.495 2.13 . . . . 0.0 113.241 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -78.82 -34.4 45.3 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.678 1.191 . . . . 0.0 111.653 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -62.99 -41.81 99.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.193 . . . . 0.0 111.852 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.14 -47.37 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.975 0.91 . . . . 0.0 108.898 169.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.56 -49.49 60.78 Favored Glycine 0 C--O 1.209 -1.428 0 C-N-CA 124.996 1.284 . . . . 0.0 113.582 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -69.42 -11.82 61.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 122.109 2.955 . . . . 0.0 114.205 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.28 -49.88 5.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.582 0.753 . . . . 0.0 110.505 166.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -73.34 -30.67 63.49 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.23 -0.919 . . . . 0.0 113.049 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.54 89.15 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 119.497 -2.002 . . . . 0.0 111.479 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.544 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -84.14 -13.69 52.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.026 1.33 . . . . 0.0 111.652 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 -22.28 60.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.003 1.321 . . . . 0.0 113.012 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 -2.68 13.2 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.84 158.57 0.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.978 3.311 . . . . 0.0 106.399 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.89 -27.91 16.81 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 128.091 2.556 . . . . 0.0 114.249 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.42 156.41 79.74 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 126.701 2.001 . . . . 0.0 110.964 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.94 6.83 5.51 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.054 1.836 . . . . 0.0 114.529 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.08 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.688 -1.258 . . . . 0.0 111.936 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.24 2.36 28.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.227 1.811 . . . . 0.0 113.168 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.74 123.46 27.71 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 119.765 -1.835 . . . . 0.0 112.45 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.48 -2.85 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 125.455 1.502 . . . . 0.0 111.972 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.724 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 61.78 119.08 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.403 3.081 . . . . 0.0 112.752 -172.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -93.1 55.43 2.33 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.224 -1.547 . . . . 0.0 112.095 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.322 2.5 p -69.54 -22.02 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.711 -1.243 . . . . 0.0 113.827 -169.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -58.02 -45.74 86.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.928 1.24 . . . . 0.0 111.21 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.46 -49.87 8.8 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.16 -44.43 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.893 0.877 . . . . 0.0 111.81 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.0 66.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.511 1.505 . . . . 0.0 112.773 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -70.99 -37.48 72.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.873 1.269 . . . . 0.0 111.586 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.4 t -90.4 -21.7 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.405 1.482 . . . . 0.0 113.417 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.4 m -46.86 -59.72 4.85 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 125.998 1.719 . . . . 0.0 112.819 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.97 0.52 4.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.157 2.572 . . . . 0.0 114.206 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -88.74 -64.31 1.17 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.389 1.476 . . . . 0.0 110.441 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.29 -29.31 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.907 -1.121 . . . . 0.0 113.2 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.32 -47.33 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.693 0.797 . . . . 0.0 110.459 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.13 -47.34 20.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.435 0.636 . . . . 0.0 110.866 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.99 71.45 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.2 m -76.01 -13.62 60.23 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.205 -0.935 . . . . 0.0 113.48 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.3 -29.05 21.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.849 1.204 . . . . 0.0 111.282 168.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.4 -38.29 80.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.453 0.701 . . . . 0.0 111.993 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.35 90.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 112.429 170.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -55.81 -36.02 66.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.145 1.378 . . . . 0.0 111.367 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -86.99 3.58 45.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.085 1.354 . . . . 0.0 113.375 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.92 151.5 21.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.983 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -59.37 139.25 57.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.788 1.235 . . . . 0.0 111.472 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -56.07 145.14 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.054 1.342 . . . . 0.0 113.401 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 59.06 -24.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.974 2.91 . . . . 0.0 116.916 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.78 -31.13 70.51 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.875 1.67 . . . . 0.0 111.627 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -68.7 -37.03 79.21 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.76 -47.15 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.41 1.084 . . . . 0.0 109.833 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.45 -42.6 98.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.868 0.867 . . . . 0.0 112.358 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.81 -45.62 95.34 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.216 1.389 . . . . 0.0 113.257 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 25.7 mm-40 -72.11 -35.52 69.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.461 1.131 . . . . 0.0 113.16 174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -59.84 -40.55 88.89 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.018 -1.051 . . . . 0.0 111.429 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.78 -45.1 95.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.72 1.208 . . . . 0.0 111.743 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -24.59 67.93 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.135 -0.978 . . . . 0.0 112.623 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.258 5.5 mt . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.111 1.364 . . . . 0.0 112.729 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.542 0.896 0 CA-C-O 120.919 0.3 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.26 -25.95 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 125.621 1.568 . . . . 0.0 114.75 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -79.11 -16.76 56.24 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 18.1 m -128.28 -22.29 3.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -86.95 166.26 15.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.447 1.099 . . . . 0.0 112.598 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 51.5 p -96.46 158.6 15.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.2 -24.56 67.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.32 1.448 . . . . 0.0 114.437 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.66 -37.78 73.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.812 1.187 . . . . 0.0 111.213 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.12 -30.56 71.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.268 1.027 . . . . 0.0 112.786 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -67.02 -23.73 65.94 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.175 -0.953 . . . . 0.0 111.67 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 49.6 mt -80.71 -15.77 55.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.504 1.122 . . . . 0.0 113.178 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.06 -28.85 43.2 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.121 0.968 . . . . 0.0 112.172 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.68 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.916 1.686 . . . . 0.0 110.191 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.39 158.62 33.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.0 112.856 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -53.88 -34.17 58.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.098 1.359 . . . . 0.0 112.368 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 33.5 m -65.95 -22.36 66.48 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.699 1.199 . . . . 0.0 114.107 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.08 -8.16 5.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.556 1.142 . . . . 0.0 113.509 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -57.77 -44.57 99.53 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 119.785 -1.822 . . . . 0.0 112.2 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.29 -27.43 77.99 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.693 2.262 . . . . 0.0 113.254 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.724 HG22 HD21 ' A' ' 50' ' ' LEU . 65.5 m -72.87 -38.92 66.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 0.0 110.962 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.4 94.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.334 1.453 . . . . 0.0 114.147 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.83 -32.69 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 119.432 1.014 . . . . 0.0 110.75 169.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.48 -55.11 21.31 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 125.301 1.429 . . . . 0.0 113.667 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.86 -35.73 79.14 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.561 2.181 . . . . 0.0 112.178 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.92 65.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -104.95 -31.44 9.23 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.1 99.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.34 1.456 . . . . 0.0 111.319 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.544 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -76.86 -32.02 57.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.942 0.897 . . . . 0.0 110.93 -178.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -65.12 -27.51 68.8 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -98.01 -8.61 27.55 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 -132.62 0.07 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.961 1.705 . . . . 0.0 110.478 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -156.79 -55.75 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.268 2.227 . . . . 0.0 112.276 -173.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -120.21 168.09 11.2 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 127.179 2.192 . . . . 0.0 110.194 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.78 10.37 3.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.108 1.872 . . . . 0.0 114.308 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 -25.92 67.22 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.782 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -118.5 25.18 10.45 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.734 2.014 . . . . 0.0 113.366 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.96 34.88 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.586 -1.322 . . . . 0.0 112.702 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.96 -13.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.284 1.034 . . . . 0.0 113.52 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 65.6 107.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.48 2.312 . . . . 0.0 110.648 -168.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.68 62.96 7.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.734 -1.229 . . . . 0.0 110.804 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.35 1.6 p -66.69 -25.14 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.148 -0.929 . . . . 0.0 113.334 -168.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.28 -50.75 72.49 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.807 1.64 . . . . 0.0 111.6 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.54 80.09 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mt -62.86 -45.26 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.049 0.94 . . . . 0.0 112.036 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.48 -32.34 72.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 120.628 1.558 . . . . 0.0 112.475 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 42.8 m -64.55 -44.21 91.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.832 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 28.5 t -82.67 -29.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.953 1.301 . . . . 0.0 113.161 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.7 m -41.04 -62.51 1.0 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 126.532 1.933 . . . . 0.0 114.018 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.99 -22.47 73.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.18 1.92 . . . . 0.0 112.931 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.57 -58.03 4.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.4 1.08 . . . . 0.0 111.33 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.485 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.07 -24.58 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.086 -1.009 . . . . 0.0 112.895 174.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.11 -52.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.466 1.03 . . . . 0.0 110.629 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -72.16 -47.16 52.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.586 0.232 . . . . 0.0 111.131 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.19 72.2 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.666 -1.271 . . . . 0.0 113.316 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.6 -13.44 61.38 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.66 16.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.247 1.385 . . . . 0.0 111.212 167.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.56 -43.15 97.58 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.26 0.624 . . . . 0.0 111.657 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -134.96 63.93 1.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.529 1.531 . . . . 0.0 111.093 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -51.34 -32.88 27.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.611 -1.305 . . . . 0.0 112.452 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -87.74 -3.12 58.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.099 1.36 . . . . 0.0 113.562 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 155.06 39.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.074 0.95 . . . . 0.0 111.599 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -66.84 135.55 54.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.565 1.146 . . . . 0.0 109.64 169.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.79 -51.7 60.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -67.81 -29.28 68.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.47 1.486 . . . . 0.0 112.521 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.58 -37.37 83.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.643 -0.661 . . . . 0.0 111.739 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -71.87 -35.34 69.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.477 -0.764 . . . . 0.0 112.914 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.15 -46.46 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.455 1.025 . . . . 0.0 109.926 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -65.44 -43.55 90.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.282 1.033 . . . . 0.0 112.475 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.17 -41.07 99.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.299 0.952 . . . . 0.0 113.246 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.71 -34.18 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.234 -1.156 . . . . 0.0 112.654 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -58.12 -41.98 84.8 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.753 1.615 . . . . 0.0 111.919 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.08 -50.79 72.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.862 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -29.15 70.6 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.896 -1.128 . . . . 0.0 112.256 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 30.7 mt -76.37 -49.5 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.229 1.811 . . . . 0.0 112.448 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 125.132 1.373 . . . . 0.0 112.769 -170.294 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.531 0.33 0 CA-C-O 120.602 0.167 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.17 -17.72 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -71.74 -29.92 65.04 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 112.396 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 -32.47 9.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 114.008 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.44 148.68 50.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.159 0.98 . . . . 0.0 111.526 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.6 p -97.31 167.44 11.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.028 1.394 . . . . 0.0 114.167 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.4 m -66.06 -24.21 66.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.948 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.88 -44.82 91.89 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.65 1.114 . . . . 0.0 110.249 169.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.79 -29.43 69.43 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.919 -0.488 . . . . 0.0 111.601 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -72.32 -11.88 60.9 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.983 -1.073 . . . . 0.0 113.336 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.54 -2.19 45.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.253 1.021 . . . . 0.0 112.48 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.81 -34.08 17.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.725 1.21 . . . . 0.0 112.352 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.35 138.84 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.31 1.844 . . . . 0.0 111.136 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.4 156.27 39.09 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 113.062 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.52 -35.03 38.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.834 1.254 . . . . 0.0 112.817 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 t -65.6 -26.37 67.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.369 1.068 . . . . 0.0 113.432 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -123.14 -0.66 8.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.228 1.411 . . . . 0.0 113.312 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -59.18 -46.42 99.26 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 119.574 -1.954 . . . . 0.0 111.424 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.35 -17.77 55.11 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.427 2.085 . . . . 0.0 114.412 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.522 HG22 HD21 ' B' ' 139' ' ' LEU . 37.6 m -67.71 -40.31 84.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 110.527 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.55 75.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.448 1.099 . . . . 0.0 113.866 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.55 -34.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.753 0.706 . . . . 0.0 109.989 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -57.89 15.11 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.644 -1.087 . . . . 0.0 112.919 168.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.73 -43.47 98.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.367 2.084 . . . . 0.0 112.411 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.7 -26.71 66.31 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -98.49 -35.75 10.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 113.159 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.02 71.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.041 1.336 . . . . 0.0 111.745 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.35 -24.88 61.35 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.884 -0.51 . . . . 0.0 110.954 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -24.42 57.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.73 0.812 . . . . 0.0 112.898 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.96 -7.17 25.49 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.77 -130.62 0.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.13 1.772 . . . . 0.0 110.342 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.61 -44.06 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.232 2.213 . . . . 0.0 112.245 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -123.62 164.95 25.46 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 127.966 2.507 . . . . 0.0 110.148 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.33 13.02 2.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.324 2.016 . . . . 0.0 114.185 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.98 -27.43 66.84 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.806 -1.184 . . . . 0.0 112.926 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.73 18.56 14.86 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.268 1.427 . . . . 0.0 114.196 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 129.7 40.62 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.851 -1.156 . . . . 0.0 112.607 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.52 -11.67 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.775 1.23 . . . . 0.0 113.271 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 62.77 114.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.787 2.435 . . . . 0.0 110.555 -167.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -82.85 51.87 2.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.403 -1.435 . . . . 0.0 110.74 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.422 2.7 p -69.04 -28.37 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.12 -39.37 82.08 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.332 1.878 . . . . 0.0 111.389 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.2 -51.24 10.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.369 0.985 . . . . 0.0 112.102 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -40.36 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.179 0.992 . . . . 0.0 111.987 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.43 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.19 1.359 . . . . 0.0 112.652 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -68.27 -40.98 81.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.751 1.22 . . . . 0.0 111.492 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 62' ' ' ILE . 36.7 t -81.66 -31.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.202 1.401 . . . . 0.0 113.617 -176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -41.78 -59.92 2.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 125.798 1.639 . . . . 0.0 114.47 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.42 -24.23 75.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.96 1.773 . . . . 0.0 113.204 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -61.29 -61.56 2.46 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.426 1.49 . . . . 0.0 110.571 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.67 -31.95 53.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 t -59.47 -51.85 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.805 1.242 . . . . 0.0 110.466 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.08 -49.96 45.77 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.066 0.46 . . . . 0.0 110.872 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.86 70.24 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.829 0.852 . . . . 0.0 112.727 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.9 m -72.9 -17.05 61.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -30.34 20.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.677 1.191 . . . . 0.0 111.233 168.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -64.0 -38.26 90.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.126 0.97 . . . . 0.0 112.405 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -145.3 85.09 1.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.818 1.247 . . . . 0.0 111.574 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.76 -39.78 71.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.223 1.409 . . . . 0.0 112.209 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.11 -11.99 59.99 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.22 152.5 44.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.005 0.922 . . . . 0.0 112.162 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -73.35 144.81 46.35 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.8 -44.32 90.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -67.11 -32.02 72.88 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.783 -1.198 . . . . 0.0 113.011 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.48 -40.42 86.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.969 0.908 . . . . 0.0 111.152 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.747 -1.12 . . . . 0.0 112.888 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -41.4 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.607 1.549 . . . . 0.0 111.334 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -64.21 -48.48 75.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.719 0.808 . . . . 0.0 111.676 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.41 99.72 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.36 0.981 . . . . 0.0 113.099 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.492 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 26.0 mm-40 -74.26 -35.63 63.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.605 1.202 . . . . 0.0 113.196 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -59.56 -40.21 86.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.005 1.275 . . . . 0.0 111.486 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.47 -45.51 93.94 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.21 1.004 . . . . 0.0 111.742 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -23.5 67.34 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.969 -1.082 . . . . 0.0 112.655 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.841 1.256 . . . . 0.0 113.065 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 CA-C-O 121.094 0.372 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 m -66.01 -4.82 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.668 1.587 . . . . 0.0 114.558 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -112.93 21.37 15.51 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.234 1.813 . . . . 0.0 112.934 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -143.82 -49.48 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -93.71 147.08 23.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.922 0.783 . . . . 0.0 112.207 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p -70.92 173.36 7.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.368 1.867 . . . . 0.0 113.965 -171.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -49.91 -20.56 0.93 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.66 -40.27 39.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.62 -30.63 69.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.144 0.978 . . . . 0.0 112.619 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -70.96 -17.65 62.66 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.511 -0.743 . . . . 0.0 111.967 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.92 -18.49 23.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.188 0.995 . . . . 0.0 112.911 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.85 62.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.278 1.031 . . . . 0.0 112.436 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.72 138.9 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.814 2.046 . . . . 0.0 111.119 171.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.67 159.13 32.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.477 1.111 . . . . 0.0 113.223 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.09 -33.64 58.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.353 1.461 . . . . 0.0 111.809 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.0 m -59.17 -27.46 65.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.114 1.765 . . . . 0.0 113.817 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.58 -3.95 5.99 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.392 1.477 . . . . 0.0 113.307 -171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -56.96 -44.85 99.94 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.241 -1.537 . . . . 0.0 112.528 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.41 -18.34 59.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.595 2.197 . . . . 0.0 114.007 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 40.6 m -81.43 -31.86 32.91 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.789 1.236 . . . . 0.0 111.449 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.1 97.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.521 1.055 . . . . 0.0 110.902 167.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.55 -47.0 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.084 0.954 . . . . 0.0 109.191 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.88 12.64 1.03 Allowed Glycine 0 CA--C 1.544 1.891 0 C-N-CA 126.798 2.142 . . . . 0.0 117.353 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.39 -14.18 7.46 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.609 1.563 . . . . 0.0 112.98 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.67 -72.6 0.62 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.84 0.856 . . . . 0.0 110.086 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -72.69 -20.44 61.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.042 -1.036 . . . . 0.0 112.61 -170.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.29 -42.42 70.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.427 1.091 . . . . 0.0 112.843 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -47.02 13.88 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.701 0.801 . . . . 0.0 109.541 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -6.9 57.79 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.93 -15.2 52.28 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.237 0.926 . . . . 0.0 113.205 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -150.92 -129.97 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.757 1.623 . . . . 0.0 110.861 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -156.41 -61.38 0.1 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.872 1.669 . . . . 0.0 113.104 -169.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.42 161.13 65.02 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.956 2.102 . . . . 0.0 110.705 -172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -86.49 10.41 3.64 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.705 2.27 . . . . 0.0 113.789 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.02 -27.74 63.9 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.876 -1.14 . . . . 0.0 112.052 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.79 -9.28 11.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.241 1.416 . . . . 0.0 114.158 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.35 136.19 47.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.958 -1.088 . . . . 0.0 111.949 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.68 8.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.987 1.715 . . . . 0.0 112.888 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 31' ' ' THR . 1.8 tm? 58.67 113.79 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 129.564 3.146 . . . . 0.0 111.344 -169.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.37 51.62 2.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.717 1.607 . . . . 0.0 111.506 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 0.4 OUTLIER -68.52 -31.7 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -164.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -64.61 -42.04 95.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.401 1.001 . . . . 0.0 111.575 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.29 -44.22 60.27 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mt -58.86 -48.22 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.278 1.031 . . . . 0.0 111.471 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.25 73.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.237 0.926 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 47.0 m -67.71 -43.86 79.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.455 1.102 . . . . 0.0 112.2 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' B' ' 151' ' ' ILE . 16.9 t -80.52 -30.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.886 1.674 . . . . 0.0 113.353 -177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -39.97 -62.08 0.96 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.026 1.73 . . . . 0.0 113.783 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.19 -13.56 38.64 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.729 2.286 . . . . 0.0 114.176 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.97 -64.87 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.048 0.939 . . . . 0.0 111.081 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.55 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.92 -25.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.766 -1.209 . . . . 0.0 113.379 -178.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.8 -49.71 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.263 1.025 . . . . 0.0 110.586 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.78 -44.99 22.0 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 111.464 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.59 -30.41 70.01 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.592 -1.318 . . . . 0.0 112.833 -169.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.4 m -72.44 -13.09 61.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 169.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -35.1 16.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.493 1.497 . . . . 0.0 111.15 167.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -59.29 -39.05 81.76 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 112.071 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -142.47 79.88 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.816 0.847 . . . . 0.0 111.676 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -55.5 -29.18 58.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.94 1.79 55.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.549 1.54 . . . . 0.0 113.116 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 155.55 37.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.647 1.179 . . . . 0.0 113.306 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.07 57.1 2.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.307 1.843 . . . . 0.0 113.374 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 p90 44.62 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.866 2.066 . . . . 0.0 116.005 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -67.43 -26.53 66.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 0.0 112.239 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.9 -36.56 77.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.153 0.981 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -72.33 -40.48 67.4 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 118.477 -0.773 . . . . 0.0 112.774 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.81 -42.46 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.326 0.966 . . . . 0.0 110.565 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -69.42 -46.99 65.5 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.924 1.29 . . . . 0.0 112.526 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.15 98.49 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.861 0.743 . . . . 0.0 113.129 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.52 -27.16 63.96 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.344 -1.092 . . . . 0.0 113.215 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -67.95 -41.0 83.14 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.081 -1.012 . . . . 0.0 111.1 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.56 -41.29 98.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.446 0.698 . . . . 0.0 111.411 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.63 -38.43 6.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 113.151 168.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.94 -39.58 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 112.286 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 57.2 mttt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.542 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 CA-C-O 121.341 0.475 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -19.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -78.99 -13.95 59.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.682 1.193 . . . . 0.0 114.084 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 m -131.5 -26.91 2.0 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -169.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.24 156.27 39.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.193 0.906 . . . . 0.0 112.681 -177.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.0 p -92.63 157.9 16.25 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.369 1.081 . . . . 0.0 113.62 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.33 -22.85 65.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.28 -39.69 87.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.949 -1.094 . . . . 0.0 111.203 173.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.02 -25.5 62.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 118.722 -0.656 . . . . 0.0 112.593 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.61 -30.6 70.23 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.6 1.545 . . . . 0.0 111.304 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.34 -13.21 60.15 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 171.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.45 -28.39 52.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.32 136.11 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.933 1.693 . . . . 0.0 110.534 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.03 159.99 31.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 113.189 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -33.73 72.22 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.769 -1.207 . . . . 0.0 111.849 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.8 m -61.93 -23.58 66.44 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 114.164 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.97 -7.38 6.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.84 1.256 . . . . 0.0 113.317 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -57.99 -41.96 92.65 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 119.498 -2.001 . . . . 0.0 112.544 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -64.93 -17.96 60.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.665 2.243 . . . . 0.0 114.109 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 HD21 ' B' ' 139' ' ' LEU . 47.5 m -76.71 -38.26 54.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.924 1.29 . . . . 0.0 111.148 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.31 97.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.433 1.093 . . . . 0.0 112.73 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.75 -46.56 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.24 -56.34 13.01 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 125.559 1.552 . . . . 0.0 113.889 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -11.51 59.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 122.072 2.936 . . . . 0.0 113.938 -173.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.55 -47.77 5.81 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.618 1.099 . . . . 0.0 111.995 168.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -76.52 -27.58 56.06 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.959 -1.088 . . . . 0.0 113.566 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.36 -62.94 1.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.854 1.261 . . . . 0.0 110.412 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.592 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -65.77 -18.81 65.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.766 1.226 . . . . 0.0 111.55 -174.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.09 -18.88 58.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.299 1.04 . . . . 0.0 113.671 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.47 9.19 5.52 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.52 148.06 7.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.999 2.92 . . . . 0.0 105.909 171.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.16 -44.11 8.52 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.5 2.32 . . . . 0.0 115.195 -166.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.33 160.13 58.43 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 127.375 2.27 . . . . 0.0 109.622 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.26 16.58 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 121.25 1.482 . . . . 0.0 114.126 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.58 -22.45 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.341 1.456 . . . . 0.0 112.841 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -128.37 -0.9 5.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.515 1.526 . . . . 0.0 114.195 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.84 146.18 53.08 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' B' ' 101' ' ' PRO . 2.7 p -126.34 151.21 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.873 1.669 . . . . 0.0 110.491 168.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.732 HD21 HG22 ' B' ' 120' ' ' THR . 2.8 tm? -75.38 124.49 27.21 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.461 1.105 . . . . 0.0 109.687 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -89.28 46.66 1.4 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.772 1.229 . . . . 0.0 112.493 -168.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.37 2.7 p -64.49 -27.86 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -60.45 -41.56 94.34 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.084 1.765 . . . . 0.0 111.708 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.36 -49.29 9.48 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.4 mt -57.11 -46.21 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.527 1.131 . . . . 0.0 111.525 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.76 68.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.841 1.201 . . . . 0.0 112.681 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -68.99 -39.89 79.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.868 1.267 . . . . 0.0 111.551 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 62' ' ' ILE . 55.8 t -87.43 -27.03 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.132 1.373 . . . . 0.0 113.334 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 m -41.77 -61.39 1.49 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.318 1.847 . . . . 0.0 113.928 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.91 -21.87 73.45 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.349 2.032 . . . . 0.0 113.093 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -67.14 -61.54 1.87 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.78 1.632 . . . . 0.0 110.424 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.458 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.09 -28.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.696 176.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -57.57 -46.84 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -74.73 -50.42 17.49 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.438 0.637 . . . . 0.0 111.168 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.01 71.16 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.53 -15.12 61.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.05 -33.48 17.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.224 1.374 . . . . 0.0 111.526 168.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -61.43 -37.96 85.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.262 1.025 . . . . 0.0 111.897 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -143.42 61.18 1.39 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.951 1.3 . . . . 0.0 113.0 -170.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -54.52 -37.16 65.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.386 1.874 . . . . 0.0 113.022 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.79 -10.04 59.06 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.43 162.65 19.88 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.258 1.023 . . . . 0.0 112.803 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -63.78 136.87 57.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.135 1.374 . . . . 0.0 110.808 173.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.18 -39.67 79.51 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.009 0.924 . . . . 0.0 112.785 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -65.25 -37.67 87.96 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.208 -0.933 . . . . 0.0 112.345 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.24 -39.99 88.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.468 1.107 . . . . 0.0 111.27 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -38.56 80.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.9 -43.67 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.267 0.627 . . . . 0.0 110.618 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -61.94 -45.01 95.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.472 0.709 . . . . 0.0 112.088 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.55 -47.88 87.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.706 1.146 . . . . 0.0 113.159 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 24.8 mm-40 -73.11 -31.43 64.33 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.659 1.23 . . . . 0.0 113.348 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.31 -44.2 95.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.067 1.303 . . . . 0.0 111.081 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.62 -48.79 79.28 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.794 0.837 . . . . 0.0 110.935 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -30.3 70.87 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.885 -1.134 . . . . 0.0 111.728 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 124.263 1.025 . . . . 0.0 112.234 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 101' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 42.0 Cg_endo . . . . . 0 C--O 1.231 0.171 0 N-CA-C 115.96 1.485 . . . . 0.0 115.96 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.91 15.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.344 2.258 . . . . 0.0 114.555 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.425 ' HA ' ' CE2' ' B' ' 163' ' ' PHE . 0.7 OUTLIER -134.1 10.05 3.84 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.812 1.645 . . . . 0.0 113.586 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 13.9 m -141.6 -2.23 1.23 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -170.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -132.91 156.72 46.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.554 1.142 . . . . 0.0 113.243 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 40.3 p -87.2 163.21 17.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.301 1.041 . . . . 0.0 112.046 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.321 0.1 OUTLIER -67.62 -4.25 11.37 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -172.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -35.42 68.67 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.715 -1.241 . . . . 0.0 111.243 168.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.07 -23.74 67.25 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.4 -0.813 . . . . 0.0 112.984 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -67.5 -18.51 65.08 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.074 -1.016 . . . . 0.0 112.219 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.27 -18.62 31.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.094 0.958 . . . . 0.0 112.819 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.32 50.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 112.886 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.75 139.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.939 1.695 . . . . 0.0 110.749 170.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.87 159.35 33.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.459 1.104 . . . . 0.0 113.466 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -52.73 -35.61 56.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.25 1.42 . . . . 0.0 112.303 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -62.73 -22.93 66.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.31 -2.98 6.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.216 1.406 . . . . 0.0 112.909 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -60.18 -47.22 97.31 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 119.625 -1.922 . . . . 0.0 111.706 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.52 -20.19 60.61 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.945 2.43 . . . . 0.0 113.812 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.732 HG22 HD21 ' A' ' 50' ' ' LEU . 94.1 m -75.19 -37.78 61.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.889 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.432 1.093 . . . . 0.0 112.013 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.67 -46.47 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.088 0.955 . . . . 0.0 109.511 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.96 13.42 0.48 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 127.106 2.289 . . . . 0.0 117.081 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.36 -54.1 2.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.843 1.822 . . . . 0.0 110.538 167.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.75 92.5 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.838 -1.164 . . . . 0.0 111.3 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.31 -37.47 52.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.35 94.45 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.728 -1.232 . . . . 0.0 111.58 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.49 -32.29 58.25 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.849 -0.532 . . . . 0.0 111.184 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.24 -29.26 68.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.935 0.789 . . . . 0.0 112.55 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -89.48 -8.12 53.58 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -136.18 -148.01 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.372 1.869 . . . . 0.0 111.493 -168.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -170.36 -48.83 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 130.839 3.655 . . . . 0.0 110.908 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.42 165.83 33.84 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 128.436 2.694 . . . . 0.0 109.518 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.15 7.55 4.93 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 121.917 1.72 . . . . 0.0 115.15 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -64.24 -25.62 68.14 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.836 -1.165 . . . . 0.0 112.592 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.73 8.6 26.91 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.274 1.83 . . . . 0.0 112.476 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.47 125.83 33.34 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 119.888 -1.758 . . . . 0.0 111.927 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.89 134.52 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.103 1.761 . . . . 0.0 106.93 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.763 HD21 HG22 ' A' ' 31' ' ' THR . 1.9 tm? -77.31 107.49 9.76 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.312 0.96 . . . . 0.0 110.349 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -89.57 51.23 2.05 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.36 1.864 . . . . 0.0 111.704 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.269 3.6 p -62.0 -35.98 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -166.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.2 -36.99 78.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.706 2.048 . . . . 0.0 111.856 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.68 -46.96 51.75 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.267 0.46 . . . . 0.0 112.336 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.06 -45.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.579 1.152 . . . . 0.0 111.492 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.87 75.27 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.824 1.25 . . . . 0.0 112.222 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 49.6 m -64.82 -42.53 94.91 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.869 0.868 . . . . 0.0 111.95 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' B' ' 151' ' ' ILE . 24.3 t -83.69 -27.01 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.133 1.373 . . . . 0.0 112.974 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.6 m -42.33 -61.13 1.72 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 126.247 1.819 . . . . 0.0 113.886 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.76 -23.02 75.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.177 1.918 . . . . 0.0 112.93 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.26 -58.11 4.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.211 1.004 . . . . 0.0 111.466 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.453 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -68.18 -24.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.638 1.108 . . . . 0.0 113.016 175.004 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 11.8 t -62.76 -50.74 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.712 1.142 . . . . 0.0 110.674 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.11 -43.63 42.32 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.152 -0.343 . . . . 0.0 111.667 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.53 81.42 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 120.956 -1.09 . . . . 0.0 112.177 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 92.0 m -76.88 -3.69 39.91 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.932 -1.105 . . . . 0.0 113.97 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -37.22 11.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.377 1.071 . . . . 0.0 111.592 168.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.11 -32.27 50.44 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -121.55 45.96 2.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.686 1.995 . . . . 0.0 110.744 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -50.48 -30.11 12.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.811 1.244 . . . . 0.0 113.272 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -90.17 -0.92 57.85 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.386 1.474 . . . . 0.0 112.958 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.25 159.42 33.47 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.856 1.262 . . . . 0.0 112.713 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.89 142.11 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.583 1.553 . . . . 0.0 112.463 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' B' ' 103' ' ' ASN . 14.5 p90 -43.71 -47.12 7.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.787 2.435 . . . . 0.0 115.966 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -95.18 -38.06 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.765 1.226 . . . . 0.0 110.904 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.23 -33.61 75.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.816 0.847 . . . . 0.0 112.324 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -73.93 -36.43 64.68 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.211 1.004 . . . . 0.0 113.049 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.4 -50.89 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.374 -0.829 . . . . 0.0 110.55 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.61 -37.47 82.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.411 1.084 . . . . 0.0 112.416 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.03 88.69 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.97 1.272 . . . . 0.0 113.063 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -71.83 -35.3 69.85 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.975 1.388 . . . . 0.0 112.638 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -59.74 -42.14 92.49 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.191 -0.943 . . . . 0.0 111.96 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.14 -47.52 85.57 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.796 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -23.31 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.932 -1.105 . . . . 0.0 112.678 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.33 -44.94 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.638 1.975 . . . . 0.0 113.149 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 124.767 1.227 . . . . 0.0 113.05 -173.689 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.531 0.362 0 CA-C-O 121.176 0.407 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.99 -23.35 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.2 -4.86 59.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.944 1.697 . . . . 0.0 115.108 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.8 m -127.85 -25.68 3.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.183 1.393 . . . . 0.0 114.341 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.47 160.03 32.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.308 1.052 . . . . 0.0 111.892 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -93.36 168.3 11.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.088 1.423 . . . . 0.0 113.645 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -26.02 67.91 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.787 168.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.78 -43.09 99.72 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.772 -1.205 . . . . 0.0 110.751 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.18 -28.06 69.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.176 -0.953 . . . . 0.0 112.344 169.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD2' ' CE1' ' A' ' 74' ' ' PHE . 41.1 t80 -69.37 -12.83 61.99 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.687 -1.258 . . . . 0.0 112.62 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 mt -94.47 -7.84 40.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.325 1.05 . . . . 0.0 112.49 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.88 -31.17 28.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 0.0 111.633 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.79 138.12 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.276 1.43 . . . . 0.0 110.608 169.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.2 159.61 33.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.185 1.394 . . . . 0.0 113.619 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.39 -36.28 75.52 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.038 -1.039 . . . . 0.0 112.076 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.9 m -61.26 -24.47 66.41 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.933 1.693 . . . . 0.0 113.806 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.33 -3.43 7.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.217 1.407 . . . . 0.0 113.033 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -58.13 -47.59 98.58 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.224 -1.548 . . . . 0.0 110.852 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 -16.48 50.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.738 2.292 . . . . 0.0 114.007 172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.787 HG22 HD21 ' B' ' 139' ' ' LEU . 97.5 m -77.84 -38.75 45.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.295 1.438 . . . . 0.0 110.738 173.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.61 97.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.612 1.165 . . . . 0.0 112.23 168.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.77 -46.48 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.86 -48.21 57.73 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 125.736 1.636 . . . . 0.0 114.684 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -68.78 -36.22 78.02 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.995 2.397 . . . . 0.0 112.551 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.1 75.23 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.853 0.751 . . . . 0.0 112.325 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -80.43 -46.52 15.82 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.477 -0.764 . . . . 0.0 111.645 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.96 78.08 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.016 -1.052 . . . . 0.0 111.735 -171.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -24.67 61.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.163 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 -14.6 63.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -89.18 -28.64 19.87 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.87 -121.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -168.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -158.89 -72.88 0.08 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.43 2.292 . . . . 0.0 111.078 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -103.13 163.95 16.48 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 126.75 2.02 . . . . 0.0 110.7 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.2 10.18 3.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.602 2.202 . . . . 0.0 114.402 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -12.73 61.65 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.906 -1.121 . . . . 0.0 112.949 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.79 30.47 4.04 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.605 1.962 . . . . 0.0 111.722 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.21 136.19 33.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 119.724 -1.86 . . . . 0.0 113.489 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.72 141.77 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.966 1.707 . . . . 0.0 109.192 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -67.54 131.94 46.62 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.456 1.503 . . . . 0.0 111.73 -168.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -83.26 50.48 1.76 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 119.982 -1.699 . . . . 0.0 111.958 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.431 2.1 p -66.85 -45.26 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -163.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.63 -34.24 72.53 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 121.621 2.009 . . . . 0.0 111.526 174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.16 -53.44 18.25 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.737 0.684 . . . . 0.0 112.448 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 mt -52.27 -46.45 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.784 1.634 . . . . 0.0 110.872 171.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.05 75.58 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.441 1.096 . . . . 0.0 113.103 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.6 m -71.48 -36.98 71.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 111.793 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.6 t -87.02 -23.11 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 112.923 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -47.32 -59.46 5.44 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 125.922 1.689 . . . . 0.0 112.412 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.84 -2.12 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.258 2.639 . . . . 0.0 114.219 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.82 -64.95 1.07 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 171.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.81 -30.91 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.652 -1.28 . . . . 0.0 113.004 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 t -58.57 -48.45 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.163 0.985 . . . . 0.0 110.838 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.01 -48.53 20.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.335 0.588 . . . . 0.0 110.904 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.86 69.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 25.3 m -77.19 -13.59 59.92 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.85 -32.85 17.59 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.886 1.221 . . . . 0.0 111.068 167.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.59 -38.62 88.24 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.835 0.854 . . . . 0.0 111.854 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -139.06 57.5 1.66 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.017 1.327 . . . . 0.0 112.765 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -52.84 -36.07 58.28 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.754 1.621 . . . . 0.0 113.108 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.21 -8.34 59.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.265 1.026 . . . . 0.0 113.519 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.75 161.21 27.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.213 1.005 . . . . 0.0 112.711 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.23 132.86 47.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.747 1.219 . . . . 0.0 110.235 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CD2' ' A' ' 21' ' ' PHE . 50.5 t80 -58.26 -44.22 88.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -66.17 -33.78 76.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.516 1.053 . . . . 0.0 112.221 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.11 -31.47 71.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.304 0.641 . . . . 0.0 112.372 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -70.16 -37.11 75.12 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.219 -0.926 . . . . 0.0 113.243 169.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -42.6 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 118.962 0.801 . . . . 0.0 110.597 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -62.1 -45.72 92.24 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.828 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.18 -43.42 98.64 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.26 0.933 . . . . 0.0 113.322 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -75.59 -25.29 56.88 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.118 -1.225 . . . . 0.0 113.573 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -67.42 -42.21 83.57 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.958 -1.089 . . . . 0.0 110.592 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.451 1.101 . . . . 0.0 112.165 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -49.0 16.59 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.32 1.848 . . . . 0.0 113.003 169.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.25 3.1 mt . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.888 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 116.135 1.552 . . . . 0.0 116.135 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.5 2.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.21 1.404 . . . . 0.0 114.573 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 17.1 m-80 -119.72 20.92 12.2 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.257 1.823 . . . . 0.0 112.898 169.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 57.0 m -142.49 -24.63 0.65 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.78 166.8 22.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -170.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.7 p -112.44 154.05 26.42 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.14 1.776 . . . . 0.0 110.434 168.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -25.21 62.24 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.8 -43.01 68.99 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.052 1.341 . . . . 0.0 111.184 170.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.72 -22.02 61.69 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.37 -0.831 . . . . 0.0 112.805 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -68.44 -15.06 63.41 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 111.861 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -91.27 -12.48 35.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.01 1.324 . . . . 0.0 113.061 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.32 -34.0 55.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.417 1.087 . . . . 0.0 112.743 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.04 137.28 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.608 1.563 . . . . 0.0 110.546 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.81 160.12 31.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.073 1.349 . . . . 0.0 113.724 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -59.48 -34.63 72.8 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 0.0 111.932 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.1 m -62.64 -25.01 67.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.036 1.734 . . . . 0.0 113.855 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.62 -6.03 8.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.797 1.239 . . . . 0.0 113.38 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -58.04 -42.68 96.39 Favored Pre-proline 0 N--CA 1.481 1.077 0 O-C-N 119.927 -1.733 . . . . 0.0 113.396 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.88 -28.37 86.28 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.962 2.441 . . . . 0.0 112.93 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.434 HG22 HD21 ' A' ' 50' ' ' LEU . 54.2 m -75.93 -33.52 59.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.373 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -65.35 -45.55 83.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.528 1.531 . . . . 0.0 113.665 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.27 -33.23 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.221 0.919 . . . . 0.0 110.18 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.13 -52.78 44.75 Favored Glycine 0 C--O 1.216 -1.007 0 C-N-CA 124.535 1.064 . . . . 0.0 113.225 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.08 -12.76 29.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.973 2.387 . . . . 0.0 113.892 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.48 -62.41 1.46 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.762 0.825 . . . . 0.0 110.659 164.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -68.19 -34.33 76.08 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.897 -1.127 . . . . 0.0 113.257 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.74 81.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.197 1.799 . . . . 0.0 112.114 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -39.29 50.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.584 1.154 . . . . 0.0 110.471 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -9.72 50.5 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -173.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -87.71 -23.92 24.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.233 1.013 . . . . 0.0 113.311 173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -153.95 -122.03 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.857 1.263 . . . . 0.0 114.044 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -162.24 -65.44 0.05 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.403 1.881 . . . . 0.0 112.055 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -116.02 161.91 28.51 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 126.229 1.812 . . . . 0.0 110.568 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.5 11.61 2.84 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.364 2.043 . . . . 0.0 114.407 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.13 -34.11 65.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.06 1.344 . . . . 0.0 111.785 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.48 19.34 16.98 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.494 1.918 . . . . 0.0 112.733 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.7 118.2 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 119.78 -1.825 . . . . 0.0 111.229 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.69 -4.91 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.003 1.321 . . . . 0.0 112.389 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.787 HD21 HG22 ' A' ' 31' ' ' THR . 2.0 tm? 59.61 112.75 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.414 3.085 . . . . 0.0 112.869 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -91.99 62.48 4.26 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.634 -1.291 . . . . 0.0 111.744 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 1.2 p -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 117.338 -1.315 . . . . 0.0 114.041 -168.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -63.96 -35.31 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.789 2.086 . . . . 0.0 111.672 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.89 -48.36 61.27 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.679 0.657 . . . . 0.0 111.857 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.88 -40.52 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.122 0.969 . . . . 0.0 112.257 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.62 71.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.785 1.234 . . . . 0.0 112.382 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 0.0 111.632 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.95 -33.1 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.356 1.463 . . . . 0.0 113.319 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.9 m -43.89 -58.37 4.78 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 126.235 1.814 . . . . 0.0 113.855 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.92 -11.36 30.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.807 2.338 . . . . 0.0 113.822 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -65.61 0.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.667 1.187 . . . . 0.0 111.601 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.495 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.0 -27.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.664 -1.272 . . . . 0.0 113.671 -173.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.5 -44.68 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.526 1.057 . . . . 0.0 112.304 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -73.68 -46.75 44.43 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.024 0.929 . . . . 0.0 110.885 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.27 67.54 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 113.2 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 9.4 m -74.87 -13.07 60.51 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -33.92 18.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.317 1.417 . . . . 0.0 110.755 167.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -60.76 -40.35 92.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.807 0.843 . . . . 0.0 112.16 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -132.81 64.99 1.6 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.727 1.211 . . . . 0.0 111.902 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -52.15 -32.61 36.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.512 -1.367 . . . . 0.0 113.63 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -92.83 1.31 57.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.825 1.25 . . . . 0.0 113.068 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.96 154.53 41.4 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.246 1.022 . . . . 0.0 112.301 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.97 152.25 33.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.834 1.654 . . . . 0.0 112.61 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 35.0 p90 -47.6 153.9 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.982 1.713 . . . . 0.0 113.526 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 43.7 tttt 60.82 -40.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 129.642 3.177 . . . . 0.0 115.93 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.41 -34.67 77.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.485 1.914 . . . . 0.0 112.199 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -69.09 -37.81 78.62 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.605 -0.684 . . . . 0.0 112.334 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.15 -41.3 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 119.101 0.864 . . . . 0.0 111.11 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.13 -45.44 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.664 0.786 . . . . 0.0 111.633 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.83 95.41 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.994 1.283 . . . . 0.0 113.485 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.95 -35.66 77.03 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 112.593 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -63.66 -36.94 85.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.69 -1.256 . . . . 0.0 112.007 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.87 -47.48 77.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.501 0.72 . . . . 0.0 111.683 171.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -24.66 67.57 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.573 -1.329 . . . . 0.0 111.93 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.7 mt -75.6 -45.96 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.934 1.693 . . . . 0.0 112.687 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.075 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 N--CA 1.476 0.481 0 N-CA-C 112.487 0.149 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.37 -16.44 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -76.76 -35.15 57.91 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.33 1.052 . . . . 0.0 112.615 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.8 m -100.48 -22.49 14.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.325 2.25 . . . . 0.0 113.904 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -64.78 140.78 58.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.018 2.527 . . . . 0.0 109.648 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.4 p -100.95 166.47 10.81 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.827 1.298 . . . . 0.0 113.54 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.16 -25.28 66.88 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.587 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -65.5 -42.83 91.69 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.853 -1.155 . . . . 0.0 110.421 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.59 -27.05 68.92 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.848 -0.532 . . . . 0.0 112.09 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -69.08 -12.19 61.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.785 -1.197 . . . . 0.0 113.119 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.09 -6.45 38.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.754 1.221 . . . . 0.0 112.64 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.13 -30.51 21.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.674 1.189 . . . . 0.0 112.375 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 p -72.56 141.95 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.751 1.62 . . . . 0.0 110.753 169.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.17 160.31 32.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.46 1.104 . . . . 0.0 113.084 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.21 -35.41 73.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.726 1.21 . . . . 0.0 111.848 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -62.95 -21.96 66.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.547 1.539 . . . . 0.0 113.79 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.09 -5.25 6.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 113.47 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -55.42 -47.22 99.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 O-C-N 120.131 -1.606 . . . . 0.0 111.478 170.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -60.47 -25.74 81.22 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.565 2.177 . . . . 0.0 113.857 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -70.5 -34.44 72.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.391 0.676 . . . . 0.0 111.915 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.72 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -67.05 -46.52 74.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.848 1.203 . . . . 0.0 113.005 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.11 -34.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 118.75 0.705 . . . . 0.0 110.249 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.13 88.13 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 118.819 -0.989 . . . . 0.0 113.524 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.13 -24.16 66.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.249 2.524 . . . . 0.0 113.609 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.88 -55.25 4.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.495 -0.753 . . . . 0.0 110.939 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -68.01 -31.64 71.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.454 -0.779 . . . . 0.0 112.5 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.98 84.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.396 1.078 . . . . 0.0 111.576 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD13 HD13 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -77.91 -36.75 49.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.329 -178.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -23.15 63.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -81.6 -17.91 46.59 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.85 -122.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.186 1.394 . . . . 0.0 112.341 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -160.8 -66.99 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.399 1.48 . . . . 0.0 113.03 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -129.73 164.29 41.16 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 127.906 2.482 . . . . 0.0 109.669 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 3.82 6.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.352 1.519 . . . . 0.0 114.716 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -55.27 -23.79 24.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.479 1.512 . . . . 0.0 112.564 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.16 9.27 15.8 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.788 2.035 . . . . 0.0 113.014 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.76 125.16 32.31 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 119.614 -1.929 . . . . 0.0 113.644 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.38 129.53 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.933 2.093 . . . . 0.0 105.866 173.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER -69.6 116.62 10.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.14 1.336 . . . . 0.0 109.678 -173.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.47 58.2 4.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.806 1.642 . . . . 0.0 110.991 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -69.55 -31.67 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.74 -35.13 79.86 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 121.239 1.836 . . . . 0.0 111.875 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.84 68.24 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.724 0.678 . . . . 0.0 112.237 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.41 -47.31 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.6 1.16 . . . . 0.0 111.123 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.76 -28.3 67.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.359 1.464 . . . . 0.0 112.993 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.5 m -66.02 -48.52 70.87 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.771 1.229 . . . . 0.0 111.001 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.67 -19.98 8.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -46.9 -63.07 1.52 Allowed Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 125.129 1.372 . . . . 0.0 112.258 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.65 -5.61 16.56 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.553 2.835 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.57 -61.15 1.83 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.437 1.495 . . . . 0.0 110.05 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.64 -30.72 48.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 124.752 1.221 . . . . 0.0 111.721 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.08 -44.18 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.431 1.014 . . . . 0.0 112.849 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -74.42 -46.01 42.85 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.029 0.531 . . . . 0.0 109.706 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.31 75.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.927 0.891 . . . . 0.0 112.861 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.8 m -74.24 -17.43 60.88 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -30.58 32.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.257 1.39 . . . . 0.0 110.79 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -65.29 -38.68 91.01 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.329 0.652 . . . . 0.0 112.626 170.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -130.26 55.81 1.79 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.606 1.563 . . . . 0.0 112.674 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -49.27 -40.19 33.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.602 1.161 . . . . 0.0 112.845 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.29 -2.5 57.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.105 0.962 . . . . 0.0 113.494 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.53 158.74 28.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.16 0.984 . . . . 0.0 112.007 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.9 141.32 47.88 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.825 0.85 . . . . 0.0 110.588 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -66.9 -47.39 71.94 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -64.14 -33.24 75.34 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.064 -1.023 . . . . 0.0 113.009 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.64 -34.03 74.98 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.241 0.616 . . . . 0.0 111.979 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -75.07 -36.38 61.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.28 -39.88 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.295 1.407 . . . . 0.0 111.203 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -61.55 -45.68 93.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.477 0.711 . . . . 0.0 111.584 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.16 -45.48 95.25 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.74 1.162 . . . . 0.0 113.789 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.24 -35.57 63.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.752 1.276 . . . . 0.0 112.867 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -59.58 -40.42 87.33 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.69 1.132 . . . . 0.0 111.562 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.66 -46.17 89.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.515 1.126 . . . . 0.0 112.052 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -26.39 68.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.205 -0.934 . . . . 0.0 112.331 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 124.722 1.209 . . . . 0.0 112.291 -178.042 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.542 0.877 0 N-CA-C 114.007 0.733 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -63.62 6.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 127.041 2.137 . . . . 0.0 115.796 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ASN . . . . . 0.461 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 2.1 p30 -135.36 32.53 3.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.635 2.374 . . . . 0.0 111.215 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -148.28 -47.53 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.175 1.39 . . . . 0.0 113.673 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -99.01 139.3 34.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.872 0.869 . . . . 0.0 111.346 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 p -75.29 172.19 12.88 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.202 1.801 . . . . 0.0 114.578 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -21.63 1.54 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -55.34 -36.09 65.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.952 1.251 . . . . 0.0 111.444 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.6 -26.38 68.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.245 -0.91 . . . . 0.0 112.829 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -70.18 -18.45 63.19 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.206 -0.933 . . . . 0.0 111.884 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -91.84 -21.23 20.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 112.222 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.31 -34.25 61.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.663 1.185 . . . . 0.0 112.49 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.85 137.48 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.083 1.353 . . . . 0.0 110.64 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.35 158.31 31.94 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.065 1.346 . . . . 0.0 113.303 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -57.91 -35.82 71.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.684 1.194 . . . . 0.0 112.213 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -22.98 65.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.699 1.6 . . . . 0.0 114.002 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.82 0.09 6.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.56 1.544 . . . . 0.0 112.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.17 -42.75 94.97 Favored Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 119.765 -1.834 . . . . 0.0 112.788 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -61.66 -26.84 80.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.582 2.188 . . . . 0.0 113.386 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -74.57 -32.86 62.53 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 124.105 0.962 . . . . 0.0 111.246 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -61.62 -46.27 90.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.85 1.26 . . . . 0.0 114.11 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.05 -36.15 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.436 1.016 . . . . 0.0 110.69 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.01 -49.48 58.85 Favored Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.889 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.25 -13.57 60.59 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.797 2.299 . . . . 0.0 114.331 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.64 -56.7 2.92 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.753 -0.592 . . . . 0.0 109.862 165.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.09 -37.28 81.03 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.154 -0.966 . . . . 0.0 113.032 -169.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.88 72.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.655 1.982 . . . . 0.0 112.397 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -87.84 -37.2 16.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.167 1.387 . . . . 0.0 110.676 -177.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.02 -30.46 35.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.375 1.87 . . . . 0.0 113.798 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -98.33 -10.86 23.18 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -170.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.25 1.1 ptpm? -150.0 -126.7 0.05 OUTLIER 'General case' 0 C--N 1.351 0.636 0 CA-C-N 120.114 1.325 . . . . 0.0 113.328 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -161.82 -48.63 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -167.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -143.54 161.4 47.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 126.92 2.088 . . . . 0.0 110.664 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.51 -1.08 11.29 Favored 'Trans proline' 0 C--N 1.358 1.034 0 CA-C-N 121.453 1.555 . . . . 0.0 115.654 -174.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.83 -24.85 54.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.629 1.172 . . . . 0.0 113.037 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -114.86 7.06 15.62 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.0 1.72 . . . . 0.0 113.176 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.9 123.68 32.28 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 119.727 -1.858 . . . . 0.0 112.035 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.5 136.8 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.72 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -68.49 110.2 4.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.323 1.419 . . . . 0.0 108.186 178.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -91.02 59.64 4.1 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.072 0.949 . . . . 0.0 110.356 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.326 2.9 p -67.39 -15.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.063 -1.023 . . . . 0.0 112.183 -170.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.23 -33.03 57.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.416 1.486 . . . . 0.0 112.245 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.34 -61.23 1.92 Allowed Glycine 0 N--CA 1.467 0.728 0 C-N-CA 124.443 1.02 . . . . 0.0 112.171 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.48 -44.4 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.842 -1.387 . . . . 0.0 113.189 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.95 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.989 1.268 . . . . 0.0 112.547 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 8.9 m -67.31 -46.68 72.82 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.548 1.139 . . . . 0.0 112.066 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.408 HG12 HD13 ' B' ' 151' ' ' ILE . 1.5 t -93.99 -16.33 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.4 m -41.5 -60.47 1.83 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 125.906 1.682 . . . . 0.0 113.359 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.47 -14.39 44.66 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.73 2.287 . . . . 0.0 113.361 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.05 -57.61 3.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.723 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 147' ' ' VAL . 0.0 OUTLIER -60.33 -37.98 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 119.392 0.996 . . . . 0.0 112.221 -176.119 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.96 -43.22 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.99 -0.443 . . . . 0.0 112.052 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -71.31 -47.45 56.61 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.931 0.893 . . . . 0.0 110.866 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.95 71.64 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.496 -1.378 . . . . 0.0 113.205 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.4 m -76.16 -11.03 59.86 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.02 -34.15 16.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.397 1.453 . . . . 0.0 110.614 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -57.94 -38.67 76.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.308 1.043 . . . . 0.0 111.996 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -145.53 86.4 1.74 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.906 0.86 . . . . 0.0 112.001 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -55.0 -28.48 52.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.574 1.55 . . . . 0.0 112.89 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.23 3.5 55.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 113.048 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.46 161.08 15.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.115 1.366 . . . . 0.0 113.828 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.52 54.73 0.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.505 1.922 . . . . 0.0 113.495 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 1.1 p90 45.2 -104.31 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 115.391 166.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -48.45 -32.67 8.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.155 2.182 . . . . 0.0 113.892 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.03 -29.67 68.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 112.703 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -72.52 -39.71 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.319 -0.863 . . . . 0.0 112.557 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.72 -39.93 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.732 1.151 . . . . 0.0 110.964 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.22 -42.32 96.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.006 0.922 . . . . 0.0 112.142 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.37 99.34 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.789 1.185 . . . . 0.0 113.354 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.72 -34.15 66.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 1.153 . . . . 0.0 112.574 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -58.14 -42.77 86.6 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.781 1.173 . . . . 0.0 111.475 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.03 -45.17 94.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 0.0 111.624 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -23.89 67.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.982 -1.074 . . . . 0.0 112.655 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 19.0 mt -85.97 -49.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.334 1.853 . . . . 0.0 112.661 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 125.653 1.581 . . . . 0.0 112.92 -171.071 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -73.69 0.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.08 1.352 . . . . 0.0 113.886 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HA ' ' CE1' ' A' ' 74' ' ' PHE . 61.1 m-80 -123.98 19.79 9.2 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.76 1.624 . . . . 0.0 112.864 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -140.06 -39.87 0.44 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -94.81 153.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 111.818 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -79.97 175.39 10.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.698 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -19.4 0.66 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -55.8 -31.74 62.9 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 120.041 1.292 . . . . 0.0 112.029 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.04 -33.25 64.77 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.002 -1.061 . . . . 0.0 111.901 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.03 -10.62 60.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 mt -103.77 -22.17 13.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.53 70.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.202 1.001 . . . . 0.0 111.745 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.24 137.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 111.201 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.47 158.88 30.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.375 1.07 . . . . 0.0 112.683 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.16 -34.29 56.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.11 1.364 . . . . 0.0 112.153 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 m -60.04 -28.18 67.54 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.066 1.746 . . . . 0.0 113.697 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -127.49 0.4 6.25 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.655 1.582 . . . . 0.0 113.179 -171.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.88 -45.88 99.91 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.533 -1.354 . . . . 0.0 111.883 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -60.15 -25.43 79.9 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.935 2.423 . . . . 0.0 113.938 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.6 m -77.84 -30.79 51.22 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.331 1.053 . . . . 0.0 111.56 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -65.01 -45.43 85.57 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.883 -1.136 . . . . 0.0 113.36 172.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.27 -36.87 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 119.108 0.867 . . . . 0.0 110.084 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.53 -52.76 31.77 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 124.628 1.109 . . . . 0.0 113.234 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -69.34 -15.21 63.28 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 121.374 2.587 . . . . 0.0 114.128 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.17 -31.79 15.34 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.498 1.044 . . . . 0.0 113.183 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -93.65 -29.36 15.48 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.17 90.12 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.164 1.785 . . . . 0.0 111.963 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 HD13 ' B' ' 128' ' ' LEU . 0.7 OUTLIER -82.21 -36.05 27.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.979 0.912 . . . . 0.0 111.106 -174.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -65.06 -27.09 68.55 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -91.59 -9.08 45.46 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.85 -130.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.159 1.784 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.23 -43.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.282 1.833 . . . . 0.0 114.556 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.6 mmpp? -128.13 164.51 36.88 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 127.193 2.197 . . . . 0.0 110.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.13 -2.72 8.75 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.016 1.811 . . . . 0.0 114.281 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.62 -22.87 65.32 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.85 -1.157 . . . . 0.0 113.061 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.92 -5.11 23.84 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.563 1.545 . . . . 0.0 114.03 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 127.52 32.91 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.947 -1.096 . . . . 0.0 113.739 -169.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.26 128.29 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.212 1.805 . . . . 0.0 107.303 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -68.04 120.78 14.83 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 119.153 0.888 . . . . 0.0 110.439 -170.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -90.15 52.42 2.26 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.58 -1.325 . . . . 0.0 111.369 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.295 0.9 OUTLIER -64.32 -28.21 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -167.571 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -59.42 -39.9 85.01 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.756 2.071 . . . . 0.0 111.458 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.08 -54.6 13.15 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.48 -45.37 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.754 -0.851 . . . . 0.0 111.626 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.19 67.91 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.883 1.22 . . . . 0.0 112.747 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -69.02 -47.3 65.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.646 1.178 . . . . 0.0 111.885 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 62' ' ' ILE . 1.1 t -89.96 -18.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -43.22 -60.8 2.17 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 125.862 1.665 . . . . 0.0 112.395 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.1 -0.47 5.63 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.585 2.856 . . . . 0.0 114.503 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.32 -57.77 2.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.082 1.753 . . . . 0.0 111.219 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.69 -35.75 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 119.874 1.216 . . . . 0.0 111.986 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.06 -41.49 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 112.604 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -76.63 -47.7 21.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.474 0.709 . . . . 0.0 110.198 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.19 75.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.075 -1.016 . . . . 0.0 112.937 -170.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.1 m -76.2 -10.52 59.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -33.32 19.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.565 1.53 . . . . 0.0 110.381 167.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -61.52 -39.13 89.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.312 0.645 . . . . 0.0 111.695 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.45 61.29 1.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 112.744 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -54.0 -33.37 56.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.479 -1.388 . . . . 0.0 113.143 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.3 -1.82 58.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.149 1.379 . . . . 0.0 113.329 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.33 171.09 12.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.331 1.062 . . . . 0.0 113.271 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -64.71 141.02 58.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.44 1.496 . . . . 0.0 113.349 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 14' ' ' ASN . 7.0 p90 -58.35 -41.65 85.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.762 2.425 . . . . 0.0 115.173 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -93.25 -35.5 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.598 1.159 . . . . 0.0 111.621 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.2 -30.83 69.63 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.157 0.983 . . . . 0.0 111.621 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -74.72 -40.06 61.54 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -68.21 -40.8 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.879 1.218 . . . . 0.0 111.088 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.47 -45.71 78.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.236 1.014 . . . . 0.0 111.451 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.31 -44.07 97.48 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.324 1.44 . . . . 0.0 113.401 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.74 -32.74 65.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.165 1.483 . . . . 0.0 113.171 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -62.0 -42.95 99.71 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.642 -1.287 . . . . 0.0 111.21 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.71 -46.53 89.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.806 1.242 . . . . 0.0 111.878 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -28.23 69.88 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.118 -0.989 . . . . 0.0 111.812 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 mt . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 124.055 0.942 . . . . 0.0 111.889 179.774 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 CA-C-O 120.581 0.159 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.59 -20.85 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.8 -40.17 29.18 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.51 -0.744 . . . . 0.0 112.824 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 17.9 m -94.44 -27.44 16.02 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -169.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.31 161.79 27.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.983 0.897 . . . . 0.0 111.989 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 48.9 p -100.07 171.38 7.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 122.472 1.129 . . . . 0.0 113.899 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.33 -26.21 66.39 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.62 -0.675 . . . . 0.0 112.616 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.52 -43.81 97.91 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.39 0.995 . . . . 0.0 110.146 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -63.81 -31.51 72.71 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.485 0.714 . . . . 0.0 111.895 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 89.7 t80 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.765 1.166 . . . . 0.0 111.328 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.48 -8.2 55.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.01 45.2 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.319 0.963 . . . . 0.0 112.164 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.03 140.6 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.333 1.853 . . . . 0.0 109.124 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.35 155.3 35.77 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -52.67 -35.13 54.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.809 1.244 . . . . 0.0 112.093 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.9 m -64.49 -23.49 67.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -124.53 -1.77 8.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.998 1.319 . . . . 0.0 112.787 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.32 -46.43 90.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.061 -1.65 . . . . 0.0 111.546 171.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -61.19 -25.98 81.62 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.587 2.191 . . . . 0.0 113.497 169.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 50' ' ' LEU . 89.6 m -72.76 -36.96 67.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.208 175.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.49 92.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.872 1.269 . . . . 0.0 114.071 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.33 -33.05 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 119.975 1.261 . . . . 0.0 110.497 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.75 -52.0 36.3 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 124.998 1.285 . . . . 0.0 113.816 170.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -65.8 -25.85 67.43 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.663 2.231 . . . . 0.0 113.206 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.39 -58.7 3.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.091 0.86 . . . . 0.0 110.935 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -58.44 -44.07 89.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.267 1.827 . . . . 0.0 112.165 -174.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.39 -46.73 82.05 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.421 1.488 . . . . 0.0 112.075 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.452 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -78.88 -31.49 45.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.843 0.857 . . . . 0.0 111.809 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -71.2 -23.14 61.98 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -96.58 -11.5 25.27 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 -132.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.929 1.691 . . . . 0.0 110.88 -176.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -155.11 -56.2 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.998 2.119 . . . . 0.0 112.581 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -122.03 168.71 10.87 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.781 2.432 . . . . 0.0 109.965 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.22 6.28 4.58 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.66 1.573 . . . . 0.0 114.466 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.61 -26.66 68.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 112.625 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.22 21.7 15.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.686 1.995 . . . . 0.0 113.897 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.03 133.11 35.1 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.248 -1.532 . . . . 0.0 112.261 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.92 -1.36 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.67 1.188 . . . . 0.0 112.86 -173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 56.31 106.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.233 2.613 . . . . 0.0 110.561 -168.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.54 60.03 4.96 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.283 -1.511 . . . . 0.0 111.075 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.349 2.1 p -68.92 -24.77 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 120.721 -1.237 . . . . 0.0 112.282 -169.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -65.46 -42.96 91.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.723 -1.236 . . . . 0.0 112.209 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.96 -49.0 57.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.05 -43.79 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.953 1.301 . . . . 0.0 111.924 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -28.71 65.3 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.001 1.273 . . . . 0.0 112.736 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 50.5 m -69.8 -42.06 74.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 111.607 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 151' ' ' ILE . 29.0 t -85.41 -27.79 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.971 1.708 . . . . 0.0 113.474 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 22.2 m -50.74 -63.44 1.88 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 112.495 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.3 -17.68 58.75 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.459 2.106 . . . . 0.0 113.096 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.76 -58.29 4.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.434 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.445 HD12 HG12 ' B' ' 147' ' ' VAL . 33.0 mt -71.88 -32.32 44.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 112.34 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.49 -51.07 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.517 1.127 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.41 -48.16 73.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.632 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.6 74.17 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.0 113.454 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.0 m -73.5 -17.55 61.21 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.12 -31.11 19.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.624 1.102 . . . . 0.0 111.886 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.97 -41.89 97.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 111.253 169.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.34 80.02 1.55 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.895 0.855 . . . . 0.0 111.448 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.78 -38.98 67.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.176 1.79 . . . . 0.0 112.408 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.24 -8.86 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -169.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.8 148.08 52.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 112.266 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -65.22 135.29 55.24 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.209 1.004 . . . . 0.0 109.214 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.464 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 61.9 t80 -62.27 -52.32 64.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -58.9 -32.45 69.53 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.734 1.152 . . . . 0.0 112.386 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -70.94 -34.51 71.55 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 112.905 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -71.61 -34.95 70.27 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.682 -1.261 . . . . 0.0 112.606 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.89 -48.96 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.066 0.946 . . . . 0.0 110.077 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -59.0 -43.17 91.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.684 1.193 . . . . 0.0 111.744 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.04 -43.94 88.2 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.392 0.996 . . . . 0.0 113.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -80.39 -30.29 37.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.389 1.095 . . . . 0.0 113.517 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 171' ' ' TRP . . . . . 0.44 ' CD1' ' HE3' ' B' ' 175' ' ' LYS . 45.0 m0 -57.05 -40.02 75.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.195 1.362 . . . . 0.0 111.081 169.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -70.13 -14.78 62.8 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.653 -1.279 . . . . 0.0 114.083 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -21.55 25.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.339 1.456 . . . . 0.0 113.749 170.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.59 -45.66 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 126.523 1.929 . . . . 0.0 113.997 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' B' ' 171' ' ' TRP . 55.5 mttt . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 127.094 2.158 . . . . 0.0 111.829 -175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 CA-C-O 121.276 0.448 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.87 -26.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -74.4 -27.91 60.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.176 0.991 . . . . 0.0 112.932 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.6 m -114.79 -26.87 7.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.905 1.282 . . . . 0.0 114.304 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -92.97 171.88 8.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.632 1.173 . . . . 0.0 112.951 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.5 p -97.58 165.07 12.16 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -167.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.07 -16.92 8.4 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.763 1.625 . . . . 0.0 114.491 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.4 -35.44 62.88 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.729 1.149 . . . . 0.0 111.049 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.01 -32.31 67.82 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.765 -1.21 . . . . 0.0 112.502 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.95 -7.59 51.75 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 112.318 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.77 -16.46 14.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.248 1.419 . . . . 0.0 112.207 169.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.19 65.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.545 1.138 . . . . 0.0 111.513 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.64 139.32 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.334 1.854 . . . . 0.0 109.897 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.85 158.18 28.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.69 0.796 . . . . 0.0 112.092 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.77 -34.63 62.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.782 1.233 . . . . 0.0 111.69 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.8 m -59.14 -27.69 65.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.181 1.792 . . . . 0.0 113.516 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.44 3.16 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.482 1.513 . . . . 0.0 113.117 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -55.57 -45.63 99.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 120.002 -1.686 . . . . 0.0 111.276 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -60.31 -24.64 78.1 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.324 . . . . 0.0 114.249 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.768 HG22 HD21 ' B' ' 139' ' ' LEU . 62.3 m -75.95 -37.62 58.44 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.791 1.236 . . . . 0.0 110.759 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.23 97.42 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.42 -37.06 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 118.808 0.731 . . . . 0.0 111.574 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.23 12.04 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.798 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.73 -44.83 93.6 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.714 2.257 . . . . 0.0 112.409 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.0 -26.65 67.64 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -94.44 -35.93 12.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.48 84.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.428 1.891 . . . . 0.0 112.18 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD22 HD22 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -80.27 -26.22 39.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.151 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -18.33 48.54 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.458 -0.776 . . . . 0.0 113.091 -169.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -97.2 -14.18 21.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.4 -136.06 0.1 Allowed 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.972 1.709 . . . . 0.0 110.731 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -149.97 -60.78 0.2 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.594 1.958 . . . . 0.0 113.187 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -127.5 162.96 45.69 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.973 2.109 . . . . 0.0 110.326 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.05 5.85 5.96 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.722 1.615 . . . . 0.0 114.219 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -58.57 -24.77 61.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.523 1.129 . . . . 0.0 111.446 168.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -111.22 11.94 21.78 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.781 2.032 . . . . 0.0 113.383 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.09 34.83 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.023 -1.673 . . . . 0.0 113.005 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.34 -3.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 125.065 1.346 . . . . 0.0 112.387 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.1 OUTLIER 67.41 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.691 2.796 . . . . 0.0 110.749 -168.219 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -89.04 63.83 6.85 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.502 -1.374 . . . . 0.0 110.93 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.27 -28.63 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -168.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -54.13 -43.69 70.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.074 1.35 . . . . 0.0 112.199 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.9 -51.67 7.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.44 -48.19 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.188 0.995 . . . . 0.0 111.923 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.42 -28.34 67.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -70.2 -51.6 29.75 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.647 1.179 . . . . 0.0 112.539 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.01 -15.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -170.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.6 m -45.26 -63.31 1.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 120.261 1.391 . . . . 0.0 112.095 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -2.0 6.48 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.131 2.554 . . . . 0.0 114.805 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -64.13 1.14 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.964 1.706 . . . . 0.0 110.92 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -27.4 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.871 -1.143 . . . . 0.0 113.008 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -54.17 -48.2 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.926 1.29 . . . . 0.0 110.815 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -81.47 -48.47 11.82 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.239 0.543 . . . . 0.0 110.689 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.76 68.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.0 m -77.42 -13.92 59.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.08 -33.19 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.417 1.462 . . . . 0.0 110.917 168.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -61.82 -38.75 89.3 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.412 1.085 . . . . 0.0 111.847 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.82 55.61 1.72 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 0.0 112.834 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -53.75 -33.66 56.49 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.386 1.474 . . . . 0.0 113.232 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.18 -6.38 56.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.847 1.259 . . . . 0.0 113.705 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.04 159.61 26.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.785 0.834 . . . . 0.0 111.649 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -58.9 134.35 56.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 111.08 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.26 -47.24 71.31 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.391 -0.818 . . . . 0.0 112.96 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -64.27 -36.48 84.24 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.287 0.949 . . . . 0.0 111.963 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -59.61 -32.0 70.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.019 0.528 . . . . 0.0 112.068 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -74.83 -38.34 62.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.781 -1.104 . . . . 0.0 113.829 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.73 -41.15 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.923 1.692 . . . . 0.0 111.031 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.57 -44.05 91.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.317 1.047 . . . . 0.0 111.438 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.31 94.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.21 1.385 . . . . 0.0 113.5 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -71.93 -33.9 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.276 1.538 . . . . 0.0 113.4 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -60.33 -42.82 96.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.681 1.128 . . . . 0.0 111.383 171.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.04 -45.76 90.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.558 1.143 . . . . 0.0 111.969 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.59 71.62 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.002 -1.061 . . . . 0.0 111.826 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 124.142 0.977 . . . . 0.0 111.785 179.515 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 CA--C 1.541 0.854 0 CA-C-O 120.844 0.268 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.21 -26.82 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -80.08 -17.64 52.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.365 1.066 . . . . 0.0 113.563 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -106.4 -44.98 4.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.874 1.27 . . . . 0.0 113.939 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -101.8 176.05 5.35 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 77.7 p -91.2 164.55 13.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -167.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -20.7 21.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.553 1.941 . . . . 0.0 114.272 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.64 -31.78 57.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.625 1.102 . . . . 0.0 111.468 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.51 -36.32 64.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.839 1.256 . . . . 0.0 113.025 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.88 -20.05 64.25 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 111.633 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 43.4 mt -89.47 -12.52 39.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.008 1.323 . . . . 0.0 113.228 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -40.28 46.35 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.925 0.89 . . . . 0.0 111.176 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.34 137.74 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 128.013 2.525 . . . . 0.0 110.243 168.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.3 157.31 31.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.283 1.033 . . . . 0.0 112.947 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -50.34 -36.7 33.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.94 1.296 . . . . 0.0 112.68 171.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -66.58 -25.65 66.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.601 1.161 . . . . 0.0 113.483 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.4 -3.35 10.48 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.956 1.302 . . . . 0.0 113.843 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -56.88 -40.94 88.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.851 -1.781 . . . . 0.0 113.218 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -61.3 -26.82 82.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.606 2.204 . . . . 0.0 113.386 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 46.8 m -76.18 -35.0 59.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.377 1.071 . . . . 0.0 111.211 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -62.06 -47.26 85.47 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.204 1.002 . . . . 0.0 113.228 174.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.78 -36.59 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 118.34 0.518 . . . . 0.0 110.926 170.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.51 -55.29 17.42 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 125.267 1.413 . . . . 0.0 113.711 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -59.89 -33.95 72.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.23 2.015 . . . . 0.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.6 -47.74 30.59 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.472 -0.768 . . . . 0.0 112.943 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.08 -32.44 50.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.71 1.141 . . . . 0.0 112.847 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.77 55.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.067 1.347 . . . . 0.0 112.066 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.44 HD22 HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -69.4 -30.61 68.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.76 0.824 . . . . 0.0 110.95 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -68.11 -25.79 65.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.149 0.979 . . . . 0.0 113.218 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -80.18 -22.48 41.9 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -151.95 -130.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.245 1.418 . . . . 0.0 111.25 -169.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -163.82 -38.28 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.396 1.878 . . . . 0.0 114.023 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.49 164.86 40.96 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 127.377 2.271 . . . . 0.0 109.593 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -87.65 15.09 2.22 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.395 2.063 . . . . 0.0 114.26 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.12 -30.23 67.98 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.135 1.334 . . . . 0.0 113.239 -170.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.29 8.37 18.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.538 1.535 . . . . 0.0 114.259 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.17 127.64 33.5 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.938 -1.101 . . . . 0.0 112.045 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.53 14.05 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 126.201 1.8 . . . . 0.0 111.574 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 31' ' ' THR . 2.6 tm? 57.72 109.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.427 3.091 . . . . 0.0 110.439 -168.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -85.68 51.89 2.32 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.071 -1.643 . . . . 0.0 112.838 -167.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.31 0.4 OUTLIER -70.44 -11.82 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.744 -1.223 . . . . 0.0 113.564 -169.453 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -52.66 -34.09 50.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.362 . . . . 0.0 111.077 167.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.53 -58.39 1.85 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 113.002 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -43.53 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 118.301 1.051 . . . . 0.0 113.312 -174.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.96 64.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.996 1.271 . . . . 0.0 112.642 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 73.8 m -70.03 -38.77 75.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 112.097 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.93 -24.98 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.728 1.611 . . . . 0.0 114.011 -169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.4 m -43.56 -56.25 7.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 120.283 1.401 . . . . 0.0 113.525 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.62 -9.43 18.29 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.038 2.492 . . . . 0.0 114.587 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.94 -64.52 1.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.098 1.359 . . . . 0.0 112.225 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.479 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -71.86 -21.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.68 -40.76 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.845 1.202 . . . . 0.0 112.17 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.67 -47.93 13.33 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.218 1.007 . . . . 0.0 111.307 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 154' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' B' ' 151' ' ' ILE . . . -65.67 -37.39 86.38 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.543 -1.348 . . . . 0.0 113.069 -169.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -76.26 -8.66 57.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.94 -37.27 14.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.111 1.323 . . . . 0.0 111.685 169.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -75.64 -31.51 59.86 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -129.02 54.3 1.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.702 1.201 . . . . 0.0 111.752 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -52.35 -32.21 37.15 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.861 1.664 . . . . 0.0 113.075 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -90.02 -6.63 55.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.301 1.44 . . . . 0.0 114.05 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.2 156.71 31.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.95 0.796 . . . . 0.0 110.867 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -69.19 137.59 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.738 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -65.36 -38.63 90.66 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.062 -1.024 . . . . 0.0 112.721 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -59.35 -37.88 78.98 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.426 -0.796 . . . . 0.0 112.833 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.8 -35.27 76.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.27 0.628 . . . . 0.0 111.96 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -72.95 -37.9 66.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.237 -0.887 . . . . 0.0 113.235 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 14.2 m -64.45 -38.19 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.127 1.33 . . . . 0.0 111.285 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -63.79 -44.86 92.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.38 0.672 . . . . 0.0 111.948 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.1 98.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.303 0.954 . . . . 0.0 113.256 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.54 -36.06 65.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.464 1.132 . . . . 0.0 113.066 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -57.89 -41.57 82.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.406 1.003 . . . . 0.0 111.408 171.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.26 -47.56 81.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.603 1.161 . . . . 0.0 111.231 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -26.59 68.59 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.487 -1.383 . . . . 0.0 112.452 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.72 -46.62 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.982 1.713 . . . . 0.0 112.914 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 48.6 mttt . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.259 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.534 0.51 0 CA-C-O 121.466 0.528 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -62.67 -15.26 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -96.88 2.1 51.31 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.476 1.51 . . . . 0.0 113.607 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 m -137.97 -17.95 1.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.18 173.19 11.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.8 p -105.63 159.43 15.97 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.051 0.941 . . . . 0.0 111.706 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -21.32 43.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.63 -37.52 70.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.617 1.099 . . . . 0.0 111.46 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -67.68 -23.29 65.29 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.128 -0.983 . . . . 0.0 112.628 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.53 -11.05 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.877 -1.139 . . . . 0.0 111.908 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -98.34 -11.02 22.95 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.269 1.428 . . . . 0.0 112.663 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.96 -30.96 44.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.151 0.98 . . . . 0.0 111.73 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.85 137.23 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.767 2.027 . . . . 0.0 111.07 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.26 158.24 26.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 113.198 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -53.81 -33.47 56.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.956 1.302 . . . . 0.0 111.974 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 m -60.83 -27.71 68.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 113.623 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -127.18 -2.26 6.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 113.408 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.45 -43.44 98.08 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 119.91 -1.744 . . . . 0.0 112.348 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.84 -25.95 82.18 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.851 2.368 . . . . 0.0 113.367 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 HD21 ' B' ' 139' ' ' LEU . 52.3 m -76.23 -34.76 59.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.061 0.944 . . . . 0.0 111.531 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.63 1.172 . . . . 0.0 113.348 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.88 -34.54 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.92 0.782 . . . . 0.0 110.436 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.1 -46.05 79.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.614 1.578 . . . . 0.0 114.902 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.6 -41.62 83.75 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 121.361 2.58 . . . . 0.0 111.953 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.14 98.78 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.474 0.71 . . . . 0.0 112.173 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -85.24 -38.65 18.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.308 0.643 . . . . 0.0 112.524 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.24 63.8 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.28 -1.512 . . . . 0.0 111.146 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.51 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -72.58 -18.24 61.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.123 0.569 . . . . 0.0 111.726 -174.424 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -72.5 -21.71 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 113.029 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -98.04 -20.32 17.45 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.33 153.89 1.61 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 129.156 2.983 . . . . 0.0 106.56 -170.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.41 -17.92 19.39 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 128.836 2.854 . . . . 0.0 115.035 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -133.28 152.58 79.67 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.414 1.885 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -86.41 4.46 6.37 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.793 1.662 . . . . 0.0 114.503 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.15 -24.6 63.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.486 1.114 . . . . 0.0 112.439 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -111.36 15.38 21.37 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.536 1.934 . . . . 0.0 112.579 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.57 117.13 22.93 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 119.769 -1.832 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.28 107.92 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? -57.32 126.77 28.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -165.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -98.01 52.25 1.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.422 1.489 . . . . 0.0 112.298 -170.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.24 -30.75 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.128 -0.983 . . . . 0.0 112.16 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -60.27 -34.78 74.21 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.256 1.389 . . . . 0.0 112.064 175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.31 -55.06 5.3 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.204 0.906 . . . . 0.0 112.835 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.19 -42.24 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.026 -1.279 . . . . 0.0 112.394 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.28 64.99 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.687 -1.258 . . . . 0.0 112.872 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -69.8 -44.07 70.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 0.0 111.616 172.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.5 -20.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -43.23 -62.51 1.33 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.751 1.62 . . . . 0.0 112.371 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.17 -0.6 6.66 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.743 2.962 . . . . 0.0 114.485 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.68 -61.37 1.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.743 1.617 . . . . 0.0 109.766 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.14 -35.01 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.72 0.808 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.94 -43.6 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.872 0.869 . . . . 0.0 112.217 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.53 -46.83 45.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.356 0.598 . . . . 0.0 110.164 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.02 72.06 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.885 0.874 . . . . 0.0 113.039 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -75.86 -13.26 60.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.61 -33.68 16.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.111 1.323 . . . . 0.0 111.072 167.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -59.67 -40.44 87.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.403 1.081 . . . . 0.0 111.714 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -138.95 71.72 1.39 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -51.99 -31.17 28.2 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.649 1.18 . . . . 0.0 113.149 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -92.32 1.29 57.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 113.067 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.59 150.98 42.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.083 0.953 . . . . 0.0 112.053 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -93.38 103.03 15.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.938 1.295 . . . . 0.0 112.451 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.258 14.7 p90 43.12 -144.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -53.88 -17.13 2.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.644 2.778 . . . . 0.0 115.176 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.13 -27.84 62.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.168 0.987 . . . . 0.0 112.41 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -65.99 -43.34 88.06 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.733 1.151 . . . . 0.0 112.42 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.99 -38.08 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.138 0.881 . . . . 0.0 111.126 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.07 -45.18 93.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.703 0.801 . . . . 0.0 111.874 171.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.82 -43.5 98.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.93 1.252 . . . . 0.0 113.261 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.96 -35.33 69.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.039 1.42 . . . . 0.0 112.754 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -61.48 -41.26 96.99 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.909 -1.119 . . . . 0.0 111.479 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.91 -46.43 89.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.649 1.18 . . . . 0.0 111.853 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -26.66 68.48 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.004 -1.06 . . . . 0.0 111.735 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 124.28 1.032 . . . . 0.0 112.351 -179.314 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 CA--C 1.538 0.712 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -58.32 -22.98 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -79.12 -18.1 53.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.226 . . . . 0.0 114.147 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -127.4 -23.16 3.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.49 161.64 30.53 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.962 0.887 . . . . 0.0 112.845 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 50.1 p -93.99 167.2 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.646 1.212 . . . . 0.0 114.086 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.83 -26.55 66.98 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.08 -40.93 97.32 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.977 -1.077 . . . . 0.0 110.495 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.1 -31.4 72.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.106 0.563 . . . . 0.0 112.069 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -69.75 -26.75 64.46 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.47 -11.85 59.62 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.031 -1.043 . . . . 0.0 113.666 170.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.27 38.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.315 0.961 . . . . 0.0 112.866 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.51 141.91 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.045 1.738 . . . . 0.0 110.823 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.17 157.79 32.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.374 1.069 . . . . 0.0 113.346 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.34 -31.48 54.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.551 1.54 . . . . 0.0 112.04 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -61.54 -27.92 68.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.8 1.64 . . . . 0.0 114.079 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.62 -4.37 5.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.365 1.466 . . . . 0.0 112.697 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -57.02 -45.89 99.92 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 120.078 -1.639 . . . . 0.0 111.696 169.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -64.95 -22.52 62.69 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.356 2.038 . . . . 0.0 113.67 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.684 HG22 HD21 ' A' ' 50' ' ' LEU . 65.0 m -73.26 -35.81 66.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.988 0.915 . . . . 0.0 110.531 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.4 -41.91 84.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.04 -33.53 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.243 1.383 . . . . 0.0 110.875 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.94 -55.14 29.41 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 124.485 1.041 . . . . 0.0 111.912 168.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.76 -10.7 29.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 120.857 2.329 . . . . 0.0 114.408 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.15 -62.76 1.37 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.54 0.736 . . . . 0.0 110.051 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -73.43 -28.97 62.26 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.72 -1.237 . . . . 0.0 114.115 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.82 78.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.102 1.761 . . . . 0.0 112.274 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -85.53 -37.79 19.26 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.737 1.215 . . . . 0.0 110.082 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -59.58 -38.67 81.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.59 1.156 . . . . 0.0 113.381 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -91.4 -9.59 44.17 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 -128.49 0.09 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.663 1.585 . . . . 0.0 110.974 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -162.6 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.279 1.431 . . . . 0.0 113.24 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -135.76 165.6 34.8 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 127.283 2.233 . . . . 0.0 109.834 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.08 2.09 8.72 Favored 'Trans proline' 0 C--N 1.354 0.868 0 CA-C-N 121.429 1.546 . . . . 0.0 114.136 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.22 -28.36 67.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.446 1.098 . . . . 0.0 112.6 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.93 -20.23 30.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.281 1.432 . . . . 0.0 113.306 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.62 123.9 24.91 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.021 -1.049 . . . . 0.0 112.983 -169.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.31 17.18 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 126.202 1.801 . . . . 0.0 110.897 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 31' ' ' THR . 1.7 tm? 52.63 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.983 3.713 . . . . 0.0 110.127 -166.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.14 48.77 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.488 . . . . 0.0 112.425 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.289 3.9 p -70.77 -11.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -169.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.26 -29.73 24.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.611 1.564 . . . . 0.0 112.921 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.68 -55.62 1.88 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.71 0.671 . . . . 0.0 113.128 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 10.1 mt -51.16 -45.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.8 1.24 . . . . 0.0 113.282 -172.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.29 -28.79 63.32 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.611 1.096 . . . . 0.0 112.848 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 18.8 m -73.38 -41.59 63.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.897 1.279 . . . . 0.0 111.908 170.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.405 HG12 HD12 ' B' ' 151' ' ' ILE . 34.4 t -78.81 -28.9 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.076 1.75 . . . . 0.0 112.89 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.0 m -51.75 -63.76 1.88 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 125.697 1.599 . . . . 0.0 113.144 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.23 -18.59 61.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.745 2.297 . . . . 0.0 113.219 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.7 -58.84 3.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.893 0.877 . . . . 0.0 110.802 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.405 HD12 HG12 ' B' ' 147' ' ' VAL . 31.8 mt -72.59 -28.92 28.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 O-C-N 121.372 -0.83 . . . . 0.0 112.402 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -51.1 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 110.618 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.22 -47.42 70.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.719 0.408 . . . . 0.0 110.903 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.09 71.18 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.739 -1.225 . . . . 0.0 113.239 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.3 m -75.35 -12.7 60.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.09 -35.55 16.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.483 1.492 . . . . 0.0 110.945 167.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -58.1 -38.13 75.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.009 0.924 . . . . 0.0 111.95 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.6 57.33 1.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.567 1.147 . . . . 0.0 112.85 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -52.12 -40.33 61.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.047 1.739 . . . . 0.0 112.968 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -80.53 -7.58 59.26 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.07 165.6 17.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.239 1.016 . . . . 0.0 112.657 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -62.57 138.79 58.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.851 1.261 . . . . 0.0 110.739 170.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.41 -43.7 88.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.253 1.021 . . . . 0.0 113.294 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -65.19 -30.53 71.44 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.224 -0.923 . . . . 0.0 112.446 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.69 -38.46 81.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.472 1.109 . . . . 0.0 112.128 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -39.57 72.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.87 0.868 . . . . 0.0 112.577 172.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.91 -47.03 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 118.594 0.634 . . . . 0.0 110.302 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.16 -50.06 65.24 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.466 1.106 . . . . 0.0 111.921 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.63 98.94 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.599 1.095 . . . . 0.0 113.779 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -73.96 -33.14 63.77 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.751 1.275 . . . . 0.0 112.584 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.81 -37.26 86.04 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.965 -1.084 . . . . 0.0 111.852 170.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.83 -46.77 86.36 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.352 -0.843 . . . . 0.0 111.048 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -23.18 66.41 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 119.91 -1.744 . . . . 0.0 112.609 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -78.05 -46.58 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.358 1.863 . . . . 0.0 112.74 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 N--CA 1.482 1.169 0 C-N-CA 124.904 1.281 . . . . 0.0 113.203 -172.963 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.535 0.55 0 CA-C-O 121.034 0.347 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.81 -29.28 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.306 1.443 . . . . 0.0 114.507 -169.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.19 -15.96 57.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 114.13 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 t -110.95 -38.23 5.15 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 113.345 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -85.25 169.85 13.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.309 1.052 . . . . 0.0 113.597 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.5 p -99.93 161.15 13.79 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -19.51 49.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.572 1.949 . . . . 0.0 115.171 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.81 -34.98 70.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.792 1.178 . . . . 0.0 111.049 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.89 -26.53 68.65 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.081 -1.012 . . . . 0.0 112.802 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.66 -13.31 62.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.246 -0.909 . . . . 0.0 112.146 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.13 -19.36 18.72 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.644 1.178 . . . . 0.0 112.117 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.25 -37.45 32.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.759 1.224 . . . . 0.0 112.163 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.89 134.38 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 0.0 109.604 168.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.76 160.48 22.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 112.513 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.36 -36.63 73.76 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.134 -0.979 . . . . 0.0 111.788 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.6 m -59.65 -26.92 65.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.222 1.809 . . . . 0.0 113.728 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.45 -2.9 9.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.465 1.506 . . . . 0.0 112.76 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.2 mt-30 -59.07 -50.48 87.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 120.049 -1.657 . . . . 0.0 111.025 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 52.4 Cg_exo -67.69 -16.85 47.34 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.294 1.996 . . . . 0.0 113.622 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 m -75.75 -36.14 59.97 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.134 0.974 . . . . 0.0 110.912 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.18 83.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.464 1.106 . . . . 0.0 111.418 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.82 -47.41 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.257 1.023 . . . . 0.0 109.567 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 10.64 0.58 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.824 2.155 . . . . 0.0 117.209 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.64 -53.72 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.408 1.604 . . . . 0.0 109.945 167.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.7 85.11 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.221 -0.925 . . . . 0.0 112.655 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.3 -37.06 26.36 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.303 -0.873 . . . . 0.0 112.26 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.55 -49.21 72.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.993 -1.067 . . . . 0.0 111.778 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -18.32 61.03 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.956 0.902 . . . . 0.0 112.061 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -78.25 -21.97 49.06 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.062 -1.024 . . . . 0.0 112.916 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.69 -20.48 20.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.98 151.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.883 2.873 . . . . 0.0 106.969 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.95 -32.85 17.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.936 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -134.61 159.51 71.94 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 127.386 2.274 . . . . 0.0 109.736 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.2 15.92 2.05 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.698 1.599 . . . . 0.0 114.426 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -61.75 -21.96 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.935 1.294 . . . . 0.0 112.307 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.31 20.14 13.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.646 1.979 . . . . 0.0 112.438 173.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.85 109.38 16.93 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 119.493 -2.004 . . . . 0.0 110.875 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.94 8.03 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.038 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.839 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 49.17 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.518 3.927 . . . . 0.0 114.67 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -89.46 64.51 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.028 1.331 . . . . 0.0 111.475 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' CG ' ' B' ' 117' ' ' PHE . 0.7 OUTLIER -64.25 -39.1 84.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.073 -171.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.91 -36.55 84.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.366 1.439 . . . . 0.0 112.415 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.48 -48.91 59.9 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.676 0.655 . . . . 0.0 112.029 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.15 -42.79 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.528 1.131 . . . . 0.0 111.745 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.68 62.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.891 1.676 . . . . 0.0 113.159 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.1 m -72.62 -37.88 67.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.826 1.25 . . . . 0.0 111.463 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.81 -24.33 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.373 1.469 . . . . 0.0 113.626 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.8 m -49.65 -62.93 2.01 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 125.665 1.586 . . . . 0.0 112.619 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.93 -4.21 11.99 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.402 2.735 . . . . 0.0 113.926 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.35 -64.56 1.16 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.364 1.466 . . . . 0.0 108.807 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.94 -27.59 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.269 -0.894 . . . . 0.0 112.028 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -55.51 -48.43 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.674 1.189 . . . . 0.0 110.727 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.34 -48.06 18.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.546 0.688 . . . . 0.0 110.544 174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.71 69.89 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -169.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.1 m -76.94 -13.39 59.98 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -32.82 21.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.426 1.466 . . . . 0.0 110.757 168.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -61.24 -38.61 87.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.739 0.815 . . . . 0.0 112.089 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -135.81 58.72 1.74 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.379 1.471 . . . . 0.0 112.814 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -50.75 -36.1 34.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.562 -1.337 . . . . 0.0 113.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.61 -3.77 58.12 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.995 1.318 . . . . 0.0 113.624 -172.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.34 161.56 23.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.264 1.026 . . . . 0.0 111.496 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -65.52 134.64 53.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.844 1.258 . . . . 0.0 111.412 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -66.06 -52.27 50.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.397 -0.815 . . . . 0.0 112.826 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -62.33 -34.16 76.09 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.576 1.08 . . . . 0.0 112.297 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.6 -36.24 82.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.476 0.71 . . . . 0.0 112.152 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.0 -34.29 68.76 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.54 -46.2 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.089 0.556 . . . . 0.0 110.018 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -62.59 -43.4 98.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.763 0.825 . . . . 0.0 112.185 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.92 -44.38 98.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.018 1.294 . . . . 0.0 113.545 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.19 -35.1 68.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.784 1.292 . . . . 0.0 112.864 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -61.99 -38.06 87.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.909 1.232 . . . . 0.0 112.127 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.68 -49.85 75.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.537 1.135 . . . . 0.0 111.214 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -28.54 69.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.371 -1.456 . . . . 0.0 112.458 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.816 1.246 . . . . 0.0 112.541 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 CA--C 1.538 0.72 0 N-CA-C 110.962 -0.438 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.41 -24.46 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -70.85 -25.91 63.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.259 1.024 . . . . 0.0 113.445 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -126.82 -18.5 4.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.27 1.428 . . . . 0.0 114.73 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -86.68 170.59 11.66 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.013 1.725 . . . . 0.0 111.835 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.3 p -104.45 156.24 18.11 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.342 1.057 . . . . 0.0 113.142 -170.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.353 0.3 OUTLIER -73.63 -3.21 26.65 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.98 -31.6 65.22 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.851 -1.155 . . . . 0.0 111.353 168.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.38 -35.75 60.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.226 1.01 . . . . 0.0 112.754 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.25 -15.47 63.58 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.214 -0.929 . . . . 0.0 112.64 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.5 mt -92.2 -19.22 22.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.164 0.986 . . . . 0.0 112.764 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.48 -25.69 20.18 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.555 1.542 . . . . 0.0 112.954 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.93 -2.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 t70 66.12 157.85 0.11 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 128.232 2.613 . . . . 0.0 116.611 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -55.47 -35.21 65.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.155 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 30.4 m -69.04 -24.09 64.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 52' ' ' VAL . 9.9 m-85 -127.71 4.67 6.09 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.546 1.138 . . . . 0.0 112.547 -174.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.84 -52.07 77.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 125.71 1.604 . . . . 0.0 111.998 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -61.52 -23.7 77.0 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.323 2.016 . . . . 0.0 113.573 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.839 HG22 HD21 ' A' ' 50' ' ' LEU . 23.2 m -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.007 1.323 . . . . 0.0 111.171 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.43 82.4 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.665 1.186 . . . . 0.0 113.793 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.5 -33.85 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 119.627 1.103 . . . . 0.0 110.458 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.8 -51.56 44.18 Favored Glycine 0 C--O 1.216 -0.973 0 C-N-CA 124.347 0.975 . . . . 0.0 112.795 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.65 -16.81 64.09 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.87 2.335 . . . . 0.0 113.862 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.78 -43.7 12.32 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.55 1.068 . . . . 0.0 112.211 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.55 -34.01 23.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.002 -1.061 . . . . 0.0 113.548 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.24 99.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.864 2.066 . . . . 0.0 112.69 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -34.19 34.47 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.242 1.017 . . . . 0.0 110.583 -175.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.09 -28.4 68.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -94.02 -1.73 54.05 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.53 -127.31 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.598 1.559 . . . . 0.0 111.248 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.26 -55.67 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.604 1.562 . . . . 0.0 113.513 -170.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -136.41 162.32 57.02 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 126.763 2.025 . . . . 0.0 110.446 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.31 6.01 5.05 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.729 1.619 . . . . 0.0 114.979 -174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.0 -29.37 43.03 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.944 0.898 . . . . 0.0 111.496 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -112.32 17.67 19.21 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.215 2.206 . . . . 0.0 113.117 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.94 134.78 38.54 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.174 -1.579 . . . . 0.0 113.955 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.41 -4.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.013 1.325 . . . . 0.0 113.828 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.26 119.16 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.878 2.471 . . . . 0.0 111.52 -167.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -81.95 53.25 2.15 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 119.608 -1.932 . . . . 0.0 112.016 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.404 0.6 OUTLIER -65.38 -46.9 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -163.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -60.54 -34.38 74.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.909 2.14 . . . . 0.0 111.783 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.35 -48.93 48.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.188 0.899 . . . . 0.0 112.424 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.21 -42.18 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 111.443 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.54 71.2 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.682 1.128 . . . . 0.0 112.817 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -66.35 -38.89 88.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.709 1.204 . . . . 0.0 111.682 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.6 -30.36 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.508 1.523 . . . . 0.0 113.212 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 37.0 m -45.19 -56.11 9.95 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 -7.59 16.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.445 2.763 . . . . 0.0 114.593 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -61.97 1.69 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.099 1.36 . . . . 0.0 111.658 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -70.77 -20.18 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 120.884 -1.135 . . . . 0.0 113.972 -176.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.39 -41.88 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.581 1.537 . . . . 0.0 112.018 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.01 -51.25 10.63 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 110.436 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.14 69.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.361 -1.462 . . . . 0.0 113.38 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 78.9 m -80.17 -7.37 58.91 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.73 -34.56 14.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.341 1.056 . . . . 0.0 110.44 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -60.91 -39.7 90.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.517 1.127 . . . . 0.0 112.229 171.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -142.49 54.85 1.42 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.948 0.899 . . . . 0.0 112.906 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -53.73 -37.24 63.13 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.427 1.891 . . . . 0.0 113.302 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.71 -8.85 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.842 1.257 . . . . 0.0 113.84 -169.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -83.88 166.81 17.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 112.078 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.57 139.0 56.49 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.172 1.389 . . . . 0.0 112.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -63.79 -46.97 82.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.564 1.146 . . . . 0.0 111.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -64.03 -38.52 91.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.854 0.862 . . . . 0.0 112.188 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.926 0.89 . . . . 0.0 111.952 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' B' ' 166' ' ' LYS . 0.1 OUTLIER -71.94 -43.39 65.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.189 -0.91 . . . . 0.0 113.234 174.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.37 -40.41 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.182 1.355 . . . . 0.0 111.669 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.11 -42.99 93.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.875 0.87 . . . . 0.0 112.258 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.2 -45.3 96.81 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.312 0.958 . . . . 0.0 112.983 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.77 -33.74 64.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.485 1.142 . . . . 0.0 112.973 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -59.43 -41.83 90.45 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.862 1.21 . . . . 0.0 111.943 170.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.51 -47.26 84.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.562 1.145 . . . . 0.0 111.943 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.36 68.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.161 -0.962 . . . . 0.0 112.061 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.49 -50.89 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.886 1.674 . . . . 0.0 112.175 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 125.33 1.452 . . . . 0.0 113.322 -170.237 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 CA--C 1.532 0.388 0 CA-C-O 121.312 0.463 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.97 -20.08 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.107 1.363 . . . . 0.0 114.417 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -72.7 -35.31 67.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.105 0.962 . . . . 0.0 113.523 173.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 m -110.5 -21.89 11.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.769 1.227 . . . . 0.0 114.112 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -94.37 171.27 8.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.2 1.4 . . . . 0.0 112.219 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.5 p -107.5 166.21 10.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.838 1.304 . . . . 0.0 114.498 -168.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -19.18 35.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.983 1.713 . . . . 0.0 115.436 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.49 -32.81 63.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.92 1.236 . . . . 0.0 111.365 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.83 -32.21 67.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.939 0.896 . . . . 0.0 112.728 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -74.05 -14.68 61.04 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.81 -0.556 . . . . 0.0 112.142 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.0 mt -96.45 -18.89 19.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.47 1.108 . . . . 0.0 112.281 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.76 54.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.425 1.09 . . . . 0.0 111.951 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.41 138.29 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.563 1.545 . . . . 0.0 110.652 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.23 160.51 31.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.287 1.035 . . . . 0.0 112.987 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.23 -37.43 74.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.696 1.198 . . . . 0.0 111.786 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.67 -20.84 63.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.526 1.53 . . . . 0.0 113.873 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -126.73 -2.91 6.62 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.237 1.415 . . . . 0.0 113.001 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -55.51 -47.71 98.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.143 -1.598 . . . . 0.0 111.91 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -62.45 -23.06 74.81 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.764 2.31 . . . . 0.0 113.804 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 HD21 ' B' ' 139' ' ' LEU . 27.6 m -77.02 -36.79 56.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.749 1.22 . . . . 0.0 110.977 175.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.45 98.44 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 113.519 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.91 -35.77 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 119.417 1.008 . . . . 0.0 110.329 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.54 -48.19 49.79 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.327 1.441 . . . . 0.0 114.571 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.44 -39.69 89.05 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 121.253 2.526 . . . . 0.0 112.306 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.54 76.16 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.467 -0.771 . . . . 0.0 112.528 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -85.22 -38.81 18.51 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.06 -52.52 62.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.37 1.068 . . . . 0.0 110.878 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.432 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -68.78 -18.24 64.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.503 1.121 . . . . 0.0 111.732 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -80.17 -17.46 52.36 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.209 1.004 . . . . 0.0 113.386 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.27 3.3 p30 -123.39 11.12 9.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 150.21 1.49 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 129.73 3.212 . . . . 0.0 106.504 168.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -86.41 -31.8 21.24 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 128.563 2.745 . . . . 0.0 113.204 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.59 158.09 73.9 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 127.518 2.327 . . . . 0.0 109.375 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.35 5.58 6.17 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.023 1.401 . . . . 0.0 114.046 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.7 -16.36 63.32 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.603 -1.311 . . . . 0.0 112.724 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -103.58 3.98 35.19 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.339 1.855 . . . . 0.0 113.22 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.69 122.67 26.28 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 119.981 -1.699 . . . . 0.0 112.654 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.53 -7.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 125.161 1.384 . . . . 0.0 112.271 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.866 HD21 HG22 ' B' ' 120' ' ' THR . 2.0 tm? 62.53 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.826 3.25 . . . . 0.0 113.224 -171.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.07 58.17 4.04 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.775 1.23 . . . . 0.0 111.453 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.6 p -65.94 -22.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.995 -1.066 . . . . 0.0 113.459 -169.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -62.85 -49.82 73.36 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 121.157 1.799 . . . . 0.0 112.076 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.23 76.8 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.3 -44.26 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.281 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.4 68.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.95 1.705 . . . . 0.0 112.858 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 m -68.77 -36.58 78.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 73.5 t -90.8 -23.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.109 1.363 . . . . 0.0 113.523 -175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -44.27 -60.46 2.82 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 126.211 1.804 . . . . 0.0 112.477 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.5 -0.61 5.35 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.328 2.685 . . . . 0.0 114.462 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 -64.6 1.12 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.215 1.406 . . . . 0.0 110.584 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.04 -29.29 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.234 -0.916 . . . . 0.0 112.313 177.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 t -52.74 -48.33 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.988 1.315 . . . . 0.0 110.488 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.74 -47.88 11.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.435 0.636 . . . . 0.0 110.609 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.85 69.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.1 m -77.8 -12.05 59.94 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -33.64 16.66 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.133 1.333 . . . . 0.0 110.764 167.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -58.78 -38.63 78.93 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.507 1.123 . . . . 0.0 112.116 172.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -145.55 85.5 1.71 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.715 0.806 . . . . 0.0 112.293 170.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -57.73 -27.94 63.44 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.973 1.309 . . . . 0.0 112.505 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -92.26 -4.75 53.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.551 1.541 . . . . 0.0 112.943 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.54 154.37 41.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.542 1.137 . . . . 0.0 111.346 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -65.72 137.24 57.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.089 0.956 . . . . 0.0 111.544 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.04 -47.43 80.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.676 0.791 . . . . 0.0 112.64 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -61.69 -41.2 97.26 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.96 0.904 . . . . 0.0 111.479 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.28 -34.35 77.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.665 0.786 . . . . 0.0 112.34 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.58 -42.17 68.1 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.748 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.22 -38.53 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.159 1.345 . . . . 0.0 111.203 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -63.28 -45.1 93.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.179 0.592 . . . . 0.0 111.837 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.32 -44.71 97.28 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.958 1.266 . . . . 0.0 113.422 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.44 -35.41 70.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.972 1.386 . . . . 0.0 112.967 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -62.49 -41.26 98.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.644 1.111 . . . . 0.0 111.651 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.17 -48.82 80.12 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.788 1.235 . . . . 0.0 111.479 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.22 72.22 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.815 -1.178 . . . . 0.0 111.678 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 124.307 1.043 . . . . 0.0 112.375 -178.314 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.543 0.945 0 CA-C-O 121.484 0.535 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.35 0.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -108.24 15.57 24.0 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.279 1.832 . . . . 0.0 112.652 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 28.4 m -144.08 -43.83 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.52 120.17 32.1 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.301 0.955 . . . . 0.0 111.726 -174.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -71.04 169.23 15.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.045 1.738 . . . . 0.0 114.41 -169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -24.88 17.74 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.0 -35.75 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.907 1.231 . . . . 0.0 111.578 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.33 -20.68 58.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.198 0.999 . . . . 0.0 113.208 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -67.66 -25.22 65.6 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.086 -1.009 . . . . 0.0 111.292 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.35 -13.85 56.24 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.335 1.054 . . . . 0.0 113.17 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.04 -36.36 30.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.388 1.075 . . . . 0.0 113.07 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.07 139.47 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.052 1.341 . . . . 0.0 110.212 169.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.81 160.48 30.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.466 1.106 . . . . 0.0 113.289 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -58.98 -34.87 72.32 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 0.0 111.885 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -62.37 -22.1 65.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.547 1.539 . . . . 0.0 113.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -127.3 -3.13 6.25 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -60.95 -45.85 96.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 O-C-N 119.957 -1.714 . . . . 0.0 111.937 170.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.28 -28.92 85.35 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.004 2.469 . . . . 0.0 113.13 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 50' ' ' LEU . 61.1 m -70.15 -38.49 75.48 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.487 1.115 . . . . 0.0 110.743 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.08 95.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.172 1.389 . . . . 0.0 114.457 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.74 -33.41 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 119.984 1.266 . . . . 0.0 110.824 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.99 -55.28 26.72 Favored Glycine 0 C--O 1.217 -0.937 0 C-N-CA 124.292 0.949 . . . . 0.0 112.65 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -64.81 -11.36 36.26 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.504 2.152 . . . . 0.0 114.386 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.61 -62.64 1.44 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.84 0.745 . . . . 0.0 110.169 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.46 -27.16 58.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.57 89.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.634 1.573 . . . . 0.0 112.069 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -83.14 -38.63 22.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.828 1.251 . . . . 0.0 110.241 -178.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -59.42 -33.18 70.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.792 1.237 . . . . 0.0 113.603 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.34 -11.49 37.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -143.51 -123.31 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.66 1.118 . . . . 0.0 113.744 -171.201 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.95 -68.89 0.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.894 1.278 . . . . 0.0 112.94 -168.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -139.38 167.01 20.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 127.588 2.355 . . . . 0.0 109.4 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.18 6.26 4.82 Favored 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.331 1.868 . . . . 0.0 114.439 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.76 -19.98 64.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.391 1.477 . . . . 0.0 111.434 168.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -113.12 11.63 18.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.854 2.062 . . . . 0.0 113.378 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.05 129.74 35.62 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 119.991 -1.693 . . . . 0.0 113.301 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.11 -6.05 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 125.03 1.332 . . . . 0.0 113.143 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.799 HD21 HG22 ' A' ' 31' ' ' THR . 1.4 tm? 61.21 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.855 3.262 . . . . 0.0 112.96 -169.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.13 60.35 1.19 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.361 -1.462 . . . . 0.0 111.849 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.297 2.4 p -66.11 -21.57 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.75 -1.219 . . . . 0.0 113.225 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.673 1.579 . . . . 0.0 112.522 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.44 -50.36 26.84 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mt -61.7 -43.21 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.642 0.777 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.67 -28.46 64.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.548 1.522 . . . . 0.0 112.491 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 39.0 m -68.7 -42.67 77.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.112 0.965 . . . . 0.0 111.698 169.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' VAL . . . . . 0.435 HG12 HD12 ' B' ' 151' ' ' ILE . 31.5 t -84.24 -26.91 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.796 1.638 . . . . 0.0 113.503 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.2 m -50.51 -63.38 1.88 Allowed Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 126.184 1.793 . . . . 0.0 113.087 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.52 -25.89 70.06 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.924 1.75 . . . . 0.0 112.334 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -57.83 9.85 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.447 1.099 . . . . 0.0 110.341 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.435 HD12 HG12 ' B' ' 147' ' ' VAL . 27.7 mt -71.96 -31.92 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.442 -0.786 . . . . 0.0 111.957 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.71 -51.15 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.351 1.061 . . . . 0.0 110.393 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.35 -45.99 68.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.767 0.317 . . . . 0.0 111.159 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.19 -30.75 71.84 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.658 -1.276 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 29.2 m -73.85 -12.71 60.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -37.48 14.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.507 1.503 . . . . 0.0 110.78 166.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -57.3 -40.4 77.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.958 0.903 . . . . 0.0 111.806 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -142.15 72.71 1.38 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.481 1.112 . . . . 0.0 111.027 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -53.42 -31.06 43.4 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.116 1.766 . . . . 0.0 112.923 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.98 1.91 51.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.071 1.348 . . . . 0.0 113.114 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.41 152.98 36.66 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 114.305 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.18 59.27 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.351 1.86 . . . . 0.0 113.334 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 46.0 -103.73 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 165.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -47.07 -33.34 4.81 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.682 2.393 . . . . 0.0 113.716 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.0 -36.52 79.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.084 . . . . 0.0 112.807 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.4 -33.34 63.0 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.238 -0.914 . . . . 0.0 112.353 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.5 -48.79 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.709 0.803 . . . . 0.0 110.121 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.08 -42.81 99.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.979 0.911 . . . . 0.0 112.172 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.4 94.55 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.85 1.214 . . . . 0.0 113.48 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.61 -35.36 67.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.561 1.18 . . . . 0.0 112.608 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -60.66 -37.66 82.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.609 1.095 . . . . 0.0 112.216 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.77 -45.56 92.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.324 1.05 . . . . 0.0 111.933 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -24.45 67.24 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.584 -1.322 . . . . 0.0 112.438 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.41 -46.04 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.517 1.927 . . . . 0.0 112.821 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 125.193 1.397 . . . . 0.0 113.45 -174.357 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo . . . . . 0 C--O 1.234 0.321 0 CA-C-O 121.645 0.602 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.9 5.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.833 1.653 . . . . 0.0 115.031 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -122.27 11.24 10.06 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.027 2.131 . . . . 0.0 113.914 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 m -141.02 -27.79 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -175.27 4.03 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -171.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.6 p -119.93 164.69 15.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.19 1.396 . . . . 0.0 114.391 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.12 -19.86 55.57 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.44 -37.14 79.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.228 1.376 . . . . 0.0 111.465 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.72 -20.3 63.53 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.377 -0.827 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -67.02 -18.45 65.37 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.874 -1.141 . . . . 0.0 111.631 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.12 -6.75 41.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.193 1.397 . . . . 0.0 112.704 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.94 -34.1 17.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.648 1.179 . . . . 0.0 112.04 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.0 137.75 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.016 1.326 . . . . 0.0 109.954 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.27 160.25 29.69 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.184 0.993 . . . . 0.0 112.804 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -58.44 -36.58 73.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 m -62.08 -21.87 65.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.653 1.581 . . . . 0.0 113.743 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -126.27 -3.57 6.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.575 1.55 . . . . 0.0 112.684 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -59.46 -46.58 98.85 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 120.103 -1.623 . . . . 0.0 110.996 171.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -28.33 87.2 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.195 2.597 . . . . 0.0 113.564 169.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 m -72.27 -35.6 68.8 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.034 0.934 . . . . 0.0 111.423 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.26 81.35 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.819 1.248 . . . . 0.0 113.927 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -36.69 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 119.377 0.989 . . . . 0.0 110.845 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.52 63.58 Favored Glycine 0 C--O 1.214 -1.11 0 C-N-CA 124.326 0.965 . . . . 0.0 112.826 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.11 -18.09 65.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 121.276 2.538 . . . . 0.0 113.988 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.37 -57.72 3.04 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.471 0.578 . . . . 0.0 110.444 165.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -76.46 -21.24 56.14 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.18 94.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.344 1.458 . . . . 0.0 111.107 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -84.2 -40.15 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.509 1.123 . . . . 0.0 110.642 -178.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -62.18 -30.09 70.82 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -93.41 -5.31 49.68 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -124.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.005 1.322 . . . . 0.0 112.274 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -161.79 -58.3 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.24 1.416 . . . . 0.0 113.932 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.14 162.43 48.0 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 127.615 2.366 . . . . 0.0 110.678 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.22 -1.77 11.96 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.811 1.674 . . . . 0.0 114.693 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -54.91 -27.87 46.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.893 1.277 . . . . 0.0 113.423 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -95.54 -11.27 27.67 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.098 1.359 . . . . 0.0 113.846 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 121.78 26.24 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.674 -1.266 . . . . 0.0 113.754 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.44 9.96 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 125.41 1.484 . . . . 0.0 111.701 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.742 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? 59.99 121.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.591 3.156 . . . . 0.0 111.992 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -87.11 45.62 1.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.619 -1.301 . . . . 0.0 111.963 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 3.0 p -66.19 -22.22 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.234 -1.541 . . . . 0.0 112.182 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.86 -33.5 66.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.845 1.258 . . . . 0.0 112.552 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.15 -59.56 1.94 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.619 1.104 . . . . 0.0 112.097 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.56 -44.77 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.709 -1.465 . . . . 0.0 112.949 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.97 -27.21 64.54 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.275 1.398 . . . . 0.0 112.435 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -66.96 -46.38 74.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.27 1.428 . . . . 0.0 111.955 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 62' ' ' ILE . 1.4 t -94.12 -18.08 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 m -42.52 -59.32 2.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 C-N-CA 125.676 1.591 . . . . 0.0 112.588 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.65 -2.69 9.77 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.352 2.701 . . . . 0.0 114.539 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.81 -58.1 2.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.959 1.304 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.53 -36.5 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 120.489 1.495 . . . . 0.0 112.123 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.5 -49.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.821 1.248 . . . . 0.0 110.62 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.98 -45.52 34.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.655 0.741 . . . . 0.0 110.986 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.78 70.02 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.781 0.832 . . . . 0.0 112.954 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.3 m -75.48 -13.2 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 170.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.13 -36.09 18.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.797 1.635 . . . . 0.0 110.516 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -57.02 -38.65 73.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.253 1.021 . . . . 0.0 111.813 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -144.92 84.55 1.72 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.534 0.683 . . . . 0.0 111.768 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -54.98 -31.34 60.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.105 1.362 . . . . 0.0 112.188 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.68 -0.93 57.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.272 1.429 . . . . 0.0 112.909 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.65 144.58 56.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.252 1.021 . . . . 0.0 111.72 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -77.75 160.89 28.1 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.377 1.084 . . . . 0.0 113.669 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -40.58 151.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.563 2.745 . . . . 0.0 115.13 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt 62.03 -38.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 129.487 3.115 . . . . 0.0 116.309 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.73 -31.86 70.01 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.846 1.659 . . . . 0.0 112.174 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -69.67 -43.91 71.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.71 -0.619 . . . . 0.0 112.509 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.03 -36.69 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.763 1.165 . . . . 0.0 111.459 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.15 -46.05 78.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.274 1.029 . . . . 0.0 111.949 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.87 96.97 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.824 1.202 . . . . 0.0 113.1 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -25.93 59.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.846 -1.385 . . . . 0.0 113.485 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -70.93 -42.32 70.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.479 -0.763 . . . . 0.0 111.248 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -58.23 -42.89 87.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.205 1.402 . . . . 0.0 111.68 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.18 -38.8 27.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.483 1.913 . . . . 0.0 114.212 170.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.241 -168.609 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 0 CA--C 1.543 0.948 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.57 -21.26 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -74.33 -19.99 60.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.688 1.195 . . . . 0.0 113.565 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 70.0 m -122.46 -20.86 5.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.849 2.46 . . . . 0.0 113.953 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -53.09 140.97 24.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.367 2.667 . . . . 0.0 111.556 172.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -98.6 168.12 10.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.869 1.319 . . . . 0.0 112.866 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.36 -28.35 67.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.035 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -61.22 -43.58 98.64 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.078 -1.014 . . . . 0.0 110.327 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -66.64 -30.11 70.29 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.449 0.7 . . . . 0.0 112.139 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.409 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 73.7 t80 -67.69 -31.87 72.13 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.317 -1.489 . . . . 0.0 111.751 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.78 -9.3 58.48 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.03 44.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.769 1.168 . . . . 0.0 112.353 172.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.42 135.18 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.663 1.585 . . . . 0.0 110.145 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.22 157.77 34.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.375 1.07 . . . . 0.0 112.888 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.28 -34.26 72.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.271 1.028 . . . . 0.0 111.851 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.3 m -61.24 -25.55 67.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.421 1.888 . . . . 0.0 113.973 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.0 -6.11 7.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.246 1.018 . . . . 0.0 113.73 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.86 -43.49 98.66 Favored Pre-proline 0 N--CA 1.476 0.858 0 O-C-N 120.204 -1.56 . . . . 0.0 113.389 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -61.71 -27.73 81.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.932 2.421 . . . . 0.0 113.046 170.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.742 HG22 HD21 ' A' ' 50' ' ' LEU . 26.2 m -74.24 -36.84 63.92 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.903 1.281 . . . . 0.0 111.294 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.19 93.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.015 1.326 . . . . 0.0 113.996 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.06 -33.07 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 119.422 1.01 . . . . 0.0 110.767 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.54 -51.08 50.49 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 125.492 1.52 . . . . 0.0 114.099 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.43 -32.78 74.59 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.283 2.542 . . . . 0.0 112.419 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.46 -54.02 19.7 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.046 0.839 . . . . 0.0 111.21 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.44 -22.59 40.98 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.63 -46.19 32.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.594 1.158 . . . . 0.0 111.056 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.41 HD13 HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -75.97 -33.99 59.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.009 -176.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -73.13 -10.3 59.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -101.61 -11.27 19.35 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.61 -129.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.084 1.354 . . . . 0.0 112.303 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -161.64 -51.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.141 1.776 . . . . 0.0 113.189 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -132.66 166.93 25.42 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.339 2.256 . . . . 0.0 109.757 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.87 12.43 2.87 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 114.183 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.78 -14.62 62.86 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.679 -1.263 . . . . 0.0 113.934 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -119.89 4.68 10.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 113.518 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.29 134.2 41.13 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.911 -1.118 . . . . 0.0 113.605 -169.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.37 136.6 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.902 2.081 . . . . 0.0 107.317 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.28 119.95 11.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.461 1.028 . . . . 0.0 109.163 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.4 54.65 3.23 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.698 -1.251 . . . . 0.0 110.996 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 1.5 p -67.03 -25.03 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -165.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -63.04 -41.63 99.56 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 121.161 1.801 . . . . 0.0 111.133 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.08 -49.31 34.73 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 123.984 0.802 . . . . 0.0 111.416 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.22 -43.18 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.869 0.868 . . . . 0.0 111.533 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.15 -31.75 68.08 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 120.253 1.388 . . . . 0.0 112.726 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m -65.36 -42.84 92.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.097 0.959 . . . . 0.0 111.568 170.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -82.73 -29.41 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.978 1.311 . . . . 0.0 113.047 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.6 m -43.48 -61.05 2.06 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 126.113 1.765 . . . . 0.0 113.77 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.16 -14.44 44.35 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.577 2.185 . . . . 0.0 113.367 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.66 -63.47 1.16 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.131 0.972 . . . . 0.0 110.838 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -66.94 -25.53 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.05 -1.031 . . . . 0.0 113.141 177.661 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.69 -51.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.605 1.093 . . . . 0.0 110.753 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.39 -47.21 51.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.935 0.397 . . . . 0.0 111.057 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.54 -28.32 69.08 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.662 -1.274 . . . . 0.0 113.175 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.96 -15.89 60.09 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 169.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -30.32 21.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 111.202 168.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -61.23 -38.38 86.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.875 0.87 . . . . 0.0 112.535 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.68 88.16 1.68 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.636 0.774 . . . . 0.0 111.922 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.93 -41.91 68.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.356 1.462 . . . . 0.0 111.579 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -79.51 -3.24 45.85 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.8 153.07 44.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.012 0.925 . . . . 0.0 112.071 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.69 134.0 46.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 0.0 109.333 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.409 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 46.2 t80 -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.289 -0.882 . . . . 0.0 112.663 -175.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -62.67 -40.14 96.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.209 0.913 . . . . 0.0 111.588 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.31 -38.97 93.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.557 0.743 . . . . 0.0 111.913 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.72 -37.14 73.48 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.953 0.797 . . . . 0.0 113.027 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.45 -48.33 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.173 0.989 . . . . 0.0 110.116 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -64.07 -47.36 80.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.989 0.916 . . . . 0.0 112.011 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.91 99.39 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.627 1.108 . . . . 0.0 113.269 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -73.12 -35.83 66.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.225 -1.162 . . . . 0.0 112.792 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -60.53 -38.16 83.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.633 1.106 . . . . 0.0 111.881 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.87 -44.68 96.32 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.395 -0.815 . . . . 0.0 111.611 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -19.33 65.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.838 -1.164 . . . . 0.0 112.558 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.3 -41.48 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.466 1.906 . . . . 0.0 112.973 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 124.796 1.239 . . . . 0.0 113.441 -177.806 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.364 0 CA-C-O 122.202 0.834 . . . . 0.0 114.035 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.53 -12.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -104.76 -4.26 22.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.318 1.447 . . . . 0.0 114.807 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -124.36 -28.31 3.67 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -92.5 151.84 19.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.151 0.977 . . . . 0.0 111.484 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -85.47 170.07 13.01 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.49 -18.78 3.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.845 1.658 . . . . 0.0 114.732 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -51.7 -28.99 16.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 111.961 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -46.35 -42.06 14.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.206 1.402 . . . . 0.0 113.178 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.32 -15.25 61.89 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.98 -18.11 17.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.02 1.328 . . . . 0.0 111.799 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.92 -37.46 22.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.501 1.52 . . . . 0.0 112.374 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.49 137.72 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.593 1.557 . . . . 0.0 110.744 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.59 159.56 31.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 112.923 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.85 -36.19 74.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.889 -1.132 . . . . 0.0 111.97 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -60.43 -25.53 66.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.732 1.613 . . . . 0.0 113.857 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -124.33 -2.41 8.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.591 1.556 . . . . 0.0 112.96 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -53.92 -46.72 98.45 Favored Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 120.28 -1.513 . . . . 0.0 111.794 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -70.71 -16.42 33.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.226 1.951 . . . . 0.0 113.459 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.2 m -75.74 -33.84 60.28 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.047 -1.033 . . . . 0.0 111.136 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.51 82.0 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.406 -0.809 . . . . 0.0 111.569 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 t -59.1 -49.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.388 1.075 . . . . 0.0 109.031 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.8 19.1 0.32 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 126.321 1.915 . . . . 0.0 116.874 172.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.56 -63.14 1.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.404 1.881 . . . . 0.0 109.101 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.96 93.16 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.158 -0.964 . . . . 0.0 112.337 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -86.52 -28.82 23.14 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.708 -0.62 . . . . 0.0 112.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.05 -48.12 81.65 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.36 -1.462 . . . . 0.0 112.013 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -74.1 -26.78 60.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.268 0.627 . . . . 0.0 111.302 -178.161 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.82 -26.44 68.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.617 1.167 . . . . 0.0 113.672 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.85 -1.22 43.56 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -171.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -125.61 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.757 1.623 . . . . 0.0 111.255 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -167.14 -46.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.363 2.265 . . . . 0.0 112.399 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -129.36 165.69 30.85 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 127.991 2.517 . . . . 0.0 109.938 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.74 15.73 2.14 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.231 1.954 . . . . 0.0 114.527 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -61.36 -33.44 73.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.376 1.07 . . . . 0.0 112.071 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.22 23.91 11.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.478 1.911 . . . . 0.0 113.575 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 118.2 19.42 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.613 -1.305 . . . . 0.0 110.827 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 t -106.91 -11.31 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.218 1.007 . . . . 0.0 113.101 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.915 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 64.91 113.24 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.946 2.498 . . . . 0.0 111.164 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -95.1 64.05 2.72 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.337 5.2 p -70.45 -21.66 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 111.74 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -54.11 -48.8 70.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.981 0.81 . . . . 0.0 110.991 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.98 -52.16 5.48 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.9 mt -56.83 -46.25 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.35 69.55 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.277 1.399 . . . . 0.0 112.781 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.3 m -78.24 -34.81 48.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.104 1.362 . . . . 0.0 112.098 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 62' ' ' ILE . 76.9 t -88.29 -19.9 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.713 1.605 . . . . 0.0 112.77 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.8 m -43.77 -61.07 2.14 Favored Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 126.235 1.814 . . . . 0.0 112.866 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.31 -0.19 6.19 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.329 2.686 . . . . 0.0 114.348 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.56 -64.23 1.18 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.885 1.274 . . . . 0.0 110.614 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.488 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.1 -31.65 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.068 -1.02 . . . . 0.0 113.216 177.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.35 -46.54 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.252 0.933 . . . . 0.0 110.713 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -73.82 -47.52 37.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.069 0.548 . . . . 0.0 111.329 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.19 73.77 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.428 -0.795 . . . . 0.0 112.989 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.5 m -75.42 -16.62 60.33 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.979 -1.076 . . . . 0.0 113.315 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -30.22 47.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.716 1.598 . . . . 0.0 110.917 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -61.1 -36.41 79.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.774 0.83 . . . . 0.0 112.789 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -142.47 76.45 1.53 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -54.45 -37.16 64.86 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.965 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -86.72 -0.21 55.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.058 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.89 29.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.957 0.903 . . . . 0.0 112.492 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -85.64 53.67 2.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.16 1.384 . . . . 0.0 110.475 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -102.33 90.5 3.92 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -166.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -68.41 -22.49 64.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.111 -0.993 . . . . 0.0 109.327 162.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.26 -24.81 66.65 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.237 1.815 . . . . 0.0 112.802 168.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -63.4 -40.43 97.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 0.0 110.49 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.58 -50.77 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.852 1.261 . . . . 0.0 110.294 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -63.5 -42.0 98.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.196 0.598 . . . . 0.0 112.022 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.78 93.11 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.135 1.35 . . . . 0.0 112.76 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.55 -31.33 63.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.802 1.301 . . . . 0.0 113.481 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.12 -43.97 97.66 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 169.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.79 -41.45 97.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.455 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -25.25 66.94 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 125.01 1.324 . . . . 0.0 112.403 -174.901 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 CA--C 1.54 0.777 0 CA-C-O 120.54 0.142 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.13 -21.99 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.892 1.677 . . . . 0.0 114.649 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -81.37 -16.65 51.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 60.3 m -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.225 1.81 . . . . 0.0 113.492 170.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -54.69 148.72 12.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 123.039 1.399 . . . . 0.0 113.226 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.9 p -95.11 167.95 11.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.81 166.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.0 -26.05 66.61 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.53 -0.731 . . . . 0.0 112.266 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.94 -40.32 95.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.764 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.02 -31.34 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.396 -0.815 . . . . 0.0 112.152 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.43 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 53.1 t80 -70.2 -24.25 63.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.121 0.873 . . . . 0.0 112.322 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 68.5 mt -80.9 -16.98 52.12 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.135 -0.978 . . . . 0.0 113.318 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -33.06 53.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.839 0.855 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.5 p -76.24 141.27 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.932 1.693 . . . . 0.0 110.53 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.69 161.68 30.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.435 1.094 . . . . 0.0 113.471 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.71 -36.1 73.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.129 1.372 . . . . 0.0 112.083 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -64.48 -20.55 66.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.104 1.361 . . . . 0.0 113.835 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.3 -5.28 6.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.866 1.267 . . . . 0.0 113.397 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -57.7 -45.55 99.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 O-C-N 120.184 -1.573 . . . . 0.0 112.162 169.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.45 -28.19 86.89 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.32 2.68 . . . . 0.0 113.414 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' THR . . . . . 0.915 HG22 HD21 ' A' ' 50' ' ' LEU . 29.4 m -76.87 -36.06 57.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.349 1.459 . . . . 0.0 111.45 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.67 91.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.669 1.188 . . . . 0.0 113.649 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.98 -35.75 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 119.78 1.173 . . . . 0.0 110.973 169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.37 -53.21 32.72 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.274 0.94 . . . . 0.0 112.195 168.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.97 -11.93 58.22 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 121.08 2.44 . . . . 0.0 114.513 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.35 -55.99 3.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.073 0.851 . . . . 0.0 109.841 166.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.14 -36.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.321 1.049 . . . . 0.0 113.455 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.0 76.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.203 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.14 -36.87 22.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.747 1.219 . . . . 0.0 110.617 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -54.41 -34.93 62.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.604 1.561 . . . . 0.0 113.688 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.53 -7.03 45.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.02 -133.4 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.394 1.477 . . . . 0.0 110.898 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.57 -58.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.599 2.36 . . . . 0.0 112.454 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 164.5 43.57 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 127.359 2.264 . . . . 0.0 109.831 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.01 36.81 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.711 2.274 . . . . 0.0 113.409 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.73 -28.86 50.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 111.947 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.22 0.7 11.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.341 1.456 . . . . 0.0 113.847 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.09 133.92 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.221 1.009 . . . . 0.0 113.295 -170.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.6 -12.66 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.93 1.292 . . . . 0.0 113.727 -174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.87 102.05 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.699 1.999 . . . . 0.0 107.747 -165.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -85.12 71.01 10.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.985 -1.072 . . . . 0.0 108.841 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.323 1.6 p -66.27 -18.81 24.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 O-C-N 121.38 -0.825 . . . . 0.0 110.327 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -42.79 97.06 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.598 -1.314 . . . . 0.0 111.381 167.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.19 14.98 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.636 -0.665 . . . . 0.0 111.908 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.8 -44.34 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 121.383 -1.069 . . . . 0.0 112.55 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.97 66.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.667 1.576 . . . . 0.0 112.255 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 99.9 m -66.37 -46.24 77.35 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 111.853 169.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -84.34 -31.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.829 1.252 . . . . 0.0 112.845 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -40.05 -62.98 0.77 Allowed Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 126.937 2.095 . . . . 0.0 113.569 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.97 -22.66 73.93 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.245 1.963 . . . . 0.0 113.208 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.01 -59.46 3.02 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.162 0.985 . . . . 0.0 111.312 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.477 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.98 -24.5 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.401 -0.812 . . . . 0.0 112.688 175.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.0 -51.85 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.811 1.187 . . . . 0.0 110.69 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.88 -47.49 45.53 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.157 -0.339 . . . . 0.0 111.084 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.755 -1.216 . . . . 0.0 113.257 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.8 m -76.13 -12.4 60.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.56 -33.58 16.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.184 1.356 . . . . 0.0 111.005 167.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -60.35 -39.04 85.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.871 0.868 . . . . 0.0 112.167 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.73 59.85 1.49 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.105 0.962 . . . . 0.0 112.618 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -53.7 -36.34 62.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.931 1.692 . . . . 0.0 113.109 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -86.27 -6.08 59.04 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.15 164.02 26.05 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.084 0.954 . . . . 0.0 111.966 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.88 138.05 52.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.467 1.107 . . . . 0.0 111.152 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 16.5 t80 -64.15 -51.28 64.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.418 -0.801 . . . . 0.0 112.81 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -66.29 -30.82 71.32 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.616 1.098 . . . . 0.0 112.071 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.38 -39.57 94.88 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.808 -0.558 . . . . 0.0 111.813 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -70.41 -34.79 72.92 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.248 -0.907 . . . . 0.0 112.832 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.12 -49.0 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.163 0.892 . . . . 0.0 109.67 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.29 -42.68 99.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.027 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.15 -44.89 97.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.513 1.054 . . . . 0.0 113.299 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -72.93 -35.4 67.02 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.052 -1.264 . . . . 0.0 112.618 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -60.06 -39.92 87.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.68 -1.262 . . . . 0.0 111.78 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.2 -46.57 88.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 111.874 173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -26.66 68.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 112.104 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 mt -79.29 -49.19 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.307 1.843 . . . . 0.0 112.087 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.482 1.155 0 C-N-CA 125.308 1.443 . . . . 0.0 113.254 -171.952 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.74 -22.3 14.44 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.03 53.04 2.63 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.038 0.923 . . . . 0.0 111.857 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -158.89 150.26 20.53 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.008 2.123 . . . . 0.0 111.621 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 56.46 -69.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.021 2.528 . . . . 0.0 115.166 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.04 -56.84 0.13 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.423 2.289 . . . . 0.0 110.684 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -165.57 166.34 18.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.475 1.91 . . . . 0.0 111.346 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.56 124.17 22.47 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' H ' HG11 ' B' ' 138' ' ' VAL 0.309 13.8 p30 62.76 13.91 6.86 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.961 2.904 . . . . 0.0 118.617 172.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -95.51 -33.36 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.1 51.86 4.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 125.656 1.582 . . . . 0.0 112.56 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.89 165.74 20.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.589 2.859 . . . . 0.0 115.807 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -64.33 2.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -126.04 21.32 7.49 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.932 1.693 . . . . 0.0 113.124 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -142.55 -13.22 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -131.26 169.75 15.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.624 1.556 . . . . 0.0 113.835 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.1 p -85.86 166.11 16.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.2 1.4 . . . . 0.0 114.221 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -21.37 2.75 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.87 -35.86 62.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.981 1.264 . . . . 0.0 111.596 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.66 -16.28 64.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.762 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.61 -24.18 45.49 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.799 -1.188 . . . . 0.0 112.129 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.35 -8.67 57.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.872 1.269 . . . . 0.0 113.046 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.39 60.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.084 1.354 . . . . 0.0 112.551 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.73 141.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.939 2.495 . . . . 0.0 110.508 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.35 156.88 36.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.921 0.888 . . . . 0.0 112.743 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.38 -30.67 60.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.109 1.364 . . . . 0.0 111.64 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 m -61.0 -28.32 68.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.156 1.783 . . . . 0.0 113.872 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -127.4 -7.1 5.82 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -56.47 -38.74 71.78 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 119.584 -1.948 . . . . 0.0 114.024 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.84 -27.09 79.96 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.624 2.216 . . . . 0.0 113.272 169.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 55.3 m -79.59 -34.35 40.87 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.712 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.14 92.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.452 . . . . 0.0 113.75 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.09 -36.51 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 119.367 0.985 . . . . 0.0 110.913 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.11 13.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.984 1.278 . . . . 0.0 113.798 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.15 -39.58 93.18 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.249 2.025 . . . . 0.0 112.323 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.0 67.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -102.11 -34.05 9.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.93 0.892 . . . . 0.0 112.714 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -52.44 65.67 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.746 1.619 . . . . 0.0 110.401 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -14.97 63.11 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.837 0.855 . . . . 0.0 111.144 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -14.79 50.13 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.142 -0.974 . . . . 0.0 113.436 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.283 4.6 p30 -123.41 10.67 9.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.83 152.63 0.97 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 130.59 3.556 . . . . 0.0 105.568 168.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.69 -32.33 18.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.222 2.209 . . . . 0.0 113.059 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.5 156.83 79.6 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 127.227 2.211 . . . . 0.0 110.151 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -84.65 8.65 4.51 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.989 1.793 . . . . 0.0 114.84 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.22 -21.33 22.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.393 1.477 . . . . 0.0 114.232 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.52 14.68 20.24 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.285 1.434 . . . . 0.0 113.332 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.97 113.59 24.66 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.262 -1.523 . . . . 0.0 112.106 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.78 11.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 125.647 1.579 . . . . 0.0 111.423 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER 64.49 155.0 0.07 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 129.495 3.118 . . . . 0.0 112.801 -168.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.619 ' H ' HD13 ' A' ' 50' ' ' LEU . 44.5 t0 -119.11 62.22 0.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.522 1.529 . . . . 0.0 110.811 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.0 -56.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.641 1.177 . . . . 0.0 113.475 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' B' ' 93' ' ' GLN . 55.5 tp60 -63.14 -36.87 85.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.343 0.974 . . . . 0.0 111.5 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.55 -52.51 52.68 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mt -62.72 -42.77 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.45 0.7 . . . . 0.0 111.449 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.06 -34.72 71.47 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.102 -0.999 . . . . 0.0 113.067 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -70.25 -37.11 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.029 1.332 . . . . 0.0 111.848 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.1 t -87.76 -23.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.117 1.367 . . . . 0.0 113.327 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.3 m -45.28 -59.83 3.93 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 125.877 1.671 . . . . 0.0 112.935 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.48 0.85 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.56 -66.43 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.6 1.16 . . . . 0.0 110.603 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.43 -32.2 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.017 -1.052 . . . . 0.0 112.911 -178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.74 -49.31 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.367 1.067 . . . . 0.0 110.353 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.51 -46.86 36.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.274 0.559 . . . . 0.0 110.892 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.54 68.94 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.1 m -76.34 -17.17 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.29 -30.85 21.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.087 1.312 . . . . 0.0 111.429 169.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -60.63 -38.24 84.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.408 1.083 . . . . 0.0 112.012 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -146.15 86.56 1.71 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.656 0.783 . . . . 0.0 112.425 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -54.07 -33.82 58.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.647 1.179 . . . . 0.0 111.714 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -86.85 -0.07 55.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.339 1.455 . . . . 0.0 113.526 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.36 147.83 43.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.938 0.895 . . . . 0.0 111.384 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.93 155.14 40.81 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.396 1.078 . . . . 0.0 112.312 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -53.32 151.37 5.44 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 112.049 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 tptp 60.44 -32.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 129.039 2.935 . . . . 0.0 116.299 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.87 -28.26 68.73 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.36 1.864 . . . . 0.0 112.259 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -70.77 -44.11 67.39 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.54 -0.725 . . . . 0.0 112.567 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.11 -37.12 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.027 1.285 . . . . 0.0 111.268 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -64.84 -48.44 74.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.65 0.78 . . . . 0.0 111.614 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.9 -39.48 96.55 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.975 1.274 . . . . 0.0 113.242 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -35.33 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.818 1.309 . . . . 0.0 113.013 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -63.35 -38.09 89.8 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.958 -1.089 . . . . 0.0 111.956 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.41 -43.84 98.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.523 1.129 . . . . 0.0 111.782 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -25.02 67.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.83 -1.169 . . . . 0.0 112.86 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mt -87.98 -40.6 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.038 1.335 . . . . 0.0 112.523 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.64 -59.75 1.83 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.287 1.435 . . . . 0.0 113.692 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.6 -25.12 67.25 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.845 1.658 . . . . 0.0 113.501 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -26.02 67.43 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.732 1.213 . . . . 0.0 113.712 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 44.6 ttp . . . . . 0 C--O 1.254 1.318 0 C-N-CA 128.298 2.639 . . . . 0.0 115.371 172.005 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.89 -29.18 25.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.42 15.8 7.34 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 53' ' ' GLN . 3.1 pp0? -144.66 140.47 28.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.633 1.173 . . . . 0.0 113.09 -174.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp 37.51 48.94 0.94 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.567 2.347 . . . . 0.0 115.723 166.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.29 128.31 35.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.188 0.595 . . . . 0.0 110.343 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.85 150.83 42.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -135.68 123.36 22.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.122 1.769 . . . . 0.0 107.748 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 51.98 15.53 0.42 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.024 2.13 . . . . 0.0 116.103 -174.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 56.4 105.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.244 2.617 . . . . 0.0 112.04 -167.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -122.6 61.86 16.41 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 126.387 1.875 . . . . 0.0 112.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.48 -175.37 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.314 4.009 . . . . 0.0 112.518 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 23.0 m -49.82 -23.56 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 125.988 1.715 . . . . 0.0 115.292 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -82.49 4.36 24.67 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.618 1.567 . . . . 0.0 113.987 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -142.05 -40.52 0.36 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.453 2.301 . . . . 0.0 112.358 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -50.67 143.36 9.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.724 2.809 . . . . 0.0 112.79 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -109.3 155.45 21.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.16 -24.83 66.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.35 -38.24 79.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.592 -1.317 . . . . 0.0 111.122 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.23 -13.18 53.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.433 1.093 . . . . 0.0 112.95 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -67.47 -28.53 67.94 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.721 -1.237 . . . . 0.0 110.664 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 mt -74.13 -16.78 61.0 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.33 -0.856 . . . . 0.0 113.175 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.79 28.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.296 1.039 . . . . 0.0 113.346 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 p -71.58 140.12 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 109.872 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.81 157.34 30.64 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.847 1.259 . . . . 0.0 113.342 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -58.57 -34.52 71.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.575 1.15 . . . . 0.0 111.748 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.9 m -57.84 -25.66 60.97 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.427 1.891 . . . . 0.0 113.901 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -124.97 0.13 7.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 113.122 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.49 -44.47 97.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 119.809 -1.807 . . . . 0.0 112.416 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -63.49 -20.2 69.29 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.804 2.336 . . . . 0.0 114.393 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 57.2 m -67.8 -37.29 81.8 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.087 -1.008 . . . . 0.0 110.13 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.8 86.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.453 1.501 . . . . 0.0 114.076 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.86 -34.29 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.432 -1.418 . . . . 0.0 110.731 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.9 4.07 8.48 Favored Glycine 0 CA--C 1.545 1.969 0 C-N-CA 125.985 1.755 . . . . 0.0 116.148 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.77 -10.36 9.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.435 1.894 . . . . 0.0 113.547 170.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.72 -70.98 0.7 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.407 1.083 . . . . 0.0 111.571 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -71.24 -20.78 62.2 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.98 -1.075 . . . . 0.0 112.424 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.18 97.63 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.963 1.705 . . . . 0.0 113.833 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -43.91 18.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.653 0.781 . . . . 0.0 109.679 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.36 -24.52 67.4 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -85.77 -10.48 55.45 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -130.08 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 110.933 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -157.07 -54.12 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 127.407 2.283 . . . . 0.0 112.499 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -125.07 164.25 32.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 126.768 2.027 . . . . 0.0 111.639 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.75 9.78 3.04 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.156 2.57 . . . . 0.0 114.055 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.69 -28.4 69.91 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.625 -1.297 . . . . 0.0 113.14 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -106.14 -7.24 18.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.855 1.262 . . . . 0.0 114.035 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.57 145.21 47.56 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 120.848 -1.158 . . . . 0.0 113.403 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 9' ' ' ASN . 14.2 p -136.18 25.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.547 1.539 . . . . 0.0 111.277 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 60.47 144.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.671 2.788 . . . . 0.0 112.738 -166.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -87.93 44.44 1.19 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.621 -1.299 . . . . 0.0 110.469 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -47.16 -53.55 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.836 1.655 . . . . 0.0 114.109 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -70.24 -34.04 72.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.689 1.131 . . . . 0.0 111.444 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.68 -48.23 74.87 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.533 0.587 . . . . 0.0 111.856 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.22 -43.57 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.642 1.577 . . . . 0.0 110.73 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.09 -32.64 73.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.108 0.963 . . . . 0.0 112.916 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 43.2 m -68.69 -42.9 77.15 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.558 1.143 . . . . 0.0 111.926 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.497 HG12 HD12 ' B' ' 151' ' ' ILE . 38.1 t -84.16 -26.09 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.91 1.684 . . . . 0.0 113.313 -171.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.5 m -50.65 -64.21 1.44 Allowed Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 125.733 1.613 . . . . 0.0 113.094 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.91 -25.35 77.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.19 1.927 . . . . 0.0 112.685 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.39 -59.12 5.1 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.229 1.012 . . . . 0.0 110.805 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.497 HD12 HG12 ' B' ' 147' ' ' VAL . 24.1 mt -70.01 -31.49 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.11 -0.994 . . . . 0.0 112.224 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.83 -51.27 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.937 1.295 . . . . 0.0 110.657 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -68.35 -44.29 75.56 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.397 0.279 . . . . 0.0 110.885 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.8 73.12 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.056 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.49 -14.51 62.14 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -35.91 13.81 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.902 1.228 . . . . 0.0 111.542 167.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -58.03 -42.66 85.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.062 0.945 . . . . 0.0 111.796 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -141.44 69.98 1.34 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 111.32 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -52.37 -34.88 49.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.693 1.997 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -84.59 -1.5 56.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.061 0.944 . . . . 0.0 113.263 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.53 147.82 48.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.637 1.175 . . . . 0.0 112.852 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.47 130.4 41.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.673 1.189 . . . . 0.0 108.406 168.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.4 -42.03 95.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.615 0.766 . . . . 0.0 113.063 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -60.08 -38.39 82.75 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.466 -0.771 . . . . 0.0 112.757 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -69.48 -34.42 74.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.282 0.633 . . . . 0.0 112.093 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -73.14 -38.12 66.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.98 -37.81 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.03 1.287 . . . . 0.0 111.64 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -62.38 -43.64 98.35 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.616 0.766 . . . . 0.0 112.182 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.76 -47.16 91.82 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.545 1.069 . . . . 0.0 113.194 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.32 -33.52 65.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.544 1.172 . . . . 0.0 113.009 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.81 -39.92 90.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.203 1.365 . . . . 0.0 111.998 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.59 -47.38 84.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.514 1.126 . . . . 0.0 112.048 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -27.24 68.73 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.101 -0.999 . . . . 0.0 111.944 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 36.9 mt -76.83 -51.67 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.059 1.744 . . . . 0.0 111.812 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -101.47 -61.82 1.33 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.509 1.524 . . . . 0.0 113.294 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.39 -24.86 67.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.232 1.813 . . . . 0.0 113.647 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.82 -22.66 67.03 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.198 1.399 . . . . 0.0 114.135 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 124.762 1.225 . . . . 0.0 113.315 -179.651 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -145.74 96.44 2.81 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.02 33.58 7.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -63.11 -22.41 66.84 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -12.92 61.31 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 45.35 -115.4 0.5 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.67 1.588 . . . . 0.0 113.054 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.98 5.83 17.97 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.3 t0 60.16 24.6 13.92 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.205 1.802 . . . . 0.0 113.511 -170.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -147.57 -5.56 0.48 Allowed 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -95.52 -29.06 14.57 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -119.76 33.99 0.21 Allowed Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.23 152.1 72.08 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.891 . . . . 0.0 113.53 -169.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.08 -24.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -76.22 -35.07 59.22 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.348 0.659 . . . . 0.0 112.629 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -103.56 -27.98 12.02 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -91.09 174.71 7.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.041 0.924 . . . . 0.0 113.425 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 p -103.86 165.96 10.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.667 1.587 . . . . 0.0 114.213 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -17.53 48.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 115.211 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.97 -34.71 73.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.774 1.17 . . . . 0.0 111.424 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.08 -28.98 70.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.656 -0.653 . . . . 0.0 112.319 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.61 -21.48 66.72 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.882 -1.136 . . . . 0.0 111.646 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -91.65 -13.42 31.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.418 1.487 . . . . 0.0 113.202 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.02 -31.65 34.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.378 1.071 . . . . 0.0 110.983 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -68.84 132.68 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.68 1.592 . . . . 0.0 109.782 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -68.9 160.67 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.252 1.421 . . . . 0.0 113.111 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.26 -35.92 72.48 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.906 -1.121 . . . . 0.0 112.09 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 m -62.22 -23.86 66.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.004 1.722 . . . . 0.0 113.827 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -125.45 -3.83 7.3 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.801 1.24 . . . . 0.0 113.51 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.17 -41.86 93.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 120.019 -1.676 . . . . 0.0 112.815 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -59.34 -27.35 84.75 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.927 2.418 . . . . 0.0 113.691 168.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.5 m -78.92 -27.9 43.79 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 111.902 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -64.96 -48.43 74.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 112.811 170.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.03 -36.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 118.73 0.695 . . . . 0.0 110.466 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.94 -48.17 52.27 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.674 1.13 . . . . 0.0 113.849 170.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.05 -19.0 64.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.864 2.832 . . . . 0.0 113.192 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.93 -53.46 5.29 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.47 -0.769 . . . . 0.0 110.7 165.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.7 -19.73 60.14 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.99 27.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 111.951 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.95 -31.42 18.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.282 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -67.33 -20.57 65.62 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.04 -8.38 21.51 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.26 0.4 OUTLIER -141.41 -129.52 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.187 1.395 . . . . 0.0 113.287 -175.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.87 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.989 1.716 . . . . 0.0 113.759 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -136.41 164.44 42.79 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.763 2.425 . . . . 0.0 110.056 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.34 -5.27 14.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.498 1.466 . . . . 0.0 114.55 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.61 -25.21 68.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.937 1.244 . . . . 0.0 113.747 -168.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.31 -16.55 29.03 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.157 2.183 . . . . 0.0 113.648 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 154.26 33.46 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -169.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.77 1.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 125.133 1.373 . . . . 0.0 113.795 -174.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? 62.78 112.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.842 2.857 . . . . 0.0 112.584 -168.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.9 54.07 2.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.899 1.68 . . . . 0.0 112.495 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 0.6 OUTLIER -55.22 -40.82 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 -165.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.73 -35.45 78.1 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 122.746 2.521 . . . . 0.0 112.707 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.02 -22.16 60.03 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 124.755 1.169 . . . . 0.0 113.804 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.74 -50.78 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.433 1.493 . . . . 0.0 111.132 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.18 77.54 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.016 1.326 . . . . 0.0 113.78 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -63.73 -39.24 93.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.391 1.076 . . . . 0.0 111.735 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HD13 ' A' ' 62' ' ' ILE . 1.3 t -95.45 -19.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.681 1.192 . . . . 0.0 113.314 -172.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.6 m -41.85 -60.0 2.22 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 125.962 1.705 . . . . 0.0 112.368 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.4 1.24 4.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.715 2.943 . . . . 0.0 114.822 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.46 -59.66 1.78 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 0.0 110.485 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.471 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.23 -34.99 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.345 0.975 . . . . 0.0 112.118 -178.049 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.82 -40.9 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.444 0.565 . . . . 0.0 112.326 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -78.26 -47.91 16.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.25 -29.39 70.17 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.096 0.958 . . . . 0.0 113.561 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.37 -11.6 59.86 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.54 -33.95 16.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.304 1.411 . . . . 0.0 110.58 166.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -58.02 -40.11 80.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 111.652 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.51 88.0 1.75 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.757 0.789 . . . . 0.0 111.984 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -55.01 -31.42 61.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.747 1.619 . . . . 0.0 112.489 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -89.53 -2.74 58.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.188 1.395 . . . . 0.0 112.854 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 154.95 40.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.716 0.806 . . . . 0.0 110.548 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -64.58 137.34 57.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.992 0.517 . . . . 0.0 110.349 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.52 -53.1 62.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.907 1.283 . . . . 0.0 111.766 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -65.54 -38.23 89.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.08 0.952 . . . . 0.0 112.245 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.56 -37.36 83.55 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.485 0.714 . . . . 0.0 111.463 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -73.61 -33.68 64.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.85 -47.3 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 118.448 0.567 . . . . 0.0 110.698 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.66 -44.57 95.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.876 0.87 . . . . 0.0 111.825 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.65 -46.13 93.74 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.722 1.153 . . . . 0.0 113.092 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -73.29 -31.99 64.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.695 1.248 . . . . 0.0 113.447 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -61.49 -42.21 98.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.982 1.265 . . . . 0.0 111.714 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.68 -47.99 78.99 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.66 0.784 . . . . 0.0 111.476 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.413 -1.429 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.1 mt -72.96 -44.97 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.84 0.856 . . . . 0.0 112.038 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -99.63 -59.34 1.74 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.903 1.281 . . . . 0.0 113.541 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -67.32 -40.63 85.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.303 1.441 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.7 t70 54.57 15.3 1.01 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.484 2.313 . . . . 0.0 115.129 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.403 2.281 . . . . 0.0 111.218 179.615 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -140.23 143.07 35.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.103 0.961 . . . . 0.0 112.1 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.12 66.99 0.42 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.946 1.298 . . . . 0.0 111.544 171.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -58.84 -16.95 19.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -11.17 60.55 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 169.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.12 67.99 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -170.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.7 -2.49 54.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . 0.257 1.6 p30 59.86 -29.78 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 130.198 3.399 . . . . 0.0 119.128 171.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.84 7.3 6.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.654 1.582 . . . . 0.0 113.865 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -99.77 124.29 44.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.195 1.398 . . . . 0.0 110.774 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 48.67 40.56 0.78 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 127.211 2.204 . . . . 0.0 116.781 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -65.5 159.17 49.11 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 122.149 1.803 . . . . 0.0 109.832 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -48.3 -30.01 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -87.69 -7.75 56.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m -132.13 28.83 4.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.041 2.536 . . . . 0.0 111.084 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -101.15 141.52 33.92 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.679 1.992 . . . . 0.0 111.299 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 36.7 p -110.33 149.82 29.65 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -19.92 66.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.52 -39.29 61.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 110.986 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.67 -34.86 78.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 112.179 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.47 -30.16 71.33 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.083 -1.011 . . . . 0.0 111.445 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.4 -4.23 58.11 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.558 1.143 . . . . 0.0 113.466 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.99 15.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.113 1.365 . . . . 0.0 111.152 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.57 138.49 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.356 1.862 . . . . 0.0 109.646 169.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.92 158.62 32.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.244 1.018 . . . . 0.0 112.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.88 -35.85 71.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.596 1.158 . . . . 0.0 111.349 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.5 m -61.92 -23.0 66.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.782 1.633 . . . . 0.0 114.029 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.89 -1.46 7.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.294 1.438 . . . . 0.0 112.746 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.57 -43.91 90.13 Favored Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 119.728 -1.858 . . . . 0.0 112.444 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.52 -25.22 75.63 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.035 1.823 . . . . 0.0 113.214 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.747 HG22 HD21 ' A' ' 50' ' ' LEU . 24.2 m -72.69 -39.99 66.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.146 0.978 . . . . 0.0 110.159 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -20.07 63.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.975 1.71 . . . . 0.0 115.537 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.8 -39.99 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-N 121.145 1.793 . . . . 0.0 109.612 163.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.79 23.13 0.18 Allowed Glycine 0 CA--C 1.54 1.624 0 C-N-CA 127.907 2.67 . . . . 0.0 117.424 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -126.39 -57.57 1.38 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.362 1.581 . . . . 0.0 111.041 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.59 78.16 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.221 -0.924 . . . . 0.0 111.773 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.38 -38.41 35.01 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.811 -0.556 . . . . 0.0 111.956 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.76 -46.04 69.84 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 113.296 -171.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -33.32 69.02 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.924 -0.485 . . . . 0.0 110.871 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.27 -28.19 66.98 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.12 -3.93 50.16 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -146.11 -122.97 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.361 1.864 . . . . 0.0 111.208 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -160.3 -79.31 0.05 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.625 1.57 . . . . 0.0 112.092 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -123.88 164.2 30.61 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 127.065 2.146 . . . . 0.0 109.262 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.74 1.98 7.48 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 121.283 1.494 . . . . 0.0 114.826 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -55.74 -27.84 52.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.206 1.402 . . . . 0.0 111.481 168.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.75 3.97 23.2 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.816 2.046 . . . . 0.0 113.279 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.94 126.88 35.59 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 119.725 -1.86 . . . . 0.0 113.744 -169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.96 132.52 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.151 2.181 . . . . 0.0 106.471 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -69.81 116.24 9.96 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.631 1.105 . . . . 0.0 109.787 -174.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -86.28 61.44 6.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.06 1.344 . . . . 0.0 110.588 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.315 1.2 p -68.65 -34.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.385 -167.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.13 -39.04 89.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.852 1.66 . . . . 0.0 111.991 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.39 -48.39 79.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.538 0.589 . . . . 0.0 111.677 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.75 -43.21 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.46 1.104 . . . . 0.0 111.702 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.9 -37.8 76.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.288 1.035 . . . . 0.0 112.315 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -62.12 -39.89 94.06 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.453 1.101 . . . . 0.0 112.007 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.0 -26.19 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.41 1.484 . . . . 0.0 113.594 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -44.77 -60.49 2.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 126.603 1.961 . . . . 0.0 113.571 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.52 -19.49 67.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.262 1.975 . . . . 0.0 113.149 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -69.04 -58.07 4.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.097 0.959 . . . . 0.0 111.274 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -20.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.26 -0.9 . . . . 0.0 113.255 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.8 -52.82 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.614 1.097 . . . . 0.0 110.28 173.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.18 -47.69 34.01 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 122.458 0.303 . . . . 0.0 111.476 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.03 -28.57 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.692 -1.255 . . . . 0.0 113.24 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.01 -16.24 60.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.69 21.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.278 1.399 . . . . 0.0 111.34 168.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.95 -38.87 76.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.772 0.829 . . . . 0.0 112.544 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -146.65 83.5 1.6 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -56.86 -37.83 71.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.933 1.293 . . . . 0.0 111.937 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.9 -6.13 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 113.018 -172.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.88 137.42 58.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.836 0.744 . . . . 0.0 109.219 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -122.59 44.25 2.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.386 -167.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -138.36 143.04 39.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -165.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -67.41 -26.92 66.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.369 1.068 . . . . 0.0 110.381 166.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -64.19 -24.8 67.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.895 1.278 . . . . 0.0 113.216 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.05 -31.62 72.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.046 -1.034 . . . . 0.0 111.98 170.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.43 -47.15 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.719 1.608 . . . . 0.0 110.453 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -65.32 -34.22 77.81 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.292 1.037 . . . . 0.0 113.286 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.42 -34.87 76.89 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.659 1.124 . . . . 0.0 113.69 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 24.3 mm-40 -75.69 -32.85 60.29 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.601 1.2 . . . . 0.0 113.187 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.92 -39.47 94.25 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.893 -1.129 . . . . 0.0 111.065 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -61.48 -48.55 80.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 111.756 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -24.15 67.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.984 -1.072 . . . . 0.0 112.289 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 27.9 mt -83.94 -48.09 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.417 1.487 . . . . 0.0 112.373 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -103.57 -51.2 3.25 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.076 1.351 . . . . 0.0 114.014 -169.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -74.46 -29.14 61.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.108 1.363 . . . . 0.0 113.11 -172.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.28 -27.47 35.08 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.035 1.334 . . . . 0.0 114.13 -170.112 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.359 0.124 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -115.44 26.42 10.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.677 1.991 . . . . 0.0 111.692 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.65 156.92 16.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.707 1.203 . . . . 0.0 111.302 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.485 ' HB3' ' H ' ' B' ' 142' ' ' GLN . 12.5 pt20 -157.75 -176.94 6.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.506 1.123 . . . . 0.0 112.344 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -77.48 37.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -167.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 46.9 57.74 5.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.712 2.005 . . . . 0.0 115.86 169.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.71 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.689 -1.257 . . . . 0.0 113.184 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.74 -22.62 65.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.627 1.571 . . . . 0.0 114.315 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -122.36 12.12 10.11 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.257 1.823 . . . . 0.0 112.833 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 40.24 92.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 129.074 2.95 . . . . 0.0 115.524 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -115.9 60.71 1.81 Allowed Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 126.028 1.731 . . . . 0.0 111.372 168.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.29 167.46 23.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.358 3.372 . . . . 0.0 113.393 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.5 7.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.29 21.84 7.24 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.297 2.239 . . . . 0.0 113.153 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.0 p -116.05 -32.01 5.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -129.26 163.13 26.32 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -73.16 168.02 19.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.204 1.402 . . . . 0.0 113.733 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -27.44 46.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.68 -38.32 74.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.156 0.982 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.02 -12.67 59.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.498 1.519 . . . . 0.0 113.065 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -76.26 -16.73 59.74 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.516 -1.365 . . . . 0.0 111.344 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.37 1.76 47.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.017 1.327 . . . . 0.0 114.145 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.48 56.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 112.27 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.55 136.65 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.752 2.021 . . . . 0.0 110.954 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.42 157.8 25.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.51 1.124 . . . . 0.0 112.457 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -53.47 -31.37 45.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.482 1.513 . . . . 0.0 111.758 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 m -61.74 -29.49 70.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.193 1.797 . . . . 0.0 113.89 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -126.45 -1.51 6.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.792 1.637 . . . . 0.0 112.702 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 33.3 mm-40 -53.57 -46.81 98.04 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.91 -1.744 . . . . 0.0 112.365 170.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 36.5 Cg_exo -67.56 -17.83 48.54 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.415 2.076 . . . . 0.0 112.924 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.851 HG22 HD21 ' B' ' 139' ' ' LEU . 20.6 m -79.76 -36.91 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.218 1.407 . . . . 0.0 110.702 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.59 98.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.526 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.9 -48.41 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.723 0.809 . . . . 0.0 109.288 168.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.04 -52.37 35.8 Favored Glycine 0 C--O 1.213 -1.21 0 C-N-CA 125.214 1.388 . . . . 0.0 113.149 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -68.81 -12.69 61.79 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.649 2.725 . . . . 0.0 114.664 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.38 -50.07 5.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.002 0.819 . . . . 0.0 111.12 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -75.51 -24.1 56.79 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.126 -0.984 . . . . 0.0 113.221 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.35 76.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.404 -1.435 . . . . 0.0 112.003 -176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -74.8 -33.17 62.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.32 1.048 . . . . 0.0 110.32 -176.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -56.84 -23.19 42.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.978 1.711 . . . . 0.0 113.59 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -91.09 -18.53 24.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -120.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.115 1.325 . . . . 0.0 113.52 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -161.18 -58.88 0.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.532 1.533 . . . . 0.0 113.954 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.03 166.25 27.45 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 128.125 2.57 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.87 14.03 2.32 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.033 1.762 . . . . 0.0 114.804 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.22 -23.71 66.81 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.282 1.433 . . . . 0.0 111.783 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -127.94 26.8 5.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.901 1.68 . . . . 0.0 114.111 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.64 35.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.995 -1.69 . . . . 0.0 112.445 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.04 -16.33 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.845 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 66.64 110.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.856 2.462 . . . . 0.0 112.195 -169.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.39 59.83 1.88 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.777 1.231 . . . . 0.0 111.659 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 2.4 p -62.3 -19.61 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.606 -1.309 . . . . 0.0 114.42 -168.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.51 -44.68 56.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 112.169 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.97 -47.71 6.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -58.17 -51.09 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.746 1.218 . . . . 0.0 112.265 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.71 66.69 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -66.61 -49.0 67.74 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.018 1.327 . . . . 0.0 112.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.22 -18.45 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -46.4 -60.7 3.34 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.634 1.174 . . . . 0.0 112.807 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.93 -4.18 12.94 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.295 2.663 . . . . 0.0 114.113 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -62.72 1.43 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.363 1.465 . . . . 0.0 111.158 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -30.85 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.951 -1.093 . . . . 0.0 113.175 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.46 -41.09 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.099 0.863 . . . . 0.0 112.66 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.72 -44.34 28.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.084 0.953 . . . . 0.0 110.789 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.18 93.35 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.429 -0.794 . . . . 0.0 112.402 -171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.69 -7.15 56.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -34.52 16.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.115 1.325 . . . . 0.0 111.565 169.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -78.83 -32.98 46.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -117.09 49.18 1.21 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.665 1.586 . . . . 0.0 112.06 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -48.93 -36.79 18.18 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.743 -1.223 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -87.92 -2.86 58.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.664 1.186 . . . . 0.0 113.624 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.05 157.51 35.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.004 0.922 . . . . 0.0 111.352 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -76.68 161.39 28.57 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.505 1.145 . . . . 0.0 113.759 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -48.28 153.09 0.76 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.788 2.435 . . . . 0.0 114.132 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp 60.29 -34.63 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 130.031 3.332 . . . . 0.0 117.253 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -30.57 70.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.971 1.709 . . . . 0.0 111.995 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -74.1 -35.49 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.8 -46.15 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.086 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -63.76 -43.38 96.6 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.354 1.062 . . . . 0.0 112.113 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.24 98.5 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.931 1.729 . . . . 0.0 113.771 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -73.5 -33.57 64.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.565 1.682 . . . . 0.0 113.13 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -62.85 -39.28 93.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.364 -1.46 . . . . 0.0 111.157 171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.04 -46.64 83.5 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.547 1.139 . . . . 0.0 112.106 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -31.8 72.32 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.057 -1.027 . . . . 0.0 112.08 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.2 mt -79.08 -48.37 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 111.304 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -101.86 -59.7 1.66 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.218 1.407 . . . . 0.0 113.221 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -66.66 -26.36 67.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.7 1.6 . . . . 0.0 113.476 -170.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.62 -19.68 64.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.59 1.156 . . . . 0.0 114.086 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.0 tpp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.185 1.394 . . . . 0.0 112.939 -178.088 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -142.5 127.74 18.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.238 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.75 159.95 0.09 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.661 1.984 . . . . 0.0 114.657 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' B' ' 94' ' ' LYS . 0.0 OUTLIER -155.39 -154.21 0.48 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.005 0.922 . . . . 0.0 113.32 -167.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 21.7 mtpp -73.99 42.69 0.15 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.329 2.651 . . . . 0.0 114.058 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 58.35 90.6 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.121 2.568 . . . . 0.0 115.271 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 52.84 -154.65 0.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.985 2.114 . . . . 0.0 114.312 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.55 -11.91 24.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.641 1.576 . . . . 0.0 113.703 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -149.76 13.53 0.81 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -88.73 -40.75 13.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 121.976 2.171 . . . . 0.0 115.693 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -118.19 49.9 1.08 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 125.12 1.368 . . . . 0.0 113.074 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.7 151.2 85.18 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.392 1.394 . . . . 0.0 114.407 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 m -47.56 -29.71 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.276 2.23 . . . . 0.0 114.996 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -93.99 -9.33 37.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 58.0 p -116.15 -32.57 5.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.74 1.154 . . . . 0.0 113.757 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -93.7 163.56 13.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.207 1.003 . . . . 0.0 113.549 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.0 p -99.73 155.78 17.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.298 1.439 . . . . 0.0 114.275 -169.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -20.4 18.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.238 1.815 . . . . 0.0 115.275 -174.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.96 -40.65 89.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.03 1.286 . . . . 0.0 111.679 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -78.1 -12.36 59.98 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.938 0.895 . . . . 0.0 112.146 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -94.13 -17.29 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.774 -1.204 . . . . 0.0 112.986 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.07 -17.42 57.02 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.939 -1.101 . . . . 0.0 113.254 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.3 50.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.687 1.195 . . . . 0.0 113.905 -171.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.71 139.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.024 1.73 . . . . 0.0 111.113 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.61 158.68 29.29 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.638 1.575 . . . . 0.0 113.744 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.16 -33.27 70.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.852 1.261 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.5 m -59.43 -26.75 65.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.087 1.755 . . . . 0.0 113.656 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.51 -0.93 8.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.607 1.563 . . . . 0.0 112.523 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.44 -46.38 99.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 120.009 -1.682 . . . . 0.0 112.805 172.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -64.96 -25.4 59.53 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.353 2.035 . . . . 0.0 112.848 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 50' ' ' LEU . 58.0 m -70.12 -38.43 75.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.039 0.936 . . . . 0.0 110.345 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.05 92.54 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.35 -35.62 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.739 1.154 . . . . 0.0 110.76 170.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.31 -42.03 88.13 Favored Glycine 0 C--O 1.217 -0.915 0 C-N-CA 124.764 1.173 . . . . 0.0 113.687 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -44.4 71.16 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.147 1.973 . . . . 0.0 111.51 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.84 82.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.76 -39.14 73.41 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.012 -1.055 . . . . 0.0 113.557 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.62 87.68 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.021 -1.049 . . . . 0.0 111.386 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -79.53 -38.81 33.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.578 0.751 . . . . 0.0 111.056 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.0 -31.39 72.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.076 0.95 . . . . 0.0 113.198 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.77 -16.84 49.73 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.16 -124.14 0.03 OUTLIER 'General case' 0 C--N 1.35 0.629 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -163.66 -45.68 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.494 1.518 . . . . 0.0 114.205 -167.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.04 161.99 56.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 127.298 2.239 . . . . 0.0 110.158 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.9 5.55 6.2 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.764 1.643 . . . . 0.0 113.909 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -56.51 -29.74 62.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.377 1.471 . . . . 0.0 111.86 169.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -111.94 15.12 20.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.198 1.799 . . . . 0.0 112.964 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.72 120.96 24.12 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 119.408 -2.057 . . . . 0.0 111.999 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.34 128.81 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.791 1.636 . . . . 0.0 106.917 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 31' ' ' THR . 2.1 tm? -75.1 116.75 16.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.626 0.648 . . . . 0.0 110.488 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.07 48.98 1.73 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.27 1.828 . . . . 0.0 111.43 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.351 1.7 p -62.8 -32.73 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -166.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.485 ' H ' ' HB3' ' A' ' 4' ' ' GLN . 3.0 tm0? -59.82 -50.56 73.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.626 1.557 . . . . 0.0 110.027 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.79 -39.51 55.0 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.797 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -58.37 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.488 1.115 . . . . 0.0 110.979 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.06 75.66 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.83 1.195 . . . . 0.0 112.526 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 53.3 m -62.39 -43.38 98.95 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.383 1.073 . . . . 0.0 111.872 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' B' ' 151' ' ' ILE . 35.0 t -83.69 -30.43 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.494 1.518 . . . . 0.0 113.082 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.5 m -37.04 -61.93 0.62 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 127.132 2.173 . . . . 0.0 114.245 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.21 -22.7 60.72 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.059 1.839 . . . . 0.0 113.026 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.95 -60.53 2.56 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.286 1.035 . . . . 0.0 110.689 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.528 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -70.5 -25.6 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 178.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -52.15 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.12 0.873 . . . . 0.0 110.654 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.35 -43.44 60.71 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.655 0.382 . . . . 0.0 111.287 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.73 -29.13 69.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.749 -1.219 . . . . 0.0 112.852 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 34.4 m -69.75 -13.93 62.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 169.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.23 -38.43 13.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.652 1.569 . . . . 0.0 110.872 166.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -59.81 -38.77 82.9 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.959 0.904 . . . . 0.0 112.396 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.54 75.41 1.46 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 122.359 1.076 . . . . 0.0 111.246 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -52.26 -27.21 14.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.042 1.737 . . . . 0.0 112.357 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.94 -2.63 55.63 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.383 1.473 . . . . 0.0 113.516 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.59 152.13 36.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.51 1.124 . . . . 0.0 111.702 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -70.19 136.27 49.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.313 1.445 . . . . 0.0 111.099 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.19 -43.65 81.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -60.47 -41.34 93.96 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.217 1.371 . . . . 0.0 110.705 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.03 -36.81 84.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.343 0.657 . . . . 0.0 112.311 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -70.9 -39.31 72.84 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.92 -46.17 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 119.65 1.114 . . . . 0.0 109.968 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -65.33 -46.52 79.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.864 0.866 . . . . 0.0 112.359 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.15 99.24 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.832 1.206 . . . . 0.0 113.394 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -71.83 -34.32 69.22 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.702 1.251 . . . . 0.0 112.307 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -61.35 -39.92 92.36 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.66 -1.275 . . . . 0.0 111.725 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.81 -47.74 79.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.425 0.69 . . . . 0.0 111.394 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.52 68.95 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.393 -1.442 . . . . 0.0 111.849 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.8 mt -73.9 -47.6 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.908 1.683 . . . . 0.0 112.785 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -99.5 -58.82 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.85 1.26 . . . . 0.0 113.321 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.65 -36.19 81.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.029 1.332 . . . . 0.0 111.731 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.0 t0 50.22 50.76 18.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.658 1.983 . . . . 0.0 112.629 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.965 1.706 . . . . 0.0 113.279 -177.273 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.76 -20.95 57.89 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.21 46.36 23.95 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.26 -20.69 63.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.29 131.5 47.51 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.591 -0.693 . . . . 0.0 110.457 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.7 124.33 30.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.97 -81.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.948 1.699 . . . . 0.0 112.86 -167.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -167.73 -47.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.878 1.671 . . . . 0.0 111.127 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -115.88 15.76 16.27 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -168.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.345 0.0 OUTLIER -128.77 18.61 6.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 -168.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -123.99 57.29 12.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 125.011 1.324 . . . . 0.0 111.007 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.23 161.92 44.23 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.781 2.987 . . . . 0.0 114.667 -168.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.82 -14.98 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.37 1.468 . . . . 0.0 113.802 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -85.97 -10.73 54.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.866 2.066 . . . . 0.0 113.502 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -133.38 -25.8 1.7 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.67 151.83 46.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.175 0.898 . . . . 0.0 111.76 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -97.35 165.17 12.15 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.883 1.325 . . . . 0.0 113.05 -172.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 m -62.1 -21.97 65.42 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.48 -44.75 95.63 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.711 170.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -63.87 -25.84 68.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.397 -0.815 . . . . 0.0 112.167 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.24 -16.39 63.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.945 -1.097 . . . . 0.0 112.664 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.5 mt -87.19 -9.51 55.0 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.021 -1.049 . . . . 0.0 112.378 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -26.75 13.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.099 1.76 . . . . 0.0 113.404 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.02 -4.31 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t70 64.8 155.12 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 129.076 2.951 . . . . 0.0 116.319 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.06 -34.5 63.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.128 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 m -67.73 -25.04 65.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -127.32 3.3 6.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.583 1.153 . . . . 0.0 112.014 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -57.3 -52.3 75.28 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.311 -1.493 . . . . 0.0 110.449 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -67.66 -12.15 34.57 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.417 2.078 . . . . 0.0 114.39 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.553 HG22 HD21 ' B' ' 139' ' ' LEU . 79.6 m -73.27 -32.71 64.84 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.795 -1.191 . . . . 0.0 110.678 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.26 85.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.387 1.075 . . . . 0.0 112.145 169.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.91 -45.18 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.353 1.061 . . . . 0.0 109.001 170.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.45 6.03 0.38 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.54 2.019 . . . . 0.0 116.78 169.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -121.68 -61.36 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.999 1.72 . . . . 0.0 110.078 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.41 -30.4 70.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.26 -32.56 13.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.683 0.674 . . . . 0.0 112.392 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.05 -46.29 88.22 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.404 HD22 HD22 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -76.01 -12.43 60.13 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.05 0.94 . . . . 0.0 111.939 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -85.81 -21.92 27.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.66 1.184 . . . . 0.0 113.028 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -95.89 -16.28 21.89 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.863 0.865 . . . . 0.0 113.225 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -170.59 153.33 4.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.971 2.908 . . . . 0.0 106.835 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -84.26 -41.74 16.59 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 111.556 -2.565 . . . . 0.0 112.718 -173.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -131.56 159.59 71.14 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 127.071 2.148 . . . . 0.0 110.057 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -90.23 12.04 2.59 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.3 2.0 . . . . 0.0 114.432 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.07 -23.71 65.68 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.241 1.016 . . . . 0.0 112.651 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.77 -15.84 24.77 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.333 1.853 . . . . 0.0 113.787 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.21 127.09 32.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.51 18.38 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 125.586 1.555 . . . . 0.0 111.336 169.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER 57.21 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.833 2.853 . . . . 0.0 110.739 -168.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.38 62.37 6.03 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.876 -1.765 . . . . 0.0 110.973 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p -72.42 -24.14 21.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -167.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -58.1 -45.12 87.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.589 1.541 . . . . 0.0 111.455 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.05 -45.2 88.98 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.947 -0.47 . . . . 0.0 112.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.68 -44.86 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.775 1.23 . . . . 0.0 111.657 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.94 63.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 112.742 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.8 m -67.44 -45.55 75.71 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.667 1.187 . . . . 0.0 111.244 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -27.03 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -172.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.8 m -49.48 -62.44 2.47 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.201 1.4 . . . . 0.0 112.831 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -8.29 22.56 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.071 2.514 . . . . 0.0 113.578 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.67 -57.18 3.8 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.312 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.79 -29.8 30.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 C-N-CA 124.084 0.954 . . . . 0.0 112.135 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.55 -53.12 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.574 1.079 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.51 -40.83 80.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.952 0.405 . . . . 0.0 110.609 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.43 97.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.8 m -74.39 -14.67 60.89 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.39 -36.17 24.51 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.11 1.323 . . . . 0.0 111.494 171.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -81.33 -27.15 35.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -125.98 50.14 1.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.436 1.894 . . . . 0.0 112.532 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -51.36 -38.16 51.78 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.703 1.601 . . . . 0.0 113.158 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -81.91 -6.42 59.09 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.29 163.78 20.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.51 1.124 . . . . 0.0 113.019 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -67.0 140.12 57.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.505 1.522 . . . . 0.0 110.755 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.32 -41.02 92.65 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -65.41 -33.56 76.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.01 -1.056 . . . . 0.0 112.38 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.54 -42.24 91.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.465 1.106 . . . . 0.0 111.668 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -41.25 95.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.33 -48.72 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.104 0.411 . . . . 0.0 110.474 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -63.46 -45.79 89.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.69 92.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.701 1.144 . . . . 0.0 113.176 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.05 -34.82 61.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.513 1.156 . . . . 0.0 112.527 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -59.8 -40.26 87.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.545 1.52 . . . . 0.0 111.78 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.43 -46.49 88.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.179 0.992 . . . . 0.0 111.844 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -28.07 69.33 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.904 -1.123 . . . . 0.0 111.92 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.74 -46.17 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.831 1.253 . . . . 0.0 111.956 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -104.33 -62.83 1.27 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.923 1.689 . . . . 0.0 113.367 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -64.82 -24.02 67.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.339 1.855 . . . . 0.0 114.189 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.12 -23.46 65.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.98 1.312 . . . . 0.0 113.869 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.565 1.546 . . . . 0.0 111.888 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -150.2 120.64 7.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.144 0.978 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.21 30.82 8.27 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 167.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -45.79 -40.52 9.74 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.281 1.432 . . . . 0.0 114.035 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 0.38 51.39 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.11 9.59 7.42 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.007 1.323 . . . . 0.0 114.092 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.77 62.34 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 58.75 -22.4 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.57 3.148 . . . . 0.0 117.824 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -65.97 -17.88 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.891 1.677 . . . . 0.0 111.796 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 157.97 41.1 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 128.153 2.581 . . . . 0.0 109.765 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.31 165.41 14.32 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.19 0.996 . . . . 0.0 112.63 -169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -45.99 165.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 1 C-N-CA 126.682 4.921 . . . . 0.0 118.773 176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.01 -19.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.062 1.745 . . . . 0.0 114.82 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -98.92 -2.13 38.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.806 1.242 . . . . 0.0 114.018 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 78.0 p -134.81 -6.14 2.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -177.24 4.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.804 1.242 . . . . 0.0 113.734 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 82.2 p -97.76 166.39 11.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -16.39 6.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.76 -34.41 71.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.086 1.312 . . . . 0.0 111.41 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.56 -27.05 67.37 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.246 -0.909 . . . . 0.0 112.805 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -71.77 -15.71 62.18 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.407 -0.808 . . . . 0.0 112.346 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 mt -95.76 -19.42 19.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.525 1.13 . . . . 0.0 113.22 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.51 65.17 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.206 1.002 . . . . 0.0 112.576 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.22 140.38 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.179 2.192 . . . . 0.0 111.758 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.87 158.99 34.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.807 1.243 . . . . 0.0 113.228 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.9 -32.02 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.679 1.591 . . . . 0.0 111.876 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.2 m -59.13 -28.24 66.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.851 1.661 . . . . 0.0 113.815 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -128.06 -2.89 5.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.29 1.436 . . . . 0.0 113.443 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -58.16 -40.82 86.0 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 119.619 -1.926 . . . . 0.0 113.475 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -60.54 -26.53 83.04 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.66 2.24 . . . . 0.0 113.241 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 42.6 m -77.41 -33.88 54.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.714 1.206 . . . . 0.0 111.483 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -60.26 -48.62 80.95 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.733 1.213 . . . . 0.0 113.079 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.02 -34.33 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 111.171 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.64 -58.42 10.22 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.537 1.065 . . . . 0.0 112.655 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.32 -37.08 76.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.233 2.017 . . . . 0.0 112.677 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.74 -29.2 67.56 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -111.83 -33.3 6.35 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.465 1.906 . . . . 0.0 112.705 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.404 HD22 HD22 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -78.78 -42.2 28.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 110.21 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.03 -32.35 73.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -168.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.35 -7.06 58.77 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.14 -45.41 0.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.33 1.3 p30 56.04 140.22 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.855 2.462 . . . . 0.0 115.94 -166.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 42.9 mttp 63.79 140.9 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.758 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.75 0.09 5.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.629 1.553 . . . . 0.0 114.524 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.27 -16.48 63.6 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.038 1.29 . . . . 0.0 113.657 -170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -123.56 5.01 8.94 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.734 1.614 . . . . 0.0 113.863 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.51 141.32 44.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.469 -1.394 . . . . 0.0 113.741 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.94 132.71 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.58 1.952 . . . . 0.0 107.708 170.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.553 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -68.61 127.35 32.7 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.91 43.72 1.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.939 -1.1 . . . . 0.0 113.623 -166.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.261 14.3 p -64.69 -21.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.528 -1.358 . . . . 0.0 112.775 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -54.91 -30.46 58.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.654 1.581 . . . . 0.0 113.125 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.28 -56.27 1.49 Allowed Glycine 0 N--CA 1.465 0.583 0 C-N-CA 123.507 0.575 . . . . 0.0 112.368 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -54.36 -45.56 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 121.606 -0.938 . . . . 0.0 113.074 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.87 66.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.682 1.128 . . . . 0.0 113.071 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -71.28 -44.56 65.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.946 1.298 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -89.04 -18.32 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.3 m -41.36 -59.95 2.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.455 1.502 . . . . 0.0 113.431 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.47 -16.9 54.98 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.136 2.558 . . . . 0.0 114.121 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.26 -58.25 3.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.354 1.062 . . . . 0.0 111.612 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -37.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.189 -0.944 . . . . 0.0 112.558 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.28 -42.73 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.923 0.489 . . . . 0.0 112.069 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.54 -45.25 46.82 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.74 0.816 . . . . 0.0 110.903 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.31 71.92 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.461 -1.4 . . . . 0.0 113.43 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 10.9 m -74.82 -11.52 60.17 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.74 -34.54 16.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.49 1.496 . . . . 0.0 111.057 167.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -58.26 -38.76 77.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.699 1.2 . . . . 0.0 111.95 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -143.8 83.07 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.41 0.684 . . . . 0.0 111.871 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -55.81 -25.9 43.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.972 1.309 . . . . 0.0 112.946 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -95.13 3.98 54.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.096 1.758 . . . . 0.0 113.269 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.09 149.72 31.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.091 1.356 . . . . 0.0 113.397 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.65 86.92 6.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.58 1.152 . . . . 0.0 113.011 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . 0.258 1.4 p90 44.43 -117.95 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -21.31 64.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.23 1.412 . . . . 0.0 113.462 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.66 -31.65 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.943 0.897 . . . . 0.0 112.267 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -74.73 -42.55 58.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.3 -35.12 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.874 1.216 . . . . 0.0 111.586 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.59 -48.14 76.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.915 0.886 . . . . 0.0 111.843 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.53 -41.42 98.71 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.121 0.867 . . . . 0.0 113.178 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.25 -29.11 63.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.381 1.091 . . . . 0.0 113.161 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -66.13 -43.16 87.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.38 0.991 . . . . 0.0 111.532 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.84 -43.9 97.92 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.684 0.793 . . . . 0.0 111.183 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.3 -40.61 5.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.931 1.693 . . . . 0.0 113.307 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 mt -85.98 -38.82 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.905 0.882 . . . . 0.0 112.421 -171.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -96.42 -54.1 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -78.77 -34.77 45.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.701 1.6 . . . . 0.0 112.776 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 24.9 t0 48.78 48.67 19.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.776 2.03 . . . . 0.0 113.365 -168.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.929 2.092 . . . . 0.0 112.16 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.31 -4.06 58.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.29 36.95 28.33 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -28.12 42.62 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -94.7 13.26 24.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.04 0.936 . . . . 0.0 113.219 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.35 -20.09 65.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.757 1.623 . . . . 0.0 114.315 -172.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.6 62.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.189 0.995 . . . . 0.0 113.076 169.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 t70 61.77 -10.7 0.07 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 129.045 2.938 . . . . 0.0 116.844 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -117.18 -6.76 11.32 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.84 1.656 . . . . 0.0 113.439 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.32 -171.67 3.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 58.3 34.94 0.23 Allowed Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 129.066 2.946 . . . . 0.0 114.585 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.19 147.3 47.79 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.853 1.702 . . . . 0.0 111.15 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.15 -18.51 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -82.49 -19.52 38.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.177 1.391 . . . . 0.0 113.951 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.3 m -141.39 44.8 1.75 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.156 2.182 . . . . 0.0 110.73 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -129.86 139.72 51.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.275 1.83 . . . . 0.0 109.912 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.5 p -102.65 161.43 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.972 1.367 . . . . 0.0 114.159 -168.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 m -77.03 -21.43 54.58 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.83 -42.27 79.34 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.305 0.957 . . . . 0.0 110.648 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.76 -28.75 60.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.092 0.957 . . . . 0.0 112.209 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -66.15 -33.97 76.98 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.658 -1.276 . . . . 0.0 111.262 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.33 -10.52 59.66 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.93 -29.4 27.14 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.248 1.019 . . . . 0.0 112.551 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.85 137.47 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.047 1.739 . . . . 0.0 110.069 170.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.43 157.4 34.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.764 0.826 . . . . 0.0 113.02 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -55.96 -28.93 59.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 111.724 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.7 m -62.78 -27.17 69.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.043 1.737 . . . . 0.0 114.243 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.7 -10.58 5.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.63 1.172 . . . . 0.0 113.511 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.83 -40.45 85.12 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 119.641 -1.912 . . . . 0.0 112.522 169.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -65.53 -24.15 56.61 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.771 2.314 . . . . 0.0 113.435 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 HD21 ' B' ' 139' ' ' LEU . 95.6 m -73.35 -36.53 66.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 110.243 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.54 85.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.647 1.179 . . . . 0.0 113.898 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.84 -35.28 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 119.203 0.911 . . . . 0.0 110.684 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.17 -43.51 74.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.878 1.228 . . . . 0.0 114.448 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -68.29 -49.06 63.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.986 2.393 . . . . 0.0 112.536 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.82 -29.96 71.12 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.147 0.579 . . . . 0.0 112.186 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.55 -45.46 10.44 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.21 90.94 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.679 -1.263 . . . . 0.0 111.308 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.47 62.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.426 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -74.18 -18.96 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.053 0.842 . . . . 0.0 113.221 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.3 -28.59 42.21 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.39 -0.818 . . . . 0.0 112.868 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -154.69 -128.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.48 1.512 . . . . 0.0 112.55 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.9 -39.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.578 2.351 . . . . 0.0 114.261 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -134.2 162.09 59.81 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 127.175 2.19 . . . . 0.0 110.363 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -94.84 9.72 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.939 1.759 . . . . 0.0 114.647 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.91 -18.26 63.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.153 -0.967 . . . . 0.0 112.936 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -112.39 -2.35 14.79 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.133 1.773 . . . . 0.0 113.971 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.55 55.44 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.43 145.07 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.467 1.907 . . . . 0.0 107.339 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD21 HG22 ' B' ' 120' ' ' THR . 1.4 tm? -80.2 137.24 36.64 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 119.233 0.924 . . . . 0.0 113.11 -168.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -94.27 47.66 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.498 -1.376 . . . . 0.0 113.749 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 ' CG ' ' B' ' 117' ' ' PHE 0.387 1.7 p -63.29 -50.28 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -60.22 -35.19 74.87 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.647 2.021 . . . . 0.0 111.854 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.77 -41.83 88.03 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 121.276 0.376 . . . . 0.0 112.54 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 HD13 HG21 ' B' ' 120' ' ' THR . 21.4 mt -65.7 -45.84 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.422 1.489 . . . . 0.0 111.444 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.05 -25.69 65.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.064 1.346 . . . . 0.0 112.973 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 m -63.92 -46.45 84.71 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.927 1.291 . . . . 0.0 110.98 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.15 -19.12 7.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -47.02 -60.94 3.24 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 125.284 1.433 . . . . 0.0 112.156 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.83 1.32 5.26 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.726 2.951 . . . . 0.0 114.334 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 -55.68 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.065 1.746 . . . . 0.0 110.938 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.07 -32.15 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.017 1.327 . . . . 0.0 111.463 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.11 -45.49 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.774 0.83 . . . . 0.0 112.097 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -67.88 -46.19 72.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.836 0.455 . . . . 0.0 110.181 175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.13 -31.61 69.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.79 0.836 . . . . 0.0 112.632 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.05 -20.28 61.01 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -30.17 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.434 1.015 . . . . 0.0 111.951 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.26 -39.09 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.366 1.067 . . . . 0.0 112.119 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -145.96 82.57 1.62 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 112.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -51.77 -35.53 44.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.878 1.271 . . . . 0.0 112.036 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.75 8.36 34.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.573 1.949 . . . . 0.0 114.595 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.38 45.12 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t30 60.42 20.18 9.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -155.13 150.55 27.26 Favored 'General case' 0 N--CA 1.486 1.363 1 N-CA-C 122.662 4.319 . . . . 0.0 122.662 -170.658 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -60.21 -25.15 65.38 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 113.749 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.79 -24.15 55.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.518 0.599 . . . . 0.0 111.568 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -64.35 -34.12 77.43 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.398 1.079 . . . . 0.0 113.805 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.78 -37.73 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.886 1.221 . . . . 0.0 112.149 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -79.88 -31.9 40.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.37 -33.59 81.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.665 1.126 . . . . 0.0 113.475 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.38 -32.92 55.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.722 1.261 . . . . 0.0 113.325 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -59.91 -41.44 91.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.591 1.087 . . . . 0.0 110.683 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.23 -51.04 70.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.923 0.889 . . . . 0.0 110.967 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -28.81 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 112.451 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mt -79.82 -47.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 112.535 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -99.23 -58.09 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.522 1.129 . . . . 0.0 112.987 -171.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -64.88 -42.24 94.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.645 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.5 t70 58.05 -7.83 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 130.631 3.572 . . . . 0.0 115.868 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.254 1.297 0 C-N-CA 128.696 2.798 . . . . 0.0 111.071 178.874 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.79 0.329 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -138.74 30.72 2.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 112.205 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.65 153.4 22.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.494 1.518 . . . . 0.0 109.39 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.46 178.3 4.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.225 1.01 . . . . 0.0 112.054 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -55.21 44.44 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 130.213 3.405 . . . . 0.0 118.464 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.9 37.1 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.3 -5.92 28.89 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 56.75 5.72 0.24 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.121 2.168 . . . . 0.0 116.232 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -140.88 -4.95 1.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -88.06 147.28 25.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.41 1.459 . . . . 0.0 111.217 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.4 pttt 31.67 55.0 0.93 Allowed Pre-proline 0 N--CA 1.484 1.273 0 C-N-CA 128.405 2.682 . . . . 0.0 115.768 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.49 155.99 67.55 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.88 2.387 . . . . 0.0 112.238 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.0 -15.66 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -85.01 -10.74 56.69 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.182 1.393 . . . . 0.0 114.129 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 48.1 m -144.72 49.37 1.3 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.388 2.275 . . . . 0.0 110.477 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -141.29 139.91 33.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.498 1.519 . . . . 0.0 110.435 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 39.6 p -98.76 150.0 22.28 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.65 -26.67 65.72 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.09 -39.28 85.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.978 -1.076 . . . . 0.0 111.418 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.16 -17.41 46.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.75 -29.03 66.28 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.794 -1.192 . . . . 0.0 110.353 168.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mp -73.79 -13.77 61.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.954 -1.091 . . . . 0.0 113.478 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.36 -33.45 25.83 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.486 1.039 . . . . 0.0 113.523 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.31 140.23 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.943 1.297 . . . . 0.0 110.597 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -67.13 158.78 30.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.868 1.267 . . . . 0.0 113.347 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.47 -32.69 71.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.44 1.096 . . . . 0.0 112.03 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.4 m -62.4 -23.44 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.909 1.684 . . . . 0.0 113.924 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.4 ' CG ' HG23 ' A' ' 52' ' ' VAL . 11.2 m-85 -124.78 -5.96 7.45 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.765 1.226 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -57.0 -46.78 99.84 Favored Pre-proline 0 CA--C 1.549 0.909 0 O-C-N 120.272 -1.517 . . . . 0.0 111.699 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -65.65 -18.31 58.57 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.097 2.531 . . . . 0.0 114.366 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.545 HG22 HD21 ' A' ' 50' ' ' LEU . 25.6 m -77.13 -38.02 52.92 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.818 1.247 . . . . 0.0 110.464 173.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.26 99.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.262 1.025 . . . . 0.0 112.476 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.56 -45.71 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.78 . . . . 0.0 109.094 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.5 -57.57 10.32 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 125.645 1.593 . . . . 0.0 113.464 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.62 -12.32 60.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.485 2.642 . . . . 0.0 113.905 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.54 -31.35 13.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.841 1.2 . . . . 0.0 113.627 169.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -88.59 -45.69 9.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.215 1.006 . . . . 0.0 112.343 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.61 84.09 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.791 2.436 . . . . 0.0 113.474 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -18.27 39.25 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.49 1.116 . . . . 0.0 111.865 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -84.69 -35.78 22.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 112.563 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.27 -6.82 54.73 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -146.67 -140.23 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.139 2.576 . . . . 0.0 107.621 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -153.68 -65.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -127.71 160.92 58.33 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 126.966 2.106 . . . . 0.0 110.031 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -82.09 0.24 9.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.16 1.45 . . . . 0.0 114.475 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -60.62 -19.46 57.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 113.456 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -131.79 7.89 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.011 1.324 . . . . 0.0 113.774 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.78 138.81 40.12 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.378 -1.451 . . . . 0.0 114.502 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.86 143.28 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.01 2.124 . . . . 0.0 107.087 168.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.582 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -73.15 133.39 44.07 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.415 1.007 . . . . 0.0 108.983 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -94.35 38.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.834 -1.166 . . . . 0.0 112.684 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 13.1 p -66.66 -21.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.809 -1.807 . . . . 0.0 112.845 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -55.2 -29.84 58.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.684 1.593 . . . . 0.0 112.915 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -94.47 -53.51 1.69 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.612 0.625 . . . . 0.0 112.567 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.24 -42.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.181 0.992 . . . . 0.0 113.357 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.99 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.143 1.338 . . . . 0.0 112.945 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 16.6 m -73.19 -37.73 66.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.556 1.142 . . . . 0.0 111.844 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.419 HG12 HD12 ' B' ' 151' ' ' ILE . 23.5 t -83.42 -27.74 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.074 1.75 . . . . 0.0 113.408 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 26.4 m -53.17 -59.69 8.57 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.323 1.449 . . . . 0.0 112.917 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.32 -15.12 46.29 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.298 2.665 . . . . 0.0 113.52 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.89 -62.51 1.47 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.115 0.966 . . . . 0.0 111.052 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 147' ' ' VAL . 33.1 mt -69.74 -30.99 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.38 -0.825 . . . . 0.0 112.822 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.38 -44.02 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.01 -1.056 . . . . 0.0 112.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -71.73 -46.08 59.71 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 110.807 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -27.05 67.72 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.577 -1.327 . . . . 0.0 113.309 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 m -75.1 -14.72 60.6 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.06 -36.02 21.47 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.595 1.543 . . . . 0.0 110.562 167.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -59.8 -38.62 82.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.038 0.935 . . . . 0.0 112.464 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -135.71 61.69 1.65 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.931 1.292 . . . . 0.0 112.022 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -49.16 -38.02 24.21 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.994 1.317 . . . . 0.0 112.877 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.51 -2.53 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.407 1.083 . . . . 0.0 113.825 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.68 158.42 24.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 112.638 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -80.44 137.38 36.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.388 1.475 . . . . 0.0 111.274 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.64 -44.14 91.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.367 1.067 . . . . 0.0 113.364 -170.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.79 -41.94 78.6 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.315 0.961 . . . . 0.0 112.111 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.25 -36.71 83.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.876 0.471 . . . . 0.0 112.059 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -74.62 -37.65 62.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.34 -38.73 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.099 1.318 . . . . 0.0 111.466 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.07 -45.53 93.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.291 0.636 . . . . 0.0 111.609 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.98 -49.07 69.03 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.763 1.173 . . . . 0.0 113.613 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.75 -34.34 66.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.634 1.217 . . . . 0.0 112.939 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -61.74 -37.14 83.12 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.193 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.26 -43.36 95.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.651 0.781 . . . . 0.0 111.825 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -23.13 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.728 -1.232 . . . . 0.0 112.331 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.84 -45.8 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.565 1.946 . . . . 0.0 112.528 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.22 -60.22 1.68 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 0.0 113.8 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -62.93 -28.41 70.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.388 1.475 . . . . 0.0 113.607 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.29 -23.62 67.36 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.742 2.417 . . . . 0.0 114.333 177.827 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.96 -43.39 15.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.713 0.805 . . . . 0.0 113.163 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.24 162.57 25.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.955 0.902 . . . . 0.0 111.137 173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 59.62 -41.2 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -77.44 -30.09 53.19 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.544 1.52 . . . . 0.0 112.499 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.2 -88.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.453 2.301 . . . . 0.0 114.997 174.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.77 11.38 11.22 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.282 1.433 . . . . 0.0 113.373 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.3 t70 65.42 -30.9 0.13 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 129.583 3.153 . . . . 0.0 116.185 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -133.03 -4.85 3.1 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -169.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -84.36 -22.2 30.63 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 -166.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.271 50.2 pttt -121.51 52.62 3.34 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.55 159.09 53.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.164 2.576 . . . . 0.0 113.812 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.37 1.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.22 2.208 . . . . 0.0 116.869 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.7 9.73 7.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.226 1.41 . . . . 0.0 113.576 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -132.86 -40.84 0.94 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.742 1.217 . . . . 0.0 113.904 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -83.89 158.7 21.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.596 0.713 . . . . 0.0 112.601 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -85.0 151.15 24.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -23.93 25.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.391 1.876 . . . . 0.0 114.127 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.34 -36.13 68.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.545 1.066 . . . . 0.0 111.378 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.73 -21.66 60.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.884 0.874 . . . . 0.0 113.071 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -66.64 -24.2 66.27 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -80.32 -14.79 58.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.266 1.426 . . . . 0.0 113.146 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.71 -29.87 40.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.941 . . . . 0.0 112.248 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.37 138.16 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.591 1.956 . . . . 0.0 110.118 172.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.2 157.74 30.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.728 0.811 . . . . 0.0 112.713 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -56.06 -30.92 62.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.228 1.411 . . . . 0.0 111.577 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.6 m -62.48 -27.67 69.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.229 1.812 . . . . 0.0 113.984 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -127.45 -9.35 5.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.745 1.218 . . . . 0.0 113.896 -170.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -55.2 -40.98 88.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 119.543 -1.973 . . . . 0.0 112.034 168.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -62.74 -24.18 74.63 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.305 2.67 . . . . 0.0 113.848 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.9 m -78.73 -33.53 46.6 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.418 1.087 . . . . 0.0 110.455 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.87 91.53 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.0 -36.08 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.048 0.84 . . . . 0.0 110.974 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.58 56.92 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.437 1.017 . . . . 0.0 114.489 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -11.44 60.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.568 2.184 . . . . 0.0 113.788 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.99 -48.25 7.91 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.092 166.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.32 -33.36 55.56 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 113.691 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.03 94.22 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.937 1.295 . . . . 0.0 112.159 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' B' ' 127' ' ' ALA . 0.6 OUTLIER -77.95 -40.51 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.65 1.18 . . . . 0.0 110.595 -175.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.28 -20.84 65.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.984 0.914 . . . . 0.0 113.433 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -84.21 -19.88 33.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -153.53 -124.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.251 . . . . 0.0 112.761 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -162.91 -64.13 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.071 2.148 . . . . 0.0 111.913 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -113.62 160.57 31.28 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.539 2.336 . . . . 0.0 111.196 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.41 2.59 8.29 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 114.578 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -59.17 -26.48 64.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.663 1.185 . . . . 0.0 112.768 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -118.7 25.69 10.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.01 1.724 . . . . 0.0 112.211 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.7 118.35 29.24 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.499 -1.376 . . . . 0.0 112.165 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.89 127.99 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.627 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -63.58 122.6 16.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.648 1.113 . . . . 0.0 110.153 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -89.69 46.71 1.39 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.161 -0.962 . . . . 0.0 113.015 -168.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.369 2.5 p -63.7 -15.06 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 O-C-N 120.645 -1.285 . . . . 0.0 112.43 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.78 -44.67 70.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.695 1.598 . . . . 0.0 112.185 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.66 4.98 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -50.17 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.825 . . . . 0.0 112.702 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.39 67.14 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.501 1.046 . . . . 0.0 112.453 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 m -66.19 -48.8 69.48 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.129 1.372 . . . . 0.0 112.218 171.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.2 m -87.04 -18.47 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -46.92 -63.1 1.51 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.107 1.363 . . . . 0.0 112.037 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -69.44 0.39 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.614 2.876 . . . . 0.0 114.57 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.52 -57.2 2.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.178 1.791 . . . . 0.0 110.029 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mt -68.83 -32.2 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.828 1.251 . . . . 0.0 112.369 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.79 -42.16 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.958 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -72.99 -46.9 49.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.456 0.646 . . . . 0.0 110.017 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.43 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.305 -0.872 . . . . 0.0 113.06 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.7 m -74.17 -14.26 60.93 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -34.99 16.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.36 1.436 . . . . 0.0 111.53 168.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -60.84 -38.0 83.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.16 . . . . 0.0 111.904 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -138.72 56.64 1.7 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.541 1.536 . . . . 0.0 112.318 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -49.97 -33.98 19.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.852 2.061 . . . . 0.0 113.121 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.6 -1.9 58.16 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.55 144.36 44.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.042 0.837 . . . . 0.0 111.827 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.76 29.37 0.2 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.287 1.835 . . . . 0.0 114.411 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 t80 52.01 -171.25 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.704 2.002 . . . . 0.0 112.814 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 tttt 62.26 -44.32 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 129.657 3.183 . . . . 0.0 115.288 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.77 -35.73 64.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.494 1.918 . . . . 0.0 111.671 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -43.59 79.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.673 0.789 . . . . 0.0 112.9 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.38 -37.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.003 0.819 . . . . 0.0 111.405 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -69.37 -48.79 60.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.242 1.017 . . . . 0.0 111.968 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.96 94.64 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.147 1.356 . . . . 0.0 113.845 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.21 -34.17 63.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.202 1.501 . . . . 0.0 112.637 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.5 -41.62 94.66 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.565 1.075 . . . . 0.0 111.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.97 -48.17 83.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.25 1.02 . . . . 0.0 111.393 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -28.88 70.14 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.427 -1.421 . . . . 0.0 112.346 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.2 mt -81.2 -45.2 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.956 1.303 . . . . 0.0 112.707 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -102.61 -57.78 1.99 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.953 1.301 . . . . 0.0 113.101 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -66.25 -34.61 78.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.609 1.164 . . . . 0.0 111.835 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.53 61.38 3.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.074 2.15 . . . . 0.0 112.752 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 C--O 1.255 1.367 0 C-N-CA 127.792 2.437 . . . . 0.0 113.834 -174.32 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -142.73 118.57 10.55 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 47.2 42.54 13.49 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 166.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -11.75 61.08 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.751 -1.218 . . . . 0.0 113.621 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -75.83 53.04 0.72 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.926 2.091 . . . . 0.0 111.504 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.46 54.83 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.8 64.78 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.6 104.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.694 2.398 . . . . 0.0 114.115 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . 0.297 0.0 OUTLIER 66.51 4.49 3.33 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.385 2.274 . . . . 0.0 116.676 176.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -136.12 -162.52 1.28 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.626 1.97 . . . . 0.0 111.714 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 63.95 44.79 0.53 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 127.627 2.371 . . . . 0.0 113.266 -168.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.63 166.42 29.93 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.298 2.666 . . . . 0.0 113.249 -173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 m -55.71 -25.38 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.22 -27.68 60.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.552 1.141 . . . . 0.0 113.097 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m -119.04 -19.28 8.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -169.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.24 160.76 29.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.142 0.883 . . . . 0.0 111.878 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 53.4 p -95.73 168.42 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.708 1.242 . . . . 0.0 113.871 -169.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.46 -26.7 67.32 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.293 -0.88 . . . . 0.0 112.119 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -62.74 -42.12 99.51 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.421 168.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.4 -30.4 71.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.375 0.67 . . . . 0.0 112.087 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.417 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 66.0 t80 -69.17 -23.74 63.98 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.035 -1.041 . . . . 0.0 111.636 173.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.04 -8.96 56.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.417 1.087 . . . . 0.0 113.359 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.08 -34.99 43.13 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.187 0.995 . . . . 0.0 112.699 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.05 139.12 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.614 1.566 . . . . 0.0 110.187 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.4 158.87 32.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.368 1.067 . . . . 0.0 113.318 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.83 -32.34 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.492 1.517 . . . . 0.0 112.125 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.6 m -59.62 -29.44 68.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.727 1.611 . . . . 0.0 113.53 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.45 -4.38 6.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.871 1.268 . . . . 0.0 114.09 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -56.02 -41.18 89.71 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 120.168 -1.582 . . . . 0.0 113.001 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -62.76 -26.45 75.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.676 2.251 . . . . 0.0 113.239 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 50' ' ' LEU . 27.6 m -76.2 -35.6 59.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.526 1.13 . . . . 0.0 111.26 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.39 98.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.693 1.197 . . . . 0.0 113.645 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.63 -35.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.146 1.339 . . . . 0.0 109.793 168.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.88 -46.47 60.48 Favored Glycine 0 C--O 1.218 -0.89 0 C-N-CA 125.02 1.295 . . . . 0.0 114.589 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.29 -35.14 77.38 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 121.489 2.644 . . . . 0.0 112.738 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.83 70.81 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.186 -0.946 . . . . 0.0 112.45 173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -76.71 -46.48 25.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.348 1.059 . . . . 0.0 111.985 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -61.75 -51.64 67.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.478 1.511 . . . . 0.0 111.99 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -31.08 69.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.431 0.692 . . . . 0.0 111.086 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.41 -21.44 65.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.795 0.838 . . . . 0.0 113.196 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -84.43 -21.81 30.61 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.4 -124.79 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -162.98 -66.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 128.006 2.523 . . . . 0.0 110.281 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.6 164.97 13.76 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 126.714 2.005 . . . . 0.0 110.417 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -90.94 7.06 3.66 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.958 2.439 . . . . 0.0 114.001 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -63.95 -25.91 68.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.759 -1.213 . . . . 0.0 113.011 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.14 0.9 25.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.558 1.543 . . . . 0.0 114.382 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.62 131.27 44.37 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.833 -1.167 . . . . 0.0 113.563 -172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.24 129.58 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 127.051 2.14 . . . . 0.0 106.814 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.8 130.98 45.54 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.661 1.118 . . . . 0.0 112.269 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -88.98 50.29 1.93 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.958 1.303 . . . . 0.0 111.442 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.25 -38.87 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -166.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.84 -36.64 84.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.734 1.607 . . . . 0.0 111.476 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.5 41.19 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 123.95 0.786 . . . . 0.0 111.529 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.3 -42.95 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.998 0.919 . . . . 0.0 111.547 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.58 -34.94 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 112.761 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 24.7 m -64.56 -43.6 93.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.561 1.145 . . . . 0.0 111.73 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 25.2 t -80.14 -33.19 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.995 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.9 m -40.5 -61.9 1.08 Allowed Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.425 1.89 . . . . 0.0 113.891 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.85 -15.23 48.17 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.493 2.129 . . . . 0.0 113.632 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.44 -61.38 1.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.219 1.008 . . . . 0.0 111.231 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.34 -25.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.957 -1.089 . . . . 0.0 113.066 177.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.84 -52.77 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.026 0.83 . . . . 0.0 110.641 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -68.88 -47.1 66.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.705 0.402 . . . . 0.0 110.894 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -29.75 70.43 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.61 -1.306 . . . . 0.0 113.008 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.94 -15.25 60.21 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -32.29 22.61 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.058 1.299 . . . . 0.0 111.238 167.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -61.39 -38.22 86.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.945 0.898 . . . . 0.0 112.121 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -145.15 70.69 1.27 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 0.0 112.224 -170.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -54.91 -42.26 71.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -76.53 -15.72 59.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.87 158.4 35.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 111.926 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -69.21 143.66 53.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 169.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 35.7 t80 -58.1 -41.31 83.27 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -62.65 -33.02 74.2 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.4 -39.18 86.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.319 1.047 . . . . 0.0 111.838 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -37.86 62.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.937 0.895 . . . . 0.0 112.736 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.95 -48.33 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 119.302 0.955 . . . . 0.0 109.906 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.54 -46.83 74.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.01 0.924 . . . . 0.0 112.395 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.26 -42.23 99.72 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.26 0.934 . . . . 0.0 113.479 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.62 -33.61 62.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.454 1.127 . . . . 0.0 112.679 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.73 -37.88 88.28 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.465 -1.397 . . . . 0.0 111.878 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.41 -47.59 83.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.331 1.052 . . . . 0.0 111.933 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -26.15 68.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.051 -1.03 . . . . 0.0 112.285 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 31.6 mt -79.23 -49.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.913 1.685 . . . . 0.0 112.194 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.91 -60.19 1.59 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.138 1.375 . . . . 0.0 113.523 -171.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -65.2 -26.89 68.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.751 1.62 . . . . 0.0 113.603 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.78 -20.39 63.48 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.863 1.265 . . . . 0.0 114.391 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.241 1.417 . . . . 0.0 113.287 -175.642 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.32 -12.64 27.61 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -124.93 -175.18 3.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.754 1.622 . . . . 0.0 111.638 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.383 0.4 OUTLIER 46.59 -93.31 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.93 2.092 . . . . 0.0 115.484 175.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.8 0.94 16.25 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.04 33.53 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.2 -20.41 64.84 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.04 -6.89 0.07 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.85 2.86 . . . . 0.0 117.237 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.58 -5.12 9.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.705 1.602 . . . . 0.0 114.04 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -177.87 5.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.23 1.412 . . . . 0.0 113.454 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HE3' ' CE2' ' A' ' 16' ' ' TRP . 27.1 tttp 65.39 32.46 0.1 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 128.434 2.694 . . . . 0.0 116.973 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.23 164.19 35.9 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.192 1.928 . . . . 0.0 113.043 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.77 -22.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.656 1.182 . . . . 0.0 113.605 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -68.57 -25.62 64.99 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.736 2.014 . . . . 0.0 113.827 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -133.25 -11.53 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.428 ' CE2' ' HE3' ' A' ' 11' ' ' LYS . 4.6 t90 -76.72 123.13 25.71 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 109.161 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -90.07 148.08 23.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 112.935 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -54.96 -30.0 58.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -63.26 -42.06 99.11 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.786 1.175 . . . . 0.0 111.693 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.23 0.27 57.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.865 1.266 . . . . 0.0 112.36 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 -28.07 20.77 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.036 -1.04 . . . . 0.0 111.838 171.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.82 -5.54 6.18 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.154 -0.966 . . . . 0.0 112.588 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.49 -27.17 60.45 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.427 1.491 . . . . 0.0 112.021 170.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.44 135.02 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.355 1.862 . . . . 0.0 109.749 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.09 157.46 33.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.636 0.774 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.85 -27.77 63.52 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.181 1.392 . . . . 0.0 112.238 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 m -66.53 -23.16 66.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 172.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CG ' HG23 ' B' ' 141' ' ' VAL . 17.9 m-85 -124.94 -11.09 7.16 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -61.38 -38.72 55.58 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.619 -1.925 . . . . 0.0 112.303 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.81 -26.06 74.77 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.129 2.552 . . . . 0.0 112.714 169.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 HD21 ' B' ' 139' ' ' LEU . 51.7 m -73.71 -36.34 65.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.651 1.18 . . . . 0.0 110.772 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.08 -49.73 74.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.218 1.007 . . . . 0.0 113.577 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 58' ' ' VAL 0.256 4.2 p -64.18 -33.77 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 118.99 0.814 . . . . 0.0 110.343 170.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.39 -52.06 34.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.405 168.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.36 -39.92 89.45 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.623 2.211 . . . . 0.0 112.599 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.97 68.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.244 -0.91 . . . . 0.0 112.69 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.69 -40.52 11.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.699 1.2 . . . . 0.0 112.385 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.34 80.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 111.859 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -26.44 60.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 0.0 111.058 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -68.27 -22.79 64.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -86.65 -24.69 25.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -154.13 -141.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.503 1.521 . . . . 0.0 111.108 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -165.11 136.23 4.01 Favored 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.105 4.162 . . . . 0.0 108.291 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.98 163.6 0.1 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.772 2.029 . . . . 0.0 113.061 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -92.59 9.27 2.6 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.034 1.823 . . . . 0.0 113.807 172.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -57.26 -24.63 56.05 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 112.971 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -130.6 31.93 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.563 1.545 . . . . 0.0 111.996 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.02 138.78 31.22 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.002 -1.686 . . . . 0.0 113.638 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.42 134.76 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.787 2.435 . . . . 0.0 106.174 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 111.74 4.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.012 1.278 . . . . 0.0 108.941 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -85.61 53.87 2.92 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.935 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.363 2.7 p -64.0 -14.24 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 -169.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.4 -42.57 53.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.853 1.661 . . . . 0.0 111.993 166.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.85 -52.94 4.15 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.24 -48.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.364 1.065 . . . . 0.0 112.923 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.02 71.37 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.585 1.084 . . . . 0.0 112.457 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.3 m -71.57 -43.62 65.98 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.658 1.583 . . . . 0.0 112.829 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 33' ' ' VAL . 1.6 p -79.93 -22.97 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.135 0.974 . . . . 0.0 113.623 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 m -49.26 -60.82 4.16 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 125.155 1.382 . . . . 0.0 112.945 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -66.33 -5.34 12.4 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.374 2.716 . . . . 0.0 114.465 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.4 -61.73 1.67 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -67.41 -35.23 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.361 1.064 . . . . 0.0 112.245 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.29 -51.66 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.416 1.086 . . . . 0.0 110.384 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -73.02 -42.34 63.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.388 0.613 . . . . 0.0 110.902 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -29.69 70.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.351 0.66 . . . . 0.0 112.358 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.42 -17.16 64.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -35.45 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.216 1.371 . . . . 0.0 111.726 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.93 -38.14 84.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.893 0.877 . . . . 0.0 112.601 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -140.29 72.98 1.41 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -51.01 -31.76 19.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.659 1.983 . . . . 0.0 113.294 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -93.49 0.09 56.59 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.91 154.22 36.14 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 111.418 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.63 149.35 34.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 110.262 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.1 -37.44 82.74 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.215 -0.928 . . . . 0.0 113.261 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -60.4 -37.66 81.52 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.577 -1.327 . . . . 0.0 112.765 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.82 -39.75 94.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.438 0.695 . . . . 0.0 111.315 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -62.84 -44.02 97.24 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.32 -41.36 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.056 0.843 . . . . 0.0 110.712 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.53 -54.1 22.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.517 0.727 . . . . 0.0 112.116 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.85 99.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.944 0.783 . . . . 0.0 113.108 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -28.07 57.31 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.425 -1.044 . . . . 0.0 113.275 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -65.07 -40.74 95.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.618 1.099 . . . . 0.0 111.146 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.01 -43.33 99.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.353 0.661 . . . . 0.0 111.731 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -38.21 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.192 1.797 . . . . 0.0 114.226 169.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt -92.17 -37.01 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.425 1.09 . . . . 0.0 112.095 -168.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.98 -59.47 1.84 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.409 1.484 . . . . 0.0 113.565 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -66.83 -27.99 67.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.167 1.387 . . . . 0.0 113.596 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.58 -18.27 62.91 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.1 tpp . . . . . 0 C--O 1.255 1.385 0 C-N-CA 125.521 1.528 . . . . 0.0 112.579 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -150.39 125.1 9.73 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.585 0.754 . . . . 0.0 112.841 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 47.14 43.64 14.57 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 167.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -70.76 -47.63 58.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.192 -0.943 . . . . 0.0 112.426 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -150.87 47.21 0.86 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.078 1.751 . . . . 0.0 111.654 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.96 -17.47 63.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.412 1.085 . . . . 0.0 113.615 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.11 99.89 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.856 0.836 . . . . 0.0 110.975 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.77 -13.12 3.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.055 2.542 . . . . 0.0 114.924 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -90.68 -11.32 40.11 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.441 1.096 . . . . 0.0 113.598 171.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -101.44 149.11 24.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.756 2.022 . . . . 0.0 112.225 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 32.83 49.68 0.56 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 129.036 2.934 . . . . 0.0 115.277 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.35 152.11 38.75 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.77 1.647 . . . . 0.0 111.57 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -67.64 9.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.573 1.549 . . . . 0.0 114.266 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.35 5.29 8.41 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.567 1.947 . . . . 0.0 113.549 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 8.1 p -144.57 -21.67 0.53 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -87.82 -176.29 5.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.2 p -113.35 167.43 10.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.303 1.441 . . . . 0.0 113.912 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -20.82 28.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.01 -34.56 72.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.759 1.163 . . . . 0.0 112.44 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.5 -20.95 63.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.661 0.784 . . . . 0.0 113.099 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.66 -23.65 66.17 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.801 -1.187 . . . . 0.0 111.921 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.8 -17.62 43.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.904 1.281 . . . . 0.0 113.598 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.44 -28.82 56.75 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.93 0.892 . . . . 0.0 111.598 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.32 135.78 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.12 1.768 . . . . 0.0 110.14 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.04 158.85 30.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.008 0.923 . . . . 0.0 112.844 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.51 -35.4 60.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.833 1.253 . . . . 0.0 112.032 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 m -65.31 -22.49 66.84 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.784 1.234 . . . . 0.0 114.241 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -126.36 -5.11 6.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -58.33 -39.22 73.75 Favored Pre-proline 0 N--CA 1.478 0.936 0 O-C-N 119.689 -1.882 . . . . 0.0 113.43 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.81 -26.43 79.47 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.348 2.032 . . . . 0.0 112.984 169.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -76.96 -32.69 57.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.424 1.089 . . . . 0.0 111.715 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.57 92.36 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.879 -1.138 . . . . 0.0 113.239 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.88 -34.48 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.674 0.67 . . . . 0.0 110.764 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.81 -56.84 14.23 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.364 0.983 . . . . 0.0 112.954 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.74 -16.92 62.38 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.748 2.274 . . . . 0.0 113.807 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.72 -28.64 18.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -109.48 -30.62 7.86 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.507 1.503 . . . . 0.0 113.419 -173.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.66 77.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.313 2.245 . . . . 0.0 112.194 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.11 -24.6 30.23 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.898 1.279 . . . . 0.0 111.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -18.15 64.7 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.04 0.836 . . . . 0.0 113.053 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -110.66 -5.12 15.1 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -128.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.189 1.396 . . . . 0.0 112.163 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -159.65 -62.08 0.07 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.516 1.926 . . . . 0.0 112.491 -169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -119.89 162.25 34.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 126.975 2.11 . . . . 0.0 110.796 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.79 5.22 6.55 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.273 1.982 . . . . 0.0 114.619 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.19 -24.89 60.64 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.43 13.63 18.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.827 2.051 . . . . 0.0 112.975 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.74 22.81 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 119.78 -1.825 . . . . 0.0 112.928 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.9 107.23 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.341 1.857 . . . . 0.0 106.162 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 31' ' ' THR . 2.9 tm? -61.52 124.94 22.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.143 0.577 . . . . 0.0 109.496 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -99.21 66.79 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.477 1.035 . . . . 0.0 111.98 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' VAL . . . . . 0.404 HG23 ' CG ' ' A' ' 28' ' ' PHE . 1.8 p -64.63 -33.9 66.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.7 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.62 -39.67 84.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.827 1.649 . . . . 0.0 111.937 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.24 -48.22 66.03 Favored Glycine 0 N--CA 1.47 0.961 0 O-C-N 122.037 -0.414 . . . . 0.0 112.219 171.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.18 -41.42 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.626 -0.926 . . . . 0.0 112.264 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.04 71.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.432 1.469 . . . . 0.0 112.325 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 44.1 m -63.22 -43.25 98.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.677 0.791 . . . . 0.0 111.464 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -84.7 -27.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.987 1.315 . . . . 0.0 113.583 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.4 m -42.2 -61.36 1.6 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.681 1.993 . . . . 0.0 113.536 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.64 -12.35 34.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.313 2.009 . . . . 0.0 113.916 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.9 -64.53 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.013 . . . . 0.0 110.98 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.551 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -71.16 -24.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 120.887 -1.133 . . . . 0.0 113.432 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 t -58.94 -51.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 110.204 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -73.41 -47.91 38.1 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.184 0.594 . . . . 0.0 111.042 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.63 68.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.515 -1.365 . . . . 0.0 113.531 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.5 m -74.76 -21.64 59.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 169.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -30.99 33.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.202 1.365 . . . . 0.0 111.553 169.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -63.29 -38.24 90.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.846 0.858 . . . . 0.0 111.531 168.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -143.09 66.63 1.31 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.06 0.944 . . . . 0.0 112.243 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.16 -37.21 53.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.004 1.322 . . . . 0.0 112.328 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -82.38 -1.16 49.03 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.788 1.235 . . . . 0.0 113.545 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.47 146.44 44.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 112.094 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -65.71 149.36 50.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.749 1.22 . . . . 0.0 111.205 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -48.89 151.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.079 1.352 . . . . 0.0 112.182 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm 60.26 -29.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.489 2.716 . . . . 0.0 116.792 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.66 -34.28 76.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.809 1.644 . . . . 0.0 111.714 172.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.08 -37.55 78.54 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.601 -0.687 . . . . 0.0 112.367 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.96 -47.74 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 124.11 0.964 . . . . 0.0 110.034 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -64.68 -42.91 95.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 112.342 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.64 -41.03 99.19 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.625 1.107 . . . . 0.0 113.165 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.47 -35.45 65.7 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.111 -1.229 . . . . 0.0 112.934 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.24 -37.72 86.51 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.988 -1.07 . . . . 0.0 112.037 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.5 -46.29 90.68 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 0.0 111.812 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -20.0 65.99 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.946 -1.096 . . . . 0.0 112.789 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.3 mt -86.46 -47.02 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.552 1.941 . . . . 0.0 112.396 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -104.73 -59.77 1.7 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.215 1.406 . . . . 0.0 113.348 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -64.74 -28.31 69.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.542 1.537 . . . . 0.0 113.323 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.35 -11.68 59.93 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.213 1.405 . . . . 0.0 114.257 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 C--O 1.255 1.366 0 C-N-CA 125.201 1.4 . . . . 0.0 113.122 -175.195 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -143.94 131.42 21.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.235 1.014 . . . . 0.0 111.617 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.58 20.23 10.09 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 115.466 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 61.02 -175.3 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.007 2.123 . . . . 0.0 114.831 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -75.82 158.8 31.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.271 0.628 . . . . 0.0 110.358 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.85 99.9 0.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -167.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.9 169.2 9.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 110.082 167.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 62.93 -57.58 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.73 2.412 . . . . 0.0 112.155 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -84.65 61.07 6.49 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -46.54 121.51 3.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.8 2.44 . . . . 0.0 116.138 -166.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -130.83 55.43 18.97 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 127.083 2.153 . . . . 0.0 110.697 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -61.64 163.33 18.68 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.252 3.301 . . . . 0.0 113.727 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.25 -19.19 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.663 1.585 . . . . 0.0 114.874 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -95.29 -15.95 22.78 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.9 p -109.56 -32.73 7.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.984 1.265 . . . . 0.0 114.146 -172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -88.6 -179.96 6.15 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.771 0.829 . . . . 0.0 113.152 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.9 p -105.62 160.42 15.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.436 1.494 . . . . 0.0 114.352 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -25.29 60.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.527 1.931 . . . . 0.0 115.239 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.84 -35.31 66.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.582 1.083 . . . . 0.0 111.463 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.07 -18.12 60.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.266 1.026 . . . . 0.0 113.54 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -65.93 -29.3 69.69 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.808 -1.182 . . . . 0.0 110.573 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.91 -18.45 58.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.638 1.575 . . . . 0.0 113.082 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.36 -27.73 38.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.482 1.113 . . . . 0.0 112.006 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.8 137.62 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.843 1.657 . . . . 0.0 108.906 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -65.69 154.89 37.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.882 0.873 . . . . 0.0 112.536 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.11 -35.32 73.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.429 1.092 . . . . 0.0 111.777 -174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.4 m -61.65 -25.13 67.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.902 1.681 . . . . 0.0 113.713 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.98 -2.8 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.055 -173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -57.56 -43.73 99.08 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 119.906 -1.746 . . . . 0.0 112.148 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -62.69 -25.21 75.01 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.871 2.381 . . . . 0.0 113.92 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 HD13 ' B' ' 144' ' ' ILE . 89.5 m -75.8 -34.2 60.16 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.029 0.931 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.768 1.227 . . . . 0.0 113.587 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.18 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.079 0.854 . . . . 0.0 110.931 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.49 -51.1 50.13 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 124.973 1.273 . . . . 0.0 113.755 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 144' ' ' ILE . 3.2 m-85 -69.13 -23.51 63.99 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.283 2.542 . . . . 0.0 113.339 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 -61.48 1.79 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.325 -0.86 . . . . 0.0 109.296 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -73.66 -29.78 62.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.392 -1.443 . . . . 0.0 114.739 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' B' ' 124' ' ' PHE . . . -64.11 -41.39 97.28 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.03 -1.044 . . . . 0.0 110.933 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.434 HD13 HD13 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -83.39 -38.52 21.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.456 1.102 . . . . 0.0 110.329 -178.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -64.3 -33.52 76.02 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.571 1.148 . . . . 0.0 113.483 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -80.66 -13.77 58.73 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -155.25 -136.1 0.05 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.995 1.718 . . . . 0.0 110.769 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -172.18 127.08 0.56 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 130.532 3.533 . . . . 0.0 108.879 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 mttt 60.58 166.35 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.033 0 C-N-CA 125.787 1.635 . . . . 0.0 113.845 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -88.16 15.18 2.16 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.033 1.822 . . . . 0.0 114.846 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.77 -30.41 70.01 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.863 -1.148 . . . . 0.0 112.203 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -116.54 27.52 9.15 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.57 1.948 . . . . 0.0 112.167 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 107.75 14.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.915 -1.74 . . . . 0.0 111.763 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.54 118.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.685 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? -67.4 117.15 8.98 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.173 0.897 . . . . 0.0 112.406 -167.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -89.72 53.16 2.49 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.404 -1.435 . . . . 0.0 111.608 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.323 1.2 p -60.75 -41.33 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -167.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' B' ' 93' ' ' GLN . 43.7 tp60 -63.23 -38.51 91.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.583 1.538 . . . . 0.0 112.305 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -54.09 39.85 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -43.45 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.492 -1.005 . . . . 0.0 112.164 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.29 67.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.203 . . . . 0.0 112.804 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -71.25 -45.13 63.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.251 1.421 . . . . 0.0 111.885 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 62' ' ' ILE . 2.2 t -86.53 -19.66 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.1 m -45.64 -61.91 2.11 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 125.123 1.369 . . . . 0.0 112.415 173.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.47 -3.66 12.92 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.599 2.866 . . . . 0.0 114.178 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.8 -64.45 1.17 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.899 1.28 . . . . 0.0 108.984 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 58' ' ' VAL . 21.8 mt -67.78 -34.67 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.959 0.904 . . . . 0.0 111.977 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.57 -49.69 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.88 0.872 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.13 -45.92 58.62 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.77 -28.72 69.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.291 -0.88 . . . . 0.0 113.183 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.0 m -75.26 -13.31 60.43 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.47 -34.99 16.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.469 1.486 . . . . 0.0 111.178 167.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -60.63 -38.27 84.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.82 170.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -138.18 52.94 1.82 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.15 1.38 . . . . 0.0 112.68 -168.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -48.51 -35.8 13.92 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.731 2.013 . . . . 0.0 113.259 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -88.49 -6.99 57.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.592 1.157 . . . . 0.0 113.755 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.78 161.58 27.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.044 0.938 . . . . 0.0 112.023 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.16 139.11 57.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 112.234 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.5 -53.1 59.78 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.841 . . . . 0.0 112.844 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -71.96 -32.67 67.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.693 -1.254 . . . . 0.0 112.853 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -64.98 -27.38 68.8 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.106 -0.996 . . . . 0.0 112.383 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -70.31 -37.37 74.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.504 1.047 . . . . 0.0 113.041 171.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.97 -38.24 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.771 1.169 . . . . 0.0 111.327 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -61.02 -48.33 82.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.055 0.942 . . . . 0.0 111.509 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.02 98.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.981 1.277 . . . . 0.0 113.649 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.8 -36.47 67.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.757 1.278 . . . . 0.0 112.651 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -60.62 -39.97 90.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.562 1.073 . . . . 0.0 111.631 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.04 -44.51 96.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.463 1.105 . . . . 0.0 111.931 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -26.45 68.59 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.962 -1.086 . . . . 0.0 112.352 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.251 10.1 mt -84.44 -43.08 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.892 1.277 . . . . 0.0 112.564 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -106.31 -61.46 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.286 1.434 . . . . 0.0 113.514 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -64.4 -25.71 68.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.907 1.683 . . . . 0.0 113.78 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.77 -24.66 67.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.508 1.123 . . . . 0.0 113.907 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 C--O 1.253 1.273 0 C-N-CA 127.734 2.413 . . . . 0.0 114.147 177.572 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.405 0.145 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.83 -29.85 26.97 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -111.77 24.92 12.16 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -139.18 -151.48 0.38 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.7 1.2 . . . . 0.0 112.251 177.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -52.17 -20.01 2.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.686 2.394 . . . . 0.0 116.301 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 61.75 -23.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 61.49 -19.83 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.957 2.503 . . . . 0.0 117.554 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.41 -26.13 68.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.681 1.192 . . . . 0.0 112.331 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.38 -12.48 59.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.005 1.722 . . . . 0.0 113.921 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt 42.01 68.2 0.49 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 128.001 2.52 . . . . 0.0 113.289 -170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.28 58.69 0.69 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 126.237 1.815 . . . . 0.0 112.727 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.48 166.99 15.92 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.652 2.901 . . . . 0.0 114.175 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 m -55.39 -24.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.887 1.675 . . . . 0.0 114.242 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.98 -10.39 53.29 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.3 p -121.85 -29.74 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -86.94 172.36 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.4 p -92.67 160.91 14.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -24.0 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.38 -37.54 70.23 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.853 -1.155 . . . . 0.0 111.505 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.14 -28.43 69.64 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.981 0.912 . . . . 0.0 112.973 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.27 -27.16 69.15 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.113 -0.992 . . . . 0.0 111.152 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.2 mt -84.49 -10.71 57.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.802 1.241 . . . . 0.0 113.104 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.96 -29.38 22.09 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.959 1.303 . . . . 0.0 112.371 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.4 140.05 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.998 1.719 . . . . 0.0 110.242 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.6 159.39 32.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.271 1.029 . . . . 0.0 113.067 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.93 -33.89 71.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.086 1.354 . . . . 0.0 111.951 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m -66.18 -21.18 66.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.666 1.587 . . . . 0.0 114.007 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -126.73 -8.85 6.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.39 1.076 . . . . 0.0 113.308 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.81 -43.31 99.32 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 120.06 -1.65 . . . . 0.0 112.536 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.65 -25.0 61.99 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.688 2.259 . . . . 0.0 113.151 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.685 HG22 HD21 ' A' ' 50' ' ' LEU . 18.4 m -72.96 -32.37 65.17 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 111.218 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.77 89.42 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 170.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.98 -33.73 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.683 1.583 . . . . 0.0 110.043 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.76 7.6 2.12 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 126.57 2.033 . . . . 0.0 116.008 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 2.4 m-85 -121.48 -12.32 8.58 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.58 1.69 . . . . 0.0 112.852 169.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.17 -69.24 0.76 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.452 1.023 . . . . 0.0 110.77 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.74 -32.33 72.86 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.895 -1.128 . . . . 0.0 111.492 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.58 -35.88 68.72 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.472 1.109 . . . . 0.0 113.169 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -83.96 -42.56 16.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.186 0.994 . . . . 0.0 109.319 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.04 -39.3 74.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 0.0 113.834 -173.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -92.44 -8.28 45.17 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -9.6 0.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -171.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.326 3.8 p30 55.28 -34.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 121.437 3.866 . . . . 0.0 121.437 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -137.6 153.76 74.49 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 126.941 2.096 . . . . 0.0 110.648 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.84 -1.12 8.78 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 121.685 1.637 . . . . 0.0 114.67 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.29 -13.49 60.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.779 1.232 . . . . 0.0 112.87 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -127.78 8.25 6.29 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.133 1.373 . . . . 0.0 113.93 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.0 130.52 36.6 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.304 -1.497 . . . . 0.0 114.51 -170.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 20.6 t -117.28 135.35 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.759 2.024 . . . . 0.0 106.852 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 31' ' ' THR . 2.3 tm? -75.7 127.26 32.66 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.503 1.047 . . . . 0.0 111.446 -169.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -89.75 52.56 2.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.532 1.533 . . . . 0.0 111.939 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.378 1.7 p -67.29 -44.69 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -64.32 -36.94 85.75 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 123.075 2.671 . . . . 0.0 111.164 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.49 -47.34 88.11 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.642 HD13 HG21 ' A' ' 31' ' ' THR . 22.9 mt -56.46 -48.62 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.295 1.438 . . . . 0.0 111.618 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.6 81.45 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.531 1.059 . . . . 0.0 112.22 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 52.1 m -67.05 -42.29 85.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.937 1.295 . . . . 0.0 111.811 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.99 -24.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.498 1.519 . . . . 0.0 113.04 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -43.71 -61.02 2.14 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 126.748 2.019 . . . . 0.0 113.588 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.24 -14.16 43.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.537 2.158 . . . . 0.0 113.638 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -74.86 -56.37 4.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.105 0.962 . . . . 0.0 111.416 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -25.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.925 -1.109 . . . . 0.0 113.436 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.1 t -57.62 -51.36 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.824 0.85 . . . . 0.0 110.265 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 -46.86 34.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.429 0.692 . . . . 0.0 111.151 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.62 69.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.608 -1.308 . . . . 0.0 113.152 -171.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.3 m -77.09 -11.31 59.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.48 -31.63 18.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.074 1.306 . . . . 0.0 111.192 167.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -59.34 -38.73 81.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.199 1.0 . . . . 0.0 112.47 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -145.17 85.54 1.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.718 0.77 . . . . 0.0 112.095 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -62.53 -39.32 93.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.463 1.505 . . . . 0.0 112.406 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.89 -10.2 59.74 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.23 141.93 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.784 0.834 . . . . 0.0 112.828 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.1 40.39 0.98 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.392 2.277 . . . . 0.0 111.298 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -106.81 117.75 34.87 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -163.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -76.84 -26.42 54.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.015 1.326 . . . . 0.0 109.428 162.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.91 -23.16 63.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.376 1.471 . . . . 0.0 112.707 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -63.08 -40.32 97.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.779 0.832 . . . . 0.0 111.809 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -39.93 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.812 0.845 . . . . 0.0 110.69 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -65.41 -38.78 90.96 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.672 0.789 . . . . 0.0 112.112 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.95 99.75 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.986 1.279 . . . . 0.0 112.783 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' GLU . . . . . 0.453 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 25.7 mm-40 -71.35 -36.1 71.38 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.688 1.244 . . . . 0.0 113.075 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.93 -42.08 93.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.736 1.153 . . . . 0.0 111.594 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -49.63 76.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.088 1.355 . . . . 0.0 110.937 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -27.53 68.92 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.731 -1.231 . . . . 0.0 112.072 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -80.23 -47.41 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.957 1.703 . . . . 0.0 113.027 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -100.46 -55.53 2.58 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.749 1.22 . . . . 0.0 112.932 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -70.24 -34.38 72.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.108 1.363 . . . . 0.0 111.547 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.62 46.69 25.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.348 2.259 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 C--O 1.255 1.379 0 C-N-CA 125.513 1.525 . . . . 0.0 113.137 179.085 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -109.77 -26.16 9.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.27 -64.19 1.19 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -170.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -102.14 -55.35 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.697 0.68 . . . . 0.0 111.539 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -91.34 63.22 4.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.85 1.66 . . . . 0.0 108.707 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.58 -18.31 60.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.773 2.029 . . . . 0.0 115.3 -168.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.55 -3.46 55.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 56.22 18.91 3.54 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.636 1.575 . . . . 0.0 113.936 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -163.62 -146.8 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.781 2.432 . . . . 0.0 107.523 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt 66.3 -43.83 0.4 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 129.099 2.96 . . . . 0.0 118.425 168.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -121.12 53.99 3.84 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.055 1.342 . . . . 0.0 112.632 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.09 157.99 30.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.697 2.931 . . . . 0.0 112.795 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -65.97 -15.68 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.814 1.245 . . . . 0.0 113.241 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -93.86 10.75 31.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.182 1.793 . . . . 0.0 113.176 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -151.04 -42.07 0.12 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -83.97 148.8 26.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.34 1.066 . . . . 0.0 113.561 -169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.6 p -77.75 172.79 12.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.967 1.707 . . . . 0.0 113.653 -168.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -18.46 8.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.824 1.786 . . . . 0.0 115.824 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.4 -39.1 78.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.273 1.397 . . . . 0.0 110.751 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.55 -22.88 66.15 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.01 -1.057 . . . . 0.0 112.968 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.38 -1.87 32.21 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.699 -0.626 . . . . 0.0 112.507 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.4 mt -110.93 -24.7 10.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.546 1.539 . . . . 0.0 112.615 168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.66 67.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.128 0.971 . . . . 0.0 112.15 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.76 141.6 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.522 1.929 . . . . 0.0 110.655 169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.55 157.51 32.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.489 0.715 . . . . 0.0 112.555 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -54.61 -34.28 61.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.101 1.361 . . . . 0.0 111.981 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 m -64.48 -23.14 67.18 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -125.79 -4.1 7.07 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.738 1.215 . . . . 0.0 112.895 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -60.88 -43.85 92.87 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 119.568 -1.957 . . . . 0.0 112.591 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.05 -18.08 60.9 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.495 2.13 . . . . 0.0 113.241 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -78.82 -34.4 45.3 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.678 1.191 . . . . 0.0 111.653 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -62.99 -41.81 99.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.193 . . . . 0.0 111.852 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.14 -47.37 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.975 0.91 . . . . 0.0 108.898 169.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.56 -49.49 60.78 Favored Glycine 0 C--O 1.209 -1.428 0 C-N-CA 124.996 1.284 . . . . 0.0 113.582 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -69.42 -11.82 61.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 122.109 2.955 . . . . 0.0 114.205 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.28 -49.88 5.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.582 0.753 . . . . 0.0 110.505 166.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -73.34 -30.67 63.49 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.23 -0.919 . . . . 0.0 113.049 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.54 89.15 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 119.497 -2.002 . . . . 0.0 111.479 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.544 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -84.14 -13.69 52.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.026 1.33 . . . . 0.0 111.652 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 -22.28 60.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.003 1.321 . . . . 0.0 113.012 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 -2.68 13.2 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.84 158.57 0.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.978 3.311 . . . . 0.0 106.399 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.89 -27.91 16.81 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 128.091 2.556 . . . . 0.0 114.249 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.42 156.41 79.74 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 126.701 2.001 . . . . 0.0 110.964 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.94 6.83 5.51 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.054 1.836 . . . . 0.0 114.529 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.08 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.688 -1.258 . . . . 0.0 111.936 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.24 2.36 28.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.227 1.811 . . . . 0.0 113.168 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.74 123.46 27.71 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 119.765 -1.835 . . . . 0.0 112.45 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.48 -2.85 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 125.455 1.502 . . . . 0.0 111.972 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.724 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 61.78 119.08 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.403 3.081 . . . . 0.0 112.752 -172.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -93.1 55.43 2.33 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.224 -1.547 . . . . 0.0 112.095 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.322 2.5 p -69.54 -22.02 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.711 -1.243 . . . . 0.0 113.827 -169.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -58.02 -45.74 86.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.928 1.24 . . . . 0.0 111.21 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.46 -49.87 8.8 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.16 -44.43 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.893 0.877 . . . . 0.0 111.81 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.0 66.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.511 1.505 . . . . 0.0 112.773 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -70.99 -37.48 72.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.873 1.269 . . . . 0.0 111.586 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.4 t -90.4 -21.7 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.405 1.482 . . . . 0.0 113.417 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.4 m -46.86 -59.72 4.85 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 125.998 1.719 . . . . 0.0 112.819 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.97 0.52 4.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.157 2.572 . . . . 0.0 114.206 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -88.74 -64.31 1.17 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.389 1.476 . . . . 0.0 110.441 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.29 -29.31 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.907 -1.121 . . . . 0.0 113.2 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.32 -47.33 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.693 0.797 . . . . 0.0 110.459 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.13 -47.34 20.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.435 0.636 . . . . 0.0 110.866 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.99 71.45 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.2 m -76.01 -13.62 60.23 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.205 -0.935 . . . . 0.0 113.48 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.3 -29.05 21.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.849 1.204 . . . . 0.0 111.282 168.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.4 -38.29 80.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.453 0.701 . . . . 0.0 111.993 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.35 90.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 112.429 170.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -55.81 -36.02 66.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.145 1.378 . . . . 0.0 111.367 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -86.99 3.58 45.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.085 1.354 . . . . 0.0 113.375 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.92 151.5 21.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.983 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -59.37 139.25 57.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.788 1.235 . . . . 0.0 111.472 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -56.07 145.14 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.054 1.342 . . . . 0.0 113.401 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 59.06 -24.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.974 2.91 . . . . 0.0 116.916 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.78 -31.13 70.51 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.875 1.67 . . . . 0.0 111.627 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -68.7 -37.03 79.21 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.76 -47.15 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.41 1.084 . . . . 0.0 109.833 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.45 -42.6 98.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.868 0.867 . . . . 0.0 112.358 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.81 -45.62 95.34 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.216 1.389 . . . . 0.0 113.257 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 25.7 mm-40 -72.11 -35.52 69.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.461 1.131 . . . . 0.0 113.16 174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -59.84 -40.55 88.89 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.018 -1.051 . . . . 0.0 111.429 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.78 -45.1 95.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.72 1.208 . . . . 0.0 111.743 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -24.59 67.93 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.135 -0.978 . . . . 0.0 112.623 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.258 5.5 mt -89.33 -42.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.111 1.364 . . . . 0.0 112.729 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -106.37 -59.87 1.73 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.463 1.505 . . . . 0.0 113.084 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -66.22 -24.12 66.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.842 1.657 . . . . 0.0 113.762 -170.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.23 -23.22 66.54 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.312 1.445 . . . . 0.0 113.457 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 174.716 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 119.944 -0.074 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.0 60.84 1.61 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.756 0.822 . . . . 0.0 112.973 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.28 53.28 12.65 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.15 -24.31 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -95.68 21.5 8.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.085 1.754 . . . . 0.0 114.814 -177.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.24 64.0 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.53 63.13 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 60.01 -13.61 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 129.474 3.109 . . . . 0.0 117.051 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -122.36 -11.8 8.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.735 1.614 . . . . 0.0 113.622 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -146.55 -167.02 2.64 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 57.93 34.48 0.23 Allowed Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 128.455 2.702 . . . . 0.0 114.321 -167.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.56 159.25 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.061 1.841 . . . . 0.0 112.534 -169.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.26 -25.95 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 125.621 1.568 . . . . 0.0 114.75 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -79.11 -16.76 56.24 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 18.1 m -128.28 -22.29 3.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -86.95 166.26 15.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.447 1.099 . . . . 0.0 112.598 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 51.5 p -96.46 158.6 15.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.2 -24.56 67.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.32 1.448 . . . . 0.0 114.437 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.66 -37.78 73.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.812 1.187 . . . . 0.0 111.213 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.12 -30.56 71.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.268 1.027 . . . . 0.0 112.786 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -67.02 -23.73 65.94 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.175 -0.953 . . . . 0.0 111.67 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 49.6 mt -80.71 -15.77 55.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.504 1.122 . . . . 0.0 113.178 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.06 -28.85 43.2 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.121 0.968 . . . . 0.0 112.172 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.68 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.916 1.686 . . . . 0.0 110.191 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.39 158.62 33.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.0 112.856 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -53.88 -34.17 58.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.098 1.359 . . . . 0.0 112.368 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 33.5 m -65.95 -22.36 66.48 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.699 1.199 . . . . 0.0 114.107 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.08 -8.16 5.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.556 1.142 . . . . 0.0 113.509 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -57.77 -44.57 99.53 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 119.785 -1.822 . . . . 0.0 112.2 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.29 -27.43 77.99 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.693 2.262 . . . . 0.0 113.254 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.724 HG22 HD21 ' A' ' 50' ' ' LEU . 65.5 m -72.87 -38.92 66.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 0.0 110.962 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.4 94.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.334 1.453 . . . . 0.0 114.147 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.83 -32.69 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 119.432 1.014 . . . . 0.0 110.75 169.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.48 -55.11 21.31 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 125.301 1.429 . . . . 0.0 113.667 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.86 -35.73 79.14 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.561 2.181 . . . . 0.0 112.178 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.92 65.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -104.95 -31.44 9.23 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.1 99.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.34 1.456 . . . . 0.0 111.319 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.544 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -76.86 -32.02 57.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.942 0.897 . . . . 0.0 110.93 -178.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -65.12 -27.51 68.8 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -98.01 -8.61 27.55 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 -132.62 0.07 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.961 1.705 . . . . 0.0 110.478 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -156.79 -55.75 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.268 2.227 . . . . 0.0 112.276 -173.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -120.21 168.09 11.2 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 127.179 2.192 . . . . 0.0 110.194 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.78 10.37 3.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.108 1.872 . . . . 0.0 114.308 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 -25.92 67.22 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.782 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -118.5 25.18 10.45 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.734 2.014 . . . . 0.0 113.366 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.96 34.88 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.586 -1.322 . . . . 0.0 112.702 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.96 -13.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.284 1.034 . . . . 0.0 113.52 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 65.6 107.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.48 2.312 . . . . 0.0 110.648 -168.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.68 62.96 7.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.734 -1.229 . . . . 0.0 110.804 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.35 1.6 p -66.69 -25.14 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.148 -0.929 . . . . 0.0 113.334 -168.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.28 -50.75 72.49 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.807 1.64 . . . . 0.0 111.6 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.54 80.09 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mt -62.86 -45.26 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.049 0.94 . . . . 0.0 112.036 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.48 -32.34 72.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 120.628 1.558 . . . . 0.0 112.475 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 42.8 m -64.55 -44.21 91.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.832 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 28.5 t -82.67 -29.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.953 1.301 . . . . 0.0 113.161 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.7 m -41.04 -62.51 1.0 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 126.532 1.933 . . . . 0.0 114.018 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.99 -22.47 73.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.18 1.92 . . . . 0.0 112.931 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.57 -58.03 4.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.4 1.08 . . . . 0.0 111.33 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.485 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.07 -24.58 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.086 -1.009 . . . . 0.0 112.895 174.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.11 -52.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.466 1.03 . . . . 0.0 110.629 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -72.16 -47.16 52.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.586 0.232 . . . . 0.0 111.131 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.19 72.2 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.666 -1.271 . . . . 0.0 113.316 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.6 -13.44 61.38 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.66 16.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.247 1.385 . . . . 0.0 111.212 167.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.56 -43.15 97.58 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.26 0.624 . . . . 0.0 111.657 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -134.96 63.93 1.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.529 1.531 . . . . 0.0 111.093 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -51.34 -32.88 27.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.611 -1.305 . . . . 0.0 112.452 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -87.74 -3.12 58.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.099 1.36 . . . . 0.0 113.562 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 155.06 39.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.074 0.95 . . . . 0.0 111.599 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -66.84 135.55 54.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.565 1.146 . . . . 0.0 109.64 169.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.79 -51.7 60.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -67.81 -29.28 68.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.47 1.486 . . . . 0.0 112.521 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.58 -37.37 83.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.643 -0.661 . . . . 0.0 111.739 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -71.87 -35.34 69.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.477 -0.764 . . . . 0.0 112.914 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.15 -46.46 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.455 1.025 . . . . 0.0 109.926 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -65.44 -43.55 90.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.282 1.033 . . . . 0.0 112.475 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.17 -41.07 99.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.299 0.952 . . . . 0.0 113.246 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.71 -34.18 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.234 -1.156 . . . . 0.0 112.654 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -58.12 -41.98 84.8 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.753 1.615 . . . . 0.0 111.919 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.08 -50.79 72.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.862 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -29.15 70.6 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.896 -1.128 . . . . 0.0 112.256 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 30.7 mt -76.37 -49.5 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.229 1.811 . . . . 0.0 112.448 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.99 -55.76 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.132 1.373 . . . . 0.0 112.769 -170.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -69.92 -35.16 74.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.772 1.229 . . . . 0.0 111.431 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.62 47.73 23.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.863 2.065 . . . . 0.0 113.147 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 35.6 mmt . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.636 1.574 . . . . 0.0 112.88 176.66 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 111.306 0.113 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -140.85 55.57 1.57 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.49 38.46 29.75 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -58.42 -24.31 59.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -78.51 -9.3 59.28 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.6 -21.59 66.44 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.31 65.72 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.2 t70 57.55 -10.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 129.056 2.942 . . . . 0.0 117.571 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.54 -10.47 6.24 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.048 1.339 . . . . 0.0 114.596 -169.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 170.07 18.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -173.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 29.7 ttpt 51.15 46.18 3.45 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 129.614 3.166 . . . . 0.0 115.482 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.44 168.87 15.25 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 112.435 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.17 -17.72 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -71.74 -29.92 65.04 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 112.396 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 -32.47 9.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 114.008 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.44 148.68 50.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.159 0.98 . . . . 0.0 111.526 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.6 p -97.31 167.44 11.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.028 1.394 . . . . 0.0 114.167 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.4 m -66.06 -24.21 66.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.948 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.88 -44.82 91.89 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.65 1.114 . . . . 0.0 110.249 169.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.79 -29.43 69.43 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.919 -0.488 . . . . 0.0 111.601 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -72.32 -11.88 60.9 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.983 -1.073 . . . . 0.0 113.336 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.54 -2.19 45.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.253 1.021 . . . . 0.0 112.48 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.81 -34.08 17.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.725 1.21 . . . . 0.0 112.352 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.35 138.84 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.31 1.844 . . . . 0.0 111.136 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.4 156.27 39.09 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 113.062 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.52 -35.03 38.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.834 1.254 . . . . 0.0 112.817 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 t -65.6 -26.37 67.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.369 1.068 . . . . 0.0 113.432 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -123.14 -0.66 8.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.228 1.411 . . . . 0.0 113.312 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -59.18 -46.42 99.26 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 119.574 -1.954 . . . . 0.0 111.424 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.35 -17.77 55.11 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.427 2.085 . . . . 0.0 114.412 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.522 HG22 HD21 ' B' ' 139' ' ' LEU . 37.6 m -67.71 -40.31 84.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 110.527 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.55 75.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.448 1.099 . . . . 0.0 113.866 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.55 -34.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.753 0.706 . . . . 0.0 109.989 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -57.89 15.11 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.644 -1.087 . . . . 0.0 112.919 168.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.73 -43.47 98.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.367 2.084 . . . . 0.0 112.411 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.7 -26.71 66.31 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -98.49 -35.75 10.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 113.159 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.02 71.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.041 1.336 . . . . 0.0 111.745 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.35 -24.88 61.35 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.884 -0.51 . . . . 0.0 110.954 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -24.42 57.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.73 0.812 . . . . 0.0 112.898 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.96 -7.17 25.49 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.77 -130.62 0.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.13 1.772 . . . . 0.0 110.342 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.61 -44.06 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.232 2.213 . . . . 0.0 112.245 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -123.62 164.95 25.46 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 127.966 2.507 . . . . 0.0 110.148 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.33 13.02 2.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.324 2.016 . . . . 0.0 114.185 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.98 -27.43 66.84 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.806 -1.184 . . . . 0.0 112.926 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.73 18.56 14.86 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.268 1.427 . . . . 0.0 114.196 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 129.7 40.62 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.851 -1.156 . . . . 0.0 112.607 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.52 -11.67 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.775 1.23 . . . . 0.0 113.271 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 62.77 114.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.787 2.435 . . . . 0.0 110.555 -167.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -82.85 51.87 2.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.403 -1.435 . . . . 0.0 110.74 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.422 2.7 p -69.04 -28.37 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.12 -39.37 82.08 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.332 1.878 . . . . 0.0 111.389 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.2 -51.24 10.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.369 0.985 . . . . 0.0 112.102 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -40.36 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.179 0.992 . . . . 0.0 111.987 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.43 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.19 1.359 . . . . 0.0 112.652 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -68.27 -40.98 81.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.751 1.22 . . . . 0.0 111.492 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 62' ' ' ILE . 36.7 t -81.66 -31.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.202 1.401 . . . . 0.0 113.617 -176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -41.78 -59.92 2.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 125.798 1.639 . . . . 0.0 114.47 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.42 -24.23 75.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.96 1.773 . . . . 0.0 113.204 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -61.29 -61.56 2.46 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.426 1.49 . . . . 0.0 110.571 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.67 -31.95 53.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 t -59.47 -51.85 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.805 1.242 . . . . 0.0 110.466 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.08 -49.96 45.77 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.066 0.46 . . . . 0.0 110.872 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.86 70.24 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.829 0.852 . . . . 0.0 112.727 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.9 m -72.9 -17.05 61.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -30.34 20.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.677 1.191 . . . . 0.0 111.233 168.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -64.0 -38.26 90.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.126 0.97 . . . . 0.0 112.405 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -145.3 85.09 1.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.818 1.247 . . . . 0.0 111.574 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.76 -39.78 71.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.223 1.409 . . . . 0.0 112.209 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.11 -11.99 59.99 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.22 152.5 44.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.005 0.922 . . . . 0.0 112.162 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -73.35 144.81 46.35 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.8 -44.32 90.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -67.11 -32.02 72.88 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.783 -1.198 . . . . 0.0 113.011 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.48 -40.42 86.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.969 0.908 . . . . 0.0 111.152 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.747 -1.12 . . . . 0.0 112.888 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -41.4 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.607 1.549 . . . . 0.0 111.334 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -64.21 -48.48 75.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.719 0.808 . . . . 0.0 111.676 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.41 99.72 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.36 0.981 . . . . 0.0 113.099 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.492 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 26.0 mm-40 -74.26 -35.63 63.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.605 1.202 . . . . 0.0 113.196 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -59.56 -40.21 86.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.005 1.275 . . . . 0.0 111.486 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.47 -45.51 93.94 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.21 1.004 . . . . 0.0 111.742 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -23.5 67.34 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.969 -1.082 . . . . 0.0 112.655 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -88.42 -40.15 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.841 1.256 . . . . 0.0 113.065 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.41 -57.9 2.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.486 1.514 . . . . 0.0 113.728 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -68.47 -29.24 67.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.693 1.597 . . . . 0.0 113.467 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.73 -52.01 14.63 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.091 1.756 . . . . 0.0 111.491 178.964 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -106.37 -40.86 5.47 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 162.01 29.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.755 0.822 . . . . 0.0 111.418 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.33 0.0 OUTLIER 46.05 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 131.017 3.727 . . . . 0.0 119.66 -170.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -85.03 -13.6 49.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.306 1.842 . . . . 0.0 112.37 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 53.7 -51.27 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 1 C-N-CA 132.365 4.266 . . . . 0.0 117.908 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.439 ' HB3' ' HG2' ' B' ' 99' ' ' LYS . . . -125.02 24.94 7.42 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.661 1.584 . . . . 0.0 112.153 171.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 31.3 t70 70.86 -18.38 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.182 2.593 . . . . 0.0 114.673 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.8 5.32 8.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.634 1.573 . . . . 0.0 115.173 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' B' ' 96' ' ' ALA . 75.1 mmtt -91.38 144.83 25.18 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.091 1.314 . . . . 0.0 112.799 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 50.85 53.68 14.26 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 126.972 2.109 . . . . 0.0 114.223 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.89 165.4 26.15 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.984 2.456 . . . . 0.0 111.921 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 m -66.01 -4.82 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.668 1.587 . . . . 0.0 114.558 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -112.93 21.37 15.51 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.234 1.813 . . . . 0.0 112.934 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -143.82 -49.48 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -93.71 147.08 23.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.922 0.783 . . . . 0.0 112.207 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p -70.92 173.36 7.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.368 1.867 . . . . 0.0 113.965 -171.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -49.91 -20.56 0.93 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.66 -40.27 39.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.62 -30.63 69.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.144 0.978 . . . . 0.0 112.619 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -70.96 -17.65 62.66 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.511 -0.743 . . . . 0.0 111.967 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.92 -18.49 23.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.188 0.995 . . . . 0.0 112.911 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.85 62.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.278 1.031 . . . . 0.0 112.436 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.72 138.9 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.814 2.046 . . . . 0.0 111.119 171.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.67 159.13 32.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.477 1.111 . . . . 0.0 113.223 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.09 -33.64 58.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.353 1.461 . . . . 0.0 111.809 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.0 m -59.17 -27.46 65.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.114 1.765 . . . . 0.0 113.817 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.58 -3.95 5.99 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.392 1.477 . . . . 0.0 113.307 -171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -56.96 -44.85 99.94 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.241 -1.537 . . . . 0.0 112.528 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.41 -18.34 59.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.595 2.197 . . . . 0.0 114.007 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 40.6 m -81.43 -31.86 32.91 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.789 1.236 . . . . 0.0 111.449 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.1 97.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.521 1.055 . . . . 0.0 110.902 167.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.55 -47.0 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.084 0.954 . . . . 0.0 109.191 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.88 12.64 1.03 Allowed Glycine 0 CA--C 1.544 1.891 0 C-N-CA 126.798 2.142 . . . . 0.0 117.353 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.39 -14.18 7.46 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.609 1.563 . . . . 0.0 112.98 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.67 -72.6 0.62 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.84 0.856 . . . . 0.0 110.086 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -72.69 -20.44 61.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.042 -1.036 . . . . 0.0 112.61 -170.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.29 -42.42 70.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.427 1.091 . . . . 0.0 112.843 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -47.02 13.88 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.701 0.801 . . . . 0.0 109.541 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -6.9 57.79 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.93 -15.2 52.28 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.237 0.926 . . . . 0.0 113.205 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -150.92 -129.97 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.757 1.623 . . . . 0.0 110.861 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -156.41 -61.38 0.1 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.872 1.669 . . . . 0.0 113.104 -169.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.42 161.13 65.02 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.956 2.102 . . . . 0.0 110.705 -172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -86.49 10.41 3.64 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.705 2.27 . . . . 0.0 113.789 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.02 -27.74 63.9 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.876 -1.14 . . . . 0.0 112.052 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.79 -9.28 11.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.241 1.416 . . . . 0.0 114.158 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.35 136.19 47.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.958 -1.088 . . . . 0.0 111.949 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.68 8.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.987 1.715 . . . . 0.0 112.888 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 31' ' ' THR . 1.8 tm? 58.67 113.79 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 129.564 3.146 . . . . 0.0 111.344 -169.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.37 51.62 2.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.717 1.607 . . . . 0.0 111.506 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 0.4 OUTLIER -68.52 -31.7 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -164.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -64.61 -42.04 95.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.401 1.001 . . . . 0.0 111.575 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.29 -44.22 60.27 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mt -58.86 -48.22 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.278 1.031 . . . . 0.0 111.471 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.25 73.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.237 0.926 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 47.0 m -67.71 -43.86 79.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.455 1.102 . . . . 0.0 112.2 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' B' ' 151' ' ' ILE . 16.9 t -80.52 -30.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.886 1.674 . . . . 0.0 113.353 -177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -39.97 -62.08 0.96 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.026 1.73 . . . . 0.0 113.783 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.19 -13.56 38.64 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.729 2.286 . . . . 0.0 114.176 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.97 -64.87 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.048 0.939 . . . . 0.0 111.081 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.55 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.92 -25.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.766 -1.209 . . . . 0.0 113.379 -178.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.8 -49.71 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.263 1.025 . . . . 0.0 110.586 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.78 -44.99 22.0 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 111.464 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.59 -30.41 70.01 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.592 -1.318 . . . . 0.0 112.833 -169.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.4 m -72.44 -13.09 61.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 169.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -35.1 16.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.493 1.497 . . . . 0.0 111.15 167.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -59.29 -39.05 81.76 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 112.071 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -142.47 79.88 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.816 0.847 . . . . 0.0 111.676 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -55.5 -29.18 58.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.94 1.79 55.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.549 1.54 . . . . 0.0 113.116 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 155.55 37.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.647 1.179 . . . . 0.0 113.306 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.07 57.1 2.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.307 1.843 . . . . 0.0 113.374 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 p90 44.62 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.866 2.066 . . . . 0.0 116.005 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -67.43 -26.53 66.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 0.0 112.239 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.9 -36.56 77.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.153 0.981 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -72.33 -40.48 67.4 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 118.477 -0.773 . . . . 0.0 112.774 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.81 -42.46 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.326 0.966 . . . . 0.0 110.565 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -69.42 -46.99 65.5 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.924 1.29 . . . . 0.0 112.526 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.15 98.49 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.861 0.743 . . . . 0.0 113.129 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.52 -27.16 63.96 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.344 -1.092 . . . . 0.0 113.215 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -67.95 -41.0 83.14 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.081 -1.012 . . . . 0.0 111.1 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.56 -41.29 98.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.446 0.698 . . . . 0.0 111.411 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.63 -38.43 6.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 113.151 168.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.94 -39.58 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 112.286 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -95.36 -54.49 3.38 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -77.86 -32.69 52.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.737 1.615 . . . . 0.0 112.892 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.0 t0 46.76 48.34 14.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.16 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--O 1.256 1.398 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 179.724 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.92 102.26 2.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.197 0.999 . . . . 0.0 111.853 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.24 44.77 19.92 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.36 -20.15 65.93 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.84 36.98 4.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.137 2.175 . . . . 0.0 112.558 -170.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -23.59 60.97 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.03 -14.1 61.35 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 63.27 -32.52 0.11 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 129.896 3.279 . . . . 0.0 117.636 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -94.99 3.4 54.98 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.03 1.332 . . . . 0.0 113.98 174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -100.67 170.09 8.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.815 2.046 . . . . 0.0 112.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 52.88 41.31 0.94 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 127.86 2.464 . . . . 0.0 116.976 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -66.39 149.89 84.61 Favored 'Trans proline' 0 C--N 1.351 0.694 0 CA-C-N 121.394 1.534 . . . . 0.0 112.057 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -19.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -78.99 -13.95 59.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.682 1.193 . . . . 0.0 114.084 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 m -131.5 -26.91 2.0 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -169.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.24 156.27 39.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.193 0.906 . . . . 0.0 112.681 -177.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.0 p -92.63 157.9 16.25 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.369 1.081 . . . . 0.0 113.62 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.33 -22.85 65.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.28 -39.69 87.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.949 -1.094 . . . . 0.0 111.203 173.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.02 -25.5 62.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 118.722 -0.656 . . . . 0.0 112.593 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.61 -30.6 70.23 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.6 1.545 . . . . 0.0 111.304 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.34 -13.21 60.15 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 171.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.45 -28.39 52.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.32 136.11 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.933 1.693 . . . . 0.0 110.534 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.03 159.99 31.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 113.189 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -33.73 72.22 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.769 -1.207 . . . . 0.0 111.849 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.8 m -61.93 -23.58 66.44 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 114.164 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.97 -7.38 6.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.84 1.256 . . . . 0.0 113.317 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -57.99 -41.96 92.65 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 119.498 -2.001 . . . . 0.0 112.544 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -64.93 -17.96 60.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.665 2.243 . . . . 0.0 114.109 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 HD21 ' B' ' 139' ' ' LEU . 47.5 m -76.71 -38.26 54.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.924 1.29 . . . . 0.0 111.148 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.31 97.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.433 1.093 . . . . 0.0 112.73 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.75 -46.56 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.24 -56.34 13.01 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 125.559 1.552 . . . . 0.0 113.889 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -11.51 59.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 122.072 2.936 . . . . 0.0 113.938 -173.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.55 -47.77 5.81 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.618 1.099 . . . . 0.0 111.995 168.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -76.52 -27.58 56.06 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.959 -1.088 . . . . 0.0 113.566 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.36 -62.94 1.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.854 1.261 . . . . 0.0 110.412 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.592 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -65.77 -18.81 65.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.766 1.226 . . . . 0.0 111.55 -174.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.09 -18.88 58.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.299 1.04 . . . . 0.0 113.671 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.47 9.19 5.52 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.52 148.06 7.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.999 2.92 . . . . 0.0 105.909 171.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.16 -44.11 8.52 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.5 2.32 . . . . 0.0 115.195 -166.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.33 160.13 58.43 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 127.375 2.27 . . . . 0.0 109.622 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.26 16.58 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 121.25 1.482 . . . . 0.0 114.126 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.58 -22.45 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.341 1.456 . . . . 0.0 112.841 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -128.37 -0.9 5.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.515 1.526 . . . . 0.0 114.195 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.84 146.18 53.08 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' B' ' 101' ' ' PRO . 2.7 p -126.34 151.21 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.873 1.669 . . . . 0.0 110.491 168.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.732 HD21 HG22 ' B' ' 120' ' ' THR . 2.8 tm? -75.38 124.49 27.21 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.461 1.105 . . . . 0.0 109.687 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -89.28 46.66 1.4 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.772 1.229 . . . . 0.0 112.493 -168.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.37 2.7 p -64.49 -27.86 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -60.45 -41.56 94.34 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.084 1.765 . . . . 0.0 111.708 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.36 -49.29 9.48 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.4 mt -57.11 -46.21 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.527 1.131 . . . . 0.0 111.525 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.76 68.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.841 1.201 . . . . 0.0 112.681 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -68.99 -39.89 79.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.868 1.267 . . . . 0.0 111.551 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 62' ' ' ILE . 55.8 t -87.43 -27.03 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.132 1.373 . . . . 0.0 113.334 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 m -41.77 -61.39 1.49 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.318 1.847 . . . . 0.0 113.928 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.91 -21.87 73.45 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.349 2.032 . . . . 0.0 113.093 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -67.14 -61.54 1.87 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.78 1.632 . . . . 0.0 110.424 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.458 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.09 -28.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.696 176.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -57.57 -46.84 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -74.73 -50.42 17.49 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.438 0.637 . . . . 0.0 111.168 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.01 71.16 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.53 -15.12 61.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.05 -33.48 17.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.224 1.374 . . . . 0.0 111.526 168.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -61.43 -37.96 85.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.262 1.025 . . . . 0.0 111.897 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -143.42 61.18 1.39 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.951 1.3 . . . . 0.0 113.0 -170.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -54.52 -37.16 65.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.386 1.874 . . . . 0.0 113.022 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.79 -10.04 59.06 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.43 162.65 19.88 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.258 1.023 . . . . 0.0 112.803 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -63.78 136.87 57.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.135 1.374 . . . . 0.0 110.808 173.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.18 -39.67 79.51 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.009 0.924 . . . . 0.0 112.785 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -65.25 -37.67 87.96 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.208 -0.933 . . . . 0.0 112.345 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.24 -39.99 88.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.468 1.107 . . . . 0.0 111.27 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -38.56 80.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.9 -43.67 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.267 0.627 . . . . 0.0 110.618 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -61.94 -45.01 95.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.472 0.709 . . . . 0.0 112.088 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.55 -47.88 87.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.706 1.146 . . . . 0.0 113.159 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 24.8 mm-40 -73.11 -31.43 64.33 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.659 1.23 . . . . 0.0 113.348 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.31 -44.2 95.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.067 1.303 . . . . 0.0 111.081 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.62 -48.79 79.28 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.794 0.837 . . . . 0.0 110.935 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -30.3 70.87 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.885 -1.134 . . . . 0.0 111.728 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.86 -47.86 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.263 1.025 . . . . 0.0 112.234 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -99.92 -59.74 1.66 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.558 1.143 . . . . 0.0 113.107 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -63.43 -44.68 93.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 110.916 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.03 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 130.025 3.33 . . . . 0.0 115.519 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.255 1.352 0 C-N-CA 129.053 2.941 . . . . 0.0 110.379 177.127 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -147.91 128.02 13.73 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.808 0.843 . . . . 0.0 112.741 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.91 25.54 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 167.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.4 -28.4 63.21 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.984 -1.072 . . . . 0.0 113.719 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.56 11.48 18.32 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -169.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.3 80.47 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.007 0.923 . . . . 0.0 111.57 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.0 139.75 22.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.7 2.0 . . . . 0.0 108.294 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -11.04 60.05 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 121.157 -0.964 . . . . 0.0 113.473 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -83.97 5.1 26.86 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -82.44 -66.02 0.94 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -115.48 39.17 0.24 Allowed Pre-proline 0 N--CA 1.491 1.577 0 C-N-CA 125.533 1.533 . . . . 0.0 114.845 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 42.0 Cg_endo -66.16 151.53 83.42 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.442 2.095 . . . . 0.0 115.96 -169.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.91 15.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.344 2.258 . . . . 0.0 114.555 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.425 ' HA ' ' CE2' ' B' ' 163' ' ' PHE . 0.7 OUTLIER -134.1 10.05 3.84 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.812 1.645 . . . . 0.0 113.586 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 13.9 m -141.6 -2.23 1.23 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -170.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -132.91 156.72 46.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.554 1.142 . . . . 0.0 113.243 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 40.3 p -87.2 163.21 17.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.301 1.041 . . . . 0.0 112.046 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.321 0.1 OUTLIER -67.62 -4.25 11.37 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -172.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -35.42 68.67 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.715 -1.241 . . . . 0.0 111.243 168.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.07 -23.74 67.25 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.4 -0.813 . . . . 0.0 112.984 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -67.5 -18.51 65.08 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.074 -1.016 . . . . 0.0 112.219 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.27 -18.62 31.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.094 0.958 . . . . 0.0 112.819 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.32 50.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 112.886 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.75 139.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.939 1.695 . . . . 0.0 110.749 170.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.87 159.35 33.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.459 1.104 . . . . 0.0 113.466 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -52.73 -35.61 56.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.25 1.42 . . . . 0.0 112.303 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -62.73 -22.93 66.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.31 -2.98 6.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.216 1.406 . . . . 0.0 112.909 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -60.18 -47.22 97.31 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 119.625 -1.922 . . . . 0.0 111.706 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.52 -20.19 60.61 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.945 2.43 . . . . 0.0 113.812 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.732 HG22 HD21 ' A' ' 50' ' ' LEU . 94.1 m -75.19 -37.78 61.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.889 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.432 1.093 . . . . 0.0 112.013 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.67 -46.47 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.088 0.955 . . . . 0.0 109.511 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.96 13.42 0.48 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 127.106 2.289 . . . . 0.0 117.081 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.36 -54.1 2.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.843 1.822 . . . . 0.0 110.538 167.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.75 92.5 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.838 -1.164 . . . . 0.0 111.3 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.31 -37.47 52.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.35 94.45 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.728 -1.232 . . . . 0.0 111.58 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.49 -32.29 58.25 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.849 -0.532 . . . . 0.0 111.184 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.24 -29.26 68.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.935 0.789 . . . . 0.0 112.55 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -89.48 -8.12 53.58 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -136.18 -148.01 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.372 1.869 . . . . 0.0 111.493 -168.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -170.36 -48.83 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 130.839 3.655 . . . . 0.0 110.908 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.42 165.83 33.84 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 128.436 2.694 . . . . 0.0 109.518 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.15 7.55 4.93 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 121.917 1.72 . . . . 0.0 115.15 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -64.24 -25.62 68.14 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.836 -1.165 . . . . 0.0 112.592 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.73 8.6 26.91 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.274 1.83 . . . . 0.0 112.476 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.47 125.83 33.34 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 119.888 -1.758 . . . . 0.0 111.927 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.89 134.52 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.103 1.761 . . . . 0.0 106.93 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.763 HD21 HG22 ' A' ' 31' ' ' THR . 1.9 tm? -77.31 107.49 9.76 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.312 0.96 . . . . 0.0 110.349 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -89.57 51.23 2.05 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.36 1.864 . . . . 0.0 111.704 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.269 3.6 p -62.0 -35.98 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -166.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.2 -36.99 78.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.706 2.048 . . . . 0.0 111.856 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.68 -46.96 51.75 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.267 0.46 . . . . 0.0 112.336 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.06 -45.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.579 1.152 . . . . 0.0 111.492 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.87 75.27 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.824 1.25 . . . . 0.0 112.222 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 49.6 m -64.82 -42.53 94.91 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.869 0.868 . . . . 0.0 111.95 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' B' ' 151' ' ' ILE . 24.3 t -83.69 -27.01 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.133 1.373 . . . . 0.0 112.974 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.6 m -42.33 -61.13 1.72 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 126.247 1.819 . . . . 0.0 113.886 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.76 -23.02 75.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.177 1.918 . . . . 0.0 112.93 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.26 -58.11 4.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.211 1.004 . . . . 0.0 111.466 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.453 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -68.18 -24.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.638 1.108 . . . . 0.0 113.016 175.004 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 11.8 t -62.76 -50.74 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.712 1.142 . . . . 0.0 110.674 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.11 -43.63 42.32 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.152 -0.343 . . . . 0.0 111.667 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.53 81.42 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 120.956 -1.09 . . . . 0.0 112.177 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 92.0 m -76.88 -3.69 39.91 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.932 -1.105 . . . . 0.0 113.97 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -37.22 11.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.377 1.071 . . . . 0.0 111.592 168.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.11 -32.27 50.44 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -121.55 45.96 2.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.686 1.995 . . . . 0.0 110.744 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -50.48 -30.11 12.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.811 1.244 . . . . 0.0 113.272 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -90.17 -0.92 57.85 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.386 1.474 . . . . 0.0 112.958 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.25 159.42 33.47 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.856 1.262 . . . . 0.0 112.713 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.89 142.11 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.583 1.553 . . . . 0.0 112.463 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' B' ' 103' ' ' ASN . 14.5 p90 -43.71 -47.12 7.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.787 2.435 . . . . 0.0 115.966 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -95.18 -38.06 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.765 1.226 . . . . 0.0 110.904 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.23 -33.61 75.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.816 0.847 . . . . 0.0 112.324 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -73.93 -36.43 64.68 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.211 1.004 . . . . 0.0 113.049 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.4 -50.89 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.374 -0.829 . . . . 0.0 110.55 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.61 -37.47 82.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.411 1.084 . . . . 0.0 112.416 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.03 88.69 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.97 1.272 . . . . 0.0 113.063 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -71.83 -35.3 69.85 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.975 1.388 . . . . 0.0 112.638 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -59.74 -42.14 92.49 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.191 -0.943 . . . . 0.0 111.96 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.14 -47.52 85.57 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.796 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -23.31 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.932 -1.105 . . . . 0.0 112.678 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.33 -44.94 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.638 1.975 . . . . 0.0 113.149 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -102.17 -56.2 2.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.767 1.227 . . . . 0.0 113.05 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -68.76 -36.31 78.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.813 1.245 . . . . 0.0 111.687 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.1 t0 47.8 44.03 17.61 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.382 2.273 . . . . 0.0 113.235 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.254 1.334 0 C-N-CA 125.535 1.534 . . . . 0.0 112.96 -178.138 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.122 0.011 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -142.49 8.12 1.75 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.33 -48.95 68.04 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -168.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -99.54 -20.87 16.17 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 45.4 2.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.026 1.731 . . . . 0.0 112.692 -167.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 -22.21 66.84 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.863 1.265 . . . . 0.0 114.274 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.58 4.15 19.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.25 1.42 . . . . 0.0 113.604 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.0 t70 60.0 -51.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 131.601 3.961 . . . . 0.0 118.348 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -123.78 -9.47 7.82 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -168.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -97.29 -1.58 44.39 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -167.19 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -113.95 49.94 0.49 Allowed Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 124.755 1.222 . . . . 0.0 113.726 172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -65.85 155.9 66.97 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.972 1.782 . . . . 0.0 111.68 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.99 -23.35 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.2 -4.86 59.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.944 1.697 . . . . 0.0 115.108 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.8 m -127.85 -25.68 3.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.183 1.393 . . . . 0.0 114.341 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.47 160.03 32.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.308 1.052 . . . . 0.0 111.892 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -93.36 168.3 11.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.088 1.423 . . . . 0.0 113.645 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -26.02 67.91 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.787 168.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.78 -43.09 99.72 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.772 -1.205 . . . . 0.0 110.751 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.18 -28.06 69.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.176 -0.953 . . . . 0.0 112.344 169.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD2' ' CE1' ' A' ' 74' ' ' PHE . 41.1 t80 -69.37 -12.83 61.99 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.687 -1.258 . . . . 0.0 112.62 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 mt -94.47 -7.84 40.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.325 1.05 . . . . 0.0 112.49 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.88 -31.17 28.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 0.0 111.633 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.79 138.12 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.276 1.43 . . . . 0.0 110.608 169.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.2 159.61 33.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.185 1.394 . . . . 0.0 113.619 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.39 -36.28 75.52 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.038 -1.039 . . . . 0.0 112.076 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.9 m -61.26 -24.47 66.41 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.933 1.693 . . . . 0.0 113.806 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.33 -3.43 7.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.217 1.407 . . . . 0.0 113.033 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -58.13 -47.59 98.58 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.224 -1.548 . . . . 0.0 110.852 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 -16.48 50.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.738 2.292 . . . . 0.0 114.007 172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.787 HG22 HD21 ' B' ' 139' ' ' LEU . 97.5 m -77.84 -38.75 45.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.295 1.438 . . . . 0.0 110.738 173.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.61 97.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.612 1.165 . . . . 0.0 112.23 168.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.77 -46.48 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.86 -48.21 57.73 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 125.736 1.636 . . . . 0.0 114.684 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -68.78 -36.22 78.02 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.995 2.397 . . . . 0.0 112.551 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.1 75.23 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.853 0.751 . . . . 0.0 112.325 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -80.43 -46.52 15.82 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.477 -0.764 . . . . 0.0 111.645 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.96 78.08 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.016 -1.052 . . . . 0.0 111.735 -171.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -24.67 61.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.163 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 -14.6 63.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -89.18 -28.64 19.87 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.87 -121.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -168.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -158.89 -72.88 0.08 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.43 2.292 . . . . 0.0 111.078 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -103.13 163.95 16.48 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 126.75 2.02 . . . . 0.0 110.7 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.2 10.18 3.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.602 2.202 . . . . 0.0 114.402 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -12.73 61.65 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.906 -1.121 . . . . 0.0 112.949 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.79 30.47 4.04 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.605 1.962 . . . . 0.0 111.722 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.21 136.19 33.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 119.724 -1.86 . . . . 0.0 113.489 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.72 141.77 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.966 1.707 . . . . 0.0 109.192 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -67.54 131.94 46.62 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.456 1.503 . . . . 0.0 111.73 -168.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -83.26 50.48 1.76 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 119.982 -1.699 . . . . 0.0 111.958 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.431 2.1 p -66.85 -45.26 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -163.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.63 -34.24 72.53 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 121.621 2.009 . . . . 0.0 111.526 174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.16 -53.44 18.25 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.737 0.684 . . . . 0.0 112.448 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 mt -52.27 -46.45 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.784 1.634 . . . . 0.0 110.872 171.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.05 75.58 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.441 1.096 . . . . 0.0 113.103 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.6 m -71.48 -36.98 71.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 111.793 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.6 t -87.02 -23.11 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 112.923 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -47.32 -59.46 5.44 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 125.922 1.689 . . . . 0.0 112.412 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.84 -2.12 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.258 2.639 . . . . 0.0 114.219 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.82 -64.95 1.07 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 171.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.81 -30.91 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.652 -1.28 . . . . 0.0 113.004 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 t -58.57 -48.45 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.163 0.985 . . . . 0.0 110.838 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.01 -48.53 20.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.335 0.588 . . . . 0.0 110.904 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.86 69.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 25.3 m -77.19 -13.59 59.92 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.85 -32.85 17.59 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.886 1.221 . . . . 0.0 111.068 167.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.59 -38.62 88.24 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.835 0.854 . . . . 0.0 111.854 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -139.06 57.5 1.66 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.017 1.327 . . . . 0.0 112.765 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -52.84 -36.07 58.28 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.754 1.621 . . . . 0.0 113.108 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.21 -8.34 59.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.265 1.026 . . . . 0.0 113.519 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.75 161.21 27.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.213 1.005 . . . . 0.0 112.711 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.23 132.86 47.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.747 1.219 . . . . 0.0 110.235 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CD2' ' A' ' 21' ' ' PHE . 50.5 t80 -58.26 -44.22 88.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -66.17 -33.78 76.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.516 1.053 . . . . 0.0 112.221 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.11 -31.47 71.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.304 0.641 . . . . 0.0 112.372 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -70.16 -37.11 75.12 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.219 -0.926 . . . . 0.0 113.243 169.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -42.6 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 118.962 0.801 . . . . 0.0 110.597 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -62.1 -45.72 92.24 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.828 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.18 -43.42 98.64 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.26 0.933 . . . . 0.0 113.322 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -75.59 -25.29 56.88 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.118 -1.225 . . . . 0.0 113.573 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -67.42 -42.21 83.57 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.958 -1.089 . . . . 0.0 110.592 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.451 1.101 . . . . 0.0 112.165 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -49.0 16.59 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.32 1.848 . . . . 0.0 113.003 169.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.25 3.1 mt -88.5 -38.3 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.888 -166.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.01 -59.59 1.68 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.361 1.464 . . . . 0.0 112.799 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -67.11 -24.51 65.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.685 1.594 . . . . 0.0 114.026 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.81 -22.53 66.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.056 1.342 . . . . 0.0 113.842 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.295 1.438 . . . . 0.0 111.976 173.912 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -147.96 28.87 0.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.428 1.491 . . . . 0.0 112.897 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.16 149.97 19.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 0.0 110.109 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.79 175.97 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.183 0.993 . . . . 0.0 113.279 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 52.69 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.054 2.542 . . . . 0.0 117.252 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -28.21 68.88 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.074 0.852 . . . . 0.0 111.714 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.93 143.55 50.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.919 2.087 . . . . 0.0 108.425 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -89.66 2.32 54.9 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -113.06 11.2 18.88 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.972 1.709 . . . . 0.0 115.094 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -67.21 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.048 1.339 . . . . 0.0 114.149 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.37 50.28 5.81 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 127.091 2.156 . . . . 0.0 112.153 171.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.7 169.45 2.49 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.878 3.052 . . . . 0.0 116.135 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.5 2.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.21 1.404 . . . . 0.0 114.573 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 17.1 m-80 -119.72 20.92 12.2 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.257 1.823 . . . . 0.0 112.898 169.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 57.0 m -142.49 -24.63 0.65 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.78 166.8 22.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -170.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.7 p -112.44 154.05 26.42 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.14 1.776 . . . . 0.0 110.434 168.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -25.21 62.24 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.8 -43.01 68.99 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.052 1.341 . . . . 0.0 111.184 170.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.72 -22.02 61.69 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.37 -0.831 . . . . 0.0 112.805 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -68.44 -15.06 63.41 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 111.861 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -91.27 -12.48 35.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.01 1.324 . . . . 0.0 113.061 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.32 -34.0 55.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.417 1.087 . . . . 0.0 112.743 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.04 137.28 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.608 1.563 . . . . 0.0 110.546 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.81 160.12 31.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.073 1.349 . . . . 0.0 113.724 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -59.48 -34.63 72.8 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 0.0 111.932 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.1 m -62.64 -25.01 67.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.036 1.734 . . . . 0.0 113.855 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.62 -6.03 8.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.797 1.239 . . . . 0.0 113.38 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -58.04 -42.68 96.39 Favored Pre-proline 0 N--CA 1.481 1.077 0 O-C-N 119.927 -1.733 . . . . 0.0 113.396 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.88 -28.37 86.28 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.962 2.441 . . . . 0.0 112.93 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.434 HG22 HD21 ' A' ' 50' ' ' LEU . 54.2 m -75.93 -33.52 59.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.373 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -65.35 -45.55 83.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.528 1.531 . . . . 0.0 113.665 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.27 -33.23 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.221 0.919 . . . . 0.0 110.18 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.13 -52.78 44.75 Favored Glycine 0 C--O 1.216 -1.007 0 C-N-CA 124.535 1.064 . . . . 0.0 113.225 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.08 -12.76 29.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.973 2.387 . . . . 0.0 113.892 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.48 -62.41 1.46 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.762 0.825 . . . . 0.0 110.659 164.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -68.19 -34.33 76.08 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.897 -1.127 . . . . 0.0 113.257 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.74 81.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.197 1.799 . . . . 0.0 112.114 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -39.29 50.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.584 1.154 . . . . 0.0 110.471 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -9.72 50.5 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -173.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -87.71 -23.92 24.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.233 1.013 . . . . 0.0 113.311 173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -153.95 -122.03 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.857 1.263 . . . . 0.0 114.044 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -162.24 -65.44 0.05 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.403 1.881 . . . . 0.0 112.055 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -116.02 161.91 28.51 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 126.229 1.812 . . . . 0.0 110.568 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.5 11.61 2.84 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.364 2.043 . . . . 0.0 114.407 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.13 -34.11 65.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.06 1.344 . . . . 0.0 111.785 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.48 19.34 16.98 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.494 1.918 . . . . 0.0 112.733 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.7 118.2 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 119.78 -1.825 . . . . 0.0 111.229 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.69 -4.91 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.003 1.321 . . . . 0.0 112.389 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.787 HD21 HG22 ' A' ' 31' ' ' THR . 2.0 tm? 59.61 112.75 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.414 3.085 . . . . 0.0 112.869 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -91.99 62.48 4.26 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.634 -1.291 . . . . 0.0 111.744 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 1.2 p -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 117.338 -1.315 . . . . 0.0 114.041 -168.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -63.96 -35.31 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.789 2.086 . . . . 0.0 111.672 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.89 -48.36 61.27 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.679 0.657 . . . . 0.0 111.857 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.88 -40.52 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.122 0.969 . . . . 0.0 112.257 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.62 71.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.785 1.234 . . . . 0.0 112.382 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 0.0 111.632 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.95 -33.1 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.356 1.463 . . . . 0.0 113.319 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.9 m -43.89 -58.37 4.78 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 126.235 1.814 . . . . 0.0 113.855 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.92 -11.36 30.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.807 2.338 . . . . 0.0 113.822 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -65.61 0.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.667 1.187 . . . . 0.0 111.601 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.495 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.0 -27.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.664 -1.272 . . . . 0.0 113.671 -173.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.5 -44.68 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.526 1.057 . . . . 0.0 112.304 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -73.68 -46.75 44.43 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.024 0.929 . . . . 0.0 110.885 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.27 67.54 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 113.2 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 9.4 m -74.87 -13.07 60.51 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -33.92 18.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.317 1.417 . . . . 0.0 110.755 167.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -60.76 -40.35 92.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.807 0.843 . . . . 0.0 112.16 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -132.81 64.99 1.6 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.727 1.211 . . . . 0.0 111.902 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -52.15 -32.61 36.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.512 -1.367 . . . . 0.0 113.63 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -92.83 1.31 57.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.825 1.25 . . . . 0.0 113.068 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.96 154.53 41.4 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.246 1.022 . . . . 0.0 112.301 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.97 152.25 33.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.834 1.654 . . . . 0.0 112.61 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 35.0 p90 -47.6 153.9 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.982 1.713 . . . . 0.0 113.526 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 43.7 tttt 60.82 -40.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 129.642 3.177 . . . . 0.0 115.93 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.41 -34.67 77.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.485 1.914 . . . . 0.0 112.199 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -69.09 -37.81 78.62 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.605 -0.684 . . . . 0.0 112.334 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.15 -41.3 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 119.101 0.864 . . . . 0.0 111.11 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.13 -45.44 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.664 0.786 . . . . 0.0 111.633 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.83 95.41 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.994 1.283 . . . . 0.0 113.485 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.95 -35.66 77.03 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 112.593 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -63.66 -36.94 85.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.69 -1.256 . . . . 0.0 112.007 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.87 -47.48 77.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.501 0.72 . . . . 0.0 111.683 171.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -24.66 67.57 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.573 -1.329 . . . . 0.0 111.93 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.7 mt -75.6 -45.96 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.934 1.693 . . . . 0.0 112.687 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.51 -59.79 1.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -62.68 -26.4 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.319 1.848 . . . . 0.0 113.981 -170.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.76 -21.43 66.77 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 C--O 1.255 1.374 0 C-N-CA 125.87 1.668 . . . . 0.0 114.57 -177.985 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.258 69.4 m-20 54.58 35.93 24.7 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.934 1.294 . . . . 0.0 113.921 -170.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.32 176.31 7.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.319 1.447 . . . . 0.0 111.533 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.37 138.92 57.9 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 142.05 8.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.357 1.863 . . . . 0.0 109.759 166.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.7 29.55 5.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.415 1.486 . . . . 0.0 112.987 -170.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 -24.68 61.65 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.107 -0.996 . . . . 0.0 112.71 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.87 -24.92 67.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.01 0.924 . . . . 0.0 112.871 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -126.52 23.71 6.8 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.537 1.535 . . . . 0.0 112.117 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 27.03 86.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 128.882 2.873 . . . . 0.0 115.47 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -112.53 65.44 0.82 Allowed Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 125.212 1.405 . . . . 0.0 110.994 167.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.78 169.74 16.93 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.74 3.626 . . . . 0.0 112.487 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.37 -16.44 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -76.76 -35.15 57.91 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.33 1.052 . . . . 0.0 112.615 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.8 m -100.48 -22.49 14.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.325 2.25 . . . . 0.0 113.904 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -64.78 140.78 58.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.018 2.527 . . . . 0.0 109.648 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.4 p -100.95 166.47 10.81 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.827 1.298 . . . . 0.0 113.54 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.16 -25.28 66.88 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.587 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -65.5 -42.83 91.69 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.853 -1.155 . . . . 0.0 110.421 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.59 -27.05 68.92 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.848 -0.532 . . . . 0.0 112.09 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -69.08 -12.19 61.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.785 -1.197 . . . . 0.0 113.119 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.09 -6.45 38.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.754 1.221 . . . . 0.0 112.64 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.13 -30.51 21.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.674 1.189 . . . . 0.0 112.375 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 p -72.56 141.95 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.751 1.62 . . . . 0.0 110.753 169.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.17 160.31 32.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.46 1.104 . . . . 0.0 113.084 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.21 -35.41 73.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.726 1.21 . . . . 0.0 111.848 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -62.95 -21.96 66.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.547 1.539 . . . . 0.0 113.79 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.09 -5.25 6.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 113.47 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -55.42 -47.22 99.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 O-C-N 120.131 -1.606 . . . . 0.0 111.478 170.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -60.47 -25.74 81.22 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.565 2.177 . . . . 0.0 113.857 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -70.5 -34.44 72.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.391 0.676 . . . . 0.0 111.915 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.72 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -67.05 -46.52 74.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.848 1.203 . . . . 0.0 113.005 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.11 -34.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 118.75 0.705 . . . . 0.0 110.249 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.13 88.13 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 118.819 -0.989 . . . . 0.0 113.524 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.13 -24.16 66.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.249 2.524 . . . . 0.0 113.609 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.88 -55.25 4.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.495 -0.753 . . . . 0.0 110.939 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -68.01 -31.64 71.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.454 -0.779 . . . . 0.0 112.5 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.98 84.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.396 1.078 . . . . 0.0 111.576 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD13 HD13 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -77.91 -36.75 49.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.329 -178.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -23.15 63.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -81.6 -17.91 46.59 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.85 -122.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.186 1.394 . . . . 0.0 112.341 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -160.8 -66.99 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.399 1.48 . . . . 0.0 113.03 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -129.73 164.29 41.16 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 127.906 2.482 . . . . 0.0 109.669 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 3.82 6.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.352 1.519 . . . . 0.0 114.716 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -55.27 -23.79 24.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.479 1.512 . . . . 0.0 112.564 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.16 9.27 15.8 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.788 2.035 . . . . 0.0 113.014 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.76 125.16 32.31 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 119.614 -1.929 . . . . 0.0 113.644 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.38 129.53 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.933 2.093 . . . . 0.0 105.866 173.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER -69.6 116.62 10.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.14 1.336 . . . . 0.0 109.678 -173.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.47 58.2 4.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.806 1.642 . . . . 0.0 110.991 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -69.55 -31.67 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.74 -35.13 79.86 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 121.239 1.836 . . . . 0.0 111.875 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.84 68.24 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.724 0.678 . . . . 0.0 112.237 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.41 -47.31 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.6 1.16 . . . . 0.0 111.123 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.76 -28.3 67.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.359 1.464 . . . . 0.0 112.993 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.5 m -66.02 -48.52 70.87 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.771 1.229 . . . . 0.0 111.001 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.67 -19.98 8.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -46.9 -63.07 1.52 Allowed Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 125.129 1.372 . . . . 0.0 112.258 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.65 -5.61 16.56 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.553 2.835 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.57 -61.15 1.83 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.437 1.495 . . . . 0.0 110.05 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.64 -30.72 48.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 124.752 1.221 . . . . 0.0 111.721 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.08 -44.18 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.431 1.014 . . . . 0.0 112.849 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -74.42 -46.01 42.85 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.029 0.531 . . . . 0.0 109.706 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.31 75.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.927 0.891 . . . . 0.0 112.861 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.8 m -74.24 -17.43 60.88 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -30.58 32.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.257 1.39 . . . . 0.0 110.79 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -65.29 -38.68 91.01 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.329 0.652 . . . . 0.0 112.626 170.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -130.26 55.81 1.79 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.606 1.563 . . . . 0.0 112.674 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -49.27 -40.19 33.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.602 1.161 . . . . 0.0 112.845 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.29 -2.5 57.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.105 0.962 . . . . 0.0 113.494 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.53 158.74 28.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.16 0.984 . . . . 0.0 112.007 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.9 141.32 47.88 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.825 0.85 . . . . 0.0 110.588 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -66.9 -47.39 71.94 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -64.14 -33.24 75.34 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.064 -1.023 . . . . 0.0 113.009 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.64 -34.03 74.98 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.241 0.616 . . . . 0.0 111.979 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -75.07 -36.38 61.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.28 -39.88 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.295 1.407 . . . . 0.0 111.203 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -61.55 -45.68 93.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.477 0.711 . . . . 0.0 111.584 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.16 -45.48 95.25 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.74 1.162 . . . . 0.0 113.789 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.24 -35.57 63.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.752 1.276 . . . . 0.0 112.867 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -59.58 -40.42 87.33 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.69 1.132 . . . . 0.0 111.562 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.66 -46.17 89.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.515 1.126 . . . . 0.0 112.052 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -26.39 68.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.205 -0.934 . . . . 0.0 112.331 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.2 -44.92 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.722 1.209 . . . . 0.0 112.291 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -104.35 -60.27 1.61 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.681 1.592 . . . . 0.0 112.993 -173.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.15 -24.36 66.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.673 1.589 . . . . 0.0 113.933 -171.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.55 -22.74 67.06 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.884 1.274 . . . . 0.0 113.755 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.198 1.399 . . . . 0.0 112.417 177.699 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.92 121.25 10.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.206 1.002 . . . . 0.0 111.649 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.44 25.87 3.81 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -50.47 -33.99 23.24 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.263 0.0 OUTLIER -82.88 -8.16 59.6 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 44.86 -109.16 0.16 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.803 1.641 . . . . 0.0 113.737 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.68 5.59 9.0 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.38 1.472 . . . . 0.0 114.664 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.21 7.51 5.53 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.438 2.295 . . . . 0.0 113.828 -168.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -134.58 -25.01 1.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.428 1.891 . . . . 0.0 114.133 -170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -89.94 158.0 17.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.829 1.252 . . . . 0.0 111.825 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . 0.263 20.6 ptmt 43.77 43.73 1.21 Allowed Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 128.772 2.829 . . . . 0.0 116.684 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -66.79 172.46 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.33 2.687 . . . . 0.0 114.007 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -63.62 6.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 127.041 2.137 . . . . 0.0 115.796 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ASN . . . . . 0.461 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 2.1 p30 -135.36 32.53 3.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.635 2.374 . . . . 0.0 111.215 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -148.28 -47.53 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.175 1.39 . . . . 0.0 113.673 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -99.01 139.3 34.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.872 0.869 . . . . 0.0 111.346 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 p -75.29 172.19 12.88 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.202 1.801 . . . . 0.0 114.578 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -21.63 1.54 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -55.34 -36.09 65.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.952 1.251 . . . . 0.0 111.444 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.6 -26.38 68.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.245 -0.91 . . . . 0.0 112.829 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -70.18 -18.45 63.19 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.206 -0.933 . . . . 0.0 111.884 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -91.84 -21.23 20.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 112.222 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.31 -34.25 61.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.663 1.185 . . . . 0.0 112.49 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.85 137.48 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.083 1.353 . . . . 0.0 110.64 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.35 158.31 31.94 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.065 1.346 . . . . 0.0 113.303 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -57.91 -35.82 71.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.684 1.194 . . . . 0.0 112.213 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -22.98 65.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.699 1.6 . . . . 0.0 114.002 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.82 0.09 6.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.56 1.544 . . . . 0.0 112.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.17 -42.75 94.97 Favored Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 119.765 -1.834 . . . . 0.0 112.788 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -61.66 -26.84 80.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.582 2.188 . . . . 0.0 113.386 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -74.57 -32.86 62.53 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 124.105 0.962 . . . . 0.0 111.246 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -61.62 -46.27 90.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.85 1.26 . . . . 0.0 114.11 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.05 -36.15 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.436 1.016 . . . . 0.0 110.69 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.01 -49.48 58.85 Favored Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.889 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.25 -13.57 60.59 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.797 2.299 . . . . 0.0 114.331 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.64 -56.7 2.92 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.753 -0.592 . . . . 0.0 109.862 165.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.09 -37.28 81.03 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.154 -0.966 . . . . 0.0 113.032 -169.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.88 72.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.655 1.982 . . . . 0.0 112.397 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -87.84 -37.2 16.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.167 1.387 . . . . 0.0 110.676 -177.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.02 -30.46 35.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.375 1.87 . . . . 0.0 113.798 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -98.33 -10.86 23.18 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -170.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.25 1.1 ptpm? -150.0 -126.7 0.05 OUTLIER 'General case' 0 C--N 1.351 0.636 0 CA-C-N 120.114 1.325 . . . . 0.0 113.328 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -161.82 -48.63 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -167.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -143.54 161.4 47.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 126.92 2.088 . . . . 0.0 110.664 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.51 -1.08 11.29 Favored 'Trans proline' 0 C--N 1.358 1.034 0 CA-C-N 121.453 1.555 . . . . 0.0 115.654 -174.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.83 -24.85 54.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.629 1.172 . . . . 0.0 113.037 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -114.86 7.06 15.62 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.0 1.72 . . . . 0.0 113.176 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.9 123.68 32.28 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 119.727 -1.858 . . . . 0.0 112.035 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.5 136.8 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.72 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -68.49 110.2 4.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.323 1.419 . . . . 0.0 108.186 178.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -91.02 59.64 4.1 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.072 0.949 . . . . 0.0 110.356 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.326 2.9 p -67.39 -15.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.063 -1.023 . . . . 0.0 112.183 -170.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.23 -33.03 57.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.416 1.486 . . . . 0.0 112.245 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.34 -61.23 1.92 Allowed Glycine 0 N--CA 1.467 0.728 0 C-N-CA 124.443 1.02 . . . . 0.0 112.171 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.48 -44.4 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.842 -1.387 . . . . 0.0 113.189 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.95 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.989 1.268 . . . . 0.0 112.547 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 8.9 m -67.31 -46.68 72.82 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.548 1.139 . . . . 0.0 112.066 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.408 HG12 HD13 ' B' ' 151' ' ' ILE . 1.5 t -93.99 -16.33 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.4 m -41.5 -60.47 1.83 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 125.906 1.682 . . . . 0.0 113.359 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.47 -14.39 44.66 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.73 2.287 . . . . 0.0 113.361 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.05 -57.61 3.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.723 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 147' ' ' VAL . 0.0 OUTLIER -60.33 -37.98 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 119.392 0.996 . . . . 0.0 112.221 -176.119 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.96 -43.22 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.99 -0.443 . . . . 0.0 112.052 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -71.31 -47.45 56.61 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.931 0.893 . . . . 0.0 110.866 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.95 71.64 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.496 -1.378 . . . . 0.0 113.205 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.4 m -76.16 -11.03 59.86 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.02 -34.15 16.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.397 1.453 . . . . 0.0 110.614 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -57.94 -38.67 76.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.308 1.043 . . . . 0.0 111.996 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -145.53 86.4 1.74 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.906 0.86 . . . . 0.0 112.001 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -55.0 -28.48 52.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.574 1.55 . . . . 0.0 112.89 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.23 3.5 55.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 113.048 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.46 161.08 15.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.115 1.366 . . . . 0.0 113.828 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.52 54.73 0.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.505 1.922 . . . . 0.0 113.495 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 1.1 p90 45.2 -104.31 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 115.391 166.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -48.45 -32.67 8.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.155 2.182 . . . . 0.0 113.892 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.03 -29.67 68.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 112.703 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -72.52 -39.71 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.319 -0.863 . . . . 0.0 112.557 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.72 -39.93 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.732 1.151 . . . . 0.0 110.964 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.22 -42.32 96.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.006 0.922 . . . . 0.0 112.142 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.37 99.34 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.789 1.185 . . . . 0.0 113.354 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.72 -34.15 66.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 1.153 . . . . 0.0 112.574 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -58.14 -42.77 86.6 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.781 1.173 . . . . 0.0 111.475 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.03 -45.17 94.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 0.0 111.624 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -23.89 67.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.982 -1.074 . . . . 0.0 112.655 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 19.0 mt -85.97 -49.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.334 1.853 . . . . 0.0 112.661 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -100.48 -59.3 1.73 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.653 1.581 . . . . 0.0 112.92 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -65.08 -26.86 68.41 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.468 1.507 . . . . 0.0 113.123 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.04 -18.77 63.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.249 1.42 . . . . 0.0 114.21 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.957 1.303 . . . . 0.0 113.394 -177.413 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 119.855 -0.117 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -138.28 54.91 1.77 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -169.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.491 ' H ' ' HB2' ' B' ' 142' ' ' GLN . . . 52.55 40.29 29.61 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -63.15 -15.65 57.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -171.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.76 4.66 13.23 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.79 -36.28 16.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.605 1.562 . . . . 0.0 114.068 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.25 151.98 32.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.389 1.076 . . . . 0.0 111.573 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -71.91 56.88 0.31 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.36 2.264 . . . . 0.0 112.248 173.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -151.57 -47.75 0.11 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.545 1.538 . . . . 0.0 113.374 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -72.76 -47.38 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -172.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -137.55 32.07 0.19 Allowed Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -59.08 139.21 89.58 Favored 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 123.188 2.174 . . . . 0.0 113.848 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -73.69 0.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.08 1.352 . . . . 0.0 113.886 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HA ' ' CE1' ' A' ' 74' ' ' PHE . 61.1 m-80 -123.98 19.79 9.2 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.76 1.624 . . . . 0.0 112.864 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -140.06 -39.87 0.44 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -94.81 153.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 111.818 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -79.97 175.39 10.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.698 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -19.4 0.66 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -55.8 -31.74 62.9 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 120.041 1.292 . . . . 0.0 112.029 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.04 -33.25 64.77 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.002 -1.061 . . . . 0.0 111.901 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.03 -10.62 60.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 mt -103.77 -22.17 13.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.53 70.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.202 1.001 . . . . 0.0 111.745 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.24 137.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 111.201 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.47 158.88 30.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.375 1.07 . . . . 0.0 112.683 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.16 -34.29 56.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.11 1.364 . . . . 0.0 112.153 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 m -60.04 -28.18 67.54 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.066 1.746 . . . . 0.0 113.697 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -127.49 0.4 6.25 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.655 1.582 . . . . 0.0 113.179 -171.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.88 -45.88 99.91 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.533 -1.354 . . . . 0.0 111.883 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -60.15 -25.43 79.9 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.935 2.423 . . . . 0.0 113.938 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.6 m -77.84 -30.79 51.22 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.331 1.053 . . . . 0.0 111.56 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -65.01 -45.43 85.57 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.883 -1.136 . . . . 0.0 113.36 172.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.27 -36.87 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 119.108 0.867 . . . . 0.0 110.084 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.53 -52.76 31.77 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 124.628 1.109 . . . . 0.0 113.234 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -69.34 -15.21 63.28 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 121.374 2.587 . . . . 0.0 114.128 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.17 -31.79 15.34 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.498 1.044 . . . . 0.0 113.183 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -93.65 -29.36 15.48 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.17 90.12 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.164 1.785 . . . . 0.0 111.963 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 HD13 ' B' ' 128' ' ' LEU . 0.7 OUTLIER -82.21 -36.05 27.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.979 0.912 . . . . 0.0 111.106 -174.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -65.06 -27.09 68.55 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -91.59 -9.08 45.46 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.85 -130.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.159 1.784 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.23 -43.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.282 1.833 . . . . 0.0 114.556 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.6 mmpp? -128.13 164.51 36.88 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 127.193 2.197 . . . . 0.0 110.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.13 -2.72 8.75 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.016 1.811 . . . . 0.0 114.281 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.62 -22.87 65.32 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.85 -1.157 . . . . 0.0 113.061 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.92 -5.11 23.84 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.563 1.545 . . . . 0.0 114.03 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 127.52 32.91 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.947 -1.096 . . . . 0.0 113.739 -169.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.26 128.29 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.212 1.805 . . . . 0.0 107.303 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -68.04 120.78 14.83 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 119.153 0.888 . . . . 0.0 110.439 -170.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -90.15 52.42 2.26 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.58 -1.325 . . . . 0.0 111.369 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.295 0.9 OUTLIER -64.32 -28.21 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -167.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -59.42 -39.9 85.01 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.756 2.071 . . . . 0.0 111.458 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.08 -54.6 13.15 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.48 -45.37 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.754 -0.851 . . . . 0.0 111.626 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.19 67.91 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.883 1.22 . . . . 0.0 112.747 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -69.02 -47.3 65.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.646 1.178 . . . . 0.0 111.885 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 62' ' ' ILE . 1.1 t -89.96 -18.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -43.22 -60.8 2.17 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 125.862 1.665 . . . . 0.0 112.395 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.1 -0.47 5.63 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.585 2.856 . . . . 0.0 114.503 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.32 -57.77 2.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.082 1.753 . . . . 0.0 111.219 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.69 -35.75 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 119.874 1.216 . . . . 0.0 111.986 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.06 -41.49 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 112.604 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -76.63 -47.7 21.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.474 0.709 . . . . 0.0 110.198 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.19 75.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.075 -1.016 . . . . 0.0 112.937 -170.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.1 m -76.2 -10.52 59.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -33.32 19.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.565 1.53 . . . . 0.0 110.381 167.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -61.52 -39.13 89.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.312 0.645 . . . . 0.0 111.695 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.45 61.29 1.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 112.744 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -54.0 -33.37 56.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.479 -1.388 . . . . 0.0 113.143 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.3 -1.82 58.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.149 1.379 . . . . 0.0 113.329 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.33 171.09 12.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.331 1.062 . . . . 0.0 113.271 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -64.71 141.02 58.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.44 1.496 . . . . 0.0 113.349 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 14' ' ' ASN . 7.0 p90 -58.35 -41.65 85.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.762 2.425 . . . . 0.0 115.173 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -93.25 -35.5 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.598 1.159 . . . . 0.0 111.621 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.2 -30.83 69.63 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.157 0.983 . . . . 0.0 111.621 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -74.72 -40.06 61.54 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -68.21 -40.8 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.879 1.218 . . . . 0.0 111.088 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.47 -45.71 78.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.236 1.014 . . . . 0.0 111.451 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.31 -44.07 97.48 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.324 1.44 . . . . 0.0 113.401 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.74 -32.74 65.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.165 1.483 . . . . 0.0 113.171 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -62.0 -42.95 99.71 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.642 -1.287 . . . . 0.0 111.21 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.71 -46.53 89.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.806 1.242 . . . . 0.0 111.878 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -28.23 69.88 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.118 -0.989 . . . . 0.0 111.812 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 mt -79.44 -48.48 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.055 0.942 . . . . 0.0 111.889 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.2 -57.18 2.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.355 1.462 . . . . 0.0 113.629 -169.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.16 -28.2 65.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.888 1.675 . . . . 0.0 113.242 -171.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.38 -49.61 47.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 113.352 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 C--O 1.254 1.299 0 C-N-CA 126.629 1.972 . . . . 0.0 112.762 175.186 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.57 -50.39 2.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.76 147.38 53.47 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.225 -0.922 . . . . 0.0 112.791 -169.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.26 -15.56 0.41 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.761 2.424 . . . . 0.0 115.047 -172.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 45.35 0.85 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.13 1.372 . . . . 0.0 113.207 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.59 -27.99 68.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 -10.29 59.27 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 59.32 -16.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.097 2.959 . . . . 0.0 116.901 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -114.08 -10.56 12.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.458 1.903 . . . . 0.0 113.145 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -96.1 155.65 16.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.381 1.872 . . . . 0.0 111.372 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 51.49 43.64 1.74 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 127.862 2.465 . . . . 0.0 115.89 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -64.41 163.19 27.6 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.964 1.776 . . . . 0.0 112.031 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.59 -20.85 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.8 -40.17 29.18 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.51 -0.744 . . . . 0.0 112.824 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 17.9 m -94.44 -27.44 16.02 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -169.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.31 161.79 27.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.983 0.897 . . . . 0.0 111.989 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 48.9 p -100.07 171.38 7.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 122.472 1.129 . . . . 0.0 113.899 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.33 -26.21 66.39 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.62 -0.675 . . . . 0.0 112.616 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.52 -43.81 97.91 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.39 0.995 . . . . 0.0 110.146 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -63.81 -31.51 72.71 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.485 0.714 . . . . 0.0 111.895 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 89.7 t80 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.765 1.166 . . . . 0.0 111.328 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.48 -8.2 55.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.01 45.2 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.319 0.963 . . . . 0.0 112.164 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.03 140.6 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.333 1.853 . . . . 0.0 109.124 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.35 155.3 35.77 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -52.67 -35.13 54.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.809 1.244 . . . . 0.0 112.093 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.9 m -64.49 -23.49 67.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -124.53 -1.77 8.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.998 1.319 . . . . 0.0 112.787 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.32 -46.43 90.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.061 -1.65 . . . . 0.0 111.546 171.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -61.19 -25.98 81.62 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.587 2.191 . . . . 0.0 113.497 169.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 50' ' ' LEU . 89.6 m -72.76 -36.96 67.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.208 175.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.49 92.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.872 1.269 . . . . 0.0 114.071 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.33 -33.05 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 119.975 1.261 . . . . 0.0 110.497 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.75 -52.0 36.3 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 124.998 1.285 . . . . 0.0 113.816 170.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -65.8 -25.85 67.43 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.663 2.231 . . . . 0.0 113.206 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.39 -58.7 3.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.091 0.86 . . . . 0.0 110.935 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -58.44 -44.07 89.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.267 1.827 . . . . 0.0 112.165 -174.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.39 -46.73 82.05 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.421 1.488 . . . . 0.0 112.075 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.452 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -78.88 -31.49 45.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.843 0.857 . . . . 0.0 111.809 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -71.2 -23.14 61.98 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -96.58 -11.5 25.27 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 -132.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.929 1.691 . . . . 0.0 110.88 -176.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -155.11 -56.2 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.998 2.119 . . . . 0.0 112.581 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -122.03 168.71 10.87 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.781 2.432 . . . . 0.0 109.965 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.22 6.28 4.58 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.66 1.573 . . . . 0.0 114.466 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.61 -26.66 68.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 112.625 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.22 21.7 15.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.686 1.995 . . . . 0.0 113.897 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.03 133.11 35.1 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.248 -1.532 . . . . 0.0 112.261 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.92 -1.36 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.67 1.188 . . . . 0.0 112.86 -173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 56.31 106.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.233 2.613 . . . . 0.0 110.561 -168.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.54 60.03 4.96 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.283 -1.511 . . . . 0.0 111.075 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.349 2.1 p -68.92 -24.77 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 120.721 -1.237 . . . . 0.0 112.282 -169.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.491 ' HB2' ' H ' ' A' ' 3' ' ' ALA . 18.7 tm0? -65.46 -42.96 91.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.723 -1.236 . . . . 0.0 112.209 169.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.96 -49.0 57.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.05 -43.79 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.953 1.301 . . . . 0.0 111.924 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -28.71 65.3 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.001 1.273 . . . . 0.0 112.736 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 50.5 m -69.8 -42.06 74.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 111.607 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 151' ' ' ILE . 29.0 t -85.41 -27.79 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.971 1.708 . . . . 0.0 113.474 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 22.2 m -50.74 -63.44 1.88 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 112.495 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.3 -17.68 58.75 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.459 2.106 . . . . 0.0 113.096 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.76 -58.29 4.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.434 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.445 HD12 HG12 ' B' ' 147' ' ' VAL . 33.0 mt -71.88 -32.32 44.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 112.34 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.49 -51.07 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.517 1.127 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.41 -48.16 73.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.632 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.6 74.17 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.0 113.454 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.0 m -73.5 -17.55 61.21 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.12 -31.11 19.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.624 1.102 . . . . 0.0 111.886 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.97 -41.89 97.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 111.253 169.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.34 80.02 1.55 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.895 0.855 . . . . 0.0 111.448 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.78 -38.98 67.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.176 1.79 . . . . 0.0 112.408 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.24 -8.86 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -169.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.8 148.08 52.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 112.266 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -65.22 135.29 55.24 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.209 1.004 . . . . 0.0 109.214 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.464 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 61.9 t80 -62.27 -52.32 64.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -58.9 -32.45 69.53 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.734 1.152 . . . . 0.0 112.386 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -70.94 -34.51 71.55 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 112.905 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -71.61 -34.95 70.27 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.682 -1.261 . . . . 0.0 112.606 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.89 -48.96 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.066 0.946 . . . . 0.0 110.077 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -59.0 -43.17 91.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.684 1.193 . . . . 0.0 111.744 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.04 -43.94 88.2 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.392 0.996 . . . . 0.0 113.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -80.39 -30.29 37.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.389 1.095 . . . . 0.0 113.517 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 171' ' ' TRP . . . . . 0.44 ' CD1' ' HE3' ' B' ' 175' ' ' LYS . 45.0 m0 -57.05 -40.02 75.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.195 1.362 . . . . 0.0 111.081 169.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -70.13 -14.78 62.8 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.653 -1.279 . . . . 0.0 114.083 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -21.55 25.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.339 1.456 . . . . 0.0 113.749 170.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.59 -45.66 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 126.523 1.929 . . . . 0.0 113.997 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' B' ' 171' ' ' TRP . 55.5 mttt -87.83 -52.55 5.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.094 2.158 . . . . 0.0 111.829 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -69.85 -26.79 64.38 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.128 1.371 . . . . 0.0 113.279 -172.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -71.57 -16.56 62.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.047 1.339 . . . . 0.0 114.156 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.255 1.36 0 C-N-CA 125.593 1.557 . . . . 0.0 113.378 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 t70 51.0 41.99 27.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.815 1.646 . . . . 0.0 114.779 -176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.7 -45.58 7.63 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -168.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -96.92 -159.12 0.71 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.386 1.475 . . . . 0.0 112.664 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt 57.02 40.36 28.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.325 1.85 . . . . 0.0 112.939 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.39 144.1 37.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.641 1.177 . . . . 0.0 110.937 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.5 1.97 0.3 Allowed 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.5 t70 60.61 -50.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 129.669 3.188 . . . . 0.0 117.262 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -105.33 -1.29 25.34 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -144.86 -156.84 0.73 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.83 1.252 . . . . 0.0 113.944 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 58.81 35.87 0.26 Allowed Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 128.384 2.674 . . . . 0.0 115.45 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.97 160.51 45.74 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.503 2.135 . . . . 0.0 112.726 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.87 -26.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -74.4 -27.91 60.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.176 0.991 . . . . 0.0 112.932 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.6 m -114.79 -26.87 7.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.905 1.282 . . . . 0.0 114.304 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -92.97 171.88 8.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.632 1.173 . . . . 0.0 112.951 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.5 p -97.58 165.07 12.16 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -167.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.07 -16.92 8.4 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.763 1.625 . . . . 0.0 114.491 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.4 -35.44 62.88 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.729 1.149 . . . . 0.0 111.049 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.01 -32.31 67.82 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.765 -1.21 . . . . 0.0 112.502 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.95 -7.59 51.75 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 112.318 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.77 -16.46 14.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.248 1.419 . . . . 0.0 112.207 169.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.19 65.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.545 1.138 . . . . 0.0 111.513 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.64 139.32 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.334 1.854 . . . . 0.0 109.897 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.85 158.18 28.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.69 0.796 . . . . 0.0 112.092 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.77 -34.63 62.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.782 1.233 . . . . 0.0 111.69 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.8 m -59.14 -27.69 65.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.181 1.792 . . . . 0.0 113.516 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.44 3.16 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.482 1.513 . . . . 0.0 113.117 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -55.57 -45.63 99.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 120.002 -1.686 . . . . 0.0 111.276 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -60.31 -24.64 78.1 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.324 . . . . 0.0 114.249 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.768 HG22 HD21 ' B' ' 139' ' ' LEU . 62.3 m -75.95 -37.62 58.44 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.791 1.236 . . . . 0.0 110.759 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.23 97.42 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.42 -37.06 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 118.808 0.731 . . . . 0.0 111.574 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.23 12.04 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.798 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.73 -44.83 93.6 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.714 2.257 . . . . 0.0 112.409 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.0 -26.65 67.64 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -94.44 -35.93 12.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.48 84.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.428 1.891 . . . . 0.0 112.18 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD22 HD22 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -80.27 -26.22 39.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.151 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -18.33 48.54 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.458 -0.776 . . . . 0.0 113.091 -169.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -97.2 -14.18 21.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.4 -136.06 0.1 Allowed 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.972 1.709 . . . . 0.0 110.731 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -149.97 -60.78 0.2 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.594 1.958 . . . . 0.0 113.187 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -127.5 162.96 45.69 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.973 2.109 . . . . 0.0 110.326 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.05 5.85 5.96 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.722 1.615 . . . . 0.0 114.219 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -58.57 -24.77 61.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.523 1.129 . . . . 0.0 111.446 168.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -111.22 11.94 21.78 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.781 2.032 . . . . 0.0 113.383 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.09 34.83 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.023 -1.673 . . . . 0.0 113.005 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.34 -3.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 125.065 1.346 . . . . 0.0 112.387 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.1 OUTLIER 67.41 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.691 2.796 . . . . 0.0 110.749 -168.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -89.04 63.83 6.85 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.502 -1.374 . . . . 0.0 110.93 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.27 -28.63 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -168.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -54.13 -43.69 70.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.074 1.35 . . . . 0.0 112.199 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.9 -51.67 7.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.44 -48.19 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.188 0.995 . . . . 0.0 111.923 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.42 -28.34 67.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.441 ' HG1' ' N ' ' B' ' 90' ' ' ALA . 26.9 m -70.2 -51.6 29.75 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.647 1.179 . . . . 0.0 112.539 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.01 -15.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -170.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.6 m -45.26 -63.31 1.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 120.261 1.391 . . . . 0.0 112.095 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -2.0 6.48 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.131 2.554 . . . . 0.0 114.805 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -64.13 1.14 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.964 1.706 . . . . 0.0 110.92 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -27.4 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.871 -1.143 . . . . 0.0 113.008 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -54.17 -48.2 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.926 1.29 . . . . 0.0 110.815 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -81.47 -48.47 11.82 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.239 0.543 . . . . 0.0 110.689 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.76 68.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.0 m -77.42 -13.92 59.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.08 -33.19 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.417 1.462 . . . . 0.0 110.917 168.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -61.82 -38.75 89.3 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.412 1.085 . . . . 0.0 111.847 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.82 55.61 1.72 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 0.0 112.834 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -53.75 -33.66 56.49 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.386 1.474 . . . . 0.0 113.232 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.18 -6.38 56.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.847 1.259 . . . . 0.0 113.705 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.04 159.61 26.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.785 0.834 . . . . 0.0 111.649 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -58.9 134.35 56.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 111.08 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.26 -47.24 71.31 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.391 -0.818 . . . . 0.0 112.96 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -64.27 -36.48 84.24 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.287 0.949 . . . . 0.0 111.963 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -59.61 -32.0 70.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.019 0.528 . . . . 0.0 112.068 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -74.83 -38.34 62.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.781 -1.104 . . . . 0.0 113.829 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.73 -41.15 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.923 1.692 . . . . 0.0 111.031 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.57 -44.05 91.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.317 1.047 . . . . 0.0 111.438 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.31 94.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.21 1.385 . . . . 0.0 113.5 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -71.93 -33.9 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.276 1.538 . . . . 0.0 113.4 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -60.33 -42.82 96.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.681 1.128 . . . . 0.0 111.383 171.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.04 -45.76 90.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.558 1.143 . . . . 0.0 111.969 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.59 71.62 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.002 -1.061 . . . . 0.0 111.826 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.72 -49.01 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.142 0.977 . . . . 0.0 111.785 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -101.66 -59.83 1.63 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.296 1.439 . . . . 0.0 113.319 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -66.67 -25.97 66.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.956 1.702 . . . . 0.0 113.587 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.97 -20.54 65.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.894 1.278 . . . . 0.0 114.2 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.389 1.476 . . . . 0.0 112.883 -178.585 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.441 ' N ' ' HG1' ' A' ' 57' ' ' THR . . . . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.18 15.0 4.19 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.857 -1.152 . . . . 0.0 113.248 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -162.48 156.9 21.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.379 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -144.52 -97.5 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 174.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -97.32 -7.16 32.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.05 1.74 . . . . 0.0 113.934 -167.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 61.15 152.26 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.18 2.592 . . . . 0.0 114.723 -170.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 57.47 -18.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 128.029 2.531 . . . . 0.0 117.185 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 60.43 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 130.065 3.346 . . . . 0.0 116.84 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -110.5 -1.17 17.11 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.959 2.104 . . . . 0.0 112.562 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.65 158.55 19.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.086 2.154 . . . . 0.0 112.314 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 51.78 43.81 1.8 Allowed Pre-proline 0 N--CA 1.483 1.202 0 C-N-CA 128.017 2.527 . . . . 0.0 115.713 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -65.26 164.19 26.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.562 2.174 . . . . 0.0 112.64 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.21 -26.82 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -80.08 -17.64 52.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.365 1.066 . . . . 0.0 113.563 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -106.4 -44.98 4.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.874 1.27 . . . . 0.0 113.939 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -101.8 176.05 5.35 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 77.7 p -91.2 164.55 13.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -167.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -20.7 21.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.553 1.941 . . . . 0.0 114.272 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.64 -31.78 57.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.625 1.102 . . . . 0.0 111.468 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.51 -36.32 64.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.839 1.256 . . . . 0.0 113.025 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.88 -20.05 64.25 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 111.633 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 43.4 mt -89.47 -12.52 39.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.008 1.323 . . . . 0.0 113.228 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -40.28 46.35 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.925 0.89 . . . . 0.0 111.176 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.34 137.74 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 128.013 2.525 . . . . 0.0 110.243 168.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.3 157.31 31.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.283 1.033 . . . . 0.0 112.947 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -50.34 -36.7 33.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.94 1.296 . . . . 0.0 112.68 171.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -66.58 -25.65 66.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.601 1.161 . . . . 0.0 113.483 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.4 -3.35 10.48 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.956 1.302 . . . . 0.0 113.843 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -56.88 -40.94 88.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.851 -1.781 . . . . 0.0 113.218 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -61.3 -26.82 82.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.606 2.204 . . . . 0.0 113.386 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 46.8 m -76.18 -35.0 59.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.377 1.071 . . . . 0.0 111.211 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -62.06 -47.26 85.47 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.204 1.002 . . . . 0.0 113.228 174.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.78 -36.59 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 118.34 0.518 . . . . 0.0 110.926 170.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.51 -55.29 17.42 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 125.267 1.413 . . . . 0.0 113.711 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -59.89 -33.95 72.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.23 2.015 . . . . 0.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.6 -47.74 30.59 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.472 -0.768 . . . . 0.0 112.943 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.08 -32.44 50.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.71 1.141 . . . . 0.0 112.847 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.77 55.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.067 1.347 . . . . 0.0 112.066 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.44 HD22 HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -69.4 -30.61 68.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.76 0.824 . . . . 0.0 110.95 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -68.11 -25.79 65.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.149 0.979 . . . . 0.0 113.218 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -80.18 -22.48 41.9 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -151.95 -130.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.245 1.418 . . . . 0.0 111.25 -169.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -163.82 -38.28 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.396 1.878 . . . . 0.0 114.023 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.49 164.86 40.96 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 127.377 2.271 . . . . 0.0 109.593 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -87.65 15.09 2.22 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.395 2.063 . . . . 0.0 114.26 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.12 -30.23 67.98 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.135 1.334 . . . . 0.0 113.239 -170.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.29 8.37 18.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.538 1.535 . . . . 0.0 114.259 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.17 127.64 33.5 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.938 -1.101 . . . . 0.0 112.045 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.53 14.05 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 126.201 1.8 . . . . 0.0 111.574 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 31' ' ' THR . 2.6 tm? 57.72 109.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.427 3.091 . . . . 0.0 110.439 -168.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -85.68 51.89 2.32 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.071 -1.643 . . . . 0.0 112.838 -167.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.31 0.4 OUTLIER -70.44 -11.82 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.744 -1.223 . . . . 0.0 113.564 -169.453 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -52.66 -34.09 50.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.362 . . . . 0.0 111.077 167.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.53 -58.39 1.85 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 113.002 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -43.53 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 118.301 1.051 . . . . 0.0 113.312 -174.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.96 64.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.996 1.271 . . . . 0.0 112.642 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 73.8 m -70.03 -38.77 75.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 112.097 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.93 -24.98 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.728 1.611 . . . . 0.0 114.011 -169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.4 m -43.56 -56.25 7.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 120.283 1.401 . . . . 0.0 113.525 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.62 -9.43 18.29 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.038 2.492 . . . . 0.0 114.587 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.94 -64.52 1.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.098 1.359 . . . . 0.0 112.225 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.479 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -71.86 -21.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.68 -40.76 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.845 1.202 . . . . 0.0 112.17 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.67 -47.93 13.33 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.218 1.007 . . . . 0.0 111.307 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' B' ' 151' ' ' ILE . . . -65.67 -37.39 86.38 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.543 -1.348 . . . . 0.0 113.069 -169.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -76.26 -8.66 57.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.94 -37.27 14.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.111 1.323 . . . . 0.0 111.685 169.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -75.64 -31.51 59.86 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -129.02 54.3 1.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.702 1.201 . . . . 0.0 111.752 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -52.35 -32.21 37.15 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.861 1.664 . . . . 0.0 113.075 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -90.02 -6.63 55.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.301 1.44 . . . . 0.0 114.05 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.2 156.71 31.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.95 0.796 . . . . 0.0 110.867 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -69.19 137.59 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.738 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -65.36 -38.63 90.66 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.062 -1.024 . . . . 0.0 112.721 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -59.35 -37.88 78.98 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.426 -0.796 . . . . 0.0 112.833 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.8 -35.27 76.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.27 0.628 . . . . 0.0 111.96 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -72.95 -37.9 66.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.237 -0.887 . . . . 0.0 113.235 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 14.2 m -64.45 -38.19 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.127 1.33 . . . . 0.0 111.285 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -63.79 -44.86 92.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.38 0.672 . . . . 0.0 111.948 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.1 98.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.303 0.954 . . . . 0.0 113.256 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.54 -36.06 65.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.464 1.132 . . . . 0.0 113.066 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -57.89 -41.57 82.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.406 1.003 . . . . 0.0 111.408 171.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.26 -47.56 81.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.603 1.161 . . . . 0.0 111.231 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -26.59 68.59 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.487 -1.383 . . . . 0.0 112.452 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.72 -46.62 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.982 1.713 . . . . 0.0 112.914 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -100.44 -58.49 1.89 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -63.57 -36.75 84.81 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.724 1.21 . . . . 0.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.58 48.37 21.51 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.245 2.218 . . . . 0.0 113.485 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 C--O 1.254 1.299 0 C-N-CA 126.541 1.936 . . . . 0.0 114.352 -176.361 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.86 -26.49 66.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.24 47.8 23.16 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.93 -74.22 0.14 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.382 0.673 . . . . 0.0 111.741 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 41.44 46.19 2.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.165 2.186 . . . . 0.0 114.266 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.43 36.26 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.447 1.899 . . . . 0.0 115.349 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.84 -22.32 62.34 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.349 -1.469 . . . . 0.0 112.206 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.03 -21.14 66.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.706 1.202 . . . . 0.0 113.699 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -126.77 21.81 6.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.535 1.534 . . . . 0.0 111.989 169.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 35.3 73.4 0.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.31 2.644 . . . . 0.0 114.504 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -113.1 58.17 0.63 Allowed Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 124.841 1.256 . . . . 0.0 114.209 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.27 169.44 18.27 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.22 2.613 . . . . 0.0 112.137 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -62.67 -15.26 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -96.88 2.1 51.31 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.476 1.51 . . . . 0.0 113.607 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 m -137.97 -17.95 1.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.18 173.19 11.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.8 p -105.63 159.43 15.97 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.051 0.941 . . . . 0.0 111.706 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -21.32 43.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.63 -37.52 70.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.617 1.099 . . . . 0.0 111.46 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -67.68 -23.29 65.29 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.128 -0.983 . . . . 0.0 112.628 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.53 -11.05 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.877 -1.139 . . . . 0.0 111.908 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -98.34 -11.02 22.95 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.269 1.428 . . . . 0.0 112.663 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.96 -30.96 44.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.151 0.98 . . . . 0.0 111.73 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.85 137.23 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.767 2.027 . . . . 0.0 111.07 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.26 158.24 26.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 113.198 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -53.81 -33.47 56.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.956 1.302 . . . . 0.0 111.974 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 m -60.83 -27.71 68.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 113.623 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -127.18 -2.26 6.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 113.408 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.45 -43.44 98.08 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 119.91 -1.744 . . . . 0.0 112.348 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.84 -25.95 82.18 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.851 2.368 . . . . 0.0 113.367 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 HD21 ' B' ' 139' ' ' LEU . 52.3 m -76.23 -34.76 59.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.061 0.944 . . . . 0.0 111.531 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.63 1.172 . . . . 0.0 113.348 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.88 -34.54 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.92 0.782 . . . . 0.0 110.436 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.1 -46.05 79.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.614 1.578 . . . . 0.0 114.902 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.6 -41.62 83.75 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 121.361 2.58 . . . . 0.0 111.953 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.14 98.78 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.474 0.71 . . . . 0.0 112.173 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -85.24 -38.65 18.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.308 0.643 . . . . 0.0 112.524 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.24 63.8 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.28 -1.512 . . . . 0.0 111.146 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.51 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -72.58 -18.24 61.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.123 0.569 . . . . 0.0 111.726 -174.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -72.5 -21.71 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 113.029 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -98.04 -20.32 17.45 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.33 153.89 1.61 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 129.156 2.983 . . . . 0.0 106.56 -170.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.41 -17.92 19.39 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 128.836 2.854 . . . . 0.0 115.035 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -133.28 152.58 79.67 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.414 1.885 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -86.41 4.46 6.37 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.793 1.662 . . . . 0.0 114.503 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.15 -24.6 63.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.486 1.114 . . . . 0.0 112.439 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -111.36 15.38 21.37 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.536 1.934 . . . . 0.0 112.579 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.57 117.13 22.93 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 119.769 -1.832 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.28 107.92 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? -57.32 126.77 28.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -165.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -98.01 52.25 1.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.422 1.489 . . . . 0.0 112.298 -170.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.24 -30.75 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.128 -0.983 . . . . 0.0 112.16 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -60.27 -34.78 74.21 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.256 1.389 . . . . 0.0 112.064 175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.31 -55.06 5.3 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.204 0.906 . . . . 0.0 112.835 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.19 -42.24 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.026 -1.279 . . . . 0.0 112.394 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.28 64.99 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.687 -1.258 . . . . 0.0 112.872 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -69.8 -44.07 70.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 0.0 111.616 172.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.5 -20.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -43.23 -62.51 1.33 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.751 1.62 . . . . 0.0 112.371 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.17 -0.6 6.66 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.743 2.962 . . . . 0.0 114.485 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.68 -61.37 1.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.743 1.617 . . . . 0.0 109.766 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.14 -35.01 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.72 0.808 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.94 -43.6 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.872 0.869 . . . . 0.0 112.217 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.53 -46.83 45.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.356 0.598 . . . . 0.0 110.164 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.02 72.06 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.885 0.874 . . . . 0.0 113.039 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -75.86 -13.26 60.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.61 -33.68 16.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.111 1.323 . . . . 0.0 111.072 167.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -59.67 -40.44 87.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.403 1.081 . . . . 0.0 111.714 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -138.95 71.72 1.39 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -51.99 -31.17 28.2 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.649 1.18 . . . . 0.0 113.149 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -92.32 1.29 57.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 113.067 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.59 150.98 42.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.083 0.953 . . . . 0.0 112.053 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -93.38 103.03 15.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.938 1.295 . . . . 0.0 112.451 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.258 14.7 p90 43.12 -144.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -53.88 -17.13 2.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.644 2.778 . . . . 0.0 115.176 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.13 -27.84 62.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.168 0.987 . . . . 0.0 112.41 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -65.99 -43.34 88.06 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.733 1.151 . . . . 0.0 112.42 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.99 -38.08 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.138 0.881 . . . . 0.0 111.126 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.07 -45.18 93.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.703 0.801 . . . . 0.0 111.874 171.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.82 -43.5 98.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.93 1.252 . . . . 0.0 113.261 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.96 -35.33 69.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.039 1.42 . . . . 0.0 112.754 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -61.48 -41.26 96.99 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.909 -1.119 . . . . 0.0 111.479 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.91 -46.43 89.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.649 1.18 . . . . 0.0 111.853 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -26.66 68.48 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.004 -1.06 . . . . 0.0 111.735 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 mt -81.69 -45.49 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.28 1.032 . . . . 0.0 112.351 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -104.42 -59.04 1.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.342 1.457 . . . . 0.0 113.217 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.08 -28.68 67.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.809 1.643 . . . . 0.0 113.631 -171.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.91 -56.6 4.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.774 0.829 . . . . 0.0 113.022 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.992 2.117 . . . . 0.0 110.966 178.264 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -82.86 -9.39 59.34 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.46 174.97 10.05 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.02 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 57.09 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.004 1.722 . . . . 0.0 114.051 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -96.26 28.51 3.22 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -169.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.11 -27.13 42.91 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.259 1.023 . . . . 0.0 112.42 171.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.79 152.53 43.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.491 1.917 . . . . 0.0 110.01 167.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -107.59 -19.04 13.68 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.308 1.443 . . . . 0.0 114.1 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -77.09 -9.77 58.95 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.733 -1.23 . . . . 0.0 113.521 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -74.63 -82.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.52 1.928 . . . . 0.0 115.777 -170.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -129.43 57.19 28.68 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.103 1.761 . . . . 0.0 114.585 -171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.48 157.85 6.51 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.178 2.585 . . . . 0.0 114.175 168.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -58.32 -22.98 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -79.12 -18.1 53.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.226 . . . . 0.0 114.147 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -127.4 -23.16 3.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.49 161.64 30.53 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.962 0.887 . . . . 0.0 112.845 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 50.1 p -93.99 167.2 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.646 1.212 . . . . 0.0 114.086 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.83 -26.55 66.98 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.08 -40.93 97.32 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.977 -1.077 . . . . 0.0 110.495 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.1 -31.4 72.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.106 0.563 . . . . 0.0 112.069 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -69.75 -26.75 64.46 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.47 -11.85 59.62 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.031 -1.043 . . . . 0.0 113.666 170.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.27 38.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.315 0.961 . . . . 0.0 112.866 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.51 141.91 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.045 1.738 . . . . 0.0 110.823 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.17 157.79 32.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.374 1.069 . . . . 0.0 113.346 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.34 -31.48 54.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.551 1.54 . . . . 0.0 112.04 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -61.54 -27.92 68.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.8 1.64 . . . . 0.0 114.079 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.62 -4.37 5.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.365 1.466 . . . . 0.0 112.697 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -57.02 -45.89 99.92 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 120.078 -1.639 . . . . 0.0 111.696 169.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -64.95 -22.52 62.69 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.356 2.038 . . . . 0.0 113.67 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.684 HG22 HD21 ' A' ' 50' ' ' LEU . 65.0 m -73.26 -35.81 66.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.988 0.915 . . . . 0.0 110.531 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.4 -41.91 84.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.04 -33.53 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.243 1.383 . . . . 0.0 110.875 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.94 -55.14 29.41 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 124.485 1.041 . . . . 0.0 111.912 168.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.76 -10.7 29.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 120.857 2.329 . . . . 0.0 114.408 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.15 -62.76 1.37 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.54 0.736 . . . . 0.0 110.051 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -73.43 -28.97 62.26 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.72 -1.237 . . . . 0.0 114.115 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.82 78.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.102 1.761 . . . . 0.0 112.274 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -85.53 -37.79 19.26 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.737 1.215 . . . . 0.0 110.082 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -59.58 -38.67 81.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.59 1.156 . . . . 0.0 113.381 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -91.4 -9.59 44.17 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 -128.49 0.09 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.663 1.585 . . . . 0.0 110.974 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -162.6 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.279 1.431 . . . . 0.0 113.24 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -135.76 165.6 34.8 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 127.283 2.233 . . . . 0.0 109.834 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.08 2.09 8.72 Favored 'Trans proline' 0 C--N 1.354 0.868 0 CA-C-N 121.429 1.546 . . . . 0.0 114.136 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.22 -28.36 67.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.446 1.098 . . . . 0.0 112.6 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.93 -20.23 30.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.281 1.432 . . . . 0.0 113.306 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.62 123.9 24.91 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.021 -1.049 . . . . 0.0 112.983 -169.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.31 17.18 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 126.202 1.801 . . . . 0.0 110.897 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 31' ' ' THR . 1.7 tm? 52.63 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.983 3.713 . . . . 0.0 110.127 -166.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.14 48.77 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.488 . . . . 0.0 112.425 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.289 3.9 p -70.77 -11.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -169.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.26 -29.73 24.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.611 1.564 . . . . 0.0 112.921 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.68 -55.62 1.88 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.71 0.671 . . . . 0.0 113.128 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 10.1 mt -51.16 -45.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.8 1.24 . . . . 0.0 113.282 -172.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.29 -28.79 63.32 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.611 1.096 . . . . 0.0 112.848 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 18.8 m -73.38 -41.59 63.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.897 1.279 . . . . 0.0 111.908 170.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.405 HG12 HD12 ' B' ' 151' ' ' ILE . 34.4 t -78.81 -28.9 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.076 1.75 . . . . 0.0 112.89 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.0 m -51.75 -63.76 1.88 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 125.697 1.599 . . . . 0.0 113.144 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.23 -18.59 61.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.745 2.297 . . . . 0.0 113.219 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.7 -58.84 3.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.893 0.877 . . . . 0.0 110.802 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.405 HD12 HG12 ' B' ' 147' ' ' VAL . 31.8 mt -72.59 -28.92 28.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 O-C-N 121.372 -0.83 . . . . 0.0 112.402 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -51.1 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 110.618 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.22 -47.42 70.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.719 0.408 . . . . 0.0 110.903 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.09 71.18 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.739 -1.225 . . . . 0.0 113.239 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.3 m -75.35 -12.7 60.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.09 -35.55 16.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.483 1.492 . . . . 0.0 110.945 167.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -58.1 -38.13 75.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.009 0.924 . . . . 0.0 111.95 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.6 57.33 1.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.567 1.147 . . . . 0.0 112.85 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -52.12 -40.33 61.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.047 1.739 . . . . 0.0 112.968 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -80.53 -7.58 59.26 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.07 165.6 17.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.239 1.016 . . . . 0.0 112.657 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -62.57 138.79 58.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.851 1.261 . . . . 0.0 110.739 170.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.41 -43.7 88.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.253 1.021 . . . . 0.0 113.294 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -65.19 -30.53 71.44 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.224 -0.923 . . . . 0.0 112.446 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.69 -38.46 81.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.472 1.109 . . . . 0.0 112.128 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -39.57 72.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.87 0.868 . . . . 0.0 112.577 172.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.91 -47.03 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 118.594 0.634 . . . . 0.0 110.302 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.16 -50.06 65.24 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.466 1.106 . . . . 0.0 111.921 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.63 98.94 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.599 1.095 . . . . 0.0 113.779 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -73.96 -33.14 63.77 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.751 1.275 . . . . 0.0 112.584 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.81 -37.26 86.04 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.965 -1.084 . . . . 0.0 111.852 170.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.83 -46.77 86.36 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.352 -0.843 . . . . 0.0 111.048 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -23.18 66.41 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 119.91 -1.744 . . . . 0.0 112.609 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -78.05 -46.58 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.358 1.863 . . . . 0.0 112.74 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.43 -52.88 3.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.904 1.281 . . . . 0.0 113.203 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -68.8 -37.78 79.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.39 1.476 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.6 t0 51.52 49.76 20.24 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.471 1.908 . . . . 0.0 112.956 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.93 1.692 . . . . 0.0 113.267 -179.276 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -140.95 41.66 1.82 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.497 1.519 . . . . 0.0 110.461 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.67 147.9 20.64 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.006 1.323 . . . . 0.0 109.154 -169.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -169.63 -161.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.042 0.937 . . . . 0.0 111.417 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -68.82 -34.66 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.43 -96.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.704 1.602 . . . . 0.0 113.798 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.6 1.2 56.75 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.386 1.474 . . . . 0.0 114.544 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.9 -4.73 0.59 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.124 2.57 . . . . 0.0 116.169 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -130.68 5.15 4.65 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -169.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -90.7 -46.77 8.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -125.2 41.44 0.63 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.635 1.174 . . . . 0.0 113.549 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -65.83 153.97 75.9 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 112.426 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.81 -29.28 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.306 1.443 . . . . 0.0 114.507 -169.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.19 -15.96 57.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 114.13 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 t -110.95 -38.23 5.15 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 113.345 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -85.25 169.85 13.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.309 1.052 . . . . 0.0 113.597 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.5 p -99.93 161.15 13.79 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -19.51 49.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.572 1.949 . . . . 0.0 115.171 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.81 -34.98 70.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.792 1.178 . . . . 0.0 111.049 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.89 -26.53 68.65 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.081 -1.012 . . . . 0.0 112.802 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.66 -13.31 62.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.246 -0.909 . . . . 0.0 112.146 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.13 -19.36 18.72 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.644 1.178 . . . . 0.0 112.117 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.25 -37.45 32.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.759 1.224 . . . . 0.0 112.163 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.89 134.38 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 0.0 109.604 168.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.76 160.48 22.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 112.513 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.36 -36.63 73.76 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.134 -0.979 . . . . 0.0 111.788 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.6 m -59.65 -26.92 65.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.222 1.809 . . . . 0.0 113.728 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.45 -2.9 9.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.465 1.506 . . . . 0.0 112.76 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.2 mt-30 -59.07 -50.48 87.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 120.049 -1.657 . . . . 0.0 111.025 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 52.4 Cg_exo -67.69 -16.85 47.34 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.294 1.996 . . . . 0.0 113.622 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 m -75.75 -36.14 59.97 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.134 0.974 . . . . 0.0 110.912 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.18 83.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.464 1.106 . . . . 0.0 111.418 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.82 -47.41 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.257 1.023 . . . . 0.0 109.567 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 10.64 0.58 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.824 2.155 . . . . 0.0 117.209 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.64 -53.72 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.408 1.604 . . . . 0.0 109.945 167.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.7 85.11 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.221 -0.925 . . . . 0.0 112.655 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.3 -37.06 26.36 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.303 -0.873 . . . . 0.0 112.26 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.55 -49.21 72.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.993 -1.067 . . . . 0.0 111.778 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -18.32 61.03 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.956 0.902 . . . . 0.0 112.061 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -78.25 -21.97 49.06 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.062 -1.024 . . . . 0.0 112.916 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.69 -20.48 20.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.98 151.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.883 2.873 . . . . 0.0 106.969 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.95 -32.85 17.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.936 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -134.61 159.51 71.94 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 127.386 2.274 . . . . 0.0 109.736 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.2 15.92 2.05 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.698 1.599 . . . . 0.0 114.426 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -61.75 -21.96 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.935 1.294 . . . . 0.0 112.307 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.31 20.14 13.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.646 1.979 . . . . 0.0 112.438 173.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.85 109.38 16.93 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 119.493 -2.004 . . . . 0.0 110.875 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.94 8.03 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.038 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.839 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 49.17 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.518 3.927 . . . . 0.0 114.67 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -89.46 64.51 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.028 1.331 . . . . 0.0 111.475 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' CG ' ' B' ' 117' ' ' PHE . 0.7 OUTLIER -64.25 -39.1 84.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.073 -171.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.91 -36.55 84.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.366 1.439 . . . . 0.0 112.415 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.48 -48.91 59.9 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.676 0.655 . . . . 0.0 112.029 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.15 -42.79 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.528 1.131 . . . . 0.0 111.745 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.68 62.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.891 1.676 . . . . 0.0 113.159 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.1 m -72.62 -37.88 67.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.826 1.25 . . . . 0.0 111.463 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.81 -24.33 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.373 1.469 . . . . 0.0 113.626 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.8 m -49.65 -62.93 2.01 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 125.665 1.586 . . . . 0.0 112.619 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.93 -4.21 11.99 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.402 2.735 . . . . 0.0 113.926 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.35 -64.56 1.16 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.364 1.466 . . . . 0.0 108.807 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.94 -27.59 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.269 -0.894 . . . . 0.0 112.028 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -55.51 -48.43 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.674 1.189 . . . . 0.0 110.727 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.34 -48.06 18.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.546 0.688 . . . . 0.0 110.544 174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.71 69.89 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -169.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.1 m -76.94 -13.39 59.98 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -32.82 21.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.426 1.466 . . . . 0.0 110.757 168.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -61.24 -38.61 87.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.739 0.815 . . . . 0.0 112.089 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -135.81 58.72 1.74 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.379 1.471 . . . . 0.0 112.814 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -50.75 -36.1 34.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.562 -1.337 . . . . 0.0 113.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.61 -3.77 58.12 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.995 1.318 . . . . 0.0 113.624 -172.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.34 161.56 23.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.264 1.026 . . . . 0.0 111.496 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -65.52 134.64 53.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.844 1.258 . . . . 0.0 111.412 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -66.06 -52.27 50.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.397 -0.815 . . . . 0.0 112.826 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -62.33 -34.16 76.09 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.576 1.08 . . . . 0.0 112.297 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.6 -36.24 82.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.476 0.71 . . . . 0.0 112.152 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.0 -34.29 68.76 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.54 -46.2 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.089 0.556 . . . . 0.0 110.018 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -62.59 -43.4 98.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.763 0.825 . . . . 0.0 112.185 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.92 -44.38 98.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.018 1.294 . . . . 0.0 113.545 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.19 -35.1 68.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.784 1.292 . . . . 0.0 112.864 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -61.99 -38.06 87.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.909 1.232 . . . . 0.0 112.127 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.68 -49.85 75.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.537 1.135 . . . . 0.0 111.214 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -28.54 69.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.371 -1.456 . . . . 0.0 112.458 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.0 mt -77.98 -43.9 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.816 1.246 . . . . 0.0 112.541 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -102.48 -58.92 1.79 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.96 1.304 . . . . 0.0 113.223 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -66.42 -36.56 83.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.221 1.408 . . . . 0.0 111.316 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.67 42.9 24.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.939 2.096 . . . . 0.0 113.402 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.3 ttm . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.45 1.5 . . . . 0.0 112.592 -179.787 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.31 -25.81 1.93 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.89 51.9 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.282 -0.886 . . . . 0.0 112.641 -170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 58.99 -48.02 0.06 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.374 2.67 . . . . 0.0 116.232 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -73.95 9.96 1.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -171.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.48 128.25 36.12 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.609 -0.682 . . . . 0.0 110.529 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.02 23.48 0.46 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.084 0.954 . . . . 0.0 113.088 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -59.04 -29.41 67.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.775 1.23 . . . . 0.0 113.708 -168.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -140.29 30.98 1.94 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.182 2.593 . . . . 0.0 108.64 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 60.6 -50.5 0.1 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 129.499 3.12 . . . . 0.0 115.278 -167.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 52.44 28.73 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 127.922 2.489 . . . . 0.0 117.432 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.26 158.32 54.89 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 122.838 2.049 . . . . 0.0 110.962 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.41 -24.46 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -70.85 -25.91 63.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.259 1.024 . . . . 0.0 113.445 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -126.82 -18.5 4.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.27 1.428 . . . . 0.0 114.73 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -86.68 170.59 11.66 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.013 1.725 . . . . 0.0 111.835 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.3 p -104.45 156.24 18.11 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.342 1.057 . . . . 0.0 113.142 -170.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.353 0.3 OUTLIER -73.63 -3.21 26.65 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.98 -31.6 65.22 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.851 -1.155 . . . . 0.0 111.353 168.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.38 -35.75 60.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.226 1.01 . . . . 0.0 112.754 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.25 -15.47 63.58 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.214 -0.929 . . . . 0.0 112.64 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.5 mt -92.2 -19.22 22.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.164 0.986 . . . . 0.0 112.764 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.48 -25.69 20.18 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.555 1.542 . . . . 0.0 112.954 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.93 -2.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 t70 66.12 157.85 0.11 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 128.232 2.613 . . . . 0.0 116.611 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -55.47 -35.21 65.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.155 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 30.4 m -69.04 -24.09 64.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 52' ' ' VAL . 9.9 m-85 -127.71 4.67 6.09 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.546 1.138 . . . . 0.0 112.547 -174.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.84 -52.07 77.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 125.71 1.604 . . . . 0.0 111.998 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -61.52 -23.7 77.0 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.323 2.016 . . . . 0.0 113.573 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.839 HG22 HD21 ' A' ' 50' ' ' LEU . 23.2 m -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.007 1.323 . . . . 0.0 111.171 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.43 82.4 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.665 1.186 . . . . 0.0 113.793 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.5 -33.85 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 119.627 1.103 . . . . 0.0 110.458 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.8 -51.56 44.18 Favored Glycine 0 C--O 1.216 -0.973 0 C-N-CA 124.347 0.975 . . . . 0.0 112.795 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.65 -16.81 64.09 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.87 2.335 . . . . 0.0 113.862 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.78 -43.7 12.32 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.55 1.068 . . . . 0.0 112.211 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.55 -34.01 23.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.002 -1.061 . . . . 0.0 113.548 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.24 99.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.864 2.066 . . . . 0.0 112.69 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -34.19 34.47 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.242 1.017 . . . . 0.0 110.583 -175.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.09 -28.4 68.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -94.02 -1.73 54.05 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.53 -127.31 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.598 1.559 . . . . 0.0 111.248 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.26 -55.67 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.604 1.562 . . . . 0.0 113.513 -170.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -136.41 162.32 57.02 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 126.763 2.025 . . . . 0.0 110.446 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.31 6.01 5.05 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.729 1.619 . . . . 0.0 114.979 -174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.0 -29.37 43.03 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.944 0.898 . . . . 0.0 111.496 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -112.32 17.67 19.21 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.215 2.206 . . . . 0.0 113.117 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.94 134.78 38.54 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.174 -1.579 . . . . 0.0 113.955 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.41 -4.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.013 1.325 . . . . 0.0 113.828 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.26 119.16 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.878 2.471 . . . . 0.0 111.52 -167.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -81.95 53.25 2.15 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 119.608 -1.932 . . . . 0.0 112.016 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.404 0.6 OUTLIER -65.38 -46.9 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -163.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -60.54 -34.38 74.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.909 2.14 . . . . 0.0 111.783 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.35 -48.93 48.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.188 0.899 . . . . 0.0 112.424 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.21 -42.18 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 111.443 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.54 71.2 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.682 1.128 . . . . 0.0 112.817 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -66.35 -38.89 88.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.709 1.204 . . . . 0.0 111.682 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.6 -30.36 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.508 1.523 . . . . 0.0 113.212 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 37.0 m -45.19 -56.11 9.95 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 -7.59 16.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.445 2.763 . . . . 0.0 114.593 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -61.97 1.69 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.099 1.36 . . . . 0.0 111.658 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -70.77 -20.18 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 120.884 -1.135 . . . . 0.0 113.972 -176.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.39 -41.88 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.581 1.537 . . . . 0.0 112.018 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.01 -51.25 10.63 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 110.436 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.14 69.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.361 -1.462 . . . . 0.0 113.38 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 78.9 m -80.17 -7.37 58.91 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.73 -34.56 14.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.341 1.056 . . . . 0.0 110.44 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -60.91 -39.7 90.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.517 1.127 . . . . 0.0 112.229 171.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -142.49 54.85 1.42 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.948 0.899 . . . . 0.0 112.906 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -53.73 -37.24 63.13 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.427 1.891 . . . . 0.0 113.302 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.71 -8.85 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.842 1.257 . . . . 0.0 113.84 -169.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -83.88 166.81 17.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 112.078 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.57 139.0 56.49 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.172 1.389 . . . . 0.0 112.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -63.79 -46.97 82.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.564 1.146 . . . . 0.0 111.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -64.03 -38.52 91.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.854 0.862 . . . . 0.0 112.188 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.926 0.89 . . . . 0.0 111.952 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' B' ' 166' ' ' LYS . 0.1 OUTLIER -71.94 -43.39 65.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.189 -0.91 . . . . 0.0 113.234 174.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.37 -40.41 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.182 1.355 . . . . 0.0 111.669 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.11 -42.99 93.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.875 0.87 . . . . 0.0 112.258 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.2 -45.3 96.81 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.312 0.958 . . . . 0.0 112.983 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.77 -33.74 64.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.485 1.142 . . . . 0.0 112.973 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -59.43 -41.83 90.45 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.862 1.21 . . . . 0.0 111.943 170.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.51 -47.26 84.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.562 1.145 . . . . 0.0 111.943 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.36 68.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.161 -0.962 . . . . 0.0 112.061 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.49 -50.89 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.886 1.674 . . . . 0.0 112.175 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -100.79 -59.71 1.65 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.33 1.452 . . . . 0.0 113.322 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -67.66 -25.2 65.59 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.245 1.818 . . . . 0.0 113.749 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.1 -19.55 65.66 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.393 1.477 . . . . 0.0 114.307 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.121 1.768 . . . . 0.0 114.574 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.82 -14.63 31.5 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.16 177.58 8.87 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.147 1.379 . . . . 0.0 111.222 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 62.69 -54.6 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.171 2.588 . . . . 0.0 115.238 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.615 ' HE2' HG12 ' B' ' 138' ' ' VAL . 20.8 mmmt -78.5 -11.36 59.95 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.202 1.001 . . . . 0.0 113.266 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.91 -76.12 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.294 3.037 . . . . 0.0 116.505 168.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.38 90.86 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.952 0.796 . . . . 0.0 111.951 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.03 -34.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 129.452 3.101 . . . . 0.0 118.072 171.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -80.62 -1.05 40.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.279 1.432 . . . . 0.0 114.148 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.52 -175.5 4.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.563 1.945 . . . . 0.0 112.791 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 59.35 49.45 2.52 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 127.324 2.25 . . . . 0.0 114.927 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.53 163.95 37.33 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.669 2.912 . . . . 0.0 112.434 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.97 -20.08 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.107 1.363 . . . . 0.0 114.417 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -72.7 -35.31 67.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.105 0.962 . . . . 0.0 113.523 173.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 m -110.5 -21.89 11.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.769 1.227 . . . . 0.0 114.112 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -94.37 171.27 8.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.2 1.4 . . . . 0.0 112.219 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.5 p -107.5 166.21 10.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.838 1.304 . . . . 0.0 114.498 -168.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -19.18 35.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.983 1.713 . . . . 0.0 115.436 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.49 -32.81 63.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.92 1.236 . . . . 0.0 111.365 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.83 -32.21 67.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.939 0.896 . . . . 0.0 112.728 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -74.05 -14.68 61.04 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.81 -0.556 . . . . 0.0 112.142 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.0 mt -96.45 -18.89 19.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.47 1.108 . . . . 0.0 112.281 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.76 54.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.425 1.09 . . . . 0.0 111.951 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.41 138.29 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.563 1.545 . . . . 0.0 110.652 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.23 160.51 31.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.287 1.035 . . . . 0.0 112.987 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.23 -37.43 74.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.696 1.198 . . . . 0.0 111.786 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.67 -20.84 63.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.526 1.53 . . . . 0.0 113.873 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -126.73 -2.91 6.62 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.237 1.415 . . . . 0.0 113.001 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -55.51 -47.71 98.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.143 -1.598 . . . . 0.0 111.91 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -62.45 -23.06 74.81 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.764 2.31 . . . . 0.0 113.804 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 HD21 ' B' ' 139' ' ' LEU . 27.6 m -77.02 -36.79 56.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.749 1.22 . . . . 0.0 110.977 175.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.45 98.44 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 113.519 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.91 -35.77 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 119.417 1.008 . . . . 0.0 110.329 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.54 -48.19 49.79 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.327 1.441 . . . . 0.0 114.571 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.44 -39.69 89.05 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 121.253 2.526 . . . . 0.0 112.306 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.54 76.16 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.467 -0.771 . . . . 0.0 112.528 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -85.22 -38.81 18.51 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.06 -52.52 62.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.37 1.068 . . . . 0.0 110.878 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.432 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -68.78 -18.24 64.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.503 1.121 . . . . 0.0 111.732 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -80.17 -17.46 52.36 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.209 1.004 . . . . 0.0 113.386 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.27 3.3 p30 -123.39 11.12 9.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 150.21 1.49 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 129.73 3.212 . . . . 0.0 106.504 168.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -86.41 -31.8 21.24 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 128.563 2.745 . . . . 0.0 113.204 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.59 158.09 73.9 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 127.518 2.327 . . . . 0.0 109.375 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.35 5.58 6.17 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.023 1.401 . . . . 0.0 114.046 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.7 -16.36 63.32 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.603 -1.311 . . . . 0.0 112.724 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -103.58 3.98 35.19 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.339 1.855 . . . . 0.0 113.22 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.69 122.67 26.28 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 119.981 -1.699 . . . . 0.0 112.654 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.53 -7.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 125.161 1.384 . . . . 0.0 112.271 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.866 HD21 HG22 ' B' ' 120' ' ' THR . 2.0 tm? 62.53 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.826 3.25 . . . . 0.0 113.224 -171.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.07 58.17 4.04 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.775 1.23 . . . . 0.0 111.453 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.6 p -65.94 -22.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.995 -1.066 . . . . 0.0 113.459 -169.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -62.85 -49.82 73.36 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 121.157 1.799 . . . . 0.0 112.076 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.23 76.8 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.3 -44.26 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.281 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.4 68.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.95 1.705 . . . . 0.0 112.858 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 m -68.77 -36.58 78.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 73.5 t -90.8 -23.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.109 1.363 . . . . 0.0 113.523 -175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -44.27 -60.46 2.82 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 126.211 1.804 . . . . 0.0 112.477 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.5 -0.61 5.35 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.328 2.685 . . . . 0.0 114.462 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 -64.6 1.12 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.215 1.406 . . . . 0.0 110.584 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.04 -29.29 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.234 -0.916 . . . . 0.0 112.313 177.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 t -52.74 -48.33 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.988 1.315 . . . . 0.0 110.488 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.74 -47.88 11.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.435 0.636 . . . . 0.0 110.609 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.85 69.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.1 m -77.8 -12.05 59.94 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -33.64 16.66 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.133 1.333 . . . . 0.0 110.764 167.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -58.78 -38.63 78.93 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.507 1.123 . . . . 0.0 112.116 172.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -145.55 85.5 1.71 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.715 0.806 . . . . 0.0 112.293 170.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -57.73 -27.94 63.44 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.973 1.309 . . . . 0.0 112.505 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -92.26 -4.75 53.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.551 1.541 . . . . 0.0 112.943 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.54 154.37 41.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.542 1.137 . . . . 0.0 111.346 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -65.72 137.24 57.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.089 0.956 . . . . 0.0 111.544 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.04 -47.43 80.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.676 0.791 . . . . 0.0 112.64 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -61.69 -41.2 97.26 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.96 0.904 . . . . 0.0 111.479 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.28 -34.35 77.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.665 0.786 . . . . 0.0 112.34 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.58 -42.17 68.1 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.748 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.22 -38.53 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.159 1.345 . . . . 0.0 111.203 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -63.28 -45.1 93.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.179 0.592 . . . . 0.0 111.837 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.32 -44.71 97.28 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.958 1.266 . . . . 0.0 113.422 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.44 -35.41 70.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.972 1.386 . . . . 0.0 112.967 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -62.49 -41.26 98.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.644 1.111 . . . . 0.0 111.651 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.17 -48.82 80.12 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.788 1.235 . . . . 0.0 111.479 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.22 72.22 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.815 -1.178 . . . . 0.0 111.678 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt -76.93 -46.07 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.307 1.043 . . . . 0.0 112.375 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -101.89 -57.54 2.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.045 1.338 . . . . 0.0 113.136 -172.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.47 -34.94 79.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.88 1.272 . . . . 0.0 111.686 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t0 48.57 51.19 15.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.984 2.114 . . . . 0.0 112.828 171.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.459 1.904 . . . . 0.0 113.68 -175.178 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -106.08 -37.13 6.71 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -168.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.06 47.94 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.78 140.4 48.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 49.87 41.43 22.61 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.522 1.529 . . . . 0.0 114.62 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.35 45.69 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.253 0.621 . . . . 0.0 111.686 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.37 12.32 2.48 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -76.34 -22.14 55.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.88 1.272 . . . . 0.0 112.67 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.68 52.42 1.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.768 2.427 . . . . 0.0 107.585 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -47.99 122.72 5.36 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.83 72.42 52.86 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 127.865 2.466 . . . . 0.0 108.014 168.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.57 -176.96 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.66 2.907 . . . . 0.0 113.05 -171.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.35 0.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -108.24 15.57 24.0 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.279 1.832 . . . . 0.0 112.652 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 28.4 m -144.08 -43.83 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.52 120.17 32.1 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.301 0.955 . . . . 0.0 111.726 -174.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -71.04 169.23 15.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.045 1.738 . . . . 0.0 114.41 -169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -24.88 17.74 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.0 -35.75 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.907 1.231 . . . . 0.0 111.578 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.33 -20.68 58.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.198 0.999 . . . . 0.0 113.208 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -67.66 -25.22 65.6 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.086 -1.009 . . . . 0.0 111.292 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.35 -13.85 56.24 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.335 1.054 . . . . 0.0 113.17 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.04 -36.36 30.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.388 1.075 . . . . 0.0 113.07 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.07 139.47 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.052 1.341 . . . . 0.0 110.212 169.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.81 160.48 30.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.466 1.106 . . . . 0.0 113.289 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -58.98 -34.87 72.32 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 0.0 111.885 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -62.37 -22.1 65.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.547 1.539 . . . . 0.0 113.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -127.3 -3.13 6.25 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -60.95 -45.85 96.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 O-C-N 119.957 -1.714 . . . . 0.0 111.937 170.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.28 -28.92 85.35 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.004 2.469 . . . . 0.0 113.13 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 50' ' ' LEU . 61.1 m -70.15 -38.49 75.48 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.487 1.115 . . . . 0.0 110.743 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.08 95.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.172 1.389 . . . . 0.0 114.457 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.74 -33.41 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 119.984 1.266 . . . . 0.0 110.824 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.99 -55.28 26.72 Favored Glycine 0 C--O 1.217 -0.937 0 C-N-CA 124.292 0.949 . . . . 0.0 112.65 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -64.81 -11.36 36.26 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.504 2.152 . . . . 0.0 114.386 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.61 -62.64 1.44 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.84 0.745 . . . . 0.0 110.169 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.46 -27.16 58.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.57 89.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.634 1.573 . . . . 0.0 112.069 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -83.14 -38.63 22.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.828 1.251 . . . . 0.0 110.241 -178.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -59.42 -33.18 70.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.792 1.237 . . . . 0.0 113.603 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.34 -11.49 37.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -143.51 -123.31 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.66 1.118 . . . . 0.0 113.744 -171.201 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.95 -68.89 0.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.894 1.278 . . . . 0.0 112.94 -168.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -139.38 167.01 20.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 127.588 2.355 . . . . 0.0 109.4 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.18 6.26 4.82 Favored 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.331 1.868 . . . . 0.0 114.439 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.76 -19.98 64.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.391 1.477 . . . . 0.0 111.434 168.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -113.12 11.63 18.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.854 2.062 . . . . 0.0 113.378 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.05 129.74 35.62 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 119.991 -1.693 . . . . 0.0 113.301 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' VAL . . . . . 0.615 HG12 ' HE2' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -123.11 -6.05 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 125.03 1.332 . . . . 0.0 113.143 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.799 HD21 HG22 ' A' ' 31' ' ' THR . 1.4 tm? 61.21 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.855 3.262 . . . . 0.0 112.96 -169.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.13 60.35 1.19 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.361 -1.462 . . . . 0.0 111.849 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.297 2.4 p -66.11 -21.57 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.75 -1.219 . . . . 0.0 113.225 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.673 1.579 . . . . 0.0 112.522 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.44 -50.36 26.84 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mt -61.7 -43.21 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.642 0.777 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.67 -28.46 64.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.548 1.522 . . . . 0.0 112.491 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 39.0 m -68.7 -42.67 77.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.112 0.965 . . . . 0.0 111.698 169.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' VAL . . . . . 0.435 HG12 HD12 ' B' ' 151' ' ' ILE . 31.5 t -84.24 -26.91 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.796 1.638 . . . . 0.0 113.503 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.2 m -50.51 -63.38 1.88 Allowed Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 126.184 1.793 . . . . 0.0 113.087 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.52 -25.89 70.06 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.924 1.75 . . . . 0.0 112.334 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -57.83 9.85 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.447 1.099 . . . . 0.0 110.341 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.435 HD12 HG12 ' B' ' 147' ' ' VAL . 27.7 mt -71.96 -31.92 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.442 -0.786 . . . . 0.0 111.957 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.71 -51.15 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.351 1.061 . . . . 0.0 110.393 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.35 -45.99 68.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.767 0.317 . . . . 0.0 111.159 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.19 -30.75 71.84 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.658 -1.276 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 29.2 m -73.85 -12.71 60.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -37.48 14.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.507 1.503 . . . . 0.0 110.78 166.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -57.3 -40.4 77.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.958 0.903 . . . . 0.0 111.806 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -142.15 72.71 1.38 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.481 1.112 . . . . 0.0 111.027 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -53.42 -31.06 43.4 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.116 1.766 . . . . 0.0 112.923 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.98 1.91 51.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.071 1.348 . . . . 0.0 113.114 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.41 152.98 36.66 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 114.305 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.18 59.27 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.351 1.86 . . . . 0.0 113.334 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 46.0 -103.73 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 165.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -47.07 -33.34 4.81 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.682 2.393 . . . . 0.0 113.716 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.0 -36.52 79.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.084 . . . . 0.0 112.807 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.4 -33.34 63.0 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.238 -0.914 . . . . 0.0 112.353 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.5 -48.79 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.709 0.803 . . . . 0.0 110.121 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.08 -42.81 99.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.979 0.911 . . . . 0.0 112.172 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.4 94.55 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.85 1.214 . . . . 0.0 113.48 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.61 -35.36 67.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.561 1.18 . . . . 0.0 112.608 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -60.66 -37.66 82.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.609 1.095 . . . . 0.0 112.216 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.77 -45.56 92.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.324 1.05 . . . . 0.0 111.933 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -24.45 67.24 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.584 -1.322 . . . . 0.0 112.438 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.41 -46.04 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.517 1.927 . . . . 0.0 112.821 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.07 -59.97 1.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.193 1.397 . . . . 0.0 113.45 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -64.83 -25.77 68.05 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.182 1.793 . . . . 0.0 113.553 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.45 -24.17 67.11 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--O 1.255 1.369 0 C-N-CA 127.64 2.376 . . . . 0.0 114.428 177.842 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.08 -33.78 2.17 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.79 148.51 50.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.686 -1.259 . . . . 0.0 112.003 -172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 68.73 -31.39 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 127.666 2.386 . . . . 0.0 114.247 -170.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.23 -38.49 51.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.246 1.418 . . . . 0.0 111.315 171.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.52 -19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 130.8 3.64 . . . . 0.0 118.39 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.46 -7.7 1.72 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.655 1.582 . . . . 0.0 114.819 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 60.25 -36.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.129 2.972 . . . . 0.0 117.622 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.55 -12.15 59.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.504 1.121 . . . . 0.0 112.866 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.79 168.98 10.32 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.584 1.954 . . . . 0.0 112.087 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 mttt 60.06 28.64 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.78 150.75 56.49 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.408 1.896 . . . . 0.0 111.81 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.9 5.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.833 1.653 . . . . 0.0 115.031 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -122.27 11.24 10.06 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.027 2.131 . . . . 0.0 113.914 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 m -141.02 -27.79 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -175.27 4.03 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -171.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.6 p -119.93 164.69 15.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.19 1.396 . . . . 0.0 114.391 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.12 -19.86 55.57 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.44 -37.14 79.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.228 1.376 . . . . 0.0 111.465 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.72 -20.3 63.53 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.377 -0.827 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -67.02 -18.45 65.37 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.874 -1.141 . . . . 0.0 111.631 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.12 -6.75 41.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.193 1.397 . . . . 0.0 112.704 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.94 -34.1 17.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.648 1.179 . . . . 0.0 112.04 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.0 137.75 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.016 1.326 . . . . 0.0 109.954 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.27 160.25 29.69 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.184 0.993 . . . . 0.0 112.804 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -58.44 -36.58 73.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 m -62.08 -21.87 65.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.653 1.581 . . . . 0.0 113.743 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -126.27 -3.57 6.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.575 1.55 . . . . 0.0 112.684 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -59.46 -46.58 98.85 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 120.103 -1.623 . . . . 0.0 110.996 171.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -28.33 87.2 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.195 2.597 . . . . 0.0 113.564 169.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 m -72.27 -35.6 68.8 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.034 0.934 . . . . 0.0 111.423 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.26 81.35 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.819 1.248 . . . . 0.0 113.927 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -36.69 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 119.377 0.989 . . . . 0.0 110.845 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.52 63.58 Favored Glycine 0 C--O 1.214 -1.11 0 C-N-CA 124.326 0.965 . . . . 0.0 112.826 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.11 -18.09 65.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 121.276 2.538 . . . . 0.0 113.988 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.37 -57.72 3.04 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.471 0.578 . . . . 0.0 110.444 165.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -76.46 -21.24 56.14 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.18 94.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.344 1.458 . . . . 0.0 111.107 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -84.2 -40.15 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.509 1.123 . . . . 0.0 110.642 -178.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -62.18 -30.09 70.82 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -93.41 -5.31 49.68 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -124.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.005 1.322 . . . . 0.0 112.274 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -161.79 -58.3 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.24 1.416 . . . . 0.0 113.932 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.14 162.43 48.0 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 127.615 2.366 . . . . 0.0 110.678 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.22 -1.77 11.96 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.811 1.674 . . . . 0.0 114.693 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -54.91 -27.87 46.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.893 1.277 . . . . 0.0 113.423 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -95.54 -11.27 27.67 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.098 1.359 . . . . 0.0 113.846 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 121.78 26.24 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.674 -1.266 . . . . 0.0 113.754 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.44 9.96 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 125.41 1.484 . . . . 0.0 111.701 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.742 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? 59.99 121.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.591 3.156 . . . . 0.0 111.992 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -87.11 45.62 1.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.619 -1.301 . . . . 0.0 111.963 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 3.0 p -66.19 -22.22 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.234 -1.541 . . . . 0.0 112.182 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.86 -33.5 66.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.845 1.258 . . . . 0.0 112.552 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.15 -59.56 1.94 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.619 1.104 . . . . 0.0 112.097 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.56 -44.77 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.709 -1.465 . . . . 0.0 112.949 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.97 -27.21 64.54 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.275 1.398 . . . . 0.0 112.435 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -66.96 -46.38 74.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.27 1.428 . . . . 0.0 111.955 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 62' ' ' ILE . 1.4 t -94.12 -18.08 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 m -42.52 -59.32 2.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 C-N-CA 125.676 1.591 . . . . 0.0 112.588 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.65 -2.69 9.77 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.352 2.701 . . . . 0.0 114.539 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.81 -58.1 2.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.959 1.304 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.53 -36.5 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 120.489 1.495 . . . . 0.0 112.123 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.5 -49.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.821 1.248 . . . . 0.0 110.62 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.98 -45.52 34.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.655 0.741 . . . . 0.0 110.986 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.78 70.02 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.781 0.832 . . . . 0.0 112.954 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.3 m -75.48 -13.2 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 170.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.13 -36.09 18.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.797 1.635 . . . . 0.0 110.516 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -57.02 -38.65 73.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.253 1.021 . . . . 0.0 111.813 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -144.92 84.55 1.72 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.534 0.683 . . . . 0.0 111.768 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -54.98 -31.34 60.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.105 1.362 . . . . 0.0 112.188 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.68 -0.93 57.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.272 1.429 . . . . 0.0 112.909 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.65 144.58 56.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.252 1.021 . . . . 0.0 111.72 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -77.75 160.89 28.1 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.377 1.084 . . . . 0.0 113.669 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -40.58 151.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.563 2.745 . . . . 0.0 115.13 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt 62.03 -38.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 129.487 3.115 . . . . 0.0 116.309 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.73 -31.86 70.01 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.846 1.659 . . . . 0.0 112.174 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -69.67 -43.91 71.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.71 -0.619 . . . . 0.0 112.509 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.03 -36.69 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.763 1.165 . . . . 0.0 111.459 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.15 -46.05 78.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.274 1.029 . . . . 0.0 111.949 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.87 96.97 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.824 1.202 . . . . 0.0 113.1 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -25.93 59.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.846 -1.385 . . . . 0.0 113.485 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -70.93 -42.32 70.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.479 -0.763 . . . . 0.0 111.248 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -58.23 -42.89 87.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.205 1.402 . . . . 0.0 111.68 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.18 -38.8 27.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.483 1.913 . . . . 0.0 114.212 170.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt -90.74 -42.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.241 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -102.96 -60.0 1.62 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 113.349 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -68.4 -25.65 65.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.347 1.459 . . . . 0.0 113.662 -171.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.99 -21.97 66.44 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.769 1.228 . . . . 0.0 114.07 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 125.198 1.399 . . . . 0.0 112.226 178.155 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -145.93 34.11 1.01 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.641 1.576 . . . . 0.0 111.005 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.38 146.0 24.17 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.256 18.4 pt20 40.54 -47.14 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 1 C-N-CA 132.962 4.505 . . . . 0.0 121.418 171.805 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -10.25 59.58 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.102 1.774 . . . . 0.0 115.04 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.31 -26.49 68.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.07 -26.37 56.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.63 -36.16 0.19 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.843 2.457 . . . . 0.0 116.184 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -77.29 42.63 0.35 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.567 1.947 . . . . 0.0 112.05 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -93.4 174.17 7.34 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 128.233 2.613 . . . . 0.0 115.277 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.68 89.2 7.31 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 127.342 2.257 . . . . 0.0 110.276 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.84 168.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 1 C-N-CA 126.24 4.627 . . . . 0.0 114.798 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.57 -21.26 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -74.33 -19.99 60.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.688 1.195 . . . . 0.0 113.565 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 70.0 m -122.46 -20.86 5.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.849 2.46 . . . . 0.0 113.953 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -53.09 140.97 24.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.367 2.667 . . . . 0.0 111.556 172.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -98.6 168.12 10.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.869 1.319 . . . . 0.0 112.866 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.36 -28.35 67.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.035 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -61.22 -43.58 98.64 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.078 -1.014 . . . . 0.0 110.327 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -66.64 -30.11 70.29 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.449 0.7 . . . . 0.0 112.139 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.409 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 73.7 t80 -67.69 -31.87 72.13 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.317 -1.489 . . . . 0.0 111.751 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.78 -9.3 58.48 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.03 44.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.769 1.168 . . . . 0.0 112.353 172.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.42 135.18 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.663 1.585 . . . . 0.0 110.145 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.22 157.77 34.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.375 1.07 . . . . 0.0 112.888 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.28 -34.26 72.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.271 1.028 . . . . 0.0 111.851 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.3 m -61.24 -25.55 67.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.421 1.888 . . . . 0.0 113.973 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.0 -6.11 7.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.246 1.018 . . . . 0.0 113.73 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.86 -43.49 98.66 Favored Pre-proline 0 N--CA 1.476 0.858 0 O-C-N 120.204 -1.56 . . . . 0.0 113.389 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -61.71 -27.73 81.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.932 2.421 . . . . 0.0 113.046 170.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.742 HG22 HD21 ' A' ' 50' ' ' LEU . 26.2 m -74.24 -36.84 63.92 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.903 1.281 . . . . 0.0 111.294 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.19 93.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.015 1.326 . . . . 0.0 113.996 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.06 -33.07 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 119.422 1.01 . . . . 0.0 110.767 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.54 -51.08 50.49 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 125.492 1.52 . . . . 0.0 114.099 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.43 -32.78 74.59 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.283 2.542 . . . . 0.0 112.419 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.46 -54.02 19.7 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.046 0.839 . . . . 0.0 111.21 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.44 -22.59 40.98 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.63 -46.19 32.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.594 1.158 . . . . 0.0 111.056 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.41 HD13 HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -75.97 -33.99 59.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.009 -176.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -73.13 -10.3 59.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -101.61 -11.27 19.35 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.61 -129.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.084 1.354 . . . . 0.0 112.303 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -161.64 -51.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.141 1.776 . . . . 0.0 113.189 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -132.66 166.93 25.42 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.339 2.256 . . . . 0.0 109.757 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.87 12.43 2.87 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 114.183 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.78 -14.62 62.86 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.679 -1.263 . . . . 0.0 113.934 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -119.89 4.68 10.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 113.518 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.29 134.2 41.13 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.911 -1.118 . . . . 0.0 113.605 -169.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.37 136.6 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.902 2.081 . . . . 0.0 107.317 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.28 119.95 11.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.461 1.028 . . . . 0.0 109.163 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.4 54.65 3.23 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.698 -1.251 . . . . 0.0 110.996 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 1.5 p -67.03 -25.03 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -165.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -63.04 -41.63 99.56 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 121.161 1.801 . . . . 0.0 111.133 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.08 -49.31 34.73 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 123.984 0.802 . . . . 0.0 111.416 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.22 -43.18 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.869 0.868 . . . . 0.0 111.533 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.15 -31.75 68.08 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 120.253 1.388 . . . . 0.0 112.726 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m -65.36 -42.84 92.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.097 0.959 . . . . 0.0 111.568 170.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -82.73 -29.41 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.978 1.311 . . . . 0.0 113.047 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.6 m -43.48 -61.05 2.06 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 126.113 1.765 . . . . 0.0 113.77 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.16 -14.44 44.35 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.577 2.185 . . . . 0.0 113.367 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.66 -63.47 1.16 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.131 0.972 . . . . 0.0 110.838 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -66.94 -25.53 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.05 -1.031 . . . . 0.0 113.141 177.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.69 -51.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.605 1.093 . . . . 0.0 110.753 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.39 -47.21 51.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.935 0.397 . . . . 0.0 111.057 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.54 -28.32 69.08 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.662 -1.274 . . . . 0.0 113.175 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.96 -15.89 60.09 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 169.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -30.32 21.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 111.202 168.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -61.23 -38.38 86.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.875 0.87 . . . . 0.0 112.535 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.68 88.16 1.68 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.636 0.774 . . . . 0.0 111.922 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.93 -41.91 68.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.356 1.462 . . . . 0.0 111.579 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -79.51 -3.24 45.85 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.8 153.07 44.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.012 0.925 . . . . 0.0 112.071 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.69 134.0 46.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 0.0 109.333 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.409 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 46.2 t80 -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.289 -0.882 . . . . 0.0 112.663 -175.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -62.67 -40.14 96.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.209 0.913 . . . . 0.0 111.588 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.31 -38.97 93.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.557 0.743 . . . . 0.0 111.913 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.72 -37.14 73.48 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.953 0.797 . . . . 0.0 113.027 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.45 -48.33 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.173 0.989 . . . . 0.0 110.116 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -64.07 -47.36 80.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.989 0.916 . . . . 0.0 112.011 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.91 99.39 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.627 1.108 . . . . 0.0 113.269 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -73.12 -35.83 66.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.225 -1.162 . . . . 0.0 112.792 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -60.53 -38.16 83.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.633 1.106 . . . . 0.0 111.881 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.87 -44.68 96.32 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.395 -0.815 . . . . 0.0 111.611 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -19.33 65.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.838 -1.164 . . . . 0.0 112.558 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.3 -41.48 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.466 1.906 . . . . 0.0 112.973 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.92 -60.51 1.74 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.796 1.239 . . . . 0.0 113.441 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -62.68 -29.66 70.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.022 1.329 . . . . 0.0 113.468 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.2 -15.43 61.01 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 C--O 1.255 1.384 0 C-N-CA 124.96 1.304 . . . . 0.0 113.629 -172.729 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 55.6 -11.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 120.802 3.63 . . . . 0.0 120.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.58 27.16 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 121.575 1.989 . . . . 0.0 114.718 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.55 12.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.082 1.353 . . . . 0.0 112.854 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -123.68 28.86 6.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.363 1.865 . . . . 0.0 112.829 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.44 69.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.564 1.145 . . . . 0.0 113.548 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.87 88.19 6.35 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -73.52 49.77 0.3 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.184 2.194 . . . . 0.0 113.503 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -151.88 -25.29 0.19 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.739 1.616 . . . . 0.0 115.176 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER -94.43 -21.63 18.81 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 119.965 3.321 . . . . 0.0 119.965 -166.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -131.99 53.47 11.44 Favored Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 171.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.91 156.32 66.35 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.071 2.514 . . . . 0.0 114.035 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.53 -12.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -104.76 -4.26 22.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.318 1.447 . . . . 0.0 114.807 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -124.36 -28.31 3.67 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -92.5 151.84 19.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.151 0.977 . . . . 0.0 111.484 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -85.47 170.07 13.01 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.49 -18.78 3.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.845 1.658 . . . . 0.0 114.732 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -51.7 -28.99 16.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 111.961 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -46.35 -42.06 14.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.206 1.402 . . . . 0.0 113.178 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.32 -15.25 61.89 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.98 -18.11 17.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.02 1.328 . . . . 0.0 111.799 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.92 -37.46 22.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.501 1.52 . . . . 0.0 112.374 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.49 137.72 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.593 1.557 . . . . 0.0 110.744 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.59 159.56 31.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 112.923 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.85 -36.19 74.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.889 -1.132 . . . . 0.0 111.97 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -60.43 -25.53 66.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.732 1.613 . . . . 0.0 113.857 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -124.33 -2.41 8.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.591 1.556 . . . . 0.0 112.96 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -53.92 -46.72 98.45 Favored Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 120.28 -1.513 . . . . 0.0 111.794 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -70.71 -16.42 33.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.226 1.951 . . . . 0.0 113.459 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.2 m -75.74 -33.84 60.28 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.047 -1.033 . . . . 0.0 111.136 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.51 82.0 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.406 -0.809 . . . . 0.0 111.569 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 t -59.1 -49.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.388 1.075 . . . . 0.0 109.031 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.8 19.1 0.32 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 126.321 1.915 . . . . 0.0 116.874 172.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.56 -63.14 1.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.404 1.881 . . . . 0.0 109.101 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.96 93.16 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.158 -0.964 . . . . 0.0 112.337 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -86.52 -28.82 23.14 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.708 -0.62 . . . . 0.0 112.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.05 -48.12 81.65 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.36 -1.462 . . . . 0.0 112.013 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -74.1 -26.78 60.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.268 0.627 . . . . 0.0 111.302 -178.161 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.82 -26.44 68.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.617 1.167 . . . . 0.0 113.672 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.85 -1.22 43.56 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -171.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -125.61 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.757 1.623 . . . . 0.0 111.255 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -167.14 -46.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.363 2.265 . . . . 0.0 112.399 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -129.36 165.69 30.85 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 127.991 2.517 . . . . 0.0 109.938 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.74 15.73 2.14 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.231 1.954 . . . . 0.0 114.527 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -61.36 -33.44 73.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.376 1.07 . . . . 0.0 112.071 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.22 23.91 11.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.478 1.911 . . . . 0.0 113.575 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 118.2 19.42 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.613 -1.305 . . . . 0.0 110.827 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 t -106.91 -11.31 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.218 1.007 . . . . 0.0 113.101 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.915 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 64.91 113.24 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.946 2.498 . . . . 0.0 111.164 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -95.1 64.05 2.72 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.337 5.2 p -70.45 -21.66 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 111.74 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' B' ' 92' ' ' ALA . 20.0 tm0? -54.11 -48.8 70.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.981 0.81 . . . . 0.0 110.991 168.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.98 -52.16 5.48 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.9 mt -56.83 -46.25 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.35 69.55 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.277 1.399 . . . . 0.0 112.781 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.3 m -78.24 -34.81 48.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.104 1.362 . . . . 0.0 112.098 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 62' ' ' ILE . 76.9 t -88.29 -19.9 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.713 1.605 . . . . 0.0 112.77 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.8 m -43.77 -61.07 2.14 Favored Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 126.235 1.814 . . . . 0.0 112.866 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.31 -0.19 6.19 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.329 2.686 . . . . 0.0 114.348 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.56 -64.23 1.18 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.885 1.274 . . . . 0.0 110.614 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.488 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.1 -31.65 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.068 -1.02 . . . . 0.0 113.216 177.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.35 -46.54 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.252 0.933 . . . . 0.0 110.713 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -73.82 -47.52 37.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.069 0.548 . . . . 0.0 111.329 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.19 73.77 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.428 -0.795 . . . . 0.0 112.989 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.5 m -75.42 -16.62 60.33 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.979 -1.076 . . . . 0.0 113.315 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -30.22 47.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.716 1.598 . . . . 0.0 110.917 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -61.1 -36.41 79.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.774 0.83 . . . . 0.0 112.789 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -142.47 76.45 1.53 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -54.45 -37.16 64.86 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.965 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -86.72 -0.21 55.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.058 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.89 29.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.957 0.903 . . . . 0.0 112.492 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -85.64 53.67 2.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.16 1.384 . . . . 0.0 110.475 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -102.33 90.5 3.92 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -166.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -68.41 -22.49 64.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.111 -0.993 . . . . 0.0 109.327 162.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.26 -24.81 66.65 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.237 1.815 . . . . 0.0 112.802 168.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -63.4 -40.43 97.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 0.0 110.49 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.58 -50.77 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.852 1.261 . . . . 0.0 110.294 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -63.5 -42.0 98.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.196 0.598 . . . . 0.0 112.022 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.78 93.11 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.135 1.35 . . . . 0.0 112.76 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.55 -31.33 63.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.802 1.301 . . . . 0.0 113.481 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.404 ' CZ2' ' HE2' ' A' ' 86' ' ' LYS . 57.7 t-105 -62.12 -43.97 97.66 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 169.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.79 -41.45 97.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.455 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -25.25 66.94 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 mt -102.62 -45.66 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.01 1.324 . . . . 0.0 112.403 -174.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.404 ' HE2' ' CZ2' ' A' ' 82' ' ' TRP . 17.8 mmmt -93.09 -57.32 2.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.428 1.491 . . . . 0.0 111.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -68.21 -26.53 65.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.254 1.422 . . . . 0.0 113.365 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.86 -20.22 65.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.964 1.305 . . . . 0.0 114.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.35 1.46 . . . . 0.0 112.773 179.43 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -149.98 127.02 11.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.085 0.954 . . . . 0.0 112.993 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 53' ' ' GLN . . . 52.68 20.66 1.61 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 118.867 2.914 . . . . 0.0 118.867 167.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -9.22 54.04 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -123.45 24.65 8.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.508 1.523 . . . . 0.0 114.457 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.01 -27.97 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 -8.89 58.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.7 t70 62.75 -40.65 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.697 3.199 . . . . 0.0 117.019 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -93.12 -18.46 22.57 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.419 1.488 . . . . 0.0 113.754 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -80.83 162.07 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.021 1.329 . . . . 0.0 113.331 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt 39.1 54.39 4.96 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 129.282 3.033 . . . . 0.0 115.411 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.24 157.15 61.46 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.494 1.463 . . . . 0.0 111.747 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.13 -21.99 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.892 1.677 . . . . 0.0 114.649 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -81.37 -16.65 51.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 60.3 m -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.225 1.81 . . . . 0.0 113.492 170.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -54.69 148.72 12.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 123.039 1.399 . . . . 0.0 113.226 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.9 p -95.11 167.95 11.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.81 166.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.0 -26.05 66.61 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.53 -0.731 . . . . 0.0 112.266 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.94 -40.32 95.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.764 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.02 -31.34 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.396 -0.815 . . . . 0.0 112.152 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.43 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 53.1 t80 -70.2 -24.25 63.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.121 0.873 . . . . 0.0 112.322 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 68.5 mt -80.9 -16.98 52.12 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.135 -0.978 . . . . 0.0 113.318 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -33.06 53.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.839 0.855 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.5 p -76.24 141.27 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.932 1.693 . . . . 0.0 110.53 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.69 161.68 30.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.435 1.094 . . . . 0.0 113.471 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.71 -36.1 73.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.129 1.372 . . . . 0.0 112.083 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -64.48 -20.55 66.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.104 1.361 . . . . 0.0 113.835 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.3 -5.28 6.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.866 1.267 . . . . 0.0 113.397 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -57.7 -45.55 99.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 O-C-N 120.184 -1.573 . . . . 0.0 112.162 169.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.45 -28.19 86.89 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.32 2.68 . . . . 0.0 113.414 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' THR . . . . . 0.915 HG22 HD21 ' A' ' 50' ' ' LEU . 29.4 m -76.87 -36.06 57.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.349 1.459 . . . . 0.0 111.45 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.67 91.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.669 1.188 . . . . 0.0 113.649 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.98 -35.75 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 119.78 1.173 . . . . 0.0 110.973 169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.37 -53.21 32.72 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.274 0.94 . . . . 0.0 112.195 168.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.97 -11.93 58.22 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 121.08 2.44 . . . . 0.0 114.513 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.35 -55.99 3.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.073 0.851 . . . . 0.0 109.841 166.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.14 -36.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.321 1.049 . . . . 0.0 113.455 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.0 76.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.203 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.14 -36.87 22.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.747 1.219 . . . . 0.0 110.617 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -54.41 -34.93 62.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.604 1.561 . . . . 0.0 113.688 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.53 -7.03 45.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.02 -133.4 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.394 1.477 . . . . 0.0 110.898 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.57 -58.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.599 2.36 . . . . 0.0 112.454 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 164.5 43.57 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 127.359 2.264 . . . . 0.0 109.831 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.01 36.81 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.711 2.274 . . . . 0.0 113.409 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.73 -28.86 50.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 111.947 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.22 0.7 11.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.341 1.456 . . . . 0.0 113.847 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.09 133.92 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.221 1.009 . . . . 0.0 113.295 -170.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.6 -12.66 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.93 1.292 . . . . 0.0 113.727 -174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.87 102.05 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.699 1.999 . . . . 0.0 107.747 -165.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -85.12 71.01 10.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.985 -1.072 . . . . 0.0 108.841 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.323 1.6 p -66.27 -18.81 24.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 O-C-N 121.38 -0.825 . . . . 0.0 110.327 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -42.79 97.06 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.598 -1.314 . . . . 0.0 111.381 167.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.19 14.98 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.636 -0.665 . . . . 0.0 111.908 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.8 -44.34 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 121.383 -1.069 . . . . 0.0 112.55 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.97 66.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.667 1.576 . . . . 0.0 112.255 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 99.9 m -66.37 -46.24 77.35 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 111.853 169.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -84.34 -31.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.829 1.252 . . . . 0.0 112.845 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -40.05 -62.98 0.77 Allowed Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 126.937 2.095 . . . . 0.0 113.569 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.97 -22.66 73.93 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.245 1.963 . . . . 0.0 113.208 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.01 -59.46 3.02 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.162 0.985 . . . . 0.0 111.312 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.477 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.98 -24.5 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.401 -0.812 . . . . 0.0 112.688 175.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.0 -51.85 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.811 1.187 . . . . 0.0 110.69 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.88 -47.49 45.53 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.157 -0.339 . . . . 0.0 111.084 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.755 -1.216 . . . . 0.0 113.257 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.8 m -76.13 -12.4 60.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.56 -33.58 16.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.184 1.356 . . . . 0.0 111.005 167.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -60.35 -39.04 85.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.871 0.868 . . . . 0.0 112.167 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.73 59.85 1.49 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.105 0.962 . . . . 0.0 112.618 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -53.7 -36.34 62.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.931 1.692 . . . . 0.0 113.109 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -86.27 -6.08 59.04 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.15 164.02 26.05 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.084 0.954 . . . . 0.0 111.966 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.88 138.05 52.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.467 1.107 . . . . 0.0 111.152 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 16.5 t80 -64.15 -51.28 64.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.418 -0.801 . . . . 0.0 112.81 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -66.29 -30.82 71.32 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.616 1.098 . . . . 0.0 112.071 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.38 -39.57 94.88 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.808 -0.558 . . . . 0.0 111.813 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -70.41 -34.79 72.92 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.248 -0.907 . . . . 0.0 112.832 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.12 -49.0 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.163 0.892 . . . . 0.0 109.67 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.29 -42.68 99.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.027 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.15 -44.89 97.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.513 1.054 . . . . 0.0 113.299 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -72.93 -35.4 67.02 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.052 -1.264 . . . . 0.0 112.618 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -60.06 -39.92 87.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.68 -1.262 . . . . 0.0 111.78 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.2 -46.57 88.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 111.874 173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -26.66 68.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 112.104 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 mt -79.29 -49.19 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.307 1.843 . . . . 0.0 112.087 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.21 -61.5 1.4 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.308 1.443 . . . . 0.0 113.254 -171.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.79 -25.94 68.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.995 1.718 . . . . 0.0 113.568 -171.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.26 -24.03 67.69 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.796 2.439 . . . . 0.0 114.423 178.448 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.529 0.27 0 N-CA-C 115.807 1.426 . . . . 0.0 115.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -64.33 2.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -126.04 21.32 7.49 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.932 1.693 . . . . 0.0 113.124 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -142.55 -13.22 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -131.26 169.75 15.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.624 1.556 . . . . 0.0 113.835 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.1 p -85.86 166.11 16.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.2 1.4 . . . . 0.0 114.221 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -21.37 2.75 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.87 -35.86 62.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.981 1.264 . . . . 0.0 111.596 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.66 -16.28 64.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.762 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.61 -24.18 45.49 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.799 -1.188 . . . . 0.0 112.129 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.35 -8.67 57.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.872 1.269 . . . . 0.0 113.046 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.39 60.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.084 1.354 . . . . 0.0 112.551 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.73 141.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.939 2.495 . . . . 0.0 110.508 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.35 156.88 36.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.921 0.888 . . . . 0.0 112.743 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.38 -30.67 60.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.109 1.364 . . . . 0.0 111.64 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 m -61.0 -28.32 68.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.156 1.783 . . . . 0.0 113.872 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -127.4 -7.1 5.82 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -56.47 -38.74 71.78 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 119.584 -1.948 . . . . 0.0 114.024 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.84 -27.09 79.96 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.624 2.216 . . . . 0.0 113.272 169.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 55.3 m -79.59 -34.35 40.87 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.712 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.14 92.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.452 . . . . 0.0 113.75 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.09 -36.51 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 119.367 0.985 . . . . 0.0 110.913 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.11 13.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.984 1.278 . . . . 0.0 113.798 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.15 -39.58 93.18 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.249 2.025 . . . . 0.0 112.323 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.0 67.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -102.11 -34.05 9.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.93 0.892 . . . . 0.0 112.714 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -52.44 65.67 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.746 1.619 . . . . 0.0 110.401 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -14.97 63.11 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.837 0.855 . . . . 0.0 111.144 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -14.79 50.13 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.142 -0.974 . . . . 0.0 113.436 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.283 4.6 p30 -123.41 10.67 9.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.83 152.63 0.97 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 130.59 3.556 . . . . 0.0 105.568 168.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.69 -32.33 18.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.222 2.209 . . . . 0.0 113.059 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.5 156.83 79.6 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 127.227 2.211 . . . . 0.0 110.151 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -84.65 8.65 4.51 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.989 1.793 . . . . 0.0 114.84 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.22 -21.33 22.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.393 1.477 . . . . 0.0 114.232 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.52 14.68 20.24 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.285 1.434 . . . . 0.0 113.332 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.97 113.59 24.66 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.262 -1.523 . . . . 0.0 112.106 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.78 11.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 125.647 1.579 . . . . 0.0 111.423 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER 64.49 155.0 0.07 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 129.495 3.118 . . . . 0.0 112.801 -168.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.619 ' H ' HD13 ' A' ' 50' ' ' LEU . 44.5 t0 -119.11 62.22 0.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.522 1.529 . . . . 0.0 110.811 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.0 -56.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.641 1.177 . . . . 0.0 113.475 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -63.14 -36.87 85.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.343 0.974 . . . . 0.0 111.5 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.55 -52.51 52.68 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mt -62.72 -42.77 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.45 0.7 . . . . 0.0 111.449 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.06 -34.72 71.47 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.102 -0.999 . . . . 0.0 113.067 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -70.25 -37.11 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.029 1.332 . . . . 0.0 111.848 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.1 t -87.76 -23.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.117 1.367 . . . . 0.0 113.327 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.3 m -45.28 -59.83 3.93 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 125.877 1.671 . . . . 0.0 112.935 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.48 0.85 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.56 -66.43 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.6 1.16 . . . . 0.0 110.603 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.43 -32.2 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.017 -1.052 . . . . 0.0 112.911 -178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.74 -49.31 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.367 1.067 . . . . 0.0 110.353 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.51 -46.86 36.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.274 0.559 . . . . 0.0 110.892 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.54 68.94 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.1 m -76.34 -17.17 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.29 -30.85 21.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.087 1.312 . . . . 0.0 111.429 169.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -60.63 -38.24 84.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.408 1.083 . . . . 0.0 112.012 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -146.15 86.56 1.71 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.656 0.783 . . . . 0.0 112.425 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -54.07 -33.82 58.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.647 1.179 . . . . 0.0 111.714 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -86.85 -0.07 55.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.339 1.455 . . . . 0.0 113.526 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.36 147.83 43.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.938 0.895 . . . . 0.0 111.384 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.93 155.14 40.81 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.396 1.078 . . . . 0.0 112.312 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -53.32 151.37 5.44 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 112.049 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 tptp 60.44 -32.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 129.039 2.935 . . . . 0.0 116.299 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.87 -28.26 68.73 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.36 1.864 . . . . 0.0 112.259 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -70.77 -44.11 67.39 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.54 -0.725 . . . . 0.0 112.567 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.11 -37.12 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.027 1.285 . . . . 0.0 111.268 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -64.84 -48.44 74.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.65 0.78 . . . . 0.0 111.614 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.9 -39.48 96.55 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.975 1.274 . . . . 0.0 113.242 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -35.33 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.818 1.309 . . . . 0.0 113.013 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -63.35 -38.09 89.8 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.958 -1.089 . . . . 0.0 111.956 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.41 -43.84 98.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.523 1.129 . . . . 0.0 111.782 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -25.02 67.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.83 -1.169 . . . . 0.0 112.86 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mt . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 125.038 1.335 . . . . 0.0 112.523 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 N-CA-C 112.518 0.161 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 23.0 m -49.82 -23.56 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 125.988 1.715 . . . . 0.0 115.292 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -82.49 4.36 24.67 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.618 1.567 . . . . 0.0 113.987 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -142.05 -40.52 0.36 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.453 2.301 . . . . 0.0 112.358 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -50.67 143.36 9.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.724 2.809 . . . . 0.0 112.79 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -109.3 155.45 21.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.16 -24.83 66.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.35 -38.24 79.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.592 -1.317 . . . . 0.0 111.122 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.23 -13.18 53.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.433 1.093 . . . . 0.0 112.95 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -67.47 -28.53 67.94 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.721 -1.237 . . . . 0.0 110.664 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 mt -74.13 -16.78 61.0 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.33 -0.856 . . . . 0.0 113.175 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.79 28.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.296 1.039 . . . . 0.0 113.346 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 p -71.58 140.12 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 109.872 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.81 157.34 30.64 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.847 1.259 . . . . 0.0 113.342 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -58.57 -34.52 71.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.575 1.15 . . . . 0.0 111.748 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.9 m -57.84 -25.66 60.97 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.427 1.891 . . . . 0.0 113.901 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -124.97 0.13 7.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 113.122 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.49 -44.47 97.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 119.809 -1.807 . . . . 0.0 112.416 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -63.49 -20.2 69.29 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.804 2.336 . . . . 0.0 114.393 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 57.2 m -67.8 -37.29 81.8 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.087 -1.008 . . . . 0.0 110.13 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.8 86.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.453 1.501 . . . . 0.0 114.076 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.86 -34.29 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.432 -1.418 . . . . 0.0 110.731 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.9 4.07 8.48 Favored Glycine 0 CA--C 1.545 1.969 0 C-N-CA 125.985 1.755 . . . . 0.0 116.148 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.77 -10.36 9.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.435 1.894 . . . . 0.0 113.547 170.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.72 -70.98 0.7 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.407 1.083 . . . . 0.0 111.571 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -71.24 -20.78 62.2 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.98 -1.075 . . . . 0.0 112.424 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.18 97.63 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.963 1.705 . . . . 0.0 113.833 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -43.91 18.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.653 0.781 . . . . 0.0 109.679 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.36 -24.52 67.4 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -85.77 -10.48 55.45 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -130.08 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 110.933 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -157.07 -54.12 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 127.407 2.283 . . . . 0.0 112.499 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -125.07 164.25 32.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 126.768 2.027 . . . . 0.0 111.639 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.75 9.78 3.04 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.156 2.57 . . . . 0.0 114.055 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.69 -28.4 69.91 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.625 -1.297 . . . . 0.0 113.14 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -106.14 -7.24 18.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.855 1.262 . . . . 0.0 114.035 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.57 145.21 47.56 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 120.848 -1.158 . . . . 0.0 113.403 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.18 25.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.547 1.539 . . . . 0.0 111.277 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 60.47 144.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.671 2.788 . . . . 0.0 112.738 -166.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -87.93 44.44 1.19 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.621 -1.299 . . . . 0.0 110.469 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -47.16 -53.55 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.836 1.655 . . . . 0.0 114.109 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -70.24 -34.04 72.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.689 1.131 . . . . 0.0 111.444 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.68 -48.23 74.87 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.533 0.587 . . . . 0.0 111.856 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.22 -43.57 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.642 1.577 . . . . 0.0 110.73 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.09 -32.64 73.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.108 0.963 . . . . 0.0 112.916 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 43.2 m -68.69 -42.9 77.15 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.558 1.143 . . . . 0.0 111.926 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.497 HG12 HD12 ' B' ' 151' ' ' ILE . 38.1 t -84.16 -26.09 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.91 1.684 . . . . 0.0 113.313 -171.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.5 m -50.65 -64.21 1.44 Allowed Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 125.733 1.613 . . . . 0.0 113.094 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.91 -25.35 77.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.19 1.927 . . . . 0.0 112.685 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.39 -59.12 5.1 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.229 1.012 . . . . 0.0 110.805 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.497 HD12 HG12 ' B' ' 147' ' ' VAL . 24.1 mt -70.01 -31.49 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.11 -0.994 . . . . 0.0 112.224 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.83 -51.27 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.937 1.295 . . . . 0.0 110.657 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -68.35 -44.29 75.56 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.397 0.279 . . . . 0.0 110.885 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.8 73.12 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.056 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.49 -14.51 62.14 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -35.91 13.81 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.902 1.228 . . . . 0.0 111.542 167.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -58.03 -42.66 85.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.062 0.945 . . . . 0.0 111.796 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -141.44 69.98 1.34 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 111.32 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -52.37 -34.88 49.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.693 1.997 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -84.59 -1.5 56.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.061 0.944 . . . . 0.0 113.263 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.53 147.82 48.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.637 1.175 . . . . 0.0 112.852 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.47 130.4 41.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.673 1.189 . . . . 0.0 108.406 168.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.4 -42.03 95.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.615 0.766 . . . . 0.0 113.063 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -60.08 -38.39 82.75 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.466 -0.771 . . . . 0.0 112.757 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -69.48 -34.42 74.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.282 0.633 . . . . 0.0 112.093 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -73.14 -38.12 66.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.98 -37.81 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.03 1.287 . . . . 0.0 111.64 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -62.38 -43.64 98.35 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.616 0.766 . . . . 0.0 112.182 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.76 -47.16 91.82 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.545 1.069 . . . . 0.0 113.194 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.32 -33.52 65.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.544 1.172 . . . . 0.0 113.009 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.81 -39.92 90.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.203 1.365 . . . . 0.0 111.998 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.59 -47.38 84.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.514 1.126 . . . . 0.0 112.048 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -27.24 68.73 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.101 -0.999 . . . . 0.0 111.944 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 36.9 mt -76.83 -51.67 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.059 1.744 . . . . 0.0 111.812 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt . . . . . 0 N--CA 1.479 1.001 0 C-N-CA 125.509 1.524 . . . . 0.0 113.294 -170.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 113.53 0.55 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.08 -24.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -76.22 -35.07 59.22 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.348 0.659 . . . . 0.0 112.629 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -103.56 -27.98 12.02 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -91.09 174.71 7.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.041 0.924 . . . . 0.0 113.425 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 p -103.86 165.96 10.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.667 1.587 . . . . 0.0 114.213 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -17.53 48.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 115.211 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.97 -34.71 73.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.774 1.17 . . . . 0.0 111.424 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.08 -28.98 70.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.656 -0.653 . . . . 0.0 112.319 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.61 -21.48 66.72 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.882 -1.136 . . . . 0.0 111.646 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -91.65 -13.42 31.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.418 1.487 . . . . 0.0 113.202 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.02 -31.65 34.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.378 1.071 . . . . 0.0 110.983 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -68.84 132.68 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.68 1.592 . . . . 0.0 109.782 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -68.9 160.67 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.252 1.421 . . . . 0.0 113.111 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.26 -35.92 72.48 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.906 -1.121 . . . . 0.0 112.09 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 m -62.22 -23.86 66.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.004 1.722 . . . . 0.0 113.827 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -125.45 -3.83 7.3 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.801 1.24 . . . . 0.0 113.51 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.17 -41.86 93.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 120.019 -1.676 . . . . 0.0 112.815 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -59.34 -27.35 84.75 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.927 2.418 . . . . 0.0 113.691 168.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.5 m -78.92 -27.9 43.79 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 111.902 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -64.96 -48.43 74.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 112.811 170.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.03 -36.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 118.73 0.695 . . . . 0.0 110.466 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.94 -48.17 52.27 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.674 1.13 . . . . 0.0 113.849 170.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.05 -19.0 64.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.864 2.832 . . . . 0.0 113.192 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.93 -53.46 5.29 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.47 -0.769 . . . . 0.0 110.7 165.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.7 -19.73 60.14 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.99 27.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 111.951 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.95 -31.42 18.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.282 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -67.33 -20.57 65.62 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.04 -8.38 21.51 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.26 0.4 OUTLIER -141.41 -129.52 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.187 1.395 . . . . 0.0 113.287 -175.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.87 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.989 1.716 . . . . 0.0 113.759 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -136.41 164.44 42.79 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.763 2.425 . . . . 0.0 110.056 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.34 -5.27 14.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.498 1.466 . . . . 0.0 114.55 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.61 -25.21 68.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.937 1.244 . . . . 0.0 113.747 -168.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.31 -16.55 29.03 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.157 2.183 . . . . 0.0 113.648 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 154.26 33.46 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -169.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.77 1.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 125.133 1.373 . . . . 0.0 113.795 -174.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? 62.78 112.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.842 2.857 . . . . 0.0 112.584 -168.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.9 54.07 2.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.899 1.68 . . . . 0.0 112.495 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 0.6 OUTLIER -55.22 -40.82 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 -165.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.73 -35.45 78.1 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 122.746 2.521 . . . . 0.0 112.707 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.02 -22.16 60.03 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 124.755 1.169 . . . . 0.0 113.804 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.74 -50.78 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.433 1.493 . . . . 0.0 111.132 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.18 77.54 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.016 1.326 . . . . 0.0 113.78 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -63.73 -39.24 93.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.391 1.076 . . . . 0.0 111.735 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HD13 ' A' ' 62' ' ' ILE . 1.3 t -95.45 -19.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.681 1.192 . . . . 0.0 113.314 -172.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.6 m -41.85 -60.0 2.22 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 125.962 1.705 . . . . 0.0 112.368 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.4 1.24 4.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.715 2.943 . . . . 0.0 114.822 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.46 -59.66 1.78 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 0.0 110.485 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.471 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.23 -34.99 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.345 0.975 . . . . 0.0 112.118 -178.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.82 -40.9 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.444 0.565 . . . . 0.0 112.326 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -78.26 -47.91 16.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.25 -29.39 70.17 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.096 0.958 . . . . 0.0 113.561 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.37 -11.6 59.86 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.54 -33.95 16.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.304 1.411 . . . . 0.0 110.58 166.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -58.02 -40.11 80.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 111.652 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.51 88.0 1.75 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.757 0.789 . . . . 0.0 111.984 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -55.01 -31.42 61.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.747 1.619 . . . . 0.0 112.489 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -89.53 -2.74 58.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.188 1.395 . . . . 0.0 112.854 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 154.95 40.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.716 0.806 . . . . 0.0 110.548 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -64.58 137.34 57.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.992 0.517 . . . . 0.0 110.349 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.52 -53.1 62.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.907 1.283 . . . . 0.0 111.766 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -65.54 -38.23 89.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.08 0.952 . . . . 0.0 112.245 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.56 -37.36 83.55 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.485 0.714 . . . . 0.0 111.463 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -73.61 -33.68 64.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.85 -47.3 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 118.448 0.567 . . . . 0.0 110.698 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.66 -44.57 95.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.876 0.87 . . . . 0.0 111.825 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.65 -46.13 93.74 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.722 1.153 . . . . 0.0 113.092 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -73.29 -31.99 64.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.695 1.248 . . . . 0.0 113.447 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -61.49 -42.21 98.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.982 1.265 . . . . 0.0 111.714 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.68 -47.99 78.99 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.66 0.784 . . . . 0.0 111.476 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.413 -1.429 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.1 mt . . . . . 0 CA--C 1.538 0.519 0 C-N-CA 123.84 0.856 . . . . 0.0 112.038 178.201 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.542 0.908 0 N-CA-C 109.832 -0.872 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -48.3 -30.01 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -87.69 -7.75 56.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m -132.13 28.83 4.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.041 2.536 . . . . 0.0 111.084 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -101.15 141.52 33.92 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.679 1.992 . . . . 0.0 111.299 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 36.7 p -110.33 149.82 29.65 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -19.92 66.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.52 -39.29 61.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 110.986 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.67 -34.86 78.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 112.179 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.47 -30.16 71.33 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.083 -1.011 . . . . 0.0 111.445 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.4 -4.23 58.11 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.558 1.143 . . . . 0.0 113.466 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.99 15.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.113 1.365 . . . . 0.0 111.152 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.57 138.49 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.356 1.862 . . . . 0.0 109.646 169.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.92 158.62 32.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.244 1.018 . . . . 0.0 112.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.88 -35.85 71.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.596 1.158 . . . . 0.0 111.349 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.5 m -61.92 -23.0 66.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.782 1.633 . . . . 0.0 114.029 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.89 -1.46 7.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.294 1.438 . . . . 0.0 112.746 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.57 -43.91 90.13 Favored Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 119.728 -1.858 . . . . 0.0 112.444 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.52 -25.22 75.63 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.035 1.823 . . . . 0.0 113.214 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.747 HG22 HD21 ' A' ' 50' ' ' LEU . 24.2 m -72.69 -39.99 66.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.146 0.978 . . . . 0.0 110.159 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -20.07 63.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.975 1.71 . . . . 0.0 115.537 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.8 -39.99 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-N 121.145 1.793 . . . . 0.0 109.612 163.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.79 23.13 0.18 Allowed Glycine 0 CA--C 1.54 1.624 0 C-N-CA 127.907 2.67 . . . . 0.0 117.424 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -126.39 -57.57 1.38 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.362 1.581 . . . . 0.0 111.041 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.59 78.16 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.221 -0.924 . . . . 0.0 111.773 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.38 -38.41 35.01 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.811 -0.556 . . . . 0.0 111.956 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.76 -46.04 69.84 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 113.296 -171.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -33.32 69.02 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.924 -0.485 . . . . 0.0 110.871 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.27 -28.19 66.98 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.12 -3.93 50.16 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -146.11 -122.97 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.361 1.864 . . . . 0.0 111.208 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -160.3 -79.31 0.05 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.625 1.57 . . . . 0.0 112.092 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -123.88 164.2 30.61 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 127.065 2.146 . . . . 0.0 109.262 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.74 1.98 7.48 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 121.283 1.494 . . . . 0.0 114.826 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -55.74 -27.84 52.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.206 1.402 . . . . 0.0 111.481 168.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.75 3.97 23.2 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.816 2.046 . . . . 0.0 113.279 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.94 126.88 35.59 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 119.725 -1.86 . . . . 0.0 113.744 -169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.96 132.52 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.151 2.181 . . . . 0.0 106.471 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -69.81 116.24 9.96 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.631 1.105 . . . . 0.0 109.787 -174.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -86.28 61.44 6.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.06 1.344 . . . . 0.0 110.588 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.315 1.2 p -68.65 -34.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.385 -167.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.13 -39.04 89.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.852 1.66 . . . . 0.0 111.991 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.39 -48.39 79.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.538 0.589 . . . . 0.0 111.677 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.75 -43.21 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.46 1.104 . . . . 0.0 111.702 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.9 -37.8 76.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.288 1.035 . . . . 0.0 112.315 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -62.12 -39.89 94.06 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.453 1.101 . . . . 0.0 112.007 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.0 -26.19 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.41 1.484 . . . . 0.0 113.594 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -44.77 -60.49 2.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 126.603 1.961 . . . . 0.0 113.571 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.52 -19.49 67.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.262 1.975 . . . . 0.0 113.149 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -69.04 -58.07 4.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.097 0.959 . . . . 0.0 111.274 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -20.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.26 -0.9 . . . . 0.0 113.255 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.8 -52.82 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.614 1.097 . . . . 0.0 110.28 173.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.18 -47.69 34.01 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 122.458 0.303 . . . . 0.0 111.476 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.03 -28.57 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.692 -1.255 . . . . 0.0 113.24 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.01 -16.24 60.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.69 21.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.278 1.399 . . . . 0.0 111.34 168.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.95 -38.87 76.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.772 0.829 . . . . 0.0 112.544 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -146.65 83.5 1.6 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -56.86 -37.83 71.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.933 1.293 . . . . 0.0 111.937 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.9 -6.13 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 113.018 -172.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.88 137.42 58.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.836 0.744 . . . . 0.0 109.219 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -122.59 44.25 2.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.386 -167.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -138.36 143.04 39.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -165.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -67.41 -26.92 66.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.369 1.068 . . . . 0.0 110.381 166.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -64.19 -24.8 67.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.895 1.278 . . . . 0.0 113.216 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.05 -31.62 72.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.046 -1.034 . . . . 0.0 111.98 170.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.43 -47.15 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.719 1.608 . . . . 0.0 110.453 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -65.32 -34.22 77.81 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.292 1.037 . . . . 0.0 113.286 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.42 -34.87 76.89 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.659 1.124 . . . . 0.0 113.69 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 24.3 mm-40 -75.69 -32.85 60.29 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.601 1.2 . . . . 0.0 113.187 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.92 -39.47 94.25 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.893 -1.129 . . . . 0.0 111.065 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -61.48 -48.55 80.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 111.756 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -24.15 67.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.984 -1.072 . . . . 0.0 112.289 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 27.9 mt -83.94 -48.09 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.417 1.487 . . . . 0.0 112.373 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.076 1.351 . . . . 0.0 114.014 -169.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.472 0.256 0 CA-C-O 121.405 0.502 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.5 7.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.29 21.84 7.24 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.297 2.239 . . . . 0.0 113.153 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.0 p -116.05 -32.01 5.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -129.26 163.13 26.32 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -73.16 168.02 19.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.204 1.402 . . . . 0.0 113.733 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -27.44 46.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.68 -38.32 74.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.156 0.982 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.02 -12.67 59.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.498 1.519 . . . . 0.0 113.065 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -76.26 -16.73 59.74 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.516 -1.365 . . . . 0.0 111.344 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.37 1.76 47.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.017 1.327 . . . . 0.0 114.145 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.48 56.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 112.27 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.55 136.65 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.752 2.021 . . . . 0.0 110.954 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.42 157.8 25.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.51 1.124 . . . . 0.0 112.457 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -53.47 -31.37 45.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.482 1.513 . . . . 0.0 111.758 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 m -61.74 -29.49 70.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.193 1.797 . . . . 0.0 113.89 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -126.45 -1.51 6.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.792 1.637 . . . . 0.0 112.702 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 33.3 mm-40 -53.57 -46.81 98.04 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.91 -1.744 . . . . 0.0 112.365 170.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 36.5 Cg_exo -67.56 -17.83 48.54 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.415 2.076 . . . . 0.0 112.924 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.851 HG22 HD21 ' B' ' 139' ' ' LEU . 20.6 m -79.76 -36.91 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.218 1.407 . . . . 0.0 110.702 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.59 98.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.526 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.9 -48.41 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.723 0.809 . . . . 0.0 109.288 168.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.04 -52.37 35.8 Favored Glycine 0 C--O 1.213 -1.21 0 C-N-CA 125.214 1.388 . . . . 0.0 113.149 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -68.81 -12.69 61.79 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.649 2.725 . . . . 0.0 114.664 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.38 -50.07 5.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.002 0.819 . . . . 0.0 111.12 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -75.51 -24.1 56.79 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.126 -0.984 . . . . 0.0 113.221 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.35 76.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.404 -1.435 . . . . 0.0 112.003 -176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -74.8 -33.17 62.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.32 1.048 . . . . 0.0 110.32 -176.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -56.84 -23.19 42.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.978 1.711 . . . . 0.0 113.59 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -91.09 -18.53 24.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -120.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.115 1.325 . . . . 0.0 113.52 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -161.18 -58.88 0.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.532 1.533 . . . . 0.0 113.954 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.03 166.25 27.45 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 128.125 2.57 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.87 14.03 2.32 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.033 1.762 . . . . 0.0 114.804 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.22 -23.71 66.81 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.282 1.433 . . . . 0.0 111.783 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -127.94 26.8 5.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.901 1.68 . . . . 0.0 114.111 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.64 35.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.995 -1.69 . . . . 0.0 112.445 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.04 -16.33 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.845 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 66.64 110.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.856 2.462 . . . . 0.0 112.195 -169.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.39 59.83 1.88 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.777 1.231 . . . . 0.0 111.659 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 2.4 p -62.3 -19.61 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.606 -1.309 . . . . 0.0 114.42 -168.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.51 -44.68 56.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 112.169 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.97 -47.71 6.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -58.17 -51.09 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.746 1.218 . . . . 0.0 112.265 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.71 66.69 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -66.61 -49.0 67.74 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.018 1.327 . . . . 0.0 112.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.22 -18.45 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -46.4 -60.7 3.34 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.634 1.174 . . . . 0.0 112.807 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.93 -4.18 12.94 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.295 2.663 . . . . 0.0 114.113 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -62.72 1.43 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.363 1.465 . . . . 0.0 111.158 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -30.85 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.951 -1.093 . . . . 0.0 113.175 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.46 -41.09 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.099 0.863 . . . . 0.0 112.66 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.72 -44.34 28.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.084 0.953 . . . . 0.0 110.789 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.18 93.35 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.429 -0.794 . . . . 0.0 112.402 -171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.69 -7.15 56.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -34.52 16.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.115 1.325 . . . . 0.0 111.565 169.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -78.83 -32.98 46.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -117.09 49.18 1.21 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.665 1.586 . . . . 0.0 112.06 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -48.93 -36.79 18.18 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.743 -1.223 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -87.92 -2.86 58.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.664 1.186 . . . . 0.0 113.624 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.05 157.51 35.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.004 0.922 . . . . 0.0 111.352 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -76.68 161.39 28.57 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.505 1.145 . . . . 0.0 113.759 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -48.28 153.09 0.76 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.788 2.435 . . . . 0.0 114.132 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp 60.29 -34.63 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 130.031 3.332 . . . . 0.0 117.253 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -30.57 70.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.971 1.709 . . . . 0.0 111.995 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -74.1 -35.49 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.8 -46.15 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.086 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -63.76 -43.38 96.6 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.354 1.062 . . . . 0.0 112.113 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.24 98.5 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.931 1.729 . . . . 0.0 113.771 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -73.5 -33.57 64.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.565 1.682 . . . . 0.0 113.13 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -62.85 -39.28 93.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.364 -1.46 . . . . 0.0 111.157 171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.04 -46.64 83.5 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.547 1.139 . . . . 0.0 112.106 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -31.8 72.32 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.057 -1.027 . . . . 0.0 112.08 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.2 mt . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 111.304 -177.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.537 0.63 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 m -47.56 -29.71 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.276 2.23 . . . . 0.0 114.996 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -93.99 -9.33 37.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 58.0 p -116.15 -32.57 5.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.74 1.154 . . . . 0.0 113.757 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -93.7 163.56 13.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.207 1.003 . . . . 0.0 113.549 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.0 p -99.73 155.78 17.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.298 1.439 . . . . 0.0 114.275 -169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -20.4 18.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.238 1.815 . . . . 0.0 115.275 -174.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.96 -40.65 89.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.03 1.286 . . . . 0.0 111.679 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -78.1 -12.36 59.98 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.938 0.895 . . . . 0.0 112.146 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -94.13 -17.29 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.774 -1.204 . . . . 0.0 112.986 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.07 -17.42 57.02 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.939 -1.101 . . . . 0.0 113.254 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.3 50.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.687 1.195 . . . . 0.0 113.905 -171.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.71 139.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.024 1.73 . . . . 0.0 111.113 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.61 158.68 29.29 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.638 1.575 . . . . 0.0 113.744 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.16 -33.27 70.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.852 1.261 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.5 m -59.43 -26.75 65.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.087 1.755 . . . . 0.0 113.656 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.51 -0.93 8.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.607 1.563 . . . . 0.0 112.523 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.44 -46.38 99.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 120.009 -1.682 . . . . 0.0 112.805 172.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -64.96 -25.4 59.53 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.353 2.035 . . . . 0.0 112.848 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 50' ' ' LEU . 58.0 m -70.12 -38.43 75.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.039 0.936 . . . . 0.0 110.345 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.05 92.54 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.35 -35.62 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.739 1.154 . . . . 0.0 110.76 170.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.31 -42.03 88.13 Favored Glycine 0 C--O 1.217 -0.915 0 C-N-CA 124.764 1.173 . . . . 0.0 113.687 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -44.4 71.16 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.147 1.973 . . . . 0.0 111.51 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.84 82.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.76 -39.14 73.41 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.012 -1.055 . . . . 0.0 113.557 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.62 87.68 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.021 -1.049 . . . . 0.0 111.386 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -79.53 -38.81 33.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.578 0.751 . . . . 0.0 111.056 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.0 -31.39 72.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.076 0.95 . . . . 0.0 113.198 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.77 -16.84 49.73 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.16 -124.14 0.03 OUTLIER 'General case' 0 C--N 1.35 0.629 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -163.66 -45.68 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.494 1.518 . . . . 0.0 114.205 -167.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.04 161.99 56.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 127.298 2.239 . . . . 0.0 110.158 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.9 5.55 6.2 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.764 1.643 . . . . 0.0 113.909 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -56.51 -29.74 62.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.377 1.471 . . . . 0.0 111.86 169.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -111.94 15.12 20.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.198 1.799 . . . . 0.0 112.964 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.72 120.96 24.12 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 119.408 -2.057 . . . . 0.0 111.999 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.34 128.81 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.791 1.636 . . . . 0.0 106.917 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 31' ' ' THR . 2.1 tm? -75.1 116.75 16.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.626 0.648 . . . . 0.0 110.488 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.07 48.98 1.73 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.27 1.828 . . . . 0.0 111.43 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.351 1.7 p -62.8 -32.73 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -166.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -59.82 -50.56 73.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.626 1.557 . . . . 0.0 110.027 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.79 -39.51 55.0 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.797 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -58.37 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.488 1.115 . . . . 0.0 110.979 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.06 75.66 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.83 1.195 . . . . 0.0 112.526 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 53.3 m -62.39 -43.38 98.95 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.383 1.073 . . . . 0.0 111.872 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' B' ' 151' ' ' ILE . 35.0 t -83.69 -30.43 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.494 1.518 . . . . 0.0 113.082 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.5 m -37.04 -61.93 0.62 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 127.132 2.173 . . . . 0.0 114.245 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.21 -22.7 60.72 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.059 1.839 . . . . 0.0 113.026 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.95 -60.53 2.56 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.286 1.035 . . . . 0.0 110.689 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.528 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -70.5 -25.6 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 178.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -52.15 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.12 0.873 . . . . 0.0 110.654 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.35 -43.44 60.71 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.655 0.382 . . . . 0.0 111.287 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.73 -29.13 69.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.749 -1.219 . . . . 0.0 112.852 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 34.4 m -69.75 -13.93 62.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 169.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.23 -38.43 13.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.652 1.569 . . . . 0.0 110.872 166.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -59.81 -38.77 82.9 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.959 0.904 . . . . 0.0 112.396 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.54 75.41 1.46 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 122.359 1.076 . . . . 0.0 111.246 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -52.26 -27.21 14.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.042 1.737 . . . . 0.0 112.357 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.94 -2.63 55.63 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.383 1.473 . . . . 0.0 113.516 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.59 152.13 36.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.51 1.124 . . . . 0.0 111.702 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -70.19 136.27 49.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.313 1.445 . . . . 0.0 111.099 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.19 -43.65 81.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -60.47 -41.34 93.96 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.217 1.371 . . . . 0.0 110.705 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.03 -36.81 84.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.343 0.657 . . . . 0.0 112.311 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -70.9 -39.31 72.84 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.92 -46.17 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 119.65 1.114 . . . . 0.0 109.968 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -65.33 -46.52 79.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.864 0.866 . . . . 0.0 112.359 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.15 99.24 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.832 1.206 . . . . 0.0 113.394 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -71.83 -34.32 69.22 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.702 1.251 . . . . 0.0 112.307 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -61.35 -39.92 92.36 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.66 -1.275 . . . . 0.0 111.725 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.81 -47.74 79.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.425 0.69 . . . . 0.0 111.394 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.52 68.95 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.393 -1.442 . . . . 0.0 111.849 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.8 mt -73.9 -47.6 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.908 1.683 . . . . 0.0 112.785 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 124.85 1.26 . . . . 0.0 113.321 -172.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.528 0.222 0 N-CA-C 114.667 0.987 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.82 -14.98 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.37 1.468 . . . . 0.0 113.802 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -85.97 -10.73 54.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.866 2.066 . . . . 0.0 113.502 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -133.38 -25.8 1.7 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.67 151.83 46.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.175 0.898 . . . . 0.0 111.76 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -97.35 165.17 12.15 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.883 1.325 . . . . 0.0 113.05 -172.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 m -62.1 -21.97 65.42 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.48 -44.75 95.63 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.711 170.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -63.87 -25.84 68.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.397 -0.815 . . . . 0.0 112.167 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.24 -16.39 63.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.945 -1.097 . . . . 0.0 112.664 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.5 mt -87.19 -9.51 55.0 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.021 -1.049 . . . . 0.0 112.378 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -26.75 13.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.099 1.76 . . . . 0.0 113.404 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.02 -4.31 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t70 64.8 155.12 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 129.076 2.951 . . . . 0.0 116.319 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.06 -34.5 63.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.128 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 m -67.73 -25.04 65.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -127.32 3.3 6.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.583 1.153 . . . . 0.0 112.014 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -57.3 -52.3 75.28 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.311 -1.493 . . . . 0.0 110.449 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -67.66 -12.15 34.57 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.417 2.078 . . . . 0.0 114.39 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.553 HG22 HD21 ' B' ' 139' ' ' LEU . 79.6 m -73.27 -32.71 64.84 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.795 -1.191 . . . . 0.0 110.678 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.26 85.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.387 1.075 . . . . 0.0 112.145 169.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.91 -45.18 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.353 1.061 . . . . 0.0 109.001 170.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.45 6.03 0.38 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.54 2.019 . . . . 0.0 116.78 169.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -121.68 -61.36 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.999 1.72 . . . . 0.0 110.078 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.41 -30.4 70.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.26 -32.56 13.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.683 0.674 . . . . 0.0 112.392 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.05 -46.29 88.22 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.404 HD22 HD22 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -76.01 -12.43 60.13 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.05 0.94 . . . . 0.0 111.939 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -85.81 -21.92 27.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.66 1.184 . . . . 0.0 113.028 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -95.89 -16.28 21.89 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.863 0.865 . . . . 0.0 113.225 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -170.59 153.33 4.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.971 2.908 . . . . 0.0 106.835 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -84.26 -41.74 16.59 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 111.556 -2.565 . . . . 0.0 112.718 -173.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -131.56 159.59 71.14 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 127.071 2.148 . . . . 0.0 110.057 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -90.23 12.04 2.59 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.3 2.0 . . . . 0.0 114.432 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.07 -23.71 65.68 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.241 1.016 . . . . 0.0 112.651 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.77 -15.84 24.77 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.333 1.853 . . . . 0.0 113.787 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.21 127.09 32.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.51 18.38 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 125.586 1.555 . . . . 0.0 111.336 169.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER 57.21 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.833 2.853 . . . . 0.0 110.739 -168.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.38 62.37 6.03 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.876 -1.765 . . . . 0.0 110.973 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p -72.42 -24.14 21.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -167.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -58.1 -45.12 87.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.589 1.541 . . . . 0.0 111.455 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.05 -45.2 88.98 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.947 -0.47 . . . . 0.0 112.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.68 -44.86 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.775 1.23 . . . . 0.0 111.657 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.94 63.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 112.742 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.8 m -67.44 -45.55 75.71 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.667 1.187 . . . . 0.0 111.244 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -27.03 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -172.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.8 m -49.48 -62.44 2.47 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.201 1.4 . . . . 0.0 112.831 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -8.29 22.56 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.071 2.514 . . . . 0.0 113.578 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.67 -57.18 3.8 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.312 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.79 -29.8 30.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 C-N-CA 124.084 0.954 . . . . 0.0 112.135 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.55 -53.12 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.574 1.079 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.51 -40.83 80.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.952 0.405 . . . . 0.0 110.609 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.43 97.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.8 m -74.39 -14.67 60.89 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.39 -36.17 24.51 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.11 1.323 . . . . 0.0 111.494 171.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -81.33 -27.15 35.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -125.98 50.14 1.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.436 1.894 . . . . 0.0 112.532 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -51.36 -38.16 51.78 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.703 1.601 . . . . 0.0 113.158 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -81.91 -6.42 59.09 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.29 163.78 20.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.51 1.124 . . . . 0.0 113.019 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -67.0 140.12 57.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.505 1.522 . . . . 0.0 110.755 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.32 -41.02 92.65 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -65.41 -33.56 76.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.01 -1.056 . . . . 0.0 112.38 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.54 -42.24 91.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.465 1.106 . . . . 0.0 111.668 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -41.25 95.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.33 -48.72 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.104 0.411 . . . . 0.0 110.474 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -63.46 -45.79 89.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.69 92.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.701 1.144 . . . . 0.0 113.176 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.05 -34.82 61.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.513 1.156 . . . . 0.0 112.527 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -59.8 -40.26 87.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.545 1.52 . . . . 0.0 111.78 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.43 -46.49 88.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.179 0.992 . . . . 0.0 111.844 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -28.07 69.33 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.904 -1.123 . . . . 0.0 111.92 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.2 mt . . . . . 0 CA--C 1.541 0.633 0 C-N-CA 124.831 1.253 . . . . 0.0 111.956 -179.153 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 CA--C 1.542 0.878 0 N-CA-C 118.773 2.567 . . . . 0.0 118.773 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.01 -19.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.062 1.745 . . . . 0.0 114.82 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -98.92 -2.13 38.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.806 1.242 . . . . 0.0 114.018 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 78.0 p -134.81 -6.14 2.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -177.24 4.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.804 1.242 . . . . 0.0 113.734 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 82.2 p -97.76 166.39 11.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -16.39 6.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.76 -34.41 71.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.086 1.312 . . . . 0.0 111.41 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.56 -27.05 67.37 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.246 -0.909 . . . . 0.0 112.805 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -71.77 -15.71 62.18 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.407 -0.808 . . . . 0.0 112.346 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 mt -95.76 -19.42 19.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.525 1.13 . . . . 0.0 113.22 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.51 65.17 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.206 1.002 . . . . 0.0 112.576 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.22 140.38 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.179 2.192 . . . . 0.0 111.758 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.87 158.99 34.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.807 1.243 . . . . 0.0 113.228 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.9 -32.02 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.679 1.591 . . . . 0.0 111.876 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.2 m -59.13 -28.24 66.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.851 1.661 . . . . 0.0 113.815 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -128.06 -2.89 5.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.29 1.436 . . . . 0.0 113.443 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -58.16 -40.82 86.0 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 119.619 -1.926 . . . . 0.0 113.475 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -60.54 -26.53 83.04 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.66 2.24 . . . . 0.0 113.241 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 42.6 m -77.41 -33.88 54.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.714 1.206 . . . . 0.0 111.483 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -60.26 -48.62 80.95 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.733 1.213 . . . . 0.0 113.079 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.02 -34.33 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 111.171 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.64 -58.42 10.22 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.537 1.065 . . . . 0.0 112.655 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.32 -37.08 76.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.233 2.017 . . . . 0.0 112.677 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.74 -29.2 67.56 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -111.83 -33.3 6.35 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.465 1.906 . . . . 0.0 112.705 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.404 HD22 HD22 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -78.78 -42.2 28.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 110.21 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.03 -32.35 73.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -168.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.35 -7.06 58.77 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.14 -45.41 0.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.33 1.3 p30 56.04 140.22 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.855 2.462 . . . . 0.0 115.94 -166.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 42.9 mttp 63.79 140.9 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.758 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.75 0.09 5.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.629 1.553 . . . . 0.0 114.524 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.27 -16.48 63.6 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.038 1.29 . . . . 0.0 113.657 -170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -123.56 5.01 8.94 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.734 1.614 . . . . 0.0 113.863 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.51 141.32 44.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.469 -1.394 . . . . 0.0 113.741 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.94 132.71 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.58 1.952 . . . . 0.0 107.708 170.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.553 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -68.61 127.35 32.7 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.91 43.72 1.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.939 -1.1 . . . . 0.0 113.623 -166.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.261 14.3 p -64.69 -21.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.528 -1.358 . . . . 0.0 112.775 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -54.91 -30.46 58.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.654 1.581 . . . . 0.0 113.125 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.28 -56.27 1.49 Allowed Glycine 0 N--CA 1.465 0.583 0 C-N-CA 123.507 0.575 . . . . 0.0 112.368 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -54.36 -45.56 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 121.606 -0.938 . . . . 0.0 113.074 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.87 66.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.682 1.128 . . . . 0.0 113.071 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -71.28 -44.56 65.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.946 1.298 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -89.04 -18.32 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.3 m -41.36 -59.95 2.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.455 1.502 . . . . 0.0 113.431 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.47 -16.9 54.98 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.136 2.558 . . . . 0.0 114.121 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.26 -58.25 3.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.354 1.062 . . . . 0.0 111.612 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -37.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.189 -0.944 . . . . 0.0 112.558 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.28 -42.73 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.923 0.489 . . . . 0.0 112.069 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.54 -45.25 46.82 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.74 0.816 . . . . 0.0 110.903 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.31 71.92 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.461 -1.4 . . . . 0.0 113.43 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 10.9 m -74.82 -11.52 60.17 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.74 -34.54 16.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.49 1.496 . . . . 0.0 111.057 167.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -58.26 -38.76 77.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.699 1.2 . . . . 0.0 111.95 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -143.8 83.07 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.41 0.684 . . . . 0.0 111.871 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -55.81 -25.9 43.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.972 1.309 . . . . 0.0 112.946 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -95.13 3.98 54.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.096 1.758 . . . . 0.0 113.269 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.09 149.72 31.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.091 1.356 . . . . 0.0 113.397 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.65 86.92 6.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.58 1.152 . . . . 0.0 113.011 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . 0.258 1.4 p90 44.43 -117.95 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -21.31 64.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.23 1.412 . . . . 0.0 113.462 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.66 -31.65 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.943 0.897 . . . . 0.0 112.267 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -74.73 -42.55 58.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.3 -35.12 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.874 1.216 . . . . 0.0 111.586 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.59 -48.14 76.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.915 0.886 . . . . 0.0 111.843 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.53 -41.42 98.71 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.121 0.867 . . . . 0.0 113.178 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.25 -29.11 63.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.381 1.091 . . . . 0.0 113.161 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -66.13 -43.16 87.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.38 0.991 . . . . 0.0 111.532 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.84 -43.9 97.92 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.684 0.793 . . . . 0.0 111.183 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.3 -40.61 5.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.931 1.693 . . . . 0.0 113.307 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 mt -85.98 -38.82 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.905 0.882 . . . . 0.0 112.421 -171.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -177.512 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 CA--C 1.529 0.272 0 N-CA-C 111.15 -0.366 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.15 -18.51 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -82.49 -19.52 38.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.177 1.391 . . . . 0.0 113.951 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.3 m -141.39 44.8 1.75 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.156 2.182 . . . . 0.0 110.73 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -129.86 139.72 51.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.275 1.83 . . . . 0.0 109.912 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.5 p -102.65 161.43 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.972 1.367 . . . . 0.0 114.159 -168.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 m -77.03 -21.43 54.58 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.83 -42.27 79.34 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.305 0.957 . . . . 0.0 110.648 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.76 -28.75 60.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.092 0.957 . . . . 0.0 112.209 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -66.15 -33.97 76.98 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.658 -1.276 . . . . 0.0 111.262 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.33 -10.52 59.66 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.93 -29.4 27.14 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.248 1.019 . . . . 0.0 112.551 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.85 137.47 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.047 1.739 . . . . 0.0 110.069 170.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.43 157.4 34.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.764 0.826 . . . . 0.0 113.02 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -55.96 -28.93 59.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 111.724 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.7 m -62.78 -27.17 69.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.043 1.737 . . . . 0.0 114.243 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.7 -10.58 5.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.63 1.172 . . . . 0.0 113.511 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.83 -40.45 85.12 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 119.641 -1.912 . . . . 0.0 112.522 169.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -65.53 -24.15 56.61 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.771 2.314 . . . . 0.0 113.435 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 HD21 ' B' ' 139' ' ' LEU . 95.6 m -73.35 -36.53 66.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 110.243 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.54 85.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.647 1.179 . . . . 0.0 113.898 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.84 -35.28 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 119.203 0.911 . . . . 0.0 110.684 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.17 -43.51 74.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.878 1.228 . . . . 0.0 114.448 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -68.29 -49.06 63.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.986 2.393 . . . . 0.0 112.536 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.82 -29.96 71.12 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.147 0.579 . . . . 0.0 112.186 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.55 -45.46 10.44 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.21 90.94 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.679 -1.263 . . . . 0.0 111.308 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.47 62.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.426 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -74.18 -18.96 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.053 0.842 . . . . 0.0 113.221 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.3 -28.59 42.21 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.39 -0.818 . . . . 0.0 112.868 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -154.69 -128.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.48 1.512 . . . . 0.0 112.55 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.9 -39.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.578 2.351 . . . . 0.0 114.261 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -134.2 162.09 59.81 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 127.175 2.19 . . . . 0.0 110.363 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -94.84 9.72 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.939 1.759 . . . . 0.0 114.647 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.91 -18.26 63.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.153 -0.967 . . . . 0.0 112.936 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -112.39 -2.35 14.79 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.133 1.773 . . . . 0.0 113.971 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.55 55.44 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.43 145.07 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.467 1.907 . . . . 0.0 107.339 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD21 HG22 ' B' ' 120' ' ' THR . 1.4 tm? -80.2 137.24 36.64 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 119.233 0.924 . . . . 0.0 113.11 -168.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -94.27 47.66 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.498 -1.376 . . . . 0.0 113.749 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 ' CG ' ' B' ' 117' ' ' PHE 0.387 1.7 p -63.29 -50.28 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -60.22 -35.19 74.87 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.647 2.021 . . . . 0.0 111.854 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.77 -41.83 88.03 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 121.276 0.376 . . . . 0.0 112.54 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 HD13 HG21 ' B' ' 120' ' ' THR . 21.4 mt -65.7 -45.84 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.422 1.489 . . . . 0.0 111.444 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.05 -25.69 65.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.064 1.346 . . . . 0.0 112.973 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 m -63.92 -46.45 84.71 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.927 1.291 . . . . 0.0 110.98 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.15 -19.12 7.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -47.02 -60.94 3.24 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 125.284 1.433 . . . . 0.0 112.156 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.83 1.32 5.26 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.726 2.951 . . . . 0.0 114.334 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 -55.68 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.065 1.746 . . . . 0.0 110.938 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.07 -32.15 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.017 1.327 . . . . 0.0 111.463 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.11 -45.49 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.774 0.83 . . . . 0.0 112.097 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -67.88 -46.19 72.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.836 0.455 . . . . 0.0 110.181 175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.13 -31.61 69.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.79 0.836 . . . . 0.0 112.632 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.05 -20.28 61.01 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -30.17 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.434 1.015 . . . . 0.0 111.951 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.26 -39.09 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.366 1.067 . . . . 0.0 112.119 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -145.96 82.57 1.62 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 112.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -51.77 -35.53 44.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.878 1.271 . . . . 0.0 112.036 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.75 8.36 34.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.573 1.949 . . . . 0.0 114.595 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.38 45.12 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t30 60.42 20.18 9.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -155.13 150.55 27.26 Favored 'General case' 0 N--CA 1.486 1.363 1 N-CA-C 122.662 4.319 . . . . 0.0 122.662 -170.658 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -60.21 -25.15 65.38 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 113.749 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.79 -24.15 55.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.518 0.599 . . . . 0.0 111.568 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -64.35 -34.12 77.43 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.398 1.079 . . . . 0.0 113.805 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.78 -37.73 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.886 1.221 . . . . 0.0 112.149 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -79.88 -31.9 40.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.37 -33.59 81.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.665 1.126 . . . . 0.0 113.475 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.38 -32.92 55.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.722 1.261 . . . . 0.0 113.325 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -59.91 -41.44 91.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.591 1.087 . . . . 0.0 110.683 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.23 -51.04 70.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.923 0.889 . . . . 0.0 110.967 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -28.81 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 112.451 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 112.535 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 120.536 0.14 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.0 -15.66 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -85.01 -10.74 56.69 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.182 1.393 . . . . 0.0 114.129 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 48.1 m -144.72 49.37 1.3 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.388 2.275 . . . . 0.0 110.477 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -141.29 139.91 33.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.498 1.519 . . . . 0.0 110.435 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 39.6 p -98.76 150.0 22.28 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.65 -26.67 65.72 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.09 -39.28 85.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.978 -1.076 . . . . 0.0 111.418 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.16 -17.41 46.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.75 -29.03 66.28 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.794 -1.192 . . . . 0.0 110.353 168.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mp -73.79 -13.77 61.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.954 -1.091 . . . . 0.0 113.478 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.36 -33.45 25.83 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.486 1.039 . . . . 0.0 113.523 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.31 140.23 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.943 1.297 . . . . 0.0 110.597 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -67.13 158.78 30.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.868 1.267 . . . . 0.0 113.347 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.47 -32.69 71.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.44 1.096 . . . . 0.0 112.03 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.4 m -62.4 -23.44 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.909 1.684 . . . . 0.0 113.924 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.4 ' CG ' HG23 ' A' ' 52' ' ' VAL . 11.2 m-85 -124.78 -5.96 7.45 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.765 1.226 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -57.0 -46.78 99.84 Favored Pre-proline 0 CA--C 1.549 0.909 0 O-C-N 120.272 -1.517 . . . . 0.0 111.699 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -65.65 -18.31 58.57 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.097 2.531 . . . . 0.0 114.366 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.545 HG22 HD21 ' A' ' 50' ' ' LEU . 25.6 m -77.13 -38.02 52.92 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.818 1.247 . . . . 0.0 110.464 173.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.26 99.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.262 1.025 . . . . 0.0 112.476 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.56 -45.71 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.78 . . . . 0.0 109.094 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.5 -57.57 10.32 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 125.645 1.593 . . . . 0.0 113.464 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.62 -12.32 60.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.485 2.642 . . . . 0.0 113.905 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.54 -31.35 13.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.841 1.2 . . . . 0.0 113.627 169.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -88.59 -45.69 9.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.215 1.006 . . . . 0.0 112.343 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.61 84.09 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.791 2.436 . . . . 0.0 113.474 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -18.27 39.25 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.49 1.116 . . . . 0.0 111.865 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -84.69 -35.78 22.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 112.563 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.27 -6.82 54.73 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -146.67 -140.23 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.139 2.576 . . . . 0.0 107.621 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -153.68 -65.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -127.71 160.92 58.33 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 126.966 2.106 . . . . 0.0 110.031 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -82.09 0.24 9.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.16 1.45 . . . . 0.0 114.475 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -60.62 -19.46 57.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 113.456 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -131.79 7.89 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.011 1.324 . . . . 0.0 113.774 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.78 138.81 40.12 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.378 -1.451 . . . . 0.0 114.502 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.86 143.28 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.01 2.124 . . . . 0.0 107.087 168.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.582 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -73.15 133.39 44.07 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.415 1.007 . . . . 0.0 108.983 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -94.35 38.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.834 -1.166 . . . . 0.0 112.684 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 13.1 p -66.66 -21.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.809 -1.807 . . . . 0.0 112.845 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -55.2 -29.84 58.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.684 1.593 . . . . 0.0 112.915 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -94.47 -53.51 1.69 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.612 0.625 . . . . 0.0 112.567 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.24 -42.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.181 0.992 . . . . 0.0 113.357 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.99 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.143 1.338 . . . . 0.0 112.945 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 16.6 m -73.19 -37.73 66.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.556 1.142 . . . . 0.0 111.844 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.419 HG12 HD12 ' B' ' 151' ' ' ILE . 23.5 t -83.42 -27.74 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.074 1.75 . . . . 0.0 113.408 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 26.4 m -53.17 -59.69 8.57 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.323 1.449 . . . . 0.0 112.917 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.32 -15.12 46.29 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.298 2.665 . . . . 0.0 113.52 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.89 -62.51 1.47 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.115 0.966 . . . . 0.0 111.052 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 147' ' ' VAL . 33.1 mt -69.74 -30.99 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.38 -0.825 . . . . 0.0 112.822 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.38 -44.02 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.01 -1.056 . . . . 0.0 112.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -71.73 -46.08 59.71 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 110.807 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -27.05 67.72 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.577 -1.327 . . . . 0.0 113.309 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 m -75.1 -14.72 60.6 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.06 -36.02 21.47 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.595 1.543 . . . . 0.0 110.562 167.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -59.8 -38.62 82.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.038 0.935 . . . . 0.0 112.464 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -135.71 61.69 1.65 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.931 1.292 . . . . 0.0 112.022 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -49.16 -38.02 24.21 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.994 1.317 . . . . 0.0 112.877 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.51 -2.53 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.407 1.083 . . . . 0.0 113.825 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.68 158.42 24.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 112.638 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -80.44 137.38 36.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.388 1.475 . . . . 0.0 111.274 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.64 -44.14 91.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.367 1.067 . . . . 0.0 113.364 -170.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.79 -41.94 78.6 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.315 0.961 . . . . 0.0 112.111 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.25 -36.71 83.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.876 0.471 . . . . 0.0 112.059 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -74.62 -37.65 62.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.34 -38.73 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.099 1.318 . . . . 0.0 111.466 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.07 -45.53 93.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.291 0.636 . . . . 0.0 111.609 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.98 -49.07 69.03 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.763 1.173 . . . . 0.0 113.613 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.75 -34.34 66.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.634 1.217 . . . . 0.0 112.939 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -61.74 -37.14 83.12 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.193 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.26 -43.36 95.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.651 0.781 . . . . 0.0 111.825 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -23.13 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.728 -1.232 . . . . 0.0 112.331 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.84 -45.8 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.565 1.946 . . . . 0.0 112.528 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt . . . . . 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 0.0 113.8 -175.436 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 CA--C 1.534 0.488 0 N-CA-C 113.812 0.659 . . . . 0.0 113.812 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.37 1.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.22 2.208 . . . . 0.0 116.869 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.7 9.73 7.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.226 1.41 . . . . 0.0 113.576 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -132.86 -40.84 0.94 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.742 1.217 . . . . 0.0 113.904 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -83.89 158.7 21.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.596 0.713 . . . . 0.0 112.601 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -85.0 151.15 24.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -23.93 25.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.391 1.876 . . . . 0.0 114.127 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.34 -36.13 68.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.545 1.066 . . . . 0.0 111.378 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.73 -21.66 60.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.884 0.874 . . . . 0.0 113.071 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -66.64 -24.2 66.27 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -80.32 -14.79 58.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.266 1.426 . . . . 0.0 113.146 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.71 -29.87 40.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.941 . . . . 0.0 112.248 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.37 138.16 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.591 1.956 . . . . 0.0 110.118 172.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.2 157.74 30.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.728 0.811 . . . . 0.0 112.713 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -56.06 -30.92 62.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.228 1.411 . . . . 0.0 111.577 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.6 m -62.48 -27.67 69.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.229 1.812 . . . . 0.0 113.984 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -127.45 -9.35 5.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.745 1.218 . . . . 0.0 113.896 -170.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -55.2 -40.98 88.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 119.543 -1.973 . . . . 0.0 112.034 168.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -62.74 -24.18 74.63 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.305 2.67 . . . . 0.0 113.848 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.9 m -78.73 -33.53 46.6 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.418 1.087 . . . . 0.0 110.455 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.87 91.53 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.0 -36.08 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.048 0.84 . . . . 0.0 110.974 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.58 56.92 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.437 1.017 . . . . 0.0 114.489 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -11.44 60.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.568 2.184 . . . . 0.0 113.788 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.99 -48.25 7.91 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.092 166.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.32 -33.36 55.56 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 113.691 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.03 94.22 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.937 1.295 . . . . 0.0 112.159 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' B' ' 127' ' ' ALA . 0.6 OUTLIER -77.95 -40.51 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.65 1.18 . . . . 0.0 110.595 -175.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.28 -20.84 65.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.984 0.914 . . . . 0.0 113.433 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -84.21 -19.88 33.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -153.53 -124.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.251 . . . . 0.0 112.761 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -162.91 -64.13 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.071 2.148 . . . . 0.0 111.913 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -113.62 160.57 31.28 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.539 2.336 . . . . 0.0 111.196 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.41 2.59 8.29 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 114.578 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -59.17 -26.48 64.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.663 1.185 . . . . 0.0 112.768 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -118.7 25.69 10.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.01 1.724 . . . . 0.0 112.211 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.7 118.35 29.24 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.499 -1.376 . . . . 0.0 112.165 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.89 127.99 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.627 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -63.58 122.6 16.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.648 1.113 . . . . 0.0 110.153 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -89.69 46.71 1.39 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.161 -0.962 . . . . 0.0 113.015 -168.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.369 2.5 p -63.7 -15.06 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 O-C-N 120.645 -1.285 . . . . 0.0 112.43 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.78 -44.67 70.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.695 1.598 . . . . 0.0 112.185 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.66 4.98 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -50.17 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.825 . . . . 0.0 112.702 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.39 67.14 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.501 1.046 . . . . 0.0 112.453 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 m -66.19 -48.8 69.48 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.129 1.372 . . . . 0.0 112.218 171.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.2 m -87.04 -18.47 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -46.92 -63.1 1.51 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.107 1.363 . . . . 0.0 112.037 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -69.44 0.39 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.614 2.876 . . . . 0.0 114.57 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.52 -57.2 2.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.178 1.791 . . . . 0.0 110.029 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mt -68.83 -32.2 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.828 1.251 . . . . 0.0 112.369 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.79 -42.16 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.958 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -72.99 -46.9 49.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.456 0.646 . . . . 0.0 110.017 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.43 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.305 -0.872 . . . . 0.0 113.06 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.7 m -74.17 -14.26 60.93 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -34.99 16.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.36 1.436 . . . . 0.0 111.53 168.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -60.84 -38.0 83.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.16 . . . . 0.0 111.904 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -138.72 56.64 1.7 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.541 1.536 . . . . 0.0 112.318 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -49.97 -33.98 19.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.852 2.061 . . . . 0.0 113.121 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.6 -1.9 58.16 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.55 144.36 44.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.042 0.837 . . . . 0.0 111.827 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.76 29.37 0.2 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.287 1.835 . . . . 0.0 114.411 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 t80 52.01 -171.25 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.704 2.002 . . . . 0.0 112.814 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 tttt 62.26 -44.32 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 129.657 3.183 . . . . 0.0 115.288 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.77 -35.73 64.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.494 1.918 . . . . 0.0 111.671 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -43.59 79.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.673 0.789 . . . . 0.0 112.9 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.38 -37.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.003 0.819 . . . . 0.0 111.405 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -69.37 -48.79 60.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.242 1.017 . . . . 0.0 111.968 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.96 94.64 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.147 1.356 . . . . 0.0 113.845 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.21 -34.17 63.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.202 1.501 . . . . 0.0 112.637 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.5 -41.62 94.66 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.565 1.075 . . . . 0.0 111.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.97 -48.17 83.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.25 1.02 . . . . 0.0 111.393 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -28.88 70.14 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.427 -1.421 . . . . 0.0 112.346 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.2 mt . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.956 1.303 . . . . 0.0 112.707 -178.039 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 CA--C 1.537 0.641 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 m -55.71 -25.38 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.22 -27.68 60.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.552 1.141 . . . . 0.0 113.097 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m -119.04 -19.28 8.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -169.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.24 160.76 29.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.142 0.883 . . . . 0.0 111.878 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 53.4 p -95.73 168.42 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.708 1.242 . . . . 0.0 113.871 -169.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.46 -26.7 67.32 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.293 -0.88 . . . . 0.0 112.119 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -62.74 -42.12 99.51 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.421 168.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.4 -30.4 71.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.375 0.67 . . . . 0.0 112.087 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.417 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 66.0 t80 -69.17 -23.74 63.98 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.035 -1.041 . . . . 0.0 111.636 173.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.04 -8.96 56.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.417 1.087 . . . . 0.0 113.359 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.08 -34.99 43.13 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.187 0.995 . . . . 0.0 112.699 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.05 139.12 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.614 1.566 . . . . 0.0 110.187 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.4 158.87 32.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.368 1.067 . . . . 0.0 113.318 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.83 -32.34 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.492 1.517 . . . . 0.0 112.125 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.6 m -59.62 -29.44 68.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.727 1.611 . . . . 0.0 113.53 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.45 -4.38 6.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.871 1.268 . . . . 0.0 114.09 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -56.02 -41.18 89.71 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 120.168 -1.582 . . . . 0.0 113.001 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -62.76 -26.45 75.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.676 2.251 . . . . 0.0 113.239 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 50' ' ' LEU . 27.6 m -76.2 -35.6 59.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.526 1.13 . . . . 0.0 111.26 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.39 98.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.693 1.197 . . . . 0.0 113.645 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.63 -35.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.146 1.339 . . . . 0.0 109.793 168.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.88 -46.47 60.48 Favored Glycine 0 C--O 1.218 -0.89 0 C-N-CA 125.02 1.295 . . . . 0.0 114.589 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.29 -35.14 77.38 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 121.489 2.644 . . . . 0.0 112.738 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.83 70.81 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.186 -0.946 . . . . 0.0 112.45 173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -76.71 -46.48 25.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.348 1.059 . . . . 0.0 111.985 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -61.75 -51.64 67.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.478 1.511 . . . . 0.0 111.99 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -31.08 69.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.431 0.692 . . . . 0.0 111.086 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.41 -21.44 65.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.795 0.838 . . . . 0.0 113.196 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -84.43 -21.81 30.61 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.4 -124.79 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -162.98 -66.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 128.006 2.523 . . . . 0.0 110.281 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.6 164.97 13.76 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 126.714 2.005 . . . . 0.0 110.417 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -90.94 7.06 3.66 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.958 2.439 . . . . 0.0 114.001 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -63.95 -25.91 68.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.759 -1.213 . . . . 0.0 113.011 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.14 0.9 25.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.558 1.543 . . . . 0.0 114.382 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.62 131.27 44.37 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.833 -1.167 . . . . 0.0 113.563 -172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.24 129.58 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 127.051 2.14 . . . . 0.0 106.814 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.8 130.98 45.54 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.661 1.118 . . . . 0.0 112.269 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -88.98 50.29 1.93 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.958 1.303 . . . . 0.0 111.442 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.25 -38.87 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -166.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.84 -36.64 84.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.734 1.607 . . . . 0.0 111.476 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.5 41.19 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 123.95 0.786 . . . . 0.0 111.529 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.3 -42.95 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.998 0.919 . . . . 0.0 111.547 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.58 -34.94 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 112.761 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 24.7 m -64.56 -43.6 93.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.561 1.145 . . . . 0.0 111.73 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 25.2 t -80.14 -33.19 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.995 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.9 m -40.5 -61.9 1.08 Allowed Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.425 1.89 . . . . 0.0 113.891 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.85 -15.23 48.17 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.493 2.129 . . . . 0.0 113.632 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.44 -61.38 1.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.219 1.008 . . . . 0.0 111.231 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.34 -25.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.957 -1.089 . . . . 0.0 113.066 177.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.84 -52.77 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.026 0.83 . . . . 0.0 110.641 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -68.88 -47.1 66.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.705 0.402 . . . . 0.0 110.894 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -29.75 70.43 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.61 -1.306 . . . . 0.0 113.008 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.94 -15.25 60.21 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -32.29 22.61 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.058 1.299 . . . . 0.0 111.238 167.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -61.39 -38.22 86.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.945 0.898 . . . . 0.0 112.121 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -145.15 70.69 1.27 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 0.0 112.224 -170.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -54.91 -42.26 71.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -76.53 -15.72 59.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.87 158.4 35.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 111.926 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -69.21 143.66 53.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 169.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 35.7 t80 -58.1 -41.31 83.27 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -62.65 -33.02 74.2 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.4 -39.18 86.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.319 1.047 . . . . 0.0 111.838 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -37.86 62.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.937 0.895 . . . . 0.0 112.736 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.95 -48.33 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 119.302 0.955 . . . . 0.0 109.906 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.54 -46.83 74.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.01 0.924 . . . . 0.0 112.395 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.26 -42.23 99.72 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.26 0.934 . . . . 0.0 113.479 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.62 -33.61 62.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.454 1.127 . . . . 0.0 112.679 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.73 -37.88 88.28 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.465 -1.397 . . . . 0.0 111.878 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.41 -47.59 83.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.331 1.052 . . . . 0.0 111.933 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -26.15 68.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.051 -1.03 . . . . 0.0 112.285 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 31.6 mt -79.23 -49.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.913 1.685 . . . . 0.0 112.194 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt . . . . . 0 N--CA 1.482 1.15 0 C-N-CA 125.138 1.375 . . . . 0.0 113.523 -171.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 N--CA 1.471 0.205 0 N-CA-C 113.043 0.363 . . . . 0.0 113.043 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.77 -22.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.656 1.182 . . . . 0.0 113.605 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -68.57 -25.62 64.99 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.736 2.014 . . . . 0.0 113.827 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -133.25 -11.53 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -76.72 123.13 25.71 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 109.161 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -90.07 148.08 23.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 112.935 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -54.96 -30.0 58.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -63.26 -42.06 99.11 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.786 1.175 . . . . 0.0 111.693 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.23 0.27 57.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.865 1.266 . . . . 0.0 112.36 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 -28.07 20.77 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.036 -1.04 . . . . 0.0 111.838 171.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.82 -5.54 6.18 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.154 -0.966 . . . . 0.0 112.588 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.49 -27.17 60.45 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.427 1.491 . . . . 0.0 112.021 170.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.44 135.02 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.355 1.862 . . . . 0.0 109.749 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.09 157.46 33.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.636 0.774 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.85 -27.77 63.52 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.181 1.392 . . . . 0.0 112.238 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 m -66.53 -23.16 66.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 172.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CG ' HG23 ' B' ' 141' ' ' VAL . 17.9 m-85 -124.94 -11.09 7.16 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -61.38 -38.72 55.58 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.619 -1.925 . . . . 0.0 112.303 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.81 -26.06 74.77 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.129 2.552 . . . . 0.0 112.714 169.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 HD21 ' B' ' 139' ' ' LEU . 51.7 m -73.71 -36.34 65.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.651 1.18 . . . . 0.0 110.772 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.08 -49.73 74.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.218 1.007 . . . . 0.0 113.577 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 58' ' ' VAL 0.256 4.2 p -64.18 -33.77 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 118.99 0.814 . . . . 0.0 110.343 170.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.39 -52.06 34.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.405 168.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.36 -39.92 89.45 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.623 2.211 . . . . 0.0 112.599 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.97 68.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.244 -0.91 . . . . 0.0 112.69 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.69 -40.52 11.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.699 1.2 . . . . 0.0 112.385 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.34 80.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 111.859 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -26.44 60.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 0.0 111.058 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -68.27 -22.79 64.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -86.65 -24.69 25.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -154.13 -141.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.503 1.521 . . . . 0.0 111.108 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -165.11 136.23 4.01 Favored 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.105 4.162 . . . . 0.0 108.291 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.98 163.6 0.1 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.772 2.029 . . . . 0.0 113.061 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -92.59 9.27 2.6 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.034 1.823 . . . . 0.0 113.807 172.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -57.26 -24.63 56.05 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 112.971 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -130.6 31.93 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.563 1.545 . . . . 0.0 111.996 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.02 138.78 31.22 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.002 -1.686 . . . . 0.0 113.638 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.42 134.76 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.787 2.435 . . . . 0.0 106.174 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 111.74 4.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.012 1.278 . . . . 0.0 108.941 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -85.61 53.87 2.92 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.935 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.363 2.7 p -64.0 -14.24 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 -169.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.4 -42.57 53.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.853 1.661 . . . . 0.0 111.993 166.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.85 -52.94 4.15 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.24 -48.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.364 1.065 . . . . 0.0 112.923 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.02 71.37 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.585 1.084 . . . . 0.0 112.457 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.3 m -71.57 -43.62 65.98 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.658 1.583 . . . . 0.0 112.829 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 33' ' ' VAL . 1.6 p -79.93 -22.97 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.135 0.974 . . . . 0.0 113.623 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 m -49.26 -60.82 4.16 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 125.155 1.382 . . . . 0.0 112.945 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -66.33 -5.34 12.4 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.374 2.716 . . . . 0.0 114.465 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.4 -61.73 1.67 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -67.41 -35.23 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.361 1.064 . . . . 0.0 112.245 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.29 -51.66 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.416 1.086 . . . . 0.0 110.384 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -73.02 -42.34 63.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.388 0.613 . . . . 0.0 110.902 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -29.69 70.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.351 0.66 . . . . 0.0 112.358 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.42 -17.16 64.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -35.45 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.216 1.371 . . . . 0.0 111.726 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.93 -38.14 84.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.893 0.877 . . . . 0.0 112.601 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -140.29 72.98 1.41 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -51.01 -31.76 19.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.659 1.983 . . . . 0.0 113.294 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -93.49 0.09 56.59 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.91 154.22 36.14 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 111.418 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.63 149.35 34.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 110.262 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.1 -37.44 82.74 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.215 -0.928 . . . . 0.0 113.261 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -60.4 -37.66 81.52 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.577 -1.327 . . . . 0.0 112.765 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.82 -39.75 94.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.438 0.695 . . . . 0.0 111.315 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -62.84 -44.02 97.24 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.32 -41.36 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.056 0.843 . . . . 0.0 110.712 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.53 -54.1 22.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.517 0.727 . . . . 0.0 112.116 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.85 99.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.944 0.783 . . . . 0.0 113.108 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -28.07 57.31 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.425 -1.044 . . . . 0.0 113.275 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -65.07 -40.74 95.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.618 1.099 . . . . 0.0 111.146 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.01 -43.33 99.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.353 0.661 . . . . 0.0 111.731 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -38.21 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.192 1.797 . . . . 0.0 114.226 169.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 124.425 1.09 . . . . 0.0 112.095 -168.445 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 CA-C-O 121.339 0.475 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -67.64 9.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.573 1.549 . . . . 0.0 114.266 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.35 5.29 8.41 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.567 1.947 . . . . 0.0 113.549 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 8.1 p -144.57 -21.67 0.53 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -87.82 -176.29 5.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.2 p -113.35 167.43 10.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.303 1.441 . . . . 0.0 113.912 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -20.82 28.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.01 -34.56 72.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.759 1.163 . . . . 0.0 112.44 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.5 -20.95 63.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.661 0.784 . . . . 0.0 113.099 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.66 -23.65 66.17 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.801 -1.187 . . . . 0.0 111.921 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.8 -17.62 43.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.904 1.281 . . . . 0.0 113.598 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.44 -28.82 56.75 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.93 0.892 . . . . 0.0 111.598 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.32 135.78 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.12 1.768 . . . . 0.0 110.14 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.04 158.85 30.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.008 0.923 . . . . 0.0 112.844 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.51 -35.4 60.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.833 1.253 . . . . 0.0 112.032 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 m -65.31 -22.49 66.84 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.784 1.234 . . . . 0.0 114.241 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -126.36 -5.11 6.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -58.33 -39.22 73.75 Favored Pre-proline 0 N--CA 1.478 0.936 0 O-C-N 119.689 -1.882 . . . . 0.0 113.43 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.81 -26.43 79.47 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.348 2.032 . . . . 0.0 112.984 169.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -76.96 -32.69 57.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.424 1.089 . . . . 0.0 111.715 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.57 92.36 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.879 -1.138 . . . . 0.0 113.239 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.88 -34.48 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.674 0.67 . . . . 0.0 110.764 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.81 -56.84 14.23 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.364 0.983 . . . . 0.0 112.954 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.74 -16.92 62.38 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.748 2.274 . . . . 0.0 113.807 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.72 -28.64 18.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -109.48 -30.62 7.86 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.507 1.503 . . . . 0.0 113.419 -173.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.66 77.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.313 2.245 . . . . 0.0 112.194 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.11 -24.6 30.23 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.898 1.279 . . . . 0.0 111.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -18.15 64.7 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.04 0.836 . . . . 0.0 113.053 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -110.66 -5.12 15.1 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -128.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.189 1.396 . . . . 0.0 112.163 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -159.65 -62.08 0.07 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.516 1.926 . . . . 0.0 112.491 -169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -119.89 162.25 34.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 126.975 2.11 . . . . 0.0 110.796 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.79 5.22 6.55 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.273 1.982 . . . . 0.0 114.619 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.19 -24.89 60.64 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.43 13.63 18.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.827 2.051 . . . . 0.0 112.975 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.74 22.81 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 119.78 -1.825 . . . . 0.0 112.928 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.9 107.23 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.341 1.857 . . . . 0.0 106.162 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 31' ' ' THR . 2.9 tm? -61.52 124.94 22.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.143 0.577 . . . . 0.0 109.496 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -99.21 66.79 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.477 1.035 . . . . 0.0 111.98 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . 0.404 HG23 ' CG ' ' A' ' 28' ' ' PHE . 1.8 p -64.63 -33.9 66.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.7 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.62 -39.67 84.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.827 1.649 . . . . 0.0 111.937 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.24 -48.22 66.03 Favored Glycine 0 N--CA 1.47 0.961 0 O-C-N 122.037 -0.414 . . . . 0.0 112.219 171.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.18 -41.42 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.626 -0.926 . . . . 0.0 112.264 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.04 71.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.432 1.469 . . . . 0.0 112.325 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 44.1 m -63.22 -43.25 98.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.677 0.791 . . . . 0.0 111.464 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -84.7 -27.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.987 1.315 . . . . 0.0 113.583 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.4 m -42.2 -61.36 1.6 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.681 1.993 . . . . 0.0 113.536 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.64 -12.35 34.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.313 2.009 . . . . 0.0 113.916 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.9 -64.53 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.013 . . . . 0.0 110.98 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.551 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -71.16 -24.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 120.887 -1.133 . . . . 0.0 113.432 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 t -58.94 -51.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 110.204 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -73.41 -47.91 38.1 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.184 0.594 . . . . 0.0 111.042 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.63 68.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.515 -1.365 . . . . 0.0 113.531 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.5 m -74.76 -21.64 59.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 169.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -30.99 33.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.202 1.365 . . . . 0.0 111.553 169.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -63.29 -38.24 90.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.846 0.858 . . . . 0.0 111.531 168.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -143.09 66.63 1.31 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.06 0.944 . . . . 0.0 112.243 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.16 -37.21 53.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.004 1.322 . . . . 0.0 112.328 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -82.38 -1.16 49.03 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.788 1.235 . . . . 0.0 113.545 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.47 146.44 44.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 112.094 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -65.71 149.36 50.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.749 1.22 . . . . 0.0 111.205 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -48.89 151.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.079 1.352 . . . . 0.0 112.182 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm 60.26 -29.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.489 2.716 . . . . 0.0 116.792 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.66 -34.28 76.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.809 1.644 . . . . 0.0 111.714 172.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.08 -37.55 78.54 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.601 -0.687 . . . . 0.0 112.367 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.96 -47.74 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 124.11 0.964 . . . . 0.0 110.034 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -64.68 -42.91 95.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 112.342 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.64 -41.03 99.19 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.625 1.107 . . . . 0.0 113.165 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.47 -35.45 65.7 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.111 -1.229 . . . . 0.0 112.934 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.24 -37.72 86.51 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.988 -1.07 . . . . 0.0 112.037 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.5 -46.29 90.68 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 0.0 111.812 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -20.0 65.99 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.946 -1.096 . . . . 0.0 112.789 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.3 mt -86.46 -47.02 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.552 1.941 . . . . 0.0 112.396 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.48 1.067 0 C-N-CA 125.215 1.406 . . . . 0.0 113.348 -173.704 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.533 0.443 0 CA-C-O 122.054 0.772 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.25 -19.19 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.663 1.585 . . . . 0.0 114.874 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -95.29 -15.95 22.78 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.9 p -109.56 -32.73 7.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.984 1.265 . . . . 0.0 114.146 -172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -88.6 -179.96 6.15 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.771 0.829 . . . . 0.0 113.152 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.9 p -105.62 160.42 15.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.436 1.494 . . . . 0.0 114.352 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -25.29 60.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.527 1.931 . . . . 0.0 115.239 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.84 -35.31 66.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.582 1.083 . . . . 0.0 111.463 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.07 -18.12 60.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.266 1.026 . . . . 0.0 113.54 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -65.93 -29.3 69.69 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.808 -1.182 . . . . 0.0 110.573 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.91 -18.45 58.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.638 1.575 . . . . 0.0 113.082 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.36 -27.73 38.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.482 1.113 . . . . 0.0 112.006 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.8 137.62 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.843 1.657 . . . . 0.0 108.906 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -65.69 154.89 37.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.882 0.873 . . . . 0.0 112.536 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.11 -35.32 73.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.429 1.092 . . . . 0.0 111.777 -174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.4 m -61.65 -25.13 67.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.902 1.681 . . . . 0.0 113.713 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.98 -2.8 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.055 -173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -57.56 -43.73 99.08 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 119.906 -1.746 . . . . 0.0 112.148 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -62.69 -25.21 75.01 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.871 2.381 . . . . 0.0 113.92 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 HD13 ' B' ' 144' ' ' ILE . 89.5 m -75.8 -34.2 60.16 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.029 0.931 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.768 1.227 . . . . 0.0 113.587 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.18 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.079 0.854 . . . . 0.0 110.931 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.49 -51.1 50.13 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 124.973 1.273 . . . . 0.0 113.755 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 144' ' ' ILE . 3.2 m-85 -69.13 -23.51 63.99 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.283 2.542 . . . . 0.0 113.339 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 -61.48 1.79 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.325 -0.86 . . . . 0.0 109.296 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -73.66 -29.78 62.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.392 -1.443 . . . . 0.0 114.739 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' B' ' 124' ' ' PHE . . . -64.11 -41.39 97.28 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.03 -1.044 . . . . 0.0 110.933 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.434 HD13 HD13 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -83.39 -38.52 21.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.456 1.102 . . . . 0.0 110.329 -178.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -64.3 -33.52 76.02 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.571 1.148 . . . . 0.0 113.483 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -80.66 -13.77 58.73 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -155.25 -136.1 0.05 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.995 1.718 . . . . 0.0 110.769 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -172.18 127.08 0.56 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 130.532 3.533 . . . . 0.0 108.879 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 mttt 60.58 166.35 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.033 0 C-N-CA 125.787 1.635 . . . . 0.0 113.845 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -88.16 15.18 2.16 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.033 1.822 . . . . 0.0 114.846 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.77 -30.41 70.01 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.863 -1.148 . . . . 0.0 112.203 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -116.54 27.52 9.15 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.57 1.948 . . . . 0.0 112.167 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 107.75 14.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.915 -1.74 . . . . 0.0 111.763 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.54 118.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.685 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? -67.4 117.15 8.98 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.173 0.897 . . . . 0.0 112.406 -167.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -89.72 53.16 2.49 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.404 -1.435 . . . . 0.0 111.608 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.323 1.2 p -60.75 -41.33 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -167.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -63.23 -38.51 91.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.583 1.538 . . . . 0.0 112.305 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -54.09 39.85 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -43.45 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.492 -1.005 . . . . 0.0 112.164 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.29 67.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.203 . . . . 0.0 112.804 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -71.25 -45.13 63.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.251 1.421 . . . . 0.0 111.885 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 62' ' ' ILE . 2.2 t -86.53 -19.66 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.1 m -45.64 -61.91 2.11 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 125.123 1.369 . . . . 0.0 112.415 173.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.47 -3.66 12.92 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.599 2.866 . . . . 0.0 114.178 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.8 -64.45 1.17 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.899 1.28 . . . . 0.0 108.984 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 58' ' ' VAL . 21.8 mt -67.78 -34.67 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.959 0.904 . . . . 0.0 111.977 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.57 -49.69 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.88 0.872 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.13 -45.92 58.62 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.77 -28.72 69.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.291 -0.88 . . . . 0.0 113.183 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.0 m -75.26 -13.31 60.43 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.47 -34.99 16.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.469 1.486 . . . . 0.0 111.178 167.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -60.63 -38.27 84.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.82 170.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -138.18 52.94 1.82 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.15 1.38 . . . . 0.0 112.68 -168.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -48.51 -35.8 13.92 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.731 2.013 . . . . 0.0 113.259 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -88.49 -6.99 57.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.592 1.157 . . . . 0.0 113.755 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.78 161.58 27.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.044 0.938 . . . . 0.0 112.023 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.16 139.11 57.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 112.234 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.5 -53.1 59.78 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.841 . . . . 0.0 112.844 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -71.96 -32.67 67.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.693 -1.254 . . . . 0.0 112.853 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -64.98 -27.38 68.8 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.106 -0.996 . . . . 0.0 112.383 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -70.31 -37.37 74.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.504 1.047 . . . . 0.0 113.041 171.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.97 -38.24 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.771 1.169 . . . . 0.0 111.327 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -61.02 -48.33 82.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.055 0.942 . . . . 0.0 111.509 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.02 98.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.981 1.277 . . . . 0.0 113.649 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.8 -36.47 67.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.757 1.278 . . . . 0.0 112.651 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -60.62 -39.97 90.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.562 1.073 . . . . 0.0 111.631 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.04 -44.51 96.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.463 1.105 . . . . 0.0 111.931 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -26.45 68.59 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.962 -1.086 . . . . 0.0 112.352 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.251 10.1 mt . . . . . 0 CA--C 1.54 0.591 0 C-N-CA 124.892 1.277 . . . . 0.0 112.564 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 CA--C 1.539 0.727 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 m -55.39 -24.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.887 1.675 . . . . 0.0 114.242 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.98 -10.39 53.29 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.3 p -121.85 -29.74 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -86.94 172.36 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.4 p -92.67 160.91 14.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -24.0 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.38 -37.54 70.23 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.853 -1.155 . . . . 0.0 111.505 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.14 -28.43 69.64 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.981 0.912 . . . . 0.0 112.973 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.27 -27.16 69.15 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.113 -0.992 . . . . 0.0 111.152 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.2 mt -84.49 -10.71 57.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.802 1.241 . . . . 0.0 113.104 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.96 -29.38 22.09 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.959 1.303 . . . . 0.0 112.371 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.4 140.05 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.998 1.719 . . . . 0.0 110.242 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.6 159.39 32.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.271 1.029 . . . . 0.0 113.067 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.93 -33.89 71.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.086 1.354 . . . . 0.0 111.951 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m -66.18 -21.18 66.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.666 1.587 . . . . 0.0 114.007 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -126.73 -8.85 6.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.39 1.076 . . . . 0.0 113.308 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.81 -43.31 99.32 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 120.06 -1.65 . . . . 0.0 112.536 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.65 -25.0 61.99 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.688 2.259 . . . . 0.0 113.151 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.685 HG22 HD21 ' A' ' 50' ' ' LEU . 18.4 m -72.96 -32.37 65.17 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 111.218 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.77 89.42 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 170.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.98 -33.73 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.683 1.583 . . . . 0.0 110.043 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.76 7.6 2.12 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 126.57 2.033 . . . . 0.0 116.008 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 2.4 m-85 -121.48 -12.32 8.58 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.58 1.69 . . . . 0.0 112.852 169.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.17 -69.24 0.76 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.452 1.023 . . . . 0.0 110.77 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.74 -32.33 72.86 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.895 -1.128 . . . . 0.0 111.492 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.58 -35.88 68.72 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.472 1.109 . . . . 0.0 113.169 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -83.96 -42.56 16.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.186 0.994 . . . . 0.0 109.319 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.04 -39.3 74.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 0.0 113.834 -173.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -92.44 -8.28 45.17 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -9.6 0.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -171.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.326 3.8 p30 55.28 -34.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 121.437 3.866 . . . . 0.0 121.437 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -137.6 153.76 74.49 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 126.941 2.096 . . . . 0.0 110.648 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.84 -1.12 8.78 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 121.685 1.637 . . . . 0.0 114.67 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.29 -13.49 60.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.779 1.232 . . . . 0.0 112.87 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -127.78 8.25 6.29 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.133 1.373 . . . . 0.0 113.93 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.0 130.52 36.6 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.304 -1.497 . . . . 0.0 114.51 -170.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 20.6 t -117.28 135.35 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.759 2.024 . . . . 0.0 106.852 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 31' ' ' THR . 2.3 tm? -75.7 127.26 32.66 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.503 1.047 . . . . 0.0 111.446 -169.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -89.75 52.56 2.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.532 1.533 . . . . 0.0 111.939 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.378 1.7 p -67.29 -44.69 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -64.32 -36.94 85.75 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 123.075 2.671 . . . . 0.0 111.164 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.49 -47.34 88.11 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.642 HD13 HG21 ' A' ' 31' ' ' THR . 22.9 mt -56.46 -48.62 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.295 1.438 . . . . 0.0 111.618 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.6 81.45 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.531 1.059 . . . . 0.0 112.22 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 52.1 m -67.05 -42.29 85.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.937 1.295 . . . . 0.0 111.811 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.99 -24.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.498 1.519 . . . . 0.0 113.04 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -43.71 -61.02 2.14 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 126.748 2.019 . . . . 0.0 113.588 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.24 -14.16 43.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.537 2.158 . . . . 0.0 113.638 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -74.86 -56.37 4.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.105 0.962 . . . . 0.0 111.416 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -25.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.925 -1.109 . . . . 0.0 113.436 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.1 t -57.62 -51.36 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.824 0.85 . . . . 0.0 110.265 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 -46.86 34.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.429 0.692 . . . . 0.0 111.151 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.62 69.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.608 -1.308 . . . . 0.0 113.152 -171.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.3 m -77.09 -11.31 59.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.48 -31.63 18.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.074 1.306 . . . . 0.0 111.192 167.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -59.34 -38.73 81.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.199 1.0 . . . . 0.0 112.47 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -145.17 85.54 1.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.718 0.77 . . . . 0.0 112.095 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -62.53 -39.32 93.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.463 1.505 . . . . 0.0 112.406 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.89 -10.2 59.74 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.23 141.93 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.784 0.834 . . . . 0.0 112.828 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.1 40.39 0.98 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.392 2.277 . . . . 0.0 111.298 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -106.81 117.75 34.87 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -163.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -76.84 -26.42 54.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.015 1.326 . . . . 0.0 109.428 162.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.91 -23.16 63.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.376 1.471 . . . . 0.0 112.707 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -63.08 -40.32 97.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.779 0.832 . . . . 0.0 111.809 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -39.93 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.812 0.845 . . . . 0.0 110.69 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -65.41 -38.78 90.96 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.672 0.789 . . . . 0.0 112.112 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.95 99.75 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.986 1.279 . . . . 0.0 112.783 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . 0.453 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 25.7 mm-40 -71.35 -36.1 71.38 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.688 1.244 . . . . 0.0 113.075 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.93 -42.08 93.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.736 1.153 . . . . 0.0 111.594 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -49.63 76.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.088 1.355 . . . . 0.0 110.937 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -27.53 68.92 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.731 -1.231 . . . . 0.0 112.072 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -80.23 -47.41 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.957 1.703 . . . . 0.0 113.027 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 N--CA 1.481 1.098 0 C-N-CA 124.749 1.22 . . . . 0.0 112.932 -171.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.534 0.479 0 CA-C-O 121.273 0.447 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -65.97 -15.68 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.814 1.245 . . . . 0.0 113.241 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -93.86 10.75 31.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.182 1.793 . . . . 0.0 113.176 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -151.04 -42.07 0.12 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -83.97 148.8 26.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.34 1.066 . . . . 0.0 113.561 -169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.6 p -77.75 172.79 12.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.967 1.707 . . . . 0.0 113.653 -168.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -18.46 8.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.824 1.786 . . . . 0.0 115.824 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.4 -39.1 78.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.273 1.397 . . . . 0.0 110.751 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.55 -22.88 66.15 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.01 -1.057 . . . . 0.0 112.968 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.38 -1.87 32.21 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.699 -0.626 . . . . 0.0 112.507 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.4 mt -110.93 -24.7 10.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.546 1.539 . . . . 0.0 112.615 168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.66 67.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.128 0.971 . . . . 0.0 112.15 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.76 141.6 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.522 1.929 . . . . 0.0 110.655 169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.55 157.51 32.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.489 0.715 . . . . 0.0 112.555 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -54.61 -34.28 61.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.101 1.361 . . . . 0.0 111.981 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 m -64.48 -23.14 67.18 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -125.79 -4.1 7.07 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.738 1.215 . . . . 0.0 112.895 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -60.88 -43.85 92.87 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 119.568 -1.957 . . . . 0.0 112.591 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.05 -18.08 60.9 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.495 2.13 . . . . 0.0 113.241 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -78.82 -34.4 45.3 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.678 1.191 . . . . 0.0 111.653 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -62.99 -41.81 99.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.193 . . . . 0.0 111.852 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.14 -47.37 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.975 0.91 . . . . 0.0 108.898 169.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.56 -49.49 60.78 Favored Glycine 0 C--O 1.209 -1.428 0 C-N-CA 124.996 1.284 . . . . 0.0 113.582 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -69.42 -11.82 61.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 122.109 2.955 . . . . 0.0 114.205 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.28 -49.88 5.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.582 0.753 . . . . 0.0 110.505 166.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -73.34 -30.67 63.49 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.23 -0.919 . . . . 0.0 113.049 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.54 89.15 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 119.497 -2.002 . . . . 0.0 111.479 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.544 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -84.14 -13.69 52.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.026 1.33 . . . . 0.0 111.652 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 -22.28 60.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.003 1.321 . . . . 0.0 113.012 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 -2.68 13.2 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.84 158.57 0.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.978 3.311 . . . . 0.0 106.399 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.89 -27.91 16.81 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 128.091 2.556 . . . . 0.0 114.249 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.42 156.41 79.74 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 126.701 2.001 . . . . 0.0 110.964 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.94 6.83 5.51 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.054 1.836 . . . . 0.0 114.529 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.08 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.688 -1.258 . . . . 0.0 111.936 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.24 2.36 28.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.227 1.811 . . . . 0.0 113.168 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.74 123.46 27.71 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 119.765 -1.835 . . . . 0.0 112.45 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.48 -2.85 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 125.455 1.502 . . . . 0.0 111.972 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.724 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 61.78 119.08 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.403 3.081 . . . . 0.0 112.752 -172.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -93.1 55.43 2.33 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.224 -1.547 . . . . 0.0 112.095 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.322 2.5 p -69.54 -22.02 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.711 -1.243 . . . . 0.0 113.827 -169.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -58.02 -45.74 86.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.928 1.24 . . . . 0.0 111.21 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.46 -49.87 8.8 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.16 -44.43 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.893 0.877 . . . . 0.0 111.81 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.0 66.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.511 1.505 . . . . 0.0 112.773 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -70.99 -37.48 72.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.873 1.269 . . . . 0.0 111.586 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.4 t -90.4 -21.7 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.405 1.482 . . . . 0.0 113.417 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.4 m -46.86 -59.72 4.85 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 125.998 1.719 . . . . 0.0 112.819 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.97 0.52 4.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.157 2.572 . . . . 0.0 114.206 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -88.74 -64.31 1.17 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.389 1.476 . . . . 0.0 110.441 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.29 -29.31 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.907 -1.121 . . . . 0.0 113.2 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.32 -47.33 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.693 0.797 . . . . 0.0 110.459 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.13 -47.34 20.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.435 0.636 . . . . 0.0 110.866 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.99 71.45 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.2 m -76.01 -13.62 60.23 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.205 -0.935 . . . . 0.0 113.48 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.3 -29.05 21.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.849 1.204 . . . . 0.0 111.282 168.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.4 -38.29 80.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.453 0.701 . . . . 0.0 111.993 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.35 90.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 112.429 170.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -55.81 -36.02 66.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.145 1.378 . . . . 0.0 111.367 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -86.99 3.58 45.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.085 1.354 . . . . 0.0 113.375 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.92 151.5 21.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.983 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -59.37 139.25 57.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.788 1.235 . . . . 0.0 111.472 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -56.07 145.14 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.054 1.342 . . . . 0.0 113.401 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 59.06 -24.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.974 2.91 . . . . 0.0 116.916 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.78 -31.13 70.51 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.875 1.67 . . . . 0.0 111.627 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -68.7 -37.03 79.21 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.76 -47.15 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.41 1.084 . . . . 0.0 109.833 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.45 -42.6 98.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.868 0.867 . . . . 0.0 112.358 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.81 -45.62 95.34 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.216 1.389 . . . . 0.0 113.257 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 25.7 mm-40 -72.11 -35.52 69.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.461 1.131 . . . . 0.0 113.16 174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -59.84 -40.55 88.89 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.018 -1.051 . . . . 0.0 111.429 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.78 -45.1 95.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.72 1.208 . . . . 0.0 111.743 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -24.59 67.93 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.135 -0.978 . . . . 0.0 112.623 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.258 5.5 mt . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.111 1.364 . . . . 0.0 112.729 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.542 0.896 0 CA-C-O 120.919 0.3 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.26 -25.95 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 125.621 1.568 . . . . 0.0 114.75 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -79.11 -16.76 56.24 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 18.1 m -128.28 -22.29 3.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -86.95 166.26 15.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.447 1.099 . . . . 0.0 112.598 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 51.5 p -96.46 158.6 15.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.2 -24.56 67.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.32 1.448 . . . . 0.0 114.437 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.66 -37.78 73.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.812 1.187 . . . . 0.0 111.213 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.12 -30.56 71.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.268 1.027 . . . . 0.0 112.786 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -67.02 -23.73 65.94 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.175 -0.953 . . . . 0.0 111.67 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 49.6 mt -80.71 -15.77 55.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.504 1.122 . . . . 0.0 113.178 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.06 -28.85 43.2 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.121 0.968 . . . . 0.0 112.172 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.68 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.916 1.686 . . . . 0.0 110.191 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.39 158.62 33.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.0 112.856 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -53.88 -34.17 58.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.098 1.359 . . . . 0.0 112.368 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 33.5 m -65.95 -22.36 66.48 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.699 1.199 . . . . 0.0 114.107 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.08 -8.16 5.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.556 1.142 . . . . 0.0 113.509 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -57.77 -44.57 99.53 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 119.785 -1.822 . . . . 0.0 112.2 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.29 -27.43 77.99 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.693 2.262 . . . . 0.0 113.254 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.724 HG22 HD21 ' A' ' 50' ' ' LEU . 65.5 m -72.87 -38.92 66.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 0.0 110.962 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.4 94.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.334 1.453 . . . . 0.0 114.147 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.83 -32.69 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 119.432 1.014 . . . . 0.0 110.75 169.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.48 -55.11 21.31 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 125.301 1.429 . . . . 0.0 113.667 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.86 -35.73 79.14 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.561 2.181 . . . . 0.0 112.178 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.92 65.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -104.95 -31.44 9.23 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.1 99.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.34 1.456 . . . . 0.0 111.319 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.544 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -76.86 -32.02 57.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.942 0.897 . . . . 0.0 110.93 -178.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -65.12 -27.51 68.8 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -98.01 -8.61 27.55 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 -132.62 0.07 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.961 1.705 . . . . 0.0 110.478 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -156.79 -55.75 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.268 2.227 . . . . 0.0 112.276 -173.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -120.21 168.09 11.2 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 127.179 2.192 . . . . 0.0 110.194 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.78 10.37 3.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.108 1.872 . . . . 0.0 114.308 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 -25.92 67.22 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.782 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -118.5 25.18 10.45 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.734 2.014 . . . . 0.0 113.366 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.96 34.88 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.586 -1.322 . . . . 0.0 112.702 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.96 -13.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.284 1.034 . . . . 0.0 113.52 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 65.6 107.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.48 2.312 . . . . 0.0 110.648 -168.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.68 62.96 7.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.734 -1.229 . . . . 0.0 110.804 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.35 1.6 p -66.69 -25.14 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.148 -0.929 . . . . 0.0 113.334 -168.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.28 -50.75 72.49 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.807 1.64 . . . . 0.0 111.6 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.54 80.09 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mt -62.86 -45.26 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.049 0.94 . . . . 0.0 112.036 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.48 -32.34 72.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 120.628 1.558 . . . . 0.0 112.475 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 42.8 m -64.55 -44.21 91.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.832 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 28.5 t -82.67 -29.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.953 1.301 . . . . 0.0 113.161 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.7 m -41.04 -62.51 1.0 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 126.532 1.933 . . . . 0.0 114.018 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.99 -22.47 73.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.18 1.92 . . . . 0.0 112.931 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.57 -58.03 4.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.4 1.08 . . . . 0.0 111.33 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.485 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.07 -24.58 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.086 -1.009 . . . . 0.0 112.895 174.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.11 -52.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.466 1.03 . . . . 0.0 110.629 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -72.16 -47.16 52.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.586 0.232 . . . . 0.0 111.131 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.19 72.2 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.666 -1.271 . . . . 0.0 113.316 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.6 -13.44 61.38 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.66 16.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.247 1.385 . . . . 0.0 111.212 167.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.56 -43.15 97.58 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.26 0.624 . . . . 0.0 111.657 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -134.96 63.93 1.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.529 1.531 . . . . 0.0 111.093 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -51.34 -32.88 27.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.611 -1.305 . . . . 0.0 112.452 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -87.74 -3.12 58.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.099 1.36 . . . . 0.0 113.562 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 155.06 39.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.074 0.95 . . . . 0.0 111.599 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -66.84 135.55 54.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.565 1.146 . . . . 0.0 109.64 169.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.79 -51.7 60.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -67.81 -29.28 68.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.47 1.486 . . . . 0.0 112.521 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.58 -37.37 83.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.643 -0.661 . . . . 0.0 111.739 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -71.87 -35.34 69.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.477 -0.764 . . . . 0.0 112.914 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.15 -46.46 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.455 1.025 . . . . 0.0 109.926 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -65.44 -43.55 90.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.282 1.033 . . . . 0.0 112.475 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.17 -41.07 99.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.299 0.952 . . . . 0.0 113.246 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.71 -34.18 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.234 -1.156 . . . . 0.0 112.654 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -58.12 -41.98 84.8 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.753 1.615 . . . . 0.0 111.919 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.08 -50.79 72.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.862 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -29.15 70.6 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.896 -1.128 . . . . 0.0 112.256 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 30.7 mt -76.37 -49.5 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.229 1.811 . . . . 0.0 112.448 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 125.132 1.373 . . . . 0.0 112.769 -170.294 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.531 0.33 0 CA-C-O 120.602 0.167 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.17 -17.72 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -71.74 -29.92 65.04 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 112.396 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 -32.47 9.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 114.008 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.44 148.68 50.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.159 0.98 . . . . 0.0 111.526 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.6 p -97.31 167.44 11.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.028 1.394 . . . . 0.0 114.167 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.4 m -66.06 -24.21 66.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.948 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.88 -44.82 91.89 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.65 1.114 . . . . 0.0 110.249 169.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.79 -29.43 69.43 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.919 -0.488 . . . . 0.0 111.601 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -72.32 -11.88 60.9 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.983 -1.073 . . . . 0.0 113.336 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.54 -2.19 45.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.253 1.021 . . . . 0.0 112.48 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.81 -34.08 17.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.725 1.21 . . . . 0.0 112.352 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.35 138.84 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.31 1.844 . . . . 0.0 111.136 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.4 156.27 39.09 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 113.062 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.52 -35.03 38.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.834 1.254 . . . . 0.0 112.817 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 t -65.6 -26.37 67.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.369 1.068 . . . . 0.0 113.432 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -123.14 -0.66 8.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.228 1.411 . . . . 0.0 113.312 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -59.18 -46.42 99.26 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 119.574 -1.954 . . . . 0.0 111.424 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.35 -17.77 55.11 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.427 2.085 . . . . 0.0 114.412 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.522 HG22 HD21 ' B' ' 139' ' ' LEU . 37.6 m -67.71 -40.31 84.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 110.527 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.55 75.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.448 1.099 . . . . 0.0 113.866 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.55 -34.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.753 0.706 . . . . 0.0 109.989 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -57.89 15.11 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.644 -1.087 . . . . 0.0 112.919 168.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.73 -43.47 98.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.367 2.084 . . . . 0.0 112.411 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.7 -26.71 66.31 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -98.49 -35.75 10.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 113.159 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.02 71.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.041 1.336 . . . . 0.0 111.745 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.35 -24.88 61.35 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.884 -0.51 . . . . 0.0 110.954 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -24.42 57.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.73 0.812 . . . . 0.0 112.898 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.96 -7.17 25.49 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.77 -130.62 0.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.13 1.772 . . . . 0.0 110.342 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.61 -44.06 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.232 2.213 . . . . 0.0 112.245 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -123.62 164.95 25.46 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 127.966 2.507 . . . . 0.0 110.148 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.33 13.02 2.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.324 2.016 . . . . 0.0 114.185 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.98 -27.43 66.84 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.806 -1.184 . . . . 0.0 112.926 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.73 18.56 14.86 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.268 1.427 . . . . 0.0 114.196 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 129.7 40.62 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.851 -1.156 . . . . 0.0 112.607 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.52 -11.67 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.775 1.23 . . . . 0.0 113.271 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 62.77 114.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.787 2.435 . . . . 0.0 110.555 -167.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -82.85 51.87 2.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.403 -1.435 . . . . 0.0 110.74 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.422 2.7 p -69.04 -28.37 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.12 -39.37 82.08 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.332 1.878 . . . . 0.0 111.389 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.2 -51.24 10.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.369 0.985 . . . . 0.0 112.102 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -40.36 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.179 0.992 . . . . 0.0 111.987 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.43 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.19 1.359 . . . . 0.0 112.652 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -68.27 -40.98 81.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.751 1.22 . . . . 0.0 111.492 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 62' ' ' ILE . 36.7 t -81.66 -31.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.202 1.401 . . . . 0.0 113.617 -176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -41.78 -59.92 2.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 125.798 1.639 . . . . 0.0 114.47 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.42 -24.23 75.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.96 1.773 . . . . 0.0 113.204 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -61.29 -61.56 2.46 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.426 1.49 . . . . 0.0 110.571 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.67 -31.95 53.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 t -59.47 -51.85 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.805 1.242 . . . . 0.0 110.466 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.08 -49.96 45.77 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.066 0.46 . . . . 0.0 110.872 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.86 70.24 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.829 0.852 . . . . 0.0 112.727 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.9 m -72.9 -17.05 61.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -30.34 20.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.677 1.191 . . . . 0.0 111.233 168.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -64.0 -38.26 90.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.126 0.97 . . . . 0.0 112.405 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -145.3 85.09 1.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.818 1.247 . . . . 0.0 111.574 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.76 -39.78 71.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.223 1.409 . . . . 0.0 112.209 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.11 -11.99 59.99 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.22 152.5 44.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.005 0.922 . . . . 0.0 112.162 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -73.35 144.81 46.35 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.8 -44.32 90.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -67.11 -32.02 72.88 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.783 -1.198 . . . . 0.0 113.011 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.48 -40.42 86.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.969 0.908 . . . . 0.0 111.152 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.747 -1.12 . . . . 0.0 112.888 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -41.4 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.607 1.549 . . . . 0.0 111.334 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -64.21 -48.48 75.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.719 0.808 . . . . 0.0 111.676 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.41 99.72 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.36 0.981 . . . . 0.0 113.099 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.492 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 26.0 mm-40 -74.26 -35.63 63.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.605 1.202 . . . . 0.0 113.196 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -59.56 -40.21 86.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.005 1.275 . . . . 0.0 111.486 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.47 -45.51 93.94 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.21 1.004 . . . . 0.0 111.742 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -23.5 67.34 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.969 -1.082 . . . . 0.0 112.655 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.841 1.256 . . . . 0.0 113.065 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 CA-C-O 121.094 0.372 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 m -66.01 -4.82 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.668 1.587 . . . . 0.0 114.558 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -112.93 21.37 15.51 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.234 1.813 . . . . 0.0 112.934 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -143.82 -49.48 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -93.71 147.08 23.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.922 0.783 . . . . 0.0 112.207 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p -70.92 173.36 7.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.368 1.867 . . . . 0.0 113.965 -171.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -49.91 -20.56 0.93 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.66 -40.27 39.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.62 -30.63 69.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.144 0.978 . . . . 0.0 112.619 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -70.96 -17.65 62.66 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.511 -0.743 . . . . 0.0 111.967 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.92 -18.49 23.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.188 0.995 . . . . 0.0 112.911 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.85 62.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.278 1.031 . . . . 0.0 112.436 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.72 138.9 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.814 2.046 . . . . 0.0 111.119 171.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.67 159.13 32.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.477 1.111 . . . . 0.0 113.223 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.09 -33.64 58.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.353 1.461 . . . . 0.0 111.809 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.0 m -59.17 -27.46 65.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.114 1.765 . . . . 0.0 113.817 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.58 -3.95 5.99 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.392 1.477 . . . . 0.0 113.307 -171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -56.96 -44.85 99.94 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.241 -1.537 . . . . 0.0 112.528 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.41 -18.34 59.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.595 2.197 . . . . 0.0 114.007 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 40.6 m -81.43 -31.86 32.91 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.789 1.236 . . . . 0.0 111.449 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.1 97.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.521 1.055 . . . . 0.0 110.902 167.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.55 -47.0 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.084 0.954 . . . . 0.0 109.191 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.88 12.64 1.03 Allowed Glycine 0 CA--C 1.544 1.891 0 C-N-CA 126.798 2.142 . . . . 0.0 117.353 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.39 -14.18 7.46 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.609 1.563 . . . . 0.0 112.98 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.67 -72.6 0.62 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.84 0.856 . . . . 0.0 110.086 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -72.69 -20.44 61.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.042 -1.036 . . . . 0.0 112.61 -170.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.29 -42.42 70.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.427 1.091 . . . . 0.0 112.843 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -47.02 13.88 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.701 0.801 . . . . 0.0 109.541 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -6.9 57.79 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.93 -15.2 52.28 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.237 0.926 . . . . 0.0 113.205 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -150.92 -129.97 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.757 1.623 . . . . 0.0 110.861 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -156.41 -61.38 0.1 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.872 1.669 . . . . 0.0 113.104 -169.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.42 161.13 65.02 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.956 2.102 . . . . 0.0 110.705 -172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -86.49 10.41 3.64 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.705 2.27 . . . . 0.0 113.789 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.02 -27.74 63.9 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.876 -1.14 . . . . 0.0 112.052 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.79 -9.28 11.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.241 1.416 . . . . 0.0 114.158 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.35 136.19 47.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.958 -1.088 . . . . 0.0 111.949 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.68 8.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.987 1.715 . . . . 0.0 112.888 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 31' ' ' THR . 1.8 tm? 58.67 113.79 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 129.564 3.146 . . . . 0.0 111.344 -169.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.37 51.62 2.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.717 1.607 . . . . 0.0 111.506 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 0.4 OUTLIER -68.52 -31.7 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -164.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -64.61 -42.04 95.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.401 1.001 . . . . 0.0 111.575 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.29 -44.22 60.27 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mt -58.86 -48.22 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.278 1.031 . . . . 0.0 111.471 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.25 73.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.237 0.926 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 47.0 m -67.71 -43.86 79.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.455 1.102 . . . . 0.0 112.2 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' B' ' 151' ' ' ILE . 16.9 t -80.52 -30.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.886 1.674 . . . . 0.0 113.353 -177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -39.97 -62.08 0.96 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.026 1.73 . . . . 0.0 113.783 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.19 -13.56 38.64 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.729 2.286 . . . . 0.0 114.176 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.97 -64.87 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.048 0.939 . . . . 0.0 111.081 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.55 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.92 -25.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.766 -1.209 . . . . 0.0 113.379 -178.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.8 -49.71 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.263 1.025 . . . . 0.0 110.586 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.78 -44.99 22.0 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 111.464 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.59 -30.41 70.01 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.592 -1.318 . . . . 0.0 112.833 -169.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.4 m -72.44 -13.09 61.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 169.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -35.1 16.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.493 1.497 . . . . 0.0 111.15 167.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -59.29 -39.05 81.76 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 112.071 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -142.47 79.88 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.816 0.847 . . . . 0.0 111.676 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -55.5 -29.18 58.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.94 1.79 55.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.549 1.54 . . . . 0.0 113.116 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 155.55 37.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.647 1.179 . . . . 0.0 113.306 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.07 57.1 2.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.307 1.843 . . . . 0.0 113.374 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 p90 44.62 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.866 2.066 . . . . 0.0 116.005 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -67.43 -26.53 66.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 0.0 112.239 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.9 -36.56 77.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.153 0.981 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -72.33 -40.48 67.4 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 118.477 -0.773 . . . . 0.0 112.774 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.81 -42.46 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.326 0.966 . . . . 0.0 110.565 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -69.42 -46.99 65.5 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.924 1.29 . . . . 0.0 112.526 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.15 98.49 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.861 0.743 . . . . 0.0 113.129 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.52 -27.16 63.96 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.344 -1.092 . . . . 0.0 113.215 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -67.95 -41.0 83.14 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.081 -1.012 . . . . 0.0 111.1 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.56 -41.29 98.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.446 0.698 . . . . 0.0 111.411 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.63 -38.43 6.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 113.151 168.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.94 -39.58 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 112.286 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 57.2 mttt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 CA-C-O 121.341 0.475 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -19.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -78.99 -13.95 59.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.682 1.193 . . . . 0.0 114.084 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 m -131.5 -26.91 2.0 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -169.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.24 156.27 39.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.193 0.906 . . . . 0.0 112.681 -177.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.0 p -92.63 157.9 16.25 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.369 1.081 . . . . 0.0 113.62 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.33 -22.85 65.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.28 -39.69 87.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.949 -1.094 . . . . 0.0 111.203 173.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.02 -25.5 62.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 118.722 -0.656 . . . . 0.0 112.593 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.61 -30.6 70.23 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.6 1.545 . . . . 0.0 111.304 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.34 -13.21 60.15 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 171.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.45 -28.39 52.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.32 136.11 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.933 1.693 . . . . 0.0 110.534 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.03 159.99 31.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 113.189 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -33.73 72.22 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.769 -1.207 . . . . 0.0 111.849 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.8 m -61.93 -23.58 66.44 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 114.164 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.97 -7.38 6.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.84 1.256 . . . . 0.0 113.317 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -57.99 -41.96 92.65 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 119.498 -2.001 . . . . 0.0 112.544 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -64.93 -17.96 60.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.665 2.243 . . . . 0.0 114.109 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 HD21 ' B' ' 139' ' ' LEU . 47.5 m -76.71 -38.26 54.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.924 1.29 . . . . 0.0 111.148 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.31 97.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.433 1.093 . . . . 0.0 112.73 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.75 -46.56 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.24 -56.34 13.01 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 125.559 1.552 . . . . 0.0 113.889 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -11.51 59.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 122.072 2.936 . . . . 0.0 113.938 -173.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.55 -47.77 5.81 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.618 1.099 . . . . 0.0 111.995 168.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -76.52 -27.58 56.06 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.959 -1.088 . . . . 0.0 113.566 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.36 -62.94 1.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.854 1.261 . . . . 0.0 110.412 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.592 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -65.77 -18.81 65.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.766 1.226 . . . . 0.0 111.55 -174.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.09 -18.88 58.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.299 1.04 . . . . 0.0 113.671 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.47 9.19 5.52 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.52 148.06 7.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.999 2.92 . . . . 0.0 105.909 171.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.16 -44.11 8.52 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.5 2.32 . . . . 0.0 115.195 -166.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.33 160.13 58.43 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 127.375 2.27 . . . . 0.0 109.622 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.26 16.58 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 121.25 1.482 . . . . 0.0 114.126 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.58 -22.45 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.341 1.456 . . . . 0.0 112.841 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -128.37 -0.9 5.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.515 1.526 . . . . 0.0 114.195 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.84 146.18 53.08 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' B' ' 101' ' ' PRO . 2.7 p -126.34 151.21 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.873 1.669 . . . . 0.0 110.491 168.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.732 HD21 HG22 ' B' ' 120' ' ' THR . 2.8 tm? -75.38 124.49 27.21 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.461 1.105 . . . . 0.0 109.687 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -89.28 46.66 1.4 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.772 1.229 . . . . 0.0 112.493 -168.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.37 2.7 p -64.49 -27.86 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -60.45 -41.56 94.34 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.084 1.765 . . . . 0.0 111.708 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.36 -49.29 9.48 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.4 mt -57.11 -46.21 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.527 1.131 . . . . 0.0 111.525 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.76 68.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.841 1.201 . . . . 0.0 112.681 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -68.99 -39.89 79.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.868 1.267 . . . . 0.0 111.551 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 62' ' ' ILE . 55.8 t -87.43 -27.03 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.132 1.373 . . . . 0.0 113.334 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 m -41.77 -61.39 1.49 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.318 1.847 . . . . 0.0 113.928 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.91 -21.87 73.45 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.349 2.032 . . . . 0.0 113.093 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -67.14 -61.54 1.87 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.78 1.632 . . . . 0.0 110.424 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.458 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.09 -28.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.696 176.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -57.57 -46.84 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -74.73 -50.42 17.49 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.438 0.637 . . . . 0.0 111.168 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.01 71.16 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.53 -15.12 61.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.05 -33.48 17.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.224 1.374 . . . . 0.0 111.526 168.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -61.43 -37.96 85.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.262 1.025 . . . . 0.0 111.897 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -143.42 61.18 1.39 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.951 1.3 . . . . 0.0 113.0 -170.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -54.52 -37.16 65.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.386 1.874 . . . . 0.0 113.022 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.79 -10.04 59.06 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.43 162.65 19.88 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.258 1.023 . . . . 0.0 112.803 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -63.78 136.87 57.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.135 1.374 . . . . 0.0 110.808 173.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.18 -39.67 79.51 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.009 0.924 . . . . 0.0 112.785 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -65.25 -37.67 87.96 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.208 -0.933 . . . . 0.0 112.345 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.24 -39.99 88.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.468 1.107 . . . . 0.0 111.27 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -38.56 80.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.9 -43.67 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.267 0.627 . . . . 0.0 110.618 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -61.94 -45.01 95.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.472 0.709 . . . . 0.0 112.088 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.55 -47.88 87.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.706 1.146 . . . . 0.0 113.159 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 24.8 mm-40 -73.11 -31.43 64.33 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.659 1.23 . . . . 0.0 113.348 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.31 -44.2 95.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.067 1.303 . . . . 0.0 111.081 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.62 -48.79 79.28 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.794 0.837 . . . . 0.0 110.935 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -30.3 70.87 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.885 -1.134 . . . . 0.0 111.728 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 124.263 1.025 . . . . 0.0 112.234 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 42.0 Cg_endo . . . . . 0 C--O 1.231 0.171 0 N-CA-C 115.96 1.485 . . . . 0.0 115.96 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.91 15.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.344 2.258 . . . . 0.0 114.555 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.425 ' HA ' ' CE2' ' B' ' 163' ' ' PHE . 0.7 OUTLIER -134.1 10.05 3.84 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.812 1.645 . . . . 0.0 113.586 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 13.9 m -141.6 -2.23 1.23 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -170.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -132.91 156.72 46.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.554 1.142 . . . . 0.0 113.243 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 40.3 p -87.2 163.21 17.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.301 1.041 . . . . 0.0 112.046 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.321 0.1 OUTLIER -67.62 -4.25 11.37 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -172.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -35.42 68.67 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.715 -1.241 . . . . 0.0 111.243 168.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.07 -23.74 67.25 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.4 -0.813 . . . . 0.0 112.984 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -67.5 -18.51 65.08 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.074 -1.016 . . . . 0.0 112.219 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.27 -18.62 31.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.094 0.958 . . . . 0.0 112.819 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.32 50.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 112.886 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.75 139.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.939 1.695 . . . . 0.0 110.749 170.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.87 159.35 33.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.459 1.104 . . . . 0.0 113.466 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -52.73 -35.61 56.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.25 1.42 . . . . 0.0 112.303 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -62.73 -22.93 66.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.31 -2.98 6.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.216 1.406 . . . . 0.0 112.909 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -60.18 -47.22 97.31 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 119.625 -1.922 . . . . 0.0 111.706 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.52 -20.19 60.61 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.945 2.43 . . . . 0.0 113.812 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.732 HG22 HD21 ' A' ' 50' ' ' LEU . 94.1 m -75.19 -37.78 61.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.889 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.432 1.093 . . . . 0.0 112.013 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.67 -46.47 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.088 0.955 . . . . 0.0 109.511 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.96 13.42 0.48 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 127.106 2.289 . . . . 0.0 117.081 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.36 -54.1 2.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.843 1.822 . . . . 0.0 110.538 167.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.75 92.5 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.838 -1.164 . . . . 0.0 111.3 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.31 -37.47 52.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.35 94.45 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.728 -1.232 . . . . 0.0 111.58 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.49 -32.29 58.25 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.849 -0.532 . . . . 0.0 111.184 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.24 -29.26 68.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.935 0.789 . . . . 0.0 112.55 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -89.48 -8.12 53.58 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -136.18 -148.01 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.372 1.869 . . . . 0.0 111.493 -168.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -170.36 -48.83 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 130.839 3.655 . . . . 0.0 110.908 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.42 165.83 33.84 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 128.436 2.694 . . . . 0.0 109.518 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.15 7.55 4.93 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 121.917 1.72 . . . . 0.0 115.15 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -64.24 -25.62 68.14 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.836 -1.165 . . . . 0.0 112.592 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.73 8.6 26.91 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.274 1.83 . . . . 0.0 112.476 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.47 125.83 33.34 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 119.888 -1.758 . . . . 0.0 111.927 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.89 134.52 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.103 1.761 . . . . 0.0 106.93 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.763 HD21 HG22 ' A' ' 31' ' ' THR . 1.9 tm? -77.31 107.49 9.76 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.312 0.96 . . . . 0.0 110.349 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -89.57 51.23 2.05 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.36 1.864 . . . . 0.0 111.704 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.269 3.6 p -62.0 -35.98 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -166.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.2 -36.99 78.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.706 2.048 . . . . 0.0 111.856 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.68 -46.96 51.75 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.267 0.46 . . . . 0.0 112.336 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.06 -45.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.579 1.152 . . . . 0.0 111.492 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.87 75.27 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.824 1.25 . . . . 0.0 112.222 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 49.6 m -64.82 -42.53 94.91 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.869 0.868 . . . . 0.0 111.95 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' B' ' 151' ' ' ILE . 24.3 t -83.69 -27.01 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.133 1.373 . . . . 0.0 112.974 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.6 m -42.33 -61.13 1.72 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 126.247 1.819 . . . . 0.0 113.886 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.76 -23.02 75.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.177 1.918 . . . . 0.0 112.93 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.26 -58.11 4.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.211 1.004 . . . . 0.0 111.466 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.453 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -68.18 -24.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.638 1.108 . . . . 0.0 113.016 175.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 11.8 t -62.76 -50.74 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.712 1.142 . . . . 0.0 110.674 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.11 -43.63 42.32 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.152 -0.343 . . . . 0.0 111.667 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.53 81.42 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 120.956 -1.09 . . . . 0.0 112.177 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 92.0 m -76.88 -3.69 39.91 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.932 -1.105 . . . . 0.0 113.97 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -37.22 11.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.377 1.071 . . . . 0.0 111.592 168.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.11 -32.27 50.44 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -121.55 45.96 2.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.686 1.995 . . . . 0.0 110.744 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -50.48 -30.11 12.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.811 1.244 . . . . 0.0 113.272 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -90.17 -0.92 57.85 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.386 1.474 . . . . 0.0 112.958 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.25 159.42 33.47 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.856 1.262 . . . . 0.0 112.713 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.89 142.11 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.583 1.553 . . . . 0.0 112.463 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' B' ' 103' ' ' ASN . 14.5 p90 -43.71 -47.12 7.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.787 2.435 . . . . 0.0 115.966 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -95.18 -38.06 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.765 1.226 . . . . 0.0 110.904 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.23 -33.61 75.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.816 0.847 . . . . 0.0 112.324 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -73.93 -36.43 64.68 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.211 1.004 . . . . 0.0 113.049 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.4 -50.89 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.374 -0.829 . . . . 0.0 110.55 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.61 -37.47 82.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.411 1.084 . . . . 0.0 112.416 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.03 88.69 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.97 1.272 . . . . 0.0 113.063 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -71.83 -35.3 69.85 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.975 1.388 . . . . 0.0 112.638 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -59.74 -42.14 92.49 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.191 -0.943 . . . . 0.0 111.96 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.14 -47.52 85.57 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.796 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -23.31 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.932 -1.105 . . . . 0.0 112.678 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.33 -44.94 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.638 1.975 . . . . 0.0 113.149 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 124.767 1.227 . . . . 0.0 113.05 -173.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.531 0.362 0 CA-C-O 121.176 0.407 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.99 -23.35 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.2 -4.86 59.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.944 1.697 . . . . 0.0 115.108 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.8 m -127.85 -25.68 3.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.183 1.393 . . . . 0.0 114.341 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.47 160.03 32.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.308 1.052 . . . . 0.0 111.892 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -93.36 168.3 11.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.088 1.423 . . . . 0.0 113.645 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -26.02 67.91 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.787 168.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.78 -43.09 99.72 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.772 -1.205 . . . . 0.0 110.751 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.18 -28.06 69.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.176 -0.953 . . . . 0.0 112.344 169.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD2' ' CE1' ' A' ' 74' ' ' PHE . 41.1 t80 -69.37 -12.83 61.99 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.687 -1.258 . . . . 0.0 112.62 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 mt -94.47 -7.84 40.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.325 1.05 . . . . 0.0 112.49 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.88 -31.17 28.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 0.0 111.633 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.79 138.12 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.276 1.43 . . . . 0.0 110.608 169.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.2 159.61 33.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.185 1.394 . . . . 0.0 113.619 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.39 -36.28 75.52 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.038 -1.039 . . . . 0.0 112.076 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.9 m -61.26 -24.47 66.41 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.933 1.693 . . . . 0.0 113.806 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.33 -3.43 7.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.217 1.407 . . . . 0.0 113.033 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -58.13 -47.59 98.58 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.224 -1.548 . . . . 0.0 110.852 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 -16.48 50.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.738 2.292 . . . . 0.0 114.007 172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.787 HG22 HD21 ' B' ' 139' ' ' LEU . 97.5 m -77.84 -38.75 45.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.295 1.438 . . . . 0.0 110.738 173.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.61 97.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.612 1.165 . . . . 0.0 112.23 168.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.77 -46.48 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.86 -48.21 57.73 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 125.736 1.636 . . . . 0.0 114.684 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -68.78 -36.22 78.02 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.995 2.397 . . . . 0.0 112.551 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.1 75.23 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.853 0.751 . . . . 0.0 112.325 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -80.43 -46.52 15.82 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.477 -0.764 . . . . 0.0 111.645 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.96 78.08 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.016 -1.052 . . . . 0.0 111.735 -171.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -24.67 61.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.163 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 -14.6 63.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -89.18 -28.64 19.87 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.87 -121.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -168.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -158.89 -72.88 0.08 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.43 2.292 . . . . 0.0 111.078 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -103.13 163.95 16.48 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 126.75 2.02 . . . . 0.0 110.7 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.2 10.18 3.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.602 2.202 . . . . 0.0 114.402 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -12.73 61.65 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.906 -1.121 . . . . 0.0 112.949 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.79 30.47 4.04 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.605 1.962 . . . . 0.0 111.722 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.21 136.19 33.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 119.724 -1.86 . . . . 0.0 113.489 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.72 141.77 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.966 1.707 . . . . 0.0 109.192 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -67.54 131.94 46.62 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.456 1.503 . . . . 0.0 111.73 -168.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -83.26 50.48 1.76 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 119.982 -1.699 . . . . 0.0 111.958 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.431 2.1 p -66.85 -45.26 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -163.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.63 -34.24 72.53 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 121.621 2.009 . . . . 0.0 111.526 174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.16 -53.44 18.25 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.737 0.684 . . . . 0.0 112.448 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 mt -52.27 -46.45 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.784 1.634 . . . . 0.0 110.872 171.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.05 75.58 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.441 1.096 . . . . 0.0 113.103 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.6 m -71.48 -36.98 71.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 111.793 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.6 t -87.02 -23.11 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 112.923 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -47.32 -59.46 5.44 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 125.922 1.689 . . . . 0.0 112.412 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.84 -2.12 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.258 2.639 . . . . 0.0 114.219 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.82 -64.95 1.07 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 171.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.81 -30.91 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.652 -1.28 . . . . 0.0 113.004 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 t -58.57 -48.45 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.163 0.985 . . . . 0.0 110.838 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.01 -48.53 20.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.335 0.588 . . . . 0.0 110.904 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.86 69.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 25.3 m -77.19 -13.59 59.92 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.85 -32.85 17.59 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.886 1.221 . . . . 0.0 111.068 167.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.59 -38.62 88.24 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.835 0.854 . . . . 0.0 111.854 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -139.06 57.5 1.66 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.017 1.327 . . . . 0.0 112.765 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -52.84 -36.07 58.28 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.754 1.621 . . . . 0.0 113.108 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.21 -8.34 59.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.265 1.026 . . . . 0.0 113.519 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.75 161.21 27.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.213 1.005 . . . . 0.0 112.711 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.23 132.86 47.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.747 1.219 . . . . 0.0 110.235 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CD2' ' A' ' 21' ' ' PHE . 50.5 t80 -58.26 -44.22 88.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -66.17 -33.78 76.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.516 1.053 . . . . 0.0 112.221 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.11 -31.47 71.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.304 0.641 . . . . 0.0 112.372 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -70.16 -37.11 75.12 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.219 -0.926 . . . . 0.0 113.243 169.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -42.6 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 118.962 0.801 . . . . 0.0 110.597 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -62.1 -45.72 92.24 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.828 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.18 -43.42 98.64 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.26 0.933 . . . . 0.0 113.322 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -75.59 -25.29 56.88 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.118 -1.225 . . . . 0.0 113.573 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -67.42 -42.21 83.57 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.958 -1.089 . . . . 0.0 110.592 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.451 1.101 . . . . 0.0 112.165 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -49.0 16.59 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.32 1.848 . . . . 0.0 113.003 169.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.25 3.1 mt . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.888 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 116.135 1.552 . . . . 0.0 116.135 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.5 2.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.21 1.404 . . . . 0.0 114.573 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 17.1 m-80 -119.72 20.92 12.2 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.257 1.823 . . . . 0.0 112.898 169.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 57.0 m -142.49 -24.63 0.65 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.78 166.8 22.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -170.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.7 p -112.44 154.05 26.42 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.14 1.776 . . . . 0.0 110.434 168.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -25.21 62.24 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.8 -43.01 68.99 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.052 1.341 . . . . 0.0 111.184 170.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.72 -22.02 61.69 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.37 -0.831 . . . . 0.0 112.805 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -68.44 -15.06 63.41 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 111.861 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -91.27 -12.48 35.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.01 1.324 . . . . 0.0 113.061 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.32 -34.0 55.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.417 1.087 . . . . 0.0 112.743 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.04 137.28 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.608 1.563 . . . . 0.0 110.546 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.81 160.12 31.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.073 1.349 . . . . 0.0 113.724 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -59.48 -34.63 72.8 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 0.0 111.932 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.1 m -62.64 -25.01 67.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.036 1.734 . . . . 0.0 113.855 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.62 -6.03 8.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.797 1.239 . . . . 0.0 113.38 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -58.04 -42.68 96.39 Favored Pre-proline 0 N--CA 1.481 1.077 0 O-C-N 119.927 -1.733 . . . . 0.0 113.396 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.88 -28.37 86.28 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.962 2.441 . . . . 0.0 112.93 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.434 HG22 HD21 ' A' ' 50' ' ' LEU . 54.2 m -75.93 -33.52 59.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.373 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -65.35 -45.55 83.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.528 1.531 . . . . 0.0 113.665 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.27 -33.23 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.221 0.919 . . . . 0.0 110.18 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.13 -52.78 44.75 Favored Glycine 0 C--O 1.216 -1.007 0 C-N-CA 124.535 1.064 . . . . 0.0 113.225 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.08 -12.76 29.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.973 2.387 . . . . 0.0 113.892 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.48 -62.41 1.46 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.762 0.825 . . . . 0.0 110.659 164.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -68.19 -34.33 76.08 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.897 -1.127 . . . . 0.0 113.257 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.74 81.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.197 1.799 . . . . 0.0 112.114 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -39.29 50.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.584 1.154 . . . . 0.0 110.471 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -9.72 50.5 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -173.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -87.71 -23.92 24.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.233 1.013 . . . . 0.0 113.311 173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -153.95 -122.03 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.857 1.263 . . . . 0.0 114.044 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -162.24 -65.44 0.05 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.403 1.881 . . . . 0.0 112.055 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -116.02 161.91 28.51 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 126.229 1.812 . . . . 0.0 110.568 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.5 11.61 2.84 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.364 2.043 . . . . 0.0 114.407 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.13 -34.11 65.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.06 1.344 . . . . 0.0 111.785 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.48 19.34 16.98 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.494 1.918 . . . . 0.0 112.733 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.7 118.2 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 119.78 -1.825 . . . . 0.0 111.229 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.69 -4.91 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.003 1.321 . . . . 0.0 112.389 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.787 HD21 HG22 ' A' ' 31' ' ' THR . 2.0 tm? 59.61 112.75 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.414 3.085 . . . . 0.0 112.869 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -91.99 62.48 4.26 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.634 -1.291 . . . . 0.0 111.744 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 1.2 p -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 117.338 -1.315 . . . . 0.0 114.041 -168.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -63.96 -35.31 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.789 2.086 . . . . 0.0 111.672 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.89 -48.36 61.27 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.679 0.657 . . . . 0.0 111.857 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.88 -40.52 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.122 0.969 . . . . 0.0 112.257 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.62 71.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.785 1.234 . . . . 0.0 112.382 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 0.0 111.632 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.95 -33.1 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.356 1.463 . . . . 0.0 113.319 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.9 m -43.89 -58.37 4.78 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 126.235 1.814 . . . . 0.0 113.855 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.92 -11.36 30.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.807 2.338 . . . . 0.0 113.822 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -65.61 0.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.667 1.187 . . . . 0.0 111.601 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.495 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.0 -27.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.664 -1.272 . . . . 0.0 113.671 -173.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.5 -44.68 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.526 1.057 . . . . 0.0 112.304 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -73.68 -46.75 44.43 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.024 0.929 . . . . 0.0 110.885 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.27 67.54 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 113.2 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 9.4 m -74.87 -13.07 60.51 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -33.92 18.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.317 1.417 . . . . 0.0 110.755 167.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -60.76 -40.35 92.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.807 0.843 . . . . 0.0 112.16 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -132.81 64.99 1.6 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.727 1.211 . . . . 0.0 111.902 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -52.15 -32.61 36.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.512 -1.367 . . . . 0.0 113.63 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -92.83 1.31 57.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.825 1.25 . . . . 0.0 113.068 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.96 154.53 41.4 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.246 1.022 . . . . 0.0 112.301 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.97 152.25 33.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.834 1.654 . . . . 0.0 112.61 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 35.0 p90 -47.6 153.9 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.982 1.713 . . . . 0.0 113.526 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 43.7 tttt 60.82 -40.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 129.642 3.177 . . . . 0.0 115.93 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.41 -34.67 77.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.485 1.914 . . . . 0.0 112.199 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -69.09 -37.81 78.62 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.605 -0.684 . . . . 0.0 112.334 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.15 -41.3 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 119.101 0.864 . . . . 0.0 111.11 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.13 -45.44 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.664 0.786 . . . . 0.0 111.633 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.83 95.41 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.994 1.283 . . . . 0.0 113.485 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.95 -35.66 77.03 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 112.593 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -63.66 -36.94 85.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.69 -1.256 . . . . 0.0 112.007 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.87 -47.48 77.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.501 0.72 . . . . 0.0 111.683 171.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -24.66 67.57 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.573 -1.329 . . . . 0.0 111.93 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.7 mt -75.6 -45.96 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.934 1.693 . . . . 0.0 112.687 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.075 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 N--CA 1.476 0.481 0 N-CA-C 112.487 0.149 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.37 -16.44 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -76.76 -35.15 57.91 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.33 1.052 . . . . 0.0 112.615 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.8 m -100.48 -22.49 14.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.325 2.25 . . . . 0.0 113.904 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -64.78 140.78 58.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.018 2.527 . . . . 0.0 109.648 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.4 p -100.95 166.47 10.81 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.827 1.298 . . . . 0.0 113.54 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.16 -25.28 66.88 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.587 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -65.5 -42.83 91.69 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.853 -1.155 . . . . 0.0 110.421 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.59 -27.05 68.92 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.848 -0.532 . . . . 0.0 112.09 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -69.08 -12.19 61.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.785 -1.197 . . . . 0.0 113.119 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.09 -6.45 38.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.754 1.221 . . . . 0.0 112.64 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.13 -30.51 21.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.674 1.189 . . . . 0.0 112.375 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 p -72.56 141.95 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.751 1.62 . . . . 0.0 110.753 169.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.17 160.31 32.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.46 1.104 . . . . 0.0 113.084 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.21 -35.41 73.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.726 1.21 . . . . 0.0 111.848 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -62.95 -21.96 66.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.547 1.539 . . . . 0.0 113.79 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.09 -5.25 6.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 113.47 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -55.42 -47.22 99.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 O-C-N 120.131 -1.606 . . . . 0.0 111.478 170.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -60.47 -25.74 81.22 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.565 2.177 . . . . 0.0 113.857 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -70.5 -34.44 72.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.391 0.676 . . . . 0.0 111.915 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.72 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -67.05 -46.52 74.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.848 1.203 . . . . 0.0 113.005 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.11 -34.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 118.75 0.705 . . . . 0.0 110.249 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.13 88.13 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 118.819 -0.989 . . . . 0.0 113.524 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.13 -24.16 66.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.249 2.524 . . . . 0.0 113.609 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.88 -55.25 4.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.495 -0.753 . . . . 0.0 110.939 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -68.01 -31.64 71.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.454 -0.779 . . . . 0.0 112.5 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.98 84.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.396 1.078 . . . . 0.0 111.576 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD13 HD13 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -77.91 -36.75 49.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.329 -178.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -23.15 63.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -81.6 -17.91 46.59 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.85 -122.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.186 1.394 . . . . 0.0 112.341 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -160.8 -66.99 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.399 1.48 . . . . 0.0 113.03 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -129.73 164.29 41.16 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 127.906 2.482 . . . . 0.0 109.669 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 3.82 6.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.352 1.519 . . . . 0.0 114.716 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -55.27 -23.79 24.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.479 1.512 . . . . 0.0 112.564 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.16 9.27 15.8 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.788 2.035 . . . . 0.0 113.014 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.76 125.16 32.31 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 119.614 -1.929 . . . . 0.0 113.644 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.38 129.53 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.933 2.093 . . . . 0.0 105.866 173.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER -69.6 116.62 10.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.14 1.336 . . . . 0.0 109.678 -173.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.47 58.2 4.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.806 1.642 . . . . 0.0 110.991 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -69.55 -31.67 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.74 -35.13 79.86 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 121.239 1.836 . . . . 0.0 111.875 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.84 68.24 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.724 0.678 . . . . 0.0 112.237 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.41 -47.31 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.6 1.16 . . . . 0.0 111.123 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.76 -28.3 67.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.359 1.464 . . . . 0.0 112.993 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.5 m -66.02 -48.52 70.87 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.771 1.229 . . . . 0.0 111.001 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.67 -19.98 8.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -46.9 -63.07 1.52 Allowed Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 125.129 1.372 . . . . 0.0 112.258 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.65 -5.61 16.56 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.553 2.835 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.57 -61.15 1.83 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.437 1.495 . . . . 0.0 110.05 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.64 -30.72 48.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 124.752 1.221 . . . . 0.0 111.721 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.08 -44.18 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.431 1.014 . . . . 0.0 112.849 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -74.42 -46.01 42.85 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.029 0.531 . . . . 0.0 109.706 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.31 75.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.927 0.891 . . . . 0.0 112.861 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.8 m -74.24 -17.43 60.88 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -30.58 32.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.257 1.39 . . . . 0.0 110.79 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -65.29 -38.68 91.01 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.329 0.652 . . . . 0.0 112.626 170.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -130.26 55.81 1.79 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.606 1.563 . . . . 0.0 112.674 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -49.27 -40.19 33.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.602 1.161 . . . . 0.0 112.845 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.29 -2.5 57.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.105 0.962 . . . . 0.0 113.494 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.53 158.74 28.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.16 0.984 . . . . 0.0 112.007 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.9 141.32 47.88 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.825 0.85 . . . . 0.0 110.588 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -66.9 -47.39 71.94 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -64.14 -33.24 75.34 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.064 -1.023 . . . . 0.0 113.009 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.64 -34.03 74.98 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.241 0.616 . . . . 0.0 111.979 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -75.07 -36.38 61.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.28 -39.88 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.295 1.407 . . . . 0.0 111.203 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -61.55 -45.68 93.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.477 0.711 . . . . 0.0 111.584 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.16 -45.48 95.25 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.74 1.162 . . . . 0.0 113.789 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.24 -35.57 63.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.752 1.276 . . . . 0.0 112.867 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -59.58 -40.42 87.33 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.69 1.132 . . . . 0.0 111.562 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.66 -46.17 89.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.515 1.126 . . . . 0.0 112.052 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -26.39 68.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.205 -0.934 . . . . 0.0 112.331 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 124.722 1.209 . . . . 0.0 112.291 -178.042 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.542 0.877 0 N-CA-C 114.007 0.733 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -63.62 6.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 127.041 2.137 . . . . 0.0 115.796 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . 0.461 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 2.1 p30 -135.36 32.53 3.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.635 2.374 . . . . 0.0 111.215 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -148.28 -47.53 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.175 1.39 . . . . 0.0 113.673 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -99.01 139.3 34.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.872 0.869 . . . . 0.0 111.346 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 p -75.29 172.19 12.88 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.202 1.801 . . . . 0.0 114.578 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -21.63 1.54 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -55.34 -36.09 65.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.952 1.251 . . . . 0.0 111.444 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.6 -26.38 68.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.245 -0.91 . . . . 0.0 112.829 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -70.18 -18.45 63.19 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.206 -0.933 . . . . 0.0 111.884 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -91.84 -21.23 20.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 112.222 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.31 -34.25 61.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.663 1.185 . . . . 0.0 112.49 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.85 137.48 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.083 1.353 . . . . 0.0 110.64 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.35 158.31 31.94 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.065 1.346 . . . . 0.0 113.303 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -57.91 -35.82 71.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.684 1.194 . . . . 0.0 112.213 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -22.98 65.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.699 1.6 . . . . 0.0 114.002 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.82 0.09 6.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.56 1.544 . . . . 0.0 112.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.17 -42.75 94.97 Favored Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 119.765 -1.834 . . . . 0.0 112.788 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -61.66 -26.84 80.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.582 2.188 . . . . 0.0 113.386 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -74.57 -32.86 62.53 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 124.105 0.962 . . . . 0.0 111.246 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -61.62 -46.27 90.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.85 1.26 . . . . 0.0 114.11 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.05 -36.15 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.436 1.016 . . . . 0.0 110.69 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.01 -49.48 58.85 Favored Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.889 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.25 -13.57 60.59 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.797 2.299 . . . . 0.0 114.331 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.64 -56.7 2.92 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.753 -0.592 . . . . 0.0 109.862 165.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.09 -37.28 81.03 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.154 -0.966 . . . . 0.0 113.032 -169.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.88 72.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.655 1.982 . . . . 0.0 112.397 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -87.84 -37.2 16.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.167 1.387 . . . . 0.0 110.676 -177.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.02 -30.46 35.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.375 1.87 . . . . 0.0 113.798 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -98.33 -10.86 23.18 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -170.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.25 1.1 ptpm? -150.0 -126.7 0.05 OUTLIER 'General case' 0 C--N 1.351 0.636 0 CA-C-N 120.114 1.325 . . . . 0.0 113.328 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -161.82 -48.63 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -167.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -143.54 161.4 47.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 126.92 2.088 . . . . 0.0 110.664 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.51 -1.08 11.29 Favored 'Trans proline' 0 C--N 1.358 1.034 0 CA-C-N 121.453 1.555 . . . . 0.0 115.654 -174.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.83 -24.85 54.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.629 1.172 . . . . 0.0 113.037 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -114.86 7.06 15.62 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.0 1.72 . . . . 0.0 113.176 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.9 123.68 32.28 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 119.727 -1.858 . . . . 0.0 112.035 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.5 136.8 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.72 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -68.49 110.2 4.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.323 1.419 . . . . 0.0 108.186 178.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -91.02 59.64 4.1 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.072 0.949 . . . . 0.0 110.356 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.326 2.9 p -67.39 -15.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.063 -1.023 . . . . 0.0 112.183 -170.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.23 -33.03 57.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.416 1.486 . . . . 0.0 112.245 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.34 -61.23 1.92 Allowed Glycine 0 N--CA 1.467 0.728 0 C-N-CA 124.443 1.02 . . . . 0.0 112.171 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.48 -44.4 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.842 -1.387 . . . . 0.0 113.189 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.95 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.989 1.268 . . . . 0.0 112.547 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 8.9 m -67.31 -46.68 72.82 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.548 1.139 . . . . 0.0 112.066 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.408 HG12 HD13 ' B' ' 151' ' ' ILE . 1.5 t -93.99 -16.33 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.4 m -41.5 -60.47 1.83 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 125.906 1.682 . . . . 0.0 113.359 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.47 -14.39 44.66 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.73 2.287 . . . . 0.0 113.361 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.05 -57.61 3.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.723 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 147' ' ' VAL . 0.0 OUTLIER -60.33 -37.98 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 119.392 0.996 . . . . 0.0 112.221 -176.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.96 -43.22 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.99 -0.443 . . . . 0.0 112.052 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -71.31 -47.45 56.61 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.931 0.893 . . . . 0.0 110.866 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.95 71.64 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.496 -1.378 . . . . 0.0 113.205 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.4 m -76.16 -11.03 59.86 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.02 -34.15 16.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.397 1.453 . . . . 0.0 110.614 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -57.94 -38.67 76.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.308 1.043 . . . . 0.0 111.996 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -145.53 86.4 1.74 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.906 0.86 . . . . 0.0 112.001 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -55.0 -28.48 52.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.574 1.55 . . . . 0.0 112.89 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.23 3.5 55.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 113.048 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.46 161.08 15.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.115 1.366 . . . . 0.0 113.828 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.52 54.73 0.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.505 1.922 . . . . 0.0 113.495 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 1.1 p90 45.2 -104.31 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 115.391 166.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -48.45 -32.67 8.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.155 2.182 . . . . 0.0 113.892 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.03 -29.67 68.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 112.703 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -72.52 -39.71 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.319 -0.863 . . . . 0.0 112.557 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.72 -39.93 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.732 1.151 . . . . 0.0 110.964 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.22 -42.32 96.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.006 0.922 . . . . 0.0 112.142 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.37 99.34 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.789 1.185 . . . . 0.0 113.354 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.72 -34.15 66.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 1.153 . . . . 0.0 112.574 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -58.14 -42.77 86.6 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.781 1.173 . . . . 0.0 111.475 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.03 -45.17 94.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 0.0 111.624 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -23.89 67.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.982 -1.074 . . . . 0.0 112.655 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 19.0 mt -85.97 -49.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.334 1.853 . . . . 0.0 112.661 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 125.653 1.581 . . . . 0.0 112.92 -171.071 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -73.69 0.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.08 1.352 . . . . 0.0 113.886 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HA ' ' CE1' ' A' ' 74' ' ' PHE . 61.1 m-80 -123.98 19.79 9.2 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.76 1.624 . . . . 0.0 112.864 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -140.06 -39.87 0.44 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -94.81 153.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 111.818 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -79.97 175.39 10.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.698 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -19.4 0.66 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -55.8 -31.74 62.9 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 120.041 1.292 . . . . 0.0 112.029 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.04 -33.25 64.77 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.002 -1.061 . . . . 0.0 111.901 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.03 -10.62 60.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 mt -103.77 -22.17 13.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.53 70.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.202 1.001 . . . . 0.0 111.745 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.24 137.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 111.201 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.47 158.88 30.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.375 1.07 . . . . 0.0 112.683 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.16 -34.29 56.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.11 1.364 . . . . 0.0 112.153 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 m -60.04 -28.18 67.54 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.066 1.746 . . . . 0.0 113.697 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -127.49 0.4 6.25 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.655 1.582 . . . . 0.0 113.179 -171.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.88 -45.88 99.91 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.533 -1.354 . . . . 0.0 111.883 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -60.15 -25.43 79.9 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.935 2.423 . . . . 0.0 113.938 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.6 m -77.84 -30.79 51.22 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.331 1.053 . . . . 0.0 111.56 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -65.01 -45.43 85.57 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.883 -1.136 . . . . 0.0 113.36 172.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.27 -36.87 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 119.108 0.867 . . . . 0.0 110.084 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.53 -52.76 31.77 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 124.628 1.109 . . . . 0.0 113.234 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -69.34 -15.21 63.28 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 121.374 2.587 . . . . 0.0 114.128 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.17 -31.79 15.34 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.498 1.044 . . . . 0.0 113.183 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -93.65 -29.36 15.48 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.17 90.12 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.164 1.785 . . . . 0.0 111.963 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 HD13 ' B' ' 128' ' ' LEU . 0.7 OUTLIER -82.21 -36.05 27.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.979 0.912 . . . . 0.0 111.106 -174.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -65.06 -27.09 68.55 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -91.59 -9.08 45.46 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.85 -130.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.159 1.784 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.23 -43.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.282 1.833 . . . . 0.0 114.556 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.6 mmpp? -128.13 164.51 36.88 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 127.193 2.197 . . . . 0.0 110.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.13 -2.72 8.75 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.016 1.811 . . . . 0.0 114.281 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.62 -22.87 65.32 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.85 -1.157 . . . . 0.0 113.061 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.92 -5.11 23.84 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.563 1.545 . . . . 0.0 114.03 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 127.52 32.91 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.947 -1.096 . . . . 0.0 113.739 -169.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.26 128.29 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.212 1.805 . . . . 0.0 107.303 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -68.04 120.78 14.83 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 119.153 0.888 . . . . 0.0 110.439 -170.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -90.15 52.42 2.26 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.58 -1.325 . . . . 0.0 111.369 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.295 0.9 OUTLIER -64.32 -28.21 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -167.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -59.42 -39.9 85.01 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.756 2.071 . . . . 0.0 111.458 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.08 -54.6 13.15 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.48 -45.37 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.754 -0.851 . . . . 0.0 111.626 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.19 67.91 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.883 1.22 . . . . 0.0 112.747 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -69.02 -47.3 65.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.646 1.178 . . . . 0.0 111.885 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 62' ' ' ILE . 1.1 t -89.96 -18.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -43.22 -60.8 2.17 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 125.862 1.665 . . . . 0.0 112.395 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.1 -0.47 5.63 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.585 2.856 . . . . 0.0 114.503 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.32 -57.77 2.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.082 1.753 . . . . 0.0 111.219 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.69 -35.75 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 119.874 1.216 . . . . 0.0 111.986 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.06 -41.49 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 112.604 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -76.63 -47.7 21.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.474 0.709 . . . . 0.0 110.198 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.19 75.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.075 -1.016 . . . . 0.0 112.937 -170.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.1 m -76.2 -10.52 59.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -33.32 19.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.565 1.53 . . . . 0.0 110.381 167.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -61.52 -39.13 89.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.312 0.645 . . . . 0.0 111.695 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.45 61.29 1.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 112.744 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -54.0 -33.37 56.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.479 -1.388 . . . . 0.0 113.143 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.3 -1.82 58.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.149 1.379 . . . . 0.0 113.329 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.33 171.09 12.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.331 1.062 . . . . 0.0 113.271 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -64.71 141.02 58.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.44 1.496 . . . . 0.0 113.349 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 14' ' ' ASN . 7.0 p90 -58.35 -41.65 85.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.762 2.425 . . . . 0.0 115.173 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -93.25 -35.5 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.598 1.159 . . . . 0.0 111.621 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.2 -30.83 69.63 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.157 0.983 . . . . 0.0 111.621 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -74.72 -40.06 61.54 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -68.21 -40.8 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.879 1.218 . . . . 0.0 111.088 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.47 -45.71 78.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.236 1.014 . . . . 0.0 111.451 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.31 -44.07 97.48 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.324 1.44 . . . . 0.0 113.401 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.74 -32.74 65.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.165 1.483 . . . . 0.0 113.171 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -62.0 -42.95 99.71 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.642 -1.287 . . . . 0.0 111.21 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.71 -46.53 89.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.806 1.242 . . . . 0.0 111.878 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -28.23 69.88 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.118 -0.989 . . . . 0.0 111.812 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 mt . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 124.055 0.942 . . . . 0.0 111.889 179.774 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 CA-C-O 120.581 0.159 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.59 -20.85 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.8 -40.17 29.18 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.51 -0.744 . . . . 0.0 112.824 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 17.9 m -94.44 -27.44 16.02 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -169.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.31 161.79 27.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.983 0.897 . . . . 0.0 111.989 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 48.9 p -100.07 171.38 7.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 122.472 1.129 . . . . 0.0 113.899 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.33 -26.21 66.39 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.62 -0.675 . . . . 0.0 112.616 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.52 -43.81 97.91 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.39 0.995 . . . . 0.0 110.146 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -63.81 -31.51 72.71 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.485 0.714 . . . . 0.0 111.895 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 89.7 t80 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.765 1.166 . . . . 0.0 111.328 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.48 -8.2 55.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.01 45.2 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.319 0.963 . . . . 0.0 112.164 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.03 140.6 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.333 1.853 . . . . 0.0 109.124 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.35 155.3 35.77 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -52.67 -35.13 54.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.809 1.244 . . . . 0.0 112.093 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.9 m -64.49 -23.49 67.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -124.53 -1.77 8.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.998 1.319 . . . . 0.0 112.787 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.32 -46.43 90.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.061 -1.65 . . . . 0.0 111.546 171.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -61.19 -25.98 81.62 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.587 2.191 . . . . 0.0 113.497 169.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 50' ' ' LEU . 89.6 m -72.76 -36.96 67.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.208 175.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.49 92.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.872 1.269 . . . . 0.0 114.071 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.33 -33.05 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 119.975 1.261 . . . . 0.0 110.497 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.75 -52.0 36.3 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 124.998 1.285 . . . . 0.0 113.816 170.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -65.8 -25.85 67.43 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.663 2.231 . . . . 0.0 113.206 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.39 -58.7 3.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.091 0.86 . . . . 0.0 110.935 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -58.44 -44.07 89.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.267 1.827 . . . . 0.0 112.165 -174.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.39 -46.73 82.05 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.421 1.488 . . . . 0.0 112.075 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.452 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -78.88 -31.49 45.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.843 0.857 . . . . 0.0 111.809 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -71.2 -23.14 61.98 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -96.58 -11.5 25.27 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 -132.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.929 1.691 . . . . 0.0 110.88 -176.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -155.11 -56.2 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.998 2.119 . . . . 0.0 112.581 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -122.03 168.71 10.87 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.781 2.432 . . . . 0.0 109.965 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.22 6.28 4.58 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.66 1.573 . . . . 0.0 114.466 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.61 -26.66 68.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 112.625 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.22 21.7 15.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.686 1.995 . . . . 0.0 113.897 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.03 133.11 35.1 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.248 -1.532 . . . . 0.0 112.261 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.92 -1.36 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.67 1.188 . . . . 0.0 112.86 -173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 56.31 106.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.233 2.613 . . . . 0.0 110.561 -168.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.54 60.03 4.96 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.283 -1.511 . . . . 0.0 111.075 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.349 2.1 p -68.92 -24.77 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 120.721 -1.237 . . . . 0.0 112.282 -169.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -65.46 -42.96 91.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.723 -1.236 . . . . 0.0 112.209 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.96 -49.0 57.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.05 -43.79 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.953 1.301 . . . . 0.0 111.924 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -28.71 65.3 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.001 1.273 . . . . 0.0 112.736 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 50.5 m -69.8 -42.06 74.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 111.607 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 151' ' ' ILE . 29.0 t -85.41 -27.79 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.971 1.708 . . . . 0.0 113.474 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 22.2 m -50.74 -63.44 1.88 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 112.495 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.3 -17.68 58.75 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.459 2.106 . . . . 0.0 113.096 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.76 -58.29 4.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.434 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.445 HD12 HG12 ' B' ' 147' ' ' VAL . 33.0 mt -71.88 -32.32 44.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 112.34 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.49 -51.07 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.517 1.127 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.41 -48.16 73.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.632 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.6 74.17 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.0 113.454 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.0 m -73.5 -17.55 61.21 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.12 -31.11 19.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.624 1.102 . . . . 0.0 111.886 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.97 -41.89 97.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 111.253 169.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.34 80.02 1.55 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.895 0.855 . . . . 0.0 111.448 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.78 -38.98 67.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.176 1.79 . . . . 0.0 112.408 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.24 -8.86 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -169.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.8 148.08 52.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 112.266 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -65.22 135.29 55.24 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.209 1.004 . . . . 0.0 109.214 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.464 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 61.9 t80 -62.27 -52.32 64.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -58.9 -32.45 69.53 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.734 1.152 . . . . 0.0 112.386 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -70.94 -34.51 71.55 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 112.905 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -71.61 -34.95 70.27 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.682 -1.261 . . . . 0.0 112.606 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.89 -48.96 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.066 0.946 . . . . 0.0 110.077 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -59.0 -43.17 91.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.684 1.193 . . . . 0.0 111.744 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.04 -43.94 88.2 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.392 0.996 . . . . 0.0 113.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -80.39 -30.29 37.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.389 1.095 . . . . 0.0 113.517 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . 0.44 ' CD1' ' HE3' ' B' ' 175' ' ' LYS . 45.0 m0 -57.05 -40.02 75.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.195 1.362 . . . . 0.0 111.081 169.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -70.13 -14.78 62.8 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.653 -1.279 . . . . 0.0 114.083 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -21.55 25.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.339 1.456 . . . . 0.0 113.749 170.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.59 -45.66 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 126.523 1.929 . . . . 0.0 113.997 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' B' ' 171' ' ' TRP . 55.5 mttt . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 127.094 2.158 . . . . 0.0 111.829 -175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 CA-C-O 121.276 0.448 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.87 -26.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -74.4 -27.91 60.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.176 0.991 . . . . 0.0 112.932 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.6 m -114.79 -26.87 7.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.905 1.282 . . . . 0.0 114.304 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -92.97 171.88 8.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.632 1.173 . . . . 0.0 112.951 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.5 p -97.58 165.07 12.16 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -167.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.07 -16.92 8.4 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.763 1.625 . . . . 0.0 114.491 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.4 -35.44 62.88 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.729 1.149 . . . . 0.0 111.049 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.01 -32.31 67.82 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.765 -1.21 . . . . 0.0 112.502 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.95 -7.59 51.75 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 112.318 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.77 -16.46 14.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.248 1.419 . . . . 0.0 112.207 169.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.19 65.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.545 1.138 . . . . 0.0 111.513 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.64 139.32 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.334 1.854 . . . . 0.0 109.897 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.85 158.18 28.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.69 0.796 . . . . 0.0 112.092 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.77 -34.63 62.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.782 1.233 . . . . 0.0 111.69 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.8 m -59.14 -27.69 65.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.181 1.792 . . . . 0.0 113.516 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.44 3.16 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.482 1.513 . . . . 0.0 113.117 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -55.57 -45.63 99.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 120.002 -1.686 . . . . 0.0 111.276 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -60.31 -24.64 78.1 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.324 . . . . 0.0 114.249 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.768 HG22 HD21 ' B' ' 139' ' ' LEU . 62.3 m -75.95 -37.62 58.44 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.791 1.236 . . . . 0.0 110.759 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.23 97.42 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.42 -37.06 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 118.808 0.731 . . . . 0.0 111.574 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.23 12.04 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.798 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.73 -44.83 93.6 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.714 2.257 . . . . 0.0 112.409 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.0 -26.65 67.64 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -94.44 -35.93 12.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.48 84.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.428 1.891 . . . . 0.0 112.18 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD22 HD22 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -80.27 -26.22 39.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.151 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -18.33 48.54 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.458 -0.776 . . . . 0.0 113.091 -169.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -97.2 -14.18 21.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.4 -136.06 0.1 Allowed 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.972 1.709 . . . . 0.0 110.731 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -149.97 -60.78 0.2 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.594 1.958 . . . . 0.0 113.187 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -127.5 162.96 45.69 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.973 2.109 . . . . 0.0 110.326 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.05 5.85 5.96 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.722 1.615 . . . . 0.0 114.219 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -58.57 -24.77 61.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.523 1.129 . . . . 0.0 111.446 168.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -111.22 11.94 21.78 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.781 2.032 . . . . 0.0 113.383 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.09 34.83 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.023 -1.673 . . . . 0.0 113.005 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.34 -3.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 125.065 1.346 . . . . 0.0 112.387 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.1 OUTLIER 67.41 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.691 2.796 . . . . 0.0 110.749 -168.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -89.04 63.83 6.85 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.502 -1.374 . . . . 0.0 110.93 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.27 -28.63 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -168.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -54.13 -43.69 70.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.074 1.35 . . . . 0.0 112.199 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.9 -51.67 7.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.44 -48.19 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.188 0.995 . . . . 0.0 111.923 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.42 -28.34 67.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -70.2 -51.6 29.75 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.647 1.179 . . . . 0.0 112.539 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.01 -15.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -170.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.6 m -45.26 -63.31 1.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 120.261 1.391 . . . . 0.0 112.095 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -2.0 6.48 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.131 2.554 . . . . 0.0 114.805 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -64.13 1.14 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.964 1.706 . . . . 0.0 110.92 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -27.4 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.871 -1.143 . . . . 0.0 113.008 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -54.17 -48.2 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.926 1.29 . . . . 0.0 110.815 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -81.47 -48.47 11.82 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.239 0.543 . . . . 0.0 110.689 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.76 68.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.0 m -77.42 -13.92 59.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.08 -33.19 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.417 1.462 . . . . 0.0 110.917 168.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -61.82 -38.75 89.3 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.412 1.085 . . . . 0.0 111.847 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.82 55.61 1.72 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 0.0 112.834 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -53.75 -33.66 56.49 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.386 1.474 . . . . 0.0 113.232 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.18 -6.38 56.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.847 1.259 . . . . 0.0 113.705 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.04 159.61 26.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.785 0.834 . . . . 0.0 111.649 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -58.9 134.35 56.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 111.08 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.26 -47.24 71.31 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.391 -0.818 . . . . 0.0 112.96 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -64.27 -36.48 84.24 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.287 0.949 . . . . 0.0 111.963 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -59.61 -32.0 70.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.019 0.528 . . . . 0.0 112.068 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -74.83 -38.34 62.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.781 -1.104 . . . . 0.0 113.829 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.73 -41.15 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.923 1.692 . . . . 0.0 111.031 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.57 -44.05 91.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.317 1.047 . . . . 0.0 111.438 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.31 94.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.21 1.385 . . . . 0.0 113.5 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -71.93 -33.9 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.276 1.538 . . . . 0.0 113.4 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -60.33 -42.82 96.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.681 1.128 . . . . 0.0 111.383 171.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.04 -45.76 90.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.558 1.143 . . . . 0.0 111.969 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.59 71.62 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.002 -1.061 . . . . 0.0 111.826 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 124.142 0.977 . . . . 0.0 111.785 179.515 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 CA--C 1.541 0.854 0 CA-C-O 120.844 0.268 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.21 -26.82 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -80.08 -17.64 52.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.365 1.066 . . . . 0.0 113.563 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -106.4 -44.98 4.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.874 1.27 . . . . 0.0 113.939 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -101.8 176.05 5.35 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 77.7 p -91.2 164.55 13.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -167.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -20.7 21.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.553 1.941 . . . . 0.0 114.272 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.64 -31.78 57.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.625 1.102 . . . . 0.0 111.468 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.51 -36.32 64.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.839 1.256 . . . . 0.0 113.025 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.88 -20.05 64.25 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 111.633 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 43.4 mt -89.47 -12.52 39.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.008 1.323 . . . . 0.0 113.228 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -40.28 46.35 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.925 0.89 . . . . 0.0 111.176 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.34 137.74 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 128.013 2.525 . . . . 0.0 110.243 168.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.3 157.31 31.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.283 1.033 . . . . 0.0 112.947 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -50.34 -36.7 33.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.94 1.296 . . . . 0.0 112.68 171.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -66.58 -25.65 66.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.601 1.161 . . . . 0.0 113.483 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.4 -3.35 10.48 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.956 1.302 . . . . 0.0 113.843 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -56.88 -40.94 88.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.851 -1.781 . . . . 0.0 113.218 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -61.3 -26.82 82.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.606 2.204 . . . . 0.0 113.386 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 46.8 m -76.18 -35.0 59.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.377 1.071 . . . . 0.0 111.211 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -62.06 -47.26 85.47 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.204 1.002 . . . . 0.0 113.228 174.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.78 -36.59 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 118.34 0.518 . . . . 0.0 110.926 170.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.51 -55.29 17.42 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 125.267 1.413 . . . . 0.0 113.711 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -59.89 -33.95 72.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.23 2.015 . . . . 0.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.6 -47.74 30.59 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.472 -0.768 . . . . 0.0 112.943 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.08 -32.44 50.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.71 1.141 . . . . 0.0 112.847 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.77 55.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.067 1.347 . . . . 0.0 112.066 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.44 HD22 HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -69.4 -30.61 68.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.76 0.824 . . . . 0.0 110.95 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -68.11 -25.79 65.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.149 0.979 . . . . 0.0 113.218 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -80.18 -22.48 41.9 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -151.95 -130.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.245 1.418 . . . . 0.0 111.25 -169.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -163.82 -38.28 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.396 1.878 . . . . 0.0 114.023 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.49 164.86 40.96 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 127.377 2.271 . . . . 0.0 109.593 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -87.65 15.09 2.22 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.395 2.063 . . . . 0.0 114.26 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.12 -30.23 67.98 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.135 1.334 . . . . 0.0 113.239 -170.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.29 8.37 18.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.538 1.535 . . . . 0.0 114.259 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.17 127.64 33.5 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.938 -1.101 . . . . 0.0 112.045 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.53 14.05 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 126.201 1.8 . . . . 0.0 111.574 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 31' ' ' THR . 2.6 tm? 57.72 109.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.427 3.091 . . . . 0.0 110.439 -168.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -85.68 51.89 2.32 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.071 -1.643 . . . . 0.0 112.838 -167.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.31 0.4 OUTLIER -70.44 -11.82 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.744 -1.223 . . . . 0.0 113.564 -169.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -52.66 -34.09 50.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.362 . . . . 0.0 111.077 167.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.53 -58.39 1.85 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 113.002 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -43.53 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 118.301 1.051 . . . . 0.0 113.312 -174.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.96 64.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.996 1.271 . . . . 0.0 112.642 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 73.8 m -70.03 -38.77 75.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 112.097 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.93 -24.98 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.728 1.611 . . . . 0.0 114.011 -169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.4 m -43.56 -56.25 7.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 120.283 1.401 . . . . 0.0 113.525 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.62 -9.43 18.29 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.038 2.492 . . . . 0.0 114.587 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.94 -64.52 1.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.098 1.359 . . . . 0.0 112.225 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.479 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -71.86 -21.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.68 -40.76 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.845 1.202 . . . . 0.0 112.17 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.67 -47.93 13.33 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.218 1.007 . . . . 0.0 111.307 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' B' ' 151' ' ' ILE . . . -65.67 -37.39 86.38 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.543 -1.348 . . . . 0.0 113.069 -169.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -76.26 -8.66 57.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.94 -37.27 14.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.111 1.323 . . . . 0.0 111.685 169.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -75.64 -31.51 59.86 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -129.02 54.3 1.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.702 1.201 . . . . 0.0 111.752 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -52.35 -32.21 37.15 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.861 1.664 . . . . 0.0 113.075 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -90.02 -6.63 55.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.301 1.44 . . . . 0.0 114.05 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.2 156.71 31.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.95 0.796 . . . . 0.0 110.867 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -69.19 137.59 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.738 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -65.36 -38.63 90.66 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.062 -1.024 . . . . 0.0 112.721 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -59.35 -37.88 78.98 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.426 -0.796 . . . . 0.0 112.833 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.8 -35.27 76.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.27 0.628 . . . . 0.0 111.96 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -72.95 -37.9 66.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.237 -0.887 . . . . 0.0 113.235 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 14.2 m -64.45 -38.19 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.127 1.33 . . . . 0.0 111.285 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -63.79 -44.86 92.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.38 0.672 . . . . 0.0 111.948 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.1 98.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.303 0.954 . . . . 0.0 113.256 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.54 -36.06 65.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.464 1.132 . . . . 0.0 113.066 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -57.89 -41.57 82.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.406 1.003 . . . . 0.0 111.408 171.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.26 -47.56 81.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.603 1.161 . . . . 0.0 111.231 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -26.59 68.59 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.487 -1.383 . . . . 0.0 112.452 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.72 -46.62 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.982 1.713 . . . . 0.0 112.914 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 48.6 mttt . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.259 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.534 0.51 0 CA-C-O 121.466 0.528 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -62.67 -15.26 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -96.88 2.1 51.31 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.476 1.51 . . . . 0.0 113.607 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 m -137.97 -17.95 1.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.18 173.19 11.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.8 p -105.63 159.43 15.97 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.051 0.941 . . . . 0.0 111.706 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -21.32 43.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.63 -37.52 70.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.617 1.099 . . . . 0.0 111.46 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -67.68 -23.29 65.29 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.128 -0.983 . . . . 0.0 112.628 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.53 -11.05 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.877 -1.139 . . . . 0.0 111.908 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -98.34 -11.02 22.95 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.269 1.428 . . . . 0.0 112.663 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.96 -30.96 44.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.151 0.98 . . . . 0.0 111.73 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.85 137.23 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.767 2.027 . . . . 0.0 111.07 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.26 158.24 26.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 113.198 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -53.81 -33.47 56.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.956 1.302 . . . . 0.0 111.974 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 m -60.83 -27.71 68.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 113.623 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -127.18 -2.26 6.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 113.408 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.45 -43.44 98.08 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 119.91 -1.744 . . . . 0.0 112.348 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.84 -25.95 82.18 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.851 2.368 . . . . 0.0 113.367 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 HD21 ' B' ' 139' ' ' LEU . 52.3 m -76.23 -34.76 59.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.061 0.944 . . . . 0.0 111.531 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.63 1.172 . . . . 0.0 113.348 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.88 -34.54 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.92 0.782 . . . . 0.0 110.436 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.1 -46.05 79.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.614 1.578 . . . . 0.0 114.902 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.6 -41.62 83.75 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 121.361 2.58 . . . . 0.0 111.953 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.14 98.78 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.474 0.71 . . . . 0.0 112.173 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -85.24 -38.65 18.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.308 0.643 . . . . 0.0 112.524 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.24 63.8 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.28 -1.512 . . . . 0.0 111.146 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.51 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -72.58 -18.24 61.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.123 0.569 . . . . 0.0 111.726 -174.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -72.5 -21.71 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 113.029 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -98.04 -20.32 17.45 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.33 153.89 1.61 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 129.156 2.983 . . . . 0.0 106.56 -170.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.41 -17.92 19.39 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 128.836 2.854 . . . . 0.0 115.035 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -133.28 152.58 79.67 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.414 1.885 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -86.41 4.46 6.37 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.793 1.662 . . . . 0.0 114.503 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.15 -24.6 63.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.486 1.114 . . . . 0.0 112.439 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -111.36 15.38 21.37 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.536 1.934 . . . . 0.0 112.579 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.57 117.13 22.93 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 119.769 -1.832 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.28 107.92 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? -57.32 126.77 28.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -165.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -98.01 52.25 1.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.422 1.489 . . . . 0.0 112.298 -170.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.24 -30.75 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.128 -0.983 . . . . 0.0 112.16 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -60.27 -34.78 74.21 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.256 1.389 . . . . 0.0 112.064 175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.31 -55.06 5.3 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.204 0.906 . . . . 0.0 112.835 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.19 -42.24 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.026 -1.279 . . . . 0.0 112.394 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.28 64.99 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.687 -1.258 . . . . 0.0 112.872 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -69.8 -44.07 70.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 0.0 111.616 172.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.5 -20.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -43.23 -62.51 1.33 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.751 1.62 . . . . 0.0 112.371 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.17 -0.6 6.66 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.743 2.962 . . . . 0.0 114.485 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.68 -61.37 1.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.743 1.617 . . . . 0.0 109.766 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.14 -35.01 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.72 0.808 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.94 -43.6 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.872 0.869 . . . . 0.0 112.217 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.53 -46.83 45.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.356 0.598 . . . . 0.0 110.164 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.02 72.06 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.885 0.874 . . . . 0.0 113.039 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -75.86 -13.26 60.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.61 -33.68 16.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.111 1.323 . . . . 0.0 111.072 167.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -59.67 -40.44 87.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.403 1.081 . . . . 0.0 111.714 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -138.95 71.72 1.39 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -51.99 -31.17 28.2 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.649 1.18 . . . . 0.0 113.149 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -92.32 1.29 57.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 113.067 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.59 150.98 42.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.083 0.953 . . . . 0.0 112.053 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -93.38 103.03 15.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.938 1.295 . . . . 0.0 112.451 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.258 14.7 p90 43.12 -144.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -53.88 -17.13 2.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.644 2.778 . . . . 0.0 115.176 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.13 -27.84 62.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.168 0.987 . . . . 0.0 112.41 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -65.99 -43.34 88.06 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.733 1.151 . . . . 0.0 112.42 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.99 -38.08 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.138 0.881 . . . . 0.0 111.126 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.07 -45.18 93.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.703 0.801 . . . . 0.0 111.874 171.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.82 -43.5 98.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.93 1.252 . . . . 0.0 113.261 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.96 -35.33 69.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.039 1.42 . . . . 0.0 112.754 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -61.48 -41.26 96.99 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.909 -1.119 . . . . 0.0 111.479 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.91 -46.43 89.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.649 1.18 . . . . 0.0 111.853 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -26.66 68.48 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.004 -1.06 . . . . 0.0 111.735 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 124.28 1.032 . . . . 0.0 112.351 -179.314 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 CA--C 1.538 0.712 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -58.32 -22.98 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -79.12 -18.1 53.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.226 . . . . 0.0 114.147 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -127.4 -23.16 3.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.49 161.64 30.53 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.962 0.887 . . . . 0.0 112.845 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 50.1 p -93.99 167.2 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.646 1.212 . . . . 0.0 114.086 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.83 -26.55 66.98 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.08 -40.93 97.32 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.977 -1.077 . . . . 0.0 110.495 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.1 -31.4 72.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.106 0.563 . . . . 0.0 112.069 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -69.75 -26.75 64.46 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.47 -11.85 59.62 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.031 -1.043 . . . . 0.0 113.666 170.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.27 38.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.315 0.961 . . . . 0.0 112.866 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.51 141.91 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.045 1.738 . . . . 0.0 110.823 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.17 157.79 32.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.374 1.069 . . . . 0.0 113.346 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.34 -31.48 54.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.551 1.54 . . . . 0.0 112.04 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -61.54 -27.92 68.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.8 1.64 . . . . 0.0 114.079 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.62 -4.37 5.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.365 1.466 . . . . 0.0 112.697 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -57.02 -45.89 99.92 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 120.078 -1.639 . . . . 0.0 111.696 169.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -64.95 -22.52 62.69 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.356 2.038 . . . . 0.0 113.67 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.684 HG22 HD21 ' A' ' 50' ' ' LEU . 65.0 m -73.26 -35.81 66.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.988 0.915 . . . . 0.0 110.531 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.4 -41.91 84.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.04 -33.53 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.243 1.383 . . . . 0.0 110.875 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.94 -55.14 29.41 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 124.485 1.041 . . . . 0.0 111.912 168.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.76 -10.7 29.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 120.857 2.329 . . . . 0.0 114.408 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.15 -62.76 1.37 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.54 0.736 . . . . 0.0 110.051 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -73.43 -28.97 62.26 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.72 -1.237 . . . . 0.0 114.115 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.82 78.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.102 1.761 . . . . 0.0 112.274 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -85.53 -37.79 19.26 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.737 1.215 . . . . 0.0 110.082 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -59.58 -38.67 81.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.59 1.156 . . . . 0.0 113.381 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -91.4 -9.59 44.17 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 -128.49 0.09 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.663 1.585 . . . . 0.0 110.974 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -162.6 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.279 1.431 . . . . 0.0 113.24 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -135.76 165.6 34.8 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 127.283 2.233 . . . . 0.0 109.834 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.08 2.09 8.72 Favored 'Trans proline' 0 C--N 1.354 0.868 0 CA-C-N 121.429 1.546 . . . . 0.0 114.136 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.22 -28.36 67.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.446 1.098 . . . . 0.0 112.6 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.93 -20.23 30.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.281 1.432 . . . . 0.0 113.306 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.62 123.9 24.91 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.021 -1.049 . . . . 0.0 112.983 -169.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.31 17.18 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 126.202 1.801 . . . . 0.0 110.897 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 31' ' ' THR . 1.7 tm? 52.63 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.983 3.713 . . . . 0.0 110.127 -166.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.14 48.77 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.488 . . . . 0.0 112.425 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.289 3.9 p -70.77 -11.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -169.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.26 -29.73 24.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.611 1.564 . . . . 0.0 112.921 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.68 -55.62 1.88 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.71 0.671 . . . . 0.0 113.128 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 10.1 mt -51.16 -45.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.8 1.24 . . . . 0.0 113.282 -172.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.29 -28.79 63.32 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.611 1.096 . . . . 0.0 112.848 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 18.8 m -73.38 -41.59 63.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.897 1.279 . . . . 0.0 111.908 170.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.405 HG12 HD12 ' B' ' 151' ' ' ILE . 34.4 t -78.81 -28.9 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.076 1.75 . . . . 0.0 112.89 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.0 m -51.75 -63.76 1.88 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 125.697 1.599 . . . . 0.0 113.144 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.23 -18.59 61.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.745 2.297 . . . . 0.0 113.219 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.7 -58.84 3.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.893 0.877 . . . . 0.0 110.802 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.405 HD12 HG12 ' B' ' 147' ' ' VAL . 31.8 mt -72.59 -28.92 28.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 O-C-N 121.372 -0.83 . . . . 0.0 112.402 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -51.1 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 110.618 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.22 -47.42 70.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.719 0.408 . . . . 0.0 110.903 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.09 71.18 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.739 -1.225 . . . . 0.0 113.239 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.3 m -75.35 -12.7 60.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.09 -35.55 16.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.483 1.492 . . . . 0.0 110.945 167.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -58.1 -38.13 75.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.009 0.924 . . . . 0.0 111.95 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.6 57.33 1.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.567 1.147 . . . . 0.0 112.85 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -52.12 -40.33 61.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.047 1.739 . . . . 0.0 112.968 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -80.53 -7.58 59.26 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.07 165.6 17.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.239 1.016 . . . . 0.0 112.657 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -62.57 138.79 58.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.851 1.261 . . . . 0.0 110.739 170.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.41 -43.7 88.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.253 1.021 . . . . 0.0 113.294 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -65.19 -30.53 71.44 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.224 -0.923 . . . . 0.0 112.446 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.69 -38.46 81.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.472 1.109 . . . . 0.0 112.128 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -39.57 72.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.87 0.868 . . . . 0.0 112.577 172.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.91 -47.03 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 118.594 0.634 . . . . 0.0 110.302 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.16 -50.06 65.24 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.466 1.106 . . . . 0.0 111.921 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.63 98.94 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.599 1.095 . . . . 0.0 113.779 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -73.96 -33.14 63.77 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.751 1.275 . . . . 0.0 112.584 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.81 -37.26 86.04 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.965 -1.084 . . . . 0.0 111.852 170.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.83 -46.77 86.36 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.352 -0.843 . . . . 0.0 111.048 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -23.18 66.41 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 119.91 -1.744 . . . . 0.0 112.609 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -78.05 -46.58 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.358 1.863 . . . . 0.0 112.74 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 N--CA 1.482 1.169 0 C-N-CA 124.904 1.281 . . . . 0.0 113.203 -172.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.535 0.55 0 CA-C-O 121.034 0.347 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.81 -29.28 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.306 1.443 . . . . 0.0 114.507 -169.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.19 -15.96 57.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 114.13 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 t -110.95 -38.23 5.15 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 113.345 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -85.25 169.85 13.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.309 1.052 . . . . 0.0 113.597 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.5 p -99.93 161.15 13.79 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -19.51 49.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.572 1.949 . . . . 0.0 115.171 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.81 -34.98 70.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.792 1.178 . . . . 0.0 111.049 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.89 -26.53 68.65 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.081 -1.012 . . . . 0.0 112.802 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.66 -13.31 62.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.246 -0.909 . . . . 0.0 112.146 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.13 -19.36 18.72 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.644 1.178 . . . . 0.0 112.117 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.25 -37.45 32.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.759 1.224 . . . . 0.0 112.163 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.89 134.38 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 0.0 109.604 168.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.76 160.48 22.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 112.513 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.36 -36.63 73.76 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.134 -0.979 . . . . 0.0 111.788 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.6 m -59.65 -26.92 65.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.222 1.809 . . . . 0.0 113.728 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.45 -2.9 9.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.465 1.506 . . . . 0.0 112.76 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.2 mt-30 -59.07 -50.48 87.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 120.049 -1.657 . . . . 0.0 111.025 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 52.4 Cg_exo -67.69 -16.85 47.34 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.294 1.996 . . . . 0.0 113.622 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 m -75.75 -36.14 59.97 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.134 0.974 . . . . 0.0 110.912 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.18 83.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.464 1.106 . . . . 0.0 111.418 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.82 -47.41 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.257 1.023 . . . . 0.0 109.567 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 10.64 0.58 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.824 2.155 . . . . 0.0 117.209 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.64 -53.72 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.408 1.604 . . . . 0.0 109.945 167.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.7 85.11 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.221 -0.925 . . . . 0.0 112.655 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.3 -37.06 26.36 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.303 -0.873 . . . . 0.0 112.26 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.55 -49.21 72.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.993 -1.067 . . . . 0.0 111.778 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -18.32 61.03 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.956 0.902 . . . . 0.0 112.061 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -78.25 -21.97 49.06 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.062 -1.024 . . . . 0.0 112.916 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.69 -20.48 20.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.98 151.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.883 2.873 . . . . 0.0 106.969 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.95 -32.85 17.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.936 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -134.61 159.51 71.94 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 127.386 2.274 . . . . 0.0 109.736 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.2 15.92 2.05 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.698 1.599 . . . . 0.0 114.426 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -61.75 -21.96 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.935 1.294 . . . . 0.0 112.307 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.31 20.14 13.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.646 1.979 . . . . 0.0 112.438 173.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.85 109.38 16.93 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 119.493 -2.004 . . . . 0.0 110.875 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.94 8.03 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.038 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.839 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 49.17 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.518 3.927 . . . . 0.0 114.67 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -89.46 64.51 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.028 1.331 . . . . 0.0 111.475 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' CG ' ' B' ' 117' ' ' PHE . 0.7 OUTLIER -64.25 -39.1 84.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.073 -171.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.91 -36.55 84.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.366 1.439 . . . . 0.0 112.415 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.48 -48.91 59.9 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.676 0.655 . . . . 0.0 112.029 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.15 -42.79 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.528 1.131 . . . . 0.0 111.745 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.68 62.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.891 1.676 . . . . 0.0 113.159 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.1 m -72.62 -37.88 67.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.826 1.25 . . . . 0.0 111.463 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.81 -24.33 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.373 1.469 . . . . 0.0 113.626 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.8 m -49.65 -62.93 2.01 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 125.665 1.586 . . . . 0.0 112.619 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.93 -4.21 11.99 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.402 2.735 . . . . 0.0 113.926 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.35 -64.56 1.16 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.364 1.466 . . . . 0.0 108.807 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.94 -27.59 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.269 -0.894 . . . . 0.0 112.028 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -55.51 -48.43 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.674 1.189 . . . . 0.0 110.727 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.34 -48.06 18.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.546 0.688 . . . . 0.0 110.544 174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.71 69.89 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -169.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.1 m -76.94 -13.39 59.98 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -32.82 21.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.426 1.466 . . . . 0.0 110.757 168.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -61.24 -38.61 87.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.739 0.815 . . . . 0.0 112.089 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -135.81 58.72 1.74 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.379 1.471 . . . . 0.0 112.814 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -50.75 -36.1 34.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.562 -1.337 . . . . 0.0 113.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.61 -3.77 58.12 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.995 1.318 . . . . 0.0 113.624 -172.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.34 161.56 23.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.264 1.026 . . . . 0.0 111.496 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -65.52 134.64 53.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.844 1.258 . . . . 0.0 111.412 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -66.06 -52.27 50.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.397 -0.815 . . . . 0.0 112.826 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -62.33 -34.16 76.09 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.576 1.08 . . . . 0.0 112.297 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.6 -36.24 82.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.476 0.71 . . . . 0.0 112.152 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.0 -34.29 68.76 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.54 -46.2 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.089 0.556 . . . . 0.0 110.018 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -62.59 -43.4 98.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.763 0.825 . . . . 0.0 112.185 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.92 -44.38 98.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.018 1.294 . . . . 0.0 113.545 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.19 -35.1 68.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.784 1.292 . . . . 0.0 112.864 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -61.99 -38.06 87.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.909 1.232 . . . . 0.0 112.127 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.68 -49.85 75.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.537 1.135 . . . . 0.0 111.214 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -28.54 69.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.371 -1.456 . . . . 0.0 112.458 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.816 1.246 . . . . 0.0 112.541 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 CA--C 1.538 0.72 0 N-CA-C 110.962 -0.438 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.41 -24.46 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -70.85 -25.91 63.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.259 1.024 . . . . 0.0 113.445 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -126.82 -18.5 4.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.27 1.428 . . . . 0.0 114.73 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -86.68 170.59 11.66 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.013 1.725 . . . . 0.0 111.835 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.3 p -104.45 156.24 18.11 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.342 1.057 . . . . 0.0 113.142 -170.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.353 0.3 OUTLIER -73.63 -3.21 26.65 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.98 -31.6 65.22 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.851 -1.155 . . . . 0.0 111.353 168.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.38 -35.75 60.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.226 1.01 . . . . 0.0 112.754 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.25 -15.47 63.58 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.214 -0.929 . . . . 0.0 112.64 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.5 mt -92.2 -19.22 22.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.164 0.986 . . . . 0.0 112.764 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.48 -25.69 20.18 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.555 1.542 . . . . 0.0 112.954 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.93 -2.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 t70 66.12 157.85 0.11 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 128.232 2.613 . . . . 0.0 116.611 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -55.47 -35.21 65.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.155 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 30.4 m -69.04 -24.09 64.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 52' ' ' VAL . 9.9 m-85 -127.71 4.67 6.09 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.546 1.138 . . . . 0.0 112.547 -174.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.84 -52.07 77.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 125.71 1.604 . . . . 0.0 111.998 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -61.52 -23.7 77.0 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.323 2.016 . . . . 0.0 113.573 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.839 HG22 HD21 ' A' ' 50' ' ' LEU . 23.2 m -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.007 1.323 . . . . 0.0 111.171 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.43 82.4 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.665 1.186 . . . . 0.0 113.793 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.5 -33.85 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 119.627 1.103 . . . . 0.0 110.458 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.8 -51.56 44.18 Favored Glycine 0 C--O 1.216 -0.973 0 C-N-CA 124.347 0.975 . . . . 0.0 112.795 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.65 -16.81 64.09 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.87 2.335 . . . . 0.0 113.862 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.78 -43.7 12.32 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.55 1.068 . . . . 0.0 112.211 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.55 -34.01 23.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.002 -1.061 . . . . 0.0 113.548 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.24 99.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.864 2.066 . . . . 0.0 112.69 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -34.19 34.47 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.242 1.017 . . . . 0.0 110.583 -175.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.09 -28.4 68.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -94.02 -1.73 54.05 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.53 -127.31 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.598 1.559 . . . . 0.0 111.248 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.26 -55.67 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.604 1.562 . . . . 0.0 113.513 -170.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -136.41 162.32 57.02 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 126.763 2.025 . . . . 0.0 110.446 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.31 6.01 5.05 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.729 1.619 . . . . 0.0 114.979 -174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.0 -29.37 43.03 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.944 0.898 . . . . 0.0 111.496 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -112.32 17.67 19.21 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.215 2.206 . . . . 0.0 113.117 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.94 134.78 38.54 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.174 -1.579 . . . . 0.0 113.955 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.41 -4.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.013 1.325 . . . . 0.0 113.828 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.26 119.16 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.878 2.471 . . . . 0.0 111.52 -167.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -81.95 53.25 2.15 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 119.608 -1.932 . . . . 0.0 112.016 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.404 0.6 OUTLIER -65.38 -46.9 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -163.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -60.54 -34.38 74.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.909 2.14 . . . . 0.0 111.783 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.35 -48.93 48.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.188 0.899 . . . . 0.0 112.424 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.21 -42.18 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 111.443 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.54 71.2 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.682 1.128 . . . . 0.0 112.817 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -66.35 -38.89 88.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.709 1.204 . . . . 0.0 111.682 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.6 -30.36 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.508 1.523 . . . . 0.0 113.212 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 37.0 m -45.19 -56.11 9.95 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 -7.59 16.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.445 2.763 . . . . 0.0 114.593 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -61.97 1.69 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.099 1.36 . . . . 0.0 111.658 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -70.77 -20.18 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 120.884 -1.135 . . . . 0.0 113.972 -176.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.39 -41.88 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.581 1.537 . . . . 0.0 112.018 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.01 -51.25 10.63 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 110.436 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.14 69.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.361 -1.462 . . . . 0.0 113.38 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 78.9 m -80.17 -7.37 58.91 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.73 -34.56 14.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.341 1.056 . . . . 0.0 110.44 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -60.91 -39.7 90.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.517 1.127 . . . . 0.0 112.229 171.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -142.49 54.85 1.42 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.948 0.899 . . . . 0.0 112.906 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -53.73 -37.24 63.13 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.427 1.891 . . . . 0.0 113.302 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.71 -8.85 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.842 1.257 . . . . 0.0 113.84 -169.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -83.88 166.81 17.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 112.078 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.57 139.0 56.49 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.172 1.389 . . . . 0.0 112.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -63.79 -46.97 82.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.564 1.146 . . . . 0.0 111.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -64.03 -38.52 91.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.854 0.862 . . . . 0.0 112.188 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.926 0.89 . . . . 0.0 111.952 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' B' ' 166' ' ' LYS . 0.1 OUTLIER -71.94 -43.39 65.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.189 -0.91 . . . . 0.0 113.234 174.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.37 -40.41 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.182 1.355 . . . . 0.0 111.669 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.11 -42.99 93.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.875 0.87 . . . . 0.0 112.258 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.2 -45.3 96.81 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.312 0.958 . . . . 0.0 112.983 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.77 -33.74 64.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.485 1.142 . . . . 0.0 112.973 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -59.43 -41.83 90.45 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.862 1.21 . . . . 0.0 111.943 170.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.51 -47.26 84.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.562 1.145 . . . . 0.0 111.943 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.36 68.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.161 -0.962 . . . . 0.0 112.061 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.49 -50.89 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.886 1.674 . . . . 0.0 112.175 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 125.33 1.452 . . . . 0.0 113.322 -170.237 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 CA--C 1.532 0.388 0 CA-C-O 121.312 0.463 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.97 -20.08 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.107 1.363 . . . . 0.0 114.417 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -72.7 -35.31 67.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.105 0.962 . . . . 0.0 113.523 173.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 m -110.5 -21.89 11.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.769 1.227 . . . . 0.0 114.112 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -94.37 171.27 8.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.2 1.4 . . . . 0.0 112.219 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.5 p -107.5 166.21 10.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.838 1.304 . . . . 0.0 114.498 -168.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -19.18 35.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.983 1.713 . . . . 0.0 115.436 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.49 -32.81 63.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.92 1.236 . . . . 0.0 111.365 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.83 -32.21 67.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.939 0.896 . . . . 0.0 112.728 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -74.05 -14.68 61.04 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.81 -0.556 . . . . 0.0 112.142 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.0 mt -96.45 -18.89 19.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.47 1.108 . . . . 0.0 112.281 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.76 54.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.425 1.09 . . . . 0.0 111.951 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.41 138.29 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.563 1.545 . . . . 0.0 110.652 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.23 160.51 31.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.287 1.035 . . . . 0.0 112.987 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.23 -37.43 74.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.696 1.198 . . . . 0.0 111.786 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.67 -20.84 63.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.526 1.53 . . . . 0.0 113.873 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -126.73 -2.91 6.62 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.237 1.415 . . . . 0.0 113.001 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -55.51 -47.71 98.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.143 -1.598 . . . . 0.0 111.91 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -62.45 -23.06 74.81 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.764 2.31 . . . . 0.0 113.804 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 HD21 ' B' ' 139' ' ' LEU . 27.6 m -77.02 -36.79 56.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.749 1.22 . . . . 0.0 110.977 175.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.45 98.44 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 113.519 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.91 -35.77 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 119.417 1.008 . . . . 0.0 110.329 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.54 -48.19 49.79 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.327 1.441 . . . . 0.0 114.571 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.44 -39.69 89.05 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 121.253 2.526 . . . . 0.0 112.306 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.54 76.16 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.467 -0.771 . . . . 0.0 112.528 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -85.22 -38.81 18.51 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.06 -52.52 62.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.37 1.068 . . . . 0.0 110.878 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.432 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -68.78 -18.24 64.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.503 1.121 . . . . 0.0 111.732 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -80.17 -17.46 52.36 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.209 1.004 . . . . 0.0 113.386 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.27 3.3 p30 -123.39 11.12 9.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 150.21 1.49 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 129.73 3.212 . . . . 0.0 106.504 168.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -86.41 -31.8 21.24 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 128.563 2.745 . . . . 0.0 113.204 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.59 158.09 73.9 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 127.518 2.327 . . . . 0.0 109.375 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.35 5.58 6.17 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.023 1.401 . . . . 0.0 114.046 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.7 -16.36 63.32 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.603 -1.311 . . . . 0.0 112.724 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -103.58 3.98 35.19 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.339 1.855 . . . . 0.0 113.22 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.69 122.67 26.28 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 119.981 -1.699 . . . . 0.0 112.654 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.53 -7.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 125.161 1.384 . . . . 0.0 112.271 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.866 HD21 HG22 ' B' ' 120' ' ' THR . 2.0 tm? 62.53 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.826 3.25 . . . . 0.0 113.224 -171.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.07 58.17 4.04 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.775 1.23 . . . . 0.0 111.453 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.6 p -65.94 -22.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.995 -1.066 . . . . 0.0 113.459 -169.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -62.85 -49.82 73.36 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 121.157 1.799 . . . . 0.0 112.076 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.23 76.8 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.3 -44.26 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.281 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.4 68.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.95 1.705 . . . . 0.0 112.858 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 m -68.77 -36.58 78.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 73.5 t -90.8 -23.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.109 1.363 . . . . 0.0 113.523 -175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -44.27 -60.46 2.82 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 126.211 1.804 . . . . 0.0 112.477 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.5 -0.61 5.35 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.328 2.685 . . . . 0.0 114.462 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 -64.6 1.12 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.215 1.406 . . . . 0.0 110.584 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.04 -29.29 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.234 -0.916 . . . . 0.0 112.313 177.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 t -52.74 -48.33 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.988 1.315 . . . . 0.0 110.488 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.74 -47.88 11.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.435 0.636 . . . . 0.0 110.609 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.85 69.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.1 m -77.8 -12.05 59.94 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -33.64 16.66 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.133 1.333 . . . . 0.0 110.764 167.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -58.78 -38.63 78.93 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.507 1.123 . . . . 0.0 112.116 172.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -145.55 85.5 1.71 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.715 0.806 . . . . 0.0 112.293 170.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -57.73 -27.94 63.44 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.973 1.309 . . . . 0.0 112.505 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -92.26 -4.75 53.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.551 1.541 . . . . 0.0 112.943 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.54 154.37 41.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.542 1.137 . . . . 0.0 111.346 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -65.72 137.24 57.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.089 0.956 . . . . 0.0 111.544 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.04 -47.43 80.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.676 0.791 . . . . 0.0 112.64 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -61.69 -41.2 97.26 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.96 0.904 . . . . 0.0 111.479 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.28 -34.35 77.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.665 0.786 . . . . 0.0 112.34 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.58 -42.17 68.1 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.748 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.22 -38.53 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.159 1.345 . . . . 0.0 111.203 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -63.28 -45.1 93.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.179 0.592 . . . . 0.0 111.837 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.32 -44.71 97.28 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.958 1.266 . . . . 0.0 113.422 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.44 -35.41 70.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.972 1.386 . . . . 0.0 112.967 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -62.49 -41.26 98.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.644 1.111 . . . . 0.0 111.651 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.17 -48.82 80.12 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.788 1.235 . . . . 0.0 111.479 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.22 72.22 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.815 -1.178 . . . . 0.0 111.678 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 124.307 1.043 . . . . 0.0 112.375 -178.314 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.543 0.945 0 CA-C-O 121.484 0.535 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.35 0.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -108.24 15.57 24.0 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.279 1.832 . . . . 0.0 112.652 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 28.4 m -144.08 -43.83 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.52 120.17 32.1 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.301 0.955 . . . . 0.0 111.726 -174.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -71.04 169.23 15.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.045 1.738 . . . . 0.0 114.41 -169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -24.88 17.74 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.0 -35.75 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.907 1.231 . . . . 0.0 111.578 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.33 -20.68 58.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.198 0.999 . . . . 0.0 113.208 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -67.66 -25.22 65.6 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.086 -1.009 . . . . 0.0 111.292 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.35 -13.85 56.24 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.335 1.054 . . . . 0.0 113.17 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.04 -36.36 30.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.388 1.075 . . . . 0.0 113.07 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.07 139.47 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.052 1.341 . . . . 0.0 110.212 169.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.81 160.48 30.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.466 1.106 . . . . 0.0 113.289 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -58.98 -34.87 72.32 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 0.0 111.885 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -62.37 -22.1 65.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.547 1.539 . . . . 0.0 113.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -127.3 -3.13 6.25 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -60.95 -45.85 96.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 O-C-N 119.957 -1.714 . . . . 0.0 111.937 170.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.28 -28.92 85.35 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.004 2.469 . . . . 0.0 113.13 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 50' ' ' LEU . 61.1 m -70.15 -38.49 75.48 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.487 1.115 . . . . 0.0 110.743 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.08 95.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.172 1.389 . . . . 0.0 114.457 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.74 -33.41 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 119.984 1.266 . . . . 0.0 110.824 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.99 -55.28 26.72 Favored Glycine 0 C--O 1.217 -0.937 0 C-N-CA 124.292 0.949 . . . . 0.0 112.65 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -64.81 -11.36 36.26 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.504 2.152 . . . . 0.0 114.386 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.61 -62.64 1.44 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.84 0.745 . . . . 0.0 110.169 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.46 -27.16 58.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.57 89.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.634 1.573 . . . . 0.0 112.069 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -83.14 -38.63 22.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.828 1.251 . . . . 0.0 110.241 -178.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -59.42 -33.18 70.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.792 1.237 . . . . 0.0 113.603 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.34 -11.49 37.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -143.51 -123.31 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.66 1.118 . . . . 0.0 113.744 -171.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.95 -68.89 0.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.894 1.278 . . . . 0.0 112.94 -168.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -139.38 167.01 20.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 127.588 2.355 . . . . 0.0 109.4 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.18 6.26 4.82 Favored 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.331 1.868 . . . . 0.0 114.439 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.76 -19.98 64.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.391 1.477 . . . . 0.0 111.434 168.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -113.12 11.63 18.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.854 2.062 . . . . 0.0 113.378 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.05 129.74 35.62 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 119.991 -1.693 . . . . 0.0 113.301 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.11 -6.05 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 125.03 1.332 . . . . 0.0 113.143 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.799 HD21 HG22 ' A' ' 31' ' ' THR . 1.4 tm? 61.21 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.855 3.262 . . . . 0.0 112.96 -169.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.13 60.35 1.19 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.361 -1.462 . . . . 0.0 111.849 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.297 2.4 p -66.11 -21.57 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.75 -1.219 . . . . 0.0 113.225 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.673 1.579 . . . . 0.0 112.522 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.44 -50.36 26.84 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mt -61.7 -43.21 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.642 0.777 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.67 -28.46 64.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.548 1.522 . . . . 0.0 112.491 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 39.0 m -68.7 -42.67 77.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.112 0.965 . . . . 0.0 111.698 169.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . 0.435 HG12 HD12 ' B' ' 151' ' ' ILE . 31.5 t -84.24 -26.91 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.796 1.638 . . . . 0.0 113.503 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.2 m -50.51 -63.38 1.88 Allowed Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 126.184 1.793 . . . . 0.0 113.087 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.52 -25.89 70.06 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.924 1.75 . . . . 0.0 112.334 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -57.83 9.85 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.447 1.099 . . . . 0.0 110.341 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.435 HD12 HG12 ' B' ' 147' ' ' VAL . 27.7 mt -71.96 -31.92 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.442 -0.786 . . . . 0.0 111.957 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.71 -51.15 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.351 1.061 . . . . 0.0 110.393 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.35 -45.99 68.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.767 0.317 . . . . 0.0 111.159 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.19 -30.75 71.84 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.658 -1.276 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 29.2 m -73.85 -12.71 60.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -37.48 14.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.507 1.503 . . . . 0.0 110.78 166.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -57.3 -40.4 77.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.958 0.903 . . . . 0.0 111.806 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -142.15 72.71 1.38 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.481 1.112 . . . . 0.0 111.027 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -53.42 -31.06 43.4 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.116 1.766 . . . . 0.0 112.923 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.98 1.91 51.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.071 1.348 . . . . 0.0 113.114 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.41 152.98 36.66 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 114.305 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.18 59.27 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.351 1.86 . . . . 0.0 113.334 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 46.0 -103.73 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 165.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -47.07 -33.34 4.81 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.682 2.393 . . . . 0.0 113.716 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.0 -36.52 79.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.084 . . . . 0.0 112.807 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.4 -33.34 63.0 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.238 -0.914 . . . . 0.0 112.353 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.5 -48.79 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.709 0.803 . . . . 0.0 110.121 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.08 -42.81 99.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.979 0.911 . . . . 0.0 112.172 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.4 94.55 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.85 1.214 . . . . 0.0 113.48 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.61 -35.36 67.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.561 1.18 . . . . 0.0 112.608 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -60.66 -37.66 82.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.609 1.095 . . . . 0.0 112.216 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.77 -45.56 92.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.324 1.05 . . . . 0.0 111.933 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -24.45 67.24 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.584 -1.322 . . . . 0.0 112.438 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.41 -46.04 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.517 1.927 . . . . 0.0 112.821 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 125.193 1.397 . . . . 0.0 113.45 -174.357 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo . . . . . 0 C--O 1.234 0.321 0 CA-C-O 121.645 0.602 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.9 5.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.833 1.653 . . . . 0.0 115.031 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -122.27 11.24 10.06 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.027 2.131 . . . . 0.0 113.914 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 m -141.02 -27.79 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -175.27 4.03 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -171.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.6 p -119.93 164.69 15.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.19 1.396 . . . . 0.0 114.391 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.12 -19.86 55.57 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.44 -37.14 79.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.228 1.376 . . . . 0.0 111.465 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.72 -20.3 63.53 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.377 -0.827 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -67.02 -18.45 65.37 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.874 -1.141 . . . . 0.0 111.631 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.12 -6.75 41.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.193 1.397 . . . . 0.0 112.704 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.94 -34.1 17.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.648 1.179 . . . . 0.0 112.04 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.0 137.75 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.016 1.326 . . . . 0.0 109.954 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.27 160.25 29.69 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.184 0.993 . . . . 0.0 112.804 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -58.44 -36.58 73.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 m -62.08 -21.87 65.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.653 1.581 . . . . 0.0 113.743 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -126.27 -3.57 6.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.575 1.55 . . . . 0.0 112.684 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -59.46 -46.58 98.85 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 120.103 -1.623 . . . . 0.0 110.996 171.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -28.33 87.2 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.195 2.597 . . . . 0.0 113.564 169.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 m -72.27 -35.6 68.8 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.034 0.934 . . . . 0.0 111.423 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.26 81.35 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.819 1.248 . . . . 0.0 113.927 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -36.69 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 119.377 0.989 . . . . 0.0 110.845 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.52 63.58 Favored Glycine 0 C--O 1.214 -1.11 0 C-N-CA 124.326 0.965 . . . . 0.0 112.826 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.11 -18.09 65.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 121.276 2.538 . . . . 0.0 113.988 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.37 -57.72 3.04 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.471 0.578 . . . . 0.0 110.444 165.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -76.46 -21.24 56.14 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.18 94.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.344 1.458 . . . . 0.0 111.107 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -84.2 -40.15 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.509 1.123 . . . . 0.0 110.642 -178.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -62.18 -30.09 70.82 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -93.41 -5.31 49.68 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -124.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.005 1.322 . . . . 0.0 112.274 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -161.79 -58.3 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.24 1.416 . . . . 0.0 113.932 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.14 162.43 48.0 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 127.615 2.366 . . . . 0.0 110.678 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.22 -1.77 11.96 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.811 1.674 . . . . 0.0 114.693 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -54.91 -27.87 46.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.893 1.277 . . . . 0.0 113.423 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -95.54 -11.27 27.67 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.098 1.359 . . . . 0.0 113.846 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 121.78 26.24 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.674 -1.266 . . . . 0.0 113.754 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.44 9.96 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 125.41 1.484 . . . . 0.0 111.701 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.742 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? 59.99 121.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.591 3.156 . . . . 0.0 111.992 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -87.11 45.62 1.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.619 -1.301 . . . . 0.0 111.963 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 3.0 p -66.19 -22.22 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.234 -1.541 . . . . 0.0 112.182 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.86 -33.5 66.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.845 1.258 . . . . 0.0 112.552 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.15 -59.56 1.94 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.619 1.104 . . . . 0.0 112.097 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.56 -44.77 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.709 -1.465 . . . . 0.0 112.949 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.97 -27.21 64.54 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.275 1.398 . . . . 0.0 112.435 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -66.96 -46.38 74.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.27 1.428 . . . . 0.0 111.955 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 62' ' ' ILE . 1.4 t -94.12 -18.08 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 m -42.52 -59.32 2.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 C-N-CA 125.676 1.591 . . . . 0.0 112.588 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.65 -2.69 9.77 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.352 2.701 . . . . 0.0 114.539 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.81 -58.1 2.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.959 1.304 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.53 -36.5 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 120.489 1.495 . . . . 0.0 112.123 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.5 -49.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.821 1.248 . . . . 0.0 110.62 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.98 -45.52 34.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.655 0.741 . . . . 0.0 110.986 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.78 70.02 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.781 0.832 . . . . 0.0 112.954 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.3 m -75.48 -13.2 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 170.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.13 -36.09 18.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.797 1.635 . . . . 0.0 110.516 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -57.02 -38.65 73.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.253 1.021 . . . . 0.0 111.813 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -144.92 84.55 1.72 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.534 0.683 . . . . 0.0 111.768 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -54.98 -31.34 60.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.105 1.362 . . . . 0.0 112.188 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.68 -0.93 57.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.272 1.429 . . . . 0.0 112.909 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.65 144.58 56.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.252 1.021 . . . . 0.0 111.72 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -77.75 160.89 28.1 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.377 1.084 . . . . 0.0 113.669 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -40.58 151.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.563 2.745 . . . . 0.0 115.13 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt 62.03 -38.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 129.487 3.115 . . . . 0.0 116.309 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.73 -31.86 70.01 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.846 1.659 . . . . 0.0 112.174 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -69.67 -43.91 71.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.71 -0.619 . . . . 0.0 112.509 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.03 -36.69 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.763 1.165 . . . . 0.0 111.459 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.15 -46.05 78.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.274 1.029 . . . . 0.0 111.949 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.87 96.97 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.824 1.202 . . . . 0.0 113.1 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -25.93 59.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.846 -1.385 . . . . 0.0 113.485 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -70.93 -42.32 70.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.479 -0.763 . . . . 0.0 111.248 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -58.23 -42.89 87.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.205 1.402 . . . . 0.0 111.68 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.18 -38.8 27.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.483 1.913 . . . . 0.0 114.212 170.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.241 -168.609 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 0 CA--C 1.543 0.948 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.57 -21.26 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -74.33 -19.99 60.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.688 1.195 . . . . 0.0 113.565 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 70.0 m -122.46 -20.86 5.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.849 2.46 . . . . 0.0 113.953 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -53.09 140.97 24.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.367 2.667 . . . . 0.0 111.556 172.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -98.6 168.12 10.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.869 1.319 . . . . 0.0 112.866 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.36 -28.35 67.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.035 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -61.22 -43.58 98.64 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.078 -1.014 . . . . 0.0 110.327 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -66.64 -30.11 70.29 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.449 0.7 . . . . 0.0 112.139 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.409 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 73.7 t80 -67.69 -31.87 72.13 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.317 -1.489 . . . . 0.0 111.751 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.78 -9.3 58.48 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.03 44.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.769 1.168 . . . . 0.0 112.353 172.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.42 135.18 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.663 1.585 . . . . 0.0 110.145 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.22 157.77 34.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.375 1.07 . . . . 0.0 112.888 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.28 -34.26 72.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.271 1.028 . . . . 0.0 111.851 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.3 m -61.24 -25.55 67.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.421 1.888 . . . . 0.0 113.973 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.0 -6.11 7.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.246 1.018 . . . . 0.0 113.73 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.86 -43.49 98.66 Favored Pre-proline 0 N--CA 1.476 0.858 0 O-C-N 120.204 -1.56 . . . . 0.0 113.389 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -61.71 -27.73 81.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.932 2.421 . . . . 0.0 113.046 170.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.742 HG22 HD21 ' A' ' 50' ' ' LEU . 26.2 m -74.24 -36.84 63.92 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.903 1.281 . . . . 0.0 111.294 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.19 93.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.015 1.326 . . . . 0.0 113.996 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.06 -33.07 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 119.422 1.01 . . . . 0.0 110.767 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.54 -51.08 50.49 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 125.492 1.52 . . . . 0.0 114.099 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.43 -32.78 74.59 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.283 2.542 . . . . 0.0 112.419 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.46 -54.02 19.7 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.046 0.839 . . . . 0.0 111.21 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.44 -22.59 40.98 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.63 -46.19 32.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.594 1.158 . . . . 0.0 111.056 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.41 HD13 HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -75.97 -33.99 59.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.009 -176.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -73.13 -10.3 59.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -101.61 -11.27 19.35 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.61 -129.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.084 1.354 . . . . 0.0 112.303 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -161.64 -51.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.141 1.776 . . . . 0.0 113.189 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -132.66 166.93 25.42 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.339 2.256 . . . . 0.0 109.757 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.87 12.43 2.87 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 114.183 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.78 -14.62 62.86 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.679 -1.263 . . . . 0.0 113.934 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -119.89 4.68 10.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 113.518 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.29 134.2 41.13 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.911 -1.118 . . . . 0.0 113.605 -169.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.37 136.6 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.902 2.081 . . . . 0.0 107.317 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.28 119.95 11.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.461 1.028 . . . . 0.0 109.163 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.4 54.65 3.23 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.698 -1.251 . . . . 0.0 110.996 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 1.5 p -67.03 -25.03 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -165.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -63.04 -41.63 99.56 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 121.161 1.801 . . . . 0.0 111.133 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.08 -49.31 34.73 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 123.984 0.802 . . . . 0.0 111.416 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.22 -43.18 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.869 0.868 . . . . 0.0 111.533 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.15 -31.75 68.08 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 120.253 1.388 . . . . 0.0 112.726 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m -65.36 -42.84 92.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.097 0.959 . . . . 0.0 111.568 170.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -82.73 -29.41 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.978 1.311 . . . . 0.0 113.047 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.6 m -43.48 -61.05 2.06 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 126.113 1.765 . . . . 0.0 113.77 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.16 -14.44 44.35 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.577 2.185 . . . . 0.0 113.367 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.66 -63.47 1.16 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.131 0.972 . . . . 0.0 110.838 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -66.94 -25.53 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.05 -1.031 . . . . 0.0 113.141 177.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.69 -51.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.605 1.093 . . . . 0.0 110.753 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.39 -47.21 51.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.935 0.397 . . . . 0.0 111.057 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.54 -28.32 69.08 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.662 -1.274 . . . . 0.0 113.175 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.96 -15.89 60.09 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 169.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -30.32 21.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 111.202 168.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -61.23 -38.38 86.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.875 0.87 . . . . 0.0 112.535 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.68 88.16 1.68 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.636 0.774 . . . . 0.0 111.922 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.93 -41.91 68.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.356 1.462 . . . . 0.0 111.579 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -79.51 -3.24 45.85 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.8 153.07 44.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.012 0.925 . . . . 0.0 112.071 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.69 134.0 46.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 0.0 109.333 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.409 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 46.2 t80 -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.289 -0.882 . . . . 0.0 112.663 -175.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -62.67 -40.14 96.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.209 0.913 . . . . 0.0 111.588 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.31 -38.97 93.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.557 0.743 . . . . 0.0 111.913 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.72 -37.14 73.48 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.953 0.797 . . . . 0.0 113.027 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.45 -48.33 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.173 0.989 . . . . 0.0 110.116 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -64.07 -47.36 80.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.989 0.916 . . . . 0.0 112.011 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.91 99.39 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.627 1.108 . . . . 0.0 113.269 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -73.12 -35.83 66.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.225 -1.162 . . . . 0.0 112.792 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -60.53 -38.16 83.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.633 1.106 . . . . 0.0 111.881 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.87 -44.68 96.32 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.395 -0.815 . . . . 0.0 111.611 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -19.33 65.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.838 -1.164 . . . . 0.0 112.558 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.3 -41.48 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.466 1.906 . . . . 0.0 112.973 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 124.796 1.239 . . . . 0.0 113.441 -177.806 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.364 0 CA-C-O 122.202 0.834 . . . . 0.0 114.035 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.53 -12.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -104.76 -4.26 22.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.318 1.447 . . . . 0.0 114.807 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -124.36 -28.31 3.67 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -92.5 151.84 19.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.151 0.977 . . . . 0.0 111.484 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -85.47 170.07 13.01 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.49 -18.78 3.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.845 1.658 . . . . 0.0 114.732 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -51.7 -28.99 16.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 111.961 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -46.35 -42.06 14.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.206 1.402 . . . . 0.0 113.178 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.32 -15.25 61.89 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.98 -18.11 17.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.02 1.328 . . . . 0.0 111.799 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.92 -37.46 22.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.501 1.52 . . . . 0.0 112.374 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.49 137.72 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.593 1.557 . . . . 0.0 110.744 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.59 159.56 31.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 112.923 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.85 -36.19 74.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.889 -1.132 . . . . 0.0 111.97 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -60.43 -25.53 66.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.732 1.613 . . . . 0.0 113.857 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -124.33 -2.41 8.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.591 1.556 . . . . 0.0 112.96 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -53.92 -46.72 98.45 Favored Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 120.28 -1.513 . . . . 0.0 111.794 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -70.71 -16.42 33.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.226 1.951 . . . . 0.0 113.459 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.2 m -75.74 -33.84 60.28 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.047 -1.033 . . . . 0.0 111.136 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.51 82.0 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.406 -0.809 . . . . 0.0 111.569 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 t -59.1 -49.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.388 1.075 . . . . 0.0 109.031 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.8 19.1 0.32 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 126.321 1.915 . . . . 0.0 116.874 172.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.56 -63.14 1.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.404 1.881 . . . . 0.0 109.101 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.96 93.16 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.158 -0.964 . . . . 0.0 112.337 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -86.52 -28.82 23.14 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.708 -0.62 . . . . 0.0 112.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.05 -48.12 81.65 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.36 -1.462 . . . . 0.0 112.013 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -74.1 -26.78 60.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.268 0.627 . . . . 0.0 111.302 -178.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.82 -26.44 68.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.617 1.167 . . . . 0.0 113.672 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.85 -1.22 43.56 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -171.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -125.61 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.757 1.623 . . . . 0.0 111.255 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -167.14 -46.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.363 2.265 . . . . 0.0 112.399 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -129.36 165.69 30.85 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 127.991 2.517 . . . . 0.0 109.938 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.74 15.73 2.14 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.231 1.954 . . . . 0.0 114.527 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -61.36 -33.44 73.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.376 1.07 . . . . 0.0 112.071 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.22 23.91 11.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.478 1.911 . . . . 0.0 113.575 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 118.2 19.42 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.613 -1.305 . . . . 0.0 110.827 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 t -106.91 -11.31 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.218 1.007 . . . . 0.0 113.101 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.915 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 64.91 113.24 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.946 2.498 . . . . 0.0 111.164 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -95.1 64.05 2.72 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.337 5.2 p -70.45 -21.66 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 111.74 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -54.11 -48.8 70.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.981 0.81 . . . . 0.0 110.991 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.98 -52.16 5.48 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.9 mt -56.83 -46.25 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.35 69.55 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.277 1.399 . . . . 0.0 112.781 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.3 m -78.24 -34.81 48.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.104 1.362 . . . . 0.0 112.098 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 62' ' ' ILE . 76.9 t -88.29 -19.9 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.713 1.605 . . . . 0.0 112.77 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.8 m -43.77 -61.07 2.14 Favored Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 126.235 1.814 . . . . 0.0 112.866 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.31 -0.19 6.19 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.329 2.686 . . . . 0.0 114.348 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.56 -64.23 1.18 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.885 1.274 . . . . 0.0 110.614 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.488 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.1 -31.65 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.068 -1.02 . . . . 0.0 113.216 177.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.35 -46.54 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.252 0.933 . . . . 0.0 110.713 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -73.82 -47.52 37.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.069 0.548 . . . . 0.0 111.329 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.19 73.77 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.428 -0.795 . . . . 0.0 112.989 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.5 m -75.42 -16.62 60.33 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.979 -1.076 . . . . 0.0 113.315 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -30.22 47.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.716 1.598 . . . . 0.0 110.917 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -61.1 -36.41 79.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.774 0.83 . . . . 0.0 112.789 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -142.47 76.45 1.53 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -54.45 -37.16 64.86 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.965 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -86.72 -0.21 55.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.058 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.89 29.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.957 0.903 . . . . 0.0 112.492 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -85.64 53.67 2.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.16 1.384 . . . . 0.0 110.475 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -102.33 90.5 3.92 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -166.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -68.41 -22.49 64.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.111 -0.993 . . . . 0.0 109.327 162.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.26 -24.81 66.65 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.237 1.815 . . . . 0.0 112.802 168.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -63.4 -40.43 97.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 0.0 110.49 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.58 -50.77 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.852 1.261 . . . . 0.0 110.294 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -63.5 -42.0 98.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.196 0.598 . . . . 0.0 112.022 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.78 93.11 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.135 1.35 . . . . 0.0 112.76 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.55 -31.33 63.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.802 1.301 . . . . 0.0 113.481 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.12 -43.97 97.66 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 169.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.79 -41.45 97.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.455 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -25.25 66.94 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 125.01 1.324 . . . . 0.0 112.403 -174.901 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 CA--C 1.54 0.777 0 CA-C-O 120.54 0.142 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.13 -21.99 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.892 1.677 . . . . 0.0 114.649 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -81.37 -16.65 51.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 60.3 m -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.225 1.81 . . . . 0.0 113.492 170.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -54.69 148.72 12.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 123.039 1.399 . . . . 0.0 113.226 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.9 p -95.11 167.95 11.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.81 166.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.0 -26.05 66.61 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.53 -0.731 . . . . 0.0 112.266 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.94 -40.32 95.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.764 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.02 -31.34 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.396 -0.815 . . . . 0.0 112.152 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.43 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 53.1 t80 -70.2 -24.25 63.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.121 0.873 . . . . 0.0 112.322 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 68.5 mt -80.9 -16.98 52.12 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.135 -0.978 . . . . 0.0 113.318 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -33.06 53.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.839 0.855 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.5 p -76.24 141.27 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.932 1.693 . . . . 0.0 110.53 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.69 161.68 30.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.435 1.094 . . . . 0.0 113.471 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.71 -36.1 73.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.129 1.372 . . . . 0.0 112.083 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -64.48 -20.55 66.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.104 1.361 . . . . 0.0 113.835 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.3 -5.28 6.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.866 1.267 . . . . 0.0 113.397 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -57.7 -45.55 99.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 O-C-N 120.184 -1.573 . . . . 0.0 112.162 169.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.45 -28.19 86.89 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.32 2.68 . . . . 0.0 113.414 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' THR . . . . . 0.915 HG22 HD21 ' A' ' 50' ' ' LEU . 29.4 m -76.87 -36.06 57.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.349 1.459 . . . . 0.0 111.45 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.67 91.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.669 1.188 . . . . 0.0 113.649 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.98 -35.75 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 119.78 1.173 . . . . 0.0 110.973 169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.37 -53.21 32.72 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.274 0.94 . . . . 0.0 112.195 168.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.97 -11.93 58.22 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 121.08 2.44 . . . . 0.0 114.513 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.35 -55.99 3.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.073 0.851 . . . . 0.0 109.841 166.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.14 -36.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.321 1.049 . . . . 0.0 113.455 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.0 76.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.203 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.14 -36.87 22.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.747 1.219 . . . . 0.0 110.617 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -54.41 -34.93 62.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.604 1.561 . . . . 0.0 113.688 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.53 -7.03 45.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.02 -133.4 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.394 1.477 . . . . 0.0 110.898 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.57 -58.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.599 2.36 . . . . 0.0 112.454 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 164.5 43.57 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 127.359 2.264 . . . . 0.0 109.831 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.01 36.81 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.711 2.274 . . . . 0.0 113.409 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.73 -28.86 50.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 111.947 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.22 0.7 11.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.341 1.456 . . . . 0.0 113.847 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.09 133.92 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.221 1.009 . . . . 0.0 113.295 -170.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.6 -12.66 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.93 1.292 . . . . 0.0 113.727 -174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.87 102.05 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.699 1.999 . . . . 0.0 107.747 -165.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -85.12 71.01 10.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.985 -1.072 . . . . 0.0 108.841 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.323 1.6 p -66.27 -18.81 24.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 O-C-N 121.38 -0.825 . . . . 0.0 110.327 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -42.79 97.06 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.598 -1.314 . . . . 0.0 111.381 167.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.19 14.98 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.636 -0.665 . . . . 0.0 111.908 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.8 -44.34 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 121.383 -1.069 . . . . 0.0 112.55 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.97 66.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.667 1.576 . . . . 0.0 112.255 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 99.9 m -66.37 -46.24 77.35 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 111.853 169.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -84.34 -31.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.829 1.252 . . . . 0.0 112.845 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -40.05 -62.98 0.77 Allowed Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 126.937 2.095 . . . . 0.0 113.569 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.97 -22.66 73.93 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.245 1.963 . . . . 0.0 113.208 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.01 -59.46 3.02 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.162 0.985 . . . . 0.0 111.312 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.477 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.98 -24.5 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.401 -0.812 . . . . 0.0 112.688 175.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.0 -51.85 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.811 1.187 . . . . 0.0 110.69 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.88 -47.49 45.53 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.157 -0.339 . . . . 0.0 111.084 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.755 -1.216 . . . . 0.0 113.257 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.8 m -76.13 -12.4 60.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.56 -33.58 16.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.184 1.356 . . . . 0.0 111.005 167.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -60.35 -39.04 85.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.871 0.868 . . . . 0.0 112.167 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.73 59.85 1.49 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.105 0.962 . . . . 0.0 112.618 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -53.7 -36.34 62.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.931 1.692 . . . . 0.0 113.109 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -86.27 -6.08 59.04 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.15 164.02 26.05 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.084 0.954 . . . . 0.0 111.966 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.88 138.05 52.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.467 1.107 . . . . 0.0 111.152 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 16.5 t80 -64.15 -51.28 64.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.418 -0.801 . . . . 0.0 112.81 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -66.29 -30.82 71.32 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.616 1.098 . . . . 0.0 112.071 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.38 -39.57 94.88 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.808 -0.558 . . . . 0.0 111.813 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -70.41 -34.79 72.92 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.248 -0.907 . . . . 0.0 112.832 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.12 -49.0 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.163 0.892 . . . . 0.0 109.67 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.29 -42.68 99.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.027 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.15 -44.89 97.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.513 1.054 . . . . 0.0 113.299 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -72.93 -35.4 67.02 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.052 -1.264 . . . . 0.0 112.618 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -60.06 -39.92 87.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.68 -1.262 . . . . 0.0 111.78 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.2 -46.57 88.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 111.874 173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -26.66 68.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 112.104 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 mt -79.29 -49.19 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.307 1.843 . . . . 0.0 112.087 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.482 1.155 0 C-N-CA 125.308 1.443 . . . . 0.0 113.254 -171.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -101.74 -22.3 14.44 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.03 53.04 2.63 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.038 0.923 . . . . 0.0 111.857 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -158.89 150.26 20.53 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.008 2.123 . . . . 0.0 111.621 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 56.46 -69.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.021 2.528 . . . . 0.0 115.166 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.04 -56.84 0.13 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.423 2.289 . . . . 0.0 110.684 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -165.57 166.34 18.26 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.475 1.91 . . . . 0.0 111.346 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.56 124.17 22.47 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 166.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' H ' HG11 ' B' ' 138' ' ' VAL 0.309 13.8 p30 62.76 13.91 6.86 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 128.961 2.904 . . . . 0.0 118.617 172.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -95.51 -33.36 12.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.1 51.86 4.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 125.656 1.582 . . . . 0.0 112.56 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.89 165.74 20.39 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.589 2.859 . . . . 0.0 115.807 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -64.33 2.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -126.04 21.32 7.49 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.932 1.693 . . . . 0.0 113.124 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -142.55 -13.22 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -131.26 169.75 15.54 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.624 1.556 . . . . 0.0 113.835 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.1 p -85.86 166.11 16.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.2 1.4 . . . . 0.0 114.221 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -21.37 2.75 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.87 -35.86 62.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.981 1.264 . . . . 0.0 111.596 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.66 -16.28 64.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.762 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.61 -24.18 45.49 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.799 -1.188 . . . . 0.0 112.129 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.35 -8.67 57.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.872 1.269 . . . . 0.0 113.046 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.39 60.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.084 1.354 . . . . 0.0 112.551 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.73 141.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.939 2.495 . . . . 0.0 110.508 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.35 156.88 36.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.921 0.888 . . . . 0.0 112.743 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.38 -30.67 60.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.109 1.364 . . . . 0.0 111.64 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 m -61.0 -28.32 68.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.156 1.783 . . . . 0.0 113.872 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -127.4 -7.1 5.82 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -56.47 -38.74 71.78 Favored Pre-proline 0 N--CA 1.479 1.017 0 O-C-N 119.584 -1.948 . . . . 0.0 114.024 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.84 -27.09 79.96 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.624 2.216 . . . . 0.0 113.272 169.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 55.3 m -79.59 -34.35 40.87 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.203 1.401 . . . . 0.0 110.712 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.14 92.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.452 . . . . 0.0 113.75 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.09 -36.51 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 119.367 0.985 . . . . 0.0 110.913 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.11 13.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.984 1.278 . . . . 0.0 113.798 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.15 -39.58 93.18 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.249 2.025 . . . . 0.0 112.323 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.0 67.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -102.11 -34.05 9.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.93 0.892 . . . . 0.0 112.714 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -52.44 65.67 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.746 1.619 . . . . 0.0 110.401 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -14.97 63.11 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.837 0.855 . . . . 0.0 111.144 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.92 -14.79 50.13 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.142 -0.974 . . . . 0.0 113.436 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.283 4.6 p30 -123.41 10.67 9.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.83 152.63 0.97 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 130.59 3.556 . . . . 0.0 105.568 168.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -88.69 -32.33 18.04 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.222 2.209 . . . . 0.0 113.059 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.5 156.83 79.6 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 127.227 2.211 . . . . 0.0 110.151 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -84.65 8.65 4.51 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.989 1.793 . . . . 0.0 114.84 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.22 -21.33 22.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.393 1.477 . . . . 0.0 114.232 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.52 14.68 20.24 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.285 1.434 . . . . 0.0 113.332 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.97 113.59 24.66 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.262 -1.523 . . . . 0.0 112.106 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.78 11.78 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 125.647 1.579 . . . . 0.0 111.423 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 51' ' ' ASP . 0.2 OUTLIER 64.49 155.0 0.07 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 129.495 3.118 . . . . 0.0 112.801 -168.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.619 ' H ' HD13 ' A' ' 50' ' ' LEU . 44.5 t0 -119.11 62.22 0.8 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.522 1.529 . . . . 0.0 110.811 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.0 -56.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.641 1.177 . . . . 0.0 113.475 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' B' ' 93' ' ' GLN . 55.5 tp60 -63.14 -36.87 85.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.343 0.974 . . . . 0.0 111.5 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.55 -52.51 52.68 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mt -62.72 -42.77 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.45 0.7 . . . . 0.0 111.449 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.06 -34.72 71.47 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.102 -0.999 . . . . 0.0 113.067 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -70.25 -37.11 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.029 1.332 . . . . 0.0 111.848 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.1 t -87.76 -23.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.117 1.367 . . . . 0.0 113.327 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.3 m -45.28 -59.83 3.93 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 125.877 1.671 . . . . 0.0 112.935 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.48 0.85 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.56 -66.43 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.6 1.16 . . . . 0.0 110.603 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.43 -32.2 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.017 -1.052 . . . . 0.0 112.911 -178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.74 -49.31 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.367 1.067 . . . . 0.0 110.353 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.51 -46.86 36.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.274 0.559 . . . . 0.0 110.892 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.54 68.94 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.1 m -76.34 -17.17 59.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.29 -30.85 21.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.087 1.312 . . . . 0.0 111.429 169.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -60.63 -38.24 84.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.408 1.083 . . . . 0.0 112.012 169.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -146.15 86.56 1.71 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.656 0.783 . . . . 0.0 112.425 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -54.07 -33.82 58.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.647 1.179 . . . . 0.0 111.714 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -86.85 -0.07 55.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.339 1.455 . . . . 0.0 113.526 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.36 147.83 43.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.938 0.895 . . . . 0.0 111.384 171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.93 155.14 40.81 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.396 1.078 . . . . 0.0 112.312 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -53.32 151.37 5.44 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 112.049 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 tptp 60.44 -32.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 129.039 2.935 . . . . 0.0 116.299 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.87 -28.26 68.73 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.36 1.864 . . . . 0.0 112.259 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -70.77 -44.11 67.39 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.54 -0.725 . . . . 0.0 112.567 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.11 -37.12 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.027 1.285 . . . . 0.0 111.268 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -64.84 -48.44 74.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.65 0.78 . . . . 0.0 111.614 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.9 -39.48 96.55 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.975 1.274 . . . . 0.0 113.242 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -35.33 65.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.818 1.309 . . . . 0.0 113.013 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -63.35 -38.09 89.8 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.958 -1.089 . . . . 0.0 111.956 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.41 -43.84 98.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.523 1.129 . . . . 0.0 111.782 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -25.02 67.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.83 -1.169 . . . . 0.0 112.86 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.268 3.8 mt -87.98 -40.6 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.038 1.335 . . . . 0.0 112.523 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.64 -59.75 1.83 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.287 1.435 . . . . 0.0 113.692 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.6 -25.12 67.25 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.845 1.658 . . . . 0.0 113.501 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -26.02 67.43 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.732 1.213 . . . . 0.0 113.712 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 44.6 ttp . . . . . 0 C--O 1.254 1.318 0 C-N-CA 128.298 2.639 . . . . 0.0 115.371 172.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.89 -29.18 25.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.42 15.8 7.34 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 53' ' ' GLN . 3.1 pp0? -144.66 140.47 28.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.633 1.173 . . . . 0.0 113.09 -174.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp 37.51 48.94 0.94 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 127.567 2.347 . . . . 0.0 115.723 166.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.29 128.31 35.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.188 0.595 . . . . 0.0 110.343 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.85 150.83 42.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -135.68 123.36 22.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.122 1.769 . . . . 0.0 107.748 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 51.98 15.53 0.42 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.024 2.13 . . . . 0.0 116.103 -174.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 56.4 105.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.244 2.617 . . . . 0.0 112.04 -167.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -122.6 61.86 16.41 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 126.387 1.875 . . . . 0.0 112.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.48 -175.37 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.314 4.009 . . . . 0.0 112.518 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 23.0 m -49.82 -23.56 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 125.988 1.715 . . . . 0.0 115.292 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -82.49 4.36 24.67 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.618 1.567 . . . . 0.0 113.987 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 38.5 t -142.05 -40.52 0.36 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.453 2.301 . . . . 0.0 112.358 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -50.67 143.36 9.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.724 2.809 . . . . 0.0 112.79 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -109.3 155.45 21.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.16 -24.83 66.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -59.35 -38.24 79.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.592 -1.317 . . . . 0.0 111.122 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.23 -13.18 53.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.433 1.093 . . . . 0.0 112.95 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -67.47 -28.53 67.94 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.721 -1.237 . . . . 0.0 110.664 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 mt -74.13 -16.78 61.0 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.33 -0.856 . . . . 0.0 113.175 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.26 -34.79 28.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.296 1.039 . . . . 0.0 113.346 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 p -71.58 140.12 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 109.872 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.81 157.34 30.64 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.847 1.259 . . . . 0.0 113.342 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -58.57 -34.52 71.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.575 1.15 . . . . 0.0 111.748 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.9 m -57.84 -25.66 60.97 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.427 1.891 . . . . 0.0 113.901 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -124.97 0.13 7.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 113.122 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.49 -44.47 97.88 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 119.809 -1.807 . . . . 0.0 112.416 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -63.49 -20.2 69.29 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.804 2.336 . . . . 0.0 114.393 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 57.2 m -67.8 -37.29 81.8 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.087 -1.008 . . . . 0.0 110.13 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.55 -46.8 86.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.453 1.501 . . . . 0.0 114.076 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.86 -34.29 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.432 -1.418 . . . . 0.0 110.731 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.9 4.07 8.48 Favored Glycine 0 CA--C 1.545 1.969 0 C-N-CA 125.985 1.755 . . . . 0.0 116.148 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.77 -10.36 9.17 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.435 1.894 . . . . 0.0 113.547 170.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.72 -70.98 0.7 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.407 1.083 . . . . 0.0 111.571 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -71.24 -20.78 62.2 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.98 -1.075 . . . . 0.0 112.424 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.18 97.63 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.963 1.705 . . . . 0.0 113.833 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -43.91 18.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.653 0.781 . . . . 0.0 109.679 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.36 -24.52 67.4 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -85.77 -10.48 55.45 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -130.08 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 110.933 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -157.07 -54.12 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 127.407 2.283 . . . . 0.0 112.499 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -125.07 164.25 32.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 126.768 2.027 . . . . 0.0 111.639 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.75 9.78 3.04 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.156 2.57 . . . . 0.0 114.055 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.69 -28.4 69.91 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.625 -1.297 . . . . 0.0 113.14 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -106.14 -7.24 18.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.855 1.262 . . . . 0.0 114.035 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.57 145.21 47.56 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 120.848 -1.158 . . . . 0.0 113.403 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 9' ' ' ASN . 14.2 p -136.18 25.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.547 1.539 . . . . 0.0 111.277 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 60.47 144.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.671 2.788 . . . . 0.0 112.738 -166.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -87.93 44.44 1.19 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.621 -1.299 . . . . 0.0 110.469 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -47.16 -53.55 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.836 1.655 . . . . 0.0 114.109 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -70.24 -34.04 72.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.689 1.131 . . . . 0.0 111.444 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.68 -48.23 74.87 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.533 0.587 . . . . 0.0 111.856 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.22 -43.57 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.642 1.577 . . . . 0.0 110.73 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.09 -32.64 73.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.108 0.963 . . . . 0.0 112.916 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 43.2 m -68.69 -42.9 77.15 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.558 1.143 . . . . 0.0 111.926 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.497 HG12 HD12 ' B' ' 151' ' ' ILE . 38.1 t -84.16 -26.09 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.91 1.684 . . . . 0.0 113.313 -171.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.5 m -50.65 -64.21 1.44 Allowed Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 125.733 1.613 . . . . 0.0 113.094 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.91 -25.35 77.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.19 1.927 . . . . 0.0 112.685 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.39 -59.12 5.1 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.229 1.012 . . . . 0.0 110.805 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.497 HD12 HG12 ' B' ' 147' ' ' VAL . 24.1 mt -70.01 -31.49 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.11 -0.994 . . . . 0.0 112.224 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.83 -51.27 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.937 1.295 . . . . 0.0 110.657 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -68.35 -44.29 75.56 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.397 0.279 . . . . 0.0 110.885 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.8 73.12 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.056 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.2 m -71.49 -14.51 62.14 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -35.91 13.81 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.902 1.228 . . . . 0.0 111.542 167.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -58.03 -42.66 85.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.062 0.945 . . . . 0.0 111.796 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -141.44 69.98 1.34 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 111.32 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -52.37 -34.88 49.74 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.693 1.997 . . . . 0.0 112.771 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -84.59 -1.5 56.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.061 0.944 . . . . 0.0 113.263 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.53 147.82 48.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.637 1.175 . . . . 0.0 112.852 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.47 130.4 41.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.673 1.189 . . . . 0.0 108.406 168.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.4 -42.03 95.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.615 0.766 . . . . 0.0 113.063 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -60.08 -38.39 82.75 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.466 -0.771 . . . . 0.0 112.757 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -69.48 -34.42 74.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.282 0.633 . . . . 0.0 112.093 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -73.14 -38.12 66.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 5.1 m -65.98 -37.81 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.03 1.287 . . . . 0.0 111.64 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -62.38 -43.64 98.35 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.616 0.766 . . . . 0.0 112.182 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.76 -47.16 91.82 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.545 1.069 . . . . 0.0 113.194 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.32 -33.52 65.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.544 1.172 . . . . 0.0 113.009 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.81 -39.92 90.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.203 1.365 . . . . 0.0 111.998 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.59 -47.38 84.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.514 1.126 . . . . 0.0 112.048 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -27.24 68.73 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.101 -0.999 . . . . 0.0 111.944 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 36.9 mt -76.83 -51.67 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.059 1.744 . . . . 0.0 111.812 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -101.47 -61.82 1.33 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.509 1.524 . . . . 0.0 113.294 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.39 -24.86 67.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.232 1.813 . . . . 0.0 113.647 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.82 -22.66 67.03 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.198 1.399 . . . . 0.0 114.135 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 124.762 1.225 . . . . 0.0 113.315 -179.651 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -145.74 96.44 2.81 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.02 33.58 7.02 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -63.11 -22.41 66.84 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -12.92 61.31 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 45.35 -115.4 0.5 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.67 1.588 . . . . 0.0 113.054 175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.98 5.83 17.97 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.3 t0 60.16 24.6 13.92 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.205 1.802 . . . . 0.0 113.511 -170.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -147.57 -5.56 0.48 Allowed 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -95.52 -29.06 14.57 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -119.76 33.99 0.21 Allowed Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.23 152.1 72.08 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.137 1.891 . . . . 0.0 113.53 -169.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -62.08 -24.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -76.22 -35.07 59.22 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.348 0.659 . . . . 0.0 112.629 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 m -103.56 -27.98 12.02 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -91.09 174.71 7.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.041 0.924 . . . . 0.0 113.425 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 p -103.86 165.96 10.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.667 1.587 . . . . 0.0 114.213 -172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -17.53 48.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.215 1.806 . . . . 0.0 115.211 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.97 -34.71 73.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.774 1.17 . . . . 0.0 111.424 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.08 -28.98 70.15 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.656 -0.653 . . . . 0.0 112.319 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.61 -21.48 66.72 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.882 -1.136 . . . . 0.0 111.646 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -91.65 -13.42 31.85 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.418 1.487 . . . . 0.0 113.202 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.02 -31.65 34.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.378 1.071 . . . . 0.0 110.983 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t -68.84 132.68 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.68 1.592 . . . . 0.0 109.782 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -68.9 160.67 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.252 1.421 . . . . 0.0 113.111 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -58.26 -35.92 72.48 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 120.906 -1.121 . . . . 0.0 112.09 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 m -62.22 -23.86 66.89 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.004 1.722 . . . . 0.0 113.827 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -125.45 -3.83 7.3 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.801 1.24 . . . . 0.0 113.51 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.17 -41.86 93.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 120.019 -1.676 . . . . 0.0 112.815 170.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -59.34 -27.35 84.75 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.927 2.418 . . . . 0.0 113.691 168.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.5 m -78.92 -27.9 43.79 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.54 1.136 . . . . 0.0 111.902 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -64.96 -48.43 74.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.812 1.245 . . . . 0.0 112.811 170.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.03 -36.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 118.73 0.695 . . . . 0.0 110.466 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.94 -48.17 52.27 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.674 1.13 . . . . 0.0 113.849 170.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.05 -19.0 64.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.864 2.832 . . . . 0.0 113.192 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.93 -53.46 5.29 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.47 -0.769 . . . . 0.0 110.7 165.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.7 -19.73 60.14 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.99 27.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 111.951 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.95 -31.42 18.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.282 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -67.33 -20.57 65.62 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.04 -8.38 21.51 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.26 0.4 OUTLIER -141.41 -129.52 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.187 1.395 . . . . 0.0 113.287 -175.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.87 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.989 1.716 . . . . 0.0 113.759 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -136.41 164.44 42.79 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 127.763 2.425 . . . . 0.0 110.056 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.34 -5.27 14.88 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.498 1.466 . . . . 0.0 114.55 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.61 -25.21 68.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.937 1.244 . . . . 0.0 113.747 -168.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.31 -16.55 29.03 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.157 2.183 . . . . 0.0 113.648 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 154.26 33.46 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -169.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.77 1.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 125.133 1.373 . . . . 0.0 113.795 -174.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? 62.78 112.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.842 2.857 . . . . 0.0 112.584 -168.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.9 54.07 2.55 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.899 1.68 . . . . 0.0 112.495 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 0.6 OUTLIER -55.22 -40.82 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 -165.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.73 -35.45 78.1 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 122.746 2.521 . . . . 0.0 112.707 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.02 -22.16 60.03 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 124.755 1.169 . . . . 0.0 113.804 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.74 -50.78 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.433 1.493 . . . . 0.0 111.132 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.3 -34.18 77.54 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.016 1.326 . . . . 0.0 113.78 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -63.73 -39.24 93.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.391 1.076 . . . . 0.0 111.735 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HD13 ' A' ' 62' ' ' ILE . 1.3 t -95.45 -19.66 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.681 1.192 . . . . 0.0 113.314 -172.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.6 m -41.85 -60.0 2.22 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 125.962 1.705 . . . . 0.0 112.368 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.4 1.24 4.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.715 2.943 . . . . 0.0 114.822 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.46 -59.66 1.78 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 0.0 110.485 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.471 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.23 -34.99 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.345 0.975 . . . . 0.0 112.118 -178.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 m -61.82 -40.9 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.444 0.565 . . . . 0.0 112.326 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -78.26 -47.91 16.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.47 0.652 . . . . 0.0 110.36 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.25 -29.39 70.17 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.096 0.958 . . . . 0.0 113.561 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.37 -11.6 59.86 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.54 -33.95 16.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.304 1.411 . . . . 0.0 110.58 166.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -58.02 -40.11 80.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.495 1.118 . . . . 0.0 111.652 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.51 88.0 1.75 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.757 0.789 . . . . 0.0 111.984 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -55.01 -31.42 61.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.747 1.619 . . . . 0.0 112.489 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -89.53 -2.74 58.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.188 1.395 . . . . 0.0 112.854 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 154.95 40.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.716 0.806 . . . . 0.0 110.548 169.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -64.58 137.34 57.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.992 0.517 . . . . 0.0 110.349 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.52 -53.1 62.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.907 1.283 . . . . 0.0 111.766 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -65.54 -38.23 89.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.08 0.952 . . . . 0.0 112.245 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.56 -37.36 83.55 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.485 0.714 . . . . 0.0 111.463 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -73.61 -33.68 64.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.85 -47.3 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 118.448 0.567 . . . . 0.0 110.698 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.66 -44.57 95.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.876 0.87 . . . . 0.0 111.825 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.65 -46.13 93.74 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.722 1.153 . . . . 0.0 113.092 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -73.29 -31.99 64.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.695 1.248 . . . . 0.0 113.447 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -61.49 -42.21 98.45 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.982 1.265 . . . . 0.0 111.714 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -63.68 -47.99 78.99 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.66 0.784 . . . . 0.0 111.476 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.65 69.28 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.413 -1.429 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.1 mt -72.96 -44.97 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.84 0.856 . . . . 0.0 112.038 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -99.63 -59.34 1.74 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.903 1.281 . . . . 0.0 113.541 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -67.32 -40.63 85.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.303 1.441 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.7 t70 54.57 15.3 1.01 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.484 2.313 . . . . 0.0 115.129 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 63.7 ttp . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.403 2.281 . . . . 0.0 111.218 179.615 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -140.23 143.07 35.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.103 0.961 . . . . 0.0 112.1 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.12 66.99 0.42 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.946 1.298 . . . . 0.0 111.544 171.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -58.84 -16.95 19.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -11.17 60.55 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 169.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.12 67.99 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -170.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.7 -2.49 54.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . 0.257 1.6 p30 59.86 -29.78 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 130.198 3.399 . . . . 0.0 119.128 171.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -126.84 7.3 6.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.654 1.582 . . . . 0.0 113.865 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -99.77 124.29 44.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.195 1.398 . . . . 0.0 110.774 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 48.67 40.56 0.78 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 127.211 2.204 . . . . 0.0 116.781 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -65.5 159.17 49.11 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 122.149 1.803 . . . . 0.0 109.832 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -48.3 -30.01 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -87.69 -7.75 56.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 49.8 m -132.13 28.83 4.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.041 2.536 . . . . 0.0 111.084 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -101.15 141.52 33.92 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.679 1.992 . . . . 0.0 111.299 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 36.7 p -110.33 149.82 29.65 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -19.92 66.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.52 -39.29 61.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 0.0 110.986 168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.67 -34.86 78.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 112.179 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.47 -30.16 71.33 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.083 -1.011 . . . . 0.0 111.445 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.4 -4.23 58.11 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.558 1.143 . . . . 0.0 113.466 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.99 15.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.113 1.365 . . . . 0.0 111.152 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.57 138.49 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.356 1.862 . . . . 0.0 109.646 169.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.92 158.62 32.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.244 1.018 . . . . 0.0 112.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.88 -35.85 71.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.596 1.158 . . . . 0.0 111.349 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.5 m -61.92 -23.0 66.07 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.782 1.633 . . . . 0.0 114.029 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.89 -1.46 7.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.294 1.438 . . . . 0.0 112.746 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.57 -43.91 90.13 Favored Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 119.728 -1.858 . . . . 0.0 112.444 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.52 -25.22 75.63 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.035 1.823 . . . . 0.0 113.214 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.747 HG22 HD21 ' A' ' 50' ' ' LEU . 24.2 m -72.69 -39.99 66.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.146 0.978 . . . . 0.0 110.159 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -20.07 63.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.975 1.71 . . . . 0.0 115.537 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.8 -39.99 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-N 121.145 1.793 . . . . 0.0 109.612 163.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.79 23.13 0.18 Allowed Glycine 0 CA--C 1.54 1.624 0 C-N-CA 127.907 2.67 . . . . 0.0 117.424 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -126.39 -57.57 1.38 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.362 1.581 . . . . 0.0 111.041 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.59 78.16 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.221 -0.924 . . . . 0.0 111.773 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.38 -38.41 35.01 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.811 -0.556 . . . . 0.0 111.956 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.76 -46.04 69.84 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 113.296 -171.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -33.32 69.02 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.924 -0.485 . . . . 0.0 110.871 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.27 -28.19 66.98 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.12 -3.93 50.16 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -146.11 -122.97 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.361 1.864 . . . . 0.0 111.208 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -160.3 -79.31 0.05 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.625 1.57 . . . . 0.0 112.092 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -123.88 164.2 30.61 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 127.065 2.146 . . . . 0.0 109.262 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.74 1.98 7.48 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 121.283 1.494 . . . . 0.0 114.826 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -55.74 -27.84 52.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.206 1.402 . . . . 0.0 111.481 168.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.75 3.97 23.2 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.816 2.046 . . . . 0.0 113.279 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.94 126.88 35.59 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 119.725 -1.86 . . . . 0.0 113.744 -169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.96 132.52 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.151 2.181 . . . . 0.0 106.471 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -69.81 116.24 9.96 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.631 1.105 . . . . 0.0 109.787 -174.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -86.28 61.44 6.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.06 1.344 . . . . 0.0 110.588 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.315 1.2 p -68.65 -34.16 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.385 -167.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.13 -39.04 89.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.852 1.66 . . . . 0.0 111.991 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.39 -48.39 79.04 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.538 0.589 . . . . 0.0 111.677 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.75 -43.21 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.46 1.104 . . . . 0.0 111.702 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.9 -37.8 76.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.288 1.035 . . . . 0.0 112.315 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 23.7 m -62.12 -39.89 94.06 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.453 1.101 . . . . 0.0 112.007 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.0 -26.19 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.41 1.484 . . . . 0.0 113.594 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -44.77 -60.49 2.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 126.603 1.961 . . . . 0.0 113.571 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.52 -19.49 67.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.262 1.975 . . . . 0.0 113.149 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -69.04 -58.07 4.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.097 0.959 . . . . 0.0 111.274 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -20.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.26 -0.9 . . . . 0.0 113.255 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.8 -52.82 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 119.614 1.097 . . . . 0.0 110.28 173.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.18 -47.69 34.01 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 122.458 0.303 . . . . 0.0 111.476 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.03 -28.57 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.692 -1.255 . . . . 0.0 113.24 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.01 -16.24 60.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.69 21.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.278 1.399 . . . . 0.0 111.34 168.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.95 -38.87 76.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.772 0.829 . . . . 0.0 112.544 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -146.65 83.5 1.6 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -56.86 -37.83 71.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.933 1.293 . . . . 0.0 111.937 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.9 -6.13 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 113.018 -172.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.88 137.42 58.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.836 0.744 . . . . 0.0 109.219 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -122.59 44.25 2.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.386 -167.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -138.36 143.04 39.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -165.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -67.41 -26.92 66.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.369 1.068 . . . . 0.0 110.381 166.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -64.19 -24.8 67.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.895 1.278 . . . . 0.0 113.216 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.05 -31.62 72.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.046 -1.034 . . . . 0.0 111.98 170.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.43 -47.15 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.719 1.608 . . . . 0.0 110.453 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -65.32 -34.22 77.81 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.292 1.037 . . . . 0.0 113.286 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.42 -34.87 76.89 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.659 1.124 . . . . 0.0 113.69 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 24.3 mm-40 -75.69 -32.85 60.29 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.601 1.2 . . . . 0.0 113.187 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.92 -39.47 94.25 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.893 -1.129 . . . . 0.0 111.065 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -61.48 -48.55 80.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.275 1.03 . . . . 0.0 111.756 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -24.15 67.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.984 -1.072 . . . . 0.0 112.289 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 27.9 mt -83.94 -48.09 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.417 1.487 . . . . 0.0 112.373 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -103.57 -51.2 3.25 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.076 1.351 . . . . 0.0 114.014 -169.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -74.46 -29.14 61.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.108 1.363 . . . . 0.0 113.11 -172.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.28 -27.47 35.08 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.035 1.334 . . . . 0.0 114.13 -170.112 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.359 0.124 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -115.44 26.42 10.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.677 1.991 . . . . 0.0 111.692 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.65 156.92 16.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.707 1.203 . . . . 0.0 111.302 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.485 ' HB3' ' H ' ' B' ' 142' ' ' GLN . 12.5 pt20 -157.75 -176.94 6.22 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.506 1.123 . . . . 0.0 112.344 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -77.48 37.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -167.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 46.9 57.74 5.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.712 2.005 . . . . 0.0 115.86 169.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.36 -24.71 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.689 -1.257 . . . . 0.0 113.184 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.74 -22.62 65.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.627 1.571 . . . . 0.0 114.315 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -122.36 12.12 10.11 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.257 1.823 . . . . 0.0 112.833 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 40.24 92.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 129.074 2.95 . . . . 0.0 115.524 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -115.9 60.71 1.81 Allowed Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 126.028 1.731 . . . . 0.0 111.372 168.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.29 167.46 23.77 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.358 3.372 . . . . 0.0 113.393 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.5 7.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -126.29 21.84 7.24 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.297 2.239 . . . . 0.0 113.153 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.0 p -116.05 -32.01 5.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -129.26 163.13 26.32 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -170.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -73.16 168.02 19.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.204 1.402 . . . . 0.0 113.733 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -27.44 46.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -57.68 -38.32 74.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.156 0.982 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.02 -12.67 59.31 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.498 1.519 . . . . 0.0 113.065 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -76.26 -16.73 59.74 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.516 -1.365 . . . . 0.0 111.344 170.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.37 1.76 47.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.017 1.327 . . . . 0.0 114.145 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.48 56.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 112.27 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.55 136.65 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.752 2.021 . . . . 0.0 110.954 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.42 157.8 25.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.51 1.124 . . . . 0.0 112.457 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -53.47 -31.37 45.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.482 1.513 . . . . 0.0 111.758 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 m -61.74 -29.49 70.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.193 1.797 . . . . 0.0 113.89 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -126.45 -1.51 6.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.792 1.637 . . . . 0.0 112.702 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 33.3 mm-40 -53.57 -46.81 98.04 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.91 -1.744 . . . . 0.0 112.365 170.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 36.5 Cg_exo -67.56 -17.83 48.54 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.415 2.076 . . . . 0.0 112.924 176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.851 HG22 HD21 ' B' ' 139' ' ' LEU . 20.6 m -79.76 -36.91 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.218 1.407 . . . . 0.0 110.702 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.59 98.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.526 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.9 -48.41 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.723 0.809 . . . . 0.0 109.288 168.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.04 -52.37 35.8 Favored Glycine 0 C--O 1.213 -1.21 0 C-N-CA 125.214 1.388 . . . . 0.0 113.149 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -68.81 -12.69 61.79 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.649 2.725 . . . . 0.0 114.664 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.38 -50.07 5.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.002 0.819 . . . . 0.0 111.12 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -75.51 -24.1 56.79 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.126 -0.984 . . . . 0.0 113.221 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.35 76.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.404 -1.435 . . . . 0.0 112.003 -176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -74.8 -33.17 62.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.32 1.048 . . . . 0.0 110.32 -176.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -56.84 -23.19 42.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.978 1.711 . . . . 0.0 113.59 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -91.09 -18.53 24.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -120.15 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.115 1.325 . . . . 0.0 113.52 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -161.18 -58.88 0.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.532 1.533 . . . . 0.0 113.954 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.03 166.25 27.45 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 128.125 2.57 . . . . 0.0 109.61 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.87 14.03 2.32 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.033 1.762 . . . . 0.0 114.804 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -62.22 -23.71 66.81 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.282 1.433 . . . . 0.0 111.783 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -127.94 26.8 5.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.901 1.68 . . . . 0.0 114.111 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.64 35.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.995 -1.69 . . . . 0.0 112.445 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.04 -16.33 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.845 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 66.64 110.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.856 2.462 . . . . 0.0 112.195 -169.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -96.39 59.83 1.88 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.777 1.231 . . . . 0.0 111.659 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 2.4 p -62.3 -19.61 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.606 -1.309 . . . . 0.0 114.42 -168.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.51 -44.68 56.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.112 1.365 . . . . 0.0 112.169 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.97 -47.71 6.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -58.17 -51.09 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.746 1.218 . . . . 0.0 112.265 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.71 66.69 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -66.61 -49.0 67.74 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.018 1.327 . . . . 0.0 112.42 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.22 -18.45 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -46.4 -60.7 3.34 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.634 1.174 . . . . 0.0 112.807 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.93 -4.18 12.94 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.295 2.663 . . . . 0.0 114.113 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -62.72 1.43 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.363 1.465 . . . . 0.0 111.158 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -30.85 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.951 -1.093 . . . . 0.0 113.175 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.46 -41.09 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.099 0.863 . . . . 0.0 112.66 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.72 -44.34 28.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.084 0.953 . . . . 0.0 110.789 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.18 93.35 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.429 -0.794 . . . . 0.0 112.402 -171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.69 -7.15 56.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -34.52 16.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.115 1.325 . . . . 0.0 111.565 169.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -78.83 -32.98 46.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -117.09 49.18 1.21 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.665 1.586 . . . . 0.0 112.06 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -48.93 -36.79 18.18 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.743 -1.223 . . . . 0.0 113.566 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -87.92 -2.86 58.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.664 1.186 . . . . 0.0 113.624 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.05 157.51 35.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.004 0.922 . . . . 0.0 111.352 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -76.68 161.39 28.57 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.505 1.145 . . . . 0.0 113.759 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -48.28 153.09 0.76 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.788 2.435 . . . . 0.0 114.132 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp 60.29 -34.63 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 130.031 3.332 . . . . 0.0 117.253 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -30.57 70.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.971 1.709 . . . . 0.0 111.995 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -74.1 -35.49 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.8 -46.15 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.086 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -63.76 -43.38 96.6 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.354 1.062 . . . . 0.0 112.113 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.24 98.5 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.931 1.729 . . . . 0.0 113.771 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -73.5 -33.57 64.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.565 1.682 . . . . 0.0 113.13 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -62.85 -39.28 93.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.364 -1.46 . . . . 0.0 111.157 171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.04 -46.64 83.5 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.547 1.139 . . . . 0.0 112.106 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -31.8 72.32 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.057 -1.027 . . . . 0.0 112.08 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.2 mt -79.08 -48.37 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 111.304 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -101.86 -59.7 1.66 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.218 1.407 . . . . 0.0 113.221 -170.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -66.66 -26.36 67.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.7 1.6 . . . . 0.0 113.476 -170.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.62 -19.68 64.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.59 1.156 . . . . 0.0 114.086 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.0 tpp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.185 1.394 . . . . 0.0 112.939 -178.088 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.905 0.383 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -142.5 127.74 18.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.766 1.226 . . . . 0.0 110.238 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.75 159.95 0.09 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.661 1.984 . . . . 0.0 114.657 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' B' ' 94' ' ' LYS . 0.0 OUTLIER -155.39 -154.21 0.48 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.005 0.922 . . . . 0.0 113.32 -167.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 21.7 mtpp -73.99 42.69 0.15 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.329 2.651 . . . . 0.0 114.058 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 58.35 90.6 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.121 2.568 . . . . 0.0 115.271 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 52.84 -154.65 0.21 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.985 2.114 . . . . 0.0 114.312 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.55 -11.91 24.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.641 1.576 . . . . 0.0 113.703 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -149.76 13.53 0.81 Allowed 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -88.73 -40.75 13.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 121.976 2.171 . . . . 0.0 115.693 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -118.19 49.9 1.08 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 125.12 1.368 . . . . 0.0 113.074 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.7 151.2 85.18 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.392 1.394 . . . . 0.0 114.407 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 m -47.56 -29.71 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.276 2.23 . . . . 0.0 114.996 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -93.99 -9.33 37.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 58.0 p -116.15 -32.57 5.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.74 1.154 . . . . 0.0 113.757 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -93.7 163.56 13.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.207 1.003 . . . . 0.0 113.549 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.0 p -99.73 155.78 17.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.298 1.439 . . . . 0.0 114.275 -169.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -20.4 18.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.238 1.815 . . . . 0.0 115.275 -174.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.96 -40.65 89.77 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.03 1.286 . . . . 0.0 111.679 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -78.1 -12.36 59.98 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.938 0.895 . . . . 0.0 112.146 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -94.13 -17.29 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.774 -1.204 . . . . 0.0 112.986 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.07 -17.42 57.02 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.939 -1.101 . . . . 0.0 113.254 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.3 50.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.687 1.195 . . . . 0.0 113.905 -171.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.71 139.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.024 1.73 . . . . 0.0 111.113 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.61 158.68 29.29 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.638 1.575 . . . . 0.0 113.744 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.16 -33.27 70.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.852 1.261 . . . . 0.0 111.988 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 70.5 m -59.43 -26.75 65.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.087 1.755 . . . . 0.0 113.656 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.51 -0.93 8.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.607 1.563 . . . . 0.0 112.523 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.44 -46.38 99.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 120.009 -1.682 . . . . 0.0 112.805 172.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -64.96 -25.4 59.53 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.353 2.035 . . . . 0.0 112.848 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 50' ' ' LEU . 58.0 m -70.12 -38.43 75.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.039 0.936 . . . . 0.0 110.345 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.05 92.54 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.35 -35.62 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.739 1.154 . . . . 0.0 110.76 170.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.31 -42.03 88.13 Favored Glycine 0 C--O 1.217 -0.915 0 C-N-CA 124.764 1.173 . . . . 0.0 113.687 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -44.4 71.16 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.147 1.973 . . . . 0.0 111.51 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.84 82.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.76 -39.14 73.41 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.012 -1.055 . . . . 0.0 113.557 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.62 87.68 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.021 -1.049 . . . . 0.0 111.386 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -79.53 -38.81 33.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.578 0.751 . . . . 0.0 111.056 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.0 -31.39 72.52 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.076 0.95 . . . . 0.0 113.198 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -81.77 -16.84 49.73 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.16 -124.14 0.03 OUTLIER 'General case' 0 C--N 1.35 0.629 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -163.66 -45.68 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.494 1.518 . . . . 0.0 114.205 -167.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.04 161.99 56.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 127.298 2.239 . . . . 0.0 110.158 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.9 5.55 6.2 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.764 1.643 . . . . 0.0 113.909 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -56.51 -29.74 62.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.377 1.471 . . . . 0.0 111.86 169.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -111.94 15.12 20.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.198 1.799 . . . . 0.0 112.964 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.72 120.96 24.12 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 119.408 -2.057 . . . . 0.0 111.999 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.34 128.81 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.791 1.636 . . . . 0.0 106.917 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 31' ' ' THR . 2.1 tm? -75.1 116.75 16.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.626 0.648 . . . . 0.0 110.488 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.07 48.98 1.73 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.27 1.828 . . . . 0.0 111.43 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.351 1.7 p -62.8 -32.73 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -166.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.485 ' H ' ' HB3' ' A' ' 4' ' ' GLN . 3.0 tm0? -59.82 -50.56 73.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.626 1.557 . . . . 0.0 110.027 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.79 -39.51 55.0 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.797 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -58.37 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.488 1.115 . . . . 0.0 110.979 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.06 75.66 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.83 1.195 . . . . 0.0 112.526 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 53.3 m -62.39 -43.38 98.95 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.383 1.073 . . . . 0.0 111.872 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' B' ' 151' ' ' ILE . 35.0 t -83.69 -30.43 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.494 1.518 . . . . 0.0 113.082 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.5 m -37.04 -61.93 0.62 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 127.132 2.173 . . . . 0.0 114.245 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.21 -22.7 60.72 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.059 1.839 . . . . 0.0 113.026 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.95 -60.53 2.56 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.286 1.035 . . . . 0.0 110.689 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.528 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -70.5 -25.6 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.286 -0.884 . . . . 0.0 113.151 178.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 t -62.67 -52.15 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.12 0.873 . . . . 0.0 110.654 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.35 -43.44 60.71 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.655 0.382 . . . . 0.0 111.287 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.73 -29.13 69.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.749 -1.219 . . . . 0.0 112.852 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 34.4 m -69.75 -13.93 62.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 169.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.23 -38.43 13.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.652 1.569 . . . . 0.0 110.872 166.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -59.81 -38.77 82.9 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.959 0.904 . . . . 0.0 112.396 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.54 75.41 1.46 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 122.359 1.076 . . . . 0.0 111.246 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -52.26 -27.21 14.12 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.042 1.737 . . . . 0.0 112.357 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.94 -2.63 55.63 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.383 1.473 . . . . 0.0 113.516 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.59 152.13 36.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.51 1.124 . . . . 0.0 111.702 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -70.19 136.27 49.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.313 1.445 . . . . 0.0 111.099 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.19 -43.65 81.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -60.47 -41.34 93.96 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 120.217 1.371 . . . . 0.0 110.705 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.03 -36.81 84.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.343 0.657 . . . . 0.0 112.311 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -70.9 -39.31 72.84 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.92 -46.17 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 119.65 1.114 . . . . 0.0 109.968 172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -65.33 -46.52 79.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.864 0.866 . . . . 0.0 112.359 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.15 99.24 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.832 1.206 . . . . 0.0 113.394 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -71.83 -34.32 69.22 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.702 1.251 . . . . 0.0 112.307 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -61.35 -39.92 92.36 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.66 -1.275 . . . . 0.0 111.725 171.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.81 -47.74 79.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.425 0.69 . . . . 0.0 111.394 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -27.52 68.95 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.393 -1.442 . . . . 0.0 111.849 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.8 mt -73.9 -47.6 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.908 1.683 . . . . 0.0 112.785 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -99.5 -58.82 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.85 1.26 . . . . 0.0 113.321 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.65 -36.19 81.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.029 1.332 . . . . 0.0 111.731 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.0 t0 50.22 50.76 18.05 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.658 1.983 . . . . 0.0 112.629 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.965 1.706 . . . . 0.0 113.279 -177.273 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.76 -20.95 57.89 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.21 46.36 23.95 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.26 -20.69 63.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.29 131.5 47.51 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.591 -0.693 . . . . 0.0 110.457 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.7 124.33 30.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.97 -81.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.948 1.699 . . . . 0.0 112.86 -167.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -167.73 -47.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.878 1.671 . . . . 0.0 111.127 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -115.88 15.76 16.27 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -168.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.345 0.0 OUTLIER -128.77 18.61 6.19 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 -168.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -123.99 57.29 12.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 125.011 1.324 . . . . 0.0 111.007 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.23 161.92 44.23 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.781 2.987 . . . . 0.0 114.667 -168.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.82 -14.98 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.37 1.468 . . . . 0.0 113.802 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -85.97 -10.73 54.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.866 2.066 . . . . 0.0 113.502 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.1 m -133.38 -25.8 1.7 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -171.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.67 151.83 46.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.175 0.898 . . . . 0.0 111.76 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.7 p -97.35 165.17 12.15 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.883 1.325 . . . . 0.0 113.05 -172.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 m -62.1 -21.97 65.42 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.48 -44.75 95.63 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.933 -1.104 . . . . 0.0 110.711 170.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -63.87 -25.84 68.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.397 -0.815 . . . . 0.0 112.167 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.24 -16.39 63.04 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.945 -1.097 . . . . 0.0 112.664 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.5 mt -87.19 -9.51 55.0 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.021 -1.049 . . . . 0.0 112.378 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -26.75 13.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.099 1.76 . . . . 0.0 113.404 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.02 -4.31 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t70 64.8 155.12 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 129.076 2.951 . . . . 0.0 116.319 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.06 -34.5 63.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.813 1.245 . . . . 0.0 112.128 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 m -67.73 -25.04 65.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -127.32 3.3 6.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.583 1.153 . . . . 0.0 112.014 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -57.3 -52.3 75.28 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.311 -1.493 . . . . 0.0 110.449 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -67.66 -12.15 34.57 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.417 2.078 . . . . 0.0 114.39 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.553 HG22 HD21 ' B' ' 139' ' ' LEU . 79.6 m -73.27 -32.71 64.84 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.795 -1.191 . . . . 0.0 110.678 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.26 85.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.387 1.075 . . . . 0.0 112.145 169.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.91 -45.18 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.353 1.061 . . . . 0.0 109.001 170.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.45 6.03 0.38 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.54 2.019 . . . . 0.0 116.78 169.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -121.68 -61.36 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.999 1.72 . . . . 0.0 110.078 168.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.41 -30.4 70.15 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.26 -32.56 13.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.683 0.674 . . . . 0.0 112.392 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.05 -46.29 88.22 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.404 HD22 HD22 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -76.01 -12.43 60.13 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.05 0.94 . . . . 0.0 111.939 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -85.81 -21.92 27.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.66 1.184 . . . . 0.0 113.028 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -95.89 -16.28 21.89 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.863 0.865 . . . . 0.0 113.225 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -170.59 153.33 4.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.971 2.908 . . . . 0.0 106.835 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -84.26 -41.74 16.59 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 111.556 -2.565 . . . . 0.0 112.718 -173.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -131.56 159.59 71.14 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 127.071 2.148 . . . . 0.0 110.057 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -90.23 12.04 2.59 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.3 2.0 . . . . 0.0 114.432 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.07 -23.71 65.68 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.241 1.016 . . . . 0.0 112.651 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.77 -15.84 24.77 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.333 1.853 . . . . 0.0 113.787 173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.21 127.09 32.0 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.51 18.38 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 125.586 1.555 . . . . 0.0 111.336 169.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.468 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER 57.21 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.833 2.853 . . . . 0.0 110.739 -168.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.38 62.37 6.03 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.876 -1.765 . . . . 0.0 110.973 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p -72.42 -24.14 21.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -167.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -58.1 -45.12 87.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.589 1.541 . . . . 0.0 111.455 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.05 -45.2 88.98 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.947 -0.47 . . . . 0.0 112.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.2 mt -60.68 -44.86 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.775 1.23 . . . . 0.0 111.657 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.32 -27.94 63.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.443 1.097 . . . . 0.0 112.742 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.8 m -67.44 -45.55 75.71 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.667 1.187 . . . . 0.0 111.244 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -27.03 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -172.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.8 m -49.48 -62.44 2.47 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.201 1.4 . . . . 0.0 112.831 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -8.29 22.56 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.071 2.514 . . . . 0.0 113.578 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.67 -57.18 3.8 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 110.312 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.79 -29.8 30.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 C-N-CA 124.084 0.954 . . . . 0.0 112.135 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -61.55 -53.12 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.574 1.079 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -68.51 -40.83 80.69 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.952 0.405 . . . . 0.0 110.609 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.43 97.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.8 m -74.39 -14.67 60.89 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.39 -36.17 24.51 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.11 1.323 . . . . 0.0 111.494 171.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -81.33 -27.15 35.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -125.98 50.14 1.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.436 1.894 . . . . 0.0 112.532 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -51.36 -38.16 51.78 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.703 1.601 . . . . 0.0 113.158 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -81.91 -6.42 59.09 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.29 163.78 20.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.51 1.124 . . . . 0.0 113.019 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -67.0 140.12 57.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.505 1.522 . . . . 0.0 110.755 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.32 -41.02 92.65 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -65.41 -33.56 76.25 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.01 -1.056 . . . . 0.0 112.38 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.54 -42.24 91.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.465 1.106 . . . . 0.0 111.668 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -41.25 95.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.33 -48.72 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.104 0.411 . . . . 0.0 110.474 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -63.46 -45.79 89.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.69 92.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.701 1.144 . . . . 0.0 113.176 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.05 -34.82 61.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.513 1.156 . . . . 0.0 112.527 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -59.8 -40.26 87.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.545 1.52 . . . . 0.0 111.78 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.43 -46.49 88.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.179 0.992 . . . . 0.0 111.844 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -28.07 69.33 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.904 -1.123 . . . . 0.0 111.92 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.74 -46.17 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.831 1.253 . . . . 0.0 111.956 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -104.33 -62.83 1.27 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.923 1.689 . . . . 0.0 113.367 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -64.82 -24.02 67.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.339 1.855 . . . . 0.0 114.189 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.12 -23.46 65.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.98 1.312 . . . . 0.0 113.869 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.565 1.546 . . . . 0.0 111.888 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -150.2 120.64 7.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.144 0.978 . . . . 0.0 112.514 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.21 30.82 8.27 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 167.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -45.79 -40.52 9.74 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.281 1.432 . . . . 0.0 114.035 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 0.38 51.39 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.11 9.59 7.42 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.007 1.323 . . . . 0.0 114.092 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.77 62.34 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 58.75 -22.4 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 129.57 3.148 . . . . 0.0 117.824 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -65.97 -17.88 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.891 1.677 . . . . 0.0 111.796 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 157.97 41.1 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 128.153 2.581 . . . . 0.0 109.765 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.31 165.41 14.32 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.19 0.996 . . . . 0.0 112.63 -169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -45.99 165.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 1 C-N-CA 126.682 4.921 . . . . 0.0 118.773 176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.01 -19.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.062 1.745 . . . . 0.0 114.82 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -98.92 -2.13 38.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.806 1.242 . . . . 0.0 114.018 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 78.0 p -134.81 -6.14 2.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -177.24 4.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.804 1.242 . . . . 0.0 113.734 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 82.2 p -97.76 166.39 11.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -16.39 6.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.76 -34.41 71.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.086 1.312 . . . . 0.0 111.41 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.56 -27.05 67.37 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.246 -0.909 . . . . 0.0 112.805 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -71.77 -15.71 62.18 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.407 -0.808 . . . . 0.0 112.346 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 mt -95.76 -19.42 19.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.525 1.13 . . . . 0.0 113.22 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.51 65.17 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.206 1.002 . . . . 0.0 112.576 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.22 140.38 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.179 2.192 . . . . 0.0 111.758 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -69.87 158.99 34.5 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.807 1.243 . . . . 0.0 113.228 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.9 -32.02 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.679 1.591 . . . . 0.0 111.876 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.2 m -59.13 -28.24 66.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.851 1.661 . . . . 0.0 113.815 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -128.06 -2.89 5.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.29 1.436 . . . . 0.0 113.443 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -58.16 -40.82 86.0 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 119.619 -1.926 . . . . 0.0 113.475 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -60.54 -26.53 83.04 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.66 2.24 . . . . 0.0 113.241 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 42.6 m -77.41 -33.88 54.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.714 1.206 . . . . 0.0 111.483 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -60.26 -48.62 80.95 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.733 1.213 . . . . 0.0 113.079 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.02 -34.33 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 111.171 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.64 -58.42 10.22 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.537 1.065 . . . . 0.0 112.655 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.32 -37.08 76.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.233 2.017 . . . . 0.0 112.677 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.74 -29.2 67.56 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -111.83 -33.3 6.35 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.465 1.906 . . . . 0.0 112.705 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.404 HD22 HD22 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -78.78 -42.2 28.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 110.21 -179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.03 -32.35 73.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -168.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.35 -7.06 58.77 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.14 -45.41 0.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.33 1.3 p30 56.04 140.22 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.855 2.462 . . . . 0.0 115.94 -166.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 42.9 mttp 63.79 140.9 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.758 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -89.75 0.09 5.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.629 1.553 . . . . 0.0 114.524 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.27 -16.48 63.6 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.038 1.29 . . . . 0.0 113.657 -170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -123.56 5.01 8.94 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.734 1.614 . . . . 0.0 113.863 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.51 141.32 44.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.469 -1.394 . . . . 0.0 113.741 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.94 132.71 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.58 1.952 . . . . 0.0 107.708 170.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.553 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -68.61 127.35 32.7 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.91 43.72 1.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.939 -1.1 . . . . 0.0 113.623 -166.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.261 14.3 p -64.69 -21.61 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.528 -1.358 . . . . 0.0 112.775 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -54.91 -30.46 58.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.654 1.581 . . . . 0.0 113.125 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -93.28 -56.27 1.49 Allowed Glycine 0 N--CA 1.465 0.583 0 C-N-CA 123.507 0.575 . . . . 0.0 112.368 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -54.36 -45.56 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 121.606 -0.938 . . . . 0.0 113.074 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.87 66.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.682 1.128 . . . . 0.0 113.071 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 1.5 m -71.28 -44.56 65.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.946 1.298 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -89.04 -18.32 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.3 m -41.36 -59.95 2.05 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.455 1.502 . . . . 0.0 113.431 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.47 -16.9 54.98 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.136 2.558 . . . . 0.0 114.121 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.26 -58.25 3.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.354 1.062 . . . . 0.0 111.612 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -37.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.189 -0.944 . . . . 0.0 112.558 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.28 -42.73 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.923 0.489 . . . . 0.0 112.069 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.54 -45.25 46.82 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.74 0.816 . . . . 0.0 110.903 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.31 71.92 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.461 -1.4 . . . . 0.0 113.43 -169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 10.9 m -74.82 -11.52 60.17 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.74 -34.54 16.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.49 1.496 . . . . 0.0 111.057 167.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -58.26 -38.76 77.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.699 1.2 . . . . 0.0 111.95 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -143.8 83.07 1.74 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.41 0.684 . . . . 0.0 111.871 171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -55.81 -25.9 43.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.972 1.309 . . . . 0.0 112.946 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -95.13 3.98 54.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.096 1.758 . . . . 0.0 113.269 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.09 149.72 31.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.091 1.356 . . . . 0.0 113.397 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.65 86.92 6.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.58 1.152 . . . . 0.0 113.011 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . 0.258 1.4 p90 44.43 -117.95 0.59 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -21.31 64.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.23 1.412 . . . . 0.0 113.462 -170.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -56.66 -31.65 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.943 0.897 . . . . 0.0 112.267 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -74.73 -42.55 58.09 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.3 -35.12 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.874 1.216 . . . . 0.0 111.586 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.59 -48.14 76.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.915 0.886 . . . . 0.0 111.843 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.53 -41.42 98.71 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.121 0.867 . . . . 0.0 113.178 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.25 -29.11 63.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.381 1.091 . . . . 0.0 113.161 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -66.13 -43.16 87.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.38 0.991 . . . . 0.0 111.532 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.84 -43.9 97.92 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.684 0.793 . . . . 0.0 111.183 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.3 -40.61 5.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.931 1.693 . . . . 0.0 113.307 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.0 mt -85.98 -38.82 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.905 0.882 . . . . 0.0 112.421 -171.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -96.42 -54.1 3.37 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -78.77 -34.77 45.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.701 1.6 . . . . 0.0 112.776 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 24.9 t0 48.78 48.67 19.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.776 2.03 . . . . 0.0 113.365 -168.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.929 2.092 . . . . 0.0 112.16 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.31 -4.06 58.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.29 36.95 28.33 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -28.12 42.62 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -94.7 13.26 24.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.04 0.936 . . . . 0.0 113.219 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.35 -20.09 65.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.757 1.623 . . . . 0.0 114.315 -172.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.6 62.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.189 0.995 . . . . 0.0 113.076 169.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 t70 61.77 -10.7 0.07 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 129.045 2.938 . . . . 0.0 116.844 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -117.18 -6.76 11.32 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.84 1.656 . . . . 0.0 113.439 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -140.32 -171.67 3.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 58.3 34.94 0.23 Allowed Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 129.066 2.946 . . . . 0.0 114.585 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.19 147.3 47.79 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.853 1.702 . . . . 0.0 111.15 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.15 -18.51 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -82.49 -19.52 38.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.177 1.391 . . . . 0.0 113.951 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.3 m -141.39 44.8 1.75 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.156 2.182 . . . . 0.0 110.73 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -129.86 139.72 51.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.275 1.83 . . . . 0.0 109.912 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.5 p -102.65 161.43 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.972 1.367 . . . . 0.0 114.159 -168.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 m -77.03 -21.43 54.58 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.83 -42.27 79.34 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.305 0.957 . . . . 0.0 110.648 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.76 -28.75 60.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.092 0.957 . . . . 0.0 112.209 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -66.15 -33.97 76.98 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.658 -1.276 . . . . 0.0 111.262 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.33 -10.52 59.66 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.93 -29.4 27.14 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.248 1.019 . . . . 0.0 112.551 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.85 137.47 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.047 1.739 . . . . 0.0 110.069 170.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.43 157.4 34.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.764 0.826 . . . . 0.0 113.02 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -55.96 -28.93 59.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 111.724 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.7 m -62.78 -27.17 69.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.043 1.737 . . . . 0.0 114.243 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -127.7 -10.58 5.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.63 1.172 . . . . 0.0 113.511 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.83 -40.45 85.12 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 119.641 -1.912 . . . . 0.0 112.522 169.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -65.53 -24.15 56.61 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.771 2.314 . . . . 0.0 113.435 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 HD21 ' B' ' 139' ' ' LEU . 95.6 m -73.35 -36.53 66.15 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 110.243 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.54 85.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.647 1.179 . . . . 0.0 113.898 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.84 -35.28 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 119.203 0.911 . . . . 0.0 110.684 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.17 -43.51 74.06 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.878 1.228 . . . . 0.0 114.448 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -68.29 -49.06 63.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.986 2.393 . . . . 0.0 112.536 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.82 -29.96 71.12 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.147 0.579 . . . . 0.0 112.186 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -87.55 -45.46 10.44 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.48 -46.21 90.94 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.679 -1.263 . . . . 0.0 111.308 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.47 62.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.426 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -74.18 -18.96 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.053 0.842 . . . . 0.0 113.221 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.3 -28.59 42.21 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.39 -0.818 . . . . 0.0 112.868 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -154.69 -128.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.48 1.512 . . . . 0.0 112.55 -167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -162.9 -39.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.578 2.351 . . . . 0.0 114.261 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -134.2 162.09 59.81 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 127.175 2.19 . . . . 0.0 110.363 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -94.84 9.72 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.939 1.759 . . . . 0.0 114.647 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.91 -18.26 63.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.153 -0.967 . . . . 0.0 112.936 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -112.39 -2.35 14.79 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.133 1.773 . . . . 0.0 113.971 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.55 55.44 Favored 'General case' 0 C--N 1.343 0.317 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.43 145.07 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.467 1.907 . . . . 0.0 107.339 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD21 HG22 ' B' ' 120' ' ' THR . 1.4 tm? -80.2 137.24 36.64 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 119.233 0.924 . . . . 0.0 113.11 -168.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -94.27 47.66 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.498 -1.376 . . . . 0.0 113.749 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 ' CG ' ' B' ' 117' ' ' PHE 0.387 1.7 p -63.29 -50.28 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -60.22 -35.19 74.87 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.647 2.021 . . . . 0.0 111.854 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.77 -41.83 88.03 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 121.276 0.376 . . . . 0.0 112.54 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 HD13 HG21 ' B' ' 120' ' ' THR . 21.4 mt -65.7 -45.84 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.422 1.489 . . . . 0.0 111.444 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.05 -25.69 65.49 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.064 1.346 . . . . 0.0 112.973 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 m -63.92 -46.45 84.71 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.927 1.291 . . . . 0.0 110.98 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.15 -19.12 7.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -47.02 -60.94 3.24 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 125.284 1.433 . . . . 0.0 112.156 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.83 1.32 5.26 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.726 2.951 . . . . 0.0 114.334 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 -55.68 2.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.065 1.746 . . . . 0.0 110.938 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.07 -32.15 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.017 1.327 . . . . 0.0 111.463 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.11 -45.49 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.774 0.83 . . . . 0.0 112.097 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -67.88 -46.19 72.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.836 0.455 . . . . 0.0 110.181 175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.13 -31.61 69.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.79 0.836 . . . . 0.0 112.632 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.05 -20.28 61.01 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -30.17 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.434 1.015 . . . . 0.0 111.951 168.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.26 -39.09 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.366 1.067 . . . . 0.0 112.119 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -145.96 82.57 1.62 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 112.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -51.77 -35.53 44.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.878 1.271 . . . . 0.0 112.036 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.75 8.36 34.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.573 1.949 . . . . 0.0 114.595 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.38 45.12 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t30 60.42 20.18 9.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -155.13 150.55 27.26 Favored 'General case' 0 N--CA 1.486 1.363 1 N-CA-C 122.662 4.319 . . . . 0.0 122.662 -170.658 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -60.21 -25.15 65.38 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.877 2.471 . . . . 0.0 113.749 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.79 -24.15 55.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.518 0.599 . . . . 0.0 111.568 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -64.35 -34.12 77.43 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.398 1.079 . . . . 0.0 113.805 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.78 -37.73 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.886 1.221 . . . . 0.0 112.149 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -79.88 -31.9 40.32 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.37 -33.59 81.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.665 1.126 . . . . 0.0 113.475 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -77.38 -32.92 55.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.722 1.261 . . . . 0.0 113.325 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -59.91 -41.44 91.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.591 1.087 . . . . 0.0 110.683 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.23 -51.04 70.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.923 0.889 . . . . 0.0 110.967 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -28.81 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.738 -1.226 . . . . 0.0 112.451 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mt -79.82 -47.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 112.535 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -99.23 -58.09 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.522 1.129 . . . . 0.0 112.987 -171.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -64.88 -42.24 94.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.645 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.5 t70 58.05 -7.83 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 130.631 3.572 . . . . 0.0 115.868 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.254 1.297 0 C-N-CA 128.696 2.798 . . . . 0.0 111.071 178.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.79 0.329 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -138.74 30.72 2.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 112.205 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.65 153.4 22.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.494 1.518 . . . . 0.0 109.39 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.46 178.3 4.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.225 1.01 . . . . 0.0 112.054 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -55.21 44.44 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 130.213 3.405 . . . . 0.0 118.464 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.76 -33.9 37.1 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.3 -5.92 28.89 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 56.75 5.72 0.24 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.121 2.168 . . . . 0.0 116.232 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -140.88 -4.95 1.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -88.06 147.28 25.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.41 1.459 . . . . 0.0 111.217 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.4 pttt 31.67 55.0 0.93 Allowed Pre-proline 0 N--CA 1.484 1.273 0 C-N-CA 128.405 2.682 . . . . 0.0 115.768 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -66.49 155.99 67.55 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.88 2.387 . . . . 0.0 112.238 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.0 -15.66 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -85.01 -10.74 56.69 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.182 1.393 . . . . 0.0 114.129 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 48.1 m -144.72 49.37 1.3 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.388 2.275 . . . . 0.0 110.477 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -141.29 139.91 33.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.498 1.519 . . . . 0.0 110.435 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 39.6 p -98.76 150.0 22.28 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.65 -26.67 65.72 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.09 -39.28 85.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.978 -1.076 . . . . 0.0 111.418 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.16 -17.41 46.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -69.75 -29.03 66.28 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.794 -1.192 . . . . 0.0 110.353 168.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mp -73.79 -13.77 61.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.954 -1.091 . . . . 0.0 113.478 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.36 -33.45 25.83 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.486 1.039 . . . . 0.0 113.523 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.31 140.23 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.943 1.297 . . . . 0.0 110.597 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -67.13 158.78 30.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.868 1.267 . . . . 0.0 113.347 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.47 -32.69 71.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.44 1.096 . . . . 0.0 112.03 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.4 m -62.4 -23.44 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.909 1.684 . . . . 0.0 113.924 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.4 ' CG ' HG23 ' A' ' 52' ' ' VAL . 11.2 m-85 -124.78 -5.96 7.45 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.765 1.226 . . . . 0.0 113.206 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -57.0 -46.78 99.84 Favored Pre-proline 0 CA--C 1.549 0.909 0 O-C-N 120.272 -1.517 . . . . 0.0 111.699 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -65.65 -18.31 58.57 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.097 2.531 . . . . 0.0 114.366 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.545 HG22 HD21 ' A' ' 50' ' ' LEU . 25.6 m -77.13 -38.02 52.92 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.818 1.247 . . . . 0.0 110.464 173.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.26 99.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.262 1.025 . . . . 0.0 112.476 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -56.56 -45.71 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.78 . . . . 0.0 109.094 168.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.5 -57.57 10.32 Favored Glycine 0 C--O 1.216 -1.008 0 C-N-CA 125.645 1.593 . . . . 0.0 113.464 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.62 -12.32 60.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 121.485 2.642 . . . . 0.0 113.905 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.54 -31.35 13.36 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.841 1.2 . . . . 0.0 113.627 169.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -88.59 -45.69 9.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.215 1.006 . . . . 0.0 112.343 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.61 84.09 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.791 2.436 . . . . 0.0 113.474 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -18.27 39.25 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.49 1.116 . . . . 0.0 111.865 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -84.69 -35.78 22.32 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 112.563 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.27 -6.82 54.73 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -146.67 -140.23 0.11 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.139 2.576 . . . . 0.0 107.621 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -153.68 -65.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -127.71 160.92 58.33 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 126.966 2.106 . . . . 0.0 110.031 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -82.09 0.24 9.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.16 1.45 . . . . 0.0 114.475 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -60.62 -19.46 57.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 113.456 174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -131.79 7.89 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.011 1.324 . . . . 0.0 113.774 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.78 138.81 40.12 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 120.378 -1.451 . . . . 0.0 114.502 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.86 143.28 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.01 2.124 . . . . 0.0 107.087 168.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.582 HD21 HG22 ' A' ' 31' ' ' THR . 2.5 tm? -73.15 133.39 44.07 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.415 1.007 . . . . 0.0 108.983 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -94.35 38.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.834 -1.166 . . . . 0.0 112.684 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 13.1 p -66.66 -21.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 119.809 -1.807 . . . . 0.0 112.845 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -55.2 -29.84 58.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.684 1.593 . . . . 0.0 112.915 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -94.47 -53.51 1.69 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.612 0.625 . . . . 0.0 112.567 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.24 -42.58 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.181 0.992 . . . . 0.0 113.357 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.99 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.143 1.338 . . . . 0.0 112.945 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 16.6 m -73.19 -37.73 66.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.556 1.142 . . . . 0.0 111.844 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.419 HG12 HD12 ' B' ' 151' ' ' ILE . 23.5 t -83.42 -27.74 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.074 1.75 . . . . 0.0 113.408 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 26.4 m -53.17 -59.69 8.57 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.323 1.449 . . . . 0.0 112.917 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.32 -15.12 46.29 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.298 2.665 . . . . 0.0 113.52 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.89 -62.51 1.47 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.115 0.966 . . . . 0.0 111.052 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 147' ' ' VAL . 33.1 mt -69.74 -30.99 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.38 -0.825 . . . . 0.0 112.822 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.38 -44.02 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.01 -1.056 . . . . 0.0 112.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -71.73 -46.08 59.71 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 110.807 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -27.05 67.72 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.577 -1.327 . . . . 0.0 113.309 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 m -75.1 -14.72 60.6 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.06 -36.02 21.47 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.595 1.543 . . . . 0.0 110.562 167.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -59.8 -38.62 82.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.038 0.935 . . . . 0.0 112.464 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -135.71 61.69 1.65 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.931 1.292 . . . . 0.0 112.022 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -49.16 -38.02 24.21 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.994 1.317 . . . . 0.0 112.877 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.51 -2.53 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.407 1.083 . . . . 0.0 113.825 -172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.68 158.42 24.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.413 1.085 . . . . 0.0 112.638 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -80.44 137.38 36.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.388 1.475 . . . . 0.0 111.274 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.64 -44.14 91.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.367 1.067 . . . . 0.0 113.364 -170.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.79 -41.94 78.6 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.315 0.961 . . . . 0.0 112.111 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.25 -36.71 83.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.876 0.471 . . . . 0.0 112.059 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -74.62 -37.65 62.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 m -66.34 -38.73 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.099 1.318 . . . . 0.0 111.466 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.07 -45.53 93.11 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.291 0.636 . . . . 0.0 111.609 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.98 -49.07 69.03 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.763 1.173 . . . . 0.0 113.613 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.75 -34.34 66.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.634 1.217 . . . . 0.0 112.939 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -61.74 -37.14 83.12 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.657 -1.277 . . . . 0.0 112.193 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.26 -43.36 95.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.651 0.781 . . . . 0.0 111.825 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.47 -23.13 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.728 -1.232 . . . . 0.0 112.331 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.84 -45.8 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.565 1.946 . . . . 0.0 112.528 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.22 -60.22 1.68 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 0.0 113.8 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -62.93 -28.41 70.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.388 1.475 . . . . 0.0 113.607 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.29 -23.62 67.36 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.742 2.417 . . . . 0.0 114.333 177.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.96 -43.39 15.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.713 0.805 . . . . 0.0 113.163 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.24 162.57 25.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.955 0.902 . . . . 0.0 111.137 173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 59.62 -41.2 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -77.44 -30.09 53.19 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.544 1.52 . . . . 0.0 112.499 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.2 -88.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.453 2.301 . . . . 0.0 114.997 174.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.77 11.38 11.22 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.282 1.433 . . . . 0.0 113.373 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.3 t70 65.42 -30.9 0.13 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 129.583 3.153 . . . . 0.0 116.185 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -133.03 -4.85 3.1 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -169.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -84.36 -22.2 30.63 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 -166.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.271 50.2 pttt -121.51 52.62 3.34 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.55 159.09 53.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.164 2.576 . . . . 0.0 113.812 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -63.37 1.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.22 2.208 . . . . 0.0 116.869 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.7 9.73 7.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.226 1.41 . . . . 0.0 113.576 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 t -132.86 -40.84 0.94 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.742 1.217 . . . . 0.0 113.904 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -83.89 158.7 21.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.596 0.713 . . . . 0.0 112.601 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -85.0 151.15 24.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -23.93 25.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.391 1.876 . . . . 0.0 114.127 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.34 -36.13 68.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.545 1.066 . . . . 0.0 111.378 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.73 -21.66 60.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.884 0.874 . . . . 0.0 113.071 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -66.64 -24.2 66.27 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -80.32 -14.79 58.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.266 1.426 . . . . 0.0 113.146 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.71 -29.87 40.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.941 . . . . 0.0 112.248 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.37 138.16 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.591 1.956 . . . . 0.0 110.118 172.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.2 157.74 30.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.728 0.811 . . . . 0.0 112.713 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -56.06 -30.92 62.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.228 1.411 . . . . 0.0 111.577 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.6 m -62.48 -27.67 69.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.229 1.812 . . . . 0.0 113.984 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -127.45 -9.35 5.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.745 1.218 . . . . 0.0 113.896 -170.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -55.2 -40.98 88.24 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 119.543 -1.973 . . . . 0.0 112.034 168.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -62.74 -24.18 74.63 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.305 2.67 . . . . 0.0 113.848 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.9 m -78.73 -33.53 46.6 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.418 1.087 . . . . 0.0 110.455 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.87 91.53 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.0 -36.08 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.048 0.84 . . . . 0.0 110.974 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.58 56.92 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.437 1.017 . . . . 0.0 114.489 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -11.44 60.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.568 2.184 . . . . 0.0 113.788 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.99 -48.25 7.91 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.092 166.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.32 -33.36 55.56 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 113.691 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.03 94.22 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.937 1.295 . . . . 0.0 112.159 -173.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' B' ' 127' ' ' ALA . 0.6 OUTLIER -77.95 -40.51 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.65 1.18 . . . . 0.0 110.595 -175.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -63.28 -20.84 65.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.984 0.914 . . . . 0.0 113.433 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -84.21 -19.88 33.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -153.53 -124.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.251 . . . . 0.0 112.761 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -162.91 -64.13 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.071 2.148 . . . . 0.0 111.913 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -113.62 160.57 31.28 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.539 2.336 . . . . 0.0 111.196 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.41 2.59 8.29 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 114.578 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -59.17 -26.48 64.81 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.663 1.185 . . . . 0.0 112.768 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -118.7 25.69 10.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.01 1.724 . . . . 0.0 112.211 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.7 118.35 29.24 Favored 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.499 -1.376 . . . . 0.0 112.165 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.89 127.99 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.627 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -63.58 122.6 16.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.648 1.113 . . . . 0.0 110.153 -169.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -89.69 46.71 1.39 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.161 -0.962 . . . . 0.0 113.015 -168.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.369 2.5 p -63.7 -15.06 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 O-C-N 120.645 -1.285 . . . . 0.0 112.43 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.78 -44.67 70.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.695 1.598 . . . . 0.0 112.185 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.66 4.98 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -50.17 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 O-C-N 121.797 -0.825 . . . . 0.0 112.702 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.39 67.14 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.501 1.046 . . . . 0.0 112.453 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.9 m -66.19 -48.8 69.48 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.129 1.372 . . . . 0.0 112.218 171.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.2 m -87.04 -18.47 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.6 m -46.92 -63.1 1.51 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.107 1.363 . . . . 0.0 112.037 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -69.44 0.39 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.614 2.876 . . . . 0.0 114.57 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.52 -57.2 2.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.178 1.791 . . . . 0.0 110.029 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mt -68.83 -32.2 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.828 1.251 . . . . 0.0 112.369 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.79 -42.16 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.958 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -72.99 -46.9 49.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.456 0.646 . . . . 0.0 110.017 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.43 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.305 -0.872 . . . . 0.0 113.06 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.7 m -74.17 -14.26 60.93 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -34.99 16.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.36 1.436 . . . . 0.0 111.53 168.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -60.84 -38.0 83.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.16 . . . . 0.0 111.904 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -138.72 56.64 1.7 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.541 1.536 . . . . 0.0 112.318 -169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -49.97 -33.98 19.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.852 2.061 . . . . 0.0 113.121 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.6 -1.9 58.16 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.55 144.36 44.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.042 0.837 . . . . 0.0 111.827 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.76 29.37 0.2 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.287 1.835 . . . . 0.0 114.411 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 t80 52.01 -171.25 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.704 2.002 . . . . 0.0 112.814 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 tttt 62.26 -44.32 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 129.657 3.183 . . . . 0.0 115.288 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.77 -35.73 64.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.494 1.918 . . . . 0.0 111.671 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -43.59 79.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.673 0.789 . . . . 0.0 112.9 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.38 -37.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.003 0.819 . . . . 0.0 111.405 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -69.37 -48.79 60.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.242 1.017 . . . . 0.0 111.968 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.96 94.64 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.147 1.356 . . . . 0.0 113.845 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.21 -34.17 63.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.202 1.501 . . . . 0.0 112.637 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.5 -41.62 94.66 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.565 1.075 . . . . 0.0 111.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.97 -48.17 83.06 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.25 1.02 . . . . 0.0 111.393 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -28.88 70.14 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.427 -1.421 . . . . 0.0 112.346 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.2 mt -81.2 -45.2 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.956 1.303 . . . . 0.0 112.707 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -102.61 -57.78 1.99 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.953 1.301 . . . . 0.0 113.101 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -66.25 -34.61 78.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.609 1.164 . . . . 0.0 111.835 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.53 61.38 3.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.074 2.15 . . . . 0.0 112.752 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 C--O 1.255 1.367 0 C-N-CA 127.792 2.437 . . . . 0.0 113.834 -174.32 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -142.73 118.57 10.55 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 47.2 42.54 13.49 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 166.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -11.75 61.08 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.751 -1.218 . . . . 0.0 113.621 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -75.83 53.04 0.72 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.926 2.091 . . . . 0.0 111.504 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.46 54.83 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.8 64.78 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.6 104.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.694 2.398 . . . . 0.0 114.115 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . 0.297 0.0 OUTLIER 66.51 4.49 3.33 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.385 2.274 . . . . 0.0 116.676 176.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -136.12 -162.52 1.28 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.626 1.97 . . . . 0.0 111.714 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 63.95 44.79 0.53 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 127.627 2.371 . . . . 0.0 113.266 -168.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.63 166.42 29.93 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.298 2.666 . . . . 0.0 113.249 -173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 m -55.71 -25.38 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.22 -27.68 60.9 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.552 1.141 . . . . 0.0 113.097 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m -119.04 -19.28 8.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -169.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.24 160.76 29.99 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.142 0.883 . . . . 0.0 111.878 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 53.4 p -95.73 168.42 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.708 1.242 . . . . 0.0 113.871 -169.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.46 -26.7 67.32 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.293 -0.88 . . . . 0.0 112.119 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -62.74 -42.12 99.51 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.421 168.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.4 -30.4 71.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.375 0.67 . . . . 0.0 112.087 171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.417 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 66.0 t80 -69.17 -23.74 63.98 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.035 -1.041 . . . . 0.0 111.636 173.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -87.04 -8.96 56.62 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.417 1.087 . . . . 0.0 113.359 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.08 -34.99 43.13 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.187 0.995 . . . . 0.0 112.699 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.05 139.12 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.614 1.566 . . . . 0.0 110.187 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.4 158.87 32.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.368 1.067 . . . . 0.0 113.318 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.83 -32.34 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.492 1.517 . . . . 0.0 112.125 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.6 m -59.62 -29.44 68.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.727 1.611 . . . . 0.0 113.53 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -127.45 -4.38 6.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.871 1.268 . . . . 0.0 114.09 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -56.02 -41.18 89.71 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 120.168 -1.582 . . . . 0.0 113.001 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -62.76 -26.45 75.06 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.676 2.251 . . . . 0.0 113.239 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 50' ' ' LEU . 27.6 m -76.2 -35.6 59.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.526 1.13 . . . . 0.0 111.26 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.39 98.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.693 1.197 . . . . 0.0 113.645 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.63 -35.39 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.146 1.339 . . . . 0.0 109.793 168.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.88 -46.47 60.48 Favored Glycine 0 C--O 1.218 -0.89 0 C-N-CA 125.02 1.295 . . . . 0.0 114.589 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.29 -35.14 77.38 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 121.489 2.644 . . . . 0.0 112.738 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.83 70.81 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.186 -0.946 . . . . 0.0 112.45 173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -76.71 -46.48 25.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.348 1.059 . . . . 0.0 111.985 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -61.75 -51.64 67.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.478 1.511 . . . . 0.0 111.99 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -31.08 69.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.431 0.692 . . . . 0.0 111.086 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.41 -21.44 65.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.795 0.838 . . . . 0.0 113.196 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -84.43 -21.81 30.61 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.4 -124.79 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -169.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -162.98 -66.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 128.006 2.523 . . . . 0.0 110.281 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.6 164.97 13.76 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 126.714 2.005 . . . . 0.0 110.417 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -90.94 7.06 3.66 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.958 2.439 . . . . 0.0 114.001 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -63.95 -25.91 68.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.759 -1.213 . . . . 0.0 113.011 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.14 0.9 25.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.558 1.543 . . . . 0.0 114.382 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.62 131.27 44.37 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.833 -1.167 . . . . 0.0 113.563 -172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.24 129.58 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 127.051 2.14 . . . . 0.0 106.814 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.8 130.98 45.54 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.661 1.118 . . . . 0.0 112.269 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -88.98 50.29 1.93 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.958 1.303 . . . . 0.0 111.442 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.25 -38.87 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -166.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -63.84 -36.64 84.58 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.734 1.607 . . . . 0.0 111.476 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.5 41.19 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 123.95 0.786 . . . . 0.0 111.529 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.3 -42.95 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.998 0.919 . . . . 0.0 111.547 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.58 -34.94 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 112.761 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 24.7 m -64.56 -43.6 93.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.561 1.145 . . . . 0.0 111.73 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 25.2 t -80.14 -33.19 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.041 1.336 . . . . 0.0 112.995 -175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.9 m -40.5 -61.9 1.08 Allowed Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.425 1.89 . . . . 0.0 113.891 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.85 -15.23 48.17 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.493 2.129 . . . . 0.0 113.632 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.44 -61.38 1.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.219 1.008 . . . . 0.0 111.231 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.34 -25.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.957 -1.089 . . . . 0.0 113.066 177.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.84 -52.77 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.026 0.83 . . . . 0.0 110.641 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -68.88 -47.1 66.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.705 0.402 . . . . 0.0 110.894 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -29.75 70.43 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.61 -1.306 . . . . 0.0 113.008 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.94 -15.25 60.21 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -32.29 22.61 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.058 1.299 . . . . 0.0 111.238 167.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -61.39 -38.22 86.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.945 0.898 . . . . 0.0 112.121 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -145.15 70.69 1.27 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 0.0 112.224 -170.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -54.91 -42.26 71.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -76.53 -15.72 59.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -167.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.87 158.4 35.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.872 0.76 . . . . 0.0 111.926 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -69.21 143.66 53.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 169.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 35.7 t80 -58.1 -41.31 83.27 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -62.65 -33.02 74.2 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.4 -39.18 86.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.319 1.047 . . . . 0.0 111.838 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -37.86 62.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.937 0.895 . . . . 0.0 112.736 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.95 -48.33 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 119.302 0.955 . . . . 0.0 109.906 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.54 -46.83 74.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.01 0.924 . . . . 0.0 112.395 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.26 -42.23 99.72 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.26 0.934 . . . . 0.0 113.479 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -74.62 -33.61 62.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.454 1.127 . . . . 0.0 112.679 175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.73 -37.88 88.28 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.465 -1.397 . . . . 0.0 111.878 172.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -62.41 -47.59 83.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.331 1.052 . . . . 0.0 111.933 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -26.15 68.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.051 -1.03 . . . . 0.0 112.285 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 31.6 mt -79.23 -49.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.913 1.685 . . . . 0.0 112.194 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.91 -60.19 1.59 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.138 1.375 . . . . 0.0 113.523 -171.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -65.2 -26.89 68.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.751 1.62 . . . . 0.0 113.603 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.78 -20.39 63.48 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.863 1.265 . . . . 0.0 114.391 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.241 1.417 . . . . 0.0 113.287 -175.642 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.32 -12.64 27.61 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -124.93 -175.18 3.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.754 1.622 . . . . 0.0 111.638 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.383 0.4 OUTLIER 46.59 -93.31 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.93 2.092 . . . . 0.0 115.484 175.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.8 0.94 16.25 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.04 33.53 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.2 -20.41 64.84 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.04 -6.89 0.07 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.85 2.86 . . . . 0.0 117.237 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -121.58 -5.12 9.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.705 1.602 . . . . 0.0 114.04 -173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -177.87 5.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.23 1.412 . . . . 0.0 113.454 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HE3' ' CE2' ' A' ' 16' ' ' TRP . 27.1 tttp 65.39 32.46 0.1 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 128.434 2.694 . . . . 0.0 116.973 -174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.23 164.19 35.9 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.192 1.928 . . . . 0.0 113.043 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.77 -22.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.656 1.182 . . . . 0.0 113.605 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -68.57 -25.62 64.99 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.736 2.014 . . . . 0.0 113.827 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -133.25 -11.53 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.428 ' CE2' ' HE3' ' A' ' 11' ' ' LYS . 4.6 t90 -76.72 123.13 25.71 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 109.161 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -90.07 148.08 23.25 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.028 0.931 . . . . 0.0 112.935 -173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -54.96 -30.0 58.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -63.26 -42.06 99.11 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.786 1.175 . . . . 0.0 111.693 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.23 0.27 57.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.865 1.266 . . . . 0.0 112.36 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.73 -28.07 20.77 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.036 -1.04 . . . . 0.0 111.838 171.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.82 -5.54 6.18 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.154 -0.966 . . . . 0.0 112.588 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.49 -27.17 60.45 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.427 1.491 . . . . 0.0 112.021 170.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.44 135.02 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.355 1.862 . . . . 0.0 109.749 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.09 157.46 33.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.636 0.774 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.85 -27.77 63.52 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.181 1.392 . . . . 0.0 112.238 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 m -66.53 -23.16 66.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 172.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CG ' HG23 ' B' ' 141' ' ' VAL . 17.9 m-85 -124.94 -11.09 7.16 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -61.38 -38.72 55.58 Favored Pre-proline 0 N--CA 1.479 1.016 0 O-C-N 119.619 -1.925 . . . . 0.0 112.303 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.81 -26.06 74.77 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.129 2.552 . . . . 0.0 112.714 169.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.769 HG22 HD21 ' B' ' 139' ' ' LEU . 51.7 m -73.71 -36.34 65.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.651 1.18 . . . . 0.0 110.772 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.08 -49.73 74.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.218 1.007 . . . . 0.0 113.577 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 58' ' ' VAL 0.256 4.2 p -64.18 -33.77 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 118.99 0.814 . . . . 0.0 110.343 170.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.39 -52.06 34.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.405 168.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.36 -39.92 89.45 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.623 2.211 . . . . 0.0 112.599 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.97 68.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.244 -0.91 . . . . 0.0 112.69 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.69 -40.52 11.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.699 1.2 . . . . 0.0 112.385 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.34 80.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 111.859 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -26.44 60.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 0.0 111.058 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -68.27 -22.79 64.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -86.65 -24.69 25.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -154.13 -141.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.503 1.521 . . . . 0.0 111.108 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -165.11 136.23 4.01 Favored 'General case' 0 CA--C 1.546 0.801 1 C-N-CA 132.105 4.162 . . . . 0.0 108.291 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.98 163.6 0.1 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 126.772 2.029 . . . . 0.0 113.061 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -92.59 9.27 2.6 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.034 1.823 . . . . 0.0 113.807 172.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -57.26 -24.63 56.05 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 112.971 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -130.6 31.93 4.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.563 1.545 . . . . 0.0 111.996 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.02 138.78 31.22 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.002 -1.686 . . . . 0.0 113.638 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.42 134.76 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.787 2.435 . . . . 0.0 106.174 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 111.74 4.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.012 1.278 . . . . 0.0 108.941 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -85.61 53.87 2.92 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.935 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.363 2.7 p -64.0 -14.24 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 -169.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.4 -42.57 53.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.853 1.661 . . . . 0.0 111.993 166.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.85 -52.94 4.15 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.24 -48.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.364 1.065 . . . . 0.0 112.923 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.02 71.37 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.585 1.084 . . . . 0.0 112.457 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.3 m -71.57 -43.62 65.98 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.658 1.583 . . . . 0.0 112.829 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG11 HG21 ' A' ' 33' ' ' VAL . 1.6 p -79.93 -22.97 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.135 0.974 . . . . 0.0 113.623 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 m -49.26 -60.82 4.16 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 125.155 1.382 . . . . 0.0 112.945 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -66.33 -5.34 12.4 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.374 2.716 . . . . 0.0 114.465 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.4 -61.73 1.67 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.9 mt -67.41 -35.23 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.361 1.064 . . . . 0.0 112.245 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.29 -51.66 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.416 1.086 . . . . 0.0 110.384 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -73.02 -42.34 63.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.388 0.613 . . . . 0.0 110.902 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -29.69 70.65 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.351 0.66 . . . . 0.0 112.358 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.42 -17.16 64.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -35.45 16.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.216 1.371 . . . . 0.0 111.726 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.93 -38.14 84.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.893 0.877 . . . . 0.0 112.601 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -140.29 72.98 1.41 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -51.01 -31.76 19.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.659 1.983 . . . . 0.0 113.294 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -93.49 0.09 56.59 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.91 154.22 36.14 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 111.418 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -77.63 149.35 34.76 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 110.262 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.1 -37.44 82.74 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.215 -0.928 . . . . 0.0 113.261 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -60.4 -37.66 81.52 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.577 -1.327 . . . . 0.0 112.765 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.82 -39.75 94.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.438 0.695 . . . . 0.0 111.315 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -62.84 -44.02 97.24 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.32 -41.36 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.056 0.843 . . . . 0.0 110.712 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.53 -54.1 22.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.517 0.727 . . . . 0.0 112.116 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.92 -41.85 99.69 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.944 0.783 . . . . 0.0 113.108 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -28.07 57.31 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.425 -1.044 . . . . 0.0 113.275 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -65.07 -40.74 95.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.618 1.099 . . . . 0.0 111.146 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.01 -43.33 99.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.353 0.661 . . . . 0.0 111.731 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.86 -38.21 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.192 1.797 . . . . 0.0 114.226 169.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt -92.17 -37.01 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.425 1.09 . . . . 0.0 112.095 -168.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.98 -59.47 1.84 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.409 1.484 . . . . 0.0 113.565 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -66.83 -27.99 67.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.167 1.387 . . . . 0.0 113.596 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.58 -18.27 62.91 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.1 tpp . . . . . 0 C--O 1.255 1.385 0 C-N-CA 125.521 1.528 . . . . 0.0 112.579 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -150.39 125.1 9.73 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.585 0.754 . . . . 0.0 112.841 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 47.14 43.64 14.57 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 167.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -70.76 -47.63 58.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.192 -0.943 . . . . 0.0 112.426 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -150.87 47.21 0.86 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.078 1.751 . . . . 0.0 111.654 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.96 -17.47 63.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.412 1.085 . . . . 0.0 113.615 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.11 99.89 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.856 0.836 . . . . 0.0 110.975 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.77 -13.12 3.67 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.055 2.542 . . . . 0.0 114.924 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -90.68 -11.32 40.11 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.441 1.096 . . . . 0.0 113.598 171.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -101.44 149.11 24.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.756 2.022 . . . . 0.0 112.225 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 32.83 49.68 0.56 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 129.036 2.934 . . . . 0.0 115.277 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.35 152.11 38.75 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.77 1.647 . . . . 0.0 111.57 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 m -67.64 9.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.573 1.549 . . . . 0.0 114.266 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.35 5.29 8.41 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.567 1.947 . . . . 0.0 113.549 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 8.1 p -144.57 -21.67 0.53 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -87.82 -176.29 5.44 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.2 p -113.35 167.43 10.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.303 1.441 . . . . 0.0 113.912 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -20.82 28.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.01 -34.56 72.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.759 1.163 . . . . 0.0 112.44 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.5 -20.95 63.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.661 0.784 . . . . 0.0 113.099 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.66 -23.65 66.17 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.801 -1.187 . . . . 0.0 111.921 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.8 -17.62 43.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.904 1.281 . . . . 0.0 113.598 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.44 -28.82 56.75 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.93 0.892 . . . . 0.0 111.598 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.32 135.78 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.12 1.768 . . . . 0.0 110.14 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.04 158.85 30.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.008 0.923 . . . . 0.0 112.844 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.51 -35.4 60.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.833 1.253 . . . . 0.0 112.032 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 m -65.31 -22.49 66.84 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.784 1.234 . . . . 0.0 114.241 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -126.36 -5.11 6.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -58.33 -39.22 73.75 Favored Pre-proline 0 N--CA 1.478 0.936 0 O-C-N 119.689 -1.882 . . . . 0.0 113.43 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.81 -26.43 79.47 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.348 2.032 . . . . 0.0 112.984 169.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -76.96 -32.69 57.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.424 1.089 . . . . 0.0 111.715 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.57 92.36 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.879 -1.138 . . . . 0.0 113.239 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.88 -34.48 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 118.674 0.67 . . . . 0.0 110.764 169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.81 -56.84 14.23 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 124.364 0.983 . . . . 0.0 112.954 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.74 -16.92 62.38 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.748 2.274 . . . . 0.0 113.807 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.72 -28.64 18.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -109.48 -30.62 7.86 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.507 1.503 . . . . 0.0 113.419 -173.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.66 77.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.313 2.245 . . . . 0.0 112.194 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.11 -24.6 30.23 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.898 1.279 . . . . 0.0 111.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -18.15 64.7 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.04 0.836 . . . . 0.0 113.053 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -110.66 -5.12 15.1 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 -128.79 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 C-N-CA 125.189 1.396 . . . . 0.0 112.163 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -159.65 -62.08 0.07 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.516 1.926 . . . . 0.0 112.491 -169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -119.89 162.25 34.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 126.975 2.11 . . . . 0.0 110.796 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.79 5.22 6.55 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.273 1.982 . . . . 0.0 114.619 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.19 -24.89 60.64 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.889 1.276 . . . . 0.0 111.822 168.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.43 13.63 18.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.827 2.051 . . . . 0.0 112.975 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.74 22.81 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 119.78 -1.825 . . . . 0.0 112.928 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.9 107.23 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.341 1.857 . . . . 0.0 106.162 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 31' ' ' THR . 2.9 tm? -61.52 124.94 22.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.143 0.577 . . . . 0.0 109.496 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -99.21 66.79 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.477 1.035 . . . . 0.0 111.98 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . 0.404 HG23 ' CG ' ' A' ' 28' ' ' PHE . 1.8 p -64.63 -33.9 66.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.7 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.62 -39.67 84.71 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.827 1.649 . . . . 0.0 111.937 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.24 -48.22 66.03 Favored Glycine 0 N--CA 1.47 0.961 0 O-C-N 122.037 -0.414 . . . . 0.0 112.219 171.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.18 -41.42 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.626 -0.926 . . . . 0.0 112.264 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.04 71.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.432 1.469 . . . . 0.0 112.325 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 44.1 m -63.22 -43.25 98.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.677 0.791 . . . . 0.0 111.464 170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 t -84.7 -27.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.987 1.315 . . . . 0.0 113.583 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.4 m -42.2 -61.36 1.6 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 126.681 1.993 . . . . 0.0 113.536 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.64 -12.35 34.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.313 2.009 . . . . 0.0 113.916 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.9 -64.53 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.013 . . . . 0.0 110.98 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.551 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -71.16 -24.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 120.887 -1.133 . . . . 0.0 113.432 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 t -58.94 -51.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.128 0.971 . . . . 0.0 110.204 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -73.41 -47.91 38.1 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.184 0.594 . . . . 0.0 111.042 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.63 68.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.515 -1.365 . . . . 0.0 113.531 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.5 m -74.76 -21.64 59.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 169.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -30.99 33.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.202 1.365 . . . . 0.0 111.553 169.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -63.29 -38.24 90.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.846 0.858 . . . . 0.0 111.531 168.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -143.09 66.63 1.31 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.06 0.944 . . . . 0.0 112.243 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.16 -37.21 53.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.004 1.322 . . . . 0.0 112.328 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -82.38 -1.16 49.03 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.788 1.235 . . . . 0.0 113.545 -174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.47 146.44 44.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 112.094 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -65.71 149.36 50.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.749 1.22 . . . . 0.0 111.205 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -48.89 151.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.079 1.352 . . . . 0.0 112.182 169.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm 60.26 -29.97 0.05 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 128.489 2.716 . . . . 0.0 116.792 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.66 -34.28 76.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.809 1.644 . . . . 0.0 111.714 172.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.08 -37.55 78.54 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.601 -0.687 . . . . 0.0 112.367 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.96 -47.74 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 124.11 0.964 . . . . 0.0 110.034 172.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -64.68 -42.91 95.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 112.342 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.64 -41.03 99.19 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.625 1.107 . . . . 0.0 113.165 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.47 -35.45 65.7 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.111 -1.229 . . . . 0.0 112.934 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -62.24 -37.72 86.51 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.988 -1.07 . . . . 0.0 112.037 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.5 -46.29 90.68 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 0.0 111.812 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -20.0 65.99 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.946 -1.096 . . . . 0.0 112.789 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 26.3 mt -86.46 -47.02 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.552 1.941 . . . . 0.0 112.396 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -104.73 -59.77 1.7 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.215 1.406 . . . . 0.0 113.348 -173.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -64.74 -28.31 69.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.542 1.537 . . . . 0.0 113.323 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.35 -11.68 59.93 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.213 1.405 . . . . 0.0 114.257 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 C--O 1.255 1.366 0 C-N-CA 125.201 1.4 . . . . 0.0 113.122 -175.195 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -143.94 131.42 21.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.235 1.014 . . . . 0.0 111.617 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.58 20.23 10.09 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 115.466 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 61.02 -175.3 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.007 2.123 . . . . 0.0 114.831 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -75.82 158.8 31.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.271 0.628 . . . . 0.0 110.358 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.85 99.9 0.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -167.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.9 169.2 9.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 110.082 167.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 62.93 -57.58 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.73 2.412 . . . . 0.0 112.155 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -84.65 61.07 6.49 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -46.54 121.51 3.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.8 2.44 . . . . 0.0 116.138 -166.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -130.83 55.43 18.97 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 127.083 2.153 . . . . 0.0 110.697 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -61.64 163.33 18.68 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.252 3.301 . . . . 0.0 113.727 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.25 -19.19 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.663 1.585 . . . . 0.0 114.874 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -95.29 -15.95 22.78 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.9 p -109.56 -32.73 7.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.984 1.265 . . . . 0.0 114.146 -172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -88.6 -179.96 6.15 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.771 0.829 . . . . 0.0 113.152 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.9 p -105.62 160.42 15.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.436 1.494 . . . . 0.0 114.352 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -25.29 60.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.527 1.931 . . . . 0.0 115.239 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.84 -35.31 66.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.582 1.083 . . . . 0.0 111.463 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.07 -18.12 60.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.266 1.026 . . . . 0.0 113.54 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -65.93 -29.3 69.69 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.808 -1.182 . . . . 0.0 110.573 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.91 -18.45 58.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.638 1.575 . . . . 0.0 113.082 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.36 -27.73 38.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.482 1.113 . . . . 0.0 112.006 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.8 137.62 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.843 1.657 . . . . 0.0 108.906 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -65.69 154.89 37.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.882 0.873 . . . . 0.0 112.536 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.11 -35.32 73.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.429 1.092 . . . . 0.0 111.777 -174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.4 m -61.65 -25.13 67.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.902 1.681 . . . . 0.0 113.713 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.98 -2.8 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.055 -173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -57.56 -43.73 99.08 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 119.906 -1.746 . . . . 0.0 112.148 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -62.69 -25.21 75.01 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.871 2.381 . . . . 0.0 113.92 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 HD13 ' B' ' 144' ' ' ILE . 89.5 m -75.8 -34.2 60.16 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.029 0.931 . . . . 0.0 110.702 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.768 1.227 . . . . 0.0 113.587 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.18 -33.16 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.079 0.854 . . . . 0.0 110.931 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.49 -51.1 50.13 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 124.973 1.273 . . . . 0.0 113.755 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 144' ' ' ILE . 3.2 m-85 -69.13 -23.51 63.99 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.283 2.542 . . . . 0.0 113.339 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 -61.48 1.79 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.325 -0.86 . . . . 0.0 109.296 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -73.66 -29.78 62.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.392 -1.443 . . . . 0.0 114.739 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' B' ' 124' ' ' PHE . . . -64.11 -41.39 97.28 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.03 -1.044 . . . . 0.0 110.933 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.434 HD13 HD13 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -83.39 -38.52 21.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.456 1.102 . . . . 0.0 110.329 -178.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -64.3 -33.52 76.02 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.571 1.148 . . . . 0.0 113.483 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -80.66 -13.77 58.73 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -155.25 -136.1 0.05 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.995 1.718 . . . . 0.0 110.769 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -172.18 127.08 0.56 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 130.532 3.533 . . . . 0.0 108.879 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 mttt 60.58 166.35 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.033 0 C-N-CA 125.787 1.635 . . . . 0.0 113.845 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -88.16 15.18 2.16 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.033 1.822 . . . . 0.0 114.846 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.77 -30.41 70.01 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.863 -1.148 . . . . 0.0 112.203 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -116.54 27.52 9.15 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.57 1.948 . . . . 0.0 112.167 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 107.75 14.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.915 -1.74 . . . . 0.0 111.763 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.54 118.37 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.685 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? -67.4 117.15 8.98 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.173 0.897 . . . . 0.0 112.406 -167.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -89.72 53.16 2.49 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.404 -1.435 . . . . 0.0 111.608 -172.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.323 1.2 p -60.75 -41.33 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -167.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' B' ' 93' ' ' GLN . 43.7 tp60 -63.23 -38.51 91.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.583 1.538 . . . . 0.0 112.305 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -54.09 39.85 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -43.45 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.492 -1.005 . . . . 0.0 112.164 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.29 67.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.709 1.203 . . . . 0.0 112.804 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -71.25 -45.13 63.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.251 1.421 . . . . 0.0 111.885 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 62' ' ' ILE . 2.2 t -86.53 -19.66 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.1 m -45.64 -61.91 2.11 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 125.123 1.369 . . . . 0.0 112.415 173.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.47 -3.66 12.92 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.599 2.866 . . . . 0.0 114.178 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.8 -64.45 1.17 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.899 1.28 . . . . 0.0 108.984 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 58' ' ' VAL . 21.8 mt -67.78 -34.67 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.959 0.904 . . . . 0.0 111.977 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.57 -49.69 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.88 0.872 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.13 -45.92 58.62 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.77 -28.72 69.77 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.291 -0.88 . . . . 0.0 113.183 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.0 m -75.26 -13.31 60.43 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.47 -34.99 16.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.469 1.486 . . . . 0.0 111.178 167.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -60.63 -38.27 84.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.82 170.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -138.18 52.94 1.82 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.15 1.38 . . . . 0.0 112.68 -168.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -48.51 -35.8 13.92 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.731 2.013 . . . . 0.0 113.259 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -88.49 -6.99 57.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.592 1.157 . . . . 0.0 113.755 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.78 161.58 27.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.044 0.938 . . . . 0.0 112.023 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.16 139.11 57.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 112.234 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -62.5 -53.1 59.78 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.841 . . . . 0.0 112.844 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -71.96 -32.67 67.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.693 -1.254 . . . . 0.0 112.853 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -64.98 -27.38 68.8 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.106 -0.996 . . . . 0.0 112.383 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -70.31 -37.37 74.75 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.504 1.047 . . . . 0.0 113.041 171.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.97 -38.24 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.771 1.169 . . . . 0.0 111.327 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -61.02 -48.33 82.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.055 0.942 . . . . 0.0 111.509 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.02 98.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.981 1.277 . . . . 0.0 113.649 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.8 -36.47 67.57 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.757 1.278 . . . . 0.0 112.651 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -60.62 -39.97 90.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.562 1.073 . . . . 0.0 111.631 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.04 -44.51 96.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.463 1.105 . . . . 0.0 111.931 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -26.45 68.59 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.962 -1.086 . . . . 0.0 112.352 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.251 10.1 mt -84.44 -43.08 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.892 1.277 . . . . 0.0 112.564 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -106.31 -61.46 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.286 1.434 . . . . 0.0 113.514 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -64.4 -25.71 68.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.907 1.683 . . . . 0.0 113.78 -171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.77 -24.66 67.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.508 1.123 . . . . 0.0 113.907 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 C--O 1.253 1.273 0 C-N-CA 127.734 2.413 . . . . 0.0 114.147 177.572 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.405 0.145 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.83 -29.85 26.97 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -111.77 24.92 12.16 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -139.18 -151.48 0.38 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.7 1.2 . . . . 0.0 112.251 177.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -52.17 -20.01 2.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.686 2.394 . . . . 0.0 116.301 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 61.75 -23.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 61.49 -19.83 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.957 2.503 . . . . 0.0 117.554 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.41 -26.13 68.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.681 1.192 . . . . 0.0 112.331 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -77.38 -12.48 59.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.005 1.722 . . . . 0.0 113.921 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt 42.01 68.2 0.49 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 128.001 2.52 . . . . 0.0 113.289 -170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.28 58.69 0.69 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 126.237 1.815 . . . . 0.0 112.727 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.48 166.99 15.92 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.652 2.901 . . . . 0.0 114.175 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 m -55.39 -24.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.887 1.675 . . . . 0.0 114.242 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.98 -10.39 53.29 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.3 p -121.85 -29.74 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -86.94 172.36 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.4 p -92.67 160.91 14.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -24.0 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.38 -37.54 70.23 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.853 -1.155 . . . . 0.0 111.505 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.14 -28.43 69.64 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.981 0.912 . . . . 0.0 112.973 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.27 -27.16 69.15 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.113 -0.992 . . . . 0.0 111.152 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.2 mt -84.49 -10.71 57.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.802 1.241 . . . . 0.0 113.104 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.96 -29.38 22.09 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.959 1.303 . . . . 0.0 112.371 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.4 140.05 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.998 1.719 . . . . 0.0 110.242 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.6 159.39 32.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.271 1.029 . . . . 0.0 113.067 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.93 -33.89 71.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.086 1.354 . . . . 0.0 111.951 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m -66.18 -21.18 66.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.666 1.587 . . . . 0.0 114.007 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -126.73 -8.85 6.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.39 1.076 . . . . 0.0 113.308 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -56.81 -43.31 99.32 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 120.06 -1.65 . . . . 0.0 112.536 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -64.65 -25.0 61.99 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.688 2.259 . . . . 0.0 113.151 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.685 HG22 HD21 ' A' ' 50' ' ' LEU . 18.4 m -72.96 -32.37 65.17 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 111.218 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -45.77 89.42 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 170.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.98 -33.73 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.683 1.583 . . . . 0.0 110.043 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.76 7.6 2.12 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 126.57 2.033 . . . . 0.0 116.008 168.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 2.4 m-85 -121.48 -12.32 8.58 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.58 1.69 . . . . 0.0 112.852 169.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -96.17 -69.24 0.76 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.452 1.023 . . . . 0.0 110.77 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.74 -32.33 72.86 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.895 -1.128 . . . . 0.0 111.492 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.58 -35.88 68.72 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.472 1.109 . . . . 0.0 113.169 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.434 HD13 HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -83.96 -42.56 16.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.186 0.994 . . . . 0.0 109.319 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.04 -39.3 74.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 0.0 113.834 -173.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -92.44 -8.28 45.17 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -9.6 0.19 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -171.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . 0.326 3.8 p30 55.28 -34.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 121.437 3.866 . . . . 0.0 121.437 170.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -137.6 153.76 74.49 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 126.941 2.096 . . . . 0.0 110.648 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.84 -1.12 8.78 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 121.685 1.637 . . . . 0.0 114.67 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.29 -13.49 60.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.779 1.232 . . . . 0.0 112.87 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -127.78 8.25 6.29 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.133 1.373 . . . . 0.0 113.93 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.0 130.52 36.6 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.304 -1.497 . . . . 0.0 114.51 -170.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 20.6 t -117.28 135.35 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.759 2.024 . . . . 0.0 106.852 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 31' ' ' THR . 2.3 tm? -75.7 127.26 32.66 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.503 1.047 . . . . 0.0 111.446 -169.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -89.75 52.56 2.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.532 1.533 . . . . 0.0 111.939 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.378 1.7 p -67.29 -44.69 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -64.32 -36.94 85.75 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 123.075 2.671 . . . . 0.0 111.164 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.49 -47.34 88.11 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.642 HD13 HG21 ' A' ' 31' ' ' THR . 22.9 mt -56.46 -48.62 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.295 1.438 . . . . 0.0 111.618 171.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.6 81.45 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.531 1.059 . . . . 0.0 112.22 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 52.1 m -67.05 -42.29 85.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.937 1.295 . . . . 0.0 111.811 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.99 -24.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.498 1.519 . . . . 0.0 113.04 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -43.71 -61.02 2.14 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 126.748 2.019 . . . . 0.0 113.588 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.24 -14.16 43.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.537 2.158 . . . . 0.0 113.638 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' B' ' 170' ' ' GLU . . . -74.86 -56.37 4.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.105 0.962 . . . . 0.0 111.416 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -25.36 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.925 -1.109 . . . . 0.0 113.436 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.1 t -57.62 -51.36 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.824 0.85 . . . . 0.0 110.265 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 -46.86 34.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.429 0.692 . . . . 0.0 111.151 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.62 69.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.608 -1.308 . . . . 0.0 113.152 -171.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.3 m -77.09 -11.31 59.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.48 -31.63 18.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.074 1.306 . . . . 0.0 111.192 167.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -59.34 -38.73 81.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.199 1.0 . . . . 0.0 112.47 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -145.17 85.54 1.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.718 0.77 . . . . 0.0 112.095 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -62.53 -39.32 93.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.463 1.505 . . . . 0.0 112.406 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.89 -10.2 59.74 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.23 141.93 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.784 0.834 . . . . 0.0 112.828 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.1 40.39 0.98 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.392 2.277 . . . . 0.0 111.298 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -106.81 117.75 34.87 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -163.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -76.84 -26.42 54.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.015 1.326 . . . . 0.0 109.428 162.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.91 -23.16 63.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.376 1.471 . . . . 0.0 112.707 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -63.08 -40.32 97.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.779 0.832 . . . . 0.0 111.809 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -39.93 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.812 0.845 . . . . 0.0 110.69 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -65.41 -38.78 90.96 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.672 0.789 . . . . 0.0 112.112 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.95 99.75 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.986 1.279 . . . . 0.0 112.783 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . 0.453 ' HB3' ' HB1' ' B' ' 150' ' ' ALA . 25.7 mm-40 -71.35 -36.1 71.38 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.688 1.244 . . . . 0.0 113.075 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.93 -42.08 93.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.736 1.153 . . . . 0.0 111.594 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -49.63 76.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.088 1.355 . . . . 0.0 110.937 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -27.53 68.92 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.731 -1.231 . . . . 0.0 112.072 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -80.23 -47.41 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.957 1.703 . . . . 0.0 113.027 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -100.46 -55.53 2.58 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.749 1.22 . . . . 0.0 112.932 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -70.24 -34.38 72.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.108 1.363 . . . . 0.0 111.547 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.62 46.69 25.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.348 2.259 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 C--O 1.255 1.379 0 C-N-CA 125.513 1.525 . . . . 0.0 113.137 179.085 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -109.77 -26.16 9.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.27 -64.19 1.19 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -170.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -102.14 -55.35 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.697 0.68 . . . . 0.0 111.539 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -91.34 63.22 4.86 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.85 1.66 . . . . 0.0 108.707 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.58 -18.31 60.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.773 2.029 . . . . 0.0 115.3 -168.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.55 -3.46 55.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 56.22 18.91 3.54 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.636 1.575 . . . . 0.0 113.936 -168.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -163.62 -146.8 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.781 2.432 . . . . 0.0 107.523 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt 66.3 -43.83 0.4 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 129.099 2.96 . . . . 0.0 118.425 168.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -121.12 53.99 3.84 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.055 1.342 . . . . 0.0 112.632 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.09 157.99 30.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.697 2.931 . . . . 0.0 112.795 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -65.97 -15.68 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.814 1.245 . . . . 0.0 113.241 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -93.86 10.75 31.96 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.182 1.793 . . . . 0.0 113.176 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -151.04 -42.07 0.12 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -83.97 148.8 26.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.34 1.066 . . . . 0.0 113.561 -169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.6 p -77.75 172.79 12.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.967 1.707 . . . . 0.0 113.653 -168.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -18.46 8.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.824 1.786 . . . . 0.0 115.824 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.4 -39.1 78.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.273 1.397 . . . . 0.0 110.751 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.55 -22.88 66.15 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.01 -1.057 . . . . 0.0 112.968 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.38 -1.87 32.21 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.699 -0.626 . . . . 0.0 112.507 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.4 mt -110.93 -24.7 10.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.546 1.539 . . . . 0.0 112.615 168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.66 67.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.128 0.971 . . . . 0.0 112.15 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.76 141.6 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.522 1.929 . . . . 0.0 110.655 169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.55 157.51 32.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.489 0.715 . . . . 0.0 112.555 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -54.61 -34.28 61.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.101 1.361 . . . . 0.0 111.981 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 m -64.48 -23.14 67.18 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -125.79 -4.1 7.07 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.738 1.215 . . . . 0.0 112.895 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -60.88 -43.85 92.87 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 119.568 -1.957 . . . . 0.0 112.591 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.05 -18.08 60.9 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.495 2.13 . . . . 0.0 113.241 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -78.82 -34.4 45.3 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 124.678 1.191 . . . . 0.0 111.653 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -62.99 -41.81 99.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.193 . . . . 0.0 111.852 168.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.14 -47.37 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.975 0.91 . . . . 0.0 108.898 169.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.56 -49.49 60.78 Favored Glycine 0 C--O 1.209 -1.428 0 C-N-CA 124.996 1.284 . . . . 0.0 113.582 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -69.42 -11.82 61.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 122.109 2.955 . . . . 0.0 114.205 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.28 -49.88 5.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.582 0.753 . . . . 0.0 110.505 166.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -73.34 -30.67 63.49 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.23 -0.919 . . . . 0.0 113.049 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.54 89.15 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 119.497 -2.002 . . . . 0.0 111.479 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.544 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -84.14 -13.69 52.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.026 1.33 . . . . 0.0 111.652 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 -22.28 60.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.003 1.321 . . . . 0.0 113.012 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 -2.68 13.2 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.84 158.57 0.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.978 3.311 . . . . 0.0 106.399 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.89 -27.91 16.81 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 128.091 2.556 . . . . 0.0 114.249 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.42 156.41 79.74 Favored Pre-proline 0 N--CA 1.484 1.233 0 C-N-CA 126.701 2.001 . . . . 0.0 110.964 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.94 6.83 5.51 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.054 1.836 . . . . 0.0 114.529 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.08 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.688 -1.258 . . . . 0.0 111.936 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.24 2.36 28.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.227 1.811 . . . . 0.0 113.168 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.74 123.46 27.71 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 119.765 -1.835 . . . . 0.0 112.45 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.48 -2.85 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 125.455 1.502 . . . . 0.0 111.972 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.724 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 61.78 119.08 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.403 3.081 . . . . 0.0 112.752 -172.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -93.1 55.43 2.33 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.224 -1.547 . . . . 0.0 112.095 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.322 2.5 p -69.54 -22.02 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.711 -1.243 . . . . 0.0 113.827 -169.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -58.02 -45.74 86.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.928 1.24 . . . . 0.0 111.21 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.46 -49.87 8.8 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.16 -44.43 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.893 0.877 . . . . 0.0 111.81 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.0 66.51 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.511 1.505 . . . . 0.0 112.773 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -70.99 -37.48 72.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.873 1.269 . . . . 0.0 111.586 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.4 t -90.4 -21.7 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.405 1.482 . . . . 0.0 113.417 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.4 m -46.86 -59.72 4.85 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 125.998 1.719 . . . . 0.0 112.819 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.97 0.52 4.94 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.157 2.572 . . . . 0.0 114.206 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -88.74 -64.31 1.17 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.389 1.476 . . . . 0.0 110.441 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.29 -29.31 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.907 -1.121 . . . . 0.0 113.2 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.32 -47.33 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.693 0.797 . . . . 0.0 110.459 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -77.13 -47.34 20.69 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.435 0.636 . . . . 0.0 110.866 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.99 71.45 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.2 m -76.01 -13.62 60.23 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.205 -0.935 . . . . 0.0 113.48 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.3 -29.05 21.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.849 1.204 . . . . 0.0 111.282 168.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -59.4 -38.29 80.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.453 0.701 . . . . 0.0 111.993 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.35 90.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 112.429 170.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -55.81 -36.02 66.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.145 1.378 . . . . 0.0 111.367 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -86.99 3.58 45.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.085 1.354 . . . . 0.0 113.375 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.92 151.5 21.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.983 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -59.37 139.25 57.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.788 1.235 . . . . 0.0 111.472 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -56.07 145.14 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.054 1.342 . . . . 0.0 113.401 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 59.06 -24.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.974 2.91 . . . . 0.0 116.916 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.78 -31.13 70.51 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.875 1.67 . . . . 0.0 111.627 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -68.7 -37.03 79.21 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.76 -47.15 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.41 1.084 . . . . 0.0 109.833 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.45 -42.6 98.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.868 0.867 . . . . 0.0 112.358 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.81 -45.62 95.34 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.216 1.389 . . . . 0.0 113.257 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 25.7 mm-40 -72.11 -35.52 69.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.461 1.131 . . . . 0.0 113.16 174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -59.84 -40.55 88.89 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.018 -1.051 . . . . 0.0 111.429 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -61.78 -45.1 95.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.72 1.208 . . . . 0.0 111.743 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -24.59 67.93 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.135 -0.978 . . . . 0.0 112.623 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.258 5.5 mt -89.33 -42.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.111 1.364 . . . . 0.0 112.729 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -106.37 -59.87 1.73 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.463 1.505 . . . . 0.0 113.084 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -66.22 -24.12 66.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.842 1.657 . . . . 0.0 113.762 -170.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.23 -23.22 66.54 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.312 1.445 . . . . 0.0 113.457 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 174.716 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 119.944 -0.074 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -138.0 60.84 1.61 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.756 0.822 . . . . 0.0 112.973 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.28 53.28 12.65 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.15 -24.31 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -95.68 21.5 8.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.085 1.754 . . . . 0.0 114.814 -177.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.24 64.0 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.53 63.13 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 171.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 60.01 -13.61 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 129.474 3.109 . . . . 0.0 117.051 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -122.36 -11.8 8.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.735 1.614 . . . . 0.0 113.622 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -146.55 -167.02 2.64 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 57.93 34.48 0.23 Allowed Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 128.455 2.702 . . . . 0.0 114.321 -167.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -75.56 159.25 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.061 1.841 . . . . 0.0 112.534 -169.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.26 -25.95 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 125.621 1.568 . . . . 0.0 114.75 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -79.11 -16.76 56.24 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 18.1 m -128.28 -22.29 3.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -86.95 166.26 15.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.447 1.099 . . . . 0.0 112.598 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 51.5 p -96.46 158.6 15.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.2 -24.56 67.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.32 1.448 . . . . 0.0 114.437 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.66 -37.78 73.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.812 1.187 . . . . 0.0 111.213 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.12 -30.56 71.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.268 1.027 . . . . 0.0 112.786 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -67.02 -23.73 65.94 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.175 -0.953 . . . . 0.0 111.67 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 49.6 mt -80.71 -15.77 55.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.504 1.122 . . . . 0.0 113.178 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.06 -28.85 43.2 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.121 0.968 . . . . 0.0 112.172 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.68 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.916 1.686 . . . . 0.0 110.191 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.39 158.62 33.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.0 112.856 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -53.88 -34.17 58.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.098 1.359 . . . . 0.0 112.368 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 33.5 m -65.95 -22.36 66.48 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.699 1.199 . . . . 0.0 114.107 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.08 -8.16 5.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.556 1.142 . . . . 0.0 113.509 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -57.77 -44.57 99.53 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 119.785 -1.822 . . . . 0.0 112.2 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.29 -27.43 77.99 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.693 2.262 . . . . 0.0 113.254 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.724 HG22 HD21 ' A' ' 50' ' ' LEU . 65.5 m -72.87 -38.92 66.83 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 0.0 110.962 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.4 94.07 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.334 1.453 . . . . 0.0 114.147 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.83 -32.69 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 119.432 1.014 . . . . 0.0 110.75 169.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.48 -55.11 21.31 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 125.301 1.429 . . . . 0.0 113.667 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -61.86 -35.73 79.14 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.561 2.181 . . . . 0.0 112.178 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.92 65.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -104.95 -31.44 9.23 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.1 99.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.34 1.456 . . . . 0.0 111.319 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.544 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -76.86 -32.02 57.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.942 0.897 . . . . 0.0 110.93 -178.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -65.12 -27.51 68.8 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -98.01 -8.61 27.55 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 -132.62 0.07 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.961 1.705 . . . . 0.0 110.478 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -156.79 -55.75 0.08 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.268 2.227 . . . . 0.0 112.276 -173.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -120.21 168.09 11.2 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 127.179 2.192 . . . . 0.0 110.194 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.78 10.37 3.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.108 1.872 . . . . 0.0 114.308 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.99 -25.92 67.22 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.782 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -118.5 25.18 10.45 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.734 2.014 . . . . 0.0 113.366 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.96 34.88 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.586 -1.322 . . . . 0.0 112.702 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.96 -13.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.284 1.034 . . . . 0.0 113.52 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 65.6 107.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.48 2.312 . . . . 0.0 110.648 -168.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.68 62.96 7.3 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.734 -1.229 . . . . 0.0 110.804 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.35 1.6 p -66.69 -25.14 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.148 -0.929 . . . . 0.0 113.334 -168.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.28 -50.75 72.49 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.807 1.64 . . . . 0.0 111.6 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.54 80.09 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mt -62.86 -45.26 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.049 0.94 . . . . 0.0 112.036 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.48 -32.34 72.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 120.628 1.558 . . . . 0.0 112.475 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 42.8 m -64.55 -44.21 91.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.832 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.417 HG12 ' CD1' ' B' ' 151' ' ' ILE . 28.5 t -82.67 -29.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.953 1.301 . . . . 0.0 113.161 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.7 m -41.04 -62.51 1.0 Allowed Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 126.532 1.933 . . . . 0.0 114.018 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.99 -22.47 73.81 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.18 1.92 . . . . 0.0 112.931 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.57 -58.03 4.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.4 1.08 . . . . 0.0 111.33 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.485 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.07 -24.58 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.086 -1.009 . . . . 0.0 112.895 174.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.11 -52.1 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.466 1.03 . . . . 0.0 110.629 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -72.16 -47.16 52.93 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.586 0.232 . . . . 0.0 111.131 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.19 72.2 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.666 -1.271 . . . . 0.0 113.316 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.6 -13.44 61.38 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.67 -34.66 16.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.247 1.385 . . . . 0.0 111.212 167.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.56 -43.15 97.58 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.26 0.624 . . . . 0.0 111.657 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -134.96 63.93 1.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.529 1.531 . . . . 0.0 111.093 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -51.34 -32.88 27.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.611 -1.305 . . . . 0.0 112.452 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -87.74 -3.12 58.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.099 1.36 . . . . 0.0 113.562 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 155.06 39.83 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.074 0.95 . . . . 0.0 111.599 172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -66.84 135.55 54.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.565 1.146 . . . . 0.0 109.64 169.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -64.79 -51.7 60.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -67.81 -29.28 68.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 120.47 1.486 . . . . 0.0 112.521 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.58 -37.37 83.62 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.643 -0.661 . . . . 0.0 111.739 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -71.87 -35.34 69.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.477 -0.764 . . . . 0.0 112.914 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.15 -46.46 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.455 1.025 . . . . 0.0 109.926 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -65.44 -43.55 90.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.282 1.033 . . . . 0.0 112.475 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.17 -41.07 99.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.299 0.952 . . . . 0.0 113.246 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.71 -34.18 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.234 -1.156 . . . . 0.0 112.654 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -58.12 -41.98 84.8 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.753 1.615 . . . . 0.0 111.919 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.08 -50.79 72.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.862 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -29.15 70.6 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.896 -1.128 . . . . 0.0 112.256 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 30.7 mt -76.37 -49.5 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.229 1.811 . . . . 0.0 112.448 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.99 -55.76 2.62 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.132 1.373 . . . . 0.0 112.769 -170.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -69.92 -35.16 74.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.772 1.229 . . . . 0.0 111.431 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.62 47.73 23.79 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.863 2.065 . . . . 0.0 113.147 174.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 35.6 mmt . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.636 1.574 . . . . 0.0 112.88 176.66 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 111.306 0.113 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -140.85 55.57 1.57 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.49 38.46 29.75 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -58.42 -24.31 59.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -78.51 -9.3 59.28 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.6 -21.59 66.44 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.31 65.72 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.2 t70 57.55 -10.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 129.056 2.942 . . . . 0.0 117.571 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.54 -10.47 6.24 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.048 1.339 . . . . 0.0 114.596 -169.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 170.07 18.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -173.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 29.7 ttpt 51.15 46.18 3.45 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 129.614 3.166 . . . . 0.0 115.482 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.44 168.87 15.25 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 112.435 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.17 -17.72 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -71.74 -29.92 65.04 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 112.396 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 -32.47 9.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 114.008 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.44 148.68 50.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.159 0.98 . . . . 0.0 111.526 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.6 p -97.31 167.44 11.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.028 1.394 . . . . 0.0 114.167 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.4 m -66.06 -24.21 66.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.805 -1.089 . . . . 0.0 112.948 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.88 -44.82 91.89 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.65 1.114 . . . . 0.0 110.249 169.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.79 -29.43 69.43 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.919 -0.488 . . . . 0.0 111.601 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -72.32 -11.88 60.9 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.983 -1.073 . . . . 0.0 113.336 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.54 -2.19 45.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.253 1.021 . . . . 0.0 112.48 170.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.81 -34.08 17.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.725 1.21 . . . . 0.0 112.352 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.35 138.84 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.31 1.844 . . . . 0.0 111.136 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.4 156.27 39.09 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 113.062 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.52 -35.03 38.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.834 1.254 . . . . 0.0 112.817 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 t -65.6 -26.37 67.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.369 1.068 . . . . 0.0 113.432 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -123.14 -0.66 8.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.228 1.411 . . . . 0.0 113.312 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -59.18 -46.42 99.26 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 119.574 -1.954 . . . . 0.0 111.424 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.35 -17.77 55.11 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.427 2.085 . . . . 0.0 114.412 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.522 HG22 HD21 ' B' ' 139' ' ' LEU . 37.6 m -67.71 -40.31 84.29 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 110.527 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -48.55 75.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.448 1.099 . . . . 0.0 113.866 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.55 -34.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.753 0.706 . . . . 0.0 109.989 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -57.89 15.11 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.644 -1.087 . . . . 0.0 112.919 168.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.73 -43.47 98.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.367 2.084 . . . . 0.0 112.411 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.7 -26.71 66.31 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -98.49 -35.75 10.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 113.159 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.02 71.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.041 1.336 . . . . 0.0 111.745 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.35 -24.88 61.35 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.884 -0.51 . . . . 0.0 110.954 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -24.42 57.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.73 0.812 . . . . 0.0 112.898 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.96 -7.17 25.49 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.77 -130.62 0.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.13 1.772 . . . . 0.0 110.342 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.61 -44.06 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.232 2.213 . . . . 0.0 112.245 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -123.62 164.95 25.46 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 127.966 2.507 . . . . 0.0 110.148 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.33 13.02 2.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.324 2.016 . . . . 0.0 114.185 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.98 -27.43 66.84 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.806 -1.184 . . . . 0.0 112.926 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.73 18.56 14.86 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.268 1.427 . . . . 0.0 114.196 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 129.7 40.62 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.851 -1.156 . . . . 0.0 112.607 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.52 -11.67 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 124.775 1.23 . . . . 0.0 113.271 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 62.77 114.96 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.787 2.435 . . . . 0.0 110.555 -167.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -82.85 51.87 2.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.403 -1.435 . . . . 0.0 110.74 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.422 2.7 p -69.04 -28.37 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.12 -39.37 82.08 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.332 1.878 . . . . 0.0 111.389 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.2 -51.24 10.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.369 0.985 . . . . 0.0 112.102 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -40.36 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.179 0.992 . . . . 0.0 111.987 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.43 71.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.19 1.359 . . . . 0.0 112.652 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -68.27 -40.98 81.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.751 1.22 . . . . 0.0 111.492 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 62' ' ' ILE . 36.7 t -81.66 -31.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.202 1.401 . . . . 0.0 113.617 -176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -41.78 -59.92 2.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 125.798 1.639 . . . . 0.0 114.47 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.42 -24.23 75.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.96 1.773 . . . . 0.0 113.204 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -61.29 -61.56 2.46 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.426 1.49 . . . . 0.0 110.571 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.67 -31.95 53.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 t -59.47 -51.85 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.805 1.242 . . . . 0.0 110.466 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.08 -49.96 45.77 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.066 0.46 . . . . 0.0 110.872 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.93 -31.86 70.24 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.829 0.852 . . . . 0.0 112.727 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.9 m -72.9 -17.05 61.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.52 -30.34 20.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.677 1.191 . . . . 0.0 111.233 168.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -64.0 -38.26 90.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.126 0.97 . . . . 0.0 112.405 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -145.3 85.09 1.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.818 1.247 . . . . 0.0 111.574 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.76 -39.78 71.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.223 1.409 . . . . 0.0 112.209 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.11 -11.99 59.99 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.22 152.5 44.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.005 0.922 . . . . 0.0 112.162 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -73.35 144.81 46.35 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.8 -44.32 90.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -67.11 -32.02 72.88 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.783 -1.198 . . . . 0.0 113.011 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.48 -40.42 86.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.969 0.908 . . . . 0.0 111.152 168.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 117.747 -1.12 . . . . 0.0 112.888 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -41.4 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.607 1.549 . . . . 0.0 111.334 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -64.21 -48.48 75.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.719 0.808 . . . . 0.0 111.676 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.41 99.72 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.36 0.981 . . . . 0.0 113.099 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.492 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 26.0 mm-40 -74.26 -35.63 63.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.605 1.202 . . . . 0.0 113.196 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -59.56 -40.21 86.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.005 1.275 . . . . 0.0 111.486 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.47 -45.51 93.94 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.21 1.004 . . . . 0.0 111.742 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -23.5 67.34 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.969 -1.082 . . . . 0.0 112.655 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -88.42 -40.15 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.841 1.256 . . . . 0.0 113.065 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.41 -57.9 2.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.486 1.514 . . . . 0.0 113.728 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -68.47 -29.24 67.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.693 1.597 . . . . 0.0 113.467 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.73 -52.01 14.63 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.091 1.756 . . . . 0.0 111.491 178.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -106.37 -40.86 5.47 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 162.01 29.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.755 0.822 . . . . 0.0 111.418 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.33 0.0 OUTLIER 46.05 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 131.017 3.727 . . . . 0.0 119.66 -170.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -85.03 -13.6 49.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.306 1.842 . . . . 0.0 112.37 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 53.7 -51.27 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 1 C-N-CA 132.365 4.266 . . . . 0.0 117.908 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.439 ' HB3' ' HG2' ' B' ' 99' ' ' LYS . . . -125.02 24.94 7.42 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.661 1.584 . . . . 0.0 112.153 171.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 31.3 t70 70.86 -18.38 0.26 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.182 2.593 . . . . 0.0 114.673 -173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -124.8 5.32 8.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.634 1.573 . . . . 0.0 115.173 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' B' ' 96' ' ' ALA . 75.1 mmtt -91.38 144.83 25.18 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.091 1.314 . . . . 0.0 112.799 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 50.85 53.68 14.26 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 126.972 2.109 . . . . 0.0 114.223 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.89 165.4 26.15 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.984 2.456 . . . . 0.0 111.921 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 m -66.01 -4.82 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.668 1.587 . . . . 0.0 114.558 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -112.93 21.37 15.51 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.234 1.813 . . . . 0.0 112.934 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -143.82 -49.48 0.3 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -93.71 147.08 23.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.922 0.783 . . . . 0.0 112.207 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p -70.92 173.36 7.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.368 1.867 . . . . 0.0 113.965 -171.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -49.91 -20.56 0.93 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.66 -40.27 39.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.62 -30.63 69.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.144 0.978 . . . . 0.0 112.619 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -70.96 -17.65 62.66 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.511 -0.743 . . . . 0.0 111.967 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.92 -18.49 23.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.188 0.995 . . . . 0.0 112.911 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.85 62.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.278 1.031 . . . . 0.0 112.436 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.72 138.9 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.814 2.046 . . . . 0.0 111.119 171.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.67 159.13 32.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.477 1.111 . . . . 0.0 113.223 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.09 -33.64 58.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.353 1.461 . . . . 0.0 111.809 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.0 m -59.17 -27.46 65.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.114 1.765 . . . . 0.0 113.817 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.58 -3.95 5.99 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.392 1.477 . . . . 0.0 113.307 -171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -56.96 -44.85 99.94 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.241 -1.537 . . . . 0.0 112.528 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.41 -18.34 59.8 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.595 2.197 . . . . 0.0 114.007 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 40.6 m -81.43 -31.86 32.91 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 124.789 1.236 . . . . 0.0 111.449 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.1 97.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.521 1.055 . . . . 0.0 110.902 167.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.55 -47.0 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.084 0.954 . . . . 0.0 109.191 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.88 12.64 1.03 Allowed Glycine 0 CA--C 1.544 1.891 0 C-N-CA 126.798 2.142 . . . . 0.0 117.353 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -123.39 -14.18 7.46 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.609 1.563 . . . . 0.0 112.98 169.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -95.67 -72.6 0.62 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.84 0.856 . . . . 0.0 110.086 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -72.69 -20.44 61.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.042 -1.036 . . . . 0.0 112.61 -170.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.29 -42.42 70.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.427 1.091 . . . . 0.0 112.843 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -47.02 13.88 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.701 0.801 . . . . 0.0 109.541 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -6.9 57.79 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -82.93 -15.2 52.28 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.237 0.926 . . . . 0.0 113.205 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -150.92 -129.97 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.757 1.623 . . . . 0.0 110.861 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -156.41 -61.38 0.1 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.872 1.669 . . . . 0.0 113.104 -169.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.42 161.13 65.02 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.956 2.102 . . . . 0.0 110.705 -172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -86.49 10.41 3.64 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.705 2.27 . . . . 0.0 113.789 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.02 -27.74 63.9 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.876 -1.14 . . . . 0.0 112.052 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -116.79 -9.28 11.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.241 1.416 . . . . 0.0 114.158 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.35 136.19 47.7 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.958 -1.088 . . . . 0.0 111.949 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.68 8.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.987 1.715 . . . . 0.0 112.888 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 31' ' ' THR . 1.8 tm? 58.67 113.79 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 129.564 3.146 . . . . 0.0 111.344 -169.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.37 51.62 2.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.717 1.607 . . . . 0.0 111.506 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 0.4 OUTLIER -68.52 -31.7 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -164.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -64.61 -42.04 95.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.401 1.001 . . . . 0.0 111.575 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.29 -44.22 60.27 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mt -58.86 -48.22 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.278 1.031 . . . . 0.0 111.471 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.25 73.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.237 0.926 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 47.0 m -67.71 -43.86 79.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.455 1.102 . . . . 0.0 112.2 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' B' ' 151' ' ' ILE . 16.9 t -80.52 -30.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.886 1.674 . . . . 0.0 113.353 -177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -39.97 -62.08 0.96 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.026 1.73 . . . . 0.0 113.783 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.19 -13.56 38.64 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.729 2.286 . . . . 0.0 114.176 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.97 -64.87 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.048 0.939 . . . . 0.0 111.081 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.55 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.92 -25.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 120.766 -1.209 . . . . 0.0 113.379 -178.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.8 -49.71 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.263 1.025 . . . . 0.0 110.586 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.78 -44.99 22.0 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 111.464 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.59 -30.41 70.01 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.592 -1.318 . . . . 0.0 112.833 -169.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.4 m -72.44 -13.09 61.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 169.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -35.1 16.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.493 1.497 . . . . 0.0 111.15 167.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -59.29 -39.05 81.76 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 112.071 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -142.47 79.88 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.816 0.847 . . . . 0.0 111.676 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -55.5 -29.18 58.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -89.94 1.79 55.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.549 1.54 . . . . 0.0 113.116 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 155.55 37.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.647 1.179 . . . . 0.0 113.306 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.07 57.1 2.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.307 1.843 . . . . 0.0 113.374 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 p90 44.62 -91.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.866 2.066 . . . . 0.0 116.005 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -67.43 -26.53 66.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 0.0 112.239 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.9 -36.56 77.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.153 0.981 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -72.33 -40.48 67.4 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 118.477 -0.773 . . . . 0.0 112.774 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.81 -42.46 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 119.326 0.966 . . . . 0.0 110.565 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -69.42 -46.99 65.5 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.924 1.29 . . . . 0.0 112.526 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.15 98.49 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.861 0.743 . . . . 0.0 113.129 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -70.52 -27.16 63.96 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.344 -1.092 . . . . 0.0 113.215 173.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -67.95 -41.0 83.14 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.081 -1.012 . . . . 0.0 111.1 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.56 -41.29 98.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.446 0.698 . . . . 0.0 111.411 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.63 -38.43 6.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 113.151 168.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.94 -39.58 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 112.286 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -95.36 -54.49 3.38 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -77.86 -32.69 52.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.737 1.615 . . . . 0.0 112.892 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.0 t0 46.76 48.34 14.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.16 -169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--O 1.256 1.398 0 C-N-CA 125.681 1.592 . . . . 0.0 114.177 179.724 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.92 102.26 2.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.197 0.999 . . . . 0.0 111.853 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.24 44.77 19.92 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.36 -20.15 65.93 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.84 36.98 4.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.137 2.175 . . . . 0.0 112.558 -170.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -23.59 60.97 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.03 -14.1 61.35 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 63.27 -32.52 0.11 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 129.896 3.279 . . . . 0.0 117.636 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -94.99 3.4 54.98 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.03 1.332 . . . . 0.0 113.98 174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -100.67 170.09 8.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.815 2.046 . . . . 0.0 112.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 52.88 41.31 0.94 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 127.86 2.464 . . . . 0.0 116.976 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -66.39 149.89 84.61 Favored 'Trans proline' 0 C--N 1.351 0.694 0 CA-C-N 121.394 1.534 . . . . 0.0 112.057 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -19.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -78.99 -13.95 59.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.682 1.193 . . . . 0.0 114.084 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.1 m -131.5 -26.91 2.0 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -169.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.24 156.27 39.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.193 0.906 . . . . 0.0 112.681 -177.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.0 p -92.63 157.9 16.25 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.369 1.081 . . . . 0.0 113.62 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.33 -22.85 65.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.28 -39.69 87.76 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.949 -1.094 . . . . 0.0 111.203 173.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.02 -25.5 62.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 118.722 -0.656 . . . . 0.0 112.593 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.61 -30.6 70.23 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.6 1.545 . . . . 0.0 111.304 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.34 -13.21 60.15 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 171.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.45 -28.39 52.42 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.367 0.985 . . . . 0.0 111.542 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.32 136.11 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.933 1.693 . . . . 0.0 110.534 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.03 159.99 31.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 113.189 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -33.73 72.22 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.769 -1.207 . . . . 0.0 111.849 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.8 m -61.93 -23.58 66.44 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 114.164 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.97 -7.38 6.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.84 1.256 . . . . 0.0 113.317 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -57.99 -41.96 92.65 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 119.498 -2.001 . . . . 0.0 112.544 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -64.93 -17.96 60.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.665 2.243 . . . . 0.0 114.109 169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.763 HG22 HD21 ' B' ' 139' ' ' LEU . 47.5 m -76.71 -38.26 54.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.924 1.29 . . . . 0.0 111.148 172.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.31 97.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.433 1.093 . . . . 0.0 112.73 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.75 -46.56 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -50.24 -56.34 13.01 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 125.559 1.552 . . . . 0.0 113.889 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -11.51 59.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 122.072 2.936 . . . . 0.0 113.938 -173.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.55 -47.77 5.81 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.618 1.099 . . . . 0.0 111.995 168.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -76.52 -27.58 56.06 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.959 -1.088 . . . . 0.0 113.566 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.36 -62.94 1.29 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.854 1.261 . . . . 0.0 110.412 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.592 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -65.77 -18.81 65.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.766 1.226 . . . . 0.0 111.55 -174.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.09 -18.88 58.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.299 1.04 . . . . 0.0 113.671 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.47 9.19 5.52 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.52 148.06 7.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.999 2.92 . . . . 0.0 105.909 171.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.16 -44.11 8.52 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 127.5 2.32 . . . . 0.0 115.195 -166.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.33 160.13 58.43 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 127.375 2.27 . . . . 0.0 109.622 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.26 16.58 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 121.25 1.482 . . . . 0.0 114.126 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.58 -22.45 34.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.341 1.456 . . . . 0.0 112.841 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -128.37 -0.9 5.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.515 1.526 . . . . 0.0 114.195 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.84 146.18 53.08 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' B' ' 101' ' ' PRO . 2.7 p -126.34 151.21 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.873 1.669 . . . . 0.0 110.491 168.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.732 HD21 HG22 ' B' ' 120' ' ' THR . 2.8 tm? -75.38 124.49 27.21 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.461 1.105 . . . . 0.0 109.687 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -89.28 46.66 1.4 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.772 1.229 . . . . 0.0 112.493 -168.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.37 2.7 p -64.49 -27.86 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -60.45 -41.56 94.34 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.084 1.765 . . . . 0.0 111.708 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.36 -49.29 9.48 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.4 mt -57.11 -46.21 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.527 1.131 . . . . 0.0 111.525 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.76 68.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.841 1.201 . . . . 0.0 112.681 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -68.99 -39.89 79.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.868 1.267 . . . . 0.0 111.551 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 62' ' ' ILE . 55.8 t -87.43 -27.03 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.132 1.373 . . . . 0.0 113.334 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 m -41.77 -61.39 1.49 Allowed Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.318 1.847 . . . . 0.0 113.928 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.91 -21.87 73.45 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.349 2.032 . . . . 0.0 113.093 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 81' ' ' GLU . . . -67.14 -61.54 1.87 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.78 1.632 . . . . 0.0 110.424 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.458 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.09 -28.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.465 -0.772 . . . . 0.0 112.696 176.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -57.57 -46.84 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.852 0.861 . . . . 0.0 110.659 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -74.73 -50.42 17.49 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.438 0.637 . . . . 0.0 111.168 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.75 -30.01 71.16 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.53 -15.12 61.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.05 -33.48 17.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.224 1.374 . . . . 0.0 111.526 168.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -61.43 -37.96 85.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.262 1.025 . . . . 0.0 111.897 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -143.42 61.18 1.39 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.951 1.3 . . . . 0.0 113.0 -170.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -54.52 -37.16 65.02 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.386 1.874 . . . . 0.0 113.022 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.79 -10.04 59.06 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.43 162.65 19.88 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.258 1.023 . . . . 0.0 112.803 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -63.78 136.87 57.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.135 1.374 . . . . 0.0 110.808 173.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -58.18 -39.67 79.51 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.009 0.924 . . . . 0.0 112.785 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -65.25 -37.67 87.96 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.208 -0.933 . . . . 0.0 112.345 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.24 -39.99 88.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.468 1.107 . . . . 0.0 111.27 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -38.56 80.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.9 -43.67 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.267 0.627 . . . . 0.0 110.618 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -61.94 -45.01 95.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.472 0.709 . . . . 0.0 112.088 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.55 -47.88 87.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.706 1.146 . . . . 0.0 113.159 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 24.8 mm-40 -73.11 -31.43 64.33 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.659 1.23 . . . . 0.0 113.348 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -60.31 -44.2 95.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.067 1.303 . . . . 0.0 111.081 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.62 -48.79 79.28 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.794 0.837 . . . . 0.0 110.935 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -30.3 70.87 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.885 -1.134 . . . . 0.0 111.728 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.86 -47.86 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.263 1.025 . . . . 0.0 112.234 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -99.92 -59.74 1.66 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.558 1.143 . . . . 0.0 113.107 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -63.43 -44.68 93.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.778 1.231 . . . . 0.0 110.916 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.03 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 130.025 3.33 . . . . 0.0 115.519 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.255 1.352 0 C-N-CA 129.053 2.941 . . . . 0.0 110.379 177.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -147.91 128.02 13.73 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.808 0.843 . . . . 0.0 112.741 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.91 25.54 8.75 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 167.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.4 -28.4 63.21 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.984 -1.072 . . . . 0.0 113.719 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.56 11.48 18.32 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -169.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.3 80.47 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.007 0.923 . . . . 0.0 111.57 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.0 139.75 22.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.7 2.0 . . . . 0.0 108.294 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -11.04 60.05 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 121.157 -0.964 . . . . 0.0 113.473 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -83.97 5.1 26.86 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -82.44 -66.02 0.94 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -115.48 39.17 0.24 Allowed Pre-proline 0 N--CA 1.491 1.577 0 C-N-CA 125.533 1.533 . . . . 0.0 114.845 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 42.0 Cg_endo -66.16 151.53 83.42 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.442 2.095 . . . . 0.0 115.96 -169.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.91 15.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.344 2.258 . . . . 0.0 114.555 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.425 ' HA ' ' CE2' ' B' ' 163' ' ' PHE . 0.7 OUTLIER -134.1 10.05 3.84 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.812 1.645 . . . . 0.0 113.586 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 13.9 m -141.6 -2.23 1.23 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -170.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -132.91 156.72 46.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.554 1.142 . . . . 0.0 113.243 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 40.3 p -87.2 163.21 17.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.301 1.041 . . . . 0.0 112.046 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.321 0.1 OUTLIER -67.62 -4.25 11.37 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -172.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -35.42 68.67 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.715 -1.241 . . . . 0.0 111.243 168.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.07 -23.74 67.25 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.4 -0.813 . . . . 0.0 112.984 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -67.5 -18.51 65.08 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.074 -1.016 . . . . 0.0 112.219 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.27 -18.62 31.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.094 0.958 . . . . 0.0 112.819 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.32 50.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.443 1.097 . . . . 0.0 112.886 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.75 139.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.939 1.695 . . . . 0.0 110.749 170.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.87 159.35 33.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.459 1.104 . . . . 0.0 113.466 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -52.73 -35.61 56.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.25 1.42 . . . . 0.0 112.303 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -62.73 -22.93 66.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.31 -2.98 6.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.216 1.406 . . . . 0.0 112.909 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -60.18 -47.22 97.31 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 119.625 -1.922 . . . . 0.0 111.706 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.52 -20.19 60.61 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.945 2.43 . . . . 0.0 113.812 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.732 HG22 HD21 ' A' ' 50' ' ' LEU . 94.1 m -75.19 -37.78 61.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.889 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.32 93.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.432 1.093 . . . . 0.0 112.013 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.67 -46.47 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.088 0.955 . . . . 0.0 109.511 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.96 13.42 0.48 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 127.106 2.289 . . . . 0.0 117.081 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -115.36 -54.1 2.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.843 1.822 . . . . 0.0 110.538 167.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.75 92.5 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.838 -1.164 . . . . 0.0 111.3 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.31 -37.47 52.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.303 0.956 . . . . 0.0 112.415 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.35 94.45 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.728 -1.232 . . . . 0.0 111.58 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.49 -32.29 58.25 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.849 -0.532 . . . . 0.0 111.184 -178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.24 -29.26 68.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.935 0.789 . . . . 0.0 112.55 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -89.48 -8.12 53.58 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -136.18 -148.01 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.372 1.869 . . . . 0.0 111.493 -168.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -170.36 -48.83 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 130.839 3.655 . . . . 0.0 110.908 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -133.42 165.83 33.84 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 128.436 2.694 . . . . 0.0 109.518 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -86.15 7.55 4.93 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 121.917 1.72 . . . . 0.0 115.15 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -64.24 -25.62 68.14 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.836 -1.165 . . . . 0.0 112.592 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.73 8.6 26.91 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.274 1.83 . . . . 0.0 112.476 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.47 125.83 33.34 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 119.888 -1.758 . . . . 0.0 111.927 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.89 134.52 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.103 1.761 . . . . 0.0 106.93 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.763 HD21 HG22 ' A' ' 31' ' ' THR . 1.9 tm? -77.31 107.49 9.76 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.312 0.96 . . . . 0.0 110.349 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -89.57 51.23 2.05 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.36 1.864 . . . . 0.0 111.704 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.269 3.6 p -62.0 -35.98 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -166.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.2 -36.99 78.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.706 2.048 . . . . 0.0 111.856 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.68 -46.96 51.75 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.267 0.46 . . . . 0.0 112.336 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.06 -45.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.579 1.152 . . . . 0.0 111.492 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.87 75.27 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.824 1.25 . . . . 0.0 112.222 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 49.6 m -64.82 -42.53 94.91 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.869 0.868 . . . . 0.0 111.95 171.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' B' ' 151' ' ' ILE . 24.3 t -83.69 -27.01 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.133 1.373 . . . . 0.0 112.974 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.6 m -42.33 -61.13 1.72 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 126.247 1.819 . . . . 0.0 113.886 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.76 -23.02 75.42 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.177 1.918 . . . . 0.0 112.93 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.26 -58.11 4.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.211 1.004 . . . . 0.0 111.466 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.453 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -68.18 -24.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.638 1.108 . . . . 0.0 113.016 175.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 11.8 t -62.76 -50.74 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.712 1.142 . . . . 0.0 110.674 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.11 -43.63 42.32 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.152 -0.343 . . . . 0.0 111.667 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.53 81.42 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 120.956 -1.09 . . . . 0.0 112.177 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 92.0 m -76.88 -3.69 39.91 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.932 -1.105 . . . . 0.0 113.97 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -37.22 11.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.377 1.071 . . . . 0.0 111.592 168.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.11 -32.27 50.44 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -121.55 45.96 2.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.686 1.995 . . . . 0.0 110.744 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -50.48 -30.11 12.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.811 1.244 . . . . 0.0 113.272 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -90.17 -0.92 57.85 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.386 1.474 . . . . 0.0 112.958 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.25 159.42 33.47 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.856 1.262 . . . . 0.0 112.713 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.89 142.11 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.583 1.553 . . . . 0.0 112.463 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' B' ' 103' ' ' ASN . 14.5 p90 -43.71 -47.12 7.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.787 2.435 . . . . 0.0 115.966 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -95.18 -38.06 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.765 1.226 . . . . 0.0 110.904 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.23 -33.61 75.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.816 0.847 . . . . 0.0 112.324 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -73.93 -36.43 64.68 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.211 1.004 . . . . 0.0 113.049 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.4 -50.89 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.374 -0.829 . . . . 0.0 110.55 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -67.61 -37.47 82.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.411 1.084 . . . . 0.0 112.416 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.03 88.69 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.97 1.272 . . . . 0.0 113.063 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -71.83 -35.3 69.85 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.975 1.388 . . . . 0.0 112.638 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -59.74 -42.14 92.49 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.191 -0.943 . . . . 0.0 111.96 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.14 -47.52 85.57 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.261 1.424 . . . . 0.0 110.796 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.76 -23.31 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.932 -1.105 . . . . 0.0 112.678 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.33 -44.94 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.638 1.975 . . . . 0.0 113.149 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -102.17 -56.2 2.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.767 1.227 . . . . 0.0 113.05 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -68.76 -36.31 78.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.813 1.245 . . . . 0.0 111.687 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.1 t0 47.8 44.03 17.61 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.382 2.273 . . . . 0.0 113.235 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.254 1.334 0 C-N-CA 125.535 1.534 . . . . 0.0 112.96 -178.138 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.122 0.011 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -142.49 8.12 1.75 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.33 -48.95 68.04 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.188 1.921 . . . . 0.0 116.188 -168.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -99.54 -20.87 16.17 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.42 45.4 2.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.026 1.731 . . . . 0.0 112.692 -167.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 -22.21 66.84 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.863 1.265 . . . . 0.0 114.274 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.58 4.15 19.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.25 1.42 . . . . 0.0 113.604 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.0 t70 60.0 -51.81 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 131.601 3.961 . . . . 0.0 118.348 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -123.78 -9.47 7.82 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -168.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -97.29 -1.58 44.39 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -167.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -113.95 49.94 0.49 Allowed Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 124.755 1.222 . . . . 0.0 113.726 172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -65.85 155.9 66.97 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.972 1.782 . . . . 0.0 111.68 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.99 -23.35 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.2 -4.86 59.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.944 1.697 . . . . 0.0 115.108 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.8 m -127.85 -25.68 3.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.183 1.393 . . . . 0.0 114.341 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.47 160.03 32.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.308 1.052 . . . . 0.0 111.892 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -93.36 168.3 11.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.088 1.423 . . . . 0.0 113.645 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -26.02 67.91 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.787 168.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.78 -43.09 99.72 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.772 -1.205 . . . . 0.0 110.751 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.18 -28.06 69.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.176 -0.953 . . . . 0.0 112.344 169.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD2' ' CE1' ' A' ' 74' ' ' PHE . 41.1 t80 -69.37 -12.83 61.99 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.687 -1.258 . . . . 0.0 112.62 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 mt -94.47 -7.84 40.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.325 1.05 . . . . 0.0 112.49 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.88 -31.17 28.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.293 1.037 . . . . 0.0 111.633 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.79 138.12 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.276 1.43 . . . . 0.0 110.608 169.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.2 159.61 33.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.185 1.394 . . . . 0.0 113.619 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.39 -36.28 75.52 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.038 -1.039 . . . . 0.0 112.076 -174.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.9 m -61.26 -24.47 66.41 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.933 1.693 . . . . 0.0 113.806 176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.33 -3.43 7.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.217 1.407 . . . . 0.0 113.033 -173.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -58.13 -47.59 98.58 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.224 -1.548 . . . . 0.0 110.852 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 -16.48 50.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.738 2.292 . . . . 0.0 114.007 172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.787 HG22 HD21 ' B' ' 139' ' ' LEU . 97.5 m -77.84 -38.75 45.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.295 1.438 . . . . 0.0 110.738 173.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.61 97.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.612 1.165 . . . . 0.0 112.23 168.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.77 -46.48 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 168.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.86 -48.21 57.73 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 125.736 1.636 . . . . 0.0 114.684 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -68.78 -36.22 78.02 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.995 2.397 . . . . 0.0 112.551 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.1 75.23 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.853 0.751 . . . . 0.0 112.325 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -80.43 -46.52 15.82 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.477 -0.764 . . . . 0.0 111.645 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.96 78.08 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.016 -1.052 . . . . 0.0 111.735 -171.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 -24.67 61.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.163 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 -14.6 63.09 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -89.18 -28.64 19.87 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.87 -121.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -168.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -158.89 -72.88 0.08 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.43 2.292 . . . . 0.0 111.078 -169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -103.13 163.95 16.48 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 126.75 2.02 . . . . 0.0 110.7 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.2 10.18 3.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.602 2.202 . . . . 0.0 114.402 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.53 -12.73 61.65 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.906 -1.121 . . . . 0.0 112.949 -176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.79 30.47 4.04 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.605 1.962 . . . . 0.0 111.722 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.21 136.19 33.71 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 119.724 -1.86 . . . . 0.0 113.489 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.72 141.77 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.966 1.707 . . . . 0.0 109.192 172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' HB ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -67.54 131.94 46.62 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.456 1.503 . . . . 0.0 111.73 -168.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -83.26 50.48 1.76 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 119.982 -1.699 . . . . 0.0 111.958 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 50' ' ' LEU 0.431 2.1 p -66.85 -45.26 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -163.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.63 -34.24 72.53 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 121.621 2.009 . . . . 0.0 111.526 174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.16 -53.44 18.25 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.737 0.684 . . . . 0.0 112.448 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.3 mt -52.27 -46.45 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.784 1.634 . . . . 0.0 110.872 171.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.05 75.58 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.441 1.096 . . . . 0.0 113.103 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.6 m -71.48 -36.98 71.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 111.793 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 62' ' ' ILE . 54.6 t -87.02 -23.11 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.638 1.575 . . . . 0.0 112.923 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -47.32 -59.46 5.44 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 125.922 1.689 . . . . 0.0 112.412 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.84 -2.12 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.258 2.639 . . . . 0.0 114.219 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.82 -64.95 1.07 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 171.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.81 -30.91 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.652 -1.28 . . . . 0.0 113.004 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 t -58.57 -48.45 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.163 0.985 . . . . 0.0 110.838 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.01 -48.53 20.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.335 0.588 . . . . 0.0 110.904 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.86 69.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 25.3 m -77.19 -13.59 59.92 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.85 -32.85 17.59 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.886 1.221 . . . . 0.0 111.068 167.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.59 -38.62 88.24 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.835 0.854 . . . . 0.0 111.854 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -139.06 57.5 1.66 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.017 1.327 . . . . 0.0 112.765 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -52.84 -36.07 58.28 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.754 1.621 . . . . 0.0 113.108 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.21 -8.34 59.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.265 1.026 . . . . 0.0 113.519 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.75 161.21 27.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.213 1.005 . . . . 0.0 112.711 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -69.23 132.86 47.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.747 1.219 . . . . 0.0 110.235 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CD2' ' A' ' 21' ' ' PHE . 50.5 t80 -58.26 -44.22 88.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -66.17 -33.78 76.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.516 1.053 . . . . 0.0 112.221 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.11 -31.47 71.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.304 0.641 . . . . 0.0 112.372 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -70.16 -37.11 75.12 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.219 -0.926 . . . . 0.0 113.243 169.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -42.6 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 118.962 0.801 . . . . 0.0 110.597 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -62.1 -45.72 92.24 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.828 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.18 -43.42 98.64 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.26 0.933 . . . . 0.0 113.322 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -75.59 -25.29 56.88 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.118 -1.225 . . . . 0.0 113.573 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -67.42 -42.21 83.57 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.958 -1.089 . . . . 0.0 110.592 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.07 -42.27 99.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.451 1.101 . . . . 0.0 112.165 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -49.0 16.59 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.32 1.848 . . . . 0.0 113.003 169.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . 0.25 3.1 mt -88.5 -38.3 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.888 -166.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -103.01 -59.59 1.68 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.361 1.464 . . . . 0.0 112.799 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -67.11 -24.51 65.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.685 1.594 . . . . 0.0 114.026 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.81 -22.53 66.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.056 1.342 . . . . 0.0 113.842 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.295 1.438 . . . . 0.0 111.976 173.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -147.96 28.87 0.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.428 1.491 . . . . 0.0 112.897 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.16 149.97 19.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.652 1.181 . . . . 0.0 110.109 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.79 175.97 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.183 0.993 . . . . 0.0 113.279 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 52.69 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.054 2.542 . . . . 0.0 117.252 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -28.21 68.88 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.074 0.852 . . . . 0.0 111.714 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.93 143.55 50.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.919 2.087 . . . . 0.0 108.425 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -89.66 2.32 54.9 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -113.06 11.2 18.88 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.972 1.709 . . . . 0.0 115.094 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -67.21 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.048 1.339 . . . . 0.0 114.149 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.37 50.28 5.81 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 127.091 2.156 . . . . 0.0 112.153 171.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.7 169.45 2.49 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.878 3.052 . . . . 0.0 116.135 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.5 2.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.21 1.404 . . . . 0.0 114.573 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 17.1 m-80 -119.72 20.92 12.2 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.257 1.823 . . . . 0.0 112.898 169.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 57.0 m -142.49 -24.63 0.65 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.78 166.8 22.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -170.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.7 p -112.44 154.05 26.42 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.14 1.776 . . . . 0.0 110.434 168.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.55 -25.21 62.24 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -53.8 -43.01 68.99 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.052 1.341 . . . . 0.0 111.184 170.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.72 -22.02 61.69 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.37 -0.831 . . . . 0.0 112.805 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -68.44 -15.06 63.41 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 111.861 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -91.27 -12.48 35.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.01 1.324 . . . . 0.0 113.061 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.32 -34.0 55.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.417 1.087 . . . . 0.0 112.743 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -72.04 137.28 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.608 1.563 . . . . 0.0 110.546 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.81 160.12 31.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.073 1.349 . . . . 0.0 113.724 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -59.48 -34.63 72.8 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.6 1.16 . . . . 0.0 111.932 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.1 m -62.64 -25.01 67.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.036 1.734 . . . . 0.0 113.855 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.62 -6.03 8.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.797 1.239 . . . . 0.0 113.38 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -58.04 -42.68 96.39 Favored Pre-proline 0 N--CA 1.481 1.077 0 O-C-N 119.927 -1.733 . . . . 0.0 113.396 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.88 -28.37 86.28 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.962 2.441 . . . . 0.0 112.93 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.434 HG22 HD21 ' A' ' 50' ' ' LEU . 54.2 m -75.93 -33.52 59.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.373 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . 0.405 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -65.35 -45.55 83.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.528 1.531 . . . . 0.0 113.665 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.27 -33.23 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.221 0.919 . . . . 0.0 110.18 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.13 -52.78 44.75 Favored Glycine 0 C--O 1.216 -1.007 0 C-N-CA 124.535 1.064 . . . . 0.0 113.225 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.08 -12.76 29.15 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.973 2.387 . . . . 0.0 113.892 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.48 -62.41 1.46 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.762 0.825 . . . . 0.0 110.659 164.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -68.19 -34.33 76.08 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.897 -1.127 . . . . 0.0 113.257 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.68 -47.74 81.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.197 1.799 . . . . 0.0 112.114 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -39.29 50.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.584 1.154 . . . . 0.0 110.471 -176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -9.72 50.5 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -173.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -87.71 -23.92 24.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.233 1.013 . . . . 0.0 113.311 173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -153.95 -122.03 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.857 1.263 . . . . 0.0 114.044 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -162.24 -65.44 0.05 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.403 1.881 . . . . 0.0 112.055 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -116.02 161.91 28.51 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 126.229 1.812 . . . . 0.0 110.568 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.5 11.61 2.84 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.364 2.043 . . . . 0.0 114.407 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.13 -34.11 65.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.06 1.344 . . . . 0.0 111.785 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.48 19.34 16.98 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.494 1.918 . . . . 0.0 112.733 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.7 118.2 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 119.78 -1.825 . . . . 0.0 111.229 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.69 -4.91 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.003 1.321 . . . . 0.0 112.389 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.787 HD21 HG22 ' A' ' 31' ' ' THR . 2.0 tm? 59.61 112.75 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.414 3.085 . . . . 0.0 112.869 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -91.99 62.48 4.26 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.634 -1.291 . . . . 0.0 111.744 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.277 1.2 p -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 117.338 -1.315 . . . . 0.0 114.041 -168.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -63.96 -35.31 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.789 2.086 . . . . 0.0 111.672 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.89 -48.36 61.27 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.679 0.657 . . . . 0.0 111.857 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.88 -40.52 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.122 0.969 . . . . 0.0 112.257 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.62 71.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.785 1.234 . . . . 0.0 112.382 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 0.0 111.632 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 23.2 t -80.95 -33.1 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.356 1.463 . . . . 0.0 113.319 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.9 m -43.89 -58.37 4.78 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 126.235 1.814 . . . . 0.0 113.855 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.92 -11.36 30.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.807 2.338 . . . . 0.0 113.822 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -65.61 0.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.667 1.187 . . . . 0.0 111.601 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.495 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -69.0 -27.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.664 -1.272 . . . . 0.0 113.671 -173.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.5 -44.68 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.526 1.057 . . . . 0.0 112.304 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -73.68 -46.75 44.43 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.024 0.929 . . . . 0.0 110.885 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.65 -27.27 67.54 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 113.2 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 9.4 m -74.87 -13.07 60.51 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -33.92 18.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.317 1.417 . . . . 0.0 110.755 167.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -60.76 -40.35 92.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.807 0.843 . . . . 0.0 112.16 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -132.81 64.99 1.6 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.727 1.211 . . . . 0.0 111.902 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -52.15 -32.61 36.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.512 -1.367 . . . . 0.0 113.63 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -92.83 1.31 57.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.825 1.25 . . . . 0.0 113.068 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.96 154.53 41.4 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.246 1.022 . . . . 0.0 112.301 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.97 152.25 33.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.834 1.654 . . . . 0.0 112.61 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 35.0 p90 -47.6 153.9 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.982 1.713 . . . . 0.0 113.526 168.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 43.7 tttt 60.82 -40.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 129.642 3.177 . . . . 0.0 115.93 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.41 -34.67 77.21 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.485 1.914 . . . . 0.0 112.199 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -69.09 -37.81 78.62 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.605 -0.684 . . . . 0.0 112.334 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.15 -41.3 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 119.101 0.864 . . . . 0.0 111.11 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.13 -45.44 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.664 0.786 . . . . 0.0 111.633 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.83 95.41 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.994 1.283 . . . . 0.0 113.485 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.95 -35.66 77.03 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.634 1.217 . . . . 0.0 112.593 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -63.66 -36.94 85.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.69 -1.256 . . . . 0.0 112.007 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.87 -47.48 77.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.501 0.72 . . . . 0.0 111.683 171.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -24.66 67.57 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.573 -1.329 . . . . 0.0 111.93 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.7 mt -75.6 -45.96 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.934 1.693 . . . . 0.0 112.687 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -103.51 -59.79 1.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -62.68 -26.4 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.319 1.848 . . . . 0.0 113.981 -170.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.76 -21.43 66.77 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 C--O 1.255 1.374 0 C-N-CA 125.87 1.668 . . . . 0.0 114.57 -177.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.258 69.4 m-20 54.58 35.93 24.7 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.934 1.294 . . . . 0.0 113.921 -170.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.32 176.31 7.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.319 1.447 . . . . 0.0 111.533 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.37 138.92 57.9 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 142.05 8.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.357 1.863 . . . . 0.0 109.759 166.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.7 29.55 5.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.415 1.486 . . . . 0.0 112.987 -170.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 -24.68 61.65 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.107 -0.996 . . . . 0.0 112.71 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.87 -24.92 67.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.01 0.924 . . . . 0.0 112.871 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -126.52 23.71 6.8 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.537 1.535 . . . . 0.0 112.117 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 27.03 86.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 128.882 2.873 . . . . 0.0 115.47 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -112.53 65.44 0.82 Allowed Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 125.212 1.405 . . . . 0.0 110.994 167.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.78 169.74 16.93 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.74 3.626 . . . . 0.0 112.487 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.37 -16.44 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -76.76 -35.15 57.91 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.33 1.052 . . . . 0.0 112.615 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.8 m -100.48 -22.49 14.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.325 2.25 . . . . 0.0 113.904 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -64.78 140.78 58.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.018 2.527 . . . . 0.0 109.648 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.4 p -100.95 166.47 10.81 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.827 1.298 . . . . 0.0 113.54 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.16 -25.28 66.88 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.587 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -65.5 -42.83 91.69 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.853 -1.155 . . . . 0.0 110.421 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -62.59 -27.05 68.92 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.848 -0.532 . . . . 0.0 112.09 170.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -69.08 -12.19 61.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.785 -1.197 . . . . 0.0 113.119 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.09 -6.45 38.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.754 1.221 . . . . 0.0 112.64 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.13 -30.51 21.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.674 1.189 . . . . 0.0 112.375 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 p -72.56 141.95 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.751 1.62 . . . . 0.0 110.753 169.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.17 160.31 32.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.46 1.104 . . . . 0.0 113.084 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -59.21 -35.41 73.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.726 1.21 . . . . 0.0 111.848 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -62.95 -21.96 66.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.547 1.539 . . . . 0.0 113.79 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.09 -5.25 6.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 113.47 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -55.42 -47.22 99.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 O-C-N 120.131 -1.606 . . . . 0.0 111.478 170.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -60.47 -25.74 81.22 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.565 2.177 . . . . 0.0 113.857 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -70.5 -34.44 72.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.391 0.676 . . . . 0.0 111.915 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.72 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -67.05 -46.52 74.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.848 1.203 . . . . 0.0 113.005 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.11 -34.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 118.75 0.705 . . . . 0.0 110.249 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.78 -47.13 88.13 Favored Glycine 0 C--O 1.215 -1.06 0 CA-C-O 118.819 -0.989 . . . . 0.0 113.524 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.13 -24.16 66.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.249 2.524 . . . . 0.0 113.609 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.88 -55.25 4.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.495 -0.753 . . . . 0.0 110.939 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -68.01 -31.64 71.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.454 -0.779 . . . . 0.0 112.5 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.98 84.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.396 1.078 . . . . 0.0 111.576 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD13 HD13 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -77.91 -36.75 49.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.329 -178.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -23.15 63.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -81.6 -17.91 46.59 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.85 -122.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.186 1.394 . . . . 0.0 112.341 -169.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -160.8 -66.99 0.06 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.399 1.48 . . . . 0.0 113.03 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -129.73 164.29 41.16 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 127.906 2.482 . . . . 0.0 109.669 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.58 3.82 6.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.352 1.519 . . . . 0.0 114.716 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -55.27 -23.79 24.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.479 1.512 . . . . 0.0 112.564 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.16 9.27 15.8 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.788 2.035 . . . . 0.0 113.014 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.76 125.16 32.31 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 119.614 -1.929 . . . . 0.0 113.644 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.38 129.53 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.933 2.093 . . . . 0.0 105.866 173.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.0 OUTLIER -69.6 116.62 10.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.14 1.336 . . . . 0.0 109.678 -173.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.47 58.2 4.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.806 1.642 . . . . 0.0 110.991 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -69.55 -31.67 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.74 -35.13 79.86 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 121.239 1.836 . . . . 0.0 111.875 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.73 -44.84 68.24 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.724 0.678 . . . . 0.0 112.237 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.41 -47.31 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.6 1.16 . . . . 0.0 111.123 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.76 -28.3 67.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.359 1.464 . . . . 0.0 112.993 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.5 m -66.02 -48.52 70.87 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.771 1.229 . . . . 0.0 111.001 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -85.67 -19.98 8.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -46.9 -63.07 1.52 Allowed Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 125.129 1.372 . . . . 0.0 112.258 175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.65 -5.61 16.56 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.553 2.835 . . . . 0.0 114.133 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.57 -61.15 1.83 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.437 1.495 . . . . 0.0 110.05 172.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.64 -30.72 48.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 124.752 1.221 . . . . 0.0 111.721 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.08 -44.18 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.431 1.014 . . . . 0.0 112.849 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -74.42 -46.01 42.85 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.029 0.531 . . . . 0.0 109.706 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.31 75.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.927 0.891 . . . . 0.0 112.861 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.8 m -74.24 -17.43 60.88 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.74 -30.58 32.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.257 1.39 . . . . 0.0 110.79 169.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -65.29 -38.68 91.01 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.329 0.652 . . . . 0.0 112.626 170.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -130.26 55.81 1.79 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.606 1.563 . . . . 0.0 112.674 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -49.27 -40.19 33.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.602 1.161 . . . . 0.0 112.845 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.29 -2.5 57.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.105 0.962 . . . . 0.0 113.494 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.53 158.74 28.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.16 0.984 . . . . 0.0 112.007 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.9 141.32 47.88 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.825 0.85 . . . . 0.0 110.588 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -66.9 -47.39 71.94 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -64.14 -33.24 75.34 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.064 -1.023 . . . . 0.0 113.009 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.64 -34.03 74.98 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.241 0.616 . . . . 0.0 111.979 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -75.07 -36.38 61.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.28 -39.88 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.295 1.407 . . . . 0.0 111.203 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -61.55 -45.68 93.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.477 0.711 . . . . 0.0 111.584 169.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.16 -45.48 95.25 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.74 1.162 . . . . 0.0 113.789 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.24 -35.57 63.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.752 1.276 . . . . 0.0 112.867 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -59.58 -40.42 87.33 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.69 1.132 . . . . 0.0 111.562 171.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -62.66 -46.17 89.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.515 1.126 . . . . 0.0 112.052 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -26.39 68.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.205 -0.934 . . . . 0.0 112.331 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.2 -44.92 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.722 1.209 . . . . 0.0 112.291 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -104.35 -60.27 1.61 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.681 1.592 . . . . 0.0 112.993 -173.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.15 -24.36 66.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.673 1.589 . . . . 0.0 113.933 -171.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.55 -22.74 67.06 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.884 1.274 . . . . 0.0 113.755 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.198 1.399 . . . . 0.0 112.417 177.699 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.92 121.25 10.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.206 1.002 . . . . 0.0 111.649 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.44 25.87 3.81 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -50.47 -33.99 23.24 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -171.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.263 0.0 OUTLIER -82.88 -8.16 59.6 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 44.86 -109.16 0.16 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.803 1.641 . . . . 0.0 113.737 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.68 5.59 9.0 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.38 1.472 . . . . 0.0 114.664 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.21 7.51 5.53 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.438 2.295 . . . . 0.0 113.828 -168.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -134.58 -25.01 1.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.428 1.891 . . . . 0.0 114.133 -170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -89.94 158.0 17.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.829 1.252 . . . . 0.0 111.825 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . 0.263 20.6 ptmt 43.77 43.73 1.21 Allowed Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 128.772 2.829 . . . . 0.0 116.684 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -66.79 172.46 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.33 2.687 . . . . 0.0 114.007 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 20.6 m -63.62 6.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 127.041 2.137 . . . . 0.0 115.796 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . 0.461 ' HA ' ' CD1' ' B' ' 163' ' ' PHE . 2.1 p30 -135.36 32.53 3.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.635 2.374 . . . . 0.0 111.215 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.1 t -148.28 -47.53 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.175 1.39 . . . . 0.0 113.673 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -99.01 139.3 34.86 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.872 0.869 . . . . 0.0 111.346 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 p -75.29 172.19 12.88 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.202 1.801 . . . . 0.0 114.578 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -21.63 1.54 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -55.34 -36.09 65.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.952 1.251 . . . . 0.0 111.444 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.6 -26.38 68.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.245 -0.91 . . . . 0.0 112.829 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -70.18 -18.45 63.19 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.206 -0.933 . . . . 0.0 111.884 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 37.5 mt -91.84 -21.23 20.75 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.142 1.377 . . . . 0.0 112.222 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.31 -34.25 61.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.663 1.185 . . . . 0.0 112.49 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.85 137.48 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.083 1.353 . . . . 0.0 110.64 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -67.35 158.31 31.94 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.065 1.346 . . . . 0.0 113.303 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -57.91 -35.82 71.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.684 1.194 . . . . 0.0 112.213 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -22.98 65.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.699 1.6 . . . . 0.0 114.002 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.82 0.09 6.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.56 1.544 . . . . 0.0 112.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.17 -42.75 94.97 Favored Pre-proline 0 N--CA 1.477 0.897 0 O-C-N 119.765 -1.834 . . . . 0.0 112.788 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -61.66 -26.84 80.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.582 2.188 . . . . 0.0 113.386 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 54.2 m -74.57 -32.86 62.53 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 124.105 0.962 . . . . 0.0 111.246 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -61.62 -46.27 90.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.85 1.26 . . . . 0.0 114.11 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.05 -36.15 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.436 1.016 . . . . 0.0 110.69 170.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.01 -49.48 58.85 Favored Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.889 169.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.25 -13.57 60.59 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.797 2.299 . . . . 0.0 114.331 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.64 -56.7 2.92 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.753 -0.592 . . . . 0.0 109.862 165.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.09 -37.28 81.03 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.154 -0.966 . . . . 0.0 113.032 -169.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.88 72.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.655 1.982 . . . . 0.0 112.397 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -87.84 -37.2 16.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.167 1.387 . . . . 0.0 110.676 -177.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.02 -30.46 35.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.375 1.87 . . . . 0.0 113.798 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -98.33 -10.86 23.18 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -170.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.25 1.1 ptpm? -150.0 -126.7 0.05 OUTLIER 'General case' 0 C--N 1.351 0.636 0 CA-C-N 120.114 1.325 . . . . 0.0 113.328 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -161.82 -48.63 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -167.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -143.54 161.4 47.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 126.92 2.088 . . . . 0.0 110.664 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.51 -1.08 11.29 Favored 'Trans proline' 0 C--N 1.358 1.034 0 CA-C-N 121.453 1.555 . . . . 0.0 115.654 -174.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.83 -24.85 54.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.629 1.172 . . . . 0.0 113.037 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -114.86 7.06 15.62 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.0 1.72 . . . . 0.0 113.176 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.9 123.68 32.28 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 119.727 -1.858 . . . . 0.0 112.035 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.5 136.8 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.72 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -68.49 110.2 4.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.323 1.419 . . . . 0.0 108.186 178.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -91.02 59.64 4.1 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.072 0.949 . . . . 0.0 110.356 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.326 2.9 p -67.39 -15.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 121.063 -1.023 . . . . 0.0 112.183 -170.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.23 -33.03 57.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.416 1.486 . . . . 0.0 112.245 167.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.34 -61.23 1.92 Allowed Glycine 0 N--CA 1.467 0.728 0 C-N-CA 124.443 1.02 . . . . 0.0 112.171 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.48 -44.4 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.842 -1.387 . . . . 0.0 113.189 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.69 64.95 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.989 1.268 . . . . 0.0 112.547 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 8.9 m -67.31 -46.68 72.82 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.548 1.139 . . . . 0.0 112.066 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.408 HG12 HD13 ' B' ' 151' ' ' ILE . 1.5 t -93.99 -16.33 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.4 m -41.5 -60.47 1.83 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 125.906 1.682 . . . . 0.0 113.359 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.47 -14.39 44.66 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.73 2.287 . . . . 0.0 113.361 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.05 -57.61 3.55 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.723 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 147' ' ' VAL . 0.0 OUTLIER -60.33 -37.98 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 119.392 0.996 . . . . 0.0 112.221 -176.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.96 -43.22 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.99 -0.443 . . . . 0.0 112.052 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -71.31 -47.45 56.61 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.931 0.893 . . . . 0.0 110.866 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.95 71.64 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.496 -1.378 . . . . 0.0 113.205 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 17.4 m -76.16 -11.03 59.86 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.02 -34.15 16.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.397 1.453 . . . . 0.0 110.614 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -57.94 -38.67 76.37 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.308 1.043 . . . . 0.0 111.996 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -145.53 86.4 1.74 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.906 0.86 . . . . 0.0 112.001 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -55.0 -28.48 52.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.574 1.55 . . . . 0.0 112.89 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -94.23 3.5 55.17 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 113.048 -174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.46 161.08 15.0 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.115 1.366 . . . . 0.0 113.828 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.52 54.73 0.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.505 1.922 . . . . 0.0 113.495 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' B' ' 103' ' ' ASN . 1.1 p90 45.2 -104.31 0.08 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.259 1.824 . . . . 0.0 115.391 166.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -48.45 -32.67 8.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.155 2.182 . . . . 0.0 113.892 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.03 -29.67 68.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.328 1.051 . . . . 0.0 112.703 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -72.52 -39.71 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.319 -0.863 . . . . 0.0 112.557 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.72 -39.93 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.732 1.151 . . . . 0.0 110.964 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.22 -42.32 96.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.006 0.922 . . . . 0.0 112.142 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.37 99.34 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.789 1.185 . . . . 0.0 113.354 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.72 -34.15 66.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 1.153 . . . . 0.0 112.574 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -58.14 -42.77 86.6 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.781 1.173 . . . . 0.0 111.475 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.03 -45.17 94.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 0.0 111.624 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -23.89 67.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.982 -1.074 . . . . 0.0 112.655 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 19.0 mt -85.97 -49.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.334 1.853 . . . . 0.0 112.661 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -100.48 -59.3 1.73 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.653 1.581 . . . . 0.0 112.92 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -65.08 -26.86 68.41 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.468 1.507 . . . . 0.0 113.123 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.04 -18.77 63.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.249 1.42 . . . . 0.0 114.21 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.957 1.303 . . . . 0.0 113.394 -177.413 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 119.855 -0.117 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -138.28 54.91 1.77 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -169.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.491 ' H ' ' HB2' ' B' ' 142' ' ' GLN . . . 52.55 40.29 29.61 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -63.15 -15.65 57.51 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -171.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.76 4.66 13.23 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 172.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.79 -36.28 16.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.605 1.562 . . . . 0.0 114.068 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.25 151.98 32.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.389 1.076 . . . . 0.0 111.573 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -71.91 56.88 0.31 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.36 2.264 . . . . 0.0 112.248 173.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -151.57 -47.75 0.11 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.545 1.538 . . . . 0.0 113.374 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -72.76 -47.38 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -172.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -137.55 32.07 0.19 Allowed Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -59.08 139.21 89.58 Favored 'Trans proline' 0 C--N 1.36 1.146 0 CA-C-N 123.188 2.174 . . . . 0.0 113.848 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -73.69 0.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.08 1.352 . . . . 0.0 113.886 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HA ' ' CE1' ' A' ' 74' ' ' PHE . 61.1 m-80 -123.98 19.79 9.2 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.76 1.624 . . . . 0.0 112.864 169.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -140.06 -39.87 0.44 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -94.81 153.57 17.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 111.818 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -79.97 175.39 10.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.698 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -19.4 0.66 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -55.8 -31.74 62.9 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 120.041 1.292 . . . . 0.0 112.029 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.04 -33.25 64.77 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.002 -1.061 . . . . 0.0 111.901 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.03 -10.62 60.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 mt -103.77 -22.17 13.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.53 70.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.202 1.001 . . . . 0.0 111.745 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.24 137.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 111.201 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.47 158.88 30.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.375 1.07 . . . . 0.0 112.683 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.16 -34.29 56.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.11 1.364 . . . . 0.0 112.153 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 m -60.04 -28.18 67.54 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.066 1.746 . . . . 0.0 113.697 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -127.49 0.4 6.25 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.655 1.582 . . . . 0.0 113.179 -171.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.88 -45.88 99.91 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 120.533 -1.354 . . . . 0.0 111.883 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -60.15 -25.43 79.9 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.935 2.423 . . . . 0.0 113.938 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.6 m -77.84 -30.79 51.22 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.331 1.053 . . . . 0.0 111.56 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' B' ' 139' ' ' LEU . . . -65.01 -45.43 85.57 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.883 -1.136 . . . . 0.0 113.36 172.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.27 -36.87 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 119.108 0.867 . . . . 0.0 110.084 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.53 -52.76 31.77 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 124.628 1.109 . . . . 0.0 113.234 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -69.34 -15.21 63.28 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 121.374 2.587 . . . . 0.0 114.128 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.17 -31.79 15.34 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.498 1.044 . . . . 0.0 113.183 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -93.65 -29.36 15.48 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.3 -41.17 90.12 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.164 1.785 . . . . 0.0 111.963 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 HD13 ' B' ' 128' ' ' LEU . 0.7 OUTLIER -82.21 -36.05 27.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.979 0.912 . . . . 0.0 111.106 -174.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -65.06 -27.09 68.55 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -91.59 -9.08 45.46 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.85 -130.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.159 1.784 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.23 -43.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.282 1.833 . . . . 0.0 114.556 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.6 mmpp? -128.13 164.51 36.88 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 127.193 2.197 . . . . 0.0 110.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.13 -2.72 8.75 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.016 1.811 . . . . 0.0 114.281 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.62 -22.87 65.32 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.85 -1.157 . . . . 0.0 113.061 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.92 -5.11 23.84 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.563 1.545 . . . . 0.0 114.03 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 127.52 32.91 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.947 -1.096 . . . . 0.0 113.739 -169.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.26 128.29 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.212 1.805 . . . . 0.0 107.303 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? -68.04 120.78 14.83 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 119.153 0.888 . . . . 0.0 110.439 -170.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -90.15 52.42 2.26 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.58 -1.325 . . . . 0.0 111.369 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.295 0.9 OUTLIER -64.32 -28.21 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -167.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -59.42 -39.9 85.01 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.756 2.071 . . . . 0.0 111.458 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.08 -54.6 13.15 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.48 -45.37 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.754 -0.851 . . . . 0.0 111.626 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.19 67.91 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.883 1.22 . . . . 0.0 112.747 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -69.02 -47.3 65.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.646 1.178 . . . . 0.0 111.885 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 62' ' ' ILE . 1.1 t -89.96 -18.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -43.22 -60.8 2.17 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 125.862 1.665 . . . . 0.0 112.395 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.1 -0.47 5.63 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.585 2.856 . . . . 0.0 114.503 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.32 -57.77 2.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.082 1.753 . . . . 0.0 111.219 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.69 -35.75 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 119.874 1.216 . . . . 0.0 111.986 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.06 -41.49 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.383 0.673 . . . . 0.0 112.604 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -76.63 -47.7 21.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.474 0.709 . . . . 0.0 110.198 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.19 75.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.075 -1.016 . . . . 0.0 112.937 -170.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.1 m -76.2 -10.52 59.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -33.32 19.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.565 1.53 . . . . 0.0 110.381 167.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -61.52 -39.13 89.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.312 0.645 . . . . 0.0 111.695 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.45 61.29 1.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.047 1.339 . . . . 0.0 112.744 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -54.0 -33.37 56.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.479 -1.388 . . . . 0.0 113.143 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -89.3 -1.82 58.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.149 1.379 . . . . 0.0 113.329 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.33 171.09 12.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.331 1.062 . . . . 0.0 113.271 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -64.71 141.02 58.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.44 1.496 . . . . 0.0 113.349 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 14' ' ' ASN . 7.0 p90 -58.35 -41.65 85.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.762 2.425 . . . . 0.0 115.173 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -93.25 -35.5 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.598 1.159 . . . . 0.0 111.621 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.2 -30.83 69.63 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.157 0.983 . . . . 0.0 111.621 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -74.72 -40.06 61.54 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -68.21 -40.8 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.879 1.218 . . . . 0.0 111.088 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -66.47 -45.71 78.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.236 1.014 . . . . 0.0 111.451 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.31 -44.07 97.48 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.324 1.44 . . . . 0.0 113.401 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.74 -32.74 65.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.165 1.483 . . . . 0.0 113.171 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -62.0 -42.95 99.71 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.642 -1.287 . . . . 0.0 111.21 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.71 -46.53 89.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.806 1.242 . . . . 0.0 111.878 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -28.23 69.88 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.118 -0.989 . . . . 0.0 111.812 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 mt -79.44 -48.48 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.055 0.942 . . . . 0.0 111.889 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -102.2 -57.18 2.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.355 1.462 . . . . 0.0 113.629 -169.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.16 -28.2 65.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.888 1.675 . . . . 0.0 113.242 -171.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.38 -49.61 47.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 113.352 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 C--O 1.254 1.299 0 C-N-CA 126.629 1.972 . . . . 0.0 112.762 175.186 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.57 -50.39 2.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.76 147.38 53.47 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.225 -0.922 . . . . 0.0 112.791 -169.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.26 -15.56 0.41 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.761 2.424 . . . . 0.0 115.047 -172.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 45.35 0.85 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.13 1.372 . . . . 0.0 113.207 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.59 -27.99 68.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -168.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 -10.29 59.27 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 t70 59.32 -16.72 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.097 2.959 . . . . 0.0 116.901 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -114.08 -10.56 12.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.458 1.903 . . . . 0.0 113.145 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -96.1 155.65 16.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.381 1.872 . . . . 0.0 111.372 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 51.49 43.64 1.74 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 127.862 2.465 . . . . 0.0 115.89 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -64.41 163.19 27.6 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.964 1.776 . . . . 0.0 112.031 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.59 -20.85 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -79.8 -40.17 29.18 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.51 -0.744 . . . . 0.0 112.824 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 17.9 m -94.44 -27.44 16.02 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -169.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.31 161.79 27.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.983 0.897 . . . . 0.0 111.989 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 48.9 p -100.07 171.38 7.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 122.472 1.129 . . . . 0.0 113.899 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.33 -26.21 66.39 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.62 -0.675 . . . . 0.0 112.616 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -62.52 -43.81 97.91 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.39 0.995 . . . . 0.0 110.146 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -63.81 -31.51 72.71 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.485 0.714 . . . . 0.0 111.895 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 89.7 t80 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.765 1.166 . . . . 0.0 111.328 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.48 -8.2 55.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.71 -29.01 45.2 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.319 0.963 . . . . 0.0 112.164 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.03 140.6 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.333 1.853 . . . . 0.0 109.124 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.35 155.3 35.77 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -52.67 -35.13 54.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.809 1.244 . . . . 0.0 112.093 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.9 m -64.49 -23.49 67.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -124.53 -1.77 8.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.998 1.319 . . . . 0.0 112.787 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.32 -46.43 90.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.061 -1.65 . . . . 0.0 111.546 171.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -61.19 -25.98 81.62 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.587 2.191 . . . . 0.0 113.497 169.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.505 HG22 HD21 ' A' ' 50' ' ' LEU . 89.6 m -72.76 -36.96 67.8 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.208 175.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.49 92.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.872 1.269 . . . . 0.0 114.071 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.33 -33.05 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 119.975 1.261 . . . . 0.0 110.497 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.75 -52.0 36.3 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 124.998 1.285 . . . . 0.0 113.816 170.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -65.8 -25.85 67.43 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.663 2.231 . . . . 0.0 113.206 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.39 -58.7 3.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.091 0.86 . . . . 0.0 110.935 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -58.44 -44.07 89.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.267 1.827 . . . . 0.0 112.165 -174.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.39 -46.73 82.05 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.421 1.488 . . . . 0.0 112.075 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.452 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -78.88 -31.49 45.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.843 0.857 . . . . 0.0 111.809 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -71.2 -23.14 61.98 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -171.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -96.58 -11.5 25.27 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.52 -132.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.929 1.691 . . . . 0.0 110.88 -176.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -155.11 -56.2 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.998 2.119 . . . . 0.0 112.581 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -122.03 168.71 10.87 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.781 2.432 . . . . 0.0 109.965 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.22 6.28 4.58 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.66 1.573 . . . . 0.0 114.466 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.61 -26.66 68.12 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 112.625 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.22 21.7 15.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.686 1.995 . . . . 0.0 113.897 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.03 133.11 35.1 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.248 -1.532 . . . . 0.0 112.261 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.92 -1.36 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.67 1.188 . . . . 0.0 112.86 -173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER 56.31 106.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.233 2.613 . . . . 0.0 110.561 -168.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.54 60.03 4.96 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 120.283 -1.511 . . . . 0.0 111.075 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.349 2.1 p -68.92 -24.77 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 120.721 -1.237 . . . . 0.0 112.282 -169.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.491 ' HB2' ' H ' ' A' ' 3' ' ' ALA . 18.7 tm0? -65.46 -42.96 91.76 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.723 -1.236 . . . . 0.0 112.209 169.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.96 -49.0 57.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.05 -43.79 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.953 1.301 . . . . 0.0 111.924 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.38 -28.71 65.3 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.001 1.273 . . . . 0.0 112.736 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 50.5 m -69.8 -42.06 74.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 111.607 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 151' ' ' ILE . 29.0 t -85.41 -27.79 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.971 1.708 . . . . 0.0 113.474 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 22.2 m -50.74 -63.44 1.88 Allowed Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 125.683 1.593 . . . . 0.0 112.495 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.3 -17.68 58.75 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.459 2.106 . . . . 0.0 113.096 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.76 -58.29 4.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.434 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.445 HD12 HG12 ' B' ' 147' ' ' VAL . 33.0 mt -71.88 -32.32 44.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.247 1.019 . . . . 0.0 112.34 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.49 -51.07 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.517 1.127 . . . . 0.0 110.568 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.41 -48.16 73.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.632 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.6 74.17 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.0 113.454 -173.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 22.0 m -73.5 -17.55 61.21 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.12 -31.11 19.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.624 1.102 . . . . 0.0 111.886 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.97 -41.89 97.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 111.253 169.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.34 80.02 1.55 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.895 0.855 . . . . 0.0 111.448 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.78 -38.98 67.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.176 1.79 . . . . 0.0 112.408 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.24 -8.86 59.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -169.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.8 148.08 52.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 112.266 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -65.22 135.29 55.24 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.209 1.004 . . . . 0.0 109.214 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.464 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 61.9 t80 -62.27 -52.32 64.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -170.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -58.9 -32.45 69.53 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.734 1.152 . . . . 0.0 112.386 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -70.94 -34.51 71.55 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.049 -1.032 . . . . 0.0 112.905 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -71.61 -34.95 70.27 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.682 -1.261 . . . . 0.0 112.606 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.89 -48.96 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.066 0.946 . . . . 0.0 110.077 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -59.0 -43.17 91.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.684 1.193 . . . . 0.0 111.744 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -56.04 -43.94 88.2 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.392 0.996 . . . . 0.0 113.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -80.39 -30.29 37.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.389 1.095 . . . . 0.0 113.517 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . 0.44 ' CD1' ' HE3' ' B' ' 175' ' ' LYS . 45.0 m0 -57.05 -40.02 75.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.195 1.362 . . . . 0.0 111.081 169.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -70.13 -14.78 62.8 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.653 -1.279 . . . . 0.0 114.083 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -21.55 25.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.339 1.456 . . . . 0.0 113.749 170.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 3.1 mt -110.59 -45.66 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 126.523 1.929 . . . . 0.0 113.997 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' B' ' 171' ' ' TRP . 55.5 mttt -87.83 -52.55 5.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.094 2.158 . . . . 0.0 111.829 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -69.85 -26.79 64.38 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.128 1.371 . . . . 0.0 113.279 -172.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -71.57 -16.56 62.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.047 1.339 . . . . 0.0 114.156 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 C--O 1.255 1.36 0 C-N-CA 125.593 1.557 . . . . 0.0 113.378 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 t70 51.0 41.99 27.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.815 1.646 . . . . 0.0 114.779 -176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.7 -45.58 7.63 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -168.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -96.92 -159.12 0.71 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.386 1.475 . . . . 0.0 112.664 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt 57.02 40.36 28.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.325 1.85 . . . . 0.0 112.939 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.39 144.1 37.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.641 1.177 . . . . 0.0 110.937 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.5 1.97 0.3 Allowed 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.5 t70 60.61 -50.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 129.669 3.188 . . . . 0.0 117.262 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -105.33 -1.29 25.34 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -144.86 -156.84 0.73 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.83 1.252 . . . . 0.0 113.944 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 58.81 35.87 0.26 Allowed Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 128.384 2.674 . . . . 0.0 115.45 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.97 160.51 45.74 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.503 2.135 . . . . 0.0 112.726 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.87 -26.17 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -74.4 -27.91 60.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.176 0.991 . . . . 0.0 112.932 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.6 m -114.79 -26.87 7.64 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.905 1.282 . . . . 0.0 114.304 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -92.97 171.88 8.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.632 1.173 . . . . 0.0 112.951 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.5 p -97.58 165.07 12.16 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -167.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.07 -16.92 8.4 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.763 1.625 . . . . 0.0 114.491 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.4 -35.44 62.88 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.729 1.149 . . . . 0.0 111.049 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.01 -32.31 67.82 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.765 -1.21 . . . . 0.0 112.502 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.95 -7.59 51.75 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 112.318 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.77 -16.46 14.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.248 1.419 . . . . 0.0 112.207 169.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.19 65.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.545 1.138 . . . . 0.0 111.513 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.64 139.32 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.334 1.854 . . . . 0.0 109.897 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.85 158.18 28.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.69 0.796 . . . . 0.0 112.092 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -54.77 -34.63 62.84 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.782 1.233 . . . . 0.0 111.69 173.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.8 m -59.14 -27.69 65.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.181 1.792 . . . . 0.0 113.516 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.44 3.16 6.26 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.482 1.513 . . . . 0.0 113.117 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -55.57 -45.63 99.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 120.002 -1.686 . . . . 0.0 111.276 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -60.31 -24.64 78.1 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.324 . . . . 0.0 114.249 171.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.768 HG22 HD21 ' B' ' 139' ' ' LEU . 62.3 m -75.95 -37.62 58.44 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.791 1.236 . . . . 0.0 110.759 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.54 -44.23 97.42 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.42 -37.06 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 118.808 0.731 . . . . 0.0 111.574 170.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.23 12.04 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.264 -1.298 . . . . 0.0 113.798 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -59.73 -44.83 93.6 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.714 2.257 . . . . 0.0 112.409 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.0 -26.65 67.64 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -94.44 -35.93 12.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.48 84.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.428 1.891 . . . . 0.0 112.18 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD22 HD22 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -80.27 -26.22 39.06 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.151 -175.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -18.33 48.54 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.458 -0.776 . . . . 0.0 113.091 -169.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -97.2 -14.18 21.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.4 -136.06 0.1 Allowed 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.972 1.709 . . . . 0.0 110.731 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -149.97 -60.78 0.2 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.594 1.958 . . . . 0.0 113.187 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -127.5 162.96 45.69 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.973 2.109 . . . . 0.0 110.326 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.05 5.85 5.96 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.722 1.615 . . . . 0.0 114.219 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -58.57 -24.77 61.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.523 1.129 . . . . 0.0 111.446 168.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -111.22 11.94 21.78 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.781 2.032 . . . . 0.0 113.383 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.09 34.83 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.023 -1.673 . . . . 0.0 113.005 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.34 -3.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 125.065 1.346 . . . . 0.0 112.387 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' B' ' 121' ' ' ALA . 0.1 OUTLIER 67.41 115.2 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.691 2.796 . . . . 0.0 110.749 -168.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -89.04 63.83 6.85 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.502 -1.374 . . . . 0.0 110.93 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.27 -28.63 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -168.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 tm0? -54.13 -43.69 70.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.074 1.35 . . . . 0.0 112.199 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.9 -51.67 7.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.44 -48.19 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.188 0.995 . . . . 0.0 111.923 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.42 -28.34 67.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.441 ' HG1' ' N ' ' B' ' 90' ' ' ALA . 26.9 m -70.2 -51.6 29.75 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.647 1.179 . . . . 0.0 112.539 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.01 -15.42 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -170.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.6 m -45.26 -63.31 1.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 120.261 1.391 . . . . 0.0 112.095 173.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -2.0 6.48 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.131 2.554 . . . . 0.0 114.805 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -64.13 1.14 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.964 1.706 . . . . 0.0 110.92 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -27.4 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.871 -1.143 . . . . 0.0 113.008 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -54.17 -48.2 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.926 1.29 . . . . 0.0 110.815 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -81.47 -48.47 11.82 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.239 0.543 . . . . 0.0 110.689 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.76 68.82 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.0 m -77.42 -13.92 59.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -88.08 -33.19 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.417 1.462 . . . . 0.0 110.917 168.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -61.82 -38.75 89.3 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.412 1.085 . . . . 0.0 111.847 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.82 55.61 1.72 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 0.0 112.834 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -53.75 -33.66 56.49 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.386 1.474 . . . . 0.0 113.232 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.18 -6.38 56.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.847 1.259 . . . . 0.0 113.705 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.04 159.61 26.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.785 0.834 . . . . 0.0 111.649 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -58.9 134.35 56.84 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 111.08 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.26 -47.24 71.31 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.391 -0.818 . . . . 0.0 112.96 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -64.27 -36.48 84.24 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.287 0.949 . . . . 0.0 111.963 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -59.61 -32.0 70.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.019 0.528 . . . . 0.0 112.068 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -74.83 -38.34 62.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.781 -1.104 . . . . 0.0 113.829 172.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.5 m -63.73 -41.15 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.923 1.692 . . . . 0.0 111.031 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.57 -44.05 91.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.317 1.047 . . . . 0.0 111.438 172.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.31 94.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.21 1.385 . . . . 0.0 113.5 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -71.93 -33.9 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.276 1.538 . . . . 0.0 113.4 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -60.33 -42.82 96.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.681 1.128 . . . . 0.0 111.383 171.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.04 -45.76 90.74 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.558 1.143 . . . . 0.0 111.969 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.59 71.62 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.002 -1.061 . . . . 0.0 111.826 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.1 mt -77.72 -49.01 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.142 0.977 . . . . 0.0 111.785 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -101.66 -59.83 1.63 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.296 1.439 . . . . 0.0 113.319 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -66.67 -25.97 66.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.956 1.702 . . . . 0.0 113.587 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.97 -20.54 65.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.894 1.278 . . . . 0.0 114.2 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.389 1.476 . . . . 0.0 112.883 -178.585 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.441 ' N ' ' HG1' ' A' ' 57' ' ' THR . . . . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.18 15.0 4.19 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.857 -1.152 . . . . 0.0 113.248 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -162.48 156.9 21.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.379 -171.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.295 0.0 OUTLIER -144.52 -97.5 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 174.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -97.32 -7.16 32.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.05 1.74 . . . . 0.0 113.934 -167.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . 61.15 152.26 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.18 2.592 . . . . 0.0 114.723 -170.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . 57.47 -18.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 128.029 2.531 . . . . 0.0 117.185 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 60.43 -16.32 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 130.065 3.346 . . . . 0.0 116.84 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -110.5 -1.17 17.11 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.959 2.104 . . . . 0.0 112.562 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -111.65 158.55 19.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.086 2.154 . . . . 0.0 112.314 -170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 51.78 43.81 1.8 Allowed Pre-proline 0 N--CA 1.483 1.202 0 C-N-CA 128.017 2.527 . . . . 0.0 115.713 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -65.26 164.19 26.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.562 2.174 . . . . 0.0 112.64 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.21 -26.82 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -80.08 -17.64 52.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.365 1.066 . . . . 0.0 113.563 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -106.4 -44.98 4.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.874 1.27 . . . . 0.0 113.939 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -101.8 176.05 5.35 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 77.7 p -91.2 164.55 13.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -167.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -20.7 21.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.553 1.941 . . . . 0.0 114.272 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.64 -31.78 57.93 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.625 1.102 . . . . 0.0 111.468 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.51 -36.32 64.11 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.839 1.256 . . . . 0.0 113.025 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.88 -20.05 64.25 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.785 -0.572 . . . . 0.0 111.633 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 43.4 mt -89.47 -12.52 39.88 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.008 1.323 . . . . 0.0 113.228 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.12 -40.28 46.35 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.925 0.89 . . . . 0.0 111.176 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -64.34 137.74 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 128.013 2.525 . . . . 0.0 110.243 168.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.3 157.31 31.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.283 1.033 . . . . 0.0 112.947 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -50.34 -36.7 33.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.94 1.296 . . . . 0.0 112.68 171.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -66.58 -25.65 66.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.601 1.161 . . . . 0.0 113.483 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.4 -3.35 10.48 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.956 1.302 . . . . 0.0 113.843 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -56.88 -40.94 88.66 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 119.851 -1.781 . . . . 0.0 113.218 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -61.3 -26.82 82.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.606 2.204 . . . . 0.0 113.386 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . . . . . . . . . 46.8 m -76.18 -35.0 59.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.377 1.071 . . . . 0.0 111.211 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' LEU . . . -62.06 -47.26 85.47 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.204 1.002 . . . . 0.0 113.228 174.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.78 -36.59 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 118.34 0.518 . . . . 0.0 110.926 170.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -50.51 -55.29 17.42 Favored Glycine 0 C--O 1.218 -0.849 0 C-N-CA 125.267 1.413 . . . . 0.0 113.711 171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -59.89 -33.95 72.53 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.23 2.015 . . . . 0.0 112.158 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.6 -47.74 30.59 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.472 -0.768 . . . . 0.0 112.943 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.08 -32.44 50.7 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.71 1.141 . . . . 0.0 112.847 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.77 55.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.067 1.347 . . . . 0.0 112.066 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.44 HD22 HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -69.4 -30.61 68.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.76 0.824 . . . . 0.0 110.95 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -68.11 -25.79 65.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.149 0.979 . . . . 0.0 113.218 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -80.18 -22.48 41.9 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -151.95 -130.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.245 1.418 . . . . 0.0 111.25 -169.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -163.82 -38.28 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.396 1.878 . . . . 0.0 114.023 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.49 164.86 40.96 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 127.377 2.271 . . . . 0.0 109.593 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -87.65 15.09 2.22 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.395 2.063 . . . . 0.0 114.26 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.12 -30.23 67.98 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.135 1.334 . . . . 0.0 113.239 -170.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.29 8.37 18.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.538 1.535 . . . . 0.0 114.259 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.17 127.64 33.5 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.938 -1.101 . . . . 0.0 112.045 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.53 14.05 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 126.201 1.8 . . . . 0.0 111.574 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 31' ' ' THR . 2.6 tm? 57.72 109.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.427 3.091 . . . . 0.0 110.439 -168.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -85.68 51.89 2.32 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.071 -1.643 . . . . 0.0 112.838 -167.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.31 0.4 OUTLIER -70.44 -11.82 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.744 -1.223 . . . . 0.0 113.564 -169.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -52.66 -34.09 50.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.362 . . . . 0.0 111.077 167.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.53 -58.39 1.85 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 113.002 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.82 -43.53 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 118.301 1.051 . . . . 0.0 113.312 -174.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.96 64.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.996 1.271 . . . . 0.0 112.642 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 73.8 m -70.03 -38.77 75.97 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 112.097 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.93 -24.98 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.728 1.611 . . . . 0.0 114.011 -169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.4 m -43.56 -56.25 7.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 120.283 1.401 . . . . 0.0 113.525 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.62 -9.43 18.29 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.038 2.492 . . . . 0.0 114.587 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.94 -64.52 1.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.098 1.359 . . . . 0.0 112.225 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.479 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -71.86 -21.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -174.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.68 -40.76 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.845 1.202 . . . . 0.0 112.17 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -80.67 -47.93 13.33 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.218 1.007 . . . . 0.0 111.307 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' B' ' 151' ' ' ILE . . . -65.67 -37.39 86.38 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.543 -1.348 . . . . 0.0 113.069 -169.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 35.0 m -76.26 -8.66 57.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.94 -37.27 14.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.111 1.323 . . . . 0.0 111.685 169.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -75.64 -31.51 59.86 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -129.02 54.3 1.81 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.702 1.201 . . . . 0.0 111.752 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -52.35 -32.21 37.15 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.861 1.664 . . . . 0.0 113.075 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -90.02 -6.63 55.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.301 1.44 . . . . 0.0 114.05 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.2 156.71 31.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.95 0.796 . . . . 0.0 110.867 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -69.19 137.59 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.659 -0.651 . . . . 0.0 110.738 176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -65.36 -38.63 90.66 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.062 -1.024 . . . . 0.0 112.721 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -59.35 -37.88 78.98 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.426 -0.796 . . . . 0.0 112.833 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.8 -35.27 76.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.27 0.628 . . . . 0.0 111.96 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -72.95 -37.9 66.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.237 -0.887 . . . . 0.0 113.235 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 14.2 m -64.45 -38.19 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.127 1.33 . . . . 0.0 111.285 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -63.79 -44.86 92.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.38 0.672 . . . . 0.0 111.948 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.1 98.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.303 0.954 . . . . 0.0 113.256 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -73.54 -36.06 65.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.464 1.132 . . . . 0.0 113.066 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -57.89 -41.57 82.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.406 1.003 . . . . 0.0 111.408 171.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.26 -47.56 81.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.603 1.161 . . . . 0.0 111.231 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -26.59 68.59 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.487 -1.383 . . . . 0.0 112.452 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.72 -46.62 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.982 1.713 . . . . 0.0 112.914 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -100.44 -58.49 1.89 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -63.57 -36.75 84.81 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.724 1.21 . . . . 0.0 111.3 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.58 48.37 21.51 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.245 2.218 . . . . 0.0 113.485 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 C--O 1.254 1.299 0 C-N-CA 126.541 1.936 . . . . 0.0 114.352 -176.361 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.86 -26.49 66.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.24 47.8 23.16 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -69.93 -74.22 0.14 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.382 0.673 . . . . 0.0 111.741 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 41.44 46.19 2.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.165 2.186 . . . . 0.0 114.266 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.43 36.26 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.447 1.899 . . . . 0.0 115.349 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.84 -22.32 62.34 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.349 -1.469 . . . . 0.0 112.206 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.03 -21.14 66.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.706 1.202 . . . . 0.0 113.699 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -126.77 21.81 6.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.535 1.534 . . . . 0.0 111.989 169.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 35.3 73.4 0.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.31 2.644 . . . . 0.0 114.504 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -113.1 58.17 0.63 Allowed Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 124.841 1.256 . . . . 0.0 114.209 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.27 169.44 18.27 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.22 2.613 . . . . 0.0 112.137 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -62.67 -15.26 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -96.88 2.1 51.31 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.476 1.51 . . . . 0.0 113.607 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 m -137.97 -17.95 1.21 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.18 173.19 11.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.8 p -105.63 159.43 15.97 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.051 0.941 . . . . 0.0 111.706 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -21.32 43.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.63 -37.52 70.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.617 1.099 . . . . 0.0 111.46 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -67.68 -23.29 65.29 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.128 -0.983 . . . . 0.0 112.628 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.53 -11.05 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.877 -1.139 . . . . 0.0 111.908 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.1 mt -98.34 -11.02 22.95 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.269 1.428 . . . . 0.0 112.663 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.96 -30.96 44.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.151 0.98 . . . . 0.0 111.73 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.85 137.23 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.767 2.027 . . . . 0.0 111.07 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.26 158.24 26.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 113.198 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -53.81 -33.47 56.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.956 1.302 . . . . 0.0 111.974 173.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 m -60.83 -27.71 68.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 113.623 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -127.18 -2.26 6.37 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 113.408 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.45 -43.44 98.08 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 119.91 -1.744 . . . . 0.0 112.348 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -60.84 -25.95 82.18 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.851 2.368 . . . . 0.0 113.367 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 HD21 ' B' ' 139' ' ' LEU . 52.3 m -76.23 -34.76 59.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.061 0.944 . . . . 0.0 111.531 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.63 1.172 . . . . 0.0 113.348 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.88 -34.54 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.92 0.782 . . . . 0.0 110.436 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.1 -46.05 79.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.614 1.578 . . . . 0.0 114.902 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.6 -41.62 83.75 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 121.361 2.58 . . . . 0.0 111.953 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.14 98.78 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.474 0.71 . . . . 0.0 112.173 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -85.24 -38.65 18.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.308 0.643 . . . . 0.0 112.524 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.93 -52.24 63.8 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.28 -1.512 . . . . 0.0 111.146 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.51 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -72.58 -18.24 61.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.123 0.569 . . . . 0.0 111.726 -174.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -72.5 -21.71 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.128 0.971 . . . . 0.0 113.029 174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -98.04 -20.32 17.45 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.33 153.89 1.61 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 129.156 2.983 . . . . 0.0 106.56 -170.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.41 -17.92 19.39 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 128.836 2.854 . . . . 0.0 115.035 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -133.28 152.58 79.67 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.414 1.885 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -86.41 4.46 6.37 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.793 1.662 . . . . 0.0 114.503 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.15 -24.6 63.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.486 1.114 . . . . 0.0 112.439 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -111.36 15.38 21.37 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.536 1.934 . . . . 0.0 112.579 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.57 117.13 22.93 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 119.769 -1.832 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.28 107.92 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD21 HG22 ' B' ' 120' ' ' THR . 1.7 tm? -57.32 126.77 28.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -165.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -98.01 52.25 1.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.422 1.489 . . . . 0.0 112.298 -170.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.24 -30.75 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 121.128 -0.983 . . . . 0.0 112.16 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -60.27 -34.78 74.21 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.256 1.389 . . . . 0.0 112.064 175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.31 -55.06 5.3 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.204 0.906 . . . . 0.0 112.835 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.19 -42.24 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.026 -1.279 . . . . 0.0 112.394 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.28 64.99 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.687 -1.258 . . . . 0.0 112.872 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -69.8 -44.07 70.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 0.0 111.616 172.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.5 -20.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -43.23 -62.51 1.33 Allowed Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 125.751 1.62 . . . . 0.0 112.371 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.17 -0.6 6.66 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.743 2.962 . . . . 0.0 114.485 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.68 -61.37 1.69 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.743 1.617 . . . . 0.0 109.766 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.14 -35.01 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.72 0.808 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.94 -43.6 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.872 0.869 . . . . 0.0 112.217 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.53 -46.83 45.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.356 0.598 . . . . 0.0 110.164 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.02 72.06 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.885 0.874 . . . . 0.0 113.039 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -75.86 -13.26 60.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.61 -33.68 16.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.111 1.323 . . . . 0.0 111.072 167.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -59.67 -40.44 87.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.403 1.081 . . . . 0.0 111.714 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -138.95 71.72 1.39 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.07 1.348 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -51.99 -31.17 28.2 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.649 1.18 . . . . 0.0 113.149 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -92.32 1.29 57.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 113.067 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.59 150.98 42.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.083 0.953 . . . . 0.0 112.053 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -93.38 103.03 15.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.938 1.295 . . . . 0.0 112.451 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . 0.258 14.7 p90 43.12 -144.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -53.88 -17.13 2.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.644 2.778 . . . . 0.0 115.176 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.13 -27.84 62.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.168 0.987 . . . . 0.0 112.41 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -65.99 -43.34 88.06 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.733 1.151 . . . . 0.0 112.42 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.99 -38.08 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.138 0.881 . . . . 0.0 111.126 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -63.07 -45.18 93.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.703 0.801 . . . . 0.0 111.874 171.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.82 -43.5 98.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.93 1.252 . . . . 0.0 113.261 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.96 -35.33 69.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.039 1.42 . . . . 0.0 112.754 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -61.48 -41.26 96.99 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.909 -1.119 . . . . 0.0 111.479 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.91 -46.43 89.39 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.649 1.18 . . . . 0.0 111.853 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -26.66 68.48 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.004 -1.06 . . . . 0.0 111.735 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.1 mt -81.69 -45.49 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.28 1.032 . . . . 0.0 112.351 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -104.42 -59.04 1.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.342 1.457 . . . . 0.0 113.217 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.08 -28.68 67.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.809 1.643 . . . . 0.0 113.631 -171.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.91 -56.6 4.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.774 0.829 . . . . 0.0 113.022 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.992 2.117 . . . . 0.0 110.966 178.264 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -82.86 -9.39 59.34 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.46 174.97 10.05 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.02 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 57.09 -88.95 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.004 1.722 . . . . 0.0 114.051 -174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -96.26 28.51 3.22 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -169.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.11 -27.13 42.91 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.259 1.023 . . . . 0.0 112.42 171.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.79 152.53 43.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.491 1.917 . . . . 0.0 110.01 167.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -107.59 -19.04 13.68 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.308 1.443 . . . . 0.0 114.1 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -77.09 -9.77 58.95 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.733 -1.23 . . . . 0.0 113.521 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -74.63 -82.23 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.52 1.928 . . . . 0.0 115.777 -170.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -129.43 57.19 28.68 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.103 1.761 . . . . 0.0 114.585 -171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.48 157.85 6.51 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.178 2.585 . . . . 0.0 114.175 168.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -58.32 -22.98 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -79.12 -18.1 53.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.226 . . . . 0.0 114.147 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 95.0 p -127.4 -23.16 3.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.49 161.64 30.53 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.962 0.887 . . . . 0.0 112.845 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 50.1 p -93.99 167.2 11.75 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.646 1.212 . . . . 0.0 114.086 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -66.83 -26.55 66.98 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.08 -40.93 97.32 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.977 -1.077 . . . . 0.0 110.495 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.1 -31.4 72.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.106 0.563 . . . . 0.0 112.069 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -69.75 -26.75 64.46 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.732 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.47 -11.85 59.62 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.031 -1.043 . . . . 0.0 113.666 170.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.27 38.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.315 0.961 . . . . 0.0 112.866 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.51 141.91 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.045 1.738 . . . . 0.0 110.823 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.17 157.79 32.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.374 1.069 . . . . 0.0 113.346 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.34 -31.48 54.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.551 1.54 . . . . 0.0 112.04 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -61.54 -27.92 68.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.8 1.64 . . . . 0.0 114.079 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -127.62 -4.37 5.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.365 1.466 . . . . 0.0 112.697 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -57.02 -45.89 99.92 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 120.078 -1.639 . . . . 0.0 111.696 169.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -64.95 -22.52 62.69 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.356 2.038 . . . . 0.0 113.67 171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.684 HG22 HD21 ' A' ' 50' ' ' LEU . 65.0 m -73.26 -35.81 66.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.988 0.915 . . . . 0.0 110.531 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.4 -41.91 84.16 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.04 -33.53 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.243 1.383 . . . . 0.0 110.875 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.94 -55.14 29.41 Favored Glycine 0 C--O 1.216 -0.971 0 C-N-CA 124.485 1.041 . . . . 0.0 111.912 168.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.76 -10.7 29.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 120.857 2.329 . . . . 0.0 114.408 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.15 -62.76 1.37 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.54 0.736 . . . . 0.0 110.051 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -73.43 -28.97 62.26 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.72 -1.237 . . . . 0.0 114.115 -169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.82 78.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.102 1.761 . . . . 0.0 112.274 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -85.53 -37.79 19.26 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.737 1.215 . . . . 0.0 110.082 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -59.58 -38.67 81.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.59 1.156 . . . . 0.0 113.381 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -91.4 -9.59 44.17 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 -128.49 0.09 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.663 1.585 . . . . 0.0 110.974 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -162.6 -55.97 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.279 1.431 . . . . 0.0 113.24 -170.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -135.76 165.6 34.8 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 127.283 2.233 . . . . 0.0 109.834 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.08 2.09 8.72 Favored 'Trans proline' 0 C--N 1.354 0.868 0 CA-C-N 121.429 1.546 . . . . 0.0 114.136 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.22 -28.36 67.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.446 1.098 . . . . 0.0 112.6 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.93 -20.23 30.98 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.281 1.432 . . . . 0.0 113.306 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.62 123.9 24.91 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.021 -1.049 . . . . 0.0 112.983 -169.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.31 17.18 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 126.202 1.801 . . . . 0.0 110.897 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 31' ' ' THR . 1.7 tm? 52.63 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.983 3.713 . . . . 0.0 110.127 -166.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.14 48.77 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.488 . . . . 0.0 112.425 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.289 3.9 p -70.77 -11.44 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -169.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.26 -29.73 24.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.611 1.564 . . . . 0.0 112.921 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.68 -55.62 1.88 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.71 0.671 . . . . 0.0 113.128 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 10.1 mt -51.16 -45.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.8 1.24 . . . . 0.0 113.282 -172.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.29 -28.79 63.32 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.611 1.096 . . . . 0.0 112.848 -175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 18.8 m -73.38 -41.59 63.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.897 1.279 . . . . 0.0 111.908 170.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.405 HG12 HD12 ' B' ' 151' ' ' ILE . 34.4 t -78.81 -28.9 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.076 1.75 . . . . 0.0 112.89 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.0 m -51.75 -63.76 1.88 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 125.697 1.599 . . . . 0.0 113.144 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.23 -18.59 61.34 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.745 2.297 . . . . 0.0 113.219 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.7 -58.84 3.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.893 0.877 . . . . 0.0 110.802 172.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.405 HD12 HG12 ' B' ' 147' ' ' VAL . 31.8 mt -72.59 -28.92 28.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 O-C-N 121.372 -0.83 . . . . 0.0 112.402 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -51.1 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.45 1.1 . . . . 0.0 110.618 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.22 -47.42 70.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.719 0.408 . . . . 0.0 110.903 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.09 71.18 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.739 -1.225 . . . . 0.0 113.239 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 21.3 m -75.35 -12.7 60.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.09 -35.55 16.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.483 1.492 . . . . 0.0 110.945 167.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -58.1 -38.13 75.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.009 0.924 . . . . 0.0 111.95 170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.6 57.33 1.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.567 1.147 . . . . 0.0 112.85 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -52.12 -40.33 61.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.047 1.739 . . . . 0.0 112.968 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -80.53 -7.58 59.26 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -85.07 165.6 17.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.239 1.016 . . . . 0.0 112.657 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -62.57 138.79 58.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.851 1.261 . . . . 0.0 110.739 170.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -58.41 -43.7 88.75 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.253 1.021 . . . . 0.0 113.294 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -65.19 -30.53 71.44 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.224 -0.923 . . . . 0.0 112.446 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -59.69 -38.46 81.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.472 1.109 . . . . 0.0 112.128 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -39.57 72.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.87 0.868 . . . . 0.0 112.577 172.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.91 -47.03 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 118.594 0.634 . . . . 0.0 110.302 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.16 -50.06 65.24 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.466 1.106 . . . . 0.0 111.921 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.63 98.94 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.599 1.095 . . . . 0.0 113.779 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -73.96 -33.14 63.77 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.751 1.275 . . . . 0.0 112.584 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.81 -37.26 86.04 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.965 -1.084 . . . . 0.0 111.852 170.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.83 -46.77 86.36 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.352 -0.843 . . . . 0.0 111.048 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -23.18 66.41 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 119.91 -1.744 . . . . 0.0 112.609 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 16.4 mt -78.05 -46.58 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.358 1.863 . . . . 0.0 112.74 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.43 -52.88 3.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.904 1.281 . . . . 0.0 113.203 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -68.8 -37.78 79.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.39 1.476 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 25.6 t0 51.52 49.76 20.24 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.471 1.908 . . . . 0.0 112.956 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.93 1.692 . . . . 0.0 113.267 -179.276 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -140.95 41.66 1.82 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.497 1.519 . . . . 0.0 110.461 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.67 147.9 20.64 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.006 1.323 . . . . 0.0 109.154 -169.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -169.63 -161.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.042 0.937 . . . . 0.0 111.417 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -68.82 -34.66 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -168.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.43 -96.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.704 1.602 . . . . 0.0 113.798 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.6 1.2 56.75 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.386 1.474 . . . . 0.0 114.544 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.9 -4.73 0.59 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.124 2.57 . . . . 0.0 116.169 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -130.68 5.15 4.65 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -169.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -90.7 -46.77 8.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -125.2 41.44 0.63 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.635 1.174 . . . . 0.0 113.549 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -65.83 153.97 75.9 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 112.426 -171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.81 -29.28 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.306 1.443 . . . . 0.0 114.507 -169.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -79.19 -15.96 57.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 114.13 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 t -110.95 -38.23 5.15 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 113.345 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -85.25 169.85 13.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 122.309 1.052 . . . . 0.0 113.597 -171.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.5 p -99.93 161.15 13.79 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -19.51 49.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.572 1.949 . . . . 0.0 115.171 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.81 -34.98 70.23 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.792 1.178 . . . . 0.0 111.049 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.89 -26.53 68.65 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.081 -1.012 . . . . 0.0 112.802 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -70.66 -13.31 62.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.246 -0.909 . . . . 0.0 112.146 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.13 -19.36 18.72 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.644 1.178 . . . . 0.0 112.117 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.25 -37.45 32.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.759 1.224 . . . . 0.0 112.163 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.89 134.38 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 0.0 109.604 168.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.76 160.48 22.89 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.436 1.095 . . . . 0.0 112.513 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -58.36 -36.63 73.76 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.134 -0.979 . . . . 0.0 111.788 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.6 m -59.65 -26.92 65.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.222 1.809 . . . . 0.0 113.728 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.45 -2.9 9.94 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.465 1.506 . . . . 0.0 112.76 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.2 mt-30 -59.07 -50.48 87.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 120.049 -1.657 . . . . 0.0 111.025 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 29' ' ' GLN . 52.4 Cg_exo -67.69 -16.85 47.34 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.294 1.996 . . . . 0.0 113.622 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 m -75.75 -36.14 59.97 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.134 0.974 . . . . 0.0 110.912 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.18 83.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.464 1.106 . . . . 0.0 111.418 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.82 -47.41 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.257 1.023 . . . . 0.0 109.567 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 10.64 0.58 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.824 2.155 . . . . 0.0 117.209 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.64 -53.72 2.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.408 1.604 . . . . 0.0 109.945 167.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.7 85.11 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.221 -0.925 . . . . 0.0 112.655 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.3 -37.06 26.36 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.303 -0.873 . . . . 0.0 112.26 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.55 -49.21 72.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.993 -1.067 . . . . 0.0 111.778 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -18.32 61.03 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.956 0.902 . . . . 0.0 112.061 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -78.25 -21.97 49.06 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.062 -1.024 . . . . 0.0 112.916 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.69 -20.48 20.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.98 151.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.883 2.873 . . . . 0.0 106.969 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.95 -32.85 17.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.936 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -134.61 159.51 71.94 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 127.386 2.274 . . . . 0.0 109.736 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.2 15.92 2.05 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.698 1.599 . . . . 0.0 114.426 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -61.75 -21.96 64.98 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.935 1.294 . . . . 0.0 112.307 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -117.31 20.14 13.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.646 1.979 . . . . 0.0 112.438 173.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.85 109.38 16.93 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 119.493 -2.004 . . . . 0.0 110.875 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.94 8.03 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.038 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.839 HD21 HG22 ' B' ' 120' ' ' THR . 1.6 tm? 49.17 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.518 3.927 . . . . 0.0 114.67 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -89.46 64.51 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.028 1.331 . . . . 0.0 111.475 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' CG ' ' B' ' 117' ' ' PHE . 0.7 OUTLIER -64.25 -39.1 84.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 118.217 -0.897 . . . . 0.0 112.073 -171.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.91 -36.55 84.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.366 1.439 . . . . 0.0 112.415 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.48 -48.91 59.9 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.676 0.655 . . . . 0.0 112.029 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.15 -42.79 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.528 1.131 . . . . 0.0 111.745 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.68 62.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.891 1.676 . . . . 0.0 113.159 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.1 m -72.62 -37.88 67.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.826 1.25 . . . . 0.0 111.463 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.81 -24.33 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.373 1.469 . . . . 0.0 113.626 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.8 m -49.65 -62.93 2.01 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 125.665 1.586 . . . . 0.0 112.619 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.93 -4.21 11.99 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.402 2.735 . . . . 0.0 113.926 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.35 -64.56 1.16 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.364 1.466 . . . . 0.0 108.807 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.94 -27.59 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.269 -0.894 . . . . 0.0 112.028 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -55.51 -48.43 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.674 1.189 . . . . 0.0 110.727 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.34 -48.06 18.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.546 0.688 . . . . 0.0 110.544 174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.71 69.89 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -169.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.1 m -76.94 -13.39 59.98 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -32.82 21.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.426 1.466 . . . . 0.0 110.757 168.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -61.24 -38.61 87.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.739 0.815 . . . . 0.0 112.089 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -135.81 58.72 1.74 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.379 1.471 . . . . 0.0 112.814 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -50.75 -36.1 34.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.562 -1.337 . . . . 0.0 113.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.61 -3.77 58.12 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.995 1.318 . . . . 0.0 113.624 -172.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.34 161.56 23.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.264 1.026 . . . . 0.0 111.496 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -65.52 134.64 53.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.844 1.258 . . . . 0.0 111.412 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -66.06 -52.27 50.52 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.397 -0.815 . . . . 0.0 112.826 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -62.33 -34.16 76.09 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.576 1.08 . . . . 0.0 112.297 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.6 -36.24 82.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.476 0.71 . . . . 0.0 112.152 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.0 -34.29 68.76 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.54 -46.2 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.089 0.556 . . . . 0.0 110.018 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -62.59 -43.4 98.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.763 0.825 . . . . 0.0 112.185 172.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.92 -44.38 98.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.018 1.294 . . . . 0.0 113.545 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.19 -35.1 68.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.784 1.292 . . . . 0.0 112.864 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -61.99 -38.06 87.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.909 1.232 . . . . 0.0 112.127 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.68 -49.85 75.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.537 1.135 . . . . 0.0 111.214 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -28.54 69.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.371 -1.456 . . . . 0.0 112.458 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.0 mt -77.98 -43.9 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.816 1.246 . . . . 0.0 112.541 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -102.48 -58.92 1.79 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.96 1.304 . . . . 0.0 113.223 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -66.42 -36.56 83.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.221 1.408 . . . . 0.0 111.316 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.67 42.9 24.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.939 2.096 . . . . 0.0 113.402 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.3 ttm . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.45 1.5 . . . . 0.0 112.592 -179.787 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.31 -25.81 1.93 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.89 51.9 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.282 -0.886 . . . . 0.0 112.641 -170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 58.99 -48.02 0.06 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.374 2.67 . . . . 0.0 116.232 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -73.95 9.96 1.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -171.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.48 128.25 36.12 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.609 -0.682 . . . . 0.0 110.529 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.02 23.48 0.46 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.084 0.954 . . . . 0.0 113.088 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -59.04 -29.41 67.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.775 1.23 . . . . 0.0 113.708 -168.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -140.29 30.98 1.94 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.182 2.593 . . . . 0.0 108.64 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 60.6 -50.5 0.1 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 129.499 3.12 . . . . 0.0 115.278 -167.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 52.44 28.73 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 127.922 2.489 . . . . 0.0 117.432 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.26 158.32 54.89 Favored 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 122.838 2.049 . . . . 0.0 110.962 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.41 -24.46 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -70.85 -25.91 63.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.259 1.024 . . . . 0.0 113.445 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.5 m -126.82 -18.5 4.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.27 1.428 . . . . 0.0 114.73 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -86.68 170.59 11.66 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.013 1.725 . . . . 0.0 111.835 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.3 p -104.45 156.24 18.11 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.342 1.057 . . . . 0.0 113.142 -170.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . 0.353 0.3 OUTLIER -73.63 -3.21 26.65 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.98 -31.6 65.22 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.851 -1.155 . . . . 0.0 111.353 168.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.38 -35.75 60.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.226 1.01 . . . . 0.0 112.754 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.25 -15.47 63.58 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.214 -0.929 . . . . 0.0 112.64 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 45.5 mt -92.2 -19.22 22.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.164 0.986 . . . . 0.0 112.764 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.48 -25.69 20.18 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.555 1.542 . . . . 0.0 112.954 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.93 -2.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 t70 66.12 157.85 0.11 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 128.232 2.613 . . . . 0.0 116.611 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -55.47 -35.21 65.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.969 1.308 . . . . 0.0 112.155 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 30.4 m -69.04 -24.09 64.14 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 52' ' ' VAL . 9.9 m-85 -127.71 4.67 6.09 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.546 1.138 . . . . 0.0 112.547 -174.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.84 -52.07 77.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 125.71 1.604 . . . . 0.0 111.998 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -61.52 -23.7 77.0 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.323 2.016 . . . . 0.0 113.573 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.839 HG22 HD21 ' A' ' 50' ' ' LEU . 23.2 m -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.007 1.323 . . . . 0.0 111.171 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.43 82.4 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.665 1.186 . . . . 0.0 113.793 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.5 -33.85 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 119.627 1.103 . . . . 0.0 110.458 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.8 -51.56 44.18 Favored Glycine 0 C--O 1.216 -0.973 0 C-N-CA 124.347 0.975 . . . . 0.0 112.795 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.65 -16.81 64.09 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.87 2.335 . . . . 0.0 113.862 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.78 -43.7 12.32 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.55 1.068 . . . . 0.0 112.211 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.55 -34.01 23.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.002 -1.061 . . . . 0.0 113.548 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.24 99.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.864 2.066 . . . . 0.0 112.69 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -34.19 34.47 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.242 1.017 . . . . 0.0 110.583 -175.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.09 -28.4 68.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -94.02 -1.73 54.05 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.53 -127.31 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.598 1.559 . . . . 0.0 111.248 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.26 -55.67 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.604 1.562 . . . . 0.0 113.513 -170.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -136.41 162.32 57.02 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 126.763 2.025 . . . . 0.0 110.446 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.31 6.01 5.05 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.729 1.619 . . . . 0.0 114.979 -174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.0 -29.37 43.03 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.944 0.898 . . . . 0.0 111.496 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -112.32 17.67 19.21 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.215 2.206 . . . . 0.0 113.117 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.94 134.78 38.54 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.174 -1.579 . . . . 0.0 113.955 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.41 -4.54 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 125.013 1.325 . . . . 0.0 113.828 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.26 119.16 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.878 2.471 . . . . 0.0 111.52 -167.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -81.95 53.25 2.15 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 119.608 -1.932 . . . . 0.0 112.016 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.404 0.6 OUTLIER -65.38 -46.9 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -163.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -60.54 -34.38 74.05 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 121.909 2.14 . . . . 0.0 111.783 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.35 -48.93 48.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.188 0.899 . . . . 0.0 112.424 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.21 -42.18 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 111.443 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.54 71.2 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.682 1.128 . . . . 0.0 112.817 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -66.35 -38.89 88.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.709 1.204 . . . . 0.0 111.682 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.6 -30.36 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.508 1.523 . . . . 0.0 113.212 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 37.0 m -45.19 -56.11 9.95 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 -7.59 16.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.445 2.763 . . . . 0.0 114.593 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -61.97 1.69 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.099 1.36 . . . . 0.0 111.658 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.454 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -70.77 -20.18 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 120.884 -1.135 . . . . 0.0 113.972 -176.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.39 -41.88 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.581 1.537 . . . . 0.0 112.018 175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.01 -51.25 10.63 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 110.436 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.14 69.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.361 -1.462 . . . . 0.0 113.38 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 78.9 m -80.17 -7.37 58.91 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.73 -34.56 14.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.341 1.056 . . . . 0.0 110.44 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -60.91 -39.7 90.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.517 1.127 . . . . 0.0 112.229 171.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -142.49 54.85 1.42 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.948 0.899 . . . . 0.0 112.906 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -53.73 -37.24 63.13 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.427 1.891 . . . . 0.0 113.302 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.71 -8.85 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.842 1.257 . . . . 0.0 113.84 -169.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -83.88 166.81 17.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 112.078 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.57 139.0 56.49 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.172 1.389 . . . . 0.0 112.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -63.79 -46.97 82.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.564 1.146 . . . . 0.0 111.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -64.03 -38.52 91.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.854 0.862 . . . . 0.0 112.188 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.926 0.89 . . . . 0.0 111.952 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' B' ' 166' ' ' LYS . 0.1 OUTLIER -71.94 -43.39 65.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.189 -0.91 . . . . 0.0 113.234 174.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.37 -40.41 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.182 1.355 . . . . 0.0 111.669 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.11 -42.99 93.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.875 0.87 . . . . 0.0 112.258 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.2 -45.3 96.81 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.312 0.958 . . . . 0.0 112.983 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.77 -33.74 64.4 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.485 1.142 . . . . 0.0 112.973 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -59.43 -41.83 90.45 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.862 1.21 . . . . 0.0 111.943 170.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.51 -47.26 84.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.562 1.145 . . . . 0.0 111.943 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.36 68.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.161 -0.962 . . . . 0.0 112.061 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.49 -50.89 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.886 1.674 . . . . 0.0 112.175 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -100.79 -59.71 1.65 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.33 1.452 . . . . 0.0 113.322 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -67.66 -25.2 65.59 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.245 1.818 . . . . 0.0 113.749 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.1 -19.55 65.66 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.393 1.477 . . . . 0.0 114.307 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.121 1.768 . . . . 0.0 114.574 -176.763 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.82 -14.63 31.5 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.16 177.58 8.87 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.147 1.379 . . . . 0.0 111.222 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 62.69 -54.6 0.16 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.171 2.588 . . . . 0.0 115.238 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.615 ' HE2' HG12 ' B' ' 138' ' ' VAL . 20.8 mmmt -78.5 -11.36 59.95 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.202 1.001 . . . . 0.0 113.266 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.91 -76.12 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 129.294 3.037 . . . . 0.0 116.505 168.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.38 90.86 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.952 0.796 . . . . 0.0 111.951 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.03 -34.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 129.452 3.101 . . . . 0.0 118.072 171.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -80.62 -1.05 40.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.279 1.432 . . . . 0.0 114.148 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.52 -175.5 4.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.563 1.945 . . . . 0.0 112.791 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 59.35 49.45 2.52 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 127.324 2.25 . . . . 0.0 114.927 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.53 163.95 37.33 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.669 2.912 . . . . 0.0 112.434 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.97 -20.08 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.107 1.363 . . . . 0.0 114.417 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -72.7 -35.31 67.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.105 0.962 . . . . 0.0 113.523 173.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.8 m -110.5 -21.89 11.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.769 1.227 . . . . 0.0 114.112 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -94.37 171.27 8.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.2 1.4 . . . . 0.0 112.219 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.5 p -107.5 166.21 10.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.838 1.304 . . . . 0.0 114.498 -168.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -19.18 35.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.983 1.713 . . . . 0.0 115.436 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -55.49 -32.81 63.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.92 1.236 . . . . 0.0 111.365 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.83 -32.21 67.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.939 0.896 . . . . 0.0 112.728 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -74.05 -14.68 61.04 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.81 -0.556 . . . . 0.0 112.142 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.0 mt -96.45 -18.89 19.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.47 1.108 . . . . 0.0 112.281 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.76 54.12 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.425 1.09 . . . . 0.0 111.951 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.41 138.29 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.563 1.545 . . . . 0.0 110.652 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.23 160.51 31.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.287 1.035 . . . . 0.0 112.987 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.23 -37.43 74.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.696 1.198 . . . . 0.0 111.786 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.67 -20.84 63.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.526 1.53 . . . . 0.0 113.873 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -126.73 -2.91 6.62 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.237 1.415 . . . . 0.0 113.001 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -55.51 -47.71 98.02 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.143 -1.598 . . . . 0.0 111.91 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -62.45 -23.06 74.81 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.764 2.31 . . . . 0.0 113.804 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 HD21 ' B' ' 139' ' ' LEU . 27.6 m -77.02 -36.79 56.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.749 1.22 . . . . 0.0 110.977 175.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.45 98.44 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 113.519 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.91 -35.77 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 119.417 1.008 . . . . 0.0 110.329 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.54 -48.19 49.79 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.327 1.441 . . . . 0.0 114.571 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.44 -39.69 89.05 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 121.253 2.526 . . . . 0.0 112.306 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.54 76.16 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.467 -0.771 . . . . 0.0 112.528 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -85.22 -38.81 18.51 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.06 -52.52 62.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.37 1.068 . . . . 0.0 110.878 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.432 HD13 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -68.78 -18.24 64.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.503 1.121 . . . . 0.0 111.732 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -80.17 -17.46 52.36 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.209 1.004 . . . . 0.0 113.386 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.27 3.3 p30 -123.39 11.12 9.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -176.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 150.21 1.49 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 129.73 3.212 . . . . 0.0 106.504 168.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -86.41 -31.8 21.24 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 128.563 2.745 . . . . 0.0 113.204 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.59 158.09 73.9 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 127.518 2.327 . . . . 0.0 109.375 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.35 5.58 6.17 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.023 1.401 . . . . 0.0 114.046 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.7 -16.36 63.32 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.603 -1.311 . . . . 0.0 112.724 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -103.58 3.98 35.19 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.339 1.855 . . . . 0.0 113.22 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.69 122.67 26.28 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 119.981 -1.699 . . . . 0.0 112.654 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.53 -7.22 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 125.161 1.384 . . . . 0.0 112.271 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.866 HD21 HG22 ' B' ' 120' ' ' THR . 2.0 tm? 62.53 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.826 3.25 . . . . 0.0 113.224 -171.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.07 58.17 4.04 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.775 1.23 . . . . 0.0 111.453 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.6 p -65.94 -22.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.995 -1.066 . . . . 0.0 113.459 -169.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -62.85 -49.82 73.36 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 121.157 1.799 . . . . 0.0 112.076 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.23 76.8 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.3 -44.26 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.281 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.4 68.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.95 1.705 . . . . 0.0 112.858 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 m -68.77 -36.58 78.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 62' ' ' ILE . 73.5 t -90.8 -23.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.109 1.363 . . . . 0.0 113.523 -175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -44.27 -60.46 2.82 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 126.211 1.804 . . . . 0.0 112.477 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.5 -0.61 5.35 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.328 2.685 . . . . 0.0 114.462 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 -64.6 1.12 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.215 1.406 . . . . 0.0 110.584 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.04 -29.29 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.234 -0.916 . . . . 0.0 112.313 177.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 t -52.74 -48.33 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.988 1.315 . . . . 0.0 110.488 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.74 -47.88 11.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.435 0.636 . . . . 0.0 110.609 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.85 69.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.1 m -77.8 -12.05 59.94 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -33.64 16.66 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.133 1.333 . . . . 0.0 110.764 167.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -58.78 -38.63 78.93 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.507 1.123 . . . . 0.0 112.116 172.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -145.55 85.5 1.71 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.715 0.806 . . . . 0.0 112.293 170.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -57.73 -27.94 63.44 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.973 1.309 . . . . 0.0 112.505 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -92.26 -4.75 53.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.551 1.541 . . . . 0.0 112.943 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.54 154.37 41.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.542 1.137 . . . . 0.0 111.346 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -65.72 137.24 57.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.089 0.956 . . . . 0.0 111.544 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -64.04 -47.43 80.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.676 0.791 . . . . 0.0 112.64 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -61.69 -41.2 97.26 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.96 0.904 . . . . 0.0 111.479 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.28 -34.35 77.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.665 0.786 . . . . 0.0 112.34 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.58 -42.17 68.1 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.4 -0.81 . . . . 0.0 112.748 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.22 -38.53 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.159 1.345 . . . . 0.0 111.203 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -63.28 -45.1 93.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.179 0.592 . . . . 0.0 111.837 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.32 -44.71 97.28 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.958 1.266 . . . . 0.0 113.422 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.44 -35.41 70.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.972 1.386 . . . . 0.0 112.967 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -62.49 -41.26 98.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.644 1.111 . . . . 0.0 111.651 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -60.17 -48.82 80.12 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.788 1.235 . . . . 0.0 111.479 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -31.22 72.22 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.815 -1.178 . . . . 0.0 111.678 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.1 mt -76.93 -46.07 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.307 1.043 . . . . 0.0 112.375 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -101.89 -57.54 2.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.045 1.338 . . . . 0.0 113.136 -172.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -66.47 -34.94 79.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.88 1.272 . . . . 0.0 111.686 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t0 48.57 51.19 15.89 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.984 2.114 . . . . 0.0 112.828 171.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.459 1.904 . . . . 0.0 113.68 -175.178 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -106.08 -37.13 6.71 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -168.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.06 47.94 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -132.78 140.4 48.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 49.87 41.43 22.61 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.522 1.529 . . . . 0.0 114.62 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 152.35 45.69 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.253 0.621 . . . . 0.0 111.686 175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.37 12.32 2.48 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -76.34 -22.14 55.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.88 1.272 . . . . 0.0 112.67 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.68 52.42 1.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.768 2.427 . . . . 0.0 107.585 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -47.99 122.72 5.36 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -166.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.83 72.42 52.86 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 127.865 2.466 . . . . 0.0 108.014 168.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.57 -176.96 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.66 2.907 . . . . 0.0 113.05 -171.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.35 0.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -108.24 15.57 24.0 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.279 1.832 . . . . 0.0 112.652 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 28.4 m -144.08 -43.83 0.26 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -171.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.52 120.17 32.1 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.301 0.955 . . . . 0.0 111.726 -174.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 43.2 p -71.04 169.23 15.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.045 1.738 . . . . 0.0 114.41 -169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -24.88 17.74 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -58.0 -35.75 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.907 1.231 . . . . 0.0 111.578 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.33 -20.68 58.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.198 0.999 . . . . 0.0 113.208 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -67.66 -25.22 65.6 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.086 -1.009 . . . . 0.0 111.292 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.35 -13.85 56.24 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.335 1.054 . . . . 0.0 113.17 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.04 -36.36 30.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.388 1.075 . . . . 0.0 113.07 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.07 139.47 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.052 1.341 . . . . 0.0 110.212 169.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.81 160.48 30.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.466 1.106 . . . . 0.0 113.289 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -58.98 -34.87 72.32 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 0.0 111.885 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -62.37 -22.1 65.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.547 1.539 . . . . 0.0 113.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -127.3 -3.13 6.25 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.133 1.373 . . . . 0.0 113.208 -172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -60.95 -45.85 96.67 Favored Pre-proline 0 N--CA 1.476 0.829 0 O-C-N 119.957 -1.714 . . . . 0.0 111.937 170.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.28 -28.92 85.35 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.004 2.469 . . . . 0.0 113.13 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 50' ' ' LEU . 61.1 m -70.15 -38.49 75.48 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.487 1.115 . . . . 0.0 110.743 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.08 95.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.172 1.389 . . . . 0.0 114.457 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.74 -33.41 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 119.984 1.266 . . . . 0.0 110.824 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.99 -55.28 26.72 Favored Glycine 0 C--O 1.217 -0.937 0 C-N-CA 124.292 0.949 . . . . 0.0 112.65 169.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -64.81 -11.36 36.26 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.504 2.152 . . . . 0.0 114.386 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.61 -62.64 1.44 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.84 0.745 . . . . 0.0 110.169 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.46 -27.16 58.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.36 -41.57 89.58 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.634 1.573 . . . . 0.0 112.069 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -83.14 -38.63 22.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.828 1.251 . . . . 0.0 110.241 -178.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -59.42 -33.18 70.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.792 1.237 . . . . 0.0 113.603 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.34 -11.49 37.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -143.51 -123.31 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.66 1.118 . . . . 0.0 113.744 -171.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.95 -68.89 0.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.894 1.278 . . . . 0.0 112.94 -168.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -139.38 167.01 20.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 127.588 2.355 . . . . 0.0 109.4 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.18 6.26 4.82 Favored 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.331 1.868 . . . . 0.0 114.439 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.76 -19.98 64.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.391 1.477 . . . . 0.0 111.434 168.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -113.12 11.63 18.91 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.854 2.062 . . . . 0.0 113.378 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.05 129.74 35.62 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 119.991 -1.693 . . . . 0.0 113.301 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . 0.615 HG12 ' HE2' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -123.11 -6.05 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 125.03 1.332 . . . . 0.0 113.143 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.799 HD21 HG22 ' A' ' 31' ' ' THR . 1.4 tm? 61.21 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 129.855 3.262 . . . . 0.0 112.96 -169.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.13 60.35 1.19 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.361 -1.462 . . . . 0.0 111.849 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.297 2.4 p -66.11 -21.57 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 120.75 -1.219 . . . . 0.0 113.225 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.673 1.579 . . . . 0.0 112.522 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.44 -50.36 26.84 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mt -61.7 -43.21 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.642 0.777 . . . . 0.0 112.337 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.67 -28.46 64.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.548 1.522 . . . . 0.0 112.491 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 39.0 m -68.7 -42.67 77.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.112 0.965 . . . . 0.0 111.698 169.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . 0.435 HG12 HD12 ' B' ' 151' ' ' ILE . 31.5 t -84.24 -26.91 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.796 1.638 . . . . 0.0 113.503 -172.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.2 m -50.51 -63.38 1.88 Allowed Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 126.184 1.793 . . . . 0.0 113.087 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.52 -25.89 70.06 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.924 1.75 . . . . 0.0 112.334 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -57.83 9.85 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.447 1.099 . . . . 0.0 110.341 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.435 HD12 HG12 ' B' ' 147' ' ' VAL . 27.7 mt -71.96 -31.92 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 O-C-N 121.442 -0.786 . . . . 0.0 111.957 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.71 -51.15 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.351 1.061 . . . . 0.0 110.393 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.35 -45.99 68.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.767 0.317 . . . . 0.0 111.159 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.19 -30.75 71.84 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.658 -1.276 . . . . 0.0 113.226 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 29.2 m -73.85 -12.71 60.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -37.48 14.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.507 1.503 . . . . 0.0 110.78 166.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -57.3 -40.4 77.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.958 0.903 . . . . 0.0 111.806 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -142.15 72.71 1.38 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.481 1.112 . . . . 0.0 111.027 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -53.42 -31.06 43.4 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.116 1.766 . . . . 0.0 112.923 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.98 1.91 51.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.071 1.348 . . . . 0.0 113.114 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.41 152.98 36.66 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.278 1.431 . . . . 0.0 114.305 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.18 59.27 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.351 1.86 . . . . 0.0 113.334 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 46.0 -103.73 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 165.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -47.07 -33.34 4.81 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.682 2.393 . . . . 0.0 113.716 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.0 -36.52 79.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.411 1.084 . . . . 0.0 112.807 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.4 -33.34 63.0 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.238 -0.914 . . . . 0.0 112.353 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.5 -48.79 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.709 0.803 . . . . 0.0 110.121 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -63.08 -42.81 99.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.979 0.911 . . . . 0.0 112.172 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.4 94.55 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.85 1.214 . . . . 0.0 113.48 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.61 -35.36 67.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.561 1.18 . . . . 0.0 112.608 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -60.66 -37.66 82.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.609 1.095 . . . . 0.0 112.216 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.77 -45.56 92.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.324 1.05 . . . . 0.0 111.933 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -24.45 67.24 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.584 -1.322 . . . . 0.0 112.438 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.41 -46.04 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.517 1.927 . . . . 0.0 112.821 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.07 -59.97 1.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.193 1.397 . . . . 0.0 113.45 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -64.83 -25.77 68.05 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.182 1.793 . . . . 0.0 113.553 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.45 -24.17 67.11 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--O 1.255 1.369 0 C-N-CA 127.64 2.376 . . . . 0.0 114.428 177.842 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -128.08 -33.78 2.17 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.79 148.51 50.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.686 -1.259 . . . . 0.0 112.003 -172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 68.73 -31.39 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 127.666 2.386 . . . . 0.0 114.247 -170.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.23 -38.49 51.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.246 1.418 . . . . 0.0 111.315 171.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.52 -19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 130.8 3.64 . . . . 0.0 118.39 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.46 -7.7 1.72 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.655 1.582 . . . . 0.0 114.819 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 60.25 -36.83 0.08 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.129 2.972 . . . . 0.0 117.622 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -79.55 -12.15 59.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.504 1.121 . . . . 0.0 112.866 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.79 168.98 10.32 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.584 1.954 . . . . 0.0 112.087 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.6 mttt 60.06 28.64 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 117.812 2.523 . . . . 0.0 117.812 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.78 150.75 56.49 Favored 'Trans proline' 0 C--N 1.354 0.848 0 CA-C-N 122.408 1.896 . . . . 0.0 111.81 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.9 5.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.833 1.653 . . . . 0.0 115.031 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -122.27 11.24 10.06 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.027 2.131 . . . . 0.0 113.914 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 m -141.02 -27.79 0.7 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.06 -175.27 4.03 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -171.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.6 p -119.93 164.69 15.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.19 1.396 . . . . 0.0 114.391 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.12 -19.86 55.57 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.44 -37.14 79.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.228 1.376 . . . . 0.0 111.465 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.72 -20.3 63.53 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.377 -0.827 . . . . 0.0 112.934 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -67.02 -18.45 65.37 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.874 -1.141 . . . . 0.0 111.631 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.12 -6.75 41.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.193 1.397 . . . . 0.0 112.704 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.94 -34.1 17.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.648 1.179 . . . . 0.0 112.04 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.0 137.75 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.016 1.326 . . . . 0.0 109.954 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.27 160.25 29.69 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.184 0.993 . . . . 0.0 112.804 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -58.44 -36.58 73.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 m -62.08 -21.87 65.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.653 1.581 . . . . 0.0 113.743 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -126.27 -3.57 6.83 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.575 1.55 . . . . 0.0 112.684 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -59.46 -46.58 98.85 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 120.103 -1.623 . . . . 0.0 110.996 171.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -28.33 87.2 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.195 2.597 . . . . 0.0 113.564 169.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 m -72.27 -35.6 68.8 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.034 0.934 . . . . 0.0 111.423 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.26 81.35 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.819 1.248 . . . . 0.0 113.927 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -36.69 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 119.377 0.989 . . . . 0.0 110.845 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.52 63.58 Favored Glycine 0 C--O 1.214 -1.11 0 C-N-CA 124.326 0.965 . . . . 0.0 112.826 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.11 -18.09 65.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 121.276 2.538 . . . . 0.0 113.988 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.37 -57.72 3.04 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.471 0.578 . . . . 0.0 110.444 165.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -76.46 -21.24 56.14 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.18 94.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.344 1.458 . . . . 0.0 111.107 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -84.2 -40.15 18.48 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.509 1.123 . . . . 0.0 110.642 -178.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -62.18 -30.09 70.82 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -93.41 -5.31 49.68 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -124.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.005 1.322 . . . . 0.0 112.274 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -161.79 -58.3 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.24 1.416 . . . . 0.0 113.932 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.14 162.43 48.0 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 127.615 2.366 . . . . 0.0 110.678 -177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.22 -1.77 11.96 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.811 1.674 . . . . 0.0 114.693 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -54.91 -27.87 46.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.893 1.277 . . . . 0.0 113.423 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -95.54 -11.27 27.67 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.098 1.359 . . . . 0.0 113.846 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 121.78 26.24 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.674 -1.266 . . . . 0.0 113.754 -169.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.44 9.96 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 125.41 1.484 . . . . 0.0 111.701 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.742 HD21 HG22 ' B' ' 120' ' ' THR . 2.4 tm? 59.99 121.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 129.591 3.156 . . . . 0.0 111.992 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -87.11 45.62 1.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.619 -1.301 . . . . 0.0 111.963 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 3.0 p -66.19 -22.22 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.234 -1.541 . . . . 0.0 112.182 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.86 -33.5 66.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.845 1.258 . . . . 0.0 112.552 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.15 -59.56 1.94 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.619 1.104 . . . . 0.0 112.097 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.56 -44.77 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.709 -1.465 . . . . 0.0 112.949 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.97 -27.21 64.54 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.275 1.398 . . . . 0.0 112.435 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -66.96 -46.38 74.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.27 1.428 . . . . 0.0 111.955 170.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 62' ' ' ILE . 1.4 t -94.12 -18.08 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 m -42.52 -59.32 2.93 Favored Pre-proline 0 N--CA 1.492 1.642 0 C-N-CA 125.676 1.591 . . . . 0.0 112.588 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.65 -2.69 9.77 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.352 2.701 . . . . 0.0 114.539 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.81 -58.1 2.52 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.959 1.304 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -59.53 -36.5 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-N 120.489 1.495 . . . . 0.0 112.123 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.5 -49.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.821 1.248 . . . . 0.0 110.62 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.98 -45.52 34.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.655 0.741 . . . . 0.0 110.986 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.78 70.02 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.781 0.832 . . . . 0.0 112.954 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 18.3 m -75.48 -13.2 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 170.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.13 -36.09 18.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.797 1.635 . . . . 0.0 110.516 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -57.02 -38.65 73.45 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.253 1.021 . . . . 0.0 111.813 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -144.92 84.55 1.72 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.534 0.683 . . . . 0.0 111.768 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -54.98 -31.34 60.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.105 1.362 . . . . 0.0 112.188 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.68 -0.93 57.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.272 1.429 . . . . 0.0 112.909 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.65 144.58 56.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.252 1.021 . . . . 0.0 111.72 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -77.75 160.89 28.1 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 122.377 1.084 . . . . 0.0 113.669 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -40.58 151.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.563 2.745 . . . . 0.0 115.13 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt 62.03 -38.37 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 129.487 3.115 . . . . 0.0 116.309 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.73 -31.86 70.01 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.846 1.659 . . . . 0.0 112.174 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -69.67 -43.91 71.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.71 -0.619 . . . . 0.0 112.509 175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.03 -36.69 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.763 1.165 . . . . 0.0 111.459 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.15 -46.05 78.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.274 1.029 . . . . 0.0 111.949 173.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.87 96.97 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.824 1.202 . . . . 0.0 113.1 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -25.93 59.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.846 -1.385 . . . . 0.0 113.485 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -70.93 -42.32 70.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.479 -0.763 . . . . 0.0 111.248 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -58.23 -42.89 87.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.205 1.402 . . . . 0.0 111.68 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.18 -38.8 27.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.483 1.913 . . . . 0.0 114.212 170.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt -90.74 -42.53 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.241 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -102.96 -60.0 1.62 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 113.349 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -68.4 -25.65 65.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.347 1.459 . . . . 0.0 113.662 -171.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.99 -21.97 66.44 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.769 1.228 . . . . 0.0 114.07 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 125.198 1.399 . . . . 0.0 112.226 178.155 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -145.93 34.11 1.01 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.641 1.576 . . . . 0.0 111.005 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.38 146.0 24.17 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . 0.256 18.4 pt20 40.54 -47.14 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 1 C-N-CA 132.962 4.505 . . . . 0.0 121.418 171.805 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -10.25 59.58 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.102 1.774 . . . . 0.0 115.04 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.31 -26.49 68.08 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.07 -26.37 56.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.63 -36.16 0.19 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.843 2.457 . . . . 0.0 116.184 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -77.29 42.63 0.35 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.567 1.947 . . . . 0.0 112.05 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -93.4 174.17 7.34 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 128.233 2.613 . . . . 0.0 115.277 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.68 89.2 7.31 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 127.342 2.257 . . . . 0.0 110.276 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.84 168.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 1 C-N-CA 126.24 4.627 . . . . 0.0 114.798 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.57 -21.26 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -74.33 -19.99 60.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.688 1.195 . . . . 0.0 113.565 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 70.0 m -122.46 -20.86 5.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.849 2.46 . . . . 0.0 113.953 -177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -53.09 140.97 24.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.367 2.667 . . . . 0.0 111.556 172.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -98.6 168.12 10.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.869 1.319 . . . . 0.0 112.866 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.36 -28.35 67.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.035 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -61.22 -43.58 98.64 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.078 -1.014 . . . . 0.0 110.327 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -66.64 -30.11 70.29 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.449 0.7 . . . . 0.0 112.139 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.409 ' CD2' ' CE2' ' B' ' 163' ' ' PHE . 73.7 t80 -67.69 -31.87 72.13 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.317 -1.489 . . . . 0.0 111.751 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.78 -9.3 58.48 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.03 44.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.769 1.168 . . . . 0.0 112.353 172.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.42 135.18 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.663 1.585 . . . . 0.0 110.145 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.22 157.77 34.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.375 1.07 . . . . 0.0 112.888 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.28 -34.26 72.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.271 1.028 . . . . 0.0 111.851 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 67.3 m -61.24 -25.55 67.15 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.421 1.888 . . . . 0.0 113.973 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.0 -6.11 7.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.246 1.018 . . . . 0.0 113.73 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.86 -43.49 98.66 Favored Pre-proline 0 N--CA 1.476 0.858 0 O-C-N 120.204 -1.56 . . . . 0.0 113.389 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -61.71 -27.73 81.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.932 2.421 . . . . 0.0 113.046 170.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.742 HG22 HD21 ' A' ' 50' ' ' LEU . 26.2 m -74.24 -36.84 63.92 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.903 1.281 . . . . 0.0 111.294 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.19 93.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.015 1.326 . . . . 0.0 113.996 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.06 -33.07 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 119.422 1.01 . . . . 0.0 110.767 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.54 -51.08 50.49 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 125.492 1.52 . . . . 0.0 114.099 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.43 -32.78 74.59 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.283 2.542 . . . . 0.0 112.419 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.46 -54.02 19.7 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.046 0.839 . . . . 0.0 111.21 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.44 -22.59 40.98 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.63 -46.19 32.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.594 1.158 . . . . 0.0 111.056 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.41 HD13 HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -75.97 -33.99 59.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.009 -176.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -73.13 -10.3 59.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -101.61 -11.27 19.35 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.61 -129.07 0.07 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.084 1.354 . . . . 0.0 112.303 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -161.64 -51.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.141 1.776 . . . . 0.0 113.189 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -132.66 166.93 25.42 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.339 2.256 . . . . 0.0 109.757 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.87 12.43 2.87 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 114.183 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.78 -14.62 62.86 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.679 -1.263 . . . . 0.0 113.934 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -119.89 4.68 10.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 113.518 168.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.29 134.2 41.13 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.911 -1.118 . . . . 0.0 113.605 -169.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.37 136.6 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.902 2.081 . . . . 0.0 107.317 172.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.28 119.95 11.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.461 1.028 . . . . 0.0 109.163 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.4 54.65 3.23 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.698 -1.251 . . . . 0.0 110.996 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.366 1.5 p -67.03 -25.03 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -165.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -63.04 -41.63 99.56 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 121.161 1.801 . . . . 0.0 111.133 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.08 -49.31 34.73 Favored Glycine 0 N--CA 1.468 0.779 0 C-N-CA 123.984 0.802 . . . . 0.0 111.416 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 5.0 mt -60.22 -43.18 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.869 0.868 . . . . 0.0 111.533 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.15 -31.75 68.08 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 120.253 1.388 . . . . 0.0 112.726 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m -65.36 -42.84 92.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.097 0.959 . . . . 0.0 111.568 170.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 31.7 t -82.73 -29.41 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.978 1.311 . . . . 0.0 113.047 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 17.6 m -43.48 -61.05 2.06 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 126.113 1.765 . . . . 0.0 113.77 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.16 -14.44 44.35 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.577 2.185 . . . . 0.0 113.367 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.66 -63.47 1.16 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.131 0.972 . . . . 0.0 110.838 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.461 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.0 OUTLIER -66.94 -25.53 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.05 -1.031 . . . . 0.0 113.141 177.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.69 -51.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 119.605 1.093 . . . . 0.0 110.753 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.39 -47.21 51.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.935 0.397 . . . . 0.0 111.057 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.54 -28.32 69.08 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.662 -1.274 . . . . 0.0 113.175 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.96 -15.89 60.09 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 169.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -30.32 21.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 111.202 168.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -61.23 -38.38 86.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.875 0.87 . . . . 0.0 112.535 169.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.68 88.16 1.68 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.636 0.774 . . . . 0.0 111.922 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.93 -41.91 68.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.356 1.462 . . . . 0.0 111.579 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -79.51 -3.24 45.85 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.8 153.07 44.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.012 0.925 . . . . 0.0 112.071 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.69 134.0 46.01 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.818 0.847 . . . . 0.0 109.333 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.409 ' CE2' ' CD2' ' B' ' 110' ' ' PHE . 46.2 t80 -64.47 -41.18 96.64 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.289 -0.882 . . . . 0.0 112.663 -175.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -62.67 -40.14 96.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.209 0.913 . . . . 0.0 111.588 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.31 -38.97 93.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.557 0.743 . . . . 0.0 111.913 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.72 -37.14 73.48 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.953 0.797 . . . . 0.0 113.027 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.45 -48.33 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.173 0.989 . . . . 0.0 110.116 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -64.07 -47.36 80.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.989 0.916 . . . . 0.0 112.011 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.91 99.39 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.627 1.108 . . . . 0.0 113.269 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -73.12 -35.83 66.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.225 -1.162 . . . . 0.0 112.792 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -60.53 -38.16 83.54 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.633 1.106 . . . . 0.0 111.881 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.87 -44.68 96.32 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.395 -0.815 . . . . 0.0 111.611 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -19.33 65.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.838 -1.164 . . . . 0.0 112.558 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.3 -41.48 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.466 1.906 . . . . 0.0 112.973 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -108.92 -60.51 1.74 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.796 1.239 . . . . 0.0 113.441 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -62.68 -29.66 70.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.022 1.329 . . . . 0.0 113.468 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.2 -15.43 61.01 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 C--O 1.255 1.384 0 C-N-CA 124.96 1.304 . . . . 0.0 113.629 -172.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.97 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 55.6 -11.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 120.802 3.63 . . . . 0.0 120.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.58 27.16 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 121.575 1.989 . . . . 0.0 114.718 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.55 12.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.082 1.353 . . . . 0.0 112.854 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -123.68 28.86 6.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.363 1.865 . . . . 0.0 112.829 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.44 69.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.564 1.145 . . . . 0.0 113.548 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.87 88.19 6.35 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -73.52 49.77 0.3 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.184 2.194 . . . . 0.0 113.503 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -151.88 -25.29 0.19 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.739 1.616 . . . . 0.0 115.176 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER -94.43 -21.63 18.81 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 119.965 3.321 . . . . 0.0 119.965 -166.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -131.99 53.47 11.44 Favored Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 171.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.91 156.32 66.35 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.071 2.514 . . . . 0.0 114.035 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.53 -12.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -104.76 -4.26 22.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.318 1.447 . . . . 0.0 114.807 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 p -124.36 -28.31 3.67 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -92.5 151.84 19.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.151 0.977 . . . . 0.0 111.484 171.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.5 p -85.47 170.07 13.01 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -166.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.49 -18.78 3.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.845 1.658 . . . . 0.0 114.732 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -51.7 -28.99 16.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 111.961 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -46.35 -42.06 14.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.206 1.402 . . . . 0.0 113.178 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.32 -15.25 61.89 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.98 -18.11 17.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.02 1.328 . . . . 0.0 111.799 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.92 -37.46 22.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.501 1.52 . . . . 0.0 112.374 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.49 137.72 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.593 1.557 . . . . 0.0 110.744 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.59 159.56 31.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 112.923 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.85 -36.19 74.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.889 -1.132 . . . . 0.0 111.97 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -60.43 -25.53 66.04 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.732 1.613 . . . . 0.0 113.857 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -124.33 -2.41 8.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.591 1.556 . . . . 0.0 112.96 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -53.92 -46.72 98.45 Favored Pre-proline 0 N--CA 1.476 0.848 0 O-C-N 120.28 -1.513 . . . . 0.0 111.794 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -70.71 -16.42 33.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.226 1.951 . . . . 0.0 113.459 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.2 m -75.74 -33.84 60.28 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.047 -1.033 . . . . 0.0 111.136 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.51 82.0 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.406 -0.809 . . . . 0.0 111.569 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 t -59.1 -49.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.388 1.075 . . . . 0.0 109.031 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.8 19.1 0.32 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 126.321 1.915 . . . . 0.0 116.874 172.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.56 -63.14 1.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.404 1.881 . . . . 0.0 109.101 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.96 93.16 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.158 -0.964 . . . . 0.0 112.337 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -86.52 -28.82 23.14 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.708 -0.62 . . . . 0.0 112.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.05 -48.12 81.65 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.36 -1.462 . . . . 0.0 112.013 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD13 ' B' ' 128' ' ' LEU . 0.4 OUTLIER -74.1 -26.78 60.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.268 0.627 . . . . 0.0 111.302 -178.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.82 -26.44 68.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.617 1.167 . . . . 0.0 113.672 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.85 -1.22 43.56 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -171.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -125.61 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.757 1.623 . . . . 0.0 111.255 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -167.14 -46.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.363 2.265 . . . . 0.0 112.399 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -129.36 165.69 30.85 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 127.991 2.517 . . . . 0.0 109.938 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -85.74 15.73 2.14 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.231 1.954 . . . . 0.0 114.527 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -61.36 -33.44 73.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.376 1.07 . . . . 0.0 112.071 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.22 23.91 11.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.478 1.911 . . . . 0.0 113.575 174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 118.2 19.42 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.613 -1.305 . . . . 0.0 110.827 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 t -106.91 -11.31 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.218 1.007 . . . . 0.0 113.101 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.915 HD21 HG22 ' B' ' 120' ' ' THR . 1.8 tm? 64.91 113.24 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.946 2.498 . . . . 0.0 111.164 -168.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -95.1 64.05 2.72 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.337 5.2 p -70.45 -21.66 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 111.74 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' B' ' 92' ' ' ALA . 20.0 tm0? -54.11 -48.8 70.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.981 0.81 . . . . 0.0 110.991 168.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.98 -52.16 5.48 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.9 mt -56.83 -46.25 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.35 69.55 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.277 1.399 . . . . 0.0 112.781 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.3 m -78.24 -34.81 48.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.104 1.362 . . . . 0.0 112.098 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 62' ' ' ILE . 76.9 t -88.29 -19.9 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.713 1.605 . . . . 0.0 112.77 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.8 m -43.77 -61.07 2.14 Favored Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 126.235 1.814 . . . . 0.0 112.866 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.31 -0.19 6.19 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.329 2.686 . . . . 0.0 114.348 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.56 -64.23 1.18 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.885 1.274 . . . . 0.0 110.614 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.488 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -65.1 -31.65 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.068 -1.02 . . . . 0.0 113.216 177.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.35 -46.54 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.252 0.933 . . . . 0.0 110.713 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -73.82 -47.52 37.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.069 0.548 . . . . 0.0 111.329 172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.19 73.77 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.428 -0.795 . . . . 0.0 112.989 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.5 m -75.42 -16.62 60.33 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.979 -1.076 . . . . 0.0 113.315 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -30.22 47.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.716 1.598 . . . . 0.0 110.917 169.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -61.1 -36.41 79.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.774 0.83 . . . . 0.0 112.789 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -142.47 76.45 1.53 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -54.45 -37.16 64.86 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.965 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -86.72 -0.21 55.87 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.058 -168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.89 29.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.957 0.903 . . . . 0.0 112.492 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -85.64 53.67 2.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.16 1.384 . . . . 0.0 110.475 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -102.33 90.5 3.92 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -166.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -68.41 -22.49 64.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.111 -0.993 . . . . 0.0 109.327 162.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.26 -24.81 66.65 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.237 1.815 . . . . 0.0 112.802 168.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -63.4 -40.43 97.17 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 0.0 110.49 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.58 -50.77 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.852 1.261 . . . . 0.0 110.294 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -63.5 -42.0 98.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.196 0.598 . . . . 0.0 112.022 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.78 93.11 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.135 1.35 . . . . 0.0 112.76 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.55 -31.33 63.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.802 1.301 . . . . 0.0 113.481 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.404 ' CZ2' ' HE2' ' A' ' 86' ' ' LYS . 57.7 t-105 -62.12 -43.97 97.66 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 169.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.79 -41.45 97.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.455 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -25.25 66.94 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 mt -102.62 -45.66 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.01 1.324 . . . . 0.0 112.403 -174.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.404 ' HE2' ' CZ2' ' A' ' 82' ' ' TRP . 17.8 mmmt -93.09 -57.32 2.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.428 1.491 . . . . 0.0 111.199 -170.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -68.21 -26.53 65.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.254 1.422 . . . . 0.0 113.365 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.86 -20.22 65.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.964 1.305 . . . . 0.0 114.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.35 1.46 . . . . 0.0 112.773 179.43 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -149.98 127.02 11.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.085 0.954 . . . . 0.0 112.993 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 53' ' ' GLN . . . 52.68 20.66 1.61 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 118.867 2.914 . . . . 0.0 118.867 167.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -9.22 54.04 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -123.45 24.65 8.56 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.508 1.523 . . . . 0.0 114.457 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.01 -27.97 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 -8.89 58.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' ASP . . . . . . . . . . . . . 18.7 t70 62.75 -40.65 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.697 3.199 . . . . 0.0 117.019 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -93.12 -18.46 22.57 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.419 1.488 . . . . 0.0 113.754 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -80.83 162.07 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.021 1.329 . . . . 0.0 113.331 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt 39.1 54.39 4.96 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 129.282 3.033 . . . . 0.0 115.411 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.24 157.15 61.46 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.494 1.463 . . . . 0.0 111.747 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.13 -21.99 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.892 1.677 . . . . 0.0 114.649 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -81.37 -16.65 51.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 60.3 m -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.225 1.81 . . . . 0.0 113.492 170.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -54.69 148.72 12.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 123.039 1.399 . . . . 0.0 113.226 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 69.9 p -95.11 167.95 11.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.81 166.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.0 -26.05 66.61 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.53 -0.731 . . . . 0.0 112.266 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.94 -40.32 95.13 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.764 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.02 -31.34 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.396 -0.815 . . . . 0.0 112.152 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.43 ' CD1' ' CE1' ' B' ' 163' ' ' PHE . 53.1 t80 -70.2 -24.25 63.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.121 0.873 . . . . 0.0 112.322 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 68.5 mt -80.9 -16.98 52.12 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.135 -0.978 . . . . 0.0 113.318 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -33.06 53.54 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.839 0.855 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 5.5 p -76.24 141.27 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.932 1.693 . . . . 0.0 110.53 169.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.69 161.68 30.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.435 1.094 . . . . 0.0 113.471 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.71 -36.1 73.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.129 1.372 . . . . 0.0 112.083 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -64.48 -20.55 66.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.104 1.361 . . . . 0.0 113.835 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.3 -5.28 6.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.866 1.267 . . . . 0.0 113.397 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -57.7 -45.55 99.82 Favored Pre-proline 0 CA--C 1.547 0.851 0 O-C-N 120.184 -1.573 . . . . 0.0 112.162 169.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.45 -28.19 86.89 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.32 2.68 . . . . 0.0 113.414 170.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' THR . . . . . 0.915 HG22 HD21 ' A' ' 50' ' ' LEU . 29.4 m -76.87 -36.06 57.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.349 1.459 . . . . 0.0 111.45 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.67 91.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.669 1.188 . . . . 0.0 113.649 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 14.5 p -67.98 -35.75 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 119.78 1.173 . . . . 0.0 110.973 169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.37 -53.21 32.72 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.274 0.94 . . . . 0.0 112.195 168.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.97 -11.93 58.22 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 121.08 2.44 . . . . 0.0 114.513 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.35 -55.99 3.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.073 0.851 . . . . 0.0 109.841 166.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.14 -36.84 58.62 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.321 1.049 . . . . 0.0 113.455 -169.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.0 76.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.203 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.14 -36.87 22.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.747 1.219 . . . . 0.0 110.617 -178.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -54.41 -34.93 62.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.604 1.561 . . . . 0.0 113.688 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -93.53 -7.03 45.4 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.02 -133.4 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.394 1.477 . . . . 0.0 110.898 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -155.57 -58.45 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.599 2.36 . . . . 0.0 112.454 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -134.44 164.5 43.57 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 127.359 2.264 . . . . 0.0 109.831 -177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.01 36.81 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.711 2.274 . . . . 0.0 113.409 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.73 -28.86 50.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 111.947 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.22 0.7 11.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.341 1.456 . . . . 0.0 113.847 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.09 133.92 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.221 1.009 . . . . 0.0 113.295 -170.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.6 -12.66 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.93 1.292 . . . . 0.0 113.727 -174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 66.87 102.05 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.699 1.999 . . . . 0.0 107.747 -165.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -85.12 71.01 10.95 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.985 -1.072 . . . . 0.0 108.841 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . 0.323 1.6 p -66.27 -18.81 24.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 O-C-N 121.38 -0.825 . . . . 0.0 110.327 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -42.79 97.06 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.598 -1.314 . . . . 0.0 111.381 167.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.19 14.98 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.636 -0.665 . . . . 0.0 111.908 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.8 -44.34 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 121.383 -1.069 . . . . 0.0 112.55 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.97 66.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.667 1.576 . . . . 0.0 112.255 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' THR . . . . . . . . . . . . . 99.9 m -66.37 -46.24 77.35 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 111.853 169.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 t -84.34 -31.65 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.829 1.252 . . . . 0.0 112.845 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 15.6 m -40.05 -62.98 0.77 Allowed Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 126.937 2.095 . . . . 0.0 113.569 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.97 -22.66 73.93 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.245 1.963 . . . . 0.0 113.208 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -69.01 -59.46 3.02 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.162 0.985 . . . . 0.0 111.312 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.477 HD13 ' H ' ' B' ' 151' ' ' ILE . 0.1 OUTLIER -67.98 -24.5 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.401 -0.812 . . . . 0.0 112.688 175.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.0 -51.85 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.811 1.187 . . . . 0.0 110.69 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.88 -47.49 45.53 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.157 -0.339 . . . . 0.0 111.084 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.8 -28.87 69.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.755 -1.216 . . . . 0.0 113.257 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' CYS . . . . . . . . . . . . . 55.8 m -76.13 -12.4 60.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.56 -33.58 16.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.184 1.356 . . . . 0.0 111.005 167.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -60.35 -39.04 85.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.871 0.868 . . . . 0.0 112.167 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.73 59.85 1.49 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.105 0.962 . . . . 0.0 112.618 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -53.7 -36.34 62.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.931 1.692 . . . . 0.0 113.109 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -86.27 -6.08 59.04 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.15 164.02 26.05 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.084 0.954 . . . . 0.0 111.966 169.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.88 138.05 52.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.467 1.107 . . . . 0.0 111.152 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.43 ' CE1' ' CD1' ' B' ' 110' ' ' PHE . 16.5 t80 -64.15 -51.28 64.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.418 -0.801 . . . . 0.0 112.81 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -66.29 -30.82 71.32 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.616 1.098 . . . . 0.0 112.071 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.38 -39.57 94.88 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.808 -0.558 . . . . 0.0 111.813 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -70.41 -34.79 72.92 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.248 -0.907 . . . . 0.0 112.832 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.12 -49.0 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.163 0.892 . . . . 0.0 109.67 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.29 -42.68 99.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.531 0.732 . . . . 0.0 112.027 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.15 -44.89 97.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.513 1.054 . . . . 0.0 113.299 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -72.93 -35.4 67.02 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.052 -1.264 . . . . 0.0 112.618 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -60.06 -39.92 87.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.68 -1.262 . . . . 0.0 111.78 172.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.2 -46.57 88.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 111.874 173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -26.66 68.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 112.104 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 32.7 mt -79.29 -49.19 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.307 1.843 . . . . 0.0 112.087 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -103.21 -61.5 1.4 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.308 1.443 . . . . 0.0 113.254 -171.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.79 -25.94 68.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.995 1.718 . . . . 0.0 113.568 -171.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.26 -24.03 67.69 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.796 2.439 . . . . 0.0 114.423 178.448 . . . . . . . . 0 0 . 1 stop_ save_